,drug_id,drug_name,drug_group,target_id,target_name,target_symbol,target_organ
0,DB00001,Lepirudin,"['approved', 'withdrawn']",BE0000048,Prothrombin,F2,Humans
1,DB00002,Cetuximab,['approved'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
2,DB00002,Cetuximab,['approved'],BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
3,DB00002,Cetuximab,['approved'],BE0002094,Complement C1q subcomponent subunit A,C1QA,Humans
4,DB00002,Cetuximab,['approved'],BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
5,DB00002,Cetuximab,['approved'],BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
6,DB00002,Cetuximab,['approved'],BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
7,DB00002,Cetuximab,['approved'],BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
8,DB00002,Cetuximab,['approved'],BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
10,DB00004,Denileukin diftitox,"['approved', 'investigational']",BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
11,DB00004,Denileukin diftitox,"['approved', 'investigational']",BE0000651,Interleukin-2 receptor subunit beta,IL2RB,Humans
12,DB00004,Denileukin diftitox,"['approved', 'investigational']",BE0002102,Cytokine receptor common subunit gamma,IL2RG,Humans
13,DB00005,Etanercept,"['approved', 'investigational']",BE0000704,Tumor necrosis factor,TNF,Humans
14,DB00005,Etanercept,"['approved', 'investigational']",BE0001087,Lymphotoxin-alpha,LTA,Humans
15,DB00005,Etanercept,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
16,DB00005,Etanercept,"['approved', 'investigational']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
17,DB00005,Etanercept,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
18,DB00005,Etanercept,"['approved', 'investigational']",BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,Humans
19,DB00005,Etanercept,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
20,DB00005,Etanercept,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
21,DB00005,Etanercept,"['approved', 'investigational']",BE0009995,Complement component 1q (C1q),C1QA,Humans
22,DB00006,Bivalirudin,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
23,DB00007,Leuprolide,"['approved', 'investigational']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
24,DB00008,Peginterferon alfa-2a,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
25,DB00008,Peginterferon alfa-2a,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
26,DB00009,Alteplase,"['approved', 'investigational']",BE0000211,Plasminogen,PLG,Humans
27,DB00009,Alteplase,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
28,DB00009,Alteplase,"['approved', 'investigational']",BE0002092,Fibrinogen gamma chain,FGG,Humans
29,DB00009,Alteplase,"['approved', 'investigational']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
30,DB00010,Sermorelin,"['approved', 'withdrawn']",BE0000625,Growth hormone-releasing hormone receptor,GHRHR,Humans
31,DB00011,Interferon alfa-n1,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
32,DB00011,Interferon alfa-n1,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
33,DB00012,Darbepoetin alfa,"['approved', 'investigational']",BE0000654,Erythropoietin receptor,EPOR,Humans
34,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0000211,Plasminogen,PLG,Humans
35,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0000717,Urokinase plasminogen activator surface receptor,PLAUR,Humans
36,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
37,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0000969,Plasminogen activator inhibitor 2,SERPINB2,Humans
38,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0002112,Plasma serine protease inhibitor,SERPINA5,Humans
39,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0000942,Low-density lipoprotein receptor-related protein 2,LRP2,Humans
40,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0001656,Suppressor of tumorigenicity 14 protein,ST14,Humans
41,DB00013,Urokinase,"['approved', 'investigational', 'withdrawn']",BE0002113,Nidogen-1,NID1,Humans
42,DB00014,Goserelin,['approved'],BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
43,DB00014,Goserelin,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
44,DB00015,Reteplase,"['approved', 'investigational']",BE0000211,Plasminogen,PLG,Humans
45,DB00015,Reteplase,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
46,DB00015,Reteplase,"['approved', 'investigational']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
47,DB00016,Erythropoietin,['approved'],BE0000654,Erythropoietin receptor,EPOR,Humans
48,DB00017,Salmon calcitonin,"['approved', 'investigational']",BE0000431,Calcitonin receptor,CALCR,Humans
49,DB00018,Interferon alfa-n3,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
50,DB00018,Interferon alfa-n3,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
51,DB00019,Pegfilgrastim,['approved'],BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
52,DB00020,Sargramostim,"['approved', 'investigational']",BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
53,DB00020,Sargramostim,"['approved', 'investigational']",BE0001036,Interleukin-3 receptor subunit alpha,IL3RA,Humans
54,DB00020,Sargramostim,"['approved', 'investigational']",BE0002115,Cytokine receptor common subunit beta,CSF2RB,Humans
55,DB00020,Sargramostim,"['approved', 'investigational']",BE0002116,Syndecan-2,SDC2,Humans
56,DB00020,Sargramostim,"['approved', 'investigational']",BE0002114,Bone marrow proteoglycan,PRG2,Humans
57,DB00022,Peginterferon alfa-2b,['approved'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
58,DB00022,Peginterferon alfa-2b,['approved'],BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
60,DB00024,Thyrotropin alfa,"['approved', 'vet_approved']",BE0000490,Thyrotropin receptor,TSHR,Humans
61,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
62,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0000364,Coagulation factor IX,F9,Humans
63,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
64,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,Humans
65,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002118,Asialoglycoprotein receptor 2,ASGR2,Humans
66,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0001098,78 kDa glucose-regulated protein,HSPA5,Humans
67,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002109,Calreticulin,CALR,Humans
68,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0001011,Calnexin,CANX,Humans
69,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002119,Protein ERGIC-53,LMAN1,Humans
70,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
71,DB00025,"Antihemophilic factor, human recombinant","['approved', 'investigational']",BE0002120,Multiple coagulation factor deficiency protein 2,MCFD2,Humans
72,DB00026,Anakinra,"['approved', 'investigational']",BE0000565,Interleukin-1 receptor type 1,IL1R1,Humans
73,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
74,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0004684,High affinity immunoglobulin gamma Fc receptor IB,FCGR1B,Humans
75,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
76,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
77,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,Humans
78,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
79,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
80,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0003455,Complement C3,C3,Humans
81,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0004685,Complement C4-A,C4A,Humans
82,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0004686,Complement C4-B,C4B,Humans
83,DB00028,Human immunoglobulin G,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
84,DB00029,Anistreplase,['approved'],BE0000211,Plasminogen,PLG,Humans
85,DB00029,Anistreplase,['approved'],BE0000538,Fibrinogen alpha chain,FGA,Humans
86,DB00029,Anistreplase,['approved'],BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
87,DB00030,Insulin human,"['approved', 'investigational']",BE0000033,Insulin receptor,INSR,Humans
88,DB00030,Insulin human,"['approved', 'investigational']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
89,DB00030,Insulin human,"['approved', 'investigational']",BE0001123,Carboxypeptidase E,CPE,Humans
90,DB00030,Insulin human,"['approved', 'investigational']",BE0001147,Protein NOV homolog,NOV,Humans
91,DB00030,Insulin human,"['approved', 'investigational']",BE0000942,Low-density lipoprotein receptor-related protein 2,LRP2,Humans
92,DB00030,Insulin human,"['approved', 'investigational']",BE0002126,Insulin-like growth factor-binding protein 7,IGFBP7,Humans
93,DB00031,Tenecteplase,['approved'],BE0000211,Plasminogen,PLG,Humans
94,DB00031,Tenecteplase,['approved'],BE0000538,Fibrinogen alpha chain,FGA,Humans
95,DB00031,Tenecteplase,['approved'],BE0000717,Urokinase plasminogen activator surface receptor,PLAUR,Humans
96,DB00031,Tenecteplase,['approved'],BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
97,DB00031,Tenecteplase,['approved'],BE0000969,Plasminogen activator inhibitor 2,SERPINB2,Humans
98,DB00031,Tenecteplase,['approved'],BE0002104,Tetranectin,CLEC3B,Humans
99,DB00031,Tenecteplase,['approved'],BE0002105,"Keratin, type II cytoskeletal 8",KRT8,Humans
100,DB00031,Tenecteplase,['approved'],BE0001170,Annexin A2,ANXA2,Humans
101,DB00031,Tenecteplase,['approved'],BE0002109,Calreticulin,CALR,Humans
102,DB00031,Tenecteplase,['approved'],BE0001011,Calnexin,CANX,Humans
103,DB00031,Tenecteplase,['approved'],BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
104,DB00032,Menotropins,['approved'],BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
105,DB00032,Menotropins,['approved'],BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
106,DB00033,Interferon gamma-1b,"['approved', 'investigational']",BE0000711,Interferon gamma receptor 1,IFNGR1,Humans
107,DB00033,Interferon gamma-1b,"['approved', 'investigational']",BE0000467,Interferon gamma receptor 2,IFNGR2,Humans
108,DB00034,Interferon alfa-2a,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
109,DB00034,Interferon alfa-2a,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
110,DB00035,Desmopressin,['approved'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
111,DB00035,Desmopressin,['approved'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
112,DB00035,Desmopressin,['approved'],BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
113,DB00036,Coagulation factor VIIa Recombinant Human,['approved'],BE0000216,Coagulation factor X,F10,Humans
114,DB00036,Coagulation factor VIIa Recombinant Human,['approved'],BE0001178,Tissue factor,F3,Humans
115,DB00036,Coagulation factor VIIa Recombinant Human,['approved'],BE0000967,Tissue factor pathway inhibitor,TFPI,Humans
116,DB00036,Coagulation factor VIIa Recombinant Human,['approved'],BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
117,DB00036,Coagulation factor VIIa Recombinant Human,['approved'],BE0000333,Coagulation factor VII,F7,Humans
118,DB00038,Oprelvekin,"['approved', 'investigational']",BE0000416,Interleukin-11 receptor subunit alpha,IL11RA,Humans
119,DB00039,Palifermin,['approved'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
120,DB00039,Palifermin,['approved'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
121,DB00039,Palifermin,['approved'],BE0001031,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,Humans
122,DB00040,Glucagon,['approved'],BE0000527,Glucagon receptor,GCGR,Humans
123,DB00040,Glucagon,['approved'],BE0002134,Glucagon-like peptide 2 receptor,GLP2R,Humans
124,DB00040,Glucagon,['approved'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
125,DB00041,Aldesleukin,['approved'],BE0000651,Interleukin-2 receptor subunit beta,IL2RB,Humans
126,DB00041,Aldesleukin,['approved'],BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
127,DB00041,Aldesleukin,['approved'],BE0002102,Cytokine receptor common subunit gamma,IL2RG,Humans
128,DB00042,Botulinum toxin type B,"['approved', 'investigational']",BE0002137,Vesicle-associated membrane protein 2,VAMP2,Humans
129,DB00042,Botulinum toxin type B,"['approved', 'investigational']",BE0002136,Vesicle-associated membrane protein 1,VAMP1,Humans
130,DB00042,Botulinum toxin type B,"['approved', 'investigational']",BE0002138,Synaptotagmin-2,SYT2,Humans
131,DB00043,Omalizumab,"['approved', 'investigational']",BE0000015,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,Humans
132,DB00043,Omalizumab,"['approved', 'investigational']",BE0002139,High affinity immunoglobulin epsilon receptor subunit beta,MS4A2,Humans
133,DB00044,Lutropin alfa,['approved'],BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
134,DB00045,Lyme disease vaccine (recombinant OspA),"['approved', 'withdrawn']",BE0001164,Toll-like receptor 2,TLR2,Humans
135,DB00046,Insulin lispro,['approved'],BE0000033,Insulin receptor,INSR,Humans
136,DB00046,Insulin lispro,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
137,DB00047,Insulin glargine,['approved'],BE0000033,Insulin receptor,INSR,Humans
138,DB00047,Insulin glargine,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
139,DB00048,Collagenase clostridium histolyticum,"['approved', 'investigational']",BE0000025,Collagen alpha-1(I) chain,COL1A1,Humans
140,DB00048,Collagenase clostridium histolyticum,"['approved', 'investigational']",BE0002140,Collagen alpha-1(II) chain,COL2A1,Humans
141,DB00048,Collagenase clostridium histolyticum,"['approved', 'investigational']",BE0002130,Collagen alpha-1(III) chain,COL3A1,Humans
143,DB00050,Cetrorelix,"['approved', 'investigational']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
144,DB00050,Cetrorelix,"['approved', 'investigational']",BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
145,DB00051,Adalimumab,"['approved', 'experimental']",BE0000704,Tumor necrosis factor,TNF,Humans
146,DB00052,Somatotropin,"['approved', 'investigational']",BE0000075,Growth hormone receptor,GHR,Humans
147,DB00052,Somatotropin,"['approved', 'investigational']",BE0000345,Prolactin receptor,PRLR,Humans
149,DB00054,Abciximab,['approved'],BE0001155,Integrin beta-3,ITGB3,Humans
150,DB00054,Abciximab,['approved'],BE0000439,Integrin alpha-IIb,ITGA2B,Humans
151,DB00054,Abciximab,['approved'],BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
152,DB00054,Abciximab,['approved'],BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
153,DB00054,Abciximab,['approved'],BE0001068,Vitronectin,VTN,Humans
154,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0000016,Coagulation factor VIII,F8,Humans
155,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0000041,Coagulation factor V,F5,Humans
156,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
157,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0001151,Thrombomodulin,THBD,Humans
158,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0000943,Vitamin K-dependent protein S,PROS1,Humans
159,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0000048,Prothrombin,F2,Humans
160,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0001129,Platelet factor 4,PF4,Humans
161,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0002112,Plasma serine protease inhibitor,SERPINA5,Humans
162,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0002142,Serpin B6,SERPINB6,Humans
163,DB00055,Drotrecogin alfa,"['approved', 'investigational', 'withdrawn']",BE0001161,Endothelial protein C receptor,PROCR,Humans
164,DB00056,Gemtuzumab ozogamicin,"['approved', 'investigational']",BE0000674,Myeloid cell surface antigen CD33,CD33,Humans
165,DB00056,Gemtuzumab ozogamicin,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
166,DB00056,Gemtuzumab ozogamicin,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
167,DB00056,Gemtuzumab ozogamicin,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
169,DB00058,Alpha-1-proteinase inhibitor,['approved'],BE0000394,Neutrophil elastase,ELANE,Humans
171,DB00060,Interferon beta-1a,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
172,DB00060,Interferon beta-1a,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
174,DB00061,Pegademase,['approved'],BE0000917,Growth factor receptor-bound protein 2,GRB2,Humans
176,DB00063,Eptifibatide,"['approved', 'investigational']",BE0001155,Integrin beta-3,ITGB3,Humans
177,DB00063,Eptifibatide,"['approved', 'investigational']",BE0009351,Voltage-dependent N-type calcium channel,CACNA1B,Humans
178,DB00065,Infliximab,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
179,DB00066,Follitropin,['approved'],BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
180,DB00067,Vasopressin,['approved'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
181,DB00067,Vasopressin,['approved'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
182,DB00067,Vasopressin,['approved'],BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
183,DB00067,Vasopressin,['approved'],BE0000844,Oxytocin receptor,OXTR,Humans
184,DB00068,Interferon beta-1b,['approved'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
185,DB00068,Interferon beta-1b,['approved'],BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
186,DB00069,Interferon alfacon-1,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
187,DB00069,Interferon alfacon-1,"['approved', 'investigational']",BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
189,DB00070,Hyaluronidase (ovine),"['approved', 'investigational']",BE0000984,Transforming growth factor beta-1,TGFB1,Humans
190,DB00071,Insulin pork,['approved'],BE0000033,Insulin receptor,INSR,Humans
191,DB00071,Insulin pork,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
192,DB00072,Trastuzumab,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
193,DB00073,Rituximab,['approved'],BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
194,DB00074,Basiliximab,"['approved', 'investigational']",BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
195,DB00074,Basiliximab,"['approved', 'investigational']",BE0000651,Interleukin-2 receptor subunit beta,IL2RB,Humans
196,DB00075,Muromonab,"['approved', 'investigational']",BE0003456,T-cell surface glycoprotein CD3 delta chain,CD3D,Humans
197,DB00075,Muromonab,"['approved', 'investigational']",BE0000274,T-cell surface glycoprotein CD3 epsilon chain,CD3E,Humans
198,DB00075,Muromonab,"['approved', 'investigational']",BE0003457,T-cell surface glycoprotein CD3 gamma chain,CD3G,Humans
199,DB00075,Muromonab,"['approved', 'investigational']",BE0003458,T-cell surface glycoprotein CD3 zeta chain,CD247,Humans
200,DB00075,Muromonab,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
202,DB00078,Ibritumomab tiuxetan,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
204,DB00081,Tositumomab,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
205,DB00081,Tositumomab,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
206,DB00082,Pegvisomant,['approved'],BE0000075,Growth hormone receptor,GHR,Humans
207,DB00083,Botulinum toxin type A,"['approved', 'investigational']",BE0000390,Synaptosomal-associated protein 25,SNAP25,Humans
208,DB00083,Botulinum toxin type A,"['approved', 'investigational']",BE0003572,Rho-related GTP-binding protein RhoB,RHOB,Humans
212,DB00086,Streptokinase,"['approved', 'investigational']",BE0000211,Plasminogen,PLG,Humans
213,DB00086,Streptokinase,"['approved', 'investigational']",BE0000928,Proteinase-activated receptor 1,F2R,Humans
214,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0000083,CAMPATH-1 antigen,CD52,Humans
215,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
216,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
217,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
218,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
219,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
220,DB00087,Alemtuzumab,"['approved', 'investigational']",BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,Humans
222,DB00089,Capromab pendetide,['approved'],BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
224,DB00091,Cyclosporine,"['approved', 'investigational', 'vet_approved']",BE0000379,Calcium signal-modulating cyclophilin ligand,CAMLG,Humans
225,DB00091,Cyclosporine,"['approved', 'investigational', 'vet_approved']",BE0002143,Calcineurin subunit B type 2,PPP3R2,Humans
226,DB00091,Cyclosporine,"['approved', 'investigational', 'vet_approved']",BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
227,DB00091,Cyclosporine,"['approved', 'investigational', 'vet_approved']",BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,Humans
228,DB00092,Alefacept,"['approved', 'investigational', 'withdrawn']",BE0000719,T-cell surface antigen CD2,CD2,Humans
229,DB00092,Alefacept,"['approved', 'investigational', 'withdrawn']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
230,DB00092,Alefacept,"['approved', 'investigational', 'withdrawn']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
231,DB00093,Felypressin,['experimental'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
232,DB00094,Urofollitropin,"['approved', 'vet_approved']",BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
233,DB00095,Efalizumab,"['approved', 'investigational', 'withdrawn']",BE0009967,Integrin alpha-X,ITGAX,Humans
234,DB00095,Efalizumab,"['approved', 'investigational', 'withdrawn']",BE0000516,Integrin alpha-L,ITGAL,Humans
235,DB00097,Choriogonadotropin alfa,['approved'],BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
236,DB00097,Choriogonadotropin alfa,['approved'],BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
237,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0003573,Major histocompatibility complex class I-related gene protein,MR1,Humans
238,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0000516,Integrin alpha-L,ITGAL,Humans
239,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0000846,T-lymphocyte activation antigen CD86,CD86,Humans
240,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
241,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0003488,T-cell surface glycoprotein CD4,CD4,Humans
242,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0003575,Integrin beta-1,ITGB1,Humans
243,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0003576,Integrin alpha-V,ITGAV,Humans
244,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0001155,Integrin beta-3,ITGB3,Humans
245,DB00098,Antithymocyte immunoglobulin (rabbit),['approved'],BE0000598,T-cell surface glycoprotein CD1a,CD1A,Humans
246,DB00099,Filgrastim,['approved'],BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
247,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
248,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0001021,Coagulation factor XI,F11,Humans
249,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0000333,Coagulation factor VII,F7,Humans
250,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
251,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
252,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
253,DB00100,Coagulation Factor IX (Recombinant),"['approved', 'investigational']",BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
254,DB00102,Becaplermin,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
255,DB00102,Becaplermin,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
256,DB00102,Becaplermin,"['approved', 'investigational']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
259,DB00105,Interferon alfa-2b,['approved'],BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
260,DB00105,Interferon alfa-2b,['approved'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
261,DB00106,Abarelix,"['approved', 'investigational', 'withdrawn']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
262,DB00107,Oxytocin,"['approved', 'vet_approved']",BE0000844,Oxytocin receptor,OXTR,Humans
263,DB00108,Natalizumab,"['approved', 'investigational']",BE0000590,Integrin alpha-4,ITGA4,Humans
264,DB00108,Natalizumab,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
265,DB00108,Natalizumab,"['approved', 'investigational']",BE0001085,Intercellular adhesion molecule 1,ICAM1,Humans
266,DB00108,Natalizumab,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
269,DB00110,Palivizumab,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
270,DB00110,Palivizumab,"['approved', 'investigational']",BE0002093,Complement C1r subcomponent,C1R,Humans
271,DB00110,Palivizumab,"['approved', 'investigational']",BE0002094,Complement C1q subcomponent subunit A,C1QA,Humans
272,DB00110,Palivizumab,"['approved', 'investigational']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
273,DB00110,Palivizumab,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
274,DB00110,Palivizumab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
275,DB00110,Palivizumab,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
276,DB00110,Palivizumab,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
277,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
278,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0000651,Interleukin-2 receptor subunit beta,IL2RB,Humans
279,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
280,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002093,Complement C1r subcomponent,C1R,Humans
281,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002094,Complement C1q subcomponent subunit A,C1QA,Humans
282,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
283,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
284,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
285,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
286,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
287,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
288,DB00111,Daclizumab,"['investigational', 'withdrawn']",BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,Humans
289,DB00112,Bevacizumab,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
290,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002094,Complement C1q subcomponent subunit A,C1QA,Humans
291,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
292,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
293,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
294,DB00112,Bevacizumab,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
295,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
296,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
297,DB00112,Bevacizumab,"['approved', 'investigational']",BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,Humans
298,DB00113,Technetium Tc-99m arcitumomab,['experimental'],BE0000107,Carcinoembryonic antigen-related cell adhesion molecule 1,CEACAM1,Humans
299,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000102,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,Humans
300,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000378,Glutamate decarboxylase 1,GAD1,Humans
301,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000323,Cystathionine beta-synthase,CBS,Humans
302,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000392,Kynureninase,KYNU,Humans
303,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
304,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000151,"Cysteine desulfurase, mitochondrial",NFS1,Humans
305,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
306,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000424,"Ornithine aminotransferase, mitochondrial",OAT,Humans
307,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000404,Ornithine decarboxylase,ODC1,Humans
308,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000727,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,Humans
309,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
310,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000181,Pyridoxine-5'-phosphate oxidase,PNPO,Humans
311,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000778,Sphingosine-1-phosphate lyase 1,SGPL1,Humans
312,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000692,Tyrosine aminotransferase,TAT,Humans
313,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000273,Kynurenine--oxoglutarate transaminase 1,CCBL1,Humans
315,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000660,Serine palmitoyltransferase 2,SPTLC2,Humans
316,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000079,Cysteine sulfinic acid decarboxylase,CSAD,Humans
317,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000002,Histidine decarboxylase,HDC,Humans
318,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000448,Arginine decarboxylase,AZIN2,Humans
319,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000164,L-serine dehydratase/L-threonine deaminase,SDS,Humans
320,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000518,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,Humans
321,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000618,"Glycine dehydrogenase [decarboxylating], mitochondrial",GLDC,Humans
322,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000667,Alanine aminotransferase 1,GPT,Humans
323,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000603,Phosphoserine aminotransferase,PSAT1,Humans
324,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000409,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,Humans
325,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
326,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000278,Pyridoxal phosphate phosphatase,PDXP,Humans
327,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000441,Serine palmitoyltransferase 1,SPTLC1,Humans
328,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000791,Cystathionine gamma-lyase,CTH,Humans
329,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
330,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
331,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002149,Proline synthase co-transcribed bacterial homolog protein,PROSC,Humans
332,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000383,"Aspartate aminotransferase, mitochondrial",GOT2,Humans
333,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002150,"Glycogen phosphorylase, brain form",PYGB,Humans
334,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
335,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002151,Aromatic-L-amino-acid decarboxylase,DDC,Humans
340,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002158,5-aminolevulinate synthase,ALAS1,Humans
341,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002159,"Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)",GAD2,Humans
342,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002160,DDC protein,DDC,Humans
343,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002162,Kynurenine--oxoglutarate transaminase 3,CCBL2,Humans
344,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002163,Glutamate decarboxylase-like protein 1,GADL1,Humans
345,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0004605,Selenocysteine lyase,SCLY,Humans
346,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0004612,Immunoglobulin superfamily member 10,IGSF10,Humans
347,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002164,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,Humans
348,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002165,"Glutamate decarboxylase 1 (Brain, 67kDa)",GAD1,Humans
349,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000292,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,Humans
350,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000898,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,Humans
351,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002166,Alanine aminotransferase 2,GPT2,Humans
352,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002167,Molybdenum cofactor sulfurase,MOCOS,Humans
353,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002168,Serine dehydratase-like,SDSL,Humans
355,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0000388,Serine racemase,SRR,Humans
356,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002171,O-phosphoseryl-tRNA(Sec) selenium transferase,SEPSECS,Humans
357,DB00114,Pyridoxal phosphate,"['approved', 'investigational', 'nutraceutical']",BE0002172,Serine palmitoyltransferase 3,SPTLC3,Humans
360,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0000734,Methionine synthase,MTR,Humans
361,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0000777,"Methylmalonyl-CoA mutase, mitochondrial",MUT,Humans
362,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0000763,Methionine synthase reductase,MTRR,Humans
363,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0000320,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,Humans
364,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0002175,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,Humans
365,DB00115,Cyanocobalamin,"['approved', 'nutraceutical']",BE0002176,Methylenetetrahydrofolate reductase,MTHFR,Humans
366,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,Humans
367,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000268,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,Humans
368,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000010,"Aminomethyltransferase, mitochondrial",AMT,Humans
369,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000933,Cytosolic 10-formyltetrahydrofolate dehydrogenase,ALDH1L1,Humans
370,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000734,Methionine synthase,MTR,Humans
371,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000822,Formimidoyltransferase-cyclodeaminase,FTCD,Humans
372,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
373,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
374,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0000292,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,Humans
375,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0002176,Methylenetetrahydrofolate reductase,MTHFR,Humans
377,DB00116,Tetrahydrofolic acid,['nutraceutical'],BE0002177,"Methionyl-tRNA formyltransferase, mitochondrial",MTFMT,Humans
378,DB00117,Histidine,"['investigational', 'nutraceutical']",BE0000002,Histidine decarboxylase,HDC,Humans
379,DB00117,Histidine,"['investigational', 'nutraceutical']",BE0000740,"Histidine--tRNA ligase, cytoplasmic",HARS,Humans
380,DB00117,Histidine,"['investigational', 'nutraceutical']",BE0000285,Sodium-coupled neutral amino acid transporter 3,SLC38A3,Humans
381,DB00117,Histidine,"['investigational', 'nutraceutical']",BE0000086,Histidine ammonia-lyase,HAL,Humans
382,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0002089,Catechol O-methyltransferase,COMT,Humans
383,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0008997,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,CMTR1,Humans
384,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0005015,Arsenite methyltransferase,AS3MT,Humans
385,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0000372,Glycine N-methyltransferase,GNMT,Humans
386,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0000101,S-adenosylmethionine decarboxylase proenzyme,AMD1,Humans
387,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0000304,S-adenosylmethionine synthase isoform type-2,MAT2A,Humans
388,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0000323,Cystathionine beta-synthase,CBS,Humans
389,DB00118,Ademetionine,"['approved', 'investigational', 'nutraceutical']",BE0000407,S-adenosylmethionine synthase isoform type-1,MAT1A,Humans
390,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000449,Monocarboxylate transporter 4,SLC16A3,Humans
391,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000178,Monocarboxylate transporter 8,SLC16A2,Humans
392,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000102,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,Humans
393,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000386,Monocarboxylate transporter 6,SLC16A5,Humans
394,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000046,Pyruvate kinase PKLR,PKLR,Humans
395,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000174,Monocarboxylate transporter 7,SLC16A6,Humans
396,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000440,Monocarboxylate transporter 2,SLC16A7,Humans
397,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000098,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,Humans
398,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000088,Pyruvate kinase PKM,PKM,Humans
399,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
400,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000195,Monocarboxylate transporter 5,SLC16A4,Humans
401,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000361,Monocarboxylate transporter 3,SLC16A8,Humans
402,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000669,Monocarboxylate transporter 1,SLC16A1,Humans
403,DB00119,Pyruvic acid,"['approved', 'investigational', 'nutraceutical']",BE0000698,"Pyruvate carboxylase, mitochondrial",PC,Humans
404,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000692,Tyrosine aminotransferase,TAT,Humans
405,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000789,Large neutral amino acids transporter small subunit 2,SLC7A8,Humans
406,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000038,Phenylalanine--tRNA ligase alpha subunit,FARSA,Humans
407,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
408,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000028,"Phenylalanine--tRNA ligase, mitochondrial",FARS2,Humans
409,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000561,Phenylalanine--tRNA ligase beta subunit,FARSB,Humans
410,DB00120,Phenylalanine,"['approved', 'investigational', 'nutraceutical']",BE0000614,Tyrosine 3-monooxygenase,TH,Humans
411,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000544,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,Humans
412,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000159,Biotin--protein ligase,HLCS,Humans
413,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000072,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",MCCC2,Humans
414,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000702,Acetyl-CoA carboxylase 2,ACACB,Humans
415,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000445,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",MCCC1,Humans
416,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000698,"Pyruvate carboxylase, mitochondrial",PC,Humans
417,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000492,"Propionyl-CoA carboxylase alpha chain, mitochondrial",PCCA,Humans
418,DB00121,Biotin,"['approved', 'investigational', 'nutraceutical']",BE0000626,Acetyl-CoA carboxylase 1,ACACA,Humans
419,DB00122,Choline,"['approved', 'nutraceutical']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
420,DB00122,Choline,"['approved', 'nutraceutical']",BE0000494,Choline-phosphate cytidylyltransferase B,PCYT1B,Humans
421,DB00122,Choline,"['approved', 'nutraceutical']",BE0000426,Acetylcholinesterase,ACHE,Humans
422,DB00122,Choline,"['approved', 'nutraceutical']",BE0000615,Choline-phosphate cytidylyltransferase A,PCYT1A,Humans
423,DB00122,Choline,"['approved', 'nutraceutical']",BE0002179,Phospholipase D2,PLD2,Humans
424,DB00122,Choline,"['approved', 'nutraceutical']",BE0002180,Cholinesterase,BCHE,Humans
425,DB00122,Choline,"['approved', 'nutraceutical']",BE0002181,Phospholipase D1,PLD1,Humans
426,DB00122,Choline,"['approved', 'nutraceutical']",BE0002186,Phosphoethanolamine/phosphocholine phosphatase,PHOSPHO1,Humans
427,DB00123,Lysine,"['approved', 'nutraceutical']",BE0000212,High affinity cationic amino acid transporter 1,SLC7A1,Humans
428,DB00123,Lysine,"['approved', 'nutraceutical']",BE0000052,Cationic amino acid transporter 4,SLC7A4,Humans
429,DB00123,Lysine,"['approved', 'nutraceutical']",BE0000136,Cationic amino acid transporter 3,SLC7A3,Humans
430,DB00123,Lysine,"['approved', 'nutraceutical']",BE0000562,Low affinity cationic amino acid transporter 2,SLC7A2,Humans
431,DB00123,Lysine,"['approved', 'nutraceutical']",BE0000198,Lysine--tRNA ligase,KARS,Humans
432,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000136,Cationic amino acid transporter 3,SLC7A3,Humans
433,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000448,Arginine decarboxylase,AZIN2,Humans
434,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000520,Argininosuccinate lyase,ASL,Humans
435,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
436,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000212,High affinity cationic amino acid transporter 1,SLC7A1,Humans
437,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000758,"Arginase-2, mitochondrial",ARG2,Humans
438,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000052,Cationic amino acid transporter 4,SLC7A4,Humans
439,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000671,Argininosuccinate synthase,ASS1,Humans
440,DB00125,Arginine,"['investigational', 'nutraceutical']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
444,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002192,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,Humans
445,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,Humans
446,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002195,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,Humans
447,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002197,Gamma-butyrobetaine dioxygenase,BBOX1,Humans
448,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0000138,Dopamine beta-hydroxylase,DBH,Humans
449,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,PAM,Humans
450,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002202,Prolyl 3-hydroxylase 1,P3H1,Humans
451,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002206,Prolyl 3-hydroxylase 2,P3H2,Humans
453,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0000060,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,Humans
454,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002210,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1,OGFOD1,Humans
455,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002203,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,OGFOD2,Humans
456,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002205,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2,ALKBH2,Humans
457,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002213,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,ALKBH3,Humans
458,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002215,Lysine-specific demethylase 5D,KDM5D,Humans
459,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0000087,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,Humans
460,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002221,"Trimethyllysine dioxygenase, mitochondrial",TMLHE,Humans
461,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002223,Transmembrane prolyl 4-hydroxylase,P4HTM,Humans
462,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002217,Egl nine homolog 1,EGLN1,Humans
463,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002211,Egl nine homolog 2,EGLN2,Humans
464,DB00126,Ascorbic acid,"['approved', 'nutraceutical']",BE0002219,Egl nine homolog 3,EGLN3,Humans
465,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000964,Spermine synthase,SMS,Humans
466,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000566,Spermine oxidase,SMOX,Humans
468,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000404,Ornithine decarboxylase,ODC1,Humans
469,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
470,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
471,DB00127,Spermine,"['experimental', 'nutraceutical']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
472,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0009692,Adenylosuccinate Synthetases,ADSSL1,Humans
473,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000277,Calcium-binding mitochondrial carrier protein Aralar2,SLC25A13,Humans
474,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
475,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000187,Aspartoacylase,ASPA,Humans
476,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000219,Asparagine synthetase [glutamine-hydrolyzing],ASNS,Humans
477,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000671,Argininosuccinate synthase,ASS1,Humans
478,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000481,Aminoacylase-1,ACY1,Humans
479,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000383,"Aspartate aminotransferase, mitochondrial",GOT2,Humans
480,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000725,"Aspartate--tRNA ligase, cytoplasmic",DARS,Humans
481,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000235,Calcium-binding mitochondrial carrier protein Aralar1,SLC25A12,Humans
482,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0000528,Aspartyl/asparaginyl beta-hydroxylase,ASPH,Humans
483,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0002225,Multifunctional protein ADE2,PAICS,Humans
484,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0002228,Adenylosuccinate synthetase isozyme 2,ADSS,Humans
485,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0001054,Excitatory amino acid transporter 3,SLC1A1,Humans
487,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0002229,"Aspartate--tRNA ligase, mitochondrial",DARS2,Humans
488,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0002230,Isoaspartyl peptidase/L-asparaginase,ASRGL1,Humans
489,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0003317,Ribonuclease pancreatic,RNASE1,Humans
490,DB00128,Aspartic acid,"['approved', 'nutraceutical']",BE0003751,Lysozyme C,LYZ,Humans
491,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000424,"Ornithine aminotransferase, mitochondrial",OAT,Humans
492,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000306,"Ornithine carbamoyltransferase, mitochondrial",OTC,Humans
493,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000286,Arginase-1,ARG1,Humans
494,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000371,Ornithine decarboxylase antizyme 1,OAZ1,Humans
495,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000212,High affinity cationic amino acid transporter 1,SLC7A1,Humans
496,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000562,Low affinity cationic amino acid transporter 2,SLC7A2,Humans
497,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000258,Mitochondrial ornithine transporter 2,SLC25A2,Humans
498,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000758,"Arginase-2, mitochondrial",ARG2,Humans
499,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000201,Mitochondrial ornithine transporter 1,SLC25A15,Humans
500,DB00129,Ornithine,"['approved', 'nutraceutical']",BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
501,DB00130,L-Glutamine,"['approved', 'investigational', 'nutraceutical']",BE0000874,CTP synthase 1,CTPS1,Humans
502,DB00130,L-Glutamine,"['approved', 'investigational', 'nutraceutical']",BE0000374,Amidophosphoribosyltransferase,PPAT,Humans
503,DB00130,L-Glutamine,"['approved', 'investigational', 'nutraceutical']",BE0002240,Glutamine synthetase,GLUL,Humans
504,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0004907,5'-AMP-activated protein kinase,PRKAA1,Humans
505,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0003540,Adenosine kinase,ADK,Humans
506,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000254,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,Humans
507,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000350,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,Humans
508,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,Humans
509,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000269,Adenylate cyclase type 1,ADCY1,Humans
510,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000639,Long-chain-fatty-acid--CoA ligase 1,ACSL1,Humans
511,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000958,Cyclic AMP-responsive element-binding protein 1,CREB1,Humans
513,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
515,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0001473,Histidine triad nucleotide-binding protein 1,HINT1,Humans
516,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
517,DB00131,Adenosine phosphate,"['approved', 'investigational', 'nutraceutical', 'withdrawn']",BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
518,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0000888,Fatty acid desaturase 1,FADS1,Humans
519,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0002246,Fatty acid desaturase 2,FADS2,Humans
520,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
521,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
522,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0001777,Bile acid receptor,NR1H4,Humans
523,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
524,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
525,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
526,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0009936,Elongation of very long chain fatty acids protein 2,ELOVL2,Humans
527,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0009375,Elongation of very long chain fatty acids protein 5,ELOVL5,Humans
528,DB00132,alpha-Linolenic acid,"['approved', 'investigational', 'nutraceutical']",BE0000986,Sodium/calcium exchanger 1,SLC8A1,Humans
529,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000323,Cystathionine beta-synthase,CBS,Humans
530,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000164,L-serine dehydratase/L-threonine deaminase,SDS,Humans
531,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000388,Serine racemase,SRR,Humans
532,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000660,Serine palmitoyltransferase 2,SPTLC2,Humans
533,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000441,Serine palmitoyltransferase 1,SPTLC1,Humans
534,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000063,"Serine--tRNA ligase, cytoplasmic",SARS,Humans
535,DB00133,Serine,"['investigational', 'nutraceutical']",BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
536,DB00134,Methionine,"['approved', 'nutraceutical']",BE0000763,Methionine synthase reductase,MTRR,Humans
537,DB00134,Methionine,"['approved', 'nutraceutical']",BE0000734,Methionine synthase,MTR,Humans
538,DB00134,Methionine,"['approved', 'nutraceutical']",BE0001534,Methionine aminopeptidase 2,METAP2,Humans
539,DB00134,Methionine,"['approved', 'nutraceutical']",BE0000845,Betaine--homocysteine S-methyltransferase 1,BHMT,Humans
540,DB00134,Methionine,"['approved', 'nutraceutical']",BE0002249,S-methylmethionine--homocysteine S-methyltransferase BHMT2,BHMT2,Humans
541,DB00135,Tyrosine,"['approved', 'investigational', 'nutraceutical']",BE0000614,Tyrosine 3-monooxygenase,TH,Humans
542,DB00135,Tyrosine,"['approved', 'investigational', 'nutraceutical']",BE0000363,"Tyrosine--tRNA ligase, mitochondrial",YARS2,Humans
543,DB00135,Tyrosine,"['approved', 'investigational', 'nutraceutical']",BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
544,DB00135,Tyrosine,"['approved', 'investigational', 'nutraceutical']",BE0000692,Tyrosine aminotransferase,TAT,Humans
545,DB00136,Calcitriol,"['approved', 'nutraceutical']",BE0000779,Vitamin D3 receptor,VDR,Humans
546,DB00136,Calcitriol,"['approved', 'nutraceutical']",BE0008987,Homeobox protein Hox-A10,HOXA10,Humans
547,DB00138,Cystine,"['approved', 'nutraceutical']",BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
548,DB00138,Cystine,"['approved', 'nutraceutical']",BE0000035,Cystinosin,CTNS,Humans
549,DB00139,Succinic acid,"['approved', 'nutraceutical']",BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,Humans
550,DB00139,Succinic acid,"['approved', 'nutraceutical']",BE0002258,Succinate receptor 1,SUCNR1,Humans
551,DB00140,Riboflavin,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0000370,Riboflavin kinase,RFK,Humans
553,DB00140,Riboflavin,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0000595,Flavin reductase (NADPH),BLVRB,Humans
554,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
555,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0002263,"Beta-1,4-galactosyltransferase 4",B4GALT4,Humans
556,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0002265,N-acetyl-D-glucosamine kinase,NAGK,Humans
557,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0002266,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,NAGPA,Humans
558,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0000391,Alpha-N-acetylglucosaminidase,NAGLU,Humans
559,DB00141,N-Acetylglucosamine,"['approved', 'investigational', 'nutraceutical']",BE0000109,N-acylglucosamine 2-epimerase,RENBP,Humans
560,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000824,Metabotropic glutamate receptor 1,GRM1,Humans
561,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000833,Metabotropic glutamate receptor 4,GRM4,Humans
562,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000827,"Glutamate receptor ionotropic, kainate 4",GRIK4,Humans
563,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000828,"Glutamate receptor ionotropic, kainate 5",GRIK5,Humans
564,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000834,Metabotropic glutamate receptor 7,GRM7,Humans
565,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000835,Metabotropic glutamate receptor 8,GRM8,Humans
566,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002267,Excitatory amino acid transporter 5,SLC1A7,Humans
567,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002268,5-oxoprolinase,OPLAH,Humans
568,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002235,Phosphoribosylformylglycinamidine synthase,PFAS,Humans
569,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
570,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000396,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,Humans
571,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000825,"Glutaminase kidney isoform, mitochondrial",GLS,Humans
572,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000383,"Aspartate aminotransferase, mitochondrial",GOT2,Humans
573,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000188,Bifunctional glutamate/proline--tRNA ligase,EPRS,Humans
574,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000219,Asparagine synthetase [glutamine-hydrolyzing],ASNS,Humans
575,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002240,Glutamine synthetase,GLUL,Humans
576,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
577,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000692,Tyrosine aminotransferase,TAT,Humans
578,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000667,Alanine aminotransferase 1,GPT,Humans
579,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
580,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0001115,Excitatory amino acid transporter 1,SLC1A3,Humans
581,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000884,Excitatory amino acid transporter 2,SLC1A2,Humans
582,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0001054,Excitatory amino acid transporter 3,SLC1A1,Humans
583,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000166,Glutamate--cysteine ligase catalytic subunit,GCLC,Humans
584,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002270,Excitatory amino acid transporter 4,SLC1A6,Humans
585,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000755,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,Humans
586,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000321,GMP synthase [glutamine-hydrolyzing],GMPS,Humans
587,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
588,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
589,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
590,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000700,"Folylpolyglutamate synthase, mitochondrial",FPGS,Humans
591,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002271,Glutamyl aminopeptidase,ENPEP,Humans
592,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
593,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
594,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000454,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,Humans
596,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002272,"Probable glutamate--tRNA ligase, mitochondrial",EARS2,Humans
597,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002244,Glutamine-dependent NAD(+) synthetase,NADSYN1,Humans
598,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002274,"N-acetylglutamate synthase, mitochondrial",NAGS,Humans
599,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000727,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,Humans
600,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
601,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002166,Alanine aminotransferase 2,GPT2,Humans
602,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000073,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,Humans
603,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000003,"Glutaminase liver isoform, mitochondrial",GLS2,Humans
604,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0002277,Aspartyl aminopeptidase,DNPEP,Humans
605,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
606,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0004640,Carboxypeptidase Q,CPQ,Humans
607,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000603,Phosphoserine aminotransferase,PSAT1,Humans
608,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000180,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,Humans
609,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000346,"Glutamate receptor ionotropic, kainate 1",GRIK1,Humans
610,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000640,Glutamate receptor 1,GRIA1,Humans
611,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000606,Glutamate--cysteine ligase regulatory subunit,GCLM,Humans
612,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
613,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000602,Glutamate decarboxylase 2,GAD2,Humans
614,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000378,Glutamate decarboxylase 1,GAD1,Humans
615,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000822,Formimidoyltransferase-cyclodeaminase,FTCD,Humans
616,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000829,Glutamate receptor 2,GRIA2,Humans
617,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000831,Glutamate receptor 3,GRIA3,Humans
618,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000830,Glutamate receptor 4,GRIA4,Humans
619,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000823,Delta-1-pyrroline-5-carboxylate synthase,ALDH18A1,Humans
620,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
621,DB00142,Glutamic acid,"['approved', 'nutraceutical']",BE0000832,"Glutamate receptor ionotropic, kainate 3",GRIK3,Humans
622,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000747,Aldose reductase,AKR1B1,Humans
623,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
624,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002638,Cytochrome P450 3A4,CYP3A4,Humans
626,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
627,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000185,Glutathione synthetase,GSS,Humans
628,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
629,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000808,Glutathione S-transferase kappa 1,GSTK1,Humans
630,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000809,Glutathione S-transferase A3,GSTA3,Humans
631,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000810,Glutathione S-transferase Mu 3,GSTM3,Humans
632,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000811,Glutathione S-transferase A4,GSTA4,Humans
633,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
634,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000813,Glutathione S-transferase A5,GSTA5,Humans
635,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000814,Glutathione S-transferase P,GSTP1,Humans
636,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000815,Glutathione S-transferase omega-1,GSTO1,Humans
637,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000816,Glutathione peroxidase 1,GPX1,Humans
638,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000817,Glutathione peroxidase 2,GPX2,Humans
639,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000818,Glutathione S-transferase theta-1,GSTT1,Humans
640,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000819,Maleylacetoacetate isomerase,GSTZ1,Humans
641,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000820,Epididymal secretory glutathione peroxidase,GPX5,Humans
642,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000821,Glutathione peroxidase 3,GPX3,Humans
643,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000962,Lactoylglutathione lyase,GLO1,Humans
644,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0001117,Leukotriene C4 synthase,LTC4S,Humans
645,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002279,Microsomal glutathione S-transferase 3,MGST3,Humans
646,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
647,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002281,Glutathione S-transferase A1,GSTA1,Humans
648,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002189,Glutathione S-transferase A2,GSTA2,Humans
649,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002282,Microsomal glutathione S-transferase 1,MGST1,Humans
650,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002283,S-formylglutathione hydrolase,ESD,Humans
651,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0000889,Gamma-glutamyltranspeptidase 1,GGT1,Humans
652,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0001189,Glutathione S-transferase Mu 2,GSTM2,Humans
653,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002284,Glutaredoxin-1,GLRX,Humans
654,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",GPX4,Humans
655,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002285,Glutathione S-transferase Mu 5,GSTM5,Humans
656,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002286,Glutathione peroxidase 6,GPX6,Humans
657,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0001825,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,Humans
658,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002287,Glutathione peroxidase,GPX1,Humans
659,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002289,Glutathione peroxidase 7,GPX7,Humans
660,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002290,Microsomal glutathione S-transferase 2,MGST2,Humans
661,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002291,Glutathione S-transferase omega-2,GSTO2,Humans
662,DB00143,Glutathione,"['approved', 'investigational', 'nutraceutical']",BE0002292,"Glutaredoxin-2, mitochondrial",GLRX2,Humans
663,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0000673,Phosphatidylserine decarboxylase proenzyme,PISD,Humans
664,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0000189,Scavenger receptor class B member 1,SCARB1,Humans
665,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0001132,Protein kinase C alpha type,PRKCA,Humans
666,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0001099,Phosphatidylserine synthase 1,PTDSS1,Humans
667,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0002296,Diacylglycerol kinase gamma,DGKG,Humans
668,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0002297,Diacylglycerol kinase delta,DGKD,Humans
669,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0002299,Phosphatidylserine synthase 2,PTDSS2,Humans
670,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0002300,Sphingomyelin phosphodiesterase 4,SMPD4,Humans
671,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0002301,Sphingomyelin phosphodiesterase 3,SMPD3,Humans
672,DB00144,Phosphatidyl serine,"['investigational', 'nutraceutical']",BE0001001,Probable phospholipid-transporting ATPase IA,ATP8A1,Humans
673,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000518,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,Humans
674,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000409,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,Humans
675,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000898,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,Humans
676,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000998,Glycine--tRNA ligase,GARS,Humans
677,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
678,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002303,Bile acid-CoA:amino acid N-acyltransferase,BAAT,Humans
679,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002304,N-arachidonyl glycine receptor,GPR18,Humans
680,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000185,Glutathione synthetase,GSS,Humans
681,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000454,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,Humans
683,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002305,Glycine N-acyltransferase,GLYAT,Humans
684,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000292,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,Humans
685,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002306,Glycine N-acyltransferase-like protein 2,GLYATL2,Humans
686,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002307,Glycine N-acyltransferase-like protein 1,GLYATL1,Humans
687,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000102,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,Humans
688,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0002309,Peroxisomal sarcosine oxidase,PIPOX,Humans
689,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000534,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,Humans
690,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
691,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
692,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000055,Glycine receptor subunit beta,GLRB,Humans
693,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
694,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
695,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000745,Glycine receptor subunit alpha-2,GLRA2,Humans
696,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000372,Glycine N-methyltransferase,GNMT,Humans
697,DB00145,Glycine,"['approved', 'nutraceutical', 'vet_approved']",BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
698,DB00146,Calcifediol,"['approved', 'nutraceutical']",BE0000779,Vitamin D3 receptor,VDR,Humans
699,DB00147,Pyridoxal,"['experimental', 'nutraceutical']",BE0000042,Pyridoxal kinase,PDXK,Humans
700,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000714,Creatine kinase M-type,CKM,Humans
701,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000171,"Creatine kinase U-type, mitochondrial",CKMT1A,Humans
702,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000082,Creatine kinase B-type,CKB,Humans
703,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000410,"Creatine kinase S-type, mitochondrial",CKMT2,Humans
704,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000375,Sodium- and chloride-dependent creatine transporter 1,SLC6A8,Humans
705,DB00148,Creatine,"['approved', 'investigational', 'nutraceutical']",BE0000567,Guanidinoacetate N-methyltransferase,GAMT,Humans
706,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000204,"Probable leucine--tRNA ligase, mitochondrial",LARS2,Humans
707,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000613,Leucine carboxyl methyltransferase 2,LCMT2,Humans
708,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000450,Leucine carboxyl methyltransferase 1,LCMT1,Humans
709,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000769,"Leucine--tRNA ligase, cytoplasmic",LARS,Humans
710,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
711,DB00149,Leucine,"['investigational', 'nutraceutical']",BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
712,DB00150,Tryptophan,"['approved', 'nutraceutical', 'withdrawn']",BE0000228,"Tryptophan--tRNA ligase, cytoplasmic",WARS,Humans
714,DB00150,Tryptophan,"['approved', 'nutraceutical', 'withdrawn']",BE0002311,"Tryptophan--tRNA ligase, mitochondrial",WARS2,Humans
715,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000606,Glutamate--cysteine ligase regulatory subunit,GCLM,Humans
716,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000166,Glutamate--cysteine ligase catalytic subunit,GCLC,Humans
717,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
718,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000383,"Aspartate aminotransferase, mitochondrial",GOT2,Humans
719,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000791,Cystathionine gamma-lyase,CTH,Humans
720,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000323,Cystathionine beta-synthase,CBS,Humans
721,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000701,"Cysteine--tRNA ligase, cytoplasmic",CARS,Humans
722,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
723,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000185,Glutathione synthetase,GSS,Humans
724,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0002312,"Probable cysteine--tRNA ligase, mitochondrial",CARS2,Humans
725,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000079,Cysteine sulfinic acid decarboxylase,CSAD,Humans
726,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000151,"Cysteine desulfurase, mitochondrial",NFS1,Humans
727,DB00151,Cysteine,"['approved', 'nutraceutical']",BE0000569,Cysteine dioxygenase type 1,CDO1,Humans
728,DB00152,Thiamine,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0000157,Thiamin pyrophosphokinase 1,TPK1,Humans
729,DB00153,Ergocalciferol,"['approved', 'nutraceutical']",BE0000779,Vitamin D3 receptor,VDR,Humans
730,DB00153,Ergocalciferol,"['approved', 'nutraceutical']",BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
731,DB00154,Dihomo-gamma-linolenic acid,"['investigational', 'nutraceutical']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
732,DB00154,Dihomo-gamma-linolenic acid,"['investigational', 'nutraceutical']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
733,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
734,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000671,Argininosuccinate synthase,ASS1,Humans
735,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000608,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",DDAH2,Humans
737,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000766,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,Humans
738,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000306,"Ornithine carbamoyltransferase, mitochondrial",OTC,Humans
739,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
740,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
741,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
742,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0002313,Protein-arginine deiminase type-6,PADI6,Humans
743,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0002314,Protein-arginine deiminase type-1,PADI1,Humans
744,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0002315,Protein-arginine deiminase type-3,PADI3,Humans
745,DB00155,Citrulline,"['investigational', 'nutraceutical']",BE0002316,Protein-arginine deiminase type-2,PADI2,Humans
746,DB00156,Threonine,"['approved', 'nutraceutical']",BE0000234,"Threonine--tRNA ligase, cytoplasmic",TARS,Humans
747,DB00156,Threonine,"['approved', 'nutraceutical']",BE0002317,"Threonine--tRNA ligase, mitochondrial",TARS2,Humans
749,DB00157,NADH,"['approved', 'nutraceutical']",BE0000645,UDP-glucose 6-dehydrogenase,UGDH,Humans
750,DB00157,NADH,"['approved', 'nutraceutical']",BE0000227,Alcohol dehydrogenase 1A,ADH1A,Humans
751,DB00157,NADH,"['approved', 'nutraceutical']",BE0000299,Sorbitol dehydrogenase,SORD,Humans
752,DB00157,NADH,"['approved', 'nutraceutical']",BE0000360,Alcohol dehydrogenase 4,ADH4,Humans
753,DB00157,NADH,"['approved', 'nutraceutical']",BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
754,DB00157,NADH,"['approved', 'nutraceutical']",BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
755,DB00157,NADH,"['approved', 'nutraceutical']",BE0000522,Alcohol dehydrogenase class 4 mu/sigma chain,ADH7,Humans
756,DB00157,NADH,"['approved', 'nutraceutical']",BE0000208,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",GPD1,Humans
757,DB00157,NADH,"['approved', 'nutraceutical']",BE0000297,L-lactate dehydrogenase A-like 6A,LDHAL6A,Humans
758,DB00157,NADH,"['approved', 'nutraceutical']",BE0000009,Alcohol dehydrogenase class-3,ADH5,Humans
759,DB00157,NADH,"['approved', 'nutraceutical']",BE0000747,Aldose reductase,AKR1B1,Humans
760,DB00157,NADH,"['approved', 'nutraceutical']",BE0000317,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,Humans
761,DB00157,NADH,"['approved', 'nutraceutical']",BE0000780,"Malate dehydrogenase, mitochondrial",MDH2,Humans
762,DB00157,NADH,"['approved', 'nutraceutical']",BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
763,DB00157,NADH,"['approved', 'nutraceutical']",BE0000148,"NAD-dependent malic enzyme, mitochondrial",ME2,Humans
764,DB00157,NADH,"['approved', 'nutraceutical']",BE0000408,Peroxisomal multifunctional enzyme type 2,HSD17B4,Humans
765,DB00157,NADH,"['approved', 'nutraceutical']",BE0000100,L-lactate dehydrogenase A-like 6B,LDHAL6B,Humans
766,DB00157,NADH,"['approved', 'nutraceutical']",BE0000149,L-lactate dehydrogenase C chain,LDHC,Humans
767,DB00157,NADH,"['approved', 'nutraceutical']",BE0000068,L-lactate dehydrogenase B chain,LDHB,Humans
768,DB00157,NADH,"['approved', 'nutraceutical']",BE0000586,Peroxisomal bifunctional enzyme,EHHADH,Humans
769,DB00157,NADH,"['approved', 'nutraceutical']",BE0000377,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,Humans
770,DB00157,NADH,"['approved', 'nutraceutical']",BE0000328,"NADP-dependent malic enzyme, mitochondrial",ME3,Humans
771,DB00157,NADH,"['approved', 'nutraceutical']",BE0000175,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",BDH1,Humans
772,DB00157,NADH,"['approved', 'nutraceutical']",BE0000589,"Malate dehydrogenase, cytoplasmic",MDH1,Humans
773,DB00157,NADH,"['approved', 'nutraceutical']",BE0000128,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",HIBADH,Humans
774,DB00157,NADH,"['approved', 'nutraceutical']",BE0000336,Testosterone 17-beta-dehydrogenase 3,HSD17B3,Humans
775,DB00157,NADH,"['approved', 'nutraceutical']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
776,DB00157,NADH,"['approved', 'nutraceutical']",BE0000604,NADP-dependent malic enzyme,ME1,Humans
777,DB00157,NADH,"['approved', 'nutraceutical']",BE0000161,D-3-phosphoglycerate dehydrogenase,PHGDH,Humans
778,DB00157,NADH,"['approved', 'nutraceutical']",BE0000184,3-keto-steroid reductase,HSD17B7,Humans
779,DB00157,NADH,"['approved', 'nutraceutical']",BE0000771,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",IDH3G,Humans
780,DB00157,NADH,"['approved', 'nutraceutical']",BE0000559,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",IDH3B,Humans
781,DB00157,NADH,"['approved', 'nutraceutical']",BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,Humans
782,DB00157,NADH,"['approved', 'nutraceutical']",BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
783,DB00157,NADH,"['approved', 'nutraceutical']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
784,DB00157,NADH,"['approved', 'nutraceutical']",BE0000570,11-cis retinol dehydrogenase,RDH5,Humans
785,DB00157,NADH,"['approved', 'nutraceutical']",BE0000357,GDH/6PGL endoplasmic bifunctional protein,H6PD,Humans
786,DB00157,NADH,"['approved', 'nutraceutical']",BE0000578,Estradiol 17-beta-dehydrogenase 8,HSD17B8,Humans
787,DB00157,NADH,"['approved', 'nutraceutical']",BE0000438,Aldo-keto reductase family 1 member C4,AKR1C4,Humans
788,DB00157,NADH,"['approved', 'nutraceutical']",BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
789,DB00157,NADH,"['approved', 'nutraceutical']",BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
790,DB00157,NADH,"['approved', 'nutraceutical']",BE0000552,15-hydroxyprostaglandin dehydrogenase [NAD(+)],HPGD,Humans
791,DB00157,NADH,"['approved', 'nutraceutical']",BE0000662,GDP-L-fucose synthase,TSTA3,Humans
792,DB00157,NADH,"['approved', 'nutraceutical']",BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
793,DB00157,NADH,"['approved', 'nutraceutical']",BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
794,DB00157,NADH,"['approved', 'nutraceutical']",BE0000059,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,Humans
795,DB00157,NADH,"['approved', 'nutraceutical']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
796,DB00157,NADH,"['approved', 'nutraceutical']",BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
797,DB00157,NADH,"['approved', 'nutraceutical']",BE0000260,"Trifunctional enzyme subunit alpha, mitochondrial",HADHA,Humans
798,DB00157,NADH,"['approved', 'nutraceutical']",BE0000133,"Aldehyde dehydrogenase, mitochondrial",ALDH2,Humans
799,DB00157,NADH,"['approved', 'nutraceutical']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
800,DB00157,NADH,"['approved', 'nutraceutical']",BE0000622,Aldo-keto reductase family 1 member C2,AKR1C2,Humans
801,DB00157,NADH,"['approved', 'nutraceutical']",BE0000044,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",NSDHL,Humans
802,DB00157,NADH,"['approved', 'nutraceutical']",BE0000193,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,Humans
803,DB00157,NADH,"['approved', 'nutraceutical']",BE0000231,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",ALDH6A1,Humans
804,DB00157,NADH,"['approved', 'nutraceutical']",BE0000718,"Aldehyde dehydrogenase, dimeric NADP-preferring",ALDH3A1,Humans
805,DB00157,NADH,"['approved', 'nutraceutical']",BE0000554,Retinal dehydrogenase 1,ALDH1A1,Humans
806,DB00157,NADH,"['approved', 'nutraceutical']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
807,DB00157,NADH,"['approved', 'nutraceutical']",BE0000287,4-trimethylaminobutyraldehyde dehydrogenase,ALDH9A1,Humans
808,DB00157,NADH,"['approved', 'nutraceutical']",BE0000583,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,Humans
809,DB00157,NADH,"['approved', 'nutraceutical']",BE0000479,"Aldehyde dehydrogenase X, mitochondrial",ALDH1B1,Humans
810,DB00157,NADH,"['approved', 'nutraceutical']",BE0000446,Aldehyde dehydrogenase family 3 member B1,ALDH3B1,Humans
811,DB00157,NADH,"['approved', 'nutraceutical']",BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
812,DB00157,NADH,"['approved', 'nutraceutical']",BE0000513,Retinal dehydrogenase 2,ALDH1A2,Humans
813,DB00157,NADH,"['approved', 'nutraceutical']",BE0000600,Fatty aldehyde dehydrogenase,ALDH3A2,Humans
814,DB00157,NADH,"['approved', 'nutraceutical']",BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,Humans
815,DB00157,NADH,"['approved', 'nutraceutical']",BE0000135,Alpha-aminoadipic semialdehyde dehydrogenase,ALDH7A1,Humans
816,DB00157,NADH,"['approved', 'nutraceutical']",BE0000595,Flavin reductase (NADPH),BLVRB,Humans
817,DB00157,NADH,"['approved', 'nutraceutical']",BE0000728,Pyrroline-5-carboxylate reductase 2,PYCR2,Humans
818,DB00157,NADH,"['approved', 'nutraceutical']",BE0000225,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,Humans
819,DB00157,NADH,"['approved', 'nutraceutical']",BE0000180,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,Humans
820,DB00157,NADH,"['approved', 'nutraceutical']",BE0000098,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,Humans
821,DB00157,NADH,"['approved', 'nutraceutical']",BE0000609,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",PDHA2,Humans
822,DB00157,NADH,"['approved', 'nutraceutical']",BE0000571,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,Humans
823,DB00157,NADH,"['approved', 'nutraceutical']",BE0000741,Biliverdin reductase A,BLVRA,Humans
824,DB00157,NADH,"['approved', 'nutraceutical']",BE0000762,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,Humans
825,DB00157,NADH,"['approved', 'nutraceutical']",BE0000330,Dihydrofolate reductase,DHFR,Humans
826,DB00157,NADH,"['approved', 'nutraceutical']",BE0000162,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,Humans
827,DB00157,NADH,"['approved', 'nutraceutical']",BE0000755,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,Humans
828,DB00157,NADH,"['approved', 'nutraceutical']",BE0000031,7-dehydrocholesterol reductase,DHCR7,Humans
829,DB00157,NADH,"['approved', 'nutraceutical']",BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
830,DB00157,NADH,"['approved', 'nutraceutical']",BE0000655,NADH-ubiquinone oxidoreductase chain 2,MT-ND2,Humans
831,DB00157,NADH,"['approved', 'nutraceutical']",BE0000073,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,Humans
832,DB00157,NADH,"['approved', 'nutraceutical']",BE0000196,NADH-ubiquinone oxidoreductase chain 3,MT-ND3,Humans
833,DB00157,NADH,"['approved', 'nutraceutical']",BE0000307,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",NDUFS7,Humans
834,DB00157,NADH,"['approved', 'nutraceutical']",BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,Humans
835,DB00157,NADH,"['approved', 'nutraceutical']",BE0000268,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,Humans
836,DB00157,NADH,"['approved', 'nutraceutical']",BE0000244,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",ALDH4A1,Humans
837,DB00157,NADH,"['approved', 'nutraceutical']",BE0000160,NADH-cytochrome b5 reductase 3,CYB5R3,Humans
838,DB00157,NADH,"['approved', 'nutraceutical']",BE0000541,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,NDUFA11,Humans
839,DB00157,NADH,"['approved', 'nutraceutical']",BE0000551,NADH-ubiquinone oxidoreductase chain 4,MT-ND4,Humans
840,DB00157,NADH,"['approved', 'nutraceutical']",BE0000540,Dihydropteridine reductase,QDPR,Humans
841,DB00157,NADH,"['approved', 'nutraceutical']",BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
842,DB00157,NADH,"['approved', 'nutraceutical']",BE0000008,"NAD(P) transhydrogenase, mitochondrial",NNT,Humans
843,DB00157,NADH,"['approved', 'nutraceutical']",BE0000473,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,NDUFA5,Humans
844,DB00157,NADH,"['approved', 'nutraceutical']",BE0000305,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NDUFA9,Humans
845,DB00157,NADH,"['approved', 'nutraceutical']",BE0000272,NADH-ubiquinone oxidoreductase chain 4L,MT-ND4L,Humans
846,DB00157,NADH,"['approved', 'nutraceutical']",BE0000081,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",NDUFA10,Humans
847,DB00157,NADH,"['approved', 'nutraceutical']",BE0000401,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,NDUFA7,Humans
848,DB00157,NADH,"['approved', 'nutraceutical']",BE0000224,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,NDUFA1,Humans
849,DB00157,NADH,"['approved', 'nutraceutical']",BE0000348,NADH-ubiquinone oxidoreductase chain 6,MT-ND6,Humans
850,DB00157,NADH,"['approved', 'nutraceutical']",BE0000580,NADH-ubiquinone oxidoreductase chain 5,MT-ND5,Humans
851,DB00157,NADH,"['approved', 'nutraceutical']",BE0000169,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4,NDUFA4,Humans
852,DB00157,NADH,"['approved', 'nutraceutical']",BE0000213,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,NDUFA6,Humans
853,DB00157,NADH,"['approved', 'nutraceutical']",BE0000545,"Acyl carrier protein, mitochondrial",NDUFAB1,Humans
854,DB00157,NADH,"['approved', 'nutraceutical']",BE0000550,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,NDUFA2,Humans
855,DB00157,NADH,"['approved', 'nutraceutical']",BE0000367,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,NDUFA8,Humans
856,DB00157,NADH,"['approved', 'nutraceutical']",BE0000684,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,NDUFA3,Humans
857,DB00157,NADH,"['approved', 'nutraceutical']",BE0000676,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",NDUFB8,Humans
858,DB00157,NADH,"['approved', 'nutraceutical']",BE0000173,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,Humans
859,DB00157,NADH,"['approved', 'nutraceutical']",BE0000338,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,NDUFB1,Humans
860,DB00157,NADH,"['approved', 'nutraceutical']",BE0000493,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",NDUFS1,Humans
861,DB00157,NADH,"['approved', 'nutraceutical']",BE0000245,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,NDUFB10,Humans
862,DB00157,NADH,"['approved', 'nutraceutical']",BE0000295,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,NDUFB4,Humans
863,DB00157,NADH,"['approved', 'nutraceutical']",BE0000284,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,NDUFB3,Humans
864,DB00157,NADH,"['approved', 'nutraceutical']",BE0000427,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial",NDUFB2,Humans
865,DB00157,NADH,"['approved', 'nutraceutical']",BE0000512,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,NDUFB7,Humans
866,DB00157,NADH,"['approved', 'nutraceutical']",BE0000596,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,NDUFB9,Humans
867,DB00157,NADH,"['approved', 'nutraceutical']",BE0000729,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",NDUFS2,Humans
868,DB00157,NADH,"['approved', 'nutraceutical']",BE0000243,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",NDUFB5,Humans
869,DB00157,NADH,"['approved', 'nutraceutical']",BE0000313,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial",NDUFC1,Humans
870,DB00157,NADH,"['approved', 'nutraceutical']",BE0000376,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,NDUFB6,Humans
871,DB00157,NADH,"['approved', 'nutraceutical']",BE0000027,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NDUFV3,Humans
872,DB00157,NADH,"['approved', 'nutraceutical']",BE0000737,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,Humans
873,DB00157,NADH,"['approved', 'nutraceutical']",BE0000191,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",NDUFS3,Humans
874,DB00157,NADH,"['approved', 'nutraceutical']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
875,DB00157,NADH,"['approved', 'nutraceutical']",BE0000754,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,NDUFA12,Humans
876,DB00157,NADH,"['approved', 'nutraceutical']",BE0000089,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,NDUFS5,Humans
877,DB00157,NADH,"['approved', 'nutraceutical']",BE0000500,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",NDUFS4,Humans
878,DB00157,NADH,"['approved', 'nutraceutical']",BE0000485,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",NDUFV1,Humans
879,DB00157,NADH,"['approved', 'nutraceutical']",BE0000137,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",NDUFV2,Humans
880,DB00157,NADH,"['approved', 'nutraceutical']",BE0000525,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,NDUFA13,Humans
881,DB00157,NADH,"['approved', 'nutraceutical']",BE0000569,Cysteine dioxygenase type 1,CDO1,Humans
882,DB00157,NADH,"['approved', 'nutraceutical']",BE0000093,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",NDUFS6,Humans
883,DB00157,NADH,"['approved', 'nutraceutical']",BE0000319,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,NDUFA4L2,Humans
884,DB00157,NADH,"['approved', 'nutraceutical']",BE0000037,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",NDUFS8,Humans
885,DB00157,NADH,"['approved', 'nutraceutical']",BE0000421,Cytochrome P450 4A11,CYP4A11,Humans
886,DB00157,NADH,"['approved', 'nutraceutical']",BE0000065,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,Humans
887,DB00157,NADH,"['approved', 'nutraceutical']",BE0000010,"Aminomethyltransferase, mitochondrial",AMT,Humans
888,DB00157,NADH,"['approved', 'nutraceutical']",BE0000096,Methylsterol monooxygenase 1,MSMO1,Humans
889,DB00157,NADH,"['approved', 'nutraceutical']",BE0000735,Heme oxygenase 1,HMOX1,Humans
890,DB00157,NADH,"['approved', 'nutraceutical']",BE0000587,Heme oxygenase 2,HMOX2,Humans
891,DB00157,NADH,"['approved', 'nutraceutical']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
892,DB00157,NADH,"['approved', 'nutraceutical']",BE0000252,Tyrosinase,TYR,Humans
893,DB00158,Folic acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000652,Folate receptor gamma,FOLR3,Humans
894,DB00158,Folic acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000271,Folate receptor beta,FOLR2,Humans
895,DB00158,Folic acid,"['approved', 'nutraceutical', 'vet_approved']",BE0003405,Folate receptor alpha,FOLR1,Humans
896,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
897,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
898,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
899,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
900,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000688,Free fatty acid receptor 1,FFAR1,Humans
901,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000986,Sodium/calcium exchanger 1,SLC8A1,Humans
902,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0001821,"Fatty acid-binding protein, brain",FABP7,Humans
903,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000888,Fatty acid desaturase 1,FADS1,Humans
904,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000996,Long-chain-fatty-acid--CoA ligase 4,ACSL4,Humans
905,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
906,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
907,DB00159,Icosapent,"['approved', 'nutraceutical']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
908,DB00160,Alanine,['nutraceutical'],BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
909,DB00160,Alanine,['nutraceutical'],BE0000667,Alanine aminotransferase 1,GPT,Humans
910,DB00160,Alanine,['nutraceutical'],BE0000151,"Cysteine desulfurase, mitochondrial",NFS1,Humans
911,DB00160,Alanine,['nutraceutical'],BE0000536,Proton-coupled amino acid transporter 1,SLC36A1,Humans
912,DB00160,Alanine,['nutraceutical'],BE0000789,Large neutral amino acids transporter small subunit 2,SLC7A8,Humans
913,DB00160,Alanine,['nutraceutical'],BE0000102,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,Humans
914,DB00160,Alanine,['nutraceutical'],BE0000294,"Alanine--tRNA ligase, cytoplasmic",AARS,Humans
915,DB00160,Alanine,['nutraceutical'],BE0000480,Neutral amino acid transporter A,SLC1A4,Humans
916,DB00160,Alanine,['nutraceutical'],BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
917,DB00160,Alanine,['nutraceutical'],BE0000392,Kynureninase,KYNU,Humans
918,DB00160,Alanine,['nutraceutical'],BE0002318,"Alanine--tRNA ligase, mitochondrial",AARS2,Humans
919,DB00160,Alanine,['nutraceutical'],BE0002164,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,Humans
920,DB00160,Alanine,['nutraceutical'],BE0002166,Alanine aminotransferase 2,GPT2,Humans
921,DB00161,Valine,"['approved', 'nutraceutical']",BE0000544,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,Humans
922,DB00161,Valine,"['approved', 'nutraceutical']",BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
923,DB00161,Valine,"['approved', 'nutraceutical']",BE0000223,Valine--tRNA ligase,VARS,Humans
924,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0005056,Apolipoprotein D,APOD,Humans
925,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0009878,Prostaglandin-H2 D-isomerase,PTGDS,Humans
926,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000726,Retinol dehydrogenase 12,RDH12,Humans
927,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000570,11-cis retinol dehydrogenase,RDH5,Humans
928,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000593,Retinol dehydrogenase 13,RDH13,Humans
929,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000513,Retinal dehydrogenase 2,ALDH1A2,Humans
930,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000554,Retinal dehydrogenase 1,ALDH1A1,Humans
931,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000900,Lecithin retinol acyltransferase,LRAT,Humans
932,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0002319,Short-chain dehydrogenase/reductase 3,DHRS3,Humans
933,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000583,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,Humans
934,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0002320,"All-trans-retinol 13,14-reductase",RETSAT,Humans
935,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0002321,Retinol dehydrogenase 11,RDH11,Humans
936,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0000032,Dehydrogenase/reductase SDR family member 4,DHRS4,Humans
937,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0002322,Retinol dehydrogenase 14,RDH14,Humans
938,DB00162,Vitamin A,"['approved', 'nutraceutical', 'vet_approved']",BE0002323,Retinol dehydrogenase 8,RDH8,Humans
939,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000076,SEC14-like protein 4,SEC14L4,Humans
940,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000339,SEC14-like protein 3,SEC14L3,Humans
941,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000256,SEC14-like protein 2,SEC14L2,Humans
942,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
943,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000872,Protein kinase C beta type,PRKCB,Humans
944,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
945,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0001132,Protein kinase C alpha type,PRKCA,Humans
946,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0002324,Diacylglycerol kinase alpha,DGKA,Humans
947,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0002325,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,PPP2CB,Humans
948,DB00163,Vitamin E,"['approved', 'nutraceutical', 'vet_approved']",BE0002326,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,Humans
949,DB00165,Pyridoxine,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0000042,Pyridoxal kinase,PDXK,Humans
950,DB00166,Lipoic acid,"['approved', 'investigational', 'nutraceutical']",BE0000040,"Lipoyltransferase 1, mitochondrial",LIPT1,Humans
951,DB00166,Lipoic acid,"['approved', 'investigational', 'nutraceutical']",BE0000094,Sodium-dependent multivitamin transporter,SLC5A6,Humans
952,DB00166,Lipoic acid,"['approved', 'investigational', 'nutraceutical']",BE0002327,"Lipoyl synthase, mitochondrial",LIAS,Humans
953,DB00167,Isoleucine,"['investigational', 'nutraceutical']",BE0000573,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,Humans
954,DB00167,Isoleucine,"['investigational', 'nutraceutical']",BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
955,DB00167,Isoleucine,"['investigational', 'nutraceutical']",BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
956,DB00167,Isoleucine,"['investigational', 'nutraceutical']",BE0000491,"Isoleucine--tRNA ligase, cytoplasmic",IARS,Humans
957,DB00167,Isoleucine,"['investigational', 'nutraceutical']",BE0002328,"Isoleucine--tRNA ligase, mitochondrial",IARS2,Humans
958,DB00168,Aspartame,"['investigational', 'nutraceutical']",BE0000582,Taste receptor type 1 member 3,TAS1R3,Humans
959,DB00168,Aspartame,"['investigational', 'nutraceutical']",BE0000395,Taste receptor type 1 member 2,TAS1R2,Humans
960,DB00168,Aspartame,"['investigational', 'nutraceutical']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
961,DB00169,Cholecalciferol,"['approved', 'nutraceutical']",BE0000779,Vitamin D3 receptor,VDR,Humans
962,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
963,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
964,DB00170,Menadione,"['approved', 'nutraceutical']",BE0002329,Vitamin K epoxide reductase complex subunit 1-like protein 1,VKORC1L1,Humans
965,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000048,Prothrombin,F2,Humans
966,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000364,Coagulation factor IX,F9,Humans
967,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000380,Vitamin K-dependent protein C,PROC,Humans
968,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000943,Vitamin K-dependent protein S,PROS1,Humans
969,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
970,DB00170,Menadione,"['approved', 'nutraceutical']",BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
971,DB00170,Menadione,"['approved', 'nutraceutical']",BE0000724,Osteocalcin,BGLAP,Humans
972,DB00171,ATP,"['investigational', 'nutraceutical']",BE0003640,Multidrug resistance-associated protein 6,ABCC6,Humans
973,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001188,Multidrug resistance-associated protein 4,ABCC4,Humans
974,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000785,Multidrug resistance-associated protein 1,ABCC1,Humans
975,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
976,DB00171,ATP,"['investigational', 'nutraceutical']",BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
977,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
978,DB00171,ATP,"['investigational', 'nutraceutical']",BE0005435,Casein kinase II subunit beta,CSNK2B,Humans
979,DB00171,ATP,"['investigational', 'nutraceutical']",BE0005499,P2Y purinoceptor 11,P2RY11,Humans
980,DB00171,ATP,"['investigational', 'nutraceutical']",BE0003160,Serine/threonine-protein phosphatase 5,PPP5C,Humans
981,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000435,Abelson tyrosine-protein kinase 2,ABL2,Humans
982,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000119,ATP-binding cassette sub-family A member 1,ABCA1,Humans
983,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000350,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,Humans
984,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
985,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000202,NEDD8-activating enzyme E1 regulatory subunit,NAE1,Humans
986,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,Humans
987,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000434,Serine/threonine-protein kinase A-Raf,ARAF,Humans
988,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000459,Serine/threonine-protein kinase receptor R3,ACVRL1,Humans
989,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000639,Long-chain-fatty-acid--CoA ligase 1,ACSL1,Humans
990,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000261,Cytosolic purine 5'-nucleotidase,NT5C2,Humans
991,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000750,ATPase ASNA1,ASNA1,Humans
992,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000469,ATP-binding cassette sub-family C member 9,ABCC9,Humans
993,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
994,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000341,Beta-adrenergic receptor kinase 1,ADRBK1,Humans
995,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000310,Apoptotic protease-activating factor 1,APAF1,Humans
996,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000746,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",ACSS1,Humans
997,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000665,Activin receptor type-1B,ACVR1B,Humans
998,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000264,Activin receptor type-1,ACVR1,Humans
999,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000703,Bile salt export pump,ABCB11,Humans
1000,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000219,Asparagine synthetase [glutamine-hydrolyzing],ASNS,Humans
1001,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000437,Cyclin-dependent kinase 15,CDK15,Humans
1002,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
1003,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
1004,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000671,Argininosuccinate synthase,ASS1,Humans
1005,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000139,AFG3-like protein 2,AFG3L2,Humans
1006,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000018,Beta-adrenergic receptor kinase 2,ADRBK2,Humans
1007,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000675,Anti-Muellerian hormone type-2 receptor,AMHR2,Humans
1008,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000772,Activated CDC42 kinase 1,TNK2,Humans
1009,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
1010,DB00171,ATP,"['investigational', 'nutraceutical']",BE0000269,Adenylate cyclase type 1,ADCY1,Humans
1011,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001032,P-glycoprotein 1,ABCB1,Humans
1012,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001168,ATP-binding cassette sub-family G member 1,ABCG1,Humans
1013,DB00171,ATP,"['investigational', 'nutraceutical']",BE0001069,Canalicular multispecific organic anion transporter 1,ABCC2,Humans
1014,DB00172,Proline,['nutraceutical'],BE0000225,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,Humans
1015,DB00172,Proline,['nutraceutical'],BE0000188,Bifunctional glutamate/proline--tRNA ligase,EPRS,Humans
1016,DB00172,Proline,['nutraceutical'],BE0000423,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),SLC6A14,Humans
1017,DB00172,Proline,['nutraceutical'],BE0000723,Sodium-dependent proline transporter,SLC6A7,Humans
1018,DB00172,Proline,['nutraceutical'],BE0000728,Pyrroline-5-carboxylate reductase 2,PYCR2,Humans
1019,DB00172,Proline,['nutraceutical'],BE0002253,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,Humans
1020,DB00172,Proline,['nutraceutical'],BE0002330,"Proline dehydrogenase 1, mitochondrial",PRODH,Humans
1021,DB00172,Proline,['nutraceutical'],BE0002331,Peptidyl-prolyl cis-trans isomerase H,PPIH,Humans
1022,DB00172,Proline,['nutraceutical'],BE0002149,Proline synthase co-transcribed bacterial homolog protein,PROSC,Humans
1023,DB00172,Proline,['nutraceutical'],BE0000060,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,Humans
1024,DB00172,Proline,['nutraceutical'],BE0002332,Peptidyl-prolyl cis-trans isomerase B,PPIB,Humans
1025,DB00172,Proline,['nutraceutical'],BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,Humans
1026,DB00172,Proline,['nutraceutical'],BE0002333,Peptidyl-prolyl cis-trans isomerase C,PPIC,Humans
1027,DB00172,Proline,['nutraceutical'],BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
1028,DB00172,Proline,['nutraceutical'],BE0002334,Peptidyl-prolyl cis-trans isomerase G,PPIG,Humans
1029,DB00172,Proline,['nutraceutical'],BE0002202,Prolyl 3-hydroxylase 1,P3H1,Humans
1031,DB00172,Proline,['nutraceutical'],BE0002336,"Probable proline--tRNA ligase, mitochondrial",PARS2,Humans
1032,DB00172,Proline,['nutraceutical'],BE0002206,Prolyl 3-hydroxylase 2,P3H2,Humans
1034,DB00172,Proline,['nutraceutical'],BE0004615,Pyrroline-5-carboxylate reductase 3,PYCRL,Humans
1035,DB00172,Proline,['nutraceutical'],BE0002337,Trans-L-3-hydroxyproline dehydratase,L3HYPDH,Humans
1036,DB00173,Adenine,"['approved', 'nutraceutical']",BE0000115,Adenine phosphoribosyltransferase,APRT,Humans
1038,DB00173,Adenine,"['approved', 'nutraceutical']",BE0001128,S-methyl-5'-thioadenosine phosphorylase,MTAP,Humans
1040,DB00173,Adenine,"['approved', 'nutraceutical']",BE0000702,Acetyl-CoA carboxylase 2,ACACB,Humans
1041,DB00173,Adenine,"['approved', 'nutraceutical']",BE0003786,Low molecular weight phosphotyrosine protein phosphatase,ACP1,Humans
1043,DB00173,Adenine,"['approved', 'nutraceutical']",BE0002791,Peroxisomal trans-2-enoyl-CoA reductase,PECR,Humans
1046,DB00173,Adenine,"['approved', 'nutraceutical']",BE0004323,SRSF protein kinase 2,SRPK2,Humans
1048,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0009976,Sodium-coupled neutral amino acid transporters,SLC38A1,Humans
1049,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0000236,Neutral amino acid transporter B(0),SLC1A5,Humans
1050,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0000219,Asparagine synthetase [glutamine-hydrolyzing],ASNS,Humans
1051,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0000607,"Asparagine--tRNA ligase, cytoplasmic",NARS,Humans
1052,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0002230,Isoaspartyl peptidase/L-asparaginase,ASRGL1,Humans
1053,DB00174,Asparagine,"['approved', 'investigational', 'nutraceutical']",BE0002338,"Probable asparagine--tRNA ligase, mitochondrial",NARS2,Humans
1054,DB00175,Pravastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
1055,DB00175,Pravastatin,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
1056,DB00176,Fluvoxamine,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1057,DB00176,Fluvoxamine,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1058,DB00177,Valsartan,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
1059,DB00178,Ramipril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
1060,DB00178,Ramipril,['approved'],BE0005831,B1 bradykinin receptor,BDKRB1,Humans
1061,DB00179,Masoprocol,"['approved', 'investigational']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
1062,DB00179,Masoprocol,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
1063,DB00179,Masoprocol,"['approved', 'investigational']",BE0004624,Transient receptor potential cation channel subfamily M member 7,TRPM7,Humans
1064,DB00180,Flunisolide,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1065,DB00181,Baclofen,['approved'],BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,Humans
1066,DB00181,Baclofen,['approved'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
1067,DB00181,Baclofen,['approved'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
1068,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
1069,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
1070,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000867,Cocaine- and amphetamine-regulated transcript protein,CARTPT,Humans
1071,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
1072,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0004909,Monoamine oxidase,MAOA,Humans
1074,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1075,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
1076,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
1077,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1078,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
1079,DB00182,Amphetamine,"['approved', 'illicit', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1080,DB00183,Pentagastrin,['approved'],BE0001158,Gastrin/cholecystokinin type B receptor,CCKBR,Humans
1081,DB00184,Nicotine,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
1082,DB00184,Nicotine,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
1083,DB00184,Nicotine,['approved'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
1084,DB00184,Nicotine,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
1085,DB00184,Nicotine,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
1086,DB00184,Nicotine,['approved'],BE0003586,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,Humans
1087,DB00184,Nicotine,['approved'],BE0003587,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,Humans
1088,DB00184,Nicotine,['approved'],BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
1089,DB00184,Nicotine,['approved'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
1090,DB00184,Nicotine,['approved'],BE0003588,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,Humans
1091,DB00184,Nicotine,['approved'],BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
1092,DB00184,Nicotine,['approved'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
1093,DB00184,Nicotine,['approved'],BE0000519,Choline O-acetyltransferase,CHAT,Humans
1094,DB00185,Cevimeline,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1095,DB00185,Cevimeline,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1096,DB00186,Lorazepam,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
1097,DB00186,Lorazepam,['approved'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
1098,DB00187,Esmolol,"['approved', 'withdrawn']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1099,DB00188,Bortezomib,"['approved', 'investigational']",BE0002348,Proteasome subunit beta type-5,PSMB5,Humans
1100,DB00188,Bortezomib,"['approved', 'investigational']",BE0002347,Proteasome subunit beta type-1,PSMB1,Humans
1101,DB00189,Ethchlorvynol,"['approved', 'illicit', 'withdrawn']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1102,DB00190,Carbidopa,['approved'],BE0002151,Aromatic-L-amino-acid decarboxylase,DDC,Humans
1103,DB00191,Phentermine,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1104,DB00191,Phentermine,"['approved', 'illicit']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1105,DB00191,Phentermine,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
1106,DB00191,Phentermine,"['approved', 'illicit']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
1107,DB00191,Phentermine,"['approved', 'illicit']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
1108,DB00191,Phentermine,"['approved', 'illicit']",BE0003476,Pro-neuropeptide Y,NPY,Humans
1109,DB00192,Indecainide,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
1110,DB00193,Tramadol,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
1111,DB00193,Tramadol,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1112,DB00193,Tramadol,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1113,DB00193,Tramadol,"['approved', 'investigational']",BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
1114,DB00193,Tramadol,"['approved', 'investigational']",BE0004956,NMDA receptor,GRIN1,Humans
1115,DB00193,Tramadol,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
1116,DB00193,Tramadol,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
1117,DB00193,Tramadol,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1118,DB00193,Tramadol,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1119,DB00193,Tramadol,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
1120,DB00193,Tramadol,"['approved', 'investigational']",BE0003438,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,Humans
1121,DB00193,Tramadol,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1122,DB00193,Tramadol,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1123,DB00193,Tramadol,"['approved', 'investigational']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
1124,DB00193,Tramadol,"['approved', 'investigational']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
1128,DB00195,Betaxolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1129,DB00195,Betaxolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1131,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
1132,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
1133,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
1134,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
1135,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
1136,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0000814,Glutathione S-transferase P,GSTP1,Humans
1137,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0000996,Long-chain-fatty-acid--CoA ligase 4,ACSL4,Humans
1138,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
1139,DB00197,Troglitazone,"['approved', 'investigational', 'withdrawn']",BE0001204,Equilibrative nucleoside transporter 1,SLC29A1,Humans
1141,DB00198,Oseltamivir,['approved'],BE0000914,Sialidase-1,NEU1,Humans
1142,DB00198,Oseltamivir,['approved'],BE0003200,Sialidase-2,NEU2,Humans
1144,DB00199,Erythromycin,"['approved', 'investigational', 'vet_approved']",BE0003521,Motilin receptor,MLNR,Humans
1145,DB00199,Erythromycin,"['approved', 'investigational', 'vet_approved']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1146,DB00200,Hydroxocobalamin,['approved'],BE0000734,Methionine synthase,MTR,Humans
1147,DB00200,Hydroxocobalamin,['approved'],BE0000777,"Methylmalonyl-CoA mutase, mitochondrial",MUT,Humans
1148,DB00200,Hydroxocobalamin,['approved'],BE0000320,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,Humans
1149,DB00200,Hydroxocobalamin,['approved'],BE0000238,Transcobalamin-1,TCN1,Humans
1150,DB00200,Hydroxocobalamin,['approved'],BE0000340,Protein amnionless,AMN,Humans
1151,DB00200,Hydroxocobalamin,['approved'],BE0000936,Cubilin,CUBN,Humans
1152,DB00200,Hydroxocobalamin,['approved'],BE0002175,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,Humans
1153,DB00201,Caffeine,['approved'],BE0000013,Adenosine receptor A1,ADORA1,Humans
1154,DB00201,Caffeine,['approved'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
1155,DB00201,Caffeine,['approved'],BE0000241,Adenosine receptor A2b,ADORA2B,Humans
1156,DB00201,Caffeine,['approved'],BE0000354,Adenosine receptor A3,ADORA3,Humans
1157,DB00201,Caffeine,['approved'],BE0009789,Phosphodiesterase enzymes,PDE1B,Humans
1158,DB00201,Caffeine,['approved'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
1159,DB00201,Caffeine,['approved'],BE0000739,Ryanodine receptor 1,RYR1,Humans
1160,DB00201,Caffeine,['approved'],BE0004922,Cyclic nucleotide phosphodiesterase,PDE1A,Humans
1161,DB00201,Caffeine,['approved'],BE0002385,DNA-dependent protein kinase catalytic subunit,PRKDC,Humans
1162,DB00201,Caffeine,['approved'],BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
1163,DB00201,Caffeine,['approved'],BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
1164,DB00201,Caffeine,['approved'],BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,Humans
1165,DB00201,Caffeine,['approved'],BE0004914,"Inositol 1,4,5-trisphosphate receptor",ITPR1,Humans
1166,DB00201,Caffeine,['approved'],BE0004874,Serine-protein kinase ATM,ATM,Humans
1167,DB00202,Succinylcholine,['approved'],BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,Humans
1168,DB00202,Succinylcholine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1169,DB00202,Succinylcholine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1170,DB00203,Sildenafil,"['approved', 'investigational']",BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
1171,DB00203,Sildenafil,"['approved', 'investigational']",BE0003556,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,Humans
1172,DB00203,Sildenafil,"['approved', 'investigational']",BE0003557,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,Humans
1173,DB00203,Sildenafil,"['approved', 'investigational']",BE0000404,Ornithine decarboxylase,ODC1,Humans
1174,DB00203,Sildenafil,"['approved', 'investigational']",BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
1175,DB00204,Dofetilide,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1176,DB00204,Dofetilide,"['approved', 'investigational']",BE0000210,Potassium channel subfamily K member 2,KCNK2,Humans
1177,DB00204,Dofetilide,"['approved', 'investigational']",BE0001131,ATP-sensitive inward rectifier potassium channel 12,KCNJ12,Humans
1178,DB00205,Pyrimethamine,"['approved', 'investigational', 'vet_approved']",BE0000330,Dihydrofolate reductase,DHFR,Humans
1180,DB00205,Pyrimethamine,"['approved', 'investigational', 'vet_approved']",BE0001153,Beta-hexosaminidase subunit beta,HEXB,Humans
1181,DB00206,Reserpine,"['approved', 'investigational', 'withdrawn']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
1182,DB00206,Reserpine,"['approved', 'investigational', 'withdrawn']",BE0004674,Chromaffin granule amine transporter,SLC18A1,Humans
1183,DB00206,Reserpine,"['approved', 'investigational', 'withdrawn']",BE0003408,Baculoviral IAP repeat-containing protein 5,BIRC5,Humans
1185,DB00207,Azithromycin,['approved'],BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
1186,DB00208,Ticlopidine,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
1187,DB00209,Trospium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1188,DB00209,Trospium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1189,DB00210,Adapalene,['approved'],BE0000206,Retinoic acid receptor beta,RARB,Humans
1190,DB00210,Adapalene,['approved'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
1191,DB00210,Adapalene,['approved'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
1192,DB00210,Adapalene,['approved'],BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
1193,DB00210,Adapalene,['approved'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
1194,DB00210,Adapalene,['approved'],BE0001040,Transcription factor AP-1,JUN,Humans
1195,DB00210,Adapalene,['approved'],BE0001164,Toll-like receptor 2,TLR2,Humans
1196,DB00210,Adapalene,['approved'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
1197,DB00210,Adapalene,['approved'],BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
1198,DB00211,Midodrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1199,DB00211,Midodrine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1200,DB00211,Midodrine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1201,DB00212,Remikiren,['experimental'],BE0000270,Renin,REN,Humans
1202,DB00213,Pantoprazole,['approved'],BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
1203,DB00213,Pantoprazole,['approved'],BE0000766,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,Humans
1204,DB00214,Torasemide,['approved'],BE0000281,Solute carrier family 12 member 2,SLC12A2,Humans
1205,DB00214,Torasemide,['approved'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
1206,DB00215,Citalopram,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1207,DB00215,Citalopram,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1208,DB00216,Eletriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1209,DB00216,Eletriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1210,DB00216,Eletriptan,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
1211,DB00216,Eletriptan,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1212,DB00217,Bethanidine,['approved'],BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
1213,DB00217,Bethanidine,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
1214,DB00217,Bethanidine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
1217,DB00218,Moxifloxacin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
1218,DB00218,Moxifloxacin,"['approved', 'investigational']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
1219,DB00219,Oxyphenonium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1221,DB00221,Isoetharine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1222,DB00221,Isoetharine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1223,DB00222,Glimepiride,['approved'],BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
1224,DB00222,Glimepiride,['approved'],BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
1225,DB00222,Glimepiride,['approved'],BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
1226,DB00223,Diflorasone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
1228,DB00226,Guanadrel,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1229,DB00227,Lovastatin,"['approved', 'investigational']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
1230,DB00227,Lovastatin,"['approved', 'investigational']",BE0000516,Integrin alpha-L,ITGAL,Humans
1231,DB00227,Lovastatin,"['approved', 'investigational']",BE0002366,Histone deacetylase 2,HDAC2,Humans
1232,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1233,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
1234,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
1236,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0000218,Calcium-transporting ATPase type 2C member 1,ATP2C1,Humans
1237,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
1238,DB00228,Enflurane,"['approved', 'investigational', 'vet_approved']",BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,Humans
1240,DB00230,Pregabalin,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
1241,DB00231,Temazepam,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1242,DB00231,Temazepam,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
1243,DB00232,Methyclothiazide,['withdrawn'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
1244,DB00232,Methyclothiazide,['withdrawn'],BE0000267,Carbonic anhydrase 1,CA1,Humans
1245,DB00232,Methyclothiazide,['withdrawn'],BE0000322,Carbonic anhydrase 2,CA2,Humans
1246,DB00232,Methyclothiazide,['withdrawn'],BE0000535,Carbonic anhydrase 4,CA4,Humans
1247,DB00233,Aminosalicylic acid,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
1248,DB00233,Aminosalicylic acid,['approved'],BE0004655,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,Humans
1249,DB00233,Aminosalicylic acid,['approved'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
1250,DB00233,Aminosalicylic acid,['approved'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
1251,DB00234,Reboxetine,"['approved', 'experimental']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1252,DB00235,Milrinone,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
1254,DB00237,Butabarbital,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1255,DB00237,Butabarbital,"['approved', 'illicit']",BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,Humans
1256,DB00237,Butabarbital,"['approved', 'illicit']",BE0000640,Glutamate receptor 1,GRIA1,Humans
1257,DB00237,Butabarbital,"['approved', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
1258,DB00237,Butabarbital,"['approved', 'illicit']",BE0000831,Glutamate receptor 3,GRIA3,Humans
1259,DB00237,Butabarbital,"['approved', 'illicit']",BE0000830,Glutamate receptor 4,GRIA4,Humans
1260,DB00237,Butabarbital,"['approved', 'illicit']",BE0000346,"Glutamate receptor ionotropic, kainate 1",GRIK1,Humans
1261,DB00237,Butabarbital,"['approved', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
1262,DB00237,Butabarbital,"['approved', 'illicit']",BE0000832,"Glutamate receptor ionotropic, kainate 3",GRIK3,Humans
1263,DB00237,Butabarbital,"['approved', 'illicit']",BE0000827,"Glutamate receptor ionotropic, kainate 4",GRIK4,Humans
1264,DB00237,Butabarbital,"['approved', 'illicit']",BE0000828,"Glutamate receptor ionotropic, kainate 5",GRIK5,Humans
1268,DB00239,Oxiconazole,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
1269,DB00240,Alclometasone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
1270,DB00241,Butalbital,"['approved', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
1271,DB00241,Butalbital,"['approved', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1272,DB00241,Butalbital,"['approved', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
1273,DB00241,Butalbital,"['approved', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1274,DB00241,Butalbital,"['approved', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
1275,DB00241,Butalbital,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1276,DB00241,Butalbital,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1277,DB00241,Butalbital,"['approved', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
1278,DB00241,Butalbital,"['approved', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
1279,DB00241,Butalbital,"['approved', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
1280,DB00241,Butalbital,"['approved', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
1281,DB00242,Cladribine,"['approved', 'investigational']",BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
1282,DB00242,Cladribine,"['approved', 'investigational']",BE0002450,Ribonucleoside-diphosphate reductase subunit M2,RRM2,Humans
1283,DB00242,Cladribine,"['approved', 'investigational']",BE0003613,Ribonucleoside-diphosphate reductase subunit M2 B,RRM2B,Humans
1285,DB00242,Cladribine,"['approved', 'investigational']",BE0000546,DNA polymerase alpha catalytic subunit,POLA1,Humans
1286,DB00242,Cladribine,"['approved', 'investigational']",BE0003614,DNA polymerase epsilon catalytic subunit A,POLE,Humans
1287,DB00242,Cladribine,"['approved', 'investigational']",BE0003615,DNA polymerase epsilon subunit 2,POLE2,Humans
1288,DB00242,Cladribine,"['approved', 'investigational']",BE0003617,DNA polymerase epsilon subunit 3,POLE3,Humans
1289,DB00242,Cladribine,"['approved', 'investigational']",BE0003616,DNA polymerase epsilon subunit 4,POLE4,Humans
1290,DB00242,Cladribine,"['approved', 'investigational']",BE0000250,Purine nucleoside phosphorylase,PNP,Humans
1291,DB00243,Ranolazine,"['approved', 'investigational']",BE0004901,Sodium channel protein,SCN1A,Humans
1292,DB00243,Ranolazine,"['approved', 'investigational']",BE0009631,Inward rectifier potassium channel,KCNJ12,Humans
1293,DB00243,Ranolazine,"['approved', 'investigational']",BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
1294,DB00243,Ranolazine,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
1295,DB00243,Ranolazine,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1297,DB00244,Mesalazine,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
1298,DB00244,Mesalazine,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
1299,DB00244,Mesalazine,['approved'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
1300,DB00244,Mesalazine,['approved'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
1301,DB00244,Mesalazine,['approved'],BE0004655,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,Humans
1302,DB00244,Mesalazine,['approved'],BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
1303,DB00244,Mesalazine,['approved'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
1304,DB00245,Benzatropine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1305,DB00245,Benzatropine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
1306,DB00245,Benzatropine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1307,DB00245,Benzatropine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1308,DB00245,Benzatropine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1309,DB00246,Ziprasidone,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
1310,DB00246,Ziprasidone,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1311,DB00246,Ziprasidone,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1312,DB00246,Ziprasidone,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1313,DB00246,Ziprasidone,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1314,DB00246,Ziprasidone,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
1315,DB00246,Ziprasidone,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
1316,DB00246,Ziprasidone,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
1317,DB00246,Ziprasidone,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
1318,DB00246,Ziprasidone,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1319,DB00246,Ziprasidone,['approved'],BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1320,DB00246,Ziprasidone,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
1321,DB00246,Ziprasidone,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1322,DB00246,Ziprasidone,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1323,DB00246,Ziprasidone,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1324,DB00246,Ziprasidone,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1325,DB00246,Ziprasidone,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1326,DB00246,Ziprasidone,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1327,DB00246,Ziprasidone,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
1328,DB00246,Ziprasidone,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1329,DB00246,Ziprasidone,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1330,DB00246,Ziprasidone,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1331,DB00246,Ziprasidone,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1332,DB00246,Ziprasidone,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
1333,DB00246,Ziprasidone,['approved'],BE0009860,5-hydroxytryptamine 3 receptor,HTR3A,Humans
1334,DB00246,Ziprasidone,['approved'],BE0004688,5-hydroxytryptamine receptor 5A,HTR5A,Humans
1335,DB00247,Methysergide,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
1336,DB00247,Methysergide,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1337,DB00247,Methysergide,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1338,DB00247,Methysergide,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1339,DB00247,Methysergide,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1340,DB00247,Methysergide,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1341,DB00247,Methysergide,['approved'],BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
1342,DB00247,Methysergide,['approved'],BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1343,DB00248,Cabergoline,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
1344,DB00248,Cabergoline,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
1345,DB00248,Cabergoline,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
1346,DB00248,Cabergoline,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1347,DB00248,Cabergoline,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1348,DB00248,Cabergoline,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1349,DB00248,Cabergoline,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
1350,DB00248,Cabergoline,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1351,DB00248,Cabergoline,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1352,DB00248,Cabergoline,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
1353,DB00248,Cabergoline,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
1354,DB00248,Cabergoline,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
1355,DB00248,Cabergoline,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1356,DB00248,Cabergoline,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1357,DB00248,Cabergoline,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1358,DB00248,Cabergoline,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1359,DB00248,Cabergoline,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1360,DB00248,Cabergoline,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1361,DB00248,Cabergoline,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1362,DB00248,Cabergoline,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1363,DB00248,Cabergoline,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
1369,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
1370,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
1371,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1372,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
1373,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
1374,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0002084,Sodium channel protein type 8 subunit alpha,SCN8A,Humans
1375,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
1376,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0003635,Sodium channel subunit beta-1,SCN1B,Humans
1377,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0002082,Sodium channel protein type 3 subunit alpha,SCN3A,Humans
1378,DB00252,Phenytoin,"['approved', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1379,DB00253,Medrysone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
1381,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0000792,Estrogen receptor beta,ESR2,Humans
1382,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
1383,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
1384,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
1385,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0005001,Steroid hormone receptor ERR2,ESRRB,Humans
1386,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
1387,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
1388,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0000132,Androgen receptor,AR,Humans
1389,DB00255,Diethylstilbestrol,"['approved', 'investigational', 'withdrawn']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
1392,DB00257,Clotrimazole,"['approved', 'vet_approved']",BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,Humans
1394,DB00257,Clotrimazole,"['approved', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
1395,DB00257,Clotrimazole,"['approved', 'vet_approved']",BE0000635,Hydroxycarboxylic acid receptor 2,HCAR2,Humans
1400,DB00261,Anagrelide,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
1402,DB00262,Carmustine,"['approved', 'investigational']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
1405,DB00264,Metoprolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1406,DB00264,Metoprolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1407,DB00264,Metoprolol,"['approved', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
1408,DB00266,Dicoumarol,['approved'],BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
1409,DB00266,Dicoumarol,['approved'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
1410,DB00266,Dicoumarol,['approved'],BE0001185,Quinone oxidoreductase,CRYZ,Humans
1413,DB00268,Ropinirole,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
1414,DB00268,Ropinirole,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1415,DB00268,Ropinirole,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
1416,DB00268,Ropinirole,"['approved', 'investigational']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
1417,DB00269,Chlorotrianisene,"['investigational', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
1418,DB00270,Isradipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1419,DB00270,Isradipine,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
1420,DB00270,Isradipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
1421,DB00270,Isradipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
1422,DB00270,Isradipine,"['approved', 'investigational']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
1423,DB00270,Isradipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
1424,DB00270,Isradipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
1425,DB00272,Betazole,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
1426,DB00273,Topiramate,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1427,DB00273,Topiramate,['approved'],BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
1428,DB00273,Topiramate,['approved'],BE0009793,Kainate receptors,GRIK1,Humans
1429,DB00273,Topiramate,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
1430,DB00273,Topiramate,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
1431,DB00273,Topiramate,['approved'],BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
1432,DB00273,Topiramate,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
1433,DB00273,Topiramate,['approved'],BE0003625,Carbonic anhydrase 3,CA3,Humans
1434,DB00273,Topiramate,['approved'],BE0008718,Voltage-dependent R-type calcium channel,CACNA1E,Humans
1441,DB00275,Olmesartan,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
1443,DB00276,Amsacrine,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
1444,DB00276,Amsacrine,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1445,DB00276,Amsacrine,"['approved', 'investigational']",BE0000925,Alpha-1-acid glycoprotein 1,ORM1,Humans
1446,DB00276,Amsacrine,"['approved', 'investigational']",BE0000530,Serum albumin,ALB,Humans
1447,DB00277,Theophylline,['approved'],BE0000013,Adenosine receptor A1,ADORA1,Humans
1448,DB00277,Theophylline,['approved'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
1449,DB00277,Theophylline,['approved'],BE0000241,Adenosine receptor A2b,ADORA2B,Humans
1450,DB00277,Theophylline,['approved'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
1451,DB00277,Theophylline,['approved'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
1452,DB00277,Theophylline,['approved'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
1453,DB00277,Theophylline,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
1454,DB00277,Theophylline,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
1455,DB00277,Theophylline,['approved'],BE0009002,Copine-1,CPNE1,Humans
1456,DB00277,Theophylline,['approved'],BE0009003,Minor histocompatibility antigen H13,HM13,Humans
1457,DB00277,Theophylline,['approved'],BE0009004,Nodal modulator 1,NOMO1,Humans
1458,DB00277,Theophylline,['approved'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
1459,DB00277,Theophylline,['approved'],BE0009005,Protein RIC-3,RIC3,Humans
1460,DB00277,Theophylline,['approved'],BE0009006,Tubulin monoglycylase TTLL3,TTLL3,Humans
1461,DB00278,Argatroban,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
1462,DB00279,Liothyronine,"['approved', 'vet_approved']",BE0000687,Thyroid hormone receptor alpha,THRA,Humans
1463,DB00279,Liothyronine,"['approved', 'vet_approved']",BE0000315,Thyroid hormone receptor beta,THRB,Humans
1464,DB00279,Liothyronine,"['approved', 'vet_approved']",BE0009045,Proliferating cell nuclear antigen,PCNA,Humans
1465,DB00280,Disopyramide,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
1466,DB00280,Disopyramide,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1467,DB00280,Disopyramide,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1468,DB00280,Disopyramide,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1469,DB00280,Disopyramide,['approved'],BE0003603,Potassium voltage-gated channel subfamily D member 2,KCND2,Humans
1470,DB00280,Disopyramide,['approved'],BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
1471,DB00280,Disopyramide,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1472,DB00280,Disopyramide,['approved'],BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
1473,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
1474,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0001143,Sodium channel protein type 9 subunit alpha,SCN9A,Humans
1475,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
1476,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
1477,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0002083,Sodium channel protein type 4 subunit alpha,SCN4A,Humans
1478,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0000925,Alpha-1-acid glycoprotein 1,ORM1,Humans
1479,DB00281,Lidocaine,"['approved', 'vet_approved']",BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
1480,DB00282,Pamidronic acid,['approved'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
1482,DB00282,Pamidronic acid,['approved'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
1483,DB00282,Pamidronic acid,['approved'],BE0001162,Caspase-3,CASP3,Humans
1484,DB00282,Pamidronic acid,['approved'],BE0009991,Caspase-9,CASP9,Humans
1485,DB00283,Clemastine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
1486,DB00284,Acarbose,"['approved', 'investigational']",BE0000837,"Maltase-glucoamylase, intestinal",MGAM,Humans
1487,DB00284,Acarbose,"['approved', 'investigational']",BE0001176,"Sucrase-isomaltase, intestinal",SI,Humans
1488,DB00284,Acarbose,"['approved', 'investigational']",BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
1489,DB00284,Acarbose,"['approved', 'investigational']",BE0000876,Lysosomal alpha-glucosidase,GAA,Humans
1490,DB00285,Venlafaxine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1491,DB00285,Venlafaxine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1492,DB00285,Venlafaxine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
1493,DB00286,Conjugated estrogens,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
1494,DB00286,Conjugated estrogens,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
1495,DB00287,Travoprost,['approved'],BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
1496,DB00288,Amcinonide,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
1497,DB00288,Amcinonide,['approved'],BE0000422,Annexin A1,ANXA1,Humans
1498,DB00289,Atomoxetine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1499,DB00289,Atomoxetine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1500,DB00289,Atomoxetine,['approved'],BE0004956,NMDA receptor,GRIN1,Humans
1501,DB00289,Atomoxetine,['approved'],BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
1502,DB00289,Atomoxetine,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1504,DB00290,Bleomycin,"['approved', 'investigational']",BE0000199,DNA ligase 1,LIG1,Humans
1505,DB00290,Bleomycin,"['approved', 'investigational']",BE0000167,DNA ligase 3,LIG3,Humans
1507,DB00292,Etomidate,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1508,DB00292,Etomidate,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1509,DB00292,Etomidate,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
1510,DB00293,Raltitrexed,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
1511,DB00293,Raltitrexed,"['approved', 'investigational']",BE0000700,"Folylpolyglutamate synthase, mitochondrial",FPGS,Humans
1512,DB00294,Etonogestrel,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
1513,DB00295,Morphine,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
1514,DB00295,Morphine,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1515,DB00295,Morphine,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
1516,DB00295,Morphine,"['approved', 'investigational']",BE0004024,Lymphocyte antigen 96,LY96,Humans
1517,DB00296,Ropivacaine,['approved'],BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
1518,DB00297,Bupivacaine,"['approved', 'investigational']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
1519,DB00297,Bupivacaine,"['approved', 'investigational']",BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
1520,DB00298,Dapiprazole,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1521,DB00298,Dapiprazole,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1522,DB00298,Dapiprazole,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1528,DB00302,Tranexamic acid,['approved'],BE0000211,Plasminogen,PLG,Humans
1537,DB00304,Desogestrel,['approved'],BE0000557,Progesterone receptor,PGR,Humans
1538,DB00304,Desogestrel,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
1540,DB00306,Talbutal,"['approved', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
1541,DB00306,Talbutal,"['approved', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1542,DB00306,Talbutal,"['approved', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
1543,DB00306,Talbutal,"['approved', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1544,DB00306,Talbutal,"['approved', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
1545,DB00306,Talbutal,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1546,DB00306,Talbutal,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1547,DB00306,Talbutal,"['approved', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
1548,DB00306,Talbutal,"['approved', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
1549,DB00306,Talbutal,"['approved', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
1550,DB00306,Talbutal,"['approved', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
1551,DB00307,Bexarotene,"['approved', 'investigational']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
1552,DB00307,Bexarotene,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
1553,DB00307,Bexarotene,"['approved', 'investigational']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
1554,DB00308,Ibutilide,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1555,DB00308,Ibutilide,['approved'],BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
1556,DB00308,Ibutilide,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1557,DB00308,Ibutilide,['approved'],BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
1558,DB00308,Ibutilide,['approved'],BE0000679,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,Humans
1559,DB00308,Ibutilide,['approved'],BE0000154,Potassium channel subfamily K member 1,KCNK1,Humans
1560,DB00308,Ibutilide,['approved'],BE0000680,Potassium channel subfamily K member 6,KCNK6,Humans
1561,DB00308,Ibutilide,['approved'],BE0000462,Potassium voltage-gated channel subfamily H member 6,KCNH6,Humans
1562,DB00308,Ibutilide,['approved'],BE0000699,Potassium voltage-gated channel subfamily H member 7,KCNH7,Humans
1563,DB00308,Ibutilide,['approved'],BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
1564,DB00309,Vindesine,"['approved', 'investigational']",BE0000026,Tubulin beta-1 chain,TUBB1,Humans
1565,DB00310,Chlorthalidone,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
1566,DB00310,Chlorthalidone,['approved'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
1567,DB00311,Ethoxzolamide,['withdrawn'],BE0000322,Carbonic anhydrase 2,CA2,Humans
1568,DB00311,Ethoxzolamide,['withdrawn'],BE0000535,Carbonic anhydrase 4,CA4,Humans
1569,DB00311,Ethoxzolamide,['withdrawn'],BE0003629,Carbonic anhydrase 7,CA7,Humans
1570,DB00311,Ethoxzolamide,['withdrawn'],BE0000267,Carbonic anhydrase 1,CA1,Humans
1571,DB00311,Ethoxzolamide,['withdrawn'],BE0003625,Carbonic anhydrase 3,CA3,Humans
1572,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1573,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
1574,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1575,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
1576,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1577,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
1578,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1579,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
1580,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
1581,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000829,Glutamate receptor 2,GRIA2,Humans
1582,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
1583,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0004956,NMDA receptor,GRIN1,Humans
1584,DB00312,Pentobarbital,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
1585,DB00313,Valproic acid,"['approved', 'investigational']",BE0000881,Histone deacetylase 9,HDAC9,Humans
1586,DB00313,Valproic acid,"['approved', 'investigational']",BE0000573,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,Humans
1587,DB00313,Valproic acid,"['approved', 'investigational']",BE0000162,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,Humans
1588,DB00313,Valproic acid,"['approved', 'investigational']",BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,Humans
1589,DB00313,Valproic acid,"['approved', 'investigational']",BE0004901,Sodium channel protein,SCN1A,Humans
1590,DB00313,Valproic acid,"['approved', 'investigational']",BE0002366,Histone deacetylase 2,HDAC2,Humans
1591,DB00313,Valproic acid,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
1592,DB00313,Valproic acid,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
1593,DB00313,Valproic acid,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
1594,DB00313,Valproic acid,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
1595,DB00313,Valproic acid,"['approved', 'investigational']",BE0009012,Cyclin-dependent kinase inhibitor 1,CDKN1A,Humans
1596,DB00313,Valproic acid,"['approved', 'investigational']",BE0001121,Hepatocyte growth factor,HGF,Humans
1597,DB00313,Valproic acid,"['approved', 'investigational']",BE0000404,Ornithine decarboxylase,ODC1,Humans
1598,DB00313,Valproic acid,"['approved', 'investigational']",BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
1600,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1601,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1602,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
1603,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1604,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1605,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1606,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1607,DB00315,Zolmitriptan,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
1608,DB00316,Acetaminophen,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
1609,DB00316,Acetaminophen,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
1610,DB00316,Acetaminophen,['approved'],BE0002480,Prostaglandin E synthase 3,PTGES3,Humans
1611,DB00316,Acetaminophen,['approved'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
1612,DB00317,Gefitinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
1613,DB00318,Codeine,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
1614,DB00318,Codeine,"['approved', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1615,DB00318,Codeine,"['approved', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
1620,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1621,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1622,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
1623,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1624,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1625,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1626,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1627,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
1628,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1629,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
1630,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
1631,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1632,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
1633,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
1634,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
1635,DB00320,Dihydroergotamine,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
1636,DB00321,Amitriptyline,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1637,DB00321,Amitriptyline,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1638,DB00321,Amitriptyline,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1639,DB00321,Amitriptyline,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1640,DB00321,Amitriptyline,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
1641,DB00321,Amitriptyline,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1642,DB00321,Amitriptyline,['approved'],BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
1643,DB00321,Amitriptyline,['approved'],BE0003605,BDNF/NT-3 growth factors receptor,NTRK2,Humans
1644,DB00321,Amitriptyline,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1645,DB00321,Amitriptyline,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1646,DB00321,Amitriptyline,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1647,DB00321,Amitriptyline,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1648,DB00321,Amitriptyline,['approved'],BE0000897,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,Humans
1649,DB00321,Amitriptyline,['approved'],BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
1650,DB00321,Amitriptyline,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
1651,DB00321,Amitriptyline,['approved'],BE0000146,Histamine H4 receptor,HRH4,Humans
1652,DB00321,Amitriptyline,['approved'],BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
1653,DB00321,Amitriptyline,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1654,DB00321,Amitriptyline,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1655,DB00321,Amitriptyline,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1656,DB00321,Amitriptyline,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1657,DB00321,Amitriptyline,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
1658,DB00321,Amitriptyline,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1659,DB00321,Amitriptyline,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
1660,DB00321,Amitriptyline,['approved'],BE0002398,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,Humans
1662,DB00321,Amitriptyline,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
1663,DB00321,Amitriptyline,['approved'],BE0009629,HERG human cardiac K+ channel,KCNH2,Humans
1664,DB00322,Floxuridine,['approved'],BE0000324,Thymidylate synthase,TYMS,Humans
1665,DB00323,Tolcapone,"['approved', 'withdrawn']",BE0002089,Catechol O-methyltransferase,COMT,Humans
1666,DB00324,Fluorometholone,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1667,DB00325,Nitroprusside,"['approved', 'investigational']",BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
1668,DB00327,Hydromorphone,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
1669,DB00327,Hydromorphone,"['approved', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
1670,DB00327,Hydromorphone,"['approved', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1671,DB00328,Indomethacin,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
1672,DB00328,Indomethacin,"['approved', 'investigational']",BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
1673,DB00328,Indomethacin,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
1674,DB00328,Indomethacin,"['approved', 'investigational']",BE0003560,Prostaglandin reductase 2,PTGR2,Humans
1675,DB00328,Indomethacin,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
1676,DB00328,Indomethacin,"['approved', 'investigational']",BE0000962,Lactoylglutathione lyase,GLO1,Humans
1677,DB00328,Indomethacin,"['approved', 'investigational']",BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
1678,DB00328,Indomethacin,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
1679,DB00328,Indomethacin,"['approved', 'investigational']",BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
1680,DB00328,Indomethacin,"['approved', 'investigational']",BE0009434,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,Humans
1681,DB00328,Indomethacin,"['approved', 'investigational']",BE0010085,Human Cyclooxygenases,PTGS1,Humans
1685,DB00331,Metformin,['approved'],BE0003887,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",ETFDH,Humans
1686,DB00331,Metformin,['approved'],BE0000254,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,Humans
1687,DB00331,Metformin,['approved'],BE0000208,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",GPD1,Humans
1688,DB00332,Ipratropium,"['approved', 'experimental']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1689,DB00332,Ipratropium,"['approved', 'experimental']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1690,DB00332,Ipratropium,"['approved', 'experimental']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1691,DB00333,Methadone,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
1692,DB00333,Methadone,['approved'],BE0004956,NMDA receptor,GRIN1,Humans
1693,DB00333,Methadone,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
1694,DB00333,Methadone,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
1695,DB00333,Methadone,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
1696,DB00333,Methadone,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
1697,DB00333,Methadone,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
1698,DB00333,Methadone,['approved'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
1699,DB00334,Olanzapine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1700,DB00334,Olanzapine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1701,DB00334,Olanzapine,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
1702,DB00334,Olanzapine,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
1703,DB00334,Olanzapine,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
1704,DB00334,Olanzapine,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
1705,DB00334,Olanzapine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1706,DB00334,Olanzapine,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
1707,DB00334,Olanzapine,"['approved', 'investigational']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
1708,DB00334,Olanzapine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
1709,DB00334,Olanzapine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1710,DB00334,Olanzapine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1711,DB00334,Olanzapine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1712,DB00334,Olanzapine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1713,DB00334,Olanzapine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1714,DB00334,Olanzapine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1715,DB00334,Olanzapine,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
1716,DB00334,Olanzapine,"['approved', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
1717,DB00334,Olanzapine,"['approved', 'investigational']",BE0004958,5-hydroxytryptamine receptor 1,HTR1A,Humans
1718,DB00334,Olanzapine,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
1719,DB00335,Atenolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1720,DB00335,Atenolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1722,DB00337,Pimecrolimus,"['approved', 'investigational']",BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
1723,DB00337,Pimecrolimus,"['approved', 'investigational']",BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
1724,DB00338,Omeprazole,"['approved', 'investigational', 'vet_approved']",BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
1725,DB00338,Omeprazole,"['approved', 'investigational', 'vet_approved']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
1727,DB00340,Metixene,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
1728,DB00341,Cetirizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1729,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
1730,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1731,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1732,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
1733,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1734,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1735,DB00342,Terfenadine,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
1736,DB00343,Diltiazem,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1737,DB00343,Diltiazem,"['approved', 'investigational']",BE0000679,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,Humans
1738,DB00344,Protriptyline,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1739,DB00344,Protriptyline,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1740,DB00346,Alfuzosin,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
1741,DB00346,Alfuzosin,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1742,DB00346,Alfuzosin,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1743,DB00346,Alfuzosin,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1744,DB00347,Trimethadione,['approved'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
1745,DB00348,Nitisinone,"['approved', 'investigational']",BE0000455,4-hydroxyphenylpyruvate dioxygenase,HPD,Humans
1746,DB00349,Clobazam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1747,DB00349,Clobazam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
1748,DB00350,Minoxidil,"['approved', 'investigational']",BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
1749,DB00350,Minoxidil,"['approved', 'investigational']",BE0000270,Renin,REN,Humans
1750,DB00350,Minoxidil,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
1751,DB00351,Megestrol acetate,"['approved', 'investigational', 'vet_approved']",BE0000557,Progesterone receptor,PGR,Humans
1752,DB00351,Megestrol acetate,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1754,DB00353,Methylergometrine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
1755,DB00353,Methylergometrine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
1756,DB00354,Buclizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1757,DB00354,Buclizine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1761,DB00356,Chlorzoxazone,['approved'],BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
1762,DB00357,Aminoglutethimide,"['approved', 'investigational']",BE0003537,"Cholesterol side-chain cleavage enzyme, mitochondrial",CYP11A1,Humans
1763,DB00357,Aminoglutethimide,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
1766,DB00358,Mefloquine,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
1768,DB00360,Sapropterin,"['approved', 'investigational']",BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
1769,DB00360,Sapropterin,"['approved', 'investigational']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
1770,DB00360,Sapropterin,"['approved', 'investigational']",BE0000614,Tyrosine 3-monooxygenase,TH,Humans
1771,DB00360,Sapropterin,"['approved', 'investigational']",BE0000121,Tryptophan 5-hydroxylase 1,TPH1,Humans
1772,DB00361,Vinorelbine,"['approved', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
1774,DB00363,Clozapine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
1775,DB00363,Clozapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1776,DB00363,Clozapine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
1777,DB00363,Clozapine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
1778,DB00363,Clozapine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
1779,DB00363,Clozapine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1780,DB00363,Clozapine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1781,DB00363,Clozapine,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1782,DB00363,Clozapine,['approved'],BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1783,DB00363,Clozapine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
1784,DB00363,Clozapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1785,DB00363,Clozapine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
1786,DB00363,Clozapine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1787,DB00363,Clozapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1788,DB00363,Clozapine,['approved'],BE0000146,Histamine H4 receptor,HRH4,Humans
1789,DB00363,Clozapine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1790,DB00363,Clozapine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1791,DB00363,Clozapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1792,DB00363,Clozapine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1793,DB00363,Clozapine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
1794,DB00363,Clozapine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1795,DB00363,Clozapine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1796,DB00363,Clozapine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1797,DB00363,Clozapine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1798,DB00363,Clozapine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
1799,DB00363,Clozapine,['approved'],BE0000666,Neuron-specific vesicular protein calcyon,CALY,Humans
1800,DB00363,Clozapine,['approved'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
1801,DB00364,Sucralfate,['approved'],BE0009737,Pepsin A-5,PGA5,Humans
1802,DB00364,Sucralfate,['approved'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
1803,DB00364,Sucralfate,['approved'],BE0000953,Pro-epidermal growth factor,EGF,Humans
1804,DB00364,Sucralfate,['approved'],BE0009672,Fibrinogen,FGA,Humans
1807,DB00366,Doxylamine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
1808,DB00366,Doxylamine,"['approved', 'vet_approved']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
1809,DB00366,Doxylamine,"['approved', 'vet_approved']",BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
1810,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
1811,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,Humans
1812,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
1813,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
1814,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
1815,DB00367,Levonorgestrel,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1816,DB00368,Norepinephrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1817,DB00368,Norepinephrine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1818,DB00368,Norepinephrine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1819,DB00368,Norepinephrine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1820,DB00368,Norepinephrine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1821,DB00368,Norepinephrine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
1822,DB00368,Norepinephrine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1823,DB00368,Norepinephrine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1824,DB00368,Norepinephrine,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
1825,DB00368,Norepinephrine,['approved'],BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
1826,DB00368,Norepinephrine,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
1827,DB00368,Norepinephrine,['approved'],BE0004674,Chromaffin granule amine transporter,SLC18A1,Humans
1829,DB00370,Mirtazapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1831,DB00370,Mirtazapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1832,DB00370,Mirtazapine,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
1833,DB00370,Mirtazapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1834,DB00370,Mirtazapine,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1835,DB00370,Mirtazapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1836,DB00371,Meprobamate,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1837,DB00371,Meprobamate,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1838,DB00371,Meprobamate,"['approved', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
1839,DB00371,Meprobamate,"['approved', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1840,DB00371,Meprobamate,"['approved', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
1841,DB00371,Meprobamate,"['approved', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1842,DB00371,Meprobamate,"['approved', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
1843,DB00372,Thiethylperazine,"['approved', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1844,DB00373,Timolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1845,DB00373,Timolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1847,DB00374,Treprostinil,"['approved', 'investigational']",BE0000475,Prostacyclin receptor,PTGIR,Humans
1848,DB00374,Treprostinil,"['approved', 'investigational']",BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
1849,DB00374,Treprostinil,"['approved', 'investigational']",BE0000296,Prostaglandin D2 receptor,PTGDR,Humans
1850,DB00374,Treprostinil,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
1851,DB00374,Treprostinil,"['approved', 'investigational']",BE0000110,P2Y purinoceptor 12,P2RY12,Humans
1853,DB00376,Trihexyphenidyl,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1854,DB00376,Trihexyphenidyl,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1855,DB00376,Trihexyphenidyl,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1856,DB00376,Trihexyphenidyl,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1857,DB00376,Trihexyphenidyl,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
1858,DB00377,Palonosetron,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
1859,DB00378,Dydrogesterone,"['approved', 'investigational', 'withdrawn']",BE0000557,Progesterone receptor,PGR,Humans
1860,DB00379,Mexiletine,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
1861,DB00379,Mexiletine,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
1862,DB00380,Dexrazoxane,"['approved', 'withdrawn']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
1863,DB00380,Dexrazoxane,"['approved', 'withdrawn']",BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
1864,DB00381,Amlodipine,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1865,DB00381,Amlodipine,['approved'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
1866,DB00381,Amlodipine,['approved'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
1867,DB00381,Amlodipine,['approved'],BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
1868,DB00381,Amlodipine,['approved'],BE0003563,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,Humans
1869,DB00381,Amlodipine,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
1870,DB00381,Amlodipine,['approved'],BE0000973,Sphingomyelin phosphodiesterase,SMPD1,Humans
1871,DB00381,Amlodipine,['approved'],BE0009351,Voltage-dependent N-type calcium channel,CACNA1B,Humans
1872,DB00382,Tacrine,"['approved', 'investigational', 'withdrawn']",BE0002180,Cholinesterase,BCHE,Humans
1873,DB00382,Tacrine,"['approved', 'investigational', 'withdrawn']",BE0000426,Acetylcholinesterase,ACHE,Humans
1874,DB00382,Tacrine,"['approved', 'investigational', 'withdrawn']",BE0002705,Liver carboxylesterase 1,CES1,Humans
1875,DB00383,Oxyphencyclimine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1876,DB00383,Oxyphencyclimine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1877,DB00383,Oxyphencyclimine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1878,DB00384,Triamterene,['approved'],BE0000497,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,Humans
1879,DB00384,Triamterene,['approved'],BE0000190,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,Humans
1880,DB00384,Triamterene,['approved'],BE0000024,Amiloride-sensitive sodium channel subunit beta,SCNN1B,Humans
1881,DB00384,Triamterene,['approved'],BE0000495,Amiloride-sensitive sodium channel subunit delta,SCNN1D,Humans
1883,DB00385,Valrubicin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
1884,DB00387,Procyclidine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1885,DB00387,Procyclidine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1886,DB00387,Procyclidine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1887,DB00387,Procyclidine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1888,DB00388,Phenylephrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1889,DB00388,Phenylephrine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1890,DB00388,Phenylephrine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
1891,DB00389,Carbimazole,"['approved', 'investigational']",BE0000507,Thyroid peroxidase,TPO,Humans
1892,DB00390,Digoxin,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
1893,DB00391,Sulpiride,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1894,DB00391,Sulpiride,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
1895,DB00391,Sulpiride,"['approved', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
1896,DB00391,Sulpiride,"['approved', 'investigational']",BE0003625,Carbonic anhydrase 3,CA3,Humans
1897,DB00391,Sulpiride,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
1898,DB00392,Profenamine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1899,DB00392,Profenamine,['approved'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
1900,DB00392,Profenamine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1901,DB00393,Nimodipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1902,DB00393,Nimodipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
1903,DB00393,Nimodipine,"['approved', 'investigational']",BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
1904,DB00393,Nimodipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
1905,DB00393,Nimodipine,"['approved', 'investigational']",BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
1906,DB00393,Nimodipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
1907,DB00393,Nimodipine,"['approved', 'investigational']",BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,Humans
1908,DB00393,Nimodipine,"['approved', 'investigational']",BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,Humans
1909,DB00393,Nimodipine,"['approved', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
1910,DB00393,Nimodipine,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
1911,DB00394,Beclomethasone dipropionate,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1912,DB00395,Carisoprodol,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1913,DB00395,Carisoprodol,['approved'],BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
1914,DB00395,Carisoprodol,['approved'],BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
1915,DB00395,Carisoprodol,['approved'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1916,DB00395,Carisoprodol,['approved'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1917,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000557,Progesterone receptor,PGR,Humans
1918,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
1919,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
1920,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
1921,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
1922,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000925,Alpha-1-acid glycoprotein 1,ORM1,Humans
1923,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
1924,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
1925,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
1926,DB00396,Progesterone,"['approved', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
1927,DB00397,Phenylpropanolamine,"['approved', 'vet_approved', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
1928,DB00397,Phenylpropanolamine,"['approved', 'vet_approved', 'withdrawn']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1929,DB00397,Phenylpropanolamine,"['approved', 'vet_approved', 'withdrawn']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
1930,DB00397,Phenylpropanolamine,"['approved', 'vet_approved', 'withdrawn']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
1931,DB00398,Sorafenib,"['approved', 'investigational']",BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
1932,DB00398,Sorafenib,"['approved', 'investigational']",BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
1933,DB00398,Sorafenib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
1934,DB00398,Sorafenib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
1935,DB00398,Sorafenib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
1936,DB00398,Sorafenib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
1937,DB00398,Sorafenib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
1938,DB00398,Sorafenib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
1939,DB00398,Sorafenib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
1940,DB00398,Sorafenib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
1941,DB00399,Zoledronic acid,['approved'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
1943,DB00399,Zoledronic acid,['approved'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
1945,DB00400,Griseofulvin,"['approved', 'investigational', 'vet_approved']",BE0004660,"Keratin, type I cytoskeletal 12",KRT12,Humans
1946,DB00401,Nisoldipine,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
1947,DB00401,Nisoldipine,['approved'],BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
1948,DB00401,Nisoldipine,['approved'],BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
1949,DB00401,Nisoldipine,['approved'],BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
1950,DB00401,Nisoldipine,['approved'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
1951,DB00402,Eszopiclone,"['approved', 'investigational']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
1952,DB00402,Eszopiclone,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1953,DB00402,Eszopiclone,"['approved', 'investigational']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
1954,DB00402,Eszopiclone,"['approved', 'investigational']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
1955,DB00402,Eszopiclone,"['approved', 'investigational']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
1956,DB00403,Ceruletide,['approved'],BE0000402,Cholecystokinin receptor type A,CCKAR,Humans
1957,DB00404,Alprazolam,"['approved', 'illicit', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
1958,DB00404,Alprazolam,"['approved', 'illicit', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
1959,DB00405,Dexbrompheniramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1961,DB00407,Ardeparin,"['approved', 'investigational', 'withdrawn']",BE0000280,Antithrombin-III,SERPINC1,Humans
1962,DB00407,Ardeparin,"['approved', 'investigational', 'withdrawn']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
1963,DB00408,Loxapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
1964,DB00408,Loxapine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
1965,DB00408,Loxapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
1966,DB00408,Loxapine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
1967,DB00408,Loxapine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
1968,DB00408,Loxapine,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
1969,DB00408,Loxapine,['approved'],BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
1970,DB00408,Loxapine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
1971,DB00408,Loxapine,['approved'],BE0004688,5-hydroxytryptamine receptor 5A,HTR5A,Humans
1972,DB00408,Loxapine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
1973,DB00408,Loxapine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
1974,DB00408,Loxapine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
1975,DB00408,Loxapine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
1976,DB00408,Loxapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
1977,DB00408,Loxapine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
1978,DB00408,Loxapine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
1979,DB00408,Loxapine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
1980,DB00408,Loxapine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
1981,DB00408,Loxapine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
1982,DB00408,Loxapine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
1983,DB00408,Loxapine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
1984,DB00408,Loxapine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
1985,DB00408,Loxapine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
1986,DB00408,Loxapine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
1987,DB00408,Loxapine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
1988,DB00408,Loxapine,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
1989,DB00408,Loxapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
1990,DB00408,Loxapine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
1991,DB00408,Loxapine,['approved'],BE0000146,Histamine H4 receptor,HRH4,Humans
1992,DB00408,Loxapine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
1993,DB00408,Loxapine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
1994,DB00408,Loxapine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
1995,DB00408,Loxapine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
1996,DB00409,Remoxipride,"['approved', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
1997,DB00409,Remoxipride,"['approved', 'withdrawn']",BE0000389,Dopamine D4 receptor,DRD4,Humans
1998,DB00409,Remoxipride,"['approved', 'withdrawn']",BE0000581,Dopamine D3 receptor,DRD3,Humans
1999,DB00409,Remoxipride,"['approved', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2000,DB00409,Remoxipride,"['approved', 'withdrawn']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
2002,DB00411,Carbamoylcholine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2003,DB00411,Carbamoylcholine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2004,DB00411,Carbamoylcholine,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2005,DB00411,Carbamoylcholine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2006,DB00411,Carbamoylcholine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2007,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
2008,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000996,Long-chain-fatty-acid--CoA ligase 4,ACSL4,Humans
2009,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
2010,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
2011,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
2012,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
2013,DB00412,Rosiglitazone,"['approved', 'investigational']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
2014,DB00413,Pramipexole,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
2015,DB00413,Pramipexole,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2016,DB00413,Pramipexole,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
2017,DB00413,Pramipexole,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2018,DB00413,Pramipexole,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2019,DB00414,Acetohexamide,"['approved', 'investigational', 'withdrawn']",BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
2025,DB00415,Ampicillin,"['approved', 'vet_approved']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
2026,DB00415,Ampicillin,"['approved', 'vet_approved']",BE0001134,Solute carrier family 15 member 2,SLC15A2,Humans
2027,DB00415,Ampicillin,"['approved', 'vet_approved']",BE0003379,Angiopoietin-1 receptor,TEK,Humans
2028,DB00416,Metocurine iodide,"['approved', 'withdrawn']",BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2033,DB00417,Phenoxymethylpenicillin,"['approved', 'vet_approved']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
2034,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
2035,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
2036,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
2037,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
2038,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
2039,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2040,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2041,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2042,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000829,Glutamate receptor 2,GRIA2,Humans
2043,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
2044,DB00418,Secobarbital,"['approved', 'vet_approved']",BE0004956,NMDA receptor,GRIN1,Humans
2045,DB00419,Miglustat,['approved'],BE0000477,Ceramide glucosyltransferase,UGCG,Humans
2046,DB00420,Promazine,"['approved', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2047,DB00420,Promazine,"['approved', 'vet_approved']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2048,DB00420,Promazine,"['approved', 'vet_approved']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2049,DB00420,Promazine,"['approved', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2050,DB00420,Promazine,"['approved', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2051,DB00420,Promazine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
2052,DB00421,Spironolactone,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
2053,DB00421,Spironolactone,['approved'],BE0000132,Androgen receptor,AR,Humans
2054,DB00421,Spironolactone,['approved'],BE0000557,Progesterone receptor,PGR,Humans
2055,DB00421,Spironolactone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
2056,DB00421,Spironolactone,['approved'],BE0003542,"Cytochrome P450 11B2, mitochondrial",CYP11B2,Humans
2057,DB00421,Spironolactone,['approved'],BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
2058,DB00421,Spironolactone,['approved'],BE0004887,3-oxo-5-alpha-steroid 4-dehydrogenase,SRD5A1,Humans
2059,DB00421,Spironolactone,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
2060,DB00421,Spironolactone,['approved'],BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
2061,DB00421,Spironolactone,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2062,DB00422,Methylphenidate,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2063,DB00422,Methylphenidate,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2064,DB00422,Methylphenidate,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2065,DB00423,Methocarbamol,"['approved', 'vet_approved']",BE0000267,Carbonic anhydrase 1,CA1,Humans
2066,DB00424,Hyoscyamine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2067,DB00424,Hyoscyamine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2068,DB00424,Hyoscyamine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2069,DB00424,Hyoscyamine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2070,DB00424,Hyoscyamine,['approved'],BE0000269,Adenylate cyclase type 1,ADCY1,Humans
2071,DB00425,Zolpidem,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2072,DB00425,Zolpidem,['approved'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
2073,DB00425,Zolpidem,['approved'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
2074,DB00425,Zolpidem,['approved'],BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
2076,DB00427,Triprolidine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2079,DB00428,Streptozocin,"['approved', 'investigational']",BE0001045,"Solute carrier family 2, facilitated glucose transporter member 2",SLC2A2,Humans
2080,DB00428,Streptozocin,"['approved', 'investigational']",BE0005827,Bifunctional protein NCOAT,MGEA5,Humans
2081,DB00429,Carboprost tromethamine,['approved'],BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
2089,DB00431,Lindane,"['approved', 'withdrawn']",BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,Humans
2090,DB00431,Lindane,"['approved', 'withdrawn']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
2091,DB00431,Lindane,"['approved', 'withdrawn']",BE0000745,Glycine receptor subunit alpha-2,GLRA2,Humans
2092,DB00431,Lindane,"['approved', 'withdrawn']",BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
2093,DB00431,Lindane,"['approved', 'withdrawn']",BE0000055,Glycine receptor subunit beta,GLRB,Humans
2094,DB00431,Lindane,"['approved', 'withdrawn']",BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
2095,DB00431,Lindane,"['approved', 'withdrawn']",BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,Humans
2096,DB00431,Lindane,"['approved', 'withdrawn']",BE0000557,Progesterone receptor,PGR,Humans
2097,DB00431,Lindane,"['approved', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
2098,DB00431,Lindane,"['approved', 'withdrawn']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2100,DB00432,Trifluridine,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
2101,DB00433,Prochlorperazine,"['approved', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2102,DB00433,Prochlorperazine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
2103,DB00433,Prochlorperazine,"['approved', 'vet_approved']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2104,DB00433,Prochlorperazine,"['approved', 'vet_approved']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
2105,DB00434,Cyproheptadine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2106,DB00434,Cyproheptadine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2107,DB00434,Cyproheptadine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2108,DB00434,Cyproheptadine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
2109,DB00434,Cyproheptadine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
2110,DB00434,Cyproheptadine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2111,DB00434,Cyproheptadine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2112,DB00434,Cyproheptadine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2113,DB00434,Cyproheptadine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2114,DB00435,Nitric Oxide,['approved'],BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
2115,DB00435,Nitric Oxide,['approved'],BE0004778,Metallothionein-1A,MT1A,Humans
2116,DB00435,Nitric Oxide,['approved'],BE0000693,"Indoleamine 2,3-dioxygenase 1",IDO1,Humans
2117,DB00435,Nitric Oxide,['approved'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
2118,DB00436,Bendroflumethiazide,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
2119,DB00436,Bendroflumethiazide,['approved'],BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
2120,DB00436,Bendroflumethiazide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
2121,DB00436,Bendroflumethiazide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
2122,DB00436,Bendroflumethiazide,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
2123,DB00437,Allopurinol,['approved'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
2129,DB00439,Cerivastatin,"['approved', 'withdrawn']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
2132,DB00441,Gemcitabine,['approved'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
2133,DB00441,Gemcitabine,['approved'],BE0000324,Thymidylate synthase,TYMS,Humans
2134,DB00441,Gemcitabine,['approved'],BE0000637,UMP-CMP kinase,CMPK1,Humans
2136,DB00443,Betamethasone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
2137,DB00444,Teniposide,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
2139,DB00445,Epirubicin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
2142,DB00446,Chloramphenicol,"['approved', 'vet_approved', 'withdrawn']",BE0000929,Complement decay-accelerating factor,CD55,Humans
2145,DB00448,Lansoprazole,"['approved', 'investigational']",BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
2146,DB00448,Lansoprazole,"['approved', 'investigational']",BE0003474,Microtubule-associated protein tau,MAPT,Humans
2147,DB00449,Dipivefrin,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2148,DB00449,Dipivefrin,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2149,DB00449,Dipivefrin,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2150,DB00449,Dipivefrin,['approved'],BE0002180,Cholinesterase,BCHE,Humans
2151,DB00449,Dipivefrin,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
2152,DB00450,Droperidol,"['approved', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2153,DB00450,Droperidol,"['approved', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2154,DB00451,Levothyroxine,['approved'],BE0003576,Integrin alpha-V,ITGAV,Humans
2155,DB00451,Levothyroxine,['approved'],BE0001155,Integrin beta-3,ITGB3,Humans
2156,DB00451,Levothyroxine,['approved'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
2157,DB00451,Levothyroxine,['approved'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
2160,DB00452,Framycetin,['approved'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
2164,DB00454,Meperidine,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2165,DB00454,Meperidine,['approved'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
2166,DB00454,Meperidine,['approved'],BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
2167,DB00454,Meperidine,['approved'],BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
2168,DB00454,Meperidine,['approved'],BE0000454,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,Humans
2169,DB00454,Meperidine,['approved'],BE0000396,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,Humans
2170,DB00454,Meperidine,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
2171,DB00454,Meperidine,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
2172,DB00454,Meperidine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2173,DB00454,Meperidine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2174,DB00454,Meperidine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2175,DB00454,Meperidine,['approved'],BE0002705,Liver carboxylesterase 1,CES1,Humans
2176,DB00455,Loratadine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
2177,DB00455,Loratadine,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2186,DB00457,Prazosin,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2187,DB00457,Prazosin,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2188,DB00457,Prazosin,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2189,DB00457,Prazosin,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2190,DB00457,Prazosin,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2191,DB00457,Prazosin,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2192,DB00457,Prazosin,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2193,DB00458,Imipramine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2194,DB00458,Imipramine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2195,DB00458,Imipramine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2196,DB00458,Imipramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2197,DB00458,Imipramine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2198,DB00458,Imipramine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2199,DB00458,Imipramine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2200,DB00458,Imipramine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2201,DB00458,Imipramine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2202,DB00458,Imipramine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2203,DB00458,Imipramine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
2204,DB00458,Imipramine,['approved'],BE0003603,Potassium voltage-gated channel subfamily D member 2,KCND2,Humans
2205,DB00458,Imipramine,['approved'],BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
2206,DB00458,Imipramine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2207,DB00458,Imipramine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2208,DB00458,Imipramine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2209,DB00458,Imipramine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
2210,DB00458,Imipramine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
2211,DB00458,Imipramine,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2212,DB00458,Imipramine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2213,DB00458,Imipramine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2214,DB00458,Imipramine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
2215,DB00458,Imipramine,['approved'],BE0005191,Potassium voltage-gated channel subfamily H member 1,KCNH1,Humans
2216,DB00458,Imipramine,['approved'],BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
2217,DB00459,Acitretin,['approved'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
2218,DB00459,Acitretin,['approved'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
2219,DB00459,Acitretin,['approved'],BE0000206,Retinoic acid receptor beta,RARB,Humans
2220,DB00459,Acitretin,['approved'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
2221,DB00459,Acitretin,['approved'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
2222,DB00459,Acitretin,['approved'],BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
2223,DB00459,Acitretin,['approved'],BE0000301,Retinol-binding protein 1,RBP1,Humans
2225,DB00461,Nabumetone,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2226,DB00461,Nabumetone,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2227,DB00462,Methscopolamine bromide,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2228,DB00462,Methscopolamine bromide,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2229,DB00462,Methscopolamine bromide,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2230,DB00463,Metharbital,['withdrawn'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
2231,DB00463,Metharbital,['withdrawn'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
2232,DB00463,Metharbital,['withdrawn'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
2233,DB00463,Metharbital,['withdrawn'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
2234,DB00463,Metharbital,['withdrawn'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
2235,DB00463,Metharbital,['withdrawn'],BE0004797,GABA(A) Receptor,GABRA1,Humans
2236,DB00463,Metharbital,['withdrawn'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2237,DB00463,Metharbital,['withdrawn'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2238,DB00463,Metharbital,['withdrawn'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2239,DB00463,Metharbital,['withdrawn'],BE0000829,Glutamate receptor 2,GRIA2,Humans
2240,DB00463,Metharbital,['withdrawn'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
2241,DB00464,Sodium tetradecyl sulfate,"['approved', 'investigational']",BE0000943,Vitamin K-dependent protein S,PROS1,Humans
2242,DB00464,Sodium tetradecyl sulfate,"['approved', 'investigational']",BE0000380,Vitamin K-dependent protein C,PROC,Humans
2243,DB00465,Ketorolac,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2244,DB00465,Ketorolac,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2245,DB00466,Picrotoxin,['experimental'],BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,Humans
2246,DB00466,Picrotoxin,['experimental'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2247,DB00466,Picrotoxin,['experimental'],BE0000745,Glycine receptor subunit alpha-2,GLRA2,Humans
2248,DB00466,Picrotoxin,['experimental'],BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
2249,DB00466,Picrotoxin,['experimental'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
2252,DB00467,Enoxacin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
2254,DB00468,Quinine,['approved'],BE0000866,Platelet glycoprotein IX,GP9,Humans
2255,DB00468,Quinine,['approved'],BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,Humans
2256,DB00469,Tenoxicam,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2257,DB00469,Tenoxicam,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2258,DB00470,Dronabinol,"['approved', 'illicit']",BE0000061,Cannabinoid receptor 1,CNR1,Humans
2259,DB00470,Dronabinol,"['approved', 'illicit']",BE0000095,Cannabinoid receptor 2,CNR2,Humans
2260,DB00471,Montelukast,['approved'],BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
2261,DB00471,Montelukast,['approved'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
2262,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2263,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2264,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2265,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
2266,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
2267,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0004552,Cyclin-dependent kinases regulatory subunit 1,CKS1B,Humans
2268,DB00472,Fluoxetine,"['approved', 'vet_approved']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2269,DB00473,Hexylcaine,"['approved', 'withdrawn']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
2270,DB00473,Hexylcaine,"['approved', 'withdrawn']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
2271,DB00474,Methohexital,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2272,DB00475,Chlordiazepoxide,"['approved', 'illicit', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
2273,DB00475,Chlordiazepoxide,"['approved', 'illicit', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
2274,DB00476,Duloxetine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2275,DB00476,Duloxetine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2276,DB00476,Duloxetine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2277,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2278,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000020,Dopamine D1 receptor,DRD1,Humans
2279,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2280,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2281,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2282,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2283,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
2284,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2285,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0004889,D(1) dopamine receptor,DRD1,Humans
2286,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000581,Dopamine D3 receptor,DRD3,Humans
2287,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000389,Dopamine D4 receptor,DRD4,Humans
2288,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000145,Dopamine D5 receptor,DRD5,Humans
2289,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2290,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0004881,5-hydroxytryptamine 2 receptor,HTR2A,Humans
2291,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2292,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
2293,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2294,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2295,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000973,Sphingomyelin phosphodiesterase,SMPD1,Humans
2296,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000418,Calmodulin,CALM1,Humans
2297,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0004879,alpha1-acid glycoprotein,ORM1,Humans
2298,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
2299,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2300,DB00477,Chlorpromazine,"['approved', 'investigational', 'vet_approved']",BE0000146,Histamine H4 receptor,HRH4,Humans
2303,DB00480,Lenalidomide,['approved'],BE0004755,Protein cereblon,CRBN,Humans
2304,DB00480,Lenalidomide,['approved'],BE0003517,Tumor necrosis factor ligand superfamily member 11,TNFSF11,Humans
2305,DB00480,Lenalidomide,['approved'],BE0003403,Cadherin-5,CDH5,Humans
2306,DB00480,Lenalidomide,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2307,DB00481,Raloxifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
2308,DB00481,Raloxifene,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
2309,DB00481,Raloxifene,"['approved', 'investigational']",BE0008982,Serpin B9,SERPINB9,Humans
2310,DB00481,Raloxifene,"['approved', 'investigational']",BE0008981,Trefoil factor 1,TFF1,Humans
2311,DB00482,Celecoxib,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2312,DB00482,Celecoxib,"['approved', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
2313,DB00482,Celecoxib,"['approved', 'investigational']",BE0003625,Carbonic anhydrase 3,CA3,Humans
2314,DB00482,Celecoxib,"['approved', 'investigational']",BE0009698,Cadherin-11,CDH11,Humans
2315,DB00482,Celecoxib,"['approved', 'investigational']",BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
2316,DB00482,Celecoxib,"['approved', 'investigational']",BE0000914,Sialidase-1,NEU1,Humans
2317,DB00483,Gallamine triethiodide,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2318,DB00483,Gallamine triethiodide,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
2319,DB00483,Gallamine triethiodide,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2320,DB00483,Gallamine triethiodide,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2321,DB00483,Gallamine triethiodide,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
2322,DB00484,Brimonidine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2323,DB00484,Brimonidine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2324,DB00484,Brimonidine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
2331,DB00486,Nabilone,"['approved', 'investigational']",BE0000095,Cannabinoid receptor 2,CNR2,Humans
2332,DB00486,Nabilone,"['approved', 'investigational']",BE0000061,Cannabinoid receptor 1,CNR1,Humans
2335,DB00487,Pefloxacin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
2338,DB00489,Sotalol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2339,DB00489,Sotalol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2340,DB00489,Sotalol,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2341,DB00490,Buspirone,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2342,DB00490,Buspirone,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2343,DB00490,Buspirone,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
2344,DB00490,Buspirone,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
2345,DB00490,Buspirone,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2346,DB00491,Miglitol,['approved'],BE0000876,Lysosomal alpha-glucosidase,GAA,Humans
2347,DB00491,Miglitol,['approved'],BE0004698,Neutral alpha-glucosidase AB,GANAB,Humans
2348,DB00491,Miglitol,['approved'],BE0004699,Neutral alpha-glucosidase C,GANC,Humans
2349,DB00491,Miglitol,['approved'],BE0000837,"Maltase-glucoamylase, intestinal",MGAM,Humans
2350,DB00492,Fosinopril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
2356,DB00493,Cefotaxime,['approved'],BE0001066,Solute carrier family 22 member 6,SLC22A6,Humans
2357,DB00493,Cefotaxime,['approved'],BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
2358,DB00493,Cefotaxime,['approved'],BE0000879,Solute carrier family 22 member 11,SLC22A11,Humans
2359,DB00493,Cefotaxime,['approved'],BE0003646,Solute carrier family 22 member 7,SLC22A7,Humans
2360,DB00493,Cefotaxime,['approved'],BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
2361,DB00493,Cefotaxime,['approved'],BE0000530,Serum albumin,ALB,Humans
2363,DB00493,Cefotaxime,['approved'],BE0001134,Solute carrier family 15 member 2,SLC15A2,Humans
2364,DB00494,Entacapone,"['approved', 'investigational']",BE0002089,Catechol O-methyltransferase,COMT,Humans
2366,DB00495,Zidovudine,['approved'],BE0002449,Telomerase reverse transcriptase,TERT,Humans
2367,DB00496,Darifenacin,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2368,DB00496,Darifenacin,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2369,DB00496,Darifenacin,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2370,DB00496,Darifenacin,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2371,DB00496,Darifenacin,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
2372,DB00497,Oxycodone,"['approved', 'illicit', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
2373,DB00497,Oxycodone,"['approved', 'illicit', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2374,DB00497,Oxycodone,"['approved', 'illicit', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
2375,DB00498,Phenindione,"['approved', 'investigational']",BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
2376,DB00499,Flutamide,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
2377,DB00499,Flutamide,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
2378,DB00499,Flutamide,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2379,DB00500,Tolmetin,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2380,DB00500,Tolmetin,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2381,DB00501,Cimetidine,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
2382,DB00502,Haloperidol,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2383,DB00502,Haloperidol,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
2384,DB00502,Haloperidol,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2385,DB00502,Haloperidol,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
2386,DB00502,Haloperidol,['approved'],BE0003478,Melanin-concentrating hormone receptor 1,MCHR1,Humans
2387,DB00502,Haloperidol,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
2388,DB00502,Haloperidol,['approved'],BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
2389,DB00502,Haloperidol,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2390,DB00502,Haloperidol,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2391,DB00502,Haloperidol,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2392,DB00502,Haloperidol,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2393,DB00502,Haloperidol,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2394,DB00502,Haloperidol,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
2395,DB00502,Haloperidol,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2396,DB00502,Haloperidol,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
2397,DB00502,Haloperidol,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2398,DB00502,Haloperidol,['approved'],BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
2399,DB00502,Haloperidol,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
2401,DB00503,Ritonavir,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2402,DB00504,Levallorphan,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
2403,DB00505,Tridihexethyl,['withdrawn'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2404,DB00505,Tridihexethyl,['withdrawn'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2405,DB00505,Tridihexethyl,['withdrawn'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2407,DB00508,Triflupromazine,"['approved', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2408,DB00508,Triflupromazine,"['approved', 'vet_approved']",BE0000020,Dopamine D1 receptor,DRD1,Humans
2409,DB00508,Triflupromazine,"['approved', 'vet_approved']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
2410,DB00508,Triflupromazine,"['approved', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2411,DB00508,Triflupromazine,"['approved', 'vet_approved']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2412,DB00509,Dextrothyroxine,"['approved', 'investigational']",BE0000687,Thyroid hormone receptor alpha,THRA,Humans
2413,DB00509,Dextrothyroxine,"['approved', 'investigational']",BE0000315,Thyroid hormone receptor beta,THRB,Humans
2414,DB00509,Dextrothyroxine,"['approved', 'investigational']",BE0000507,Thyroid peroxidase,TPO,Humans
2415,DB00511,Acetyldigitoxin,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
2417,DB00513,Aminocaproic acid,"['approved', 'investigational']",BE0000211,Plasminogen,PLG,Humans
2418,DB00513,Aminocaproic acid,"['approved', 'investigational']",BE0001088,Tissue-type plasminogen activator,PLAT,Humans
2419,DB00513,Aminocaproic acid,"['approved', 'investigational']",BE0001283,Apolipoprotein(a),LPA,Humans
2420,DB00514,Dextromethorphan,['approved'],BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
2421,DB00514,Dextromethorphan,['approved'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
2422,DB00514,Dextromethorphan,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2423,DB00514,Dextromethorphan,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2424,DB00514,Dextromethorphan,['approved'],BE0004896,Membrane-associated progesterone receptor component 1,PGRMC1,Humans
2425,DB00514,Dextromethorphan,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
2426,DB00514,Dextromethorphan,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2427,DB00514,Dextromethorphan,['approved'],BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
2428,DB00514,Dextromethorphan,['approved'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
2429,DB00514,Dextromethorphan,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2430,DB00514,Dextromethorphan,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
2431,DB00514,Dextromethorphan,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
2432,DB00514,Dextromethorphan,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2433,DB00514,Dextromethorphan,['approved'],BE0004904,NADPH oxidase,CYBB,Humans
2434,DB00514,Dextromethorphan,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2436,DB00515,Cisplatin,['approved'],BE0008954,DNA-3-methyladenine glycosylase,MPG,Humans
2437,DB00515,Cisplatin,['approved'],BE0000910,Alpha-2-macroglobulin,A2M,Humans
2438,DB00515,Cisplatin,['approved'],BE0000510,Serotransferrin,TF,Humans
2439,DB00515,Cisplatin,['approved'],BE0002833,Copper transport protein ATOX1,ATOX1,Humans
2440,DB00517,Anisotropine methylbromide,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2441,DB00517,Anisotropine methylbromide,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2442,DB00517,Anisotropine methylbromide,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2444,DB00518,Albendazole,"['approved', 'vet_approved']",BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
2445,DB00518,Albendazole,"['approved', 'vet_approved']",BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
2447,DB00519,Trandolapril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
2449,DB00521,Carteolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2450,DB00521,Carteolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2451,DB00522,Bentiromide,"['investigational', 'withdrawn']",BE0002128,Serine protease hepsin,HPN,Humans
2452,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000663,Retinoic acid receptor alpha,RARA,Humans
2453,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
2454,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000206,Retinoic acid receptor beta,RARB,Humans
2455,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
2456,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000144,Retinoic acid receptor gamma,RARG,Humans
2457,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
2458,DB00523,Alitretinoin,"['approved', 'investigational']",BE0000970,Insulin-like growth factor-binding protein 3,IGFBP3,Humans
2459,DB00523,Alitretinoin,"['approved', 'investigational']",BE0008996,Pregnancy-specific beta-1-glycoprotein 5,PSG5,Humans
2460,DB00523,Alitretinoin,"['approved', 'investigational']",BE0009043,Cytochrome P450 26C1,CYP26C1,Humans
2461,DB00524,Metolazone,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
2464,DB00527,Cinchocaine,"['approved', 'vet_approved']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
2465,DB00527,Cinchocaine,"['approved', 'vet_approved']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
2466,DB00527,Cinchocaine,"['approved', 'vet_approved']",BE0000418,Calmodulin,CALM1,Humans
2467,DB00528,Lercanidipine,"['approved', 'investigational']",BE0000679,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,Humans
2470,DB00530,Erlotinib,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2471,DB00530,Erlotinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
2473,DB00531,Cyclophosphamide,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2474,DB00532,Mephenytoin,"['approved', 'investigational', 'withdrawn']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
2475,DB00532,Mephenytoin,"['approved', 'investigational', 'withdrawn']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2476,DB00533,Rofecoxib,"['approved', 'investigational', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2477,DB00533,Rofecoxib,"['approved', 'investigational', 'withdrawn']",BE0001046,Elastin,ELN,Humans
2478,DB00534,Chlormerodrin,"['approved', 'withdrawn']",BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
2479,DB00534,Chlormerodrin,"['approved', 'withdrawn']",BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,Humans
2482,DB00535,Cefdinir,['approved'],BE0001075,Myeloperoxidase,MPO,Humans
2484,DB00536,Guanidine,['approved'],BE0000133,"Aldehyde dehydrogenase, mitochondrial",ALDH2,Humans
2485,DB00536,Guanidine,['approved'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
2487,DB00536,Guanidine,['approved'],BE0004524,Disks large homolog 4,DLG4,Humans
2489,DB00536,Guanidine,['approved'],BE0000567,Guanidinoacetate N-methyltransferase,GAMT,Humans
2493,DB00537,Ciprofloxacin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
2494,DB00537,Ciprofloxacin,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2502,DB00539,Toremifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
2503,DB00539,Toremifene,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
2504,DB00540,Nortriptyline,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2505,DB00540,Nortriptyline,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2506,DB00540,Nortriptyline,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2507,DB00540,Nortriptyline,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2508,DB00540,Nortriptyline,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2509,DB00540,Nortriptyline,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2510,DB00540,Nortriptyline,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2511,DB00540,Nortriptyline,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2512,DB00540,Nortriptyline,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2513,DB00540,Nortriptyline,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
2514,DB00540,Nortriptyline,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
2515,DB00540,Nortriptyline,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
2516,DB00540,Nortriptyline,['approved'],BE0004897,Sigma receptor,PGRMC1,Humans
2518,DB00540,Nortriptyline,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
2519,DB00541,Vincristine,"['approved', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
2520,DB00541,Vincristine,"['approved', 'investigational']",BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
2521,DB00542,Benazepril,"['approved', 'investigational']",BE0000221,Angiotensin-converting enzyme,ACE,Humans
2522,DB00543,Amoxapine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2523,DB00543,Amoxapine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2524,DB00543,Amoxapine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
2525,DB00543,Amoxapine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
2526,DB00543,Amoxapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2527,DB00543,Amoxapine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2528,DB00543,Amoxapine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2529,DB00543,Amoxapine,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2530,DB00543,Amoxapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2531,DB00543,Amoxapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2532,DB00543,Amoxapine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
2533,DB00543,Amoxapine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2534,DB00543,Amoxapine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
2535,DB00543,Amoxapine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
2536,DB00543,Amoxapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2537,DB00543,Amoxapine,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2538,DB00543,Amoxapine,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
2539,DB00543,Amoxapine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
2540,DB00543,Amoxapine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
2541,DB00543,Amoxapine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2542,DB00543,Amoxapine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
2543,DB00543,Amoxapine,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
2544,DB00543,Amoxapine,['approved'],BE0000146,Histamine H4 receptor,HRH4,Humans
2545,DB00543,Amoxapine,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
2546,DB00543,Amoxapine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2549,DB00544,Fluorouracil,['approved'],BE0000324,Thymidylate synthase,TYMS,Humans
2550,DB00545,Pyridostigmine,"['approved', 'investigational']",BE0002180,Cholinesterase,BCHE,Humans
2551,DB00545,Pyridostigmine,"['approved', 'investigational']",BE0000426,Acetylcholinesterase,ACHE,Humans
2552,DB00546,Adinazolam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
2553,DB00546,Adinazolam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
2554,DB00547,Desoximetasone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
2556,DB00548,Azelaic acid,['approved'],BE0003610,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,Humans
2557,DB00548,Azelaic acid,['approved'],BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,Humans
2558,DB00548,Azelaic acid,['approved'],BE0000252,Tyrosinase,TYR,Humans
2560,DB00549,Zafirlukast,"['approved', 'investigational']",BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
2561,DB00550,Propylthiouracil,"['approved', 'investigational']",BE0000507,Thyroid peroxidase,TPO,Humans
2563,DB00551,Acetohydroxamic acid,['approved'],BE0001198,Macrophage metalloelastase,MMP12,Humans
2564,DB00552,Pentostatin,"['approved', 'investigational']",BE0002214,Adenosine deaminase,ADA,Humans
2566,DB00554,Piroxicam,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2567,DB00554,Piroxicam,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2568,DB00555,Lamotrigine,"['approved', 'investigational']",BE0009609,Voltage-dependent R-type calcium channel subunit alpha-1E (CACNA1E),CACNA1E,Humans
2569,DB00555,Lamotrigine,"['approved', 'investigational']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
2570,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
2571,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
2572,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2573,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2574,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2575,DB00555,Lamotrigine,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
2576,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2577,DB00555,Lamotrigine,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
2578,DB00555,Lamotrigine,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
2579,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
2580,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2581,DB00555,Lamotrigine,"['approved', 'investigational']",BE0004661,Acetylcholine receptor subunit alpha,CHRNA1,Humans
2582,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2583,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
2584,DB00555,Lamotrigine,"['approved', 'investigational']",BE0000640,Glutamate receptor 1,GRIA1,Humans
2585,DB00557,Hydroxyzine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
2586,DB00557,Hydroxyzine,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2589,DB00558,Zanamivir,"['approved', 'investigational']",BE0003200,Sialidase-2,NEU2,Humans
2590,DB00559,Bosentan,"['approved', 'investigational']",BE0000043,Endothelin B receptor,EDNRB,Humans
2591,DB00559,Bosentan,"['approved', 'investigational']",BE0000521,Endothelin-1 receptor,EDNRA,Humans
2598,DB00561,Doxapram,"['approved', 'vet_approved']",BE0003582,Potassium channel subfamily K member 3,KCNK3,Humans
2599,DB00561,Doxapram,"['approved', 'vet_approved']",BE0003583,Potassium channel subfamily K member 9,KCNK9,Humans
2600,DB00562,Benzthiazide,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
2601,DB00562,Benzthiazide,['approved'],BE0009965,Carbonic anhydrase,CA1,Humans
2602,DB00562,Benzthiazide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
2603,DB00562,Benzthiazide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
2604,DB00562,Benzthiazide,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
2605,DB00562,Benzthiazide,['approved'],BE0002437,Carbonic anhydrase 9,CA9,Humans
2606,DB00562,Benzthiazide,['approved'],BE0001653,Carbonic anhydrase 12,CA12,Humans
2607,DB00563,Methotrexate,['approved'],BE0000324,Thymidylate synthase,TYMS,Humans
2608,DB00563,Methotrexate,['approved'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
2609,DB00563,Methotrexate,['approved'],BE0000330,Dihydrofolate reductase,DHFR,Humans
2610,DB00564,Carbamazepine,"['approved', 'investigational']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
2611,DB00564,Carbamazepine,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2612,DB00564,Carbamazepine,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
2613,DB00565,Cisatracurium,"['approved', 'investigational']",BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,Humans
2614,DB00565,Cisatracurium,"['approved', 'investigational']",BE0004661,Acetylcholine receptor subunit alpha,CHRNA1,Humans
2615,DB00565,Cisatracurium,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2625,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
2626,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
2627,DB00568,Cinnarizine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
2628,DB00568,Cinnarizine,"['approved', 'investigational']",BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
2629,DB00568,Cinnarizine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
2630,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
2631,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
2632,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
2633,DB00568,Cinnarizine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2634,DB00568,Cinnarizine,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
2635,DB00568,Cinnarizine,"['approved', 'investigational']",BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
2636,DB00569,Fondaparinux,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
2637,DB00569,Fondaparinux,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
2638,DB00570,Vinblastine,['approved'],BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
2639,DB00570,Vinblastine,['approved'],BE0000143,Tubulin beta chain,TUBB,Humans
2640,DB00570,Vinblastine,['approved'],BE0003711,Tubulin delta chain,TUBD1,Humans
2641,DB00570,Vinblastine,['approved'],BE0003713,Tubulin gamma-1 chain,TUBG1,Humans
2642,DB00570,Vinblastine,['approved'],BE0003712,Tubulin epsilon chain,TUBE1,Humans
2643,DB00570,Vinblastine,['approved'],BE0001040,Transcription factor AP-1,JUN,Humans
2644,DB00571,Propranolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2645,DB00571,Propranolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2646,DB00571,Propranolol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
2647,DB00571,Propranolol,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2648,DB00571,Propranolol,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
2649,DB00572,Atropine,"['approved', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2650,DB00572,Atropine,"['approved', 'vet_approved']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2651,DB00572,Atropine,"['approved', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2652,DB00572,Atropine,"['approved', 'vet_approved']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2653,DB00572,Atropine,"['approved', 'vet_approved']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
2654,DB00572,Atropine,"['approved', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
2655,DB00572,Atropine,"['approved', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2656,DB00572,Atropine,"['approved', 'vet_approved']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
2657,DB00573,Fenoprofen,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2658,DB00573,Fenoprofen,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
2659,DB00573,Fenoprofen,['approved'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
2660,DB00573,Fenoprofen,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2661,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2662,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
2663,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2664,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
2665,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2666,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
2667,DB00574,Fenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2668,DB00575,Clonidine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2669,DB00575,Clonidine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
2670,DB00575,Clonidine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2671,DB00575,Clonidine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2672,DB00575,Clonidine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2673,DB00575,Clonidine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2679,DB00579,Mazindol,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
2680,DB00579,Mazindol,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
2681,DB00579,Mazindol,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2682,DB00579,Mazindol,"['approved', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
2683,DB00580,Valdecoxib,"['approved', 'investigational', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2684,DB00580,Valdecoxib,"['approved', 'investigational', 'withdrawn']",BE0000322,Carbonic anhydrase 2,CA2,Humans
2685,DB00580,Valdecoxib,"['approved', 'investigational', 'withdrawn']",BE0003625,Carbonic anhydrase 3,CA3,Humans
2688,DB00583,Levocarnitine,"['approved', 'investigational']",BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
2689,DB00583,Levocarnitine,"['approved', 'investigational']",BE0002705,Liver carboxylesterase 1,CES1,Humans
2690,DB00583,Levocarnitine,"['approved', 'investigational']",BE0001075,Myeloperoxidase,MPO,Humans
2691,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000406,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,Humans
2692,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000757,Solute carrier family 22 member 4,SLC22A4,Humans
2693,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000106,Solute carrier family 22 member 5,SLC22A5,Humans
2694,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000496,Carnitine O-acetyltransferase,CRAT,Humans
2695,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000097,Mitochondrial carnitine/acylcarnitine carrier protein CACL,SLC25A29,Humans
2696,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000579,Mitochondrial carnitine/acylcarnitine carrier protein,SLC25A20,Humans
2697,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000373,Peroxisomal carnitine O-octanoyltransferase,CROT,Humans
2698,DB00583,Levocarnitine,"['approved', 'investigational']",BE0000179,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,Humans
2699,DB00584,Enalapril,"['approved', 'vet_approved']",BE0000221,Angiotensin-converting enzyme,ACE,Humans
2700,DB00585,Nizatidine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
2701,DB00586,Diclofenac,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2702,DB00586,Diclofenac,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2703,DB00587,Cinalukast,['experimental'],BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
2704,DB00588,Fluticasone propionate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
2705,DB00588,Fluticasone propionate,['approved'],BE0000557,Progesterone receptor,PGR,Humans
2706,DB00588,Fluticasone propionate,['approved'],BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
2707,DB00588,Fluticasone propionate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
2708,DB00589,Lisuride,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
2709,DB00589,Lisuride,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
2710,DB00589,Lisuride,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
2711,DB00589,Lisuride,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2712,DB00589,Lisuride,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2713,DB00589,Lisuride,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
2714,DB00589,Lisuride,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
2715,DB00589,Lisuride,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2716,DB00589,Lisuride,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
2717,DB00589,Lisuride,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
2718,DB00589,Lisuride,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
2719,DB00589,Lisuride,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2720,DB00589,Lisuride,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2721,DB00589,Lisuride,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
2722,DB00589,Lisuride,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
2723,DB00590,Doxazosin,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2724,DB00590,Doxazosin,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2725,DB00590,Doxazosin,['approved'],BE0009629,HERG human cardiac K+ channel,KCNH2,Humans
2726,DB00590,Doxazosin,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2727,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
2728,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
2729,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0001170,Annexin A2,ANXA2,Humans
2730,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0003201,Annexin A3,ANXA3,Humans
2731,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0008969,Annexin A4,ANXA4,Humans
2732,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0004149,Annexin A5,ANXA5,Humans
2733,DB00591,Fluocinolone acetonide,"['approved', 'investigational', 'vet_approved']",BE0003997,Phospholipase A2,PLA2G1B,Humans
2734,DB00592,Piperazine,"['approved', 'vet_approved']",BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
2735,DB00593,Ethosuximide,['approved'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
2736,DB00594,Amiloride,['approved'],BE0000190,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,Humans
2737,DB00594,Amiloride,['approved'],BE0000024,Amiloride-sensitive sodium channel subunit beta,SCNN1B,Humans
2738,DB00594,Amiloride,['approved'],BE0000497,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,Humans
2739,DB00594,Amiloride,['approved'],BE0000495,Amiloride-sensitive sodium channel subunit delta,SCNN1D,Humans
2740,DB00594,Amiloride,['approved'],BE0000351,Amiloride-sensitive amine oxidase [copper-containing],AOC1,Humans
2741,DB00594,Amiloride,['approved'],BE0000678,Acid-sensing ion channel 2,ASIC2,Humans
2742,DB00594,Amiloride,['approved'],BE0000353,Acid-sensing ion channel 1,ASIC1,Humans
2743,DB00594,Amiloride,['approved'],BE0000752,Sodium/hydrogen exchanger 1,SLC9A1,Humans
2744,DB00594,Amiloride,['approved'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
2748,DB00596,Ulobetasol,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
2749,DB00598,Labetalol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2750,DB00598,Labetalol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2751,DB00598,Labetalol,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
2752,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
2753,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
2754,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
2755,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
2756,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
2757,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
2758,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2759,DB00599,Thiopental,"['approved', 'vet_approved']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2760,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000829,Glutamate receptor 2,GRIA2,Humans
2761,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
2762,DB00599,Thiopental,"['approved', 'vet_approved']",BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
2763,DB00599,Thiopental,"['approved', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2764,DB00600,Monobenzone,['approved'],BE0000252,Tyrosinase,TYR,Humans
2766,DB00603,Medroxyprogesterone acetate,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
2767,DB00603,Medroxyprogesterone acetate,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
2768,DB00603,Medroxyprogesterone acetate,"['approved', 'investigational']",BE0001032,P-glycoprotein 1,ABCB1,Humans
2769,DB00603,Medroxyprogesterone acetate,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
2770,DB00604,Cisapride,"['approved', 'investigational', 'withdrawn']",BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
2771,DB00604,Cisapride,"['approved', 'investigational', 'withdrawn']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
2772,DB00604,Cisapride,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2773,DB00604,Cisapride,"['approved', 'investigational', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2774,DB00605,Sulindac,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
2775,DB00605,Sulindac,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
2776,DB00605,Sulindac,"['approved', 'investigational']",BE0000747,Aldose reductase,AKR1B1,Humans
2777,DB00605,Sulindac,"['approved', 'investigational']",BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
2778,DB00605,Sulindac,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
2779,DB00605,Sulindac,"['approved', 'investigational']",BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
2780,DB00605,Sulindac,"['approved', 'investigational']",BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
2781,DB00606,Cyclothiazide,['approved'],BE0000229,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,Humans
2782,DB00606,Cyclothiazide,['approved'],BE0009965,Carbonic anhydrase,CA1,Humans
2783,DB00606,Cyclothiazide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
2784,DB00606,Cyclothiazide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
2785,DB00606,Cyclothiazide,['approved'],BE0009094,Secreted frizzled-related protein 4,SFRP4,Humans
2791,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0002189,Glutathione S-transferase A2,GSTA2,Humans
2792,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0000704,Tumor necrosis factor,TNF,Humans
2793,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0001171,Toll-like receptor 9,TLR9,Humans
2795,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0003428,High mobility group protein B1,HMGB1,Humans
2796,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
2797,DB00608,Chloroquine,"['approved', 'investigational', 'vet_approved']",BE0000982,Angiotensin-converting enzyme 2,ACE2,Humans
2800,DB00610,Metaraminol,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2801,DB00611,Butorphanol,"['approved', 'illicit', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2802,DB00611,Butorphanol,"['approved', 'illicit', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
2803,DB00611,Butorphanol,"['approved', 'illicit', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
2804,DB00612,Bisoprolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2805,DB00612,Bisoprolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2807,DB00613,Amodiaquine,"['approved', 'investigational']",BE0002436,Histamine N-methyltransferase,HNMT,Humans
2812,DB00615,Rifabutin,"['approved', 'investigational']",BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
2813,DB00615,Rifabutin,"['approved', 'investigational']",BE0001165,Endoplasmin,HSP90B1,Humans
2814,DB00616,Candoxatril,['experimental'],BE0000266,Neprilysin,MME,Humans
2815,DB00616,Candoxatril,['experimental'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
2816,DB00617,Paramethadione,['approved'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
2818,DB00618,Demeclocycline,['approved'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
2819,DB00619,Imatinib,['approved'],BE0004743,Breakpoint cluster region protein,BCR,Humans
2820,DB00619,Imatinib,['approved'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
2821,DB00619,Imatinib,['approved'],BE0001104,RET proto-oncogene,RET,Humans
2822,DB00619,Imatinib,['approved'],BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
2823,DB00619,Imatinib,['approved'],BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
2824,DB00619,Imatinib,['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
2825,DB00619,Imatinib,['approved'],BE0001124,Epithelial discoidin domain-containing receptor 1,DDR1,Humans
2826,DB00619,Imatinib,['approved'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
2827,DB00619,Imatinib,['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
2828,DB00619,Imatinib,['approved'],BE0004741,Discoidin domain-containing receptor 2,DDR2,Humans
2829,DB00620,Triamcinolone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
2830,DB00621,Oxandrolone,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
2831,DB00622,Nicardipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
2832,DB00622,Nicardipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
2833,DB00622,Nicardipine,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
2834,DB00622,Nicardipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
2835,DB00622,Nicardipine,"['approved', 'investigational']",BE0003565,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,Humans
2836,DB00622,Nicardipine,"['approved', 'investigational']",BE0003323,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,Humans
2837,DB00622,Nicardipine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2838,DB00622,Nicardipine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2839,DB00622,Nicardipine,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2840,DB00622,Nicardipine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2841,DB00622,Nicardipine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
2842,DB00622,Nicardipine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
2843,DB00622,Nicardipine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
2844,DB00622,Nicardipine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
2845,DB00622,Nicardipine,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
2846,DB00622,Nicardipine,"['approved', 'investigational']",BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
2847,DB00622,Nicardipine,"['approved', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
2848,DB00622,Nicardipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
2849,DB00622,Nicardipine,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
2850,DB00623,Fluphenazine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
2851,DB00623,Fluphenazine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
2852,DB00623,Fluphenazine,['approved'],BE0000418,Calmodulin,CALM1,Humans
2853,DB00623,Fluphenazine,['approved'],BE0000132,Androgen receptor,AR,Humans
2854,DB00623,Fluphenazine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2855,DB00623,Fluphenazine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2856,DB00624,Testosterone,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
2857,DB00624,Testosterone,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
2858,DB00624,Testosterone,"['approved', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
2861,DB00626,Bacitracin,"['approved', 'vet_approved']",BE0001183,Insulin-degrading enzyme,IDE,Humans
2862,DB00626,Bacitracin,"['approved', 'vet_approved']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
2863,DB00627,Niacin,"['approved', 'investigational', 'nutraceutical']",BE0000836,Hydroxycarboxylic acid receptor 3,HCAR3,Humans
2864,DB00627,Niacin,"['approved', 'investigational', 'nutraceutical']",BE0000635,Hydroxycarboxylic acid receptor 2,HCAR2,Humans
2865,DB00627,Niacin,"['approved', 'investigational', 'nutraceutical']",BE0000526,Nicotinate-nucleotide pyrophosphorylase [carboxylating],QPRT,Humans
2866,DB00627,Niacin,"['approved', 'investigational', 'nutraceutical']",BE0000783,Nicotinamide N-methyltransferase,NNMT,Humans
2867,DB00628,Clorazepic acid,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
2868,DB00628,Clorazepic acid,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
2869,DB00629,Guanabenz,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2870,DB00629,Guanabenz,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2871,DB00630,Alendronic acid,['approved'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
2873,DB00630,Alendronic acid,['approved'],BE0000980,Tyrosine-protein phosphatase non-receptor type 4,PTPN4,Humans
2874,DB00630,Alendronic acid,['approved'],BE0003567,Receptor-type tyrosine-protein phosphatase S,PTPRS,Humans
2875,DB00630,Alendronic acid,['approved'],BE0003568,Receptor-type tyrosine-protein phosphatase epsilon,PTPRE,Humans
2876,DB00630,Alendronic acid,['approved'],BE0003569,V-type proton ATPase catalytic subunit A,ATP6V1A,Humans
2878,DB00631,Clofarabine,"['approved', 'investigational']",BE0000546,DNA polymerase alpha catalytic subunit,POLA1,Humans
2879,DB00631,Clofarabine,"['approved', 'investigational']",BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
2882,DB00633,Dexmedetomidine,"['approved', 'vet_approved']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2886,DB00635,Prednisone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
2887,DB00636,Clofibrate,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
2888,DB00637,Astemizole,"['approved', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
2889,DB00637,Astemizole,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2890,DB00637,Astemizole,"['approved', 'withdrawn']",BE0005191,Potassium voltage-gated channel subfamily H member 1,KCNH1,Humans
2891,DB00637,Astemizole,"['approved', 'withdrawn']",BE0003474,Microtubule-associated protein tau,MAPT,Humans
2894,DB00640,Adenosine,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
2895,DB00640,Adenosine,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
2896,DB00640,Adenosine,"['approved', 'investigational']",BE0000241,Adenosine receptor A2b,ADORA2B,Humans
2897,DB00640,Adenosine,"['approved', 'investigational']",BE0000354,Adenosine receptor A3,ADORA3,Humans
2898,DB00641,Simvastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
2899,DB00641,Simvastatin,['approved'],BE0000516,Integrin alpha-L,ITGAL,Humans
2900,DB00641,Simvastatin,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
2901,DB00642,Pemetrexed,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
2902,DB00642,Pemetrexed,"['approved', 'investigational']",BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
2903,DB00642,Pemetrexed,"['approved', 'investigational']",BE0000330,Dihydrofolate reductase,DHFR,Humans
2904,DB00642,Pemetrexed,"['approved', 'investigational']",BE0000882,Trifunctional purine biosynthetic protein adenosine-3,GART,Humans
2905,DB00643,Mebendazole,"['approved', 'vet_approved']",BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
2906,DB00643,Mebendazole,"['approved', 'vet_approved']",BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
2907,DB00644,Gonadorelin,"['approved', 'investigational', 'vet_approved']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
2909,DB00645,Dyclonine,['approved'],BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
2911,DB00647,Dextropropoxyphene,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
2912,DB00647,Dextropropoxyphene,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
2913,DB00647,Dextropropoxyphene,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2914,DB00647,Dextropropoxyphene,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0002705,Liver carboxylesterase 1,CES1,Humans
2915,DB00647,Dextropropoxyphene,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0004956,NMDA receptor,GRIN1,Humans
2916,DB00648,Mitotane,['approved'],BE0000731,"Cytochrome P450 11B1, mitochondrial",CYP11B1,Humans
2917,DB00648,Mitotane,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
2918,DB00648,Mitotane,['approved'],BE0000557,Progesterone receptor,PGR,Humans
2919,DB00648,Mitotane,['approved'],BE0000132,Androgen receptor,AR,Humans
2920,DB00648,Mitotane,['approved'],BE0000242,"Adrenodoxin, mitochondrial",FDX1,Humans
2922,DB00651,Dyphylline,['approved'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
2923,DB00651,Dyphylline,['approved'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
2924,DB00651,Dyphylline,['approved'],BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
2925,DB00651,Dyphylline,['approved'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
2926,DB00651,Dyphylline,['approved'],BE0000013,Adenosine receptor A1,ADORA1,Humans
2927,DB00651,Dyphylline,['approved'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
2928,DB00652,Pentazocine,"['approved', 'vet_approved']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
2929,DB00652,Pentazocine,"['approved', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
2930,DB00652,Pentazocine,"['approved', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
2931,DB00653,Magnesium sulfate,"['approved', 'investigational', 'vet_approved']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
2932,DB00654,Latanoprost,"['approved', 'investigational']",BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
2933,DB00655,Estrone,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
2934,DB00655,Estrone,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
2935,DB00655,Estrone,['approved'],BE0000132,Androgen receptor,AR,Humans
2936,DB00655,Estrone,['approved'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
2937,DB00655,Estrone,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
2938,DB00656,Trazodone,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
2939,DB00656,Trazodone,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
2940,DB00656,Trazodone,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2941,DB00656,Trazodone,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2942,DB00656,Trazodone,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
2943,DB00656,Trazodone,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2944,DB00656,Trazodone,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2946,DB00657,Mecamylamine,"['approved', 'investigational']",BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
2947,DB00657,Mecamylamine,"['approved', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2948,DB00657,Mecamylamine,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
2949,DB00657,Mecamylamine,"['approved', 'investigational']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
2951,DB00659,Acamprosate,"['approved', 'investigational']",BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
2952,DB00659,Acamprosate,"['approved', 'investigational']",BE0001192,Metabotropic glutamate receptor 5,GRM5,Humans
2953,DB00659,Acamprosate,"['approved', 'investigational']",BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
2954,DB00661,Verapamil,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
2955,DB00661,Verapamil,['approved'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
2956,DB00661,Verapamil,['approved'],BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,Humans
2957,DB00661,Verapamil,['approved'],BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
2958,DB00661,Verapamil,['approved'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
2959,DB00661,Verapamil,['approved'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
2960,DB00661,Verapamil,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2961,DB00661,Verapamil,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
2962,DB00661,Verapamil,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2963,DB00661,Verapamil,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2964,DB00661,Verapamil,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2965,DB00661,Verapamil,['approved'],BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
2966,DB00661,Verapamil,['approved'],BE0001032,P-glycoprotein 1,ABCB1,Humans
2967,DB00663,Flumethasone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
2969,DB00665,Nilutamide,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
2970,DB00666,Nafarelin,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
2972,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
2973,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
2974,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
2975,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
2976,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
2977,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
2978,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
2979,DB00668,Epinephrine,"['approved', 'vet_approved']",BE0000704,Tumor necrosis factor,TNF,Humans
2980,DB00669,Sumatriptan,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
2981,DB00669,Sumatriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
2982,DB00669,Sumatriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
2983,DB00669,Sumatriptan,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
2984,DB00670,Pirenzepine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
2986,DB00672,Chlorpropamide,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
2987,DB00673,Aprepitant,"['approved', 'investigational']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
2988,DB00674,Galantamine,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
2989,DB00674,Galantamine,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
2991,DB00674,Galantamine,['approved'],BE0002180,Cholinesterase,BCHE,Humans
2992,DB00675,Tamoxifen,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
2993,DB00675,Tamoxifen,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
2994,DB00675,Tamoxifen,['approved'],BE0004895,Protein kinase C,PRKCA,Humans
2995,DB00675,Tamoxifen,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
2996,DB00675,Tamoxifen,['approved'],BE0004877,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",EBP,Humans
2997,DB00675,Tamoxifen,['approved'],BE0000132,Androgen receptor,AR,Humans
2998,DB00675,Tamoxifen,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
2999,DB00675,Tamoxifen,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3000,DB00675,Tamoxifen,['approved'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
3001,DB00675,Tamoxifen,['approved'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
3002,DB00677,Isoflurophate,"['approved', 'investigational', 'withdrawn']",BE0000426,Acetylcholinesterase,ACHE,Humans
3003,DB00677,Isoflurophate,"['approved', 'investigational', 'withdrawn']",BE0002180,Cholinesterase,BCHE,Humans
3004,DB00677,Isoflurophate,"['approved', 'investigational', 'withdrawn']",BE0000510,Serotransferrin,TF,Humans
3005,DB00678,Losartan,['approved'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
3006,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3007,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
3008,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3009,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3010,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3011,DB00679,Thioridazine,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
3012,DB00680,Moricizine,"['approved', 'investigational', 'withdrawn']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3014,DB00682,Warfarin,['approved'],BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
3015,DB00682,Warfarin,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3016,DB00683,Midazolam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3017,DB00683,Midazolam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3024,DB00685,Trovafloxacin,"['approved', 'investigational', 'withdrawn']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
3025,DB00686,Pentosan polysulfate,['approved'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
3026,DB00686,Pentosan polysulfate,['approved'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
3027,DB00686,Pentosan polysulfate,['approved'],BE0000326,Fibroblast growth factor 4,FGF4,Humans
3028,DB00687,Fludrocortisone,"['approved', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
3029,DB00687,Fludrocortisone,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
3030,DB00688,Mycophenolate mofetil,"['approved', 'investigational']",BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
3031,DB00688,Mycophenolate mofetil,"['approved', 'investigational']",BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
3032,DB00688,Mycophenolate mofetil,"['approved', 'investigational']",BE0004520,6-pyruvoyl tetrahydrobiopterin synthase,PTS,Humans
3034,DB00690,Flurazepam,"['approved', 'illicit', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3035,DB00690,Flurazepam,"['approved', 'illicit', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3036,DB00691,Moexipril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
3037,DB00692,Phentolamine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3038,DB00692,Phentolamine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3039,DB00692,Phentolamine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3040,DB00692,Phentolamine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3044,DB00694,Daunorubicin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
3045,DB00694,Daunorubicin,['approved'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
3046,DB00695,Furosemide,"['approved', 'vet_approved']",BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
3047,DB00695,Furosemide,"['approved', 'vet_approved']",BE0000322,Carbonic anhydrase 2,CA2,Humans
3048,DB00695,Furosemide,"['approved', 'vet_approved']",BE0005562,G-protein coupled receptor 35,GPR35,Humans
3049,DB00696,Ergotamine,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3050,DB00696,Ergotamine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3051,DB00696,Ergotamine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3052,DB00696,Ergotamine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3053,DB00696,Ergotamine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3054,DB00696,Ergotamine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3055,DB00696,Ergotamine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3056,DB00696,Ergotamine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3057,DB00696,Ergotamine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
3058,DB00696,Ergotamine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3059,DB00696,Ergotamine,['approved'],BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
3060,DB00696,Ergotamine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3061,DB00696,Ergotamine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
3062,DB00696,Ergotamine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3063,DB00697,Tizanidine,"['approved', 'investigational']",BE0003580,Nischarin,NISCH,Humans
3064,DB00697,Tizanidine,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
3065,DB00697,Tizanidine,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
3069,DB00699,Nicergoline,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3070,DB00700,Eplerenone,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
3072,DB00703,Methazolamide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
3073,DB00703,Methazolamide,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
3074,DB00703,Methazolamide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
3075,DB00703,Methazolamide,['approved'],BE0003629,Carbonic anhydrase 7,CA7,Humans
3076,DB00703,Methazolamide,['approved'],BE0003625,Carbonic anhydrase 3,CA3,Humans
3077,DB00704,Naltrexone,"['approved', 'investigational', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3078,DB00704,Naltrexone,"['approved', 'investigational', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3079,DB00704,Naltrexone,"['approved', 'investigational', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
3080,DB00704,Naltrexone,"['approved', 'investigational', 'vet_approved']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
3082,DB00706,Tamsulosin,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3083,DB00706,Tamsulosin,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3084,DB00706,Tamsulosin,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3085,DB00707,Porfimer sodium,"['approved', 'investigational']",BE0000499,Low-density lipoprotein receptor,LDLR,Humans
3086,DB00707,Porfimer sodium,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
3087,DB00708,Sufentanil,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3088,DB00708,Sufentanil,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
3089,DB00708,Sufentanil,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3094,DB00710,Ibandronate,"['approved', 'investigational']",BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
3095,DB00710,Ibandronate,"['approved', 'investigational']",BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
3096,DB00711,Diethylcarbamazine,"['approved', 'investigational', 'vet_approved']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
3097,DB00711,Diethylcarbamazine,"['approved', 'investigational', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3098,DB00712,Flurbiprofen,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3099,DB00712,Flurbiprofen,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3106,DB00713,Oxacillin,"['approved', 'investigational']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
3108,DB00713,Oxacillin,"['approved', 'investigational']",BE0001134,Solute carrier family 15 member 2,SLC15A2,Humans
3110,DB00714,Apomorphine,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
3111,DB00714,Apomorphine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3112,DB00714,Apomorphine,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
3113,DB00714,Apomorphine,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
3114,DB00714,Apomorphine,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
3115,DB00714,Apomorphine,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3116,DB00714,Apomorphine,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3117,DB00714,Apomorphine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3118,DB00714,Apomorphine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3119,DB00714,Apomorphine,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
3120,DB00714,Apomorphine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3121,DB00714,Apomorphine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3122,DB00714,Apomorphine,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3123,DB00714,Apomorphine,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3124,DB00715,Paroxetine,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3125,DB00715,Paroxetine,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3126,DB00715,Paroxetine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3127,DB00715,Paroxetine,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
3128,DB00715,Paroxetine,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
3129,DB00715,Paroxetine,"['approved', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
3130,DB00715,Paroxetine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3131,DB00715,Paroxetine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3132,DB00715,Paroxetine,"['approved', 'investigational']",BE0004862,Serotonin Receptors,HTR1A,Humans
3133,DB00715,Paroxetine,"['approved', 'investigational']",BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
3134,DB00715,Paroxetine,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
3135,DB00715,Paroxetine,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
3136,DB00716,Nedocromil,"['approved', 'investigational']",BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
3137,DB00716,Nedocromil,"['approved', 'investigational']",BE0000099,Cysteinyl leukotriene receptor 2,CYSLTR2,Humans
3138,DB00716,Nedocromil,"['approved', 'investigational']",BE0000995,fMet-Leu-Phe receptor,FPR1,Humans
3139,DB00716,Nedocromil,"['approved', 'investigational']",BE0000296,Prostaglandin D2 receptor,PTGDR,Humans
3140,DB00716,Nedocromil,"['approved', 'investigational']",BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
3141,DB00717,Norethisterone,['approved'],BE0000557,Progesterone receptor,PGR,Humans
3142,DB00717,Norethisterone,['approved'],BE0000132,Androgen receptor,AR,Humans
3143,DB00717,Norethisterone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3145,DB00719,Azatadine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3147,DB00720,Clodronic acid,"['approved', 'investigational', 'vet_approved']",BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
3148,DB00720,Clodronic acid,"['approved', 'investigational', 'vet_approved']",BE0000709,ADP/ATP translocase 2,SLC25A5,Humans
3149,DB00720,Clodronic acid,"['approved', 'investigational', 'vet_approved']",BE0000624,ADP/ATP translocase 3,SLC25A6,Humans
3150,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
3151,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
3152,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3153,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3154,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
3155,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
3156,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
3157,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0009743,60 kDa lysophospholipase,ASPG,Humans
3158,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0004909,Monoamine oxidase,MAOA,Humans
3159,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
3160,DB00721,Procaine,"['approved', 'investigational', 'vet_approved']",BE0009880,DNA (cytosine-5)-methyltransferase 3A,DNMT3A,Humans
3161,DB00722,Lisinopril,"['approved', 'investigational']",BE0000221,Angiotensin-converting enzyme,ACE,Humans
3162,DB00722,Lisinopril,"['approved', 'investigational']",BE0000270,Renin,REN,Humans
3163,DB00723,Methoxamine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3164,DB00723,Methoxamine,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3165,DB00723,Methoxamine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3166,DB00724,Imiquimod,"['approved', 'investigational']",BE0000155,Toll-like receptor 7,TLR7,Humans
3167,DB00724,Imiquimod,"['approved', 'investigational']",BE0003518,Toll-like receptor 8,TLR8,Humans
3168,DB00725,Homatropine methylbromide,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3169,DB00725,Homatropine methylbromide,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3170,DB00725,Homatropine methylbromide,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3171,DB00725,Homatropine methylbromide,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3172,DB00725,Homatropine methylbromide,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3173,DB00726,Trimipramine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3174,DB00726,Trimipramine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3175,DB00726,Trimipramine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3176,DB00726,Trimipramine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3177,DB00726,Trimipramine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3178,DB00726,Trimipramine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3179,DB00726,Trimipramine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3180,DB00726,Trimipramine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3181,DB00726,Trimipramine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3182,DB00726,Trimipramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3183,DB00726,Trimipramine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3184,DB00726,Trimipramine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3185,DB00726,Trimipramine,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3186,DB00726,Trimipramine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3187,DB00726,Trimipramine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
3188,DB00726,Trimipramine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
3189,DB00726,Trimipramine,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
3191,DB00727,Nitroglycerin,"['approved', 'investigational']",BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
3192,DB00728,Rocuronium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
3193,DB00728,Rocuronium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3194,DB00728,Rocuronium,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3196,DB00731,Nateglinide,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
3197,DB00731,Nateglinide,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
3198,DB00732,Atracurium besylate,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
3199,DB00733,Pralidoxime,"['approved', 'vet_approved']",BE0000426,Acetylcholinesterase,ACHE,Humans
3200,DB00733,Pralidoxime,"['approved', 'vet_approved']",BE0002180,Cholinesterase,BCHE,Humans
3201,DB00734,Risperidone,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3202,DB00734,Risperidone,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3203,DB00734,Risperidone,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3204,DB00734,Risperidone,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3205,DB00734,Risperidone,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3206,DB00734,Risperidone,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3207,DB00734,Risperidone,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3208,DB00734,Risperidone,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3209,DB00734,Risperidone,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3210,DB00734,Risperidone,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3211,DB00734,Risperidone,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
3213,DB00734,Risperidone,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
3214,DB00735,Naftifine,['approved'],BE0000577,Squalene monooxygenase,SQLE,Humans
3215,DB00736,Esomeprazole,"['approved', 'investigational']",BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
3216,DB00736,Esomeprazole,"['approved', 'investigational']",BE0000766,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,Humans
3217,DB00737,Meclizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3218,DB00737,Meclizine,['approved'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
3219,DB00738,Pentamidine,"['approved', 'investigational']",BE0002517,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,Humans
3226,DB00740,Riluzole,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3227,DB00740,Riluzole,"['approved', 'investigational']",BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
3228,DB00741,Hydrocortisone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
3229,DB00741,Hydrocortisone,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
3230,DB00744,Zileuton,"['approved', 'investigational', 'withdrawn']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
3231,DB00745,Modafinil,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3232,DB00745,Modafinil,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3235,DB00746,Deferoxamine,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
3236,DB00747,Scopolamine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3237,DB00747,Scopolamine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3238,DB00747,Scopolamine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3239,DB00747,Scopolamine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3240,DB00747,Scopolamine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3241,DB00747,Scopolamine,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3242,DB00747,Scopolamine,"['approved', 'investigational']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
3243,DB00747,Scopolamine,"['approved', 'investigational']",BE0001176,"Sucrase-isomaltase, intestinal",SI,Humans
3244,DB00748,Carbinoxamine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3245,DB00749,Etodolac,"['approved', 'investigational', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3246,DB00749,Etodolac,"['approved', 'investigational', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3247,DB00749,Etodolac,"['approved', 'investigational', 'vet_approved']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
3248,DB00750,Prilocaine,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3249,DB00751,Epinastine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3250,DB00751,Epinastine,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
3251,DB00751,Epinastine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3252,DB00751,Epinastine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3253,DB00751,Epinastine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3254,DB00751,Epinastine,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
3255,DB00752,Tranylcypromine,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
3256,DB00752,Tranylcypromine,"['approved', 'investigational']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
3257,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
3258,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000218,Calcium-transporting ATPase type 2C member 1,ATP2C1,Humans
3259,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
3260,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000640,Glutamate receptor 1,GRIA1,Humans
3261,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
3262,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3263,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000484,"ATP synthase subunit delta, mitochondrial",ATP5D,Humans
3264,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000418,Calmodulin,CALM1,Humans
3265,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3266,DB00753,Isoflurane,"['approved', 'vet_approved']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
3267,DB00754,Ethotoin,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3268,DB00754,Ethotoin,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3269,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
3270,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
3271,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000144,Retinoic acid receptor gamma,RARG,Humans
3272,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000554,Retinal dehydrogenase 1,ALDH1A1,Humans
3273,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000697,Retinoic acid-induced protein 3,GPRC5A,Humans
3274,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000513,Retinal dehydrogenase 2,ALDH1A2,Humans
3275,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000653,Retinoic acid receptor responder protein 1,RARRES1,Humans
3276,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000663,Retinoic acid receptor alpha,RARA,Humans
3277,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000206,Retinoic acid receptor beta,RARB,Humans
3278,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0005828,Lipocalin-1,LCN1,Humans
3279,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0005829,Odorant-binding protein 2a,OBP2A,Humans
3280,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000314,Retinol-binding protein 4,RBP4,Humans
3281,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0004284,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",PDK4,Humans
3282,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
3283,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0003480,Cytochrome P450 26A1,CYP26A1,Humans
3284,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0009044,Cytochrome P450 26B1,CYP26B1,Humans
3285,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0009043,Cytochrome P450 26C1,CYP26C1,Humans
3286,DB00755,Tretinoin,"['approved', 'investigational', 'nutraceutical']",BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
3289,DB00756,Hexachlorophene,"['approved', 'withdrawn']",BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,Humans
3290,DB00756,Hexachlorophene,"['approved', 'withdrawn']",BE0000180,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,Humans
3291,DB00756,Hexachlorophene,"['approved', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
3292,DB00757,Dolasetron,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3293,DB00758,Clopidogrel,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
3300,DB00759,Tetracycline,"['approved', 'vet_approved', 'withdrawn']",BE0001105,Major prion protein,PRNP,Humans
3302,DB00759,Tetracycline,"['approved', 'vet_approved', 'withdrawn']",BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
3304,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000281,Solute carrier family 12 member 2,SLC12A2,Humans
3305,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
3306,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000047,Solute carrier family 12 member 5,SLC12A5,Humans
3307,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000140,Solute carrier family 12 member 6,SLC12A6,Humans
3308,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000276,Solute carrier family 12 member 7,SLC12A7,Humans
3309,DB00761,Potassium chloride,"['approved', 'withdrawn']",BE0000601,Solute carrier family 12 member 4,SLC12A4,Humans
3310,DB00762,Irinotecan,"['approved', 'investigational']",BE0000091,"DNA topoisomerase I, mitochondrial",TOP1MT,Humans
3311,DB00762,Irinotecan,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
3312,DB00763,Methimazole,['approved'],BE0000507,Thyroid peroxidase,TPO,Humans
3313,DB00764,Mometasone,['experimental'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3314,DB00764,Mometasone,['experimental'],BE0000557,Progesterone receptor,PGR,Humans
3315,DB00765,Metyrosine,['approved'],BE0000614,Tyrosine 3-monooxygenase,TH,Humans
3317,DB00767,Benzquinamide,['withdrawn'],BE0000442,Histamine H1 receptor,HRH1,Humans
3318,DB00767,Benzquinamide,['withdrawn'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3319,DB00767,Benzquinamide,['withdrawn'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3320,DB00767,Benzquinamide,['withdrawn'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3321,DB00767,Benzquinamide,['withdrawn'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3322,DB00767,Benzquinamide,['withdrawn'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3323,DB00768,Olopatadine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3324,DB00768,Olopatadine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
3325,DB00768,Olopatadine,['approved'],BE0000968,Histamine H3 receptor,HRH3,Humans
3326,DB00768,Olopatadine,['approved'],BE0001090,Protein S100-A1,S100A1,Humans
3327,DB00768,Olopatadine,['approved'],BE0001206,Protein S100-A12,S100A12,Humans
3328,DB00768,Olopatadine,['approved'],BE0001177,Protein S100-B,S100B,Humans
3329,DB00768,Olopatadine,['approved'],BE0000885,Protein S100-A13,S100A13,Humans
3330,DB00768,Olopatadine,['approved'],BE0003602,Protein S100-A2,S100A2,Humans
3331,DB00769,Hydrocortamate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3332,DB00770,Alprostadil,"['approved', 'investigational']",BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
3333,DB00770,Alprostadil,"['approved', 'investigational']",BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
3334,DB00770,Alprostadil,"['approved', 'investigational']",BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
3335,DB00771,Clidinium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3336,DB00772,Malathion,"['approved', 'investigational']",BE0002180,Cholinesterase,BCHE,Humans
3337,DB00773,Etoposide,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
3338,DB00773,Etoposide,['approved'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
3339,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
3340,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0003629,Carbonic anhydrase 7,CA7,Humans
3341,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0002437,Carbonic anhydrase 9,CA9,Humans
3342,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
3343,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
3344,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000267,Carbonic anhydrase 1,CA1,Humans
3345,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000322,Carbonic anhydrase 2,CA2,Humans
3346,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0000535,Carbonic anhydrase 4,CA4,Humans
3347,DB00774,Hydroflumethiazide,"['approved', 'investigational', 'withdrawn']",BE0001653,Carbonic anhydrase 12,CA12,Humans
3348,DB00775,Tirofiban,['approved'],BE0000439,Integrin alpha-IIb,ITGA2B,Humans
3349,DB00775,Tirofiban,['approved'],BE0001155,Integrin beta-3,ITGB3,Humans
3350,DB00776,Oxcarbazepine,['approved'],BE0004901,Sodium channel protein,SCN1A,Humans
3351,DB00777,Propiomazine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3352,DB00777,Propiomazine,['approved'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
3353,DB00777,Propiomazine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3354,DB00777,Propiomazine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3355,DB00777,Propiomazine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3356,DB00777,Propiomazine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3358,DB00778,Roxithromycin,"['approved', 'investigational', 'withdrawn']",BE0001032,P-glycoprotein 1,ABCB1,Humans
3360,DB00780,Phenelzine,['approved'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
3361,DB00780,Phenelzine,['approved'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
3362,DB00780,Phenelzine,['approved'],BE0001002,Membrane primary amine oxidase,AOC3,Humans
3363,DB00780,Phenelzine,['approved'],BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
3364,DB00780,Phenelzine,['approved'],BE0000667,Alanine aminotransferase 1,GPT,Humans
3365,DB00780,Phenelzine,['approved'],BE0002166,Alanine aminotransferase 2,GPT2,Humans
3367,DB00782,Propantheline,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3368,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
3369,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
3370,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3371,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3372,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
3373,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
3374,DB00783,Estradiol,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
3375,DB00784,Mefenamic acid,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3376,DB00784,Mefenamic acid,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3377,DB00785,Cryptenamine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3378,DB00785,Cryptenamine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
3379,DB00786,Marimastat,['investigational'],BE0000920,Interstitial collagenase,MMP1,Humans
3380,DB00786,Marimastat,['investigational'],BE0000642,72 kDa type IV collagenase,MMP2,Humans
3381,DB00786,Marimastat,['investigational'],BE0001116,Stromelysin-1,MMP3,Humans
3382,DB00786,Marimastat,['investigational'],BE0003690,Matrilysin,MMP7,Humans
3383,DB00786,Marimastat,['investigational'],BE0001182,Neutrophil collagenase,MMP8,Humans
3384,DB00786,Marimastat,['investigational'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
3385,DB00786,Marimastat,['investigational'],BE0003689,Stromelysin-2,MMP10,Humans
3386,DB00786,Marimastat,['investigational'],BE0003691,Stromelysin-3,MMP11,Humans
3387,DB00786,Marimastat,['investigational'],BE0001198,Macrophage metalloelastase,MMP12,Humans
3388,DB00786,Marimastat,['investigational'],BE0000966,Collagenase 3,MMP13,Humans
3389,DB00786,Marimastat,['investigational'],BE0003692,Matrix metalloproteinase-14,MMP14,Humans
3390,DB00786,Marimastat,['investigational'],BE0003693,Matrix metalloproteinase-15,MMP15,Humans
3391,DB00786,Marimastat,['investigational'],BE0001637,Matrix metalloproteinase-16,MMP16,Humans
3392,DB00786,Marimastat,['investigational'],BE0003694,Matrix metalloproteinase-17,MMP17,Humans
3393,DB00786,Marimastat,['investigational'],BE0003695,Matrix metalloproteinase-19,MMP19,Humans
3394,DB00786,Marimastat,['investigational'],BE0003696,Matrix metalloproteinase-20,MMP20,Humans
3395,DB00786,Marimastat,['investigational'],BE0003697,Matrix metalloproteinase-21,MMP21,Humans
3397,DB00786,Marimastat,['investigational'],BE0003699,Matrix metalloproteinase-24,MMP24,Humans
3398,DB00786,Marimastat,['investigational'],BE0009742,Matrix metalloproteinase-25,MMP25,Humans
3399,DB00786,Marimastat,['investigational'],BE0003701,Matrix metalloproteinase-26,MMP26,Humans
3400,DB00786,Marimastat,['investigational'],BE0003702,Matrix metalloproteinase-27,MMP27,Humans
3401,DB00786,Marimastat,['investigational'],BE0003703,Matrix metalloproteinase-28,MMP28,Humans
3405,DB00788,Naproxen,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3406,DB00788,Naproxen,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3408,DB00789,Gadopentetic acid,['approved'],BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,Humans
3409,DB00790,Perindopril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
3410,DB00790,Perindopril,['approved'],BE0009094,Secreted frizzled-related protein 4,SFRP4,Humans
3412,DB00792,Tripelennamine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
3413,DB00794,Primidone,"['approved', 'vet_approved']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
3414,DB00794,Primidone,"['approved', 'vet_approved']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
3415,DB00794,Primidone,"['approved', 'vet_approved']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
3416,DB00794,Primidone,"['approved', 'vet_approved']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
3417,DB00794,Primidone,"['approved', 'vet_approved']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
3418,DB00794,Primidone,"['approved', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3419,DB00794,Primidone,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
3420,DB00794,Primidone,"['approved', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3421,DB00794,Primidone,"['approved', 'vet_approved']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
3422,DB00794,Primidone,"['approved', 'vet_approved']",BE0000829,Glutamate receptor 2,GRIA2,Humans
3423,DB00794,Primidone,"['approved', 'vet_approved']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
3424,DB00795,Sulfasalazine,['approved'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
3425,DB00795,Sulfasalazine,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3426,DB00795,Sulfasalazine,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3427,DB00795,Sulfasalazine,['approved'],BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,Humans
3428,DB00795,Sulfasalazine,['approved'],BE0003997,Phospholipase A2,PLA2G1B,Humans
3429,DB00795,Sulfasalazine,['approved'],BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
3430,DB00795,Sulfasalazine,['approved'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
3431,DB00795,Sulfasalazine,['approved'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
3432,DB00796,Candesartan cilexetil,['approved'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
3433,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3434,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3435,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
3436,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000112,Histamine H2 receptor,HRH2,Humans
3437,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3438,DB00797,Tolazoline,"['approved', 'vet_approved']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3445,DB00798,Gentamicin,"['approved', 'vet_approved']",BE0000330,Dihydrofolate reductase,DHFR,Humans
3446,DB00799,Tazarotene,"['approved', 'investigational']",BE0000663,Retinoic acid receptor alpha,RARA,Humans
3447,DB00799,Tazarotene,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
3448,DB00799,Tazarotene,"['approved', 'investigational']",BE0000144,Retinoic acid receptor gamma,RARG,Humans
3449,DB00799,Tazarotene,"['approved', 'investigational']",BE0000206,Retinoic acid receptor beta,RARB,Humans
3450,DB00800,Fenoldopam,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
3451,DB00800,Fenoldopam,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
3452,DB00800,Fenoldopam,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3453,DB00800,Fenoldopam,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3454,DB00800,Fenoldopam,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3455,DB00800,Fenoldopam,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3456,DB00800,Fenoldopam,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3457,DB00800,Fenoldopam,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3458,DB00801,Halazepam,"['approved', 'illicit', 'withdrawn']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3459,DB00801,Halazepam,"['approved', 'illicit', 'withdrawn']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3460,DB00802,Alfentanil,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3462,DB00804,Dicyclomine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3463,DB00804,Dicyclomine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3464,DB00804,Dicyclomine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3465,DB00805,Minaprine,['approved'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
3466,DB00805,Minaprine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
3467,DB00805,Minaprine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3468,DB00805,Minaprine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3469,DB00805,Minaprine,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
3470,DB00805,Minaprine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3471,DB00805,Minaprine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
3472,DB00805,Minaprine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3473,DB00805,Minaprine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3474,DB00806,Pentoxifylline,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
3476,DB00806,Pentoxifylline,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
3477,DB00806,Pentoxifylline,"['approved', 'investigational']",BE0001096,5'-nucleotidase,NT5E,Humans
3478,DB00807,Proparacaine,"['approved', 'vet_approved']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
3479,DB00808,Indapamide,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
3480,DB00809,Tropicamide,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3481,DB00809,Tropicamide,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3482,DB00809,Tropicamide,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3483,DB00809,Tropicamide,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3484,DB00810,Biperiden,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3485,DB00811,Ribavirin,['approved'],BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
3488,DB00811,Ribavirin,['approved'],BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
3490,DB00812,Phenylbutazone,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3491,DB00812,Phenylbutazone,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3492,DB00812,Phenylbutazone,"['approved', 'vet_approved']",BE0000117,Prostacyclin synthase,PTGIS,Humans
3493,DB00813,Fentanyl,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3494,DB00813,Fentanyl,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
3495,DB00813,Fentanyl,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3496,DB00813,Fentanyl,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0001032,P-glycoprotein 1,ABCB1,Humans
3497,DB00814,Meloxicam,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3498,DB00814,Meloxicam,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3499,DB00816,Orciprenaline,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3502,DB00818,Propofol,"['approved', 'investigational', 'vet_approved']",BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
3503,DB00818,Propofol,"['approved', 'investigational', 'vet_approved']",BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
3504,DB00818,Propofol,"['approved', 'investigational', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3505,DB00818,Propofol,"['approved', 'investigational', 'vet_approved']",BE0002083,Sodium channel protein type 4 subunit alpha,SCN4A,Humans
3506,DB00818,Propofol,"['approved', 'investigational', 'vet_approved']",BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
3507,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0000267,Carbonic anhydrase 1,CA1,Humans
3508,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0000322,Carbonic anhydrase 2,CA2,Humans
3509,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0000535,Carbonic anhydrase 4,CA4,Humans
3510,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0001653,Carbonic anhydrase 12,CA12,Humans
3511,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0003634,Carbonic anhydrase 14,CA14,Humans
3512,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0003625,Carbonic anhydrase 3,CA3,Humans
3513,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0003629,Carbonic anhydrase 7,CA7,Humans
3514,DB00819,Acetazolamide,"['approved', 'vet_approved']",BE0000880,Aquaporin-1,AQP1,Humans
3515,DB00820,Tadalafil,"['approved', 'investigational']",BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
3516,DB00820,Tadalafil,"['approved', 'investigational']",BE0003558,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",PDE11A,Humans
3517,DB00820,Tadalafil,"['approved', 'investigational']",BE0003556,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,Humans
3518,DB00821,Carprofen,"['approved', 'vet_approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3519,DB00821,Carprofen,"['approved', 'vet_approved', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3520,DB00822,Disulfiram,['approved'],BE0000138,Dopamine beta-hydroxylase,DBH,Humans
3521,DB00822,Disulfiram,['approved'],BE0000133,"Aldehyde dehydrogenase, mitochondrial",ALDH2,Humans
3522,DB00823,Ethynodiol diacetate,['approved'],BE0000557,Progesterone receptor,PGR,Humans
3523,DB00823,Ethynodiol diacetate,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
3524,DB00824,Enprofylline,"['approved', 'experimental']",BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
3525,DB00824,Enprofylline,"['approved', 'experimental']",BE0000241,Adenosine receptor A2b,ADORA2B,Humans
3526,DB00824,Enprofylline,"['approved', 'experimental']",BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
3527,DB00824,Enprofylline,"['approved', 'experimental']",BE0000013,Adenosine receptor A1,ADORA1,Humans
3528,DB00824,Enprofylline,"['approved', 'experimental']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
3529,DB00824,Enprofylline,"['approved', 'experimental']",BE0000354,Adenosine receptor A3,ADORA3,Humans
3530,DB00825,Levomenthol,['approved'],BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
3531,DB00825,Levomenthol,['approved'],BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
3532,DB00825,Levomenthol,['approved'],BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
3533,DB00825,Levomenthol,['approved'],BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
3534,DB00825,Levomenthol,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3539,DB00829,Diazepam,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3540,DB00829,Diazepam,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3541,DB00830,Phenmetrazine,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3542,DB00830,Phenmetrazine,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3543,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3544,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0000666,Neuron-specific vesicular protein calcyon,CALY,Humans
3545,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3546,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
3547,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
3548,DB00831,Trifluoperazine,"['approved', 'investigational']",BE0004350,Protein S100-A4,S100A4,Humans
3551,DB00834,Mifepristone,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
3552,DB00834,Mifepristone,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
3553,DB00834,Mifepristone,"['approved', 'investigational']",BE0008983,Prostate-specific antigen,KLK3,Humans
3554,DB00834,Mifepristone,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3555,DB00835,Brompheniramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3556,DB00835,Brompheniramine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3557,DB00835,Brompheniramine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3558,DB00835,Brompheniramine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3559,DB00835,Brompheniramine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3560,DB00835,Brompheniramine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3561,DB00836,Loperamide,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
3562,DB00836,Loperamide,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
3563,DB00836,Loperamide,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3564,DB00836,Loperamide,['approved'],BE0000418,Calmodulin,CALM1,Humans
3565,DB00836,Loperamide,['approved'],BE0000947,Pro-opiomelanocortin,POMC,Humans
3566,DB00836,Loperamide,['approved'],BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,Humans
3567,DB00836,Loperamide,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
3568,DB00837,Progabide,['experimental'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
3569,DB00837,Progabide,['experimental'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
3570,DB00838,Clocortolone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3571,DB00839,Tolazamide,"['approved', 'investigational']",BE0008670,"Sulfonylurea receptor 1, Kir6.2",ABCC8,Humans
3572,DB00841,Dobutamine,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
3573,DB00841,Dobutamine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
3574,DB00841,Dobutamine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3575,DB00841,Dobutamine,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
3576,DB00842,Oxazepam,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
3577,DB00842,Oxazepam,['approved'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3578,DB00843,Donepezil,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
3579,DB00843,Donepezil,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3580,DB00843,Donepezil,['approved'],BE0002180,Cholinesterase,BCHE,Humans
3581,DB00843,Donepezil,['approved'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
3582,DB00843,Donepezil,['approved'],BE0004952,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,Humans
3583,DB00843,Donepezil,['approved'],BE0001051,Interleukin-1 beta,IL1B,Humans
3584,DB00843,Donepezil,['approved'],BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
3585,DB00843,Donepezil,['approved'],BE0004956,NMDA receptor,GRIN1,Humans
3586,DB00844,Nalbuphine,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3587,DB00844,Nalbuphine,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
3588,DB00844,Nalbuphine,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
3589,DB00845,Clofazimine,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
3590,DB00845,Clofazimine,"['approved', 'investigational']",BE0004716,Potassium voltage-gated channel subfamily A member 3,KCNA3,Humans
3591,DB00846,Flurandrenolide,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3593,DB00847,Cysteamine,"['approved', 'investigational']",BE0002419,Neuropeptide Y receptor type 2,NPY2R,Humans
3594,DB00848,Levamisole,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
3595,DB00848,Levamisole,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000896,"Alkaline phosphatase, placental-like",ALPPL2,Humans
3600,DB00849,Methylphenobarbital,['approved'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
3601,DB00849,Methylphenobarbital,['approved'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
3602,DB00849,Methylphenobarbital,['approved'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
3603,DB00849,Methylphenobarbital,['approved'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
3604,DB00849,Methylphenobarbital,['approved'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
3605,DB00849,Methylphenobarbital,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
3606,DB00849,Methylphenobarbital,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3607,DB00849,Methylphenobarbital,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
3608,DB00849,Methylphenobarbital,['approved'],BE0000829,Glutamate receptor 2,GRIA2,Humans
3609,DB00849,Methylphenobarbital,['approved'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
3610,DB00849,Methylphenobarbital,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
3611,DB00850,Perphenazine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3612,DB00850,Perphenazine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
3613,DB00850,Perphenazine,['approved'],BE0000418,Calmodulin,CALM1,Humans
3615,DB00851,Dacarbazine,"['approved', 'investigational']",BE0000716,DNA polymerase alpha subunit B,POLA2,Humans
3616,DB00851,Dacarbazine,"['approved', 'investigational']",BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,Humans
3617,DB00852,Pseudoephedrine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3618,DB00852,Pseudoephedrine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3619,DB00852,Pseudoephedrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3620,DB00852,Pseudoephedrine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3621,DB00852,Pseudoephedrine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3622,DB00852,Pseudoephedrine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3623,DB00852,Pseudoephedrine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
3624,DB00852,Pseudoephedrine,['approved'],BE0004878,"Nuclear factor of activated T-cells, cytoplasmic 1",NFATC1,Humans
3625,DB00852,Pseudoephedrine,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
3626,DB00852,Pseudoephedrine,['approved'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
3627,DB00852,Pseudoephedrine,['approved'],BE0004924,activator protein 1,ATF1,Humans
3628,DB00852,Pseudoephedrine,['approved'],BE0001029,Interleukin-2,IL2,Humans
3630,DB00854,Levorphanol,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
3631,DB00854,Levorphanol,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
3632,DB00854,Levorphanol,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3633,DB00855,Aminolevulinic acid,['approved'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
3635,DB00857,Terbinafine,"['approved', 'investigational', 'vet_approved']",BE0000577,Squalene monooxygenase,SQLE,Humans
3636,DB00858,Drostanolone,['illicit'],BE0000132,Androgen receptor,AR,Humans
3638,DB00860,Prednisolone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
3639,DB00861,Diflunisal,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3640,DB00861,Diflunisal,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3641,DB00862,Vardenafil,['approved'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
3642,DB00862,Vardenafil,['approved'],BE0003556,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,Humans
3643,DB00862,Vardenafil,['approved'],BE0003557,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,Humans
3644,DB00863,Ranitidine,"['approved', 'withdrawn']",BE0000112,Histamine H2 receptor,HRH2,Humans
3645,DB00863,Ranitidine,"['approved', 'withdrawn']",BE0000426,Acetylcholinesterase,ACHE,Humans
3646,DB00864,Tacrolimus,"['approved', 'investigational']",BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
3647,DB00865,Benzphetamine,"['approved', 'illicit']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
3648,DB00865,Benzphetamine,"['approved', 'illicit']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3649,DB00865,Benzphetamine,"['approved', 'illicit']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3650,DB00865,Benzphetamine,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3651,DB00866,Alprenolol,"['experimental', 'withdrawn']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
3652,DB00866,Alprenolol,"['experimental', 'withdrawn']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3653,DB00866,Alprenolol,"['experimental', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3654,DB00866,Alprenolol,"['experimental', 'withdrawn']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
3655,DB00867,Ritodrine,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3656,DB00867,Ritodrine,"['approved', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
3657,DB00867,Ritodrine,"['approved', 'investigational']",BE0004905,ATP-sensitive potassium channel,KCNJ1,Humans
3658,DB00867,Ritodrine,"['approved', 'investigational']",BE0010002,Calcium transporting ATPases,ATP2C1,Humans
3659,DB00867,Ritodrine,"['approved', 'investigational']",BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
3660,DB00867,Ritodrine,"['approved', 'investigational']",BE0009492,"Myosin light chain kinase, smooth muscle",MYLK,Humans
3661,DB00867,Ritodrine,"['approved', 'investigational']",BE0009765,Sulfotransferase 1C4,SULT1C4,Humans
3662,DB00868,Benzonatate,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3663,DB00869,Dorzolamide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
3664,DB00869,Dorzolamide,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
3665,DB00869,Dorzolamide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
3666,DB00869,Dorzolamide,['approved'],BE0003625,Carbonic anhydrase 3,CA3,Humans
3667,DB00870,Suprofen,"['approved', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3668,DB00870,Suprofen,"['approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3669,DB00871,Terbutaline,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3670,DB00871,Terbutaline,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
3671,DB00871,Terbutaline,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
3672,DB00872,Conivaptan,"['approved', 'investigational']",BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
3673,DB00872,Conivaptan,"['approved', 'investigational']",BE0000293,Vasopressin V2 receptor,AVPR2,Humans
3674,DB14596,Loteprednol etabonate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3675,DB00874,Guaifenesin,"['approved', 'investigational', 'vet_approved']",BE0004956,NMDA receptor,GRIN1,Humans
3676,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3677,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
3678,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3679,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3680,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000581,Dopamine D3 receptor,DRD3,Humans
3681,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000389,Dopamine D4 receptor,DRD4,Humans
3682,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3683,DB00875,Flupentixol,"['approved', 'investigational', 'withdrawn']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3684,DB00876,Eprosartan,['approved'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
3685,DB00877,Sirolimus,"['approved', 'investigational']",BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
3688,DB00880,Chlorothiazide,"['approved', 'vet_approved']",BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
3689,DB00880,Chlorothiazide,"['approved', 'vet_approved']",BE0000267,Carbonic anhydrase 1,CA1,Humans
3690,DB00880,Chlorothiazide,"['approved', 'vet_approved']",BE0000322,Carbonic anhydrase 2,CA2,Humans
3691,DB00881,Quinapril,"['approved', 'investigational']",BE0000221,Angiotensin-converting enzyme,ACE,Humans
3692,DB00882,Clomifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
3693,DB00882,Clomifene,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
3694,DB00883,Isosorbide dinitrate,"['approved', 'investigational']",BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
3696,DB00884,Risedronic acid,"['approved', 'investigational']",BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
3697,DB00886,Omapatrilat,['investigational'],BE0000266,Neprilysin,MME,Humans
3698,DB00886,Omapatrilat,['investigational'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
3699,DB00887,Bumetanide,['approved'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
3700,DB00887,Bumetanide,['approved'],BE0000281,Solute carrier family 12 member 2,SLC12A2,Humans
3701,DB00887,Bumetanide,['approved'],BE0000601,Solute carrier family 12 member 4,SLC12A4,Humans
3702,DB00887,Bumetanide,['approved'],BE0000047,Solute carrier family 12 member 5,SLC12A5,Humans
3703,DB00887,Bumetanide,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
3705,DB00889,Granisetron,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3706,DB00890,Dienestrol,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
3707,DB00890,Dienestrol,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
3709,DB00892,Oxybuprocaine,"['approved', 'investigational']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
3710,DB00893,Iron Dextran,"['approved', 'vet_approved']",BE0000629,Hemoglobin subunit beta,HBB,Humans
3711,DB00893,Iron Dextran,"['approved', 'vet_approved']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
3712,DB00893,Iron Dextran,"['approved', 'vet_approved']",BE0000399,Ferritin heavy chain,FTH1,Humans
3713,DB00893,Iron Dextran,"['approved', 'vet_approved']",BE0000085,Ferritin light chain,FTL,Humans
3714,DB00894,Testolactone,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
3715,DB00895,Benzylpenicilloyl polylysine,['approved'],BE0000049,High affinity immunoglobulin epsilon receptor subunit gamma,FCER1G,Humans
3716,DB00895,Benzylpenicilloyl polylysine,['approved'],BE0000015,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,Humans
3717,DB00896,Rimexolone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
3718,DB00897,Triazolam,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
3719,DB00897,Triazolam,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3720,DB00898,Ethanol,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
3721,DB00898,Ethanol,['approved'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
3722,DB00898,Ethanol,['approved'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
3723,DB00898,Ethanol,['approved'],BE0000745,Glycine receptor subunit alpha-2,GLRA2,Humans
3724,DB00898,Ethanol,['approved'],BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
3725,DB00898,Ethanol,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3726,DB00898,Ethanol,['approved'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
3727,DB00898,Ethanol,['approved'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
3728,DB00898,Ethanol,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
3729,DB00898,Ethanol,['approved'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
3730,DB00898,Ethanol,['approved'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
3731,DB00898,Ethanol,['approved'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
3732,DB00898,Ethanol,['approved'],BE0000640,Glutamate receptor 1,GRIA1,Humans
3733,DB00898,Ethanol,['approved'],BE0000679,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,Humans
3734,DB00898,Ethanol,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
3735,DB00898,Ethanol,['approved'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
3736,DB00898,Ethanol,['approved'],BE0000829,Glutamate receptor 2,GRIA2,Humans
3737,DB00898,Ethanol,['approved'],BE0000830,Glutamate receptor 4,GRIA4,Humans
3738,DB00898,Ethanol,['approved'],BE0000831,Glutamate receptor 3,GRIA3,Humans
3739,DB00898,Ethanol,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3740,DB00898,Ethanol,['approved'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
3741,DB00898,Ethanol,['approved'],BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
3742,DB00898,Ethanol,['approved'],BE0001030,G protein-activated inward rectifier potassium channel 2,KCNJ6,Humans
3743,DB00898,Ethanol,['approved'],BE0001114,Vascular cell adhesion protein 1,VCAM1,Humans
3744,DB00898,Ethanol,['approved'],BE0001204,Equilibrative nucleoside transporter 1,SLC29A1,Humans
3745,DB00898,Ethanol,['approved'],BE0002218,G protein-activated inward rectifier potassium channel 4,KCNJ5,Humans
3746,DB00898,Ethanol,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
3747,DB00898,Ethanol,['approved'],BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
3748,DB00898,Ethanol,['approved'],BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,Humans
3749,DB00898,Ethanol,['approved'],BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
3750,DB00898,Ethanol,['approved'],BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
3751,DB00898,Ethanol,['approved'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
3752,DB00898,Ethanol,['approved'],BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
3753,DB00898,Ethanol,['approved'],BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
3754,DB00898,Ethanol,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
3755,DB00898,Ethanol,['approved'],BE0003586,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,Humans
3756,DB00898,Ethanol,['approved'],BE0003587,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,Humans
3757,DB00898,Ethanol,['approved'],BE0003588,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,Humans
3758,DB00898,Ethanol,['approved'],BE0003593,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,Humans
3759,DB00898,Ethanol,['approved'],BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,Humans
3760,DB00898,Ethanol,['approved'],BE0003595,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,Humans
3761,DB00898,Ethanol,['approved'],BE0003596,Gamma-aminobutyric acid receptor subunit pi,GABRP,Humans
3762,DB00898,Ethanol,['approved'],BE0003597,Gamma-aminobutyric acid receptor subunit theta,GABRQ,Humans
3763,DB00898,Ethanol,['approved'],BE0003599,Gamma-aminobutyric acid receptor subunit delta,GABRD,Humans
3764,DB00898,Ethanol,['approved'],BE0004706,Equilibrative nucleoside transporter 2,SLC29A2,Humans
3765,DB00898,Ethanol,['approved'],BE0009586,5-hydroxytryptamine receptor 3E,HTR3E,Humans
3766,DB00898,Ethanol,['approved'],BE0009583,5-hydroxytryptamine receptor 3B,HTR3B,Humans
3767,DB00898,Ethanol,['approved'],BE0009585,5-hydroxytryptamine receptor 3D,HTR3D,Humans
3768,DB00898,Ethanol,['approved'],BE0009584,5-hydroxytryptamine receptor 3C,HTR3C,Humans
3769,DB00898,Ethanol,['approved'],BE0005108,Voltage-dependent calcium channel gamma-2 subunit,CACNG2,Humans
3770,DB00898,Ethanol,['approved'],BE0005190,G protein-activated inward rectifier potassium channel 3,KCNJ9,Humans
3771,DB00898,Ethanol,['approved'],BE0008999,Neural cell adhesion molecule L1,L1CAM,Humans
3772,DB00898,Ethanol,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
3773,DB00898,Ethanol,['approved'],BE0000522,Alcohol dehydrogenase class 4 mu/sigma chain,ADH7,Humans
3774,DB00899,Remifentanil,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
3775,DB00899,Remifentanil,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
3776,DB00899,Remifentanil,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3778,DB00900,Didanosine,['approved'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
3779,DB00901,Bitolterol,['withdrawn'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3780,DB00902,Methdilazine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3781,DB00903,Etacrynic acid,"['approved', 'investigational']",BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
3782,DB00903,Etacrynic acid,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
3783,DB00903,Etacrynic acid,"['approved', 'investigational']",BE0009011,Lymphoid enhancer-binding factor 1,LEF1,Humans
3784,DB00903,Etacrynic acid,"['approved', 'investigational']",BE0000814,Glutathione S-transferase P,GSTP1,Humans
3785,DB00904,Ondansetron,"['approved', 'withdrawn']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
3786,DB00904,Ondansetron,"['approved', 'withdrawn']",BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
3787,DB00904,Ondansetron,"['approved', 'withdrawn']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3788,DB00904,Ondansetron,"['approved', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3789,DB00904,Ondansetron,"['approved', 'withdrawn']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3790,DB00905,Bimatoprost,"['approved', 'investigational']",BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
3791,DB00905,Bimatoprost,"['approved', 'investigational']",BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
3792,DB00905,Bimatoprost,"['approved', 'investigational']",BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
3793,DB00906,Tiagabine,"['approved', 'investigational']",BE0000249,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,Humans
3794,DB00907,Cocaine,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3795,DB00907,Cocaine,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3796,DB00907,Cocaine,"['approved', 'illicit']",BE0004901,Sodium channel protein,SCN1A,Humans
3797,DB00907,Cocaine,"['approved', 'illicit']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3798,DB00907,Cocaine,"['approved', 'illicit']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3799,DB00907,Cocaine,"['approved', 'illicit']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3800,DB00907,Cocaine,"['approved', 'illicit']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
3801,DB00907,Cocaine,"['approved', 'illicit']",BE0002705,Liver carboxylesterase 1,CES1,Humans
3802,DB00908,Quinidine,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3803,DB00908,Quinidine,"['approved', 'investigational']",BE0000154,Potassium channel subfamily K member 1,KCNK1,Humans
3804,DB00908,Quinidine,"['approved', 'investigational']",BE0000680,Potassium channel subfamily K member 6,KCNK6,Humans
3805,DB00908,Quinidine,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
3806,DB00908,Quinidine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3807,DB00908,Quinidine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3808,DB00908,Quinidine,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3809,DB00909,Zonisamide,"['approved', 'investigational']",BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
3810,DB00909,Zonisamide,"['approved', 'investigational']",BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
3811,DB00909,Zonisamide,"['approved', 'investigational']",BE0002082,Sodium channel protein type 3 subunit alpha,SCN3A,Humans
3812,DB00909,Zonisamide,"['approved', 'investigational']",BE0002083,Sodium channel protein type 4 subunit alpha,SCN4A,Humans
3813,DB00909,Zonisamide,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
3814,DB00909,Zonisamide,"['approved', 'investigational']",BE0001143,Sodium channel protein type 9 subunit alpha,SCN9A,Humans
3815,DB00909,Zonisamide,"['approved', 'investigational']",BE0000192,Sodium channel protein type 11 subunit alpha,SCN11A,Humans
3816,DB00909,Zonisamide,"['approved', 'investigational']",BE0003635,Sodium channel subunit beta-1,SCN1B,Humans
3817,DB00909,Zonisamide,"['approved', 'investigational']",BE0003636,Sodium channel subunit beta-2,SCN2B,Humans
3818,DB00909,Zonisamide,"['approved', 'investigational']",BE0003637,Sodium channel subunit beta-3,SCN3B,Humans
3819,DB00909,Zonisamide,"['approved', 'investigational']",BE0003638,Sodium channel subunit beta-4,SCN4B,Humans
3820,DB00909,Zonisamide,"['approved', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
3821,DB00909,Zonisamide,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
3822,DB00909,Zonisamide,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
3823,DB00909,Zonisamide,"['approved', 'investigational']",BE0000267,Carbonic anhydrase 1,CA1,Humans
3824,DB00909,Zonisamide,"['approved', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
3825,DB00909,Zonisamide,"['approved', 'investigational']",BE0003625,Carbonic anhydrase 3,CA3,Humans
3826,DB00909,Zonisamide,"['approved', 'investigational']",BE0000535,Carbonic anhydrase 4,CA4,Humans
3827,DB00909,Zonisamide,"['approved', 'investigational']",BE0003626,"Carbonic anhydrase 5A, mitochondrial",CA5A,Humans
3828,DB00909,Zonisamide,"['approved', 'investigational']",BE0003627,"Carbonic anhydrase 5B, mitochondrial",CA5B,Humans
3829,DB00909,Zonisamide,"['approved', 'investigational']",BE0003628,Carbonic anhydrase 6,CA6,Humans
3830,DB00909,Zonisamide,"['approved', 'investigational']",BE0003629,Carbonic anhydrase 7,CA7,Humans
3831,DB00909,Zonisamide,"['approved', 'investigational']",BE0003630,Carbonic anhydrase-related protein,CA8,Humans
3832,DB00909,Zonisamide,"['approved', 'investigational']",BE0002437,Carbonic anhydrase 9,CA9,Humans
3833,DB00909,Zonisamide,"['approved', 'investigational']",BE0003631,Carbonic anhydrase-related protein 10,CA10,Humans
3834,DB00909,Zonisamide,"['approved', 'investigational']",BE0003632,Carbonic anhydrase-related protein 11,CA11,Humans
3835,DB00909,Zonisamide,"['approved', 'investigational']",BE0001653,Carbonic anhydrase 12,CA12,Humans
3836,DB00909,Zonisamide,"['approved', 'investigational']",BE0003633,Carbonic anhydrase 13,CA13,Humans
3837,DB00909,Zonisamide,"['approved', 'investigational']",BE0003634,Carbonic anhydrase 14,CA14,Humans
3838,DB00909,Zonisamide,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
3839,DB00909,Zonisamide,"['approved', 'investigational']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
3840,DB00909,Zonisamide,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
3841,DB00910,Paricalcitol,"['approved', 'investigational']",BE0000779,Vitamin D3 receptor,VDR,Humans
3843,DB00912,Repaglinide,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
3844,DB00912,Repaglinide,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
3845,DB00912,Repaglinide,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3846,DB00913,Anileridine,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3847,DB00914,Phenformin,"['approved', 'investigational', 'withdrawn']",BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,Humans
3848,DB00914,Phenformin,"['approved', 'investigational', 'withdrawn']",BE0002441,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,Humans
3850,DB00915,Amantadine,['approved'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
3851,DB00915,Amantadine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
3852,DB00915,Amantadine,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
3853,DB00915,Amantadine,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
3854,DB00915,Amantadine,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
3858,DB00917,Dinoprostone,['approved'],BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
3859,DB00917,Dinoprostone,['approved'],BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
3860,DB00917,Dinoprostone,['approved'],BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
3861,DB00917,Dinoprostone,['approved'],BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
3862,DB00917,Dinoprostone,['approved'],BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
3863,DB00918,Almotriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3864,DB00918,Almotriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3866,DB00920,Ketotifen,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
3867,DB00920,Ketotifen,['approved'],BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,Humans
3868,DB00921,Buprenorphine,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
3869,DB00921,Buprenorphine,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
3870,DB00921,Buprenorphine,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
3871,DB00921,Buprenorphine,"['approved', 'illicit', 'investigational', 'vet_approved']",BE0002378,Nociceptin receptor,OPRL1,Humans
3872,DB00922,Levosimendan,"['approved', 'investigational']",BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
3873,DB00922,Levosimendan,"['approved', 'investigational']",BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
3874,DB00922,Levosimendan,"['approved', 'investigational']",BE0002441,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,Humans
3875,DB00922,Levosimendan,"['approved', 'investigational']",BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
3877,DB00924,Cyclobenzaprine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3878,DB00924,Cyclobenzaprine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
3879,DB00924,Cyclobenzaprine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3880,DB00924,Cyclobenzaprine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
3881,DB00924,Cyclobenzaprine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
3882,DB00924,Cyclobenzaprine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3883,DB00924,Cyclobenzaprine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
3884,DB00924,Cyclobenzaprine,['approved'],BE0002442,Toll-like receptor 4,TLR4,Humans
3885,DB00924,Cyclobenzaprine,['approved'],BE0003539,Aldehyde oxidase,AOX1,Humans
3886,DB00925,Phenoxybenzamine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3887,DB00925,Phenoxybenzamine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3888,DB00925,Phenoxybenzamine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3889,DB00925,Phenoxybenzamine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3890,DB00925,Phenoxybenzamine,['approved'],BE0000418,Calmodulin,CALM1,Humans
3891,DB00925,Phenoxybenzamine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3892,DB00925,Phenoxybenzamine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3893,DB00925,Phenoxybenzamine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3894,DB00926,Etretinate,['withdrawn'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
3895,DB00926,Etretinate,['withdrawn'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
3896,DB00926,Etretinate,['withdrawn'],BE0000206,Retinoic acid receptor beta,RARB,Humans
3897,DB00926,Etretinate,['withdrawn'],BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
3898,DB00926,Etretinate,['withdrawn'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
3899,DB00926,Etretinate,['withdrawn'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
3900,DB00927,Famotidine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
3901,DB00928,Azacitidine,"['approved', 'investigational']",BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
3904,DB00929,Misoprostol,['approved'],BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
3905,DB00929,Misoprostol,['approved'],BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
3906,DB00929,Misoprostol,['approved'],BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
3907,DB00929,Misoprostol,['approved'],BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
3911,DB00933,Mesoridazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3912,DB00933,Mesoridazine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3913,DB00934,Maprotiline,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3914,DB00934,Maprotiline,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3915,DB00934,Maprotiline,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3916,DB00934,Maprotiline,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3917,DB00934,Maprotiline,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3918,DB00934,Maprotiline,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3919,DB00934,Maprotiline,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3920,DB00934,Maprotiline,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
3921,DB00934,Maprotiline,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
3922,DB00934,Maprotiline,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
3923,DB00934,Maprotiline,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
3924,DB00934,Maprotiline,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
3925,DB00934,Maprotiline,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
3926,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
3927,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
3928,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
3929,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
3930,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
3931,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
3932,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3933,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3934,DB00935,Oxymetazoline,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3936,DB00936,Salicylic acid,"['approved', 'investigational', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3937,DB00936,Salicylic acid,"['approved', 'investigational', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3938,DB00936,Salicylic acid,"['approved', 'investigational', 'vet_approved']",BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
3939,DB00937,Diethylpropion,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
3940,DB00937,Diethylpropion,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
3941,DB00938,Salmeterol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
3942,DB00938,Salmeterol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
3943,DB00938,Salmeterol,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
3944,DB00939,Meclofenamic acid,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3945,DB00939,Meclofenamic acid,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3946,DB00939,Meclofenamic acid,"['approved', 'vet_approved']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
3947,DB00939,Meclofenamic acid,"['approved', 'vet_approved']",BE0000897,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,Humans
3948,DB00939,Meclofenamic acid,"['approved', 'vet_approved']",BE0002398,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,Humans
3949,DB00940,Methantheline,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
3950,DB00940,Methantheline,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
3951,DB00940,Methantheline,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
3952,DB00940,Methantheline,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
3953,DB00940,Methantheline,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
3954,DB00940,Methantheline,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3955,DB00941,Hexafluronium,['approved'],BE0002180,Cholinesterase,BCHE,Humans
3956,DB00942,Cycrimine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
3958,DB00944,Demecarium,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
3959,DB00944,Demecarium,['approved'],BE0002180,Cholinesterase,BCHE,Humans
3960,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
3961,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
3962,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
3963,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0004907,5'-AMP-activated protein kinase,PRKAA1,Humans
3964,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000521,Endothelin-1 receptor,EDNRA,Humans
3965,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0003380,Cellular tumor antigen p53,TP53,Humans
3966,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0001098,78 kDa glucose-regulated protein,HSPA5,Humans
3967,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0004876,Ribosomal protein S6 kinase alpha-3,RPS6KA3,Humans
3968,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0003469,NF-kappa-B inhibitor alpha,NFKBIA,Humans
3969,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0004952,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,Humans
3970,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000444,Caspase-1,CASP1,Humans
3971,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0001162,Caspase-3,CASP3,Humans
3972,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
3973,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0009668,Extracellular signal-regulated kinase (ERK),MAPK1,Humans
3974,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0001027,G1/S-specific cyclin-D1,CCND1,Humans
3975,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0004689,Myc proto-oncogene protein,MYC,Humans
3976,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0009045,Proliferating cell nuclear antigen,PCNA,Humans
3978,DB00945,Acetylsalicylic acid,"['approved', 'vet_approved']",BE0000914,Sialidase-1,NEU1,Humans
3979,DB00946,Phenprocoumon,"['approved', 'investigational']",BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
3980,DB00947,Fulvestrant,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
3984,DB00949,Felbamate,['approved'],BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
3985,DB00949,Felbamate,['approved'],BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
3986,DB00950,Fexofenadine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
3989,DB00951,Isoniazid,"['approved', 'investigational']",BE0002887,Cytochrome P450 2C8,CYP2C8,Humans
3990,DB00951,Isoniazid,"['approved', 'investigational']",BE0002433,Cytochrome P450 1A2,CYP1A2,Humans
3991,DB00951,Isoniazid,"['approved', 'investigational']",BE0002638,Cytochrome P450 3A4,CYP3A4,Humans
3992,DB00951,Isoniazid,"['approved', 'investigational']",BE0003536,Cytochrome P450 2C19,CYP2C19,Humans
3994,DB00952,Naratriptan,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
3995,DB00952,Naratriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3996,DB00952,Naratriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
3997,DB00952,Naratriptan,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
3998,DB00953,Rizatriptan,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
3999,DB00953,Rizatriptan,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4000,DB00953,Rizatriptan,['approved'],BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
4004,DB00956,Hydrocodone,"['approved', 'illicit', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4005,DB00956,Hydrocodone,"['approved', 'illicit', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
4006,DB00956,Hydrocodone,"['approved', 'illicit', 'investigational']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
4007,DB00957,Norgestimate,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
4008,DB00957,Norgestimate,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4009,DB00957,Norgestimate,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
4011,DB00959,Methylprednisolone,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
4012,DB00959,Methylprednisolone,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
4013,DB00960,Pindolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4014,DB00960,Pindolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4015,DB00960,Pindolol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
4016,DB00960,Pindolol,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4017,DB00960,Pindolol,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4018,DB00961,Mepivacaine,"['approved', 'vet_approved']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
4019,DB00962,Zaleplon,"['approved', 'illicit', 'investigational']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4020,DB00963,Bromfenac,"['approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
4021,DB00963,Bromfenac,"['approved', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
4022,DB00964,Apraclonidine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4023,DB00964,Apraclonidine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4024,DB00964,Apraclonidine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
4025,DB00966,Telmisartan,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4026,DB00966,Telmisartan,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
4027,DB00967,Desloratadine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4028,DB00968,Methyldopa,['approved'],BE0002151,Aromatic-L-amino-acid decarboxylase,DDC,Humans
4029,DB00968,Methyldopa,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4030,DB00969,Alosetron,"['approved', 'withdrawn']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4032,DB00970,Dactinomycin,"['approved', 'investigational']",BE0004951,DNA topoisomerase 2,TOP2A,Humans
4033,DB00970,Dactinomycin,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
4034,DB00972,Azelastine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4035,DB00972,Azelastine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
4036,DB00972,Azelastine,['approved'],BE0003997,Phospholipase A2,PLA2G1B,Humans
4037,DB00972,Azelastine,['approved'],BE0001117,Leukotriene C4 synthase,LTC4S,Humans
4038,DB00973,Ezetimibe,['approved'],BE0000802,Niemann-Pick C1-like protein 1,NPC1L1,Humans
4039,DB00973,Ezetimibe,['approved'],BE0000105,Sterol O-acyltransferase 1,SOAT1,Humans
4040,DB00973,Ezetimibe,['approved'],BE0001078,Aminopeptidase N,ANPEP,Humans
4044,DB00975,Dipyridamole,['approved'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
4045,DB00975,Dipyridamole,['approved'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
4046,DB00975,Dipyridamole,['approved'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
4047,DB00975,Dipyridamole,['approved'],BE0002214,Adenosine deaminase,ADA,Humans
4048,DB00975,Dipyridamole,['approved'],BE0009008,Calcipressin-1,RCAN1,Humans
4049,DB00975,Dipyridamole,['approved'],BE0000925,Alpha-1-acid glycoprotein 1,ORM1,Humans
4051,DB00977,Ethinylestradiol,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
4052,DB00977,Ethinylestradiol,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4055,DB00978,Lomefloxacin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4056,DB00979,Cyclopentolate,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4057,DB00980,Ramelteon,"['approved', 'investigational']",BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
4058,DB00980,Ramelteon,"['approved', 'investigational']",BE0000515,Melatonin receptor type 1A,MTNR1A,Humans
4059,DB00981,Physostigmine,"['approved', 'investigational']",BE0000426,Acetylcholinesterase,ACHE,Humans
4060,DB00981,Physostigmine,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
4061,DB00981,Physostigmine,"['approved', 'investigational']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
4062,DB00982,Isotretinoin,['approved'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
4063,DB00982,Isotretinoin,['approved'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
4064,DB00983,Formoterol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4065,DB00983,Formoterol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4066,DB00983,Formoterol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
4067,DB00984,Nandrolone phenpropionate,"['approved', 'illicit', 'investigational']",BE0000132,Androgen receptor,AR,Humans
4068,DB00985,Dimenhydrinate,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4069,DB00986,Glycopyrronium,"['approved', 'investigational', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4070,DB00986,Glycopyrronium,"['approved', 'investigational', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4071,DB00986,Glycopyrronium,"['approved', 'investigational', 'vet_approved']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4072,DB00986,Glycopyrronium,"['approved', 'investigational', 'vet_approved']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4073,DB00986,Glycopyrronium,"['approved', 'investigational', 'vet_approved']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4074,DB00987,Cytarabine,"['approved', 'investigational']",BE0000113,DNA polymerase beta,POLB,Humans
4076,DB00988,Dopamine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4077,DB00988,Dopamine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
4078,DB00988,Dopamine,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
4079,DB00988,Dopamine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
4080,DB00988,Dopamine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
4081,DB00988,Dopamine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4082,DB00988,Dopamine,['approved'],BE0000138,Dopamine beta-hydroxylase,DBH,Humans
4083,DB00988,Dopamine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4084,DB00988,Dopamine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
4085,DB00988,Dopamine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
4086,DB00988,Dopamine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4087,DB00988,Dopamine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4088,DB00988,Dopamine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4089,DB00988,Dopamine,['approved'],BE0009583,5-hydroxytryptamine receptor 3B,HTR3B,Humans
4090,DB00988,Dopamine,['approved'],BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
4091,DB00988,Dopamine,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
4092,DB00989,Rivastigmine,"['approved', 'investigational']",BE0000426,Acetylcholinesterase,ACHE,Humans
4093,DB00989,Rivastigmine,"['approved', 'investigational']",BE0002180,Cholinesterase,BCHE,Humans
4094,DB00990,Exemestane,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
4095,DB00991,Oxaprozin,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
4096,DB00991,Oxaprozin,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
4097,DB00993,Azathioprine,['approved'],BE0001109,Ras-related C3 botulinum toxin substrate 1,RAC1,Humans
4100,DB00994,Neomycin,"['approved', 'vet_approved']",BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
4101,DB00995,Auranofin,"['approved', 'investigational']",BE0000907,"Peroxiredoxin-5, mitochondrial",PRDX5,Humans
4102,DB00995,Auranofin,"['approved', 'investigational']",BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
4103,DB00996,Gabapentin,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
4104,DB00996,Gabapentin,"['approved', 'investigational']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
4105,DB00996,Gabapentin,"['approved', 'investigational']",BE0009351,Voltage-dependent N-type calcium channel,CACNA1B,Humans
4106,DB00996,Gabapentin,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
4107,DB00996,Gabapentin,"['approved', 'investigational']",BE0002398,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,Humans
4108,DB00996,Gabapentin,"['approved', 'investigational']",BE0002400,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,Humans
4109,DB00997,Doxorubicin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4111,DB00997,Doxorubicin,"['approved', 'investigational']",BE0005819,Nucleolar and coiled-body phosphoprotein 1,NOLC1,Humans
4112,DB00997,Doxorubicin,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
4113,DB00997,Doxorubicin,"['approved', 'investigational']",BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
4114,DB00998,Frovatriptan,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
4115,DB00998,Frovatriptan,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4116,DB00999,Hydrochlorothiazide,"['approved', 'vet_approved']",BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
4117,DB00999,Hydrochlorothiazide,"['approved', 'vet_approved']",BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
4122,DB01001,Salbutamol,"['approved', 'vet_approved']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4123,DB01001,Salbutamol,"['approved', 'vet_approved']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4124,DB01001,Salbutamol,"['approved', 'vet_approved']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
4125,DB01002,Levobupivacaine,"['approved', 'investigational']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
4126,DB01003,Cromoglicic acid,['approved'],BE0001191,Protein S100-P,S100P,Humans
4130,DB01005,Hydroxyurea,['approved'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
4131,DB01006,Letrozole,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
4133,DB01007,Tioconazole,['approved'],BE0000875,Lanosterol 14-alpha demethylase,CYP51A1,Humans
4135,DB01009,Ketoprofen,"['approved', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
4136,DB01009,Ketoprofen,"['approved', 'vet_approved']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
4137,DB01009,Ketoprofen,"['approved', 'vet_approved']",BE0003552,C-X-C chemokine receptor type 1,CXCR1,Humans
4138,DB01010,Edrophonium,['approved'],BE0002180,Cholinesterase,BCHE,Humans
4139,DB01010,Edrophonium,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
4140,DB01011,Metyrapone,"['approved', 'investigational']",BE0000731,"Cytochrome P450 11B1, mitochondrial",CYP11B1,Humans
4142,DB01012,Cinacalcet,['approved'],BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
4143,DB01013,Clobetasol propionate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
4144,DB01013,Clobetasol propionate,['approved'],BE0000422,Annexin A1,ANXA1,Humans
4145,DB01013,Clobetasol propionate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
4146,DB01014,Balsalazide,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4147,DB01014,Balsalazide,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
4148,DB01014,Balsalazide,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
4149,DB01014,Balsalazide,"['approved', 'investigational']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
4151,DB01016,Glyburide,['approved'],BE0008670,"Sulfonylurea receptor 1, Kir6.2",ABCC8,Humans
4152,DB01016,Glyburide,['approved'],BE0000469,ATP-binding cassette sub-family C member 9,ABCC9,Humans
4153,DB01016,Glyburide,['approved'],BE0000703,Bile salt export pump,ABCB11,Humans
4154,DB01016,Glyburide,['approved'],BE0000119,ATP-binding cassette sub-family A member 1,ABCA1,Humans
4155,DB01016,Glyburide,['approved'],BE0004923,Mitochondrial ATP-sensitive potassium channel,KCNJ11,Humans
4156,DB01016,Glyburide,['approved'],BE0000406,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,Humans
4157,DB01016,Glyburide,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
4158,DB01016,Glyburide,['approved'],BE0009748,Transient receptor potential cation channel subfamily M member 4,TRPM4,Humans
4162,DB01017,Minocycline,"['approved', 'investigational']",BE0001051,Interleukin-1 beta,IL1B,Humans
4163,DB01017,Minocycline,"['approved', 'investigational']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
4164,DB01017,Minocycline,"['approved', 'investigational']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
4165,DB01017,Minocycline,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
4166,DB01017,Minocycline,"['approved', 'investigational']",BE0000444,Caspase-1,CASP1,Humans
4167,DB01017,Minocycline,"['approved', 'investigational']",BE0001162,Caspase-3,CASP3,Humans
4168,DB01017,Minocycline,"['approved', 'investigational']",BE0001009,Cytochrome c,CYCS,Humans
4169,DB01017,Minocycline,"['approved', 'investigational']",BE0009853,Mitogen-activated Protein Kinases,MAPK1,Humans
4170,DB01017,Minocycline,"['approved', 'investigational']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
4171,DB01018,Guanfacine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4172,DB01018,Guanfacine,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
4173,DB01019,Bethanechol,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4174,DB01019,Bethanechol,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4175,DB01019,Bethanechol,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4176,DB01019,Bethanechol,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4177,DB01019,Bethanechol,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4178,DB01020,Isosorbide mononitrate,['approved'],BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
4179,DB01021,Trichlormethiazide,"['approved', 'vet_approved']",BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
4180,DB01021,Trichlormethiazide,"['approved', 'vet_approved']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4181,DB01021,Trichlormethiazide,"['approved', 'vet_approved']",BE0000267,Carbonic anhydrase 1,CA1,Humans
4182,DB01021,Trichlormethiazide,"['approved', 'vet_approved']",BE0000322,Carbonic anhydrase 2,CA2,Humans
4183,DB01021,Trichlormethiazide,"['approved', 'vet_approved']",BE0000535,Carbonic anhydrase 4,CA4,Humans
4184,DB01022,Phylloquinone,"['approved', 'investigational']",BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
4185,DB01022,Phylloquinone,"['approved', 'investigational']",BE0000724,Osteocalcin,BGLAP,Humans
4186,DB01023,Felodipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
4187,DB01023,Felodipine,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
4188,DB01023,Felodipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
4189,DB01023,Felodipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
4190,DB01023,Felodipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
4191,DB01023,Felodipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
4192,DB01023,Felodipine,"['approved', 'investigational']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
4193,DB01023,Felodipine,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
4194,DB01023,Felodipine,"['approved', 'investigational']",BE0003323,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,Humans
4195,DB01023,Felodipine,"['approved', 'investigational']",BE0003565,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,Humans
4196,DB01023,Felodipine,"['approved', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
4197,DB01023,Felodipine,"['approved', 'investigational']",BE0003566,"Troponin C, skeletal muscle",TNNC2,Humans
4198,DB01023,Felodipine,"['approved', 'investigational']",BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
4199,DB01024,Mycophenolic acid,"['approved', 'investigational']",BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
4200,DB01024,Mycophenolic acid,"['approved', 'investigational']",BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
4201,DB01025,Amlexanox,"['approved', 'investigational', 'withdrawn']",BE0001206,Protein S100-A12,S100A12,Humans
4202,DB01025,Amlexanox,"['approved', 'investigational', 'withdrawn']",BE0000885,Protein S100-A13,S100A13,Humans
4203,DB01025,Amlexanox,"['approved', 'investigational', 'withdrawn']",BE0000125,Interleukin-3,IL3,Humans
4204,DB01025,Amlexanox,"['approved', 'investigational', 'withdrawn']",BE0000689,Fibroblast growth factor 1,FGF1,Humans
4206,DB01026,Ketoconazole,"['approved', 'investigational']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
4207,DB01026,Ketoconazole,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
4208,DB01026,Ketoconazole,"['approved', 'investigational']",BE0004873,Steroid 21-hydroxylase,CYP21A2,Humans
4209,DB01026,Ketoconazole,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4210,DB01026,Ketoconazole,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4211,DB01026,Ketoconazole,"['approved', 'investigational']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
4212,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4213,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000640,Glutamate receptor 1,GRIA1,Humans
4214,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
4215,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
4216,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4217,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000218,Calcium-transporting ATPase type 2C member 1,ATP2C1,Humans
4218,DB01028,Methoxyflurane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
4219,DB01029,Irbesartan,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
4220,DB01029,Irbesartan,"['approved', 'investigational']",BE0001040,Transcription factor AP-1,JUN,Humans
4221,DB01030,Topotecan,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
4223,DB01030,Topotecan,"['approved', 'investigational']",BE0000091,"DNA topoisomerase I, mitochondrial",TOP1MT,Humans
4224,DB01031,Ethinamate,"['approved', 'illicit', 'withdrawn']",BE0000322,Carbonic anhydrase 2,CA2,Humans
4225,DB01031,Ethinamate,"['approved', 'illicit', 'withdrawn']",BE0000267,Carbonic anhydrase 1,CA1,Humans
4226,DB01032,Probenecid,"['approved', 'investigational']",BE0001066,Solute carrier family 22 member 6,SLC22A6,Humans
4227,DB01032,Probenecid,"['approved', 'investigational']",BE0000879,Solute carrier family 22 member 11,SLC22A11,Humans
4228,DB01032,Probenecid,"['approved', 'investigational']",BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
4229,DB01032,Probenecid,"['approved', 'investigational']",BE0003719,Pannexin-1,PANX1,Humans
4230,DB01032,Probenecid,"['approved', 'investigational']",BE0009016,Taste receptor type 2 member 16,TAS2R16,Humans
4231,DB01033,Mercaptopurine,['approved'],BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,Humans
4232,DB01033,Mercaptopurine,['approved'],BE0000374,Amidophosphoribosyltransferase,PPAT,Humans
4233,DB01033,Mercaptopurine,['approved'],BE0004941,Inosine-5'-monophosphate dehydrogenase,IMPDH1,Humans
4237,DB01034,Cerulenin,['experimental'],BE0000959,Fatty acid synthase,FASN,Humans
4238,DB01035,Procainamide,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4239,DB01035,Procainamide,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
4240,DB01035,Procainamide,['approved'],BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
4241,DB01036,Tolterodine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4242,DB01036,Tolterodine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4243,DB01036,Tolterodine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4244,DB01036,Tolterodine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4245,DB01036,Tolterodine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4246,DB01037,Selegiline,"['approved', 'investigational', 'vet_approved']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
4247,DB01037,Selegiline,"['approved', 'investigational', 'vet_approved']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
4248,DB01038,Carphenazine,['withdrawn'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4249,DB01038,Carphenazine,['withdrawn'],BE0000020,Dopamine D1 receptor,DRD1,Humans
4250,DB01038,Carphenazine,['withdrawn'],BE0000145,Dopamine D5 receptor,DRD5,Humans
4251,DB01039,Fenofibrate,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
4252,DB01039,Fenofibrate,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4253,DB01039,Fenofibrate,['approved'],BE0009742,Matrix metalloproteinase-25,MMP25,Humans
4254,DB01041,Thalidomide,"['approved', 'investigational', 'withdrawn']",BE0004755,Protein cereblon,CRBN,Humans
4256,DB01041,Thalidomide,"['approved', 'investigational', 'withdrawn']",BE0004879,alpha1-acid glycoprotein,ORM1,Humans
4258,DB01043,Memantine,"['approved', 'investigational']",BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
4259,DB01043,Memantine,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4260,DB01043,Memantine,"['approved', 'investigational']",BE0003438,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,Humans
4261,DB01043,Memantine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4262,DB01043,Memantine,"['approved', 'investigational']",BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
4263,DB01043,Memantine,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4264,DB01043,Memantine,"['approved', 'investigational']",BE0009666,Glycine receptors,GLRA1,Humans
4270,DB01045,Rifampicin,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4271,DB01046,Lubiprostone,"['approved', 'investigational']",BE0000765,Chloride channel protein 2,CLCN2,Humans
4272,DB01047,Fluocinonide,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
4273,DB01047,Fluocinonide,"['approved', 'investigational']",BE0004659,Smoothened homolog,SMO,Humans
4275,DB01048,Abacavir,"['approved', 'investigational']",BE0009142,"HLA class I histocompatibility antigen, B-57 alpha chain",HLA-B,Humans
4276,DB01049,Ergoloid mesylate,['approved'],BE0009376,Dopamine receptor,DRD1,Humans
4277,DB01049,Ergoloid mesylate,['approved'],BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
4278,DB01049,Ergoloid mesylate,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
4279,DB01049,Ergoloid mesylate,['approved'],BE0004862,Serotonin Receptors,HTR1A,Humans
4280,DB01050,Ibuprofen,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
4281,DB01050,Ibuprofen,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
4282,DB01050,Ibuprofen,['approved'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
4283,DB01050,Ibuprofen,['approved'],BE0001151,Thrombomodulin,THBD,Humans
4284,DB01050,Ibuprofen,['approved'],BE0003591,"Fatty acid-binding protein, intestinal",FABP2,Humans
4285,DB01050,Ibuprofen,['approved'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4286,DB01050,Ibuprofen,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
4287,DB01050,Ibuprofen,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
4288,DB01050,Ibuprofen,['approved'],BE0001025,Platelet glycoprotein Ib alpha chain,GP1BA,Humans
4289,DB01050,Ibuprofen,['approved'],BE0003756,Protein S100-A7,S100A7,Humans
4293,DB01053,Benzylpenicillin,"['approved', 'vet_approved']",BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
4294,DB01053,Benzylpenicillin,"['approved', 'vet_approved']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
4295,DB01053,Benzylpenicillin,"['approved', 'vet_approved']",BE0001134,Solute carrier family 15 member 2,SLC15A2,Humans
4296,DB01054,Nitrendipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
4297,DB01054,Nitrendipine,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
4298,DB01054,Nitrendipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
4299,DB01054,Nitrendipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
4300,DB01054,Nitrendipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
4301,DB01054,Nitrendipine,"['approved', 'investigational']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
4302,DB01054,Nitrendipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
4303,DB01054,Nitrendipine,"['approved', 'investigational']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
4304,DB01054,Nitrendipine,"['approved', 'investigational']",BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
4305,DB01055,Mimosine,['experimental'],BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
4306,DB01055,Mimosine,['experimental'],BE0001047,C-C motif chemokine 2,CCL2,Humans
4307,DB01055,Mimosine,['experimental'],BE0000252,Tyrosinase,TYR,Humans
4308,DB01056,Tocainide,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
4309,DB01057,Echothiophate,['approved'],BE0002180,Cholinesterase,BCHE,Humans
4313,DB01059,Norfloxacin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4315,DB01059,Norfloxacin,['approved'],BE0004951,DNA topoisomerase 2,TOP2A,Humans
4319,DB01062,Oxybutynin,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4320,DB01062,Oxybutynin,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4321,DB01062,Oxybutynin,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4322,DB01063,Acetophenazine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4323,DB01063,Acetophenazine,['approved'],BE0000132,Androgen receptor,AR,Humans
4324,DB01064,Isoprenaline,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4325,DB01064,Isoprenaline,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4326,DB01064,Isoprenaline,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
4327,DB01064,Isoprenaline,"['approved', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
4328,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0000515,Melatonin receptor type 1A,MTNR1A,Humans
4329,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
4330,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4331,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0003554,Nuclear receptor ROR-beta,RORB,Humans
4332,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0000418,Calmodulin,CALM1,Humans
4333,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0001075,Myeloperoxidase,MPO,Humans
4334,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0003555,Eosinophil peroxidase,EPX,Humans
4335,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0002109,Calreticulin,CALR,Humans
4336,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0003553,Acetylserotonin O-methyltransferase,ASMT,Humans
4337,DB01065,Melatonin,"['approved', 'nutraceutical', 'vet_approved']",BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
4340,DB01067,Glipizide,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
4341,DB01067,Glipizide,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4342,DB01068,Clonazepam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4343,DB01068,Clonazepam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
4344,DB01068,Clonazepam,"['approved', 'illicit']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4345,DB01069,Promethazine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4346,DB01069,Promethazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4347,DB01069,Promethazine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4348,DB01069,Promethazine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4349,DB01069,Promethazine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4350,DB01069,Promethazine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4351,DB01069,Promethazine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4352,DB01069,Promethazine,"['approved', 'investigational']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
4353,DB01069,Promethazine,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
4354,DB01069,Promethazine,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
4356,DB01069,Promethazine,"['approved', 'investigational']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
4358,DB01070,Dihydrotachysterol,['approved'],BE0000779,Vitamin D3 receptor,VDR,Humans
4359,DB01071,Mequitazine,['experimental'],BE0000442,Histamine H1 receptor,HRH1,Humans
4362,DB01073,Fludarabine,['approved'],BE0002804,Deoxycytidine kinase,DCK,Humans
4363,DB01073,Fludarabine,['approved'],BE0000546,DNA polymerase alpha catalytic subunit,POLA1,Humans
4364,DB01073,Fludarabine,['approved'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
4365,DB01074,Perhexiline,"['approved', 'investigational']",BE0000406,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,Humans
4366,DB01074,Perhexiline,"['approved', 'investigational']",BE0000179,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,Humans
4367,DB01074,Perhexiline,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4368,DB01075,Diphenhydramine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4369,DB01075,Diphenhydramine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4370,DB01076,Atorvastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
4371,DB01076,Atorvastatin,['approved'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
4372,DB01076,Atorvastatin,['approved'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
4373,DB01076,Atorvastatin,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
4374,DB01076,Atorvastatin,['approved'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
4376,DB01077,Etidronic acid,['approved'],BE0003567,Receptor-type tyrosine-protein phosphatase S,PTPRS,Humans
4377,DB01077,Etidronic acid,['approved'],BE0003569,V-type proton ATPase catalytic subunit A,ATP6V1A,Humans
4378,DB01077,Etidronic acid,['approved'],BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
4379,DB01077,Etidronic acid,['approved'],BE0000709,ADP/ATP translocase 2,SLC25A5,Humans
4380,DB01077,Etidronic acid,['approved'],BE0000624,ADP/ATP translocase 3,SLC25A6,Humans
4381,DB01078,Deslanoside,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4382,DB01079,Tegaserod,"['approved', 'investigational', 'withdrawn']",BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
4383,DB01079,Tegaserod,"['approved', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4384,DB01079,Tegaserod,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4385,DB01079,Tegaserod,"['approved', 'investigational', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
4386,DB01080,Vigabatrin,['approved'],BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
4387,DB01081,Diphenoxylate,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4388,DB01081,Diphenoxylate,"['approved', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
4394,DB01082,Streptomycin,"['approved', 'vet_approved']",BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
4395,DB01083,Orlistat,"['approved', 'investigational']",BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
4396,DB01083,Orlistat,"['approved', 'investigational']",BE0003620,Gastric triacylglycerol lipase,LIPF,Humans
4397,DB01083,Orlistat,"['approved', 'investigational']",BE0000959,Fatty acid synthase,FASN,Humans
4398,DB01084,Emedastine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4399,DB01085,Pilocarpine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4400,DB01085,Pilocarpine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4401,DB01085,Pilocarpine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4402,DB01085,Pilocarpine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4403,DB01086,Benzocaine,"['approved', 'investigational']",BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
4405,DB01087,Primaquine,['approved'],BE0002459,"Keratin, type II cytoskeletal 7",KRT7,Humans
4406,DB01087,Primaquine,['approved'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
4407,DB01088,Iloprost,"['approved', 'investigational']",BE0000475,Prostacyclin receptor,PTGIR,Humans
4408,DB01088,Iloprost,"['approved', 'investigational']",BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
4409,DB01088,Iloprost,"['approved', 'investigational']",BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
4410,DB01088,Iloprost,"['approved', 'investigational']",BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
4411,DB01088,Iloprost,"['approved', 'investigational']",BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
4412,DB01088,Iloprost,"['approved', 'investigational']",BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
4413,DB01088,Iloprost,"['approved', 'investigational']",BE0001088,Tissue-type plasminogen activator,PLAT,Humans
4414,DB01088,Iloprost,"['approved', 'investigational']",BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
4415,DB01089,Deserpidine,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
4416,DB01090,Pentolinium,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
4417,DB01090,Pentolinium,['approved'],BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
4418,DB01090,Pentolinium,['approved'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
4419,DB01091,Butenafine,['approved'],BE0000577,Squalene monooxygenase,SQLE,Humans
4420,DB01092,Ouabain,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4421,DB01092,Ouabain,['approved'],BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,ATP1A2,Humans
4422,DB01092,Ouabain,['approved'],BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,ATP1A3,Humans
4423,DB01093,Dimethyl sulfoxide,"['approved', 'vet_approved']",BE0003471,Interleukin-5 receptor subunit alpha,IL5RA,Humans
4424,DB01093,Dimethyl sulfoxide,"['approved', 'vet_approved']",BE0002439,Mucin-16,MUC16,Humans
4425,DB01093,Dimethyl sulfoxide,"['approved', 'vet_approved']",BE0004689,Myc proto-oncogene protein,MYC,Humans
4426,DB01094,Hesperetin,['experimental'],BE0000232,Microsomal triglyceride transfer protein large subunit,MTTP,Humans
4427,DB01094,Hesperetin,['experimental'],BE0000105,Sterol O-acyltransferase 1,SOAT1,Humans
4428,DB01094,Hesperetin,['experimental'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
4429,DB01094,Hesperetin,['experimental'],BE0004608,Sterol O-acyltransferase 2,SOAT2,Humans
4430,DB01095,Fluvastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
4431,DB01095,Fluvastatin,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
4433,DB01097,Leflunomide,"['approved', 'investigational']",BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
4434,DB01097,Leflunomide,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
4435,DB01097,Leflunomide,"['approved', 'investigational']",BE0000871,Protein-tyrosine kinase 2-beta,PTK2B,Humans
4436,DB01098,Rosuvastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
4437,DB01098,Rosuvastatin,['approved'],BE0000516,Integrin alpha-L,ITGAL,Humans
4439,DB01099,Flucytosine,"['approved', 'investigational']",BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
4441,DB01100,Pimozide,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4442,DB01100,Pimozide,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
4443,DB01100,Pimozide,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4444,DB01100,Pimozide,['approved'],BE0000418,Calmodulin,CALM1,Humans
4447,DB01101,Capecitabine,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
4448,DB01102,Arbutamine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4449,DB01102,Arbutamine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4450,DB01102,Arbutamine,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
4452,DB01103,Quinacrine,['investigational'],BE0001077,85/88 kDa calcium-independent phospholipase A2,PLA2G6,Humans
4453,DB01103,Quinacrine,['investigational'],BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
4454,DB01103,Quinacrine,['investigational'],BE0001081,Inactive phospholipase C-like protein 1,PLCL1,Humans
4455,DB01104,Sertraline,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4456,DB01104,Sertraline,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4457,DB01104,Sertraline,['approved'],BE0004897,Sigma receptor,PGRMC1,Humans
4458,DB01104,Sertraline,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4459,DB01104,Sertraline,['approved'],BE0004775,Equilibrative nucleoside transporter 4,SLC29A4,Humans
4460,DB01105,Sibutramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4461,DB01105,Sibutramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4462,DB01105,Sibutramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4463,DB01106,Levocabastine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4464,DB01106,Levocabastine,"['approved', 'investigational']",BE0000464,Neurotensin receptor type 2,NTSR2,Humans
4465,DB01107,Methyprylon,"['approved', 'illicit', 'withdrawn']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4466,DB01107,Methyprylon,"['approved', 'illicit', 'withdrawn']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4467,DB01108,Trilostane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
4468,DB01108,Trilostane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000059,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,Humans
4469,DB01108,Trilostane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4470,DB01108,Trilostane,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000792,Estrogen receptor beta,ESR2,Humans
4471,DB01109,Heparin,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
4472,DB01109,Heparin,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
4473,DB01109,Heparin,"['approved', 'investigational']",BE0001159,P-selectin,SELP,Humans
4474,DB01109,Heparin,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
4475,DB01109,Heparin,"['approved', 'investigational']",BE0000326,Fibroblast growth factor 4,FGF4,Humans
4476,DB01109,Heparin,"['approved', 'investigational']",BE0005820,Fibroblast growth factor 19,FGF19,Humans
4477,DB01109,Heparin,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
4478,DB01109,Heparin,"['approved', 'investigational']",BE0000689,Fibroblast growth factor 1,FGF1,Humans
4479,DB01109,Heparin,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
4480,DB01109,Heparin,"['approved', 'investigational']",BE0001015,Fibroblast growth factor 2,FGF2,Humans
4481,DB01109,Heparin,"['approved', 'investigational']",BE0001129,Platelet factor 4,PF4,Humans
4482,DB01109,Heparin,"['approved', 'investigational']",BE0001121,Hepatocyte growth factor,HGF,Humans
4484,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
4485,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
4486,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4487,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
4489,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0009631,Inward rectifier potassium channel,KCNJ12,Humans
4490,DB01110,Miconazole,"['approved', 'investigational', 'vet_approved']",BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
4493,DB01113,Papaverine,"['approved', 'investigational']",BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
4494,DB01113,Papaverine,"['approved', 'investigational']",BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
4495,DB01113,Papaverine,"['approved', 'investigational']",BE0009789,Phosphodiesterase enzymes,PDE1B,Humans
4496,DB01114,Chlorpheniramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4497,DB01114,Chlorpheniramine,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4498,DB01114,Chlorpheniramine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4499,DB01114,Chlorpheniramine,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4500,DB01115,Nifedipine,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
4501,DB01115,Nifedipine,['approved'],BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
4502,DB01115,Nifedipine,['approved'],BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
4503,DB01115,Nifedipine,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4504,DB01115,Nifedipine,['approved'],BE0000418,Calmodulin,CALM1,Humans
4505,DB01115,Nifedipine,['approved'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
4506,DB01115,Nifedipine,['approved'],BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
4507,DB01115,Nifedipine,['approved'],BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
4508,DB01116,Trimethaphan,"['approved', 'investigational']",BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
4511,DB01117,Atovaquone,['approved'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
4512,DB01118,Amiodarone,"['approved', 'investigational']",BE0009629,HERG human cardiac K+ channel,KCNH2,Humans
4513,DB01118,Amiodarone,"['approved', 'investigational']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
4514,DB01118,Amiodarone,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
4515,DB01118,Amiodarone,"['approved', 'investigational']",BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
4516,DB01118,Amiodarone,"['approved', 'investigational']",BE0009811,Thyroid hormone receptor,THRA,Humans and other mammals
4517,DB01118,Amiodarone,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4518,DB01118,Amiodarone,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
4519,DB01118,Amiodarone,"['approved', 'investigational']",BE0009812,Peroxisome proliferator-activated receptor gamma coactivator 1-beta,PPARGC1B,Humans
4520,DB01119,Diazoxide,['approved'],BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
4521,DB01119,Diazoxide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
4522,DB01119,Diazoxide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
4523,DB01119,Diazoxide,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4524,DB01119,Diazoxide,['approved'],BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
4525,DB01120,Gliclazide,['approved'],BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
4526,DB01120,Gliclazide,['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
4527,DB01121,Phenacemide,['approved'],BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
4528,DB01122,Ambenonium,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
4530,DB01123,Proflavine,['approved'],BE0000048,Prothrombin,F2,Humans
4533,DB01124,Tolbutamide,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
4534,DB01124,Tolbutamide,"['approved', 'investigational']",BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
4535,DB01125,Anisindione,['approved'],BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
4536,DB01126,Dutasteride,"['approved', 'investigational']",BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,Humans
4537,DB01126,Dutasteride,"['approved', 'investigational']",BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,Humans
4539,DB01127,Econazole,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4540,DB01128,Bicalutamide,['approved'],BE0000132,Androgen receptor,AR,Humans
4541,DB01129,Rabeprazole,"['approved', 'investigational']",BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
4542,DB01130,Prednicarbate,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
4543,DB01131,Proguanil,['approved'],BE0000330,Dihydrofolate reductase,DHFR,Humans
4545,DB01132,Pioglitazone,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
4546,DB01132,Pioglitazone,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
4549,DB01133,Tiludronic acid,"['approved', 'investigational', 'vet_approved']",BE0009940,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,Humans
4550,DB01133,Tiludronic acid,"['approved', 'investigational', 'vet_approved']",BE0009941,Tyrosine-protein phosphatase non-receptor type 6,PTPN6,Humans
4551,DB01133,Tiludronic acid,"['approved', 'investigational', 'vet_approved']",BE0003568,Receptor-type tyrosine-protein phosphatase epsilon,PTPRE,Humans
4552,DB01133,Tiludronic acid,"['approved', 'investigational', 'vet_approved']",BE0009961,V-ATPase Subunits,ATP6V0A1,Humans
4553,DB01134,Desoxycorticosterone pivalate,"['experimental', 'vet_approved']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
4554,DB01135,Doxacurium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
4555,DB01135,Doxacurium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4556,DB01136,Carvedilol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4557,DB01136,Carvedilol,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4558,DB01136,Carvedilol,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
4559,DB01136,Carvedilol,"['approved', 'investigational']",BE0000173,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,Humans
4560,DB01136,Carvedilol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4561,DB01136,Carvedilol,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
4562,DB01136,Carvedilol,"['approved', 'investigational']",BE0000979,Natriuretic peptides B,NPPB,Humans
4563,DB01136,Carvedilol,"['approved', 'investigational']",BE0001095,Gap junction alpha-1 protein,GJA1,Humans
4564,DB01136,Carvedilol,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4565,DB01136,Carvedilol,"['approved', 'investigational']",BE0001114,Vascular cell adhesion protein 1,VCAM1,Humans
4566,DB01136,Carvedilol,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
4567,DB01136,Carvedilol,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4568,DB01136,Carvedilol,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
4569,DB01136,Carvedilol,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
4570,DB01136,Carvedilol,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4571,DB01136,Carvedilol,"['approved', 'investigational']",BE0001074,E-selectin,SELE,Humans
4572,DB01136,Carvedilol,"['approved', 'investigational']",BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
4573,DB01136,Carvedilol,"['approved', 'investigational']",BE0005187,Inward rectifier potassium channel 4,KCNJ4,Humans
4574,DB01136,Carvedilol,"['approved', 'investigational']",BE0009710,Inward rectifier potassium channel 2,KCNJ2,Humans
4577,DB01138,Sulfinpyrazone,['approved'],BE0004782,Solute carrier family 22 member 12,SLC22A12,Humans
4578,DB01138,Sulfinpyrazone,['approved'],BE0000785,Multidrug resistance-associated protein 1,ABCC1,Humans
4579,DB01138,Sulfinpyrazone,['approved'],BE0001069,Canalicular multispecific organic anion transporter 1,ABCC2,Humans
4580,DB01138,Sulfinpyrazone,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4587,DB01142,Doxepin,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4588,DB01142,Doxepin,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
4589,DB01142,Doxepin,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4590,DB01142,Doxepin,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4591,DB01142,Doxepin,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4592,DB01142,Doxepin,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
4593,DB01142,Doxepin,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4594,DB01142,Doxepin,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4595,DB01142,Doxepin,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4596,DB01142,Doxepin,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4597,DB01142,Doxepin,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4598,DB01142,Doxepin,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4599,DB01142,Doxepin,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4600,DB01142,Doxepin,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4601,DB01142,Doxepin,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
4602,DB01142,Doxepin,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4603,DB01142,Doxepin,"['approved', 'investigational']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
4604,DB01142,Doxepin,"['approved', 'investigational']",BE0000146,Histamine H4 receptor,HRH4,Humans
4605,DB01142,Doxepin,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4606,DB01143,Amifostine,"['approved', 'investigational']",BE0000896,"Alkaline phosphatase, placental-like",ALPPL2,Humans
4607,DB01144,Diclofenamide,"['approved', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
4608,DB01144,Diclofenamide,"['approved', 'investigational']",BE0000267,Carbonic anhydrase 1,CA1,Humans
4609,DB01144,Diclofenamide,"['approved', 'investigational']",BE0000535,Carbonic anhydrase 4,CA4,Humans
4610,DB01144,Diclofenamide,"['approved', 'investigational']",BE0003629,Carbonic anhydrase 7,CA7,Humans
4611,DB01144,Diclofenamide,"['approved', 'investigational']",BE0003625,Carbonic anhydrase 3,CA3,Humans
4613,DB01146,Diphenylpyraline,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4614,DB01146,Diphenylpyraline,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4618,DB01148,Flavoxate,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4619,DB01148,Flavoxate,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4620,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4621,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4622,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4623,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4624,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4625,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4626,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4627,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4628,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4629,DB01149,Nefazodone,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4633,DB01151,Desipramine,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4634,DB01151,Desipramine,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4635,DB01151,Desipramine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4636,DB01151,Desipramine,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4637,DB01151,Desipramine,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4638,DB01151,Desipramine,"['approved', 'investigational']",BE0000973,Sphingomyelin phosphodiesterase,SMPD1,Humans
4639,DB01151,Desipramine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4640,DB01151,Desipramine,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
4641,DB01151,Desipramine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4642,DB01151,Desipramine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4643,DB01151,Desipramine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4644,DB01151,Desipramine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4645,DB01151,Desipramine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4646,DB01151,Desipramine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4647,DB01151,Desipramine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4648,DB01151,Desipramine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4649,DB01151,Desipramine,"['approved', 'investigational']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
4652,DB01154,Thiamylal,"['approved', 'vet_approved']",BE0002441,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,Humans
4653,DB01154,Thiamylal,"['approved', 'vet_approved']",BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
4654,DB01154,Thiamylal,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4657,DB01156,Bupropion,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4658,DB01156,Bupropion,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4659,DB01156,Bupropion,['approved'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
4660,DB01156,Bupropion,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4661,DB01157,Trimetrexate,"['approved', 'investigational']",BE0000330,Dihydrofolate reductase,DHFR,Humans
4662,DB01158,Bretylium,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4663,DB01159,Halothane,"['approved', 'vet_approved']",BE0003582,Potassium channel subfamily K member 3,KCNK3,Humans
4664,DB01159,Halothane,"['approved', 'vet_approved']",BE0003583,Potassium channel subfamily K member 9,KCNK9,Humans
4665,DB01159,Halothane,"['approved', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4666,DB01159,Halothane,"['approved', 'vet_approved']",BE0009972,Plasma membrane calcium-transporting ATPase,ATP2B1,Humans
4667,DB01159,Halothane,"['approved', 'vet_approved']",BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
4668,DB01159,Halothane,"['approved', 'vet_approved']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
4669,DB01159,Halothane,"['approved', 'vet_approved']",BE0000534,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,Humans
4670,DB01159,Halothane,"['approved', 'vet_approved']",BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
4671,DB01159,Halothane,"['approved', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
4672,DB01159,Halothane,"['approved', 'vet_approved']",BE0001200,Rhodopsin,RHO,Humans
4673,DB01159,Halothane,"['approved', 'vet_approved']",BE0001030,G protein-activated inward rectifier potassium channel 2,KCNJ6,Humans
4674,DB01159,Halothane,"['approved', 'vet_approved']",BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
4675,DB01159,Halothane,"['approved', 'vet_approved']",BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
4676,DB01159,Halothane,"['approved', 'vet_approved']",BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,Humans
4677,DB01159,Halothane,"['approved', 'vet_approved']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4678,DB01159,Halothane,"['approved', 'vet_approved']",BE0001080,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,GNG2,Humans
4679,DB01159,Halothane,"['approved', 'vet_approved']",BE0000948,Neuropeptide S receptor,NPSR1,Humans
4680,DB01160,Dinoprost tromethamine,"['approved', 'vet_approved']",BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
4681,DB01160,Dinoprost tromethamine,"['approved', 'vet_approved']",BE0000475,Prostacyclin receptor,PTGIR,Humans
4682,DB01161,Chloroprocaine,"['approved', 'investigational']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
4683,DB01161,Chloroprocaine,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4684,DB01162,Terazosin,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4685,DB01162,Terazosin,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4686,DB01162,Terazosin,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
4687,DB01162,Terazosin,['approved'],BE0000984,Transforming growth factor beta-1,TGFB1,Humans
4688,DB01162,Terazosin,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4689,DB01162,Terazosin,['approved'],BE0000462,Potassium voltage-gated channel subfamily H member 6,KCNH6,Humans
4690,DB01162,Terazosin,['approved'],BE0000699,Potassium voltage-gated channel subfamily H member 7,KCNH7,Humans
4697,DB01164,Calcium chloride,['approved'],BE0000885,Protein S100-A13,S100A13,Humans
4700,DB01165,Ofloxacin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4701,DB01166,Cilostazol,"['approved', 'investigational']",BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
4703,DB01167,Itraconazole,"['approved', 'investigational']",BE0000875,Lanosterol 14-alpha demethylase,CYP51A1,Humans
4704,DB01168,Procarbazine,"['approved', 'investigational']",BE0004909,Monoamine oxidase,MAOA,Humans
4706,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
4707,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
4708,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0001040,Transcription factor AP-1,JUN,Humans
4709,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0001027,G1/S-specific cyclin-D1,CCND1,Humans
4710,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
4711,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
4712,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
4713,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0009012,Cyclin-dependent kinase inhibitor 1,CDKN1A,Humans
4714,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
4715,DB01169,Arsenic trioxide,"['approved', 'investigational']",BE0005808,Protein PML,PML,Humans
4716,DB01170,Guanethidine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4717,DB01171,Moclobemide,"['approved', 'investigational']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
4718,DB01171,Moclobemide,"['approved', 'investigational']",BE0004909,Monoamine oxidase,MAOA,Humans
4719,DB01171,Moclobemide,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
4722,DB01173,Orphenadrine,['approved'],BE0000396,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,Humans
4723,DB01173,Orphenadrine,['approved'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
4724,DB01173,Orphenadrine,['approved'],BE0000534,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,Humans
4725,DB01173,Orphenadrine,['approved'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
4726,DB01173,Orphenadrine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4727,DB01173,Orphenadrine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4728,DB01173,Orphenadrine,['approved'],BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
4729,DB01174,Phenobarbital,"['approved', 'investigational']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4730,DB01174,Phenobarbital,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
4731,DB01174,Phenobarbital,"['approved', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
4732,DB01174,Phenobarbital,"['approved', 'investigational']",BE0000829,Glutamate receptor 2,GRIA2,Humans
4733,DB01174,Phenobarbital,"['approved', 'investigational']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
4734,DB01174,Phenobarbital,"['approved', 'investigational']",BE0004956,NMDA receptor,GRIN1,Humans
4735,DB01174,Phenobarbital,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4736,DB01175,Escitalopram,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4737,DB01175,Escitalopram,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4738,DB01175,Escitalopram,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4739,DB01175,Escitalopram,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4740,DB01175,Escitalopram,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4741,DB01175,Escitalopram,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
4742,DB01175,Escitalopram,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4743,DB01175,Escitalopram,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
4744,DB01175,Escitalopram,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4745,DB01175,Escitalopram,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4746,DB01175,Escitalopram,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
4747,DB01176,Cyclizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4748,DB01176,Cyclizine,['approved'],BE0000951,Estrogen sulfotransferase,SULT1E1,Humans
4750,DB01177,Idarubicin,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4751,DB01178,Chlormezanone,"['approved', 'investigational', 'withdrawn']",BE0000736,Translocator protein,TSPO,Humans
4752,DB01179,Podofilox,['approved'],BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
4753,DB01179,Podofilox,['approved'],BE0000143,Tubulin beta chain,TUBB,Humans
4754,DB01179,Podofilox,['approved'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4755,DB01180,Rescinnamine,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
4757,DB01181,Ifosfamide,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4758,DB01182,Propafenone,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
4759,DB01182,Propafenone,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4760,DB01182,Propafenone,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4761,DB01182,Propafenone,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4762,DB01183,Naloxone,"['approved', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4763,DB01183,Naloxone,"['approved', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
4764,DB01183,Naloxone,"['approved', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
4765,DB01183,Naloxone,"['approved', 'vet_approved']",BE0000958,Cyclic AMP-responsive element-binding protein 1,CREB1,Humans
4766,DB01183,Naloxone,"['approved', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4767,DB01183,Naloxone,"['approved', 'vet_approved']",BE0002442,Toll-like receptor 4,TLR4,Humans
4768,DB01183,Naloxone,"['approved', 'vet_approved']",BE0002705,Liver carboxylesterase 1,CES1,Humans
4769,DB01184,Domperidone,"['approved', 'investigational', 'vet_approved']",BE0000581,Dopamine D3 receptor,DRD3,Humans
4770,DB01184,Domperidone,"['approved', 'investigational', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4771,DB01185,Fluoxymesterone,"['approved', 'illicit']",BE0000132,Androgen receptor,AR,Humans
4772,DB01185,Fluoxymesterone,"['approved', 'illicit']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4773,DB01185,Fluoxymesterone,"['approved', 'illicit']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
4774,DB01185,Fluoxymesterone,"['approved', 'illicit']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
4775,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4776,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000581,Dopamine D3 receptor,DRD3,Humans
4777,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000389,Dopamine D4 receptor,DRD4,Humans
4778,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000145,Dopamine D5 receptor,DRD5,Humans
4779,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
4780,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4781,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
4782,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4783,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
4784,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
4785,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4786,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4787,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4788,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4789,DB01186,Pergolide,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
4790,DB01188,Ciclopirox,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
4791,DB01189,Desflurane,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
4792,DB01189,Desflurane,['approved'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
4793,DB01189,Desflurane,['approved'],BE0000640,Glutamate receptor 1,GRIA1,Humans
4794,DB01189,Desflurane,['approved'],BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
4795,DB01189,Desflurane,['approved'],BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
4796,DB01189,Desflurane,['approved'],BE0010002,Calcium transporting ATPases,ATP2C1,Humans
4797,DB01189,Desflurane,['approved'],BE0000484,"ATP synthase subunit delta, mitochondrial",ATP5D,Humans
4799,DB01191,Dexfenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
4800,DB01191,Dexfenfluramine,"['approved', 'illicit', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4801,DB01192,Oxymorphone,"['approved', 'investigational', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4802,DB01192,Oxymorphone,"['approved', 'investigational', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
4803,DB01193,Acebutolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4804,DB01193,Acebutolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4805,DB01194,Brinzolamide,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
4806,DB01194,Brinzolamide,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
4807,DB01194,Brinzolamide,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
4808,DB01194,Brinzolamide,['approved'],BE0003626,"Carbonic anhydrase 5A, mitochondrial",CA5A,Humans
4809,DB01194,Brinzolamide,['approved'],BE0003625,Carbonic anhydrase 3,CA3,Humans
4810,DB01195,Flecainide,"['approved', 'withdrawn']",BE0002083,Sodium channel protein type 4 subunit alpha,SCN4A,Humans
4811,DB01195,Flecainide,"['approved', 'withdrawn']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
4812,DB01195,Flecainide,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4813,DB01195,Flecainide,"['approved', 'withdrawn']",BE0005295,Ryanodine receptor 2,RYR2,Humans
4814,DB01196,Estramustine,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
4815,DB01196,Estramustine,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
4816,DB01196,Estramustine,"['approved', 'investigational']",BE0001100,Microtubule-associated protein 2,MAP2,Humans
4817,DB01196,Estramustine,"['approved', 'investigational']",BE0001169,Microtubule-associated protein 1A,MAP1A,Humans
4818,DB01197,Captopril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
4819,DB01197,Captopril,['approved'],BE0000642,72 kDa type IV collagenase,MMP2,Humans
4820,DB01197,Captopril,['approved'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
4821,DB01197,Captopril,['approved'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
4822,DB01197,Captopril,['approved'],BE0005831,B1 bradykinin receptor,BDKRB1,Humans
4823,DB01198,Zopiclone,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4824,DB01198,Zopiclone,['approved'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
4825,DB01198,Zopiclone,['approved'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
4826,DB01198,Zopiclone,['approved'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
4827,DB01198,Zopiclone,['approved'],BE0000736,Translocator protein,TSPO,Humans
4828,DB01199,Tubocurarine,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
4829,DB01199,Tubocurarine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4830,DB01199,Tubocurarine,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
4831,DB01199,Tubocurarine,['approved'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
4832,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4833,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000581,Dopamine D3 receptor,DRD3,Humans
4834,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
4835,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4836,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4837,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
4838,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
4839,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
4840,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000389,Dopamine D4 receptor,DRD4,Humans
4841,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4842,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4843,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4844,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000145,Dopamine D5 receptor,DRD5,Humans
4845,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
4846,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4847,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4848,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
4849,DB01200,Bromocriptine,"['approved', 'investigational', 'withdrawn']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
4851,DB01202,Levetiracetam,['approved'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
4852,DB01202,Levetiracetam,['approved'],BE0000993,Synaptic vesicle glycoprotein 2A,SV2A,Humans
4853,DB01203,Nadolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4854,DB01203,Nadolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4856,DB01204,Mitoxantrone,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4857,DB01205,Flumazenil,['approved'],BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
4858,DB01205,Flumazenil,['approved'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
4859,DB01205,Flumazenil,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
4860,DB01205,Flumazenil,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
4862,DB01206,Lomustine,"['approved', 'investigational']",BE0004003,Stathmin-4,STMN4,Humans
4863,DB01207,Ridogrel,['experimental'],BE0001893,Thromboxane-A synthase,TBXAS1,Humans
4864,DB01207,Ridogrel,['experimental'],BE0000759,Thromboxane A2 receptor,TBXA2R,Humans
4867,DB01208,Sparfloxacin,"['approved', 'investigational', 'withdrawn']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
4868,DB01209,Dezocine,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4869,DB01209,Dezocine,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
4870,DB01210,Levobunolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4871,DB01210,Levobunolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4873,DB01211,Clarithromycin,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4874,DB01211,Clarithromycin,['approved'],BE0001004,Solute carrier organic anion transporter family member 1B1,SLCO1B1,Humans
4875,DB01211,Clarithromycin,['approved'],BE0003659,Solute carrier organic anion transporter family member 1B3,SLCO1B3,Humans
4877,DB01212,Ceftriaxone,['approved'],BE0000879,Solute carrier family 22 member 11,SLC22A11,Humans
4878,DB01212,Ceftriaxone,['approved'],BE0001066,Solute carrier family 22 member 6,SLC22A6,Humans
4879,DB01212,Ceftriaxone,['approved'],BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
4880,DB01212,Ceftriaxone,['approved'],BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
4881,DB01213,Fomepizole,"['approved', 'vet_approved']",BE0000227,Alcohol dehydrogenase 1A,ADH1A,Humans
4882,DB01213,Fomepizole,"['approved', 'vet_approved']",BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
4883,DB01213,Fomepizole,"['approved', 'vet_approved']",BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
4884,DB01213,Fomepizole,"['approved', 'vet_approved']",BE0001207,Catalase,CAT,Humans
4885,DB01214,Metipranolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
4886,DB01214,Metipranolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
4887,DB01215,Estazolam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4888,DB01215,Estazolam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
4889,DB01216,Finasteride,['approved'],BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,Humans
4890,DB01216,Finasteride,['approved'],BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,Humans
4891,DB01216,Finasteride,['approved'],BE0003610,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,Humans
4892,DB01217,Anastrozole,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
4894,DB01218,Halofantrine,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
4896,DB01219,Dantrolene,"['approved', 'investigational']",BE0000739,Ryanodine receptor 1,RYR1,Humans
4898,DB01220,Rifaximin,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4899,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
4900,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4901,DB01221,Ketamine,"['approved', 'vet_approved']",BE0003438,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,Humans
4902,DB01221,Ketamine,"['approved', 'vet_approved']",BE0002180,Cholinesterase,BCHE,Humans
4903,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
4904,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
4905,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4906,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
4907,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
4908,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
4909,DB01221,Ketamine,"['approved', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4910,DB01221,Ketamine,"['approved', 'vet_approved']",BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
4911,DB01221,Ketamine,"['approved', 'vet_approved']",BE0004957,5-hydroxytryptamine receptor 2,HTR2A,Humans
4912,DB01221,Ketamine,"['approved', 'vet_approved']",BE0004958,5-hydroxytryptamine receptor 1,HTR1A,Humans
4913,DB01222,Budesonide,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
4914,DB01222,Budesonide,['approved'],BE0000422,Annexin A1,ANXA1,Humans
4915,DB01223,Aminophylline,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
4916,DB01223,Aminophylline,['approved'],BE0000013,Adenosine receptor A1,ADORA1,Humans
4917,DB01223,Aminophylline,['approved'],BE0000354,Adenosine receptor A3,ADORA3,Humans
4918,DB01223,Aminophylline,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
4919,DB01224,Quetiapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4920,DB01224,Quetiapine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4921,DB01224,Quetiapine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4922,DB01224,Quetiapine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4923,DB01224,Quetiapine,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
4924,DB01224,Quetiapine,['approved'],BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
4925,DB01224,Quetiapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4926,DB01224,Quetiapine,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4927,DB01224,Quetiapine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
4928,DB01224,Quetiapine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
4929,DB01224,Quetiapine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
4930,DB01224,Quetiapine,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
4931,DB01224,Quetiapine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
4932,DB01224,Quetiapine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
4933,DB01224,Quetiapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4934,DB01224,Quetiapine,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
4935,DB01224,Quetiapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4936,DB01224,Quetiapine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
4937,DB01224,Quetiapine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
4938,DB01224,Quetiapine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4939,DB01224,Quetiapine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4940,DB01224,Quetiapine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4941,DB01224,Quetiapine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
4942,DB01224,Quetiapine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
4943,DB01225,Enoxaparin,['approved'],BE0000280,Antithrombin-III,SERPINC1,Humans
4944,DB01225,Enoxaparin,['approved'],BE0000216,Coagulation factor X,F10,Humans
4945,DB01225,Enoxaparin,['approved'],BE0000048,Prothrombin,F2,Humans
4946,DB01226,Mivacurium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
4947,DB01226,Mivacurium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4948,DB01226,Mivacurium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4949,DB01226,Mivacurium,['approved'],BE0002180,Cholinesterase,BCHE,Humans
4950,DB01227,Levacetylmethadol,"['approved', 'investigational', 'withdrawn']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
4951,DB01227,Levacetylmethadol,"['approved', 'investigational', 'withdrawn']",BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
4952,DB01227,Levacetylmethadol,"['approved', 'investigational', 'withdrawn']",BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
4953,DB01228,Encainide,"['approved', 'investigational', 'withdrawn']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
4954,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0000026,Tubulin beta-1 chain,TUBB1,Humans
4955,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
4956,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0003475,Microtubule-associated protein 4,MAP4,Humans
4957,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0001100,Microtubule-associated protein 2,MAP2,Humans
4958,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0003474,Microtubule-associated protein tau,MAPT,Humans
4959,DB01229,Paclitaxel,"['approved', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4960,DB01231,Diphenidol,"['approved', 'investigational', 'withdrawn']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
4961,DB01231,Diphenidol,"['approved', 'investigational', 'withdrawn']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4962,DB01231,Diphenidol,"['approved', 'investigational', 'withdrawn']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
4964,DB01233,Metoclopramide,"['approved', 'investigational']",BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
4965,DB01233,Metoclopramide,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4966,DB01233,Metoclopramide,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
4967,DB01233,Metoclopramide,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4968,DB01234,Dexamethasone,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
4969,DB01234,Dexamethasone,"['approved', 'investigational', 'vet_approved']",BE0000074,Nuclear receptor subfamily 0 group B member 1,NR0B1,Humans
4970,DB01234,Dexamethasone,"['approved', 'investigational', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
4971,DB01234,Dexamethasone,"['approved', 'investigational', 'vet_approved']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
4972,DB01234,Dexamethasone,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
4973,DB01235,Levodopa,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
4974,DB01235,Levodopa,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
4975,DB01235,Levodopa,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
4976,DB01235,Levodopa,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
4977,DB01235,Levodopa,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
4978,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0004797,GABA(A) Receptor,GABRA1,Humans
4979,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
4980,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0000640,Glutamate receptor 1,GRIA1,Humans
4981,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0010002,Calcium transporting ATPases,ATP2C1,Humans
4982,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
4983,DB01236,Sevoflurane,"['approved', 'vet_approved']",BE0009966,Mitochondrial potassium channel,CCDC51,Humans
4984,DB01237,Bromodiphenhydramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
4985,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
4986,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
4987,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
4988,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
4989,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
4990,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
4991,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
4992,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
4993,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
4994,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
4995,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
4996,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
4997,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
4998,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
4999,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
5000,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5001,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
5002,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5003,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
5004,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
5005,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
5006,DB01238,Aripiprazole,"['approved', 'investigational']",BE0004688,5-hydroxytryptamine receptor 5A,HTR5A,Humans
5007,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5008,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5009,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
5010,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000968,Histamine H3 receptor,HRH3,Humans
5011,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000146,Histamine H4 receptor,HRH4,Humans
5012,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5013,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5014,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5015,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5016,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
5017,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5018,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5019,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5020,DB01238,Aripiprazole,"['approved', 'investigational']",BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
5021,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5022,DB01238,Aripiprazole,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5023,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5024,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5025,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000581,Dopamine D3 receptor,DRD3,Humans
5026,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5027,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
5028,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0004862,Serotonin Receptors,HTR1A,Humans
5029,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5030,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5031,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5032,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5033,DB01239,Chlorprothixene,"['approved', 'experimental', 'investigational', 'withdrawn']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
5034,DB01240,Epoprostenol,['approved'],BE0000117,Prostacyclin synthase,PTGIS,Humans
5035,DB01240,Epoprostenol,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
5036,DB01240,Epoprostenol,['approved'],BE0000475,Prostacyclin receptor,PTGIR,Humans
5037,DB01241,Gemfibrozil,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
5038,DB01241,Gemfibrozil,['approved'],BE0001004,Solute carrier organic anion transporter family member 1B1,SLCO1B1,Humans
5039,DB01241,Gemfibrozil,['approved'],BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
5040,DB01241,Gemfibrozil,['approved'],BE0001042,Solute carrier organic anion transporter family member 2B1,SLCO2B1,Humans
5041,DB01241,Gemfibrozil,['approved'],BE0003659,Solute carrier organic anion transporter family member 1B3,SLCO1B3,Humans
5042,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5043,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5044,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
5045,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5046,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5047,DB01242,Clomipramine,"['approved', 'investigational', 'vet_approved']",BE0000814,Glutathione S-transferase P,GSTP1,Humans
5048,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,Humans
5049,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
5050,DB01244,Bepridil,"['approved', 'withdrawn']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
5051,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5052,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000672,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,Humans
5053,DB01244,Bepridil,"['approved', 'withdrawn']",BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
5054,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000418,Calmodulin,CALM1,Humans
5055,DB01244,Bepridil,"['approved', 'withdrawn']",BE0003323,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,Humans
5056,DB01244,Bepridil,"['approved', 'withdrawn']",BE0003565,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,Humans
5057,DB01244,Bepridil,"['approved', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
5058,DB01245,Decamethonium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
5059,DB01245,Decamethonium,['approved'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5060,DB01245,Decamethonium,['approved'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
5061,DB01245,Decamethonium,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
5062,DB01246,Alimemazine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
5063,DB01247,Isocarboxazid,['approved'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5064,DB01247,Isocarboxazid,['approved'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5065,DB01248,Docetaxel,"['approved', 'investigational']",BE0000026,Tubulin beta-1 chain,TUBB1,Humans
5066,DB01248,Docetaxel,"['approved', 'investigational']",BE0001100,Microtubule-associated protein 2,MAP2,Humans
5067,DB01248,Docetaxel,"['approved', 'investigational']",BE0003475,Microtubule-associated protein 4,MAP4,Humans
5068,DB01248,Docetaxel,"['approved', 'investigational']",BE0003474,Microtubule-associated protein tau,MAPT,Humans
5069,DB01248,Docetaxel,"['approved', 'investigational']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
5070,DB01248,Docetaxel,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
5071,DB01250,Olsalazine,['approved'],BE0000987,Thiopurine S-methyltransferase,TPMT,Humans
5072,DB01250,Olsalazine,['approved'],BE0000944,Interferon gamma,IFNG,Humans
5073,DB01251,Gliquidone,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
5074,DB01251,Gliquidone,"['approved', 'investigational']",BE0002441,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,Humans
5075,DB01252,Mitiglinide,['investigational'],BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
5076,DB01252,Mitiglinide,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
5077,DB01253,Ergometrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5078,DB01254,Dasatinib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
5079,DB01254,Dasatinib,"['approved', 'investigational']",BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
5080,DB01254,Dasatinib,"['approved', 'investigational']",BE0000841,Ephrin type-A receptor 2,EPHA2,Humans
5081,DB01254,Dasatinib,"['approved', 'investigational']",BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
5082,DB01254,Dasatinib,"['approved', 'investigational']",BE0000840,Tyrosine-protein kinase Yes,YES1,Humans
5083,DB01254,Dasatinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
5084,DB01254,Dasatinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
5085,DB01254,Dasatinib,"['approved', 'investigational']",BE0000891,Signal transducer and activator of transcription 5B,STAT5B,Humans
5086,DB01254,Dasatinib,"['approved', 'investigational']",BE0000435,Abelson tyrosine-protein kinase 2,ABL2,Humans
5087,DB01254,Dasatinib,"['approved', 'investigational']",BE0000839,Tyrosine-protein kinase Fyn,FYN,Humans
5088,DB01254,Dasatinib,"['approved', 'investigational']",BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
5089,DB01254,Dasatinib,"['approved', 'investigational']",BE0008998,Nuclear receptor subfamily 4 group A member 3,NR4A3,Humans
5090,DB01254,Dasatinib,"['approved', 'investigational']",BE0004743,Breakpoint cluster region protein,BCR,Humans
5091,DB01254,Dasatinib,"['approved', 'investigational']",BE0001356,Tyrosine-protein kinase CSK,CSK,Humans
5092,DB01254,Dasatinib,"['approved', 'investigational']",BE0005587,Ephrin type-A receptor 5,EPHA5,Humans
5093,DB01254,Dasatinib,"['approved', 'investigational']",BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
5094,DB01254,Dasatinib,"['approved', 'investigational']",BE0005539,Tyrosine-protein kinase Fgr,FGR,Humans
5095,DB01254,Dasatinib,"['approved', 'investigational']",BE0004742,Tyrosine-protein kinase FRK,FRK,Humans
5096,DB01254,Dasatinib,"['approved', 'investigational']",BE0003775,Heat shock cognate 71 kDa protein,HSPA8,Humans
5097,DB01254,Dasatinib,"['approved', 'investigational']",BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
5098,DB01254,Dasatinib,"['approved', 'investigational']",BE0005595,Mitogen-activated protein kinase kinase kinase MLT,ZAK,Humans
5099,DB01254,Dasatinib,"['approved', 'investigational']",BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
5100,DB01254,Dasatinib,"['approved', 'investigational']",BE0000374,Amidophosphoribosyltransferase,PPAT,Humans
5101,DB01255,Lisdexamfetamine,"['approved', 'investigational']",BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
5103,DB01257,Eculizumab,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
5104,DB01259,Lapatinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
5105,DB01259,Lapatinib,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
5106,DB01260,Desonide,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
5107,DB01261,Sitagliptin,"['approved', 'investigational']",BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
5109,DB01262,Decitabine,"['approved', 'investigational']",BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
5110,DB01262,Decitabine,"['approved', 'investigational']",BE0009880,DNA (cytosine-5)-methyltransferase 3A,DNMT3A,Humans
5111,DB01262,Decitabine,"['approved', 'investigational']",BE0010009,DNA (cytosine-5)-methyltransferase 3B,DNMT3B,Humans
5112,DB01262,Decitabine,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
5117,DB01267,Paliperidone,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5118,DB01267,Paliperidone,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
5119,DB01267,Paliperidone,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
5120,DB01267,Paliperidone,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
5121,DB01267,Paliperidone,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5122,DB01267,Paliperidone,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
5123,DB01267,Paliperidone,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5124,DB01267,Paliperidone,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5125,DB01267,Paliperidone,['approved'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
5126,DB01267,Paliperidone,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5127,DB01267,Paliperidone,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5128,DB01267,Paliperidone,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
5129,DB01267,Paliperidone,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5130,DB01267,Paliperidone,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
5131,DB01267,Paliperidone,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
5132,DB01268,Sunitinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
5133,DB01268,Sunitinib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
5134,DB01268,Sunitinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
5135,DB01268,Sunitinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
5136,DB01268,Sunitinib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
5137,DB01268,Sunitinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
5138,DB01268,Sunitinib,"['approved', 'investigational']",BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
5139,DB01268,Sunitinib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
5140,DB01268,Sunitinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
5141,DB01269,Panitumumab,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
5142,DB01270,Ranibizumab,['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
5145,DB01271,Idursulfase,['approved'],BE0000856,Perilipin-3,PLIN3,Humans
5146,DB01272,Alglucosidase alfa,['approved'],BE0004494,Cation-dependent mannose-6-phosphate receptor,M6PR,Humans
5148,DB01273,Varenicline,"['approved', 'investigational']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5149,DB01273,Varenicline,"['approved', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5150,DB01273,Varenicline,"['approved', 'investigational']",BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
5151,DB01273,Varenicline,"['approved', 'investigational']",BE0003587,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,Humans
5152,DB01273,Varenicline,"['approved', 'investigational']",BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
5153,DB01274,Arformoterol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5154,DB01275,Hydralazine,['approved'],BE0001002,Membrane primary amine oxidase,AOC3,Humans
5155,DB01275,Hydralazine,['approved'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
5156,DB01275,Hydralazine,['approved'],BE0000060,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,Humans
5157,DB01276,Exenatide,"['approved', 'investigational']",BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
5158,DB01277,Mecasermin,"['approved', 'investigational']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
5159,DB01277,Mecasermin,"['approved', 'investigational']",BE0000970,Insulin-like growth factor-binding protein 3,IGFBP3,Humans
5160,DB01277,Mecasermin,"['approved', 'investigational']",BE0000033,Insulin receptor,INSR,Humans
5161,DB01277,Mecasermin,"['approved', 'investigational']",BE0003623,Cation-independent mannose-6-phosphate receptor,IGF2R,Humans
5162,DB01278,Pramlintide,"['approved', 'investigational']",BE0000431,Calcitonin receptor,CALCR,Humans
5163,DB01278,Pramlintide,"['approved', 'investigational']",BE0000859,Receptor activity-modifying protein 1,RAMP1,Humans
5164,DB01278,Pramlintide,"['approved', 'investigational']",BE0000860,Receptor activity-modifying protein 2,RAMP2,Humans
5165,DB01278,Pramlintide,"['approved', 'investigational']",BE0000861,Receptor activity-modifying protein 3,RAMP3,Humans
5167,DB01279,Galsulfase,"['approved', 'investigational']",BE0000856,Perilipin-3,PLIN3,Humans
5169,DB01280,Nelarabine,"['approved', 'investigational']",BE0000546,DNA polymerase alpha catalytic subunit,POLA1,Humans
5170,DB01281,Abatacept,['approved'],BE0000847,T-lymphocyte activation antigen CD80,CD80,Humans
5171,DB01281,Abatacept,['approved'],BE0000846,T-lymphocyte activation antigen CD86,CD86,Humans
5172,DB01281,Abatacept,['approved'],BE0000887,Cytotoxic T-lymphocyte protein 4,CTLA4,Humans
5173,DB01282,Carbetocin,"['approved', 'investigational']",BE0000844,Oxytocin receptor,OXTR,Humans
5174,DB01283,Lumiracoxib,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5175,DB01283,Lumiracoxib,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5176,DB01284,Tetracosactide,['approved'],BE0000848,Adrenocorticotropic hormone receptor,MC2R,Humans
5177,DB01285,Corticotropin,"['approved', 'investigational', 'vet_approved']",BE0000848,Adrenocorticotropic hormone receptor,MC2R,Humans
5178,DB01285,Corticotropin,"['approved', 'investigational', 'vet_approved']",BE0001026,Corticoliberin,CRH,Humans
5179,DB01288,Fenoterol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5180,DB01288,Fenoterol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5181,DB01288,Fenoterol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
5182,DB01289,Glisoxepide,['investigational'],BE0002441,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,Humans
5183,DB01289,Glisoxepide,['investigational'],BE0003491,Insulin,INS,Humans
5184,DB01291,Pirbuterol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5185,DB01291,Pirbuterol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5186,DB01295,Bevantolol,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5187,DB01295,Bevantolol,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5188,DB01295,Bevantolol,['experimental'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5189,DB01296,Glucosamine,"['approved', 'investigational']",BE0000944,Interferon gamma,IFNG,Humans
5190,DB01296,Glucosamine,"['approved', 'investigational']",BE0005551,Transcription factor p65,RELA,Humans
5191,DB01297,Practolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5197,DB01303,Oxtriphylline,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
5198,DB01303,Oxtriphylline,['approved'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
5199,DB01303,Oxtriphylline,['approved'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
5200,DB01303,Oxtriphylline,['approved'],BE0000013,Adenosine receptor A1,ADORA1,Humans
5201,DB01303,Oxtriphylline,['approved'],BE0002366,Histone deacetylase 2,HDAC2,Humans
5202,DB01306,Insulin aspart,['approved'],BE0000033,Insulin receptor,INSR,Humans
5203,DB01306,Insulin aspart,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
5204,DB01307,Insulin detemir,['approved'],BE0000033,Insulin receptor,INSR,Humans
5205,DB01307,Insulin detemir,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
5206,DB01309,Insulin glulisine,['approved'],BE0000033,Insulin receptor,INSR,Humans
5207,DB01309,Insulin glulisine,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
5209,DB01320,Fosphenytoin,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
5211,DB01324,Polythiazide,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
5212,DB01325,Quinethazone,['approved'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
5213,DB01325,Quinethazone,['approved'],BE0000281,Solute carrier family 12 member 2,SLC12A2,Humans
5214,DB01325,Quinethazone,['approved'],BE0000419,Solute carrier family 12 member 3,SLC12A3,Humans
5215,DB01325,Quinethazone,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
5216,DB01325,Quinethazone,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
5223,DB01327,Cefazolin,['approved'],BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
5224,DB01327,Cefazolin,['approved'],BE0003486,Interleukin-15,IL15,Humans
5225,DB01327,Cefazolin,['approved'],BE0001029,Interleukin-2,IL2,Humans
5258,DB01336,Metocurine,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
5259,DB01336,Metocurine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5260,DB01337,Pancuronium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
5261,DB01337,Pancuronium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5262,DB01337,Pancuronium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5263,DB01338,Pipecuronium,['approved'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
5264,DB01338,Pipecuronium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5265,DB01338,Pipecuronium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5266,DB01339,Vecuronium,"['approved', 'investigational']",BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
5267,DB01340,Cilazapril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
5268,DB01341,Dihydroquinidine barbiturate,['experimental'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5269,DB01342,Forasartan,['experimental'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
5271,DB01345,Potassium cation,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5272,DB01346,Quinidine barbiturate,['approved'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5273,DB01346,Quinidine barbiturate,['approved'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5274,DB01346,Quinidine barbiturate,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
5275,DB01346,Quinidine barbiturate,['approved'],BE0000154,Potassium channel subfamily K member 1,KCNK1,Humans
5276,DB01346,Quinidine barbiturate,['approved'],BE0000829,Glutamate receptor 2,GRIA2,Humans
5277,DB01347,Saprisartan,['experimental'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
5278,DB01348,Spirapril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
5279,DB01349,Tasosartan,['experimental'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
5280,DB01349,Tasosartan,['experimental'],BE0003426,Type-2 angiotensin II receptor,AGTR2,Humans
5281,DB01351,Amobarbital,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5282,DB01351,Amobarbital,"['approved', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5283,DB01351,Amobarbital,"['approved', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5284,DB01351,Amobarbital,"['approved', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5285,DB01351,Amobarbital,"['approved', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5286,DB01351,Amobarbital,"['approved', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5287,DB01351,Amobarbital,"['approved', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5288,DB01351,Amobarbital,"['approved', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5289,DB01351,Amobarbital,"['approved', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
5290,DB01351,Amobarbital,"['approved', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5291,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5292,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5293,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5294,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5295,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5296,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5297,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5298,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5299,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
5300,DB01352,Aprobarbital,"['experimental', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5301,DB01353,Butobarbital,"['approved', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5302,DB01353,Butobarbital,"['approved', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5303,DB01353,Butobarbital,"['approved', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5304,DB01353,Butobarbital,"['approved', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5305,DB01353,Butobarbital,"['approved', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5306,DB01353,Butobarbital,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5307,DB01353,Butobarbital,"['approved', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5308,DB01353,Butobarbital,"['approved', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5309,DB01353,Butobarbital,"['approved', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
5310,DB01353,Butobarbital,"['approved', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5311,DB01354,Heptabarbital,['experimental'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5312,DB01354,Heptabarbital,['experimental'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5313,DB01354,Heptabarbital,['experimental'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5314,DB01354,Heptabarbital,['experimental'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5315,DB01354,Heptabarbital,['experimental'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5316,DB01354,Heptabarbital,['experimental'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5317,DB01354,Heptabarbital,['experimental'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5318,DB01354,Heptabarbital,['experimental'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5319,DB01354,Heptabarbital,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
5320,DB01354,Heptabarbital,['experimental'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5321,DB01355,Hexobarbital,['experimental'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5322,DB01355,Hexobarbital,['experimental'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5323,DB01355,Hexobarbital,['experimental'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5324,DB01355,Hexobarbital,['experimental'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5325,DB01355,Hexobarbital,['experimental'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5326,DB01355,Hexobarbital,['experimental'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5327,DB01355,Hexobarbital,['experimental'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5328,DB01355,Hexobarbital,['experimental'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5329,DB01355,Hexobarbital,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
5330,DB01355,Hexobarbital,['experimental'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5331,DB01356,Lithium cation,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
5332,DB01356,Lithium cation,['experimental'],BE0001152,Inositol monophosphatase 1,IMPA1,Humans
5333,DB01356,Lithium cation,['experimental'],BE0000983,Inositol monophosphatase 2,IMPA2,Humans
5334,DB01356,Lithium cation,['experimental'],BE0000831,Glutamate receptor 3,GRIA3,Humans
5335,DB01357,Mestranol,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
5336,DB01359,Penbutolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5337,DB01359,Penbutolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5338,DB01359,Penbutolol,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5339,DB01359,Penbutolol,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
5340,DB01363,Ephedra sinica root,['nutraceutical'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5341,DB01363,Ephedra sinica root,['nutraceutical'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5342,DB01363,Ephedra sinica root,['nutraceutical'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5343,DB01363,Ephedra sinica root,['nutraceutical'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5344,DB01363,Ephedra sinica root,['nutraceutical'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
5345,DB01363,Ephedra sinica root,['nutraceutical'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5346,DB01363,Ephedra sinica root,['nutraceutical'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5347,DB01363,Ephedra sinica root,['nutraceutical'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5348,DB01363,Ephedra sinica root,['nutraceutical'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5349,DB01363,Ephedra sinica root,['nutraceutical'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
5350,DB01363,Ephedra sinica root,['nutraceutical'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5351,DB01363,Ephedra sinica root,['nutraceutical'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5352,DB01363,Ephedra sinica root,['nutraceutical'],BE0004674,Chromaffin granule amine transporter,SLC18A1,Humans
5353,DB01364,Ephedrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5354,DB01364,Ephedrine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5355,DB01364,Ephedrine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5356,DB01364,Ephedrine,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5357,DB01365,Mephentermine,['approved'],BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
5358,DB01365,Mephentermine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
5359,DB01366,Procaterol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5360,DB01367,Rasagiline,['approved'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5361,DB01367,Rasagiline,['approved'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
5365,DB01370,Aluminium,"['approved', 'investigational']",BE0001091,Kallikrein-1,KLK1,Humans
5366,DB01370,Aluminium,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
5367,DB01370,Aluminium,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
5368,DB01370,Aluminium,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5369,DB01373,Calcium,['nutraceutical'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
5370,DB01373,Calcium,['nutraceutical'],BE0000218,Calcium-transporting ATPase type 2C member 1,ATP2C1,Humans
5371,DB01373,Calcium,['nutraceutical'],BE0003566,"Troponin C, skeletal muscle",TNNC2,Humans
5372,DB01373,Calcium,['nutraceutical'],BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
5373,DB01373,Calcium,['nutraceutical'],BE0004593,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,Humans
5374,DB01373,Calcium,['nutraceutical'],BE0001177,Protein S100-B,S100B,Humans
5375,DB01373,Calcium,['nutraceutical'],BE0000904,Calpastatin,CAST,Humans
5376,DB01373,Calcium,['nutraceutical'],BE0000899,Cartilage oligomeric matrix protein,COMP,Humans
5377,DB01373,Calcium,['nutraceutical'],BE0000418,Calmodulin,CALM1,Humans
5378,DB01373,Calcium,['nutraceutical'],BE0000351,Amiloride-sensitive amine oxidase [copper-containing],AOC1,Humans
5379,DB01373,Calcium,['nutraceutical'],BE0000885,Protein S100-A13,S100A13,Humans
5380,DB01373,Calcium,['nutraceutical'],BE0004314,"Alkaline phosphatase, placental type",ALPP,Humans
5381,DB01373,Calcium,['nutraceutical'],BE0008955,Protein S100-A8,S100A8,Humans
5382,DB01373,Calcium,['nutraceutical'],BE0008993,Protein S100-A9,S100A9,Humans
5383,DB01373,Calcium,['nutraceutical'],BE0003602,Protein S100-A2,S100A2,Humans
5384,DB01373,Calcium,['nutraceutical'],BE0001140,Ceruloplasmin,CP,Humans
5385,DB01373,Calcium,['nutraceutical'],BE0009000,Bone morphogenetic protein 4,BMP4,Humans
5386,DB01373,Calcium,['nutraceutical'],BE0005813,Matrix Gla protein,MGP,Humans
5387,DB01373,Calcium,['nutraceutical'],BE0005814,Protocadherin-19,PCDH19,Humans
5388,DB01373,Calcium,['nutraceutical'],BE0005812,Programmed cell death protein 6,PDCD6,Humans
5389,DB01375,Aluminium monostearate,['experimental'],BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
5390,DB01375,Aluminium monostearate,['experimental'],BE0002468,Voltage-dependent anion-selective channel protein 1,VDAC1,Humans
5391,DB01375,Aluminium monostearate,['experimental'],BE0002469,Voltage-dependent anion-selective channel protein 2,VDAC2,Humans
5392,DB01375,Aluminium monostearate,['experimental'],BE0002470,Voltage-dependent anion-selective channel protein 3,VDAC3,Humans
5393,DB01378,Magnesium cation,"['approved', 'nutraceutical']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5394,DB01380,Cortisone acetate,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
5395,DB01380,Cortisone acetate,"['approved', 'investigational']",BE0000422,Annexin A1,ANXA1,Humans
5396,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5397,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
5398,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
5399,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5400,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
5401,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
5402,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5403,DB01381,Ginkgo biloba,"['approved', 'investigational', 'nutraceutical']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
5404,DB01382,Glymidine,"['approved', 'investigational']",BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
5405,DB01382,Glymidine,"['approved', 'investigational']",BE0000207,ATP-binding cassette sub-family C member 8,ABCC8,Humans
5406,DB01384,Paramethasone,['experimental'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
5407,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
5408,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
5409,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
5410,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
5411,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
5412,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
5413,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
5414,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
5415,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
5416,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,Humans
5417,DB01388,Mibefradil,"['investigational', 'withdrawn']",BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,Humans
5419,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5420,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5421,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
5422,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5423,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
5424,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
5425,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5426,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000581,Dopamine D3 receptor,DRD3,Humans
5427,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5428,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5429,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0004905,ATP-sensitive potassium channel,KCNJ1,Humans
5430,DB01392,Yohimbine,"['approved', 'investigational', 'vet_approved']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
5431,DB01393,Bezafibrate,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
5432,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
5433,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
5434,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
5435,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
5436,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
5437,DB01393,Bezafibrate,"['approved', 'investigational']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
5438,DB01394,Colchicine,['approved'],BE0000143,Tubulin beta chain,TUBB,Humans
5439,DB01395,Drospirenone,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
5440,DB01395,Drospirenone,['approved'],BE0000132,Androgen receptor,AR,Humans
5441,DB01395,Drospirenone,['approved'],BE0000557,Progesterone receptor,PGR,Humans
5442,DB01395,Drospirenone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
5443,DB01396,Digitoxin,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5444,DB01397,Magnesium salicylate,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5445,DB01397,Magnesium salicylate,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5446,DB01399,Salsalate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5447,DB01399,Salsalate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5448,DB01400,Neostigmine,"['approved', 'vet_approved']",BE0000426,Acetylcholinesterase,ACHE,Humans
5449,DB01401,Choline magnesium trisalicylate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5450,DB01401,Choline magnesium trisalicylate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5451,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5452,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5453,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
5454,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
5455,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
5456,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5457,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5458,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
5459,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5460,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5461,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5462,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5463,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
5464,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5465,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5466,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
5467,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5468,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5469,DB01403,Methotrimeprazine,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
5470,DB01404,Ginseng,"['investigational', 'nutraceutical']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
5471,DB01404,Ginseng,"['investigational', 'nutraceutical']",BE0000918,Interleukin-6,IL6,Humans
5472,DB01404,Ginseng,"['investigational', 'nutraceutical']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5475,DB01406,Danazol,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
5476,DB01406,Danazol,['approved'],BE0000132,Androgen receptor,AR,Humans
5477,DB01406,Danazol,['approved'],BE0000557,Progesterone receptor,PGR,Humans
5478,DB01406,Danazol,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
5480,DB01406,Danazol,['approved'],BE0001047,C-C motif chemokine 2,CCL2,Humans
5481,DB01407,Clenbuterol,"['approved', 'investigational', 'vet_approved']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5482,DB01407,Clenbuterol,"['approved', 'investigational', 'vet_approved']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5483,DB01407,Clenbuterol,"['approved', 'investigational', 'vet_approved']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
5484,DB01407,Clenbuterol,"['approved', 'investigational', 'vet_approved']",BE0001094,Beta-nerve growth factor,NGF,Humans
5485,DB01407,Clenbuterol,"['approved', 'investigational', 'vet_approved']",BE0000704,Tumor necrosis factor,TNF,Humans
5486,DB01408,Bambuterol,['investigational'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5487,DB01408,Bambuterol,['investigational'],BE0002180,Cholinesterase,BCHE,Humans
5488,DB01409,Tiotropium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5489,DB01409,Tiotropium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5490,DB01409,Tiotropium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5491,DB01409,Tiotropium,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5492,DB01409,Tiotropium,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
5493,DB01410,Ciclesonide,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
5494,DB01411,Pranlukast,['investigational'],BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
5495,DB01411,Pranlukast,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
5496,DB01411,Pranlukast,['investigational'],BE0001208,Interleukin-5,IL5,Humans
5497,DB01411,Pranlukast,['investigational'],BE0000908,Eosinophil cationic protein,RNASE3,Humans
5498,DB01411,Pranlukast,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
5499,DB01411,Pranlukast,['investigational'],BE0001034,Mucin-2,MUC2,Humans
5500,DB01411,Pranlukast,['investigational'],BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
5501,DB01412,Theobromine,['investigational'],BE0000013,Adenosine receptor A1,ADORA1,Humans
5502,DB01412,Theobromine,['investigational'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
5503,DB01412,Theobromine,['investigational'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
5518,DB01418,Acenocoumarol,"['approved', 'investigational']",BE0000713,Vitamin K epoxide reductase complex subunit 1,VKORC1,Humans
5519,DB01419,Antrafenine,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5520,DB01419,Antrafenine,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5521,DB01420,Testosterone propionate,"['approved', 'investigational', 'vet_approved', 'withdrawn']",BE0000132,Androgen receptor,AR,Humans
5524,DB01422,Nitroxoline,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
5527,DB01425,Alizapride,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
5528,DB01426,Ajmaline,"['approved', 'experimental']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
5529,DB01427,Amrinone,['approved'],BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,Humans
5531,DB01427,Amrinone,['approved'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
5532,DB01427,Amrinone,['approved'],BE0001223,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,Humans
5533,DB01427,Amrinone,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
5534,DB01428,Oxybenzone,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
5535,DB01428,Oxybenzone,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
5536,DB01428,Oxybenzone,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
5537,DB01428,Oxybenzone,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
5538,DB01429,Aprindine,['experimental'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
5539,DB01429,Aprindine,['experimental'],BE0000418,Calmodulin,CALM1,Humans
5540,DB01430,Almitrine,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
5541,DB01431,Allylestrenol,['experimental'],BE0000557,Progesterone receptor,PGR,Humans
5542,DB01431,Allylestrenol,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
5544,DB01433,Methadyl acetate,"['experimental', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5545,DB01435,Antipyrine,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5546,DB01435,Antipyrine,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5547,DB01436,Alfacalcidol,"['approved', 'nutraceutical']",BE0000779,Vitamin D3 receptor,VDR,Humans
5548,DB01436,Alfacalcidol,"['approved', 'nutraceutical']",BE0000443,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",CYP27B1,Humans
5549,DB01436,Alfacalcidol,"['approved', 'nutraceutical']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
5550,DB01437,Glutethimide,"['approved', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5551,DB01437,Glutethimide,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5552,DB01438,Phenazopyridine,['approved'],BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
5554,DB01439,3-Methylthiofentanyl,"['experimental', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5555,DB01439,3-Methylthiofentanyl,"['experimental', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5556,DB01439,3-Methylthiofentanyl,"['experimental', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5557,DB01440,gamma-Hydroxybutyric acid,"['approved', 'illicit', 'investigational']",BE0004841,Gamma-hydroxybutyrate (GHB) receptor,SLC52A2,Humans
5558,DB01440,gamma-Hydroxybutyric acid,"['approved', 'illicit', 'investigational']",BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,Humans
5559,DB01442,MMDA,"['experimental', 'illicit']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5560,DB01442,MMDA,"['experimental', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5561,DB01442,MMDA,"['experimental', 'illicit']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5562,DB01442,MMDA,"['experimental', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5563,DB01442,MMDA,"['experimental', 'illicit']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5564,DB01442,MMDA,"['experimental', 'illicit']",BE0004674,Chromaffin granule amine transporter,SLC18A1,Humans
5565,DB01442,MMDA,"['experimental', 'illicit']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5566,DB01442,MMDA,"['experimental', 'illicit']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5567,DB01444,Dimethylthiambutene,"['experimental', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5568,DB01444,Dimethylthiambutene,"['experimental', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5569,DB01452,Diamorphine,"['approved', 'illicit', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5570,DB01452,Diamorphine,"['approved', 'illicit', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5571,DB01452,Diamorphine,"['approved', 'illicit', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5572,DB01452,Diamorphine,"['approved', 'illicit', 'investigational']",BE0002705,Liver carboxylesterase 1,CES1,Humans
5573,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5574,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5575,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5576,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5577,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5578,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
5579,DB01454,Midomafetamine,"['experimental', 'illicit', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5580,DB01463,Fencamfamin,"['experimental', 'illicit', 'withdrawn']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5581,DB01466,Ethylmorphine,"['experimental', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5582,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5583,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5584,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5585,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5586,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5587,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5588,DB01472,4-Methoxyamphetamine,"['experimental', 'illicit']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5589,DB01481,1-Testosterone,"['experimental', 'illicit', 'investigational']",BE0000132,Androgen receptor,AR,Humans
5590,DB01483,Barbital,['illicit'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5591,DB01483,Barbital,['illicit'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5592,DB01483,Barbital,['illicit'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5593,DB01483,Barbital,['illicit'],BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5594,DB01483,Barbital,['illicit'],BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5595,DB01483,Barbital,['illicit'],BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5596,DB01483,Barbital,['illicit'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5597,DB01483,Barbital,['illicit'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5598,DB01483,Barbital,['illicit'],BE0000829,Glutamate receptor 2,GRIA2,Humans
5599,DB01483,Barbital,['illicit'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5600,DB01488,Dimethyltryptamine,"['experimental', 'illicit']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
5601,DB01488,Dimethyltryptamine,"['experimental', 'illicit']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5602,DB01488,Dimethyltryptamine,"['experimental', 'illicit']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
5603,DB01489,Camazepam,"['experimental', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5604,DB01489,Camazepam,"['experimental', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5605,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5606,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5607,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5608,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,Humans
5609,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5610,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,Humans
5611,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
5612,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
5613,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000829,Glutamate receptor 2,GRIA2,Humans
5614,DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione","['experimental', 'illicit']",BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
5615,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5616,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5617,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5618,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0002378,Nociceptin receptor,OPRL1,Humans
5619,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0001063,E3 ubiquitin-protein ligase TRIM13,TRIM13,Humans
5620,DB01497,Etorphine,"['illicit', 'vet_approved']",BE0000947,Pro-opiomelanocortin,POMC,Humans
5621,DB01511,Delorazepam,"['experimental', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5622,DB01511,Delorazepam,"['experimental', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5623,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
5624,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000534,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,Humans
5625,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
5626,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000454,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,Humans
5627,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
5628,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0003438,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,Humans
5629,DB01520,Tenocyclidine,"['experimental', 'illicit', 'investigational']",BE0000396,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,Humans
5630,DB01535,Carfentanil,"['illicit', 'investigational', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5631,DB01535,Carfentanil,"['illicit', 'investigational', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5632,DB01535,Carfentanil,"['illicit', 'investigational', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5633,DB01536,Androstenedione,"['experimental', 'illicit']",BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
5634,DB01536,Androstenedione,"['experimental', 'illicit']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
5636,DB01536,Androstenedione,"['experimental', 'illicit']",BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
5637,DB01537,"4-Bromo-2,5-dimethoxyphenethylamine","['experimental', 'illicit']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
5638,DB01537,"4-Bromo-2,5-dimethoxyphenethylamine","['experimental', 'illicit']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5639,DB01541,Boldenone,"['illicit', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
5640,DB01544,Flunitrazepam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5641,DB01544,Flunitrazepam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5642,DB01545,Ethyl loflazepate,"['experimental', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5643,DB01545,Ethyl loflazepate,"['experimental', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5644,DB01548,Diprenorphine,"['illicit', 'vet_approved']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5645,DB01548,Diprenorphine,"['illicit', 'vet_approved']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5646,DB01548,Diprenorphine,"['illicit', 'vet_approved']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5647,DB01548,Diprenorphine,"['illicit', 'vet_approved']",BE0001063,E3 ubiquitin-protein ligase TRIM13,TRIM13,Humans
5648,DB01549,Rolicyclidine,"['experimental', 'illicit']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
5649,DB01549,Rolicyclidine,"['experimental', 'illicit']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5650,DB01553,Cloxazolam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
5651,DB01553,Cloxazolam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5652,DB01558,Bromazepam,"['approved', 'illicit', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5653,DB01558,Bromazepam,"['approved', 'illicit', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5654,DB01559,Clotiazepam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5655,DB01559,Clotiazepam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5656,DB01561,Androstanedione,"['experimental', 'illicit']",BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
5658,DB01564,Calusterone,"['experimental', 'illicit']",BE0000132,Androgen receptor,AR,Humans
5659,DB01565,Dihydromorphine,"['experimental', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
5660,DB01565,Dihydromorphine,"['experimental', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
5661,DB01565,Dihydromorphine,"['experimental', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5662,DB01565,Dihydromorphine,"['experimental', 'illicit']",BE0001063,E3 ubiquitin-protein ligase TRIM13,TRIM13,Humans
5663,DB01565,Dihydromorphine,"['experimental', 'illicit']",BE0000947,Pro-opiomelanocortin,POMC,Humans
5664,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
5665,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
5666,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
5667,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,Humans
5668,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003593,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,Humans
5669,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
5670,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,Humans
5671,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,Humans
5672,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
5673,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
5674,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003599,Gamma-aminobutyric acid receptor subunit delta,GABRD,Humans
5675,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003595,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,Humans
5676,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003596,Gamma-aminobutyric acid receptor subunit pi,GABRP,Humans
5677,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,Humans
5678,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,Humans
5679,DB01567,Fludiazepam,"['experimental', 'illicit']",BE0003619,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,Humans
5680,DB01569,Formebolone,"['experimental', 'illicit']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
5681,DB01571,3-Methylfentanyl,['illicit'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
5682,DB01571,3-Methylfentanyl,['illicit'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
5683,DB01571,3-Methylfentanyl,['illicit'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
5684,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5685,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5686,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5687,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
5688,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5689,DB01576,Dextroamphetamine,"['approved', 'illicit']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
5690,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
5691,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
5692,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5693,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
5694,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0004674,Chromaffin granule amine transporter,SLC18A1,Humans
5695,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
5696,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5697,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
5698,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
5699,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5700,DB01577,Metamfetamine,"['approved', 'illicit', 'withdrawn']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5701,DB01579,Phendimetrazine,"['approved', 'illicit']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5702,DB01579,Phendimetrazine,"['approved', 'illicit']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
5703,DB01579,Phendimetrazine,"['approved', 'illicit']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5704,DB01580,Oxprenolol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
5705,DB01580,Oxprenolol,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
5706,DB01580,Oxprenolol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
5709,DB01583,Liotrix,['approved'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
5710,DB01583,Liotrix,['approved'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
5711,DB01586,Ursodeoxycholic acid,"['approved', 'investigational']",BE0000622,Aldo-keto reductase family 1 member C2,AKR1C2,Humans
5712,DB01586,Ursodeoxycholic acid,"['approved', 'investigational']",BE0001777,Bile acid receptor,NR1H4,Humans
5713,DB01587,Ketazolam,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
5714,DB01587,Ketazolam,['approved'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5715,DB01588,Prazepam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5716,DB01588,Prazepam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5717,DB01589,Quazepam,"['approved', 'illicit']",BE0004797,GABA(A) Receptor,GABRA1,Humans
5718,DB01589,Quazepam,"['approved', 'illicit']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5719,DB01590,Everolimus,['approved'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
5720,DB01591,Solifenacin,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5721,DB01591,Solifenacin,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
5722,DB01591,Solifenacin,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5723,DB01591,Solifenacin,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
5724,DB01591,Solifenacin,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5725,DB01592,Iron,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
5726,DB01592,Iron,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
5727,DB01592,Iron,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
5728,DB01592,Iron,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
5729,DB01592,Iron,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
5730,DB01592,Iron,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
5731,DB01592,Iron,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
5732,DB01592,Iron,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
5733,DB01592,Iron,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
5734,DB01592,Iron,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
5735,DB01592,Iron,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
5736,DB01592,Iron,['approved'],BE0001140,Ceruloplasmin,CP,Humans
5737,DB01592,Iron,['approved'],BE0000510,Serotransferrin,TF,Humans
5738,DB01593,Zinc,"['approved', 'investigational']",BE0005831,B1 bradykinin receptor,BDKRB1,Humans
5739,DB01593,Zinc,"['approved', 'investigational']",BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
5740,DB01593,Zinc,"['approved', 'investigational']",BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
5741,DB01593,Zinc,"['approved', 'investigational']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
5742,DB01593,Zinc,"['approved', 'investigational']",BE0005807,Alpha-enolase,ENO1,Humans
5743,DB01593,Zinc,"['approved', 'investigational']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
5744,DB01593,Zinc,"['approved', 'investigational']",BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
5745,DB01593,Zinc,"['approved', 'investigational']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
5746,DB01593,Zinc,"['approved', 'investigational']",BE0008980,Protein disulfide-isomerase A3,PDIA3,Humans
5747,DB01593,Zinc,"['approved', 'investigational']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
5748,DB01593,Zinc,"['approved', 'investigational']",BE0004590,Phosphoserine phosphatase,PSPH,Humans
5749,DB01593,Zinc,"['approved', 'investigational']",BE0003844,Triosephosphate isomerase,TPI1,Humans
5750,DB01593,Zinc,"['approved', 'investigational']",BE0004542,"Elongation factor Tu, mitochondrial",TUFM,Humans
5751,DB01593,Zinc,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
5752,DB01593,Zinc,"['approved', 'investigational']",BE0000125,Interleukin-3,IL3,Humans
5753,DB01593,Zinc,"['approved', 'investigational']",BE0004779,Metallothionein-2,MT2A,Humans
5754,DB01593,Zinc,"['approved', 'investigational']",BE0005815,Copper chaperone for superoxide dismutase,CCS,Humans
5755,DB01593,Zinc,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
5756,DB01593,Zinc,"['approved', 'investigational']",BE0003523,Histone deacetylase 4,HDAC4,Humans
5757,DB01593,Zinc,"['approved', 'investigational']",BE0008954,DNA-3-methyladenine glycosylase,MPG,Humans
5758,DB01593,Zinc,"['approved', 'investigational']",BE0005833,Semenogelin-1,SEMG1,Humans
5759,DB01593,Zinc,"['approved', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
5760,DB01593,Zinc,"['approved', 'investigational']",BE0001608,Histone deacetylase 8,HDAC8,Humans
5761,DB01593,Zinc,"['approved', 'investigational']",BE0005834,Apoptosis regulatory protein Siva,SIVA1,Humans
5762,DB01593,Zinc,"['approved', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
5763,DB01593,Zinc,"['approved', 'investigational']",BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
5764,DB01593,Zinc,"['approved', 'investigational']",BE0003491,Insulin,INS,Humans
5765,DB01593,Zinc,"['approved', 'investigational']",BE0005835,Utrophin,UTRN,Humans
5766,DB01593,Zinc,"['approved', 'investigational']",BE0000187,Aspartoacylase,ASPA,Humans
5767,DB01593,Zinc,"['approved', 'investigational']",BE0008955,Protein S100-A8,S100A8,Humans
5768,DB01593,Zinc,"['approved', 'investigational']",BE0008993,Protein S100-A9,S100A9,Humans
5769,DB01593,Zinc,"['approved', 'investigational']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
5770,DB01593,Zinc,"['approved', 'investigational']",BE0008994,Tumor protein p73,TP73,Humans
5771,DB01593,Zinc,"['approved', 'investigational']",BE0003602,Protein S100-A2,S100A2,Humans
5772,DB01593,Zinc,"['approved', 'investigational']",BE0003380,Cellular tumor antigen p53,TP53,Humans
5773,DB01593,Zinc,"['approved', 'investigational']",BE0005770,Metallothionein-3,MT3,Humans
5774,DB01593,Zinc,"['approved', 'investigational']",BE0005812,Programmed cell death protein 6,PDCD6,Humans
5775,DB01593,Zinc,"['approved', 'investigational']",BE0005538,DAN domain family member 5,DAND5,Humans
5776,DB01593,Zinc,"['approved', 'investigational']",BE0004778,Metallothionein-1A,MT1A,Humans
5777,DB01593,Zinc,"['approved', 'investigational']",BE0009047,Alpha-1B-glycoprotein,A1BG,Humans
5778,DB01593,Zinc,"['approved', 'investigational']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
5779,DB01593,Zinc,"['approved', 'investigational']",BE0001060,Angiotensinogen,AGT,Humans
5780,DB01593,Zinc,"['approved', 'investigational']",BE0009048,Alpha-2-HS-glycoprotein,AHSG,Humans
5781,DB01593,Zinc,"['approved', 'investigational']",BE0001213,Serum amyloid P-component,APCS,Humans
5782,DB01593,Zinc,"['approved', 'investigational']",BE0003449,Apolipoprotein A-I,APOA1,Humans
5783,DB01593,Zinc,"['approved', 'investigational']",BE0000922,Apolipoprotein A-II,APOA2,Humans
5784,DB01593,Zinc,"['approved', 'investigational']",BE0009049,Apolipoprotein A-IV,APOA4,Humans
5785,DB01593,Zinc,"['approved', 'investigational']",BE0005852,Apolipoprotein B receptor,APOBR,Humans
5786,DB01593,Zinc,"['approved', 'investigational']",BE0001119,Apolipoprotein E,APOE,Humans
5787,DB01593,Zinc,"['approved', 'investigational']",BE0009069,Apolipoprotein L1,APOL1,Humans
5788,DB01593,Zinc,"['approved', 'investigational']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
5789,DB01593,Zinc,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
5790,DB01593,Zinc,"['approved', 'investigational']",BE0002093,Complement C1r subcomponent,C1R,Humans
5791,DB01593,Zinc,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
5792,DB01593,Zinc,"['approved', 'investigational']",BE0003455,Complement C3,C3,Humans
5793,DB01593,Zinc,"['approved', 'investigational']",BE0004686,Complement C4-B,C4B,Humans
5794,DB01593,Zinc,"['approved', 'investigational']",BE0009050,C4b-binding protein alpha chain,C4BPA,Humans
5795,DB01593,Zinc,"['approved', 'investigational']",BE0009070,C4b-binding protein beta chain,C4BPB,Humans
5796,DB01593,Zinc,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
5797,DB01593,Zinc,"['approved', 'investigational']",BE0009071,Lys-63-specific deubiquitinase BRCC36,BRCC3,Humans
5798,DB01593,Zinc,"['approved', 'investigational']",BE0009072,Complement component C8 alpha chain,C8A,Humans
5799,DB01593,Zinc,"['approved', 'investigational']",BE0009051,Complement component C8 beta chain,C8B,Humans
5800,DB01593,Zinc,"['approved', 'investigational']",BE0003266,Complement component C8 gamma chain,C8G,Humans
5801,DB01593,Zinc,"['approved', 'investigational']",BE0001701,Complement factor B,CFB,Humans
5802,DB01593,Zinc,"['approved', 'investigational']",BE0009053,Complement factor H,CFH,Humans
5803,DB01593,Zinc,"['approved', 'investigational']",BE0009054,Complement factor I,CFI,Humans
5804,DB01593,Zinc,"['approved', 'investigational']",BE0009055,Clusterin,CLU,Humans
5805,DB01593,Zinc,"['approved', 'investigational']",BE0001140,Ceruloplasmin,CP,Humans
5806,DB01593,Zinc,"['approved', 'investigational']",BE0003503,Carboxypeptidase N catalytic chain,CPN1,Humans
5807,DB01593,Zinc,"['approved', 'investigational']",BE0003504,Carboxypeptidase N subunit 2,CPN2,Humans
5808,DB01593,Zinc,"['approved', 'investigational']",BE0009073,Dermcidin,DCD,Humans
5809,DB01593,Zinc,"['approved', 'investigational']",BE0009074,Desmoplakin,DSP,Humans
5810,DB01593,Zinc,"['approved', 'investigational']",BE0004672,Coagulation factor XII,F12,Humans
5811,DB01593,Zinc,"['approved', 'investigational']",BE0009075,Coagulation factor XIII B chain,F13B,Humans
5812,DB01593,Zinc,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
5813,DB01593,Zinc,"['approved', 'investigational']",BE0009076,Ficolin-3,FCN3,Humans
5814,DB01593,Zinc,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
5815,DB01593,Zinc,"['approved', 'investigational']",BE0001180,Fibronectin,FN1,Humans
5816,DB01593,Zinc,"['approved', 'investigational']",BE0004161,Gelsolin,GSN,Humans
5817,DB01593,Zinc,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
5818,DB01593,Zinc,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
5819,DB01593,Zinc,"['approved', 'investigational']",BE0009057,Haptoglobin-related protein,HPR,Humans
5820,DB01593,Zinc,"['approved', 'investigational']",BE0009077,Hornerin,HRNR,Humans
5821,DB01593,Zinc,"['approved', 'investigational']",BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,Humans
5822,DB01593,Zinc,"['approved', 'investigational']",BE0005097,Ig alpha-1 chain C region,IGHA1,Humans
5823,DB01593,Zinc,"['approved', 'investigational']",BE0005098,Ig mu chain C region,IGHM,Humans
5824,DB01593,Zinc,"['approved', 'investigational']",BE0009078,Immunoglobulin kappa variable 1-17,IGKV1-17,Humans
5826,DB01593,Zinc,"['approved', 'investigational']",BE0009079,Immunoglobulin lambda variable 3-21,IGLV3-21,Humans
5827,DB01593,Zinc,"['approved', 'investigational']",BE0009080,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,Humans
5828,DB01593,Zinc,"['approved', 'investigational']",BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,Humans
5829,DB01593,Zinc,"['approved', 'investigational']",BE0009081,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,Humans
5830,DB01593,Zinc,"['approved', 'investigational']",BE0009082,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,Humans
5832,DB01593,Zinc,"['approved', 'investigational']",BE0009084,Junction plakoglobin,JUP,Humans
5833,DB01593,Zinc,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
5834,DB01593,Zinc,"['approved', 'investigational']",BE0001017,Kininogen-1,KNG1,Humans
5835,DB01593,Zinc,"['approved', 'investigational']",BE0009061,"Keratin, type II cytoskeletal 1",KRT1,Humans
5836,DB01593,Zinc,"['approved', 'investigational']",BE0009062,"Keratin, type I cytoskeletal 10",KRT10,Humans
5837,DB01593,Zinc,"['approved', 'investigational']",BE0009085,"Keratin, type I cytoskeletal 14",KRT14,Humans
5838,DB01593,Zinc,"['approved', 'investigational']",BE0009086,"Keratin, type I cytoskeletal 16",KRT16,Humans
5839,DB01593,Zinc,"['approved', 'investigational']",BE0009063,"Keratin, type II cytoskeletal 2 epidermal",KRT2,Humans
5840,DB01593,Zinc,"['approved', 'investigational']",BE0009087,"Keratin, type II cytoskeletal 5",KRT5,Humans
5841,DB01593,Zinc,"['approved', 'investigational']",BE0009088,"Keratin, type II cytoskeletal 6A",KRT6A,Humans
5842,DB01593,Zinc,"['approved', 'investigational']",BE0009064,"Keratin, type I cytoskeletal 9",KRT9,Humans
5843,DB01593,Zinc,"['approved', 'investigational']",BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
5844,DB01593,Zinc,"['approved', 'investigational']",BE0004613,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,Humans
5845,DB01593,Zinc,"['approved', 'investigational']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
5846,DB01593,Zinc,"['approved', 'investigational']",BE0009089,Pregnancy zone protein,PZP,Humans
5847,DB01593,Zinc,"['approved', 'investigational']",BE0003756,Protein S100-A7,S100A7,Humans
5848,DB01593,Zinc,"['approved', 'investigational']",BE0005533,Selenoprotein P,SEPP1,Humans
5849,DB01593,Zinc,"['approved', 'investigational']",BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
5850,DB01593,Zinc,"['approved', 'investigational']",BE0009090,Alpha-1-antichymotrypsin,SERPINA3,Humans
5851,DB01593,Zinc,"['approved', 'investigational']",BE0009067,Kallistatin,SERPINA4,Humans
5852,DB01593,Zinc,"['approved', 'investigational']",BE0000209,Corticosteroid-binding globulin,SERPINA6,Humans
5853,DB01593,Zinc,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
5854,DB01593,Zinc,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
5855,DB01593,Zinc,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
5856,DB01593,Zinc,"['approved', 'investigational']",BE0000337,Transthyretin,TTR,Humans
5857,DB01593,Zinc,"['approved', 'investigational']",BE0001068,Vitronectin,VTN,Humans
5858,DB01593,Zinc,"['approved', 'investigational']",BE0009092,Amyloid-like protein 1,APLP1,Humans
5859,DB01593,Zinc,"['approved', 'investigational']",BE0009093,Amyloid-like protein 2,APLP2,Humans
5860,DB01593,Zinc,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
5861,DB01593,Zinc,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
5862,DB01594,Cinolazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
5863,DB01594,Cinolazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5864,DB01595,Nitrazepam,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
5865,DB01595,Nitrazepam,['approved'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
5866,DB01595,Nitrazepam,['approved'],BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
5867,DB01597,Cilastatin,"['approved', 'investigational']",BE0001148,Dipeptidase 1,DPEP1,Humans
5874,DB01599,Probucol,"['approved', 'investigational']",BE0000119,ATP-binding cassette sub-family A member 1,ABCA1,Humans
5875,DB01599,Probucol,"['approved', 'investigational']",BE0002705,Liver carboxylesterase 1,CES1,Humans
5876,DB01600,Tiaprofenic acid,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
5877,DB01600,Tiaprofenic acid,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5892,DB01608,Periciazine,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5893,DB01608,Periciazine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5894,DB01608,Periciazine,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5895,DB01608,Periciazine,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
5898,DB01611,Hydroxychloroquine,['approved'],BE0000155,Toll-like receptor 7,TLR7,Humans
5899,DB01611,Hydroxychloroquine,['approved'],BE0001171,Toll-like receptor 9,TLR9,Humans
5901,DB01611,Hydroxychloroquine,['approved'],BE0000982,Angiotensin-converting enzyme 2,ACE2,Humans
5902,DB01612,Amyl Nitrite,['approved'],BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
5903,DB01613,Erythrityl tetranitrate,"['approved', 'experimental', 'investigational']",BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
5904,DB01613,Erythrityl tetranitrate,"['approved', 'experimental', 'investigational']",BE0000997,Atrial natriuretic peptide receptor 2,NPR2,Humans
5905,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5906,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5907,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5908,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5909,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5910,DB01614,Acepromazine,"['experimental', 'vet_approved']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5911,DB01615,Aceprometazine,['experimental'],BE0000442,Histamine H1 receptor,HRH1,Humans
5912,DB01616,Alverine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5913,DB01618,Molindone,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
5914,DB01618,Molindone,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5915,DB01618,Molindone,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5916,DB01618,Molindone,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
5917,DB01619,Phenindamine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
5918,DB01620,Pheniramine,['approved'],BE0000146,Histamine H4 receptor,HRH4,Humans
5919,DB01620,Pheniramine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
5920,DB01620,Pheniramine,['approved'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
5921,DB01621,Pipotiazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5922,DB01621,Pipotiazine,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5923,DB01621,Pipotiazine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5924,DB01621,Pipotiazine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
5925,DB01622,Thioproperazine,['experimental'],BE0000756,Dopamine D2 receptor,DRD2,Humans
5926,DB01622,Thioproperazine,['experimental'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5927,DB01622,Thioproperazine,['experimental'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
5928,DB01622,Thioproperazine,['experimental'],BE0000020,Dopamine D1 receptor,DRD1,Humans
5929,DB01623,Thiothixene,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
5930,DB01623,Thiothixene,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
5931,DB01623,Thiothixene,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5932,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
5933,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
5934,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
5935,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
5936,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
5937,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
5938,DB01624,Zuclopenthixol,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
5939,DB01625,Isopropamide,"['approved', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
5940,DB01625,Isopropamide,"['approved', 'vet_approved']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
5941,DB01626,Pargyline,['approved'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
5942,DB01626,Pargyline,['approved'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
5944,DB01628,Etoricoxib,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
5945,DB01629,5-fluorouridine,['experimental'],BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
5947,DB01630,SC-74020,['experimental'],BE0000642,72 kDa type IV collagenase,MMP2,Humans
5948,DB01631,Methyl nonanoate,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
5949,DB01631,Methyl nonanoate,['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
5950,DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,"['approved', 'experimental', 'investigational']",BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,Humans
5952,DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,"['approved', 'experimental', 'investigational']",BE0004582,Uridine-cytidine kinase-like 1,UCKL1,Humans
5954,DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,"['approved', 'experimental', 'investigational']",BE0000115,Adenine phosphoribosyltransferase,APRT,Humans
5959,DB01640,"6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one",['experimental'],BE0001223,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,Humans
5964,DB01643,Thymidine monophosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
5966,DB01643,Thymidine monophosphate,['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
5972,DB01644,"3,6-dihydroxy-xanthene-9-propionic acid",['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
5973,DB01645,Genistein,['investigational'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
5974,DB01645,Genistein,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
5975,DB01645,Genistein,['investigational'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
5976,DB01645,Genistein,['investigational'],BE0005001,Steroid hormone receptor ERR2,ESRRB,Humans
5977,DB01645,Genistein,['investigational'],BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
5978,DB01645,Genistein,['investigational'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
5979,DB01645,Genistein,['investigational'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
5980,DB01645,Genistein,['investigational'],BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
5981,DB01645,Genistein,['investigational'],BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
5982,DB01645,Genistein,['investigational'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
5983,DB01645,Genistein,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
5984,DB01645,Genistein,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
5985,DB01645,Genistein,['investigational'],BE0000871,Protein-tyrosine kinase 2-beta,PTK2B,Humans
5986,DB01645,Genistein,['investigational'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
5987,DB01646,N-Acetylmethionine,['experimental'],BE0001200,Rhodopsin,RHO,Humans
5989,DB01647,Daxalipram,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
5990,DB01649,7-methyl-GpppA,['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
5991,DB01649,7-methyl-GpppA,['experimental'],BE0000957,Eukaryotic translation initiation factor 4E,EIF4E,Humans
5993,DB01651,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",['experimental'],BE0001213,Serum amyloid P-component,APCS,Humans
5997,DB01656,Roflumilast,['approved'],BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,Humans
6000,DB01662,Trans-O-Hydroxy-Alpha-Methyl Cinnamate,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
6002,DB01664,(S)-DES-ME-AMPA,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
6003,DB01665,2H-Benzimidazol-2-amine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6005,DB01666,D-Myo-Inositol-Hexasulphate,['experimental'],BE0004526,Follistatin,FST,Humans
6006,DB01667,8-azaguanine,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
6010,DB01671,p-Hydroxymercuribenzoic acid,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6012,DB01672,"2,3-Dihydroxy-Benzoic Acid",['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
6015,DB01675,Methacrylyl-Coenzyme A,['experimental'],BE0000605,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,Humans
6019,DB01677,Fumaric acid,['investigational'],BE0000148,"NAD-dependent malic enzyme, mitochondrial",ME2,Humans
6020,DB01677,Fumaric acid,['investigational'],BE0004531,Fumarylacetoacetase,FAH,Humans
6022,DB01678,RU84687,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6023,DB01681,Benzene Hexacarboxylic Acid,['experimental'],BE0004462,Phosphoglycerate mutase 2,PGAM2,Humans
6025,DB01684,1-Hydroxy-1-Thio-Glycerol,['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
6026,DB01685,Topiroxostat,['experimental'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
6027,DB01686,"N,N-dimethylarginine",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6028,DB01686,"N,N-dimethylarginine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6030,DB01689,Inhibitor Idd 384,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6035,DB01692,Dithioerythritol,['experimental'],BE0001260,"Thymidine kinase, cytosolic",TK1,Humans
6037,DB01694,D-tartaric acid,['experimental'],BE0001242,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,Humans
6038,DB01694,D-tartaric acid,['experimental'],BE0001288,Triggering receptor expressed on myeloid cells 1,TREM1,Humans
6039,DB01694,D-tartaric acid,['experimental'],BE0002501,Probable ATP-dependent RNA helicase DDX6,DDX6,Humans
6041,DB01694,D-tartaric acid,['experimental'],BE0002503,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,Humans
6044,DB01694,D-tartaric acid,['experimental'],BE0004525,V-type proton ATPase subunit C 1,ATP6V1C1,Humans
6049,DB01695,N-Hydroxy-4-phosphonobutanamide,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
6050,DB01698,Rutin,"['approved', 'experimental', 'investigational']",BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
6051,DB01698,Rutin,"['approved', 'experimental', 'investigational']",BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
6052,DB01699,(4e)-4-Aminohex-4-Enoic Acid,['experimental'],BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
6053,DB01700,AICA ribonucleotide,"['experimental', 'investigational']",BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
6062,DB01704,"2,4-Dihydroxy-Trans Cinnamic Acid",['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
6063,DB01705,Bis(5-Amidino-Benzimidazolyl)Methane,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6065,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000123,Estrogen receptor alpha,ESR1,Humans
6066,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000792,Estrogen receptor beta,ESR2,Humans
6067,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0004797,GABA(A) Receptor,GABRA1,Humans
6068,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0004956,NMDA receptor,GRIN1,Humans
6069,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000132,Androgen receptor,AR,Humans
6070,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
6071,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
6072,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
6073,DB01708,Prasterone,"['approved', 'investigational', 'nutraceutical']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
6077,DB01709,2-phospho-D-glyceric acid,['experimental'],BE0004460,Beta-enolase,ENO3,Humans
6078,DB01710,Porphyrin Fe(III),['experimental'],BE0004467,Myoglobin,MB,Humans
6079,DB01711,"2,3,4,5,6-Pentafluorobenzyl Alcohol",['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
6080,DB01712,"(3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester",['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
6086,DB01717,Bis(Adenosine)-5'-Pentaphosphate,['experimental'],BE0004477,"Adenylate kinase 2, mitochondrial",AK2,Humans
6087,DB01717,Bis(Adenosine)-5'-Pentaphosphate,['experimental'],BE0004536,Adenylate kinase 8,AK8,Humans
6089,DB01717,Bis(Adenosine)-5'-Pentaphosphate,['experimental'],BE0001262,Adenylate kinase isoenzyme 1,AK1,Humans
6095,DB01723,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
6096,DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",['experimental'],BE0000048,Prothrombin,F2,Humans
6097,DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
6098,DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6102,DB01727,Isocitric Acid,['experimental'],BE0004504,"Aconitate hydratase, mitochondrial",ACO2,Humans
6103,DB01727,Isocitric Acid,['experimental'],BE0004527,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,Humans
6104,DB01727,Isocitric Acid,['experimental'],BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,Humans
6106,DB01728,"1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine",['experimental'],BE0001200,Rhodopsin,RHO,Humans
6107,DB01731,(S)-wiskostatin,['experimental'],BE0002513,Wiskott-Aldrich syndrome protein,WAS,Humans
6109,DB01733,L-Phospholactate,['experimental'],BE0000088,Pyruvate kinase PKM,PKM,Humans
6110,DB01734,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
6112,DB01736,[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,['experimental'],BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
6113,DB01737,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6114,DB01738,Phosphorylcolamine,['experimental'],BE0000872,Protein kinase C beta type,PRKCB,Humans
6115,DB01741,CRA_17693,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6116,DB01742,(3r)-1-Acetyl-3-Methylpiperidine,['experimental'],BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
6117,DB01744,Camphor,"['approved', 'withdrawn']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
6118,DB01744,Camphor,"['approved', 'withdrawn']",BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
6119,DB01744,Camphor,"['approved', 'withdrawn']",BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
6120,DB01744,Camphor,"['approved', 'withdrawn']",BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
6122,DB01745,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6124,DB01748,N-Benzyl-4-Sulfamoyl-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6125,DB01750,1-naphthaleneacetic acid,['experimental'],BE0003767,S-phase kinase-associated protein 1,SKP1,Humans
6128,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0001144,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,PCMT1,Humans
6130,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
6133,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0004586,Catechol O-methyltransferase domain-containing protein 1,COMTD1,Humans
6135,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0000567,Guanidinoacetate N-methyltransferase,GAMT,Humans
6138,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0004446,Protein arginine N-methyltransferase 3,PRMT3,Humans
6139,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0002436,Histamine N-methyltransferase,HNMT,Humans
6142,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0002517,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,Humans
6143,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0000372,Glycine N-methyltransferase,GNMT,Humans
6148,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0004597,Protein arginine N-methyltransferase 1,PRMT1,Humans
6151,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0002524,Histone-lysine N-methyltransferase SETD7,SETD7,Humans
6154,DB01752,S-adenosyl-L-homocysteine,['experimental'],BE0004441,Diphthine synthase,DPH5,Humans
6163,DB01754,"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
6165,DB01756,4-phospho-L-threonic acid,['experimental'],BE0004438,Ribose-5-phosphate isomerase,RPIA,Humans
6167,DB01760,2-Methoxy-3-Isopropylpyrazine,['experimental'],BE0004320,Epididymal-specific lipocalin-9,LCN9,Humans
6168,DB01761,4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6169,DB01762,Acetoacetic acid,['experimental'],BE0004531,Fumarylacetoacetase,FAH,Humans
6170,DB01763,7-thionicotinamide-adenine-dinucleotide phosphate,['experimental'],BE0000008,"NAD(P) transhydrogenase, mitochondrial",NNT,Humans
6172,DB01765,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
6173,DB01766,Beta-(2-Naphthyl)-Alanine,['experimental'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
6174,DB01766,Beta-(2-Naphthyl)-Alanine,['experimental'],BE0003739,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,Humans
6175,DB01766,Beta-(2-Naphthyl)-Alanine,['experimental'],BE0000048,Prothrombin,F2,Humans
6176,DB01767,Hemi-Babim,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6177,DB01767,Hemi-Babim,['experimental'],BE0000048,Prothrombin,F2,Humans
6179,DB01771,CRA_10991,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6180,DB01772,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
6184,DB01776,M-Cresol,['experimental'],BE0003491,Insulin,INS,Humans
6185,DB01777,CoA-S-trimethylene-acetyl-tryptamine,['experimental'],BE0004584,Serotonin N-acetyltransferase,AANAT,Humans
6188,DB01780,Fusicoccin,['experimental'],BE0004570,14-3-3 protein epsilon,YWHAE,Humans
6189,DB01782,Pyrazolanthrone,['experimental'],BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,Humans
6190,DB01782,Pyrazolanthrone,['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
6191,DB01782,Pyrazolanthrone,['experimental'],BE0003791,Dual specificity protein kinase TTK,TTK,Humans
6192,DB01782,Pyrazolanthrone,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
6194,DB01784,4-Flourobenzenesulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6195,DB01785,Dimethylallyl Diphosphate,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
6196,DB01785,Dimethylallyl Diphosphate,['experimental'],BE0004044,Isopentenyl-diphosphate Delta-isomerase 1,IDI1,Humans
6202,DB01790,(Rp)-cAMPS,['experimental'],BE0003425,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,Humans
6203,DB01791,Piclamilast,['experimental'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
6204,DB01791,Piclamilast,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
6205,DB01791,Piclamilast,['experimental'],BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
6206,DB01791,Piclamilast,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
6208,DB01793,SB-409513,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
6213,DB01800,4-Nitrocatechol sulfate,['experimental'],BE0003195,Arylsulfatase A,ARSA,Humans
6217,DB01805,Monoisopropylphosphorylserine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
6219,DB01805,Monoisopropylphosphorylserine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6220,DB01805,Monoisopropylphosphorylserine,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
6222,DB01807,"N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6224,DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",['experimental'],BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
6225,DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",['experimental'],BE0001424,Tyrosine-protein kinase HCK,HCK,Humans
6226,DB01810,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",['experimental'],BE0001504,Cathepsin F,CTSF,Humans
6228,DB01811,"3h-Indole-5,6-Diol",['experimental'],BE0000994,Lactotransferrin,LTF,Humans
6229,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0004436,Heparan sulfate glucosamine 3-O-sulfotransferase 1,HS3ST1,Humans
6230,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0001264,Sulfotransferase family cytosolic 2B member 1,SULT2B1,Humans
6231,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0001306,Non-secretory ribonuclease,RNASE2,Humans
6232,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0000927,Sulfotransferase 1A1,SULT1A1,Humans
6233,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0001541,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,Humans
6234,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
6235,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0000886,Bile salt sulfotransferase,SULT2A1,Humans
6236,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0000951,Estrogen sulfotransferase,SULT1E1,Humans
6238,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0002559,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,NDST1,Humans
6240,DB01812,"Adenosine 3',5'-diphosphate",['experimental'],BE0002561,Sulfotransferase family cytosolic 1B member 1,SULT1B1,Humans
6247,DB01818,O3-Sulfonylgalactose,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
6249,DB01819,Phosphoenolpyruvate,['experimental'],BE0004460,Beta-enolase,ENO3,Humans
6250,DB01819,Phosphoenolpyruvate,['experimental'],BE0000906,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,Humans
6255,DB01820,2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
6256,DB01821,"L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6257,DB01821,"L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide",['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6259,DB01823,Beta-D-Glucopyranose Spirohydantoin,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
6263,DB01826,N-Butyl Isocyanide,['experimental'],BE0004467,Myoglobin,MB,Humans
6266,DB01827,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",['experimental'],BE0001353,Galectin-3,LGALS3,Humans
6269,DB01830,AP-22408,['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
6270,DB01831,Tryptophanyl-5'amp,['experimental'],BE0000228,"Tryptophan--tRNA ligase, cytoplasmic",WARS,Humans
6272,DB01832,4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,['experimental'],BE0004531,Fumarylacetoacetase,FAH,Humans
6273,DB01833,Canavanine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6274,DB01834,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
6275,DB01834,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",['experimental'],BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
6276,DB01835,4R-Fluoro-N6-ethanimidoyl-L-lysine,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6277,DB01836,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6278,DB01837,O-acetyl-L-serine,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
6280,DB01840,2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,['experimental'],BE0004496,Inositol-3-phosphate synthase 1,ISYNA1,Humans
6286,DB01842,3'-Phosphate-Adenosine-5'-Diphosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
6288,DB01843,"(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
6289,DB01844,"N,N-dimethylformamide",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
6290,DB01844,"N,N-dimethylformamide",['experimental'],BE0000270,Renin,REN,Humans
6294,DB01851,Tetrabutylammonium Ion,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
6296,DB01852,Kaempherol,['experimental'],BE0004151,UDP-glucuronosyltransferase 3A1,UGT3A1,Humans
6299,DB01854,5-Bromonicotinamide,['experimental'],BE0000931,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,ART1,Humans
6303,DB01858,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
6305,DB01860,Cordycepin Triphosphate,['experimental'],BE0004515,Poly(A) polymerase alpha,PAPOLA,Humans
6307,DB01861,Uridine diphosphate glucose,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
6312,DB01861,Uridine diphosphate glucose,['experimental'],BE0004501,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,Humans
6314,DB01861,Uridine diphosphate glucose,['experimental'],BE0004498,Glycogenin-1,GYG1,Humans
6315,DB01861,Uridine diphosphate glucose,['experimental'],BE0010169,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,Humans
6319,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0001627,Inositol-trisphosphate 3-kinase A,ITPKA,Humans
6320,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0002654,Cytohesin-2,CYTH2,Humans
6321,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0004433,Cytohesin-3,CYTH3,Humans
6322,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
6323,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
6324,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0001278,Pleckstrin homology domain-containing family A member 4,PLEKHA4,Humans
6325,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
6326,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",['experimental'],BE0001300,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,DAPP1,Humans
6327,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,['experimental'],BE0004242,ADP-ribosylation factor 6,ARF6,Humans
6328,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,['experimental'],BE0001273,Protein-glutamine gamma-glutamyltransferase E,TGM3,Humans
6330,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,['experimental'],BE0004558,Ras-related protein Rab-11A,RAB11A,Humans
6332,DB01866,RU79256,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6334,DB01870,"1,4-dithio-alpha-D-glucopyranose",['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
6335,DB01871,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
6341,DB01873,Epothilone D,['investigational'],BE0001425,Tubulin alpha-3C/D chain,TUBA3C,Humans
6342,DB01873,Epothilone D,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
6343,DB01873,Epothilone D,['investigational'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
6344,DB01873,Epothilone D,['investigational'],BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
6345,DB01873,Epothilone D,['investigational'],BE0001408,Tubulin beta-4A chain,TUBB4A,Humans
6346,DB01873,Epothilone D,['investigational'],BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
6347,DB01873,Epothilone D,['investigational'],BE0001415,Tubulin beta-3 chain,TUBB3,Humans
6348,DB01873,Epothilone D,['investigational'],BE0001388,Tubulin alpha-1C chain,TUBA1C,Humans
6349,DB01873,Epothilone D,['investigational'],BE0001359,Tubulin alpha-8 chain,TUBA8,Humans
6350,DB01873,Epothilone D,['investigational'],BE0001275,Tubulin alpha-1B chain,TUBA1B,Humans
6351,DB01873,Epothilone D,['investigational'],BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
6353,DB01876,Bis(5-Amidino-2-Benzimidazolyl)Methanone,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6354,DB01877,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
6355,DB01878,Benzophenone,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
6356,DB01878,Benzophenone,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
6359,DB01880,"3,4-Dihydroxycinnamic Acid","['experimental', 'investigational']",BE0001855,Macrophage migration inhibitory factor,MIF,Humans
6365,DB01884,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
6369,DB01888,"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6370,DB01889,"16,17-Androstene-3-Ol",['experimental'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
6371,DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",['experimental'],BE0003418,Insulin-like growth factor I,IGF1,Humans
6372,DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
6375,DB01892,Hyperforin,['nutraceutical'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
6376,DB01892,Hyperforin,['nutraceutical'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
6377,DB01892,Hyperforin,['nutraceutical'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
6378,DB01893,N6-Benzyl Adenosine-5'-Diphosphate,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6381,DB01897,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
6383,DB01901,Sucrosofate,['experimental'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
6384,DB01901,Sucrosofate,['experimental'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
6385,DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",['experimental'],BE0004508,Vesicle-fusing ATPase,NSF,Humans
6388,DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6389,DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
6391,DB01908,RU85493,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6400,DB01915,S-Hydroxycysteine,['experimental'],BE0003455,Complement C3,C3,Humans
6402,DB01915,S-Hydroxycysteine,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
6403,DB01915,S-Hydroxycysteine,['experimental'],BE0001317,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,Humans
6404,DB01915,S-Hydroxycysteine,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
6405,DB01915,S-Hydroxycysteine,['experimental'],BE0004171,Myelin P2 protein,PMP2,Humans
6408,DB01917,Putrescine,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
6409,DB01917,Putrescine,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
6410,DB01917,Putrescine,['experimental'],BE0000404,Ornithine decarboxylase,ODC1,Humans
6411,DB01917,Putrescine,['experimental'],BE0000101,S-adenosylmethionine decarboxylase proenzyme,AMD1,Humans
6414,DB01919,Pentanal,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
6417,DB01922,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
6420,DB01926,Carboxymycobactin S,['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
6421,DB01927,Duroquinone,['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
6422,DB01929,"5-Chloryl-2,4,6-quinazolinetriamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
6425,DB01931,"5,7-Dichlorokynurenic acid",['experimental'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
6427,DB01933,7-Hydroxystaurosporine,"['experimental', 'investigational']",BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
6434,DB01939,5-Amidino-Benzimidazole,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6435,DB01940,Balanol Analog 2,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
6436,DB01941,LG-100268,['experimental'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
6439,DB01942,Formic acid,"['experimental', 'investigational']",BE0000735,Heme oxygenase 1,HMOX1,Humans
6440,DB01942,Formic acid,"['experimental', 'investigational']",BE0003317,Ribonuclease pancreatic,RNASE1,Humans
6443,DB01942,Formic acid,"['experimental', 'investigational']",BE0000689,Fibroblast growth factor 1,FGF1,Humans
6446,DB01942,Formic acid,"['experimental', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
6454,DB01942,Formic acid,"['experimental', 'investigational']",BE0002624,C-terminal-binding protein 1,CTBP1,Humans
6457,DB01942,Formic acid,"['experimental', 'investigational']",BE0002641,Peripheral plasma membrane protein CASK,CASK,Humans
6460,DB01942,Formic acid,"['experimental', 'investigational']",BE0004623,Gamma-glutamylaminecyclotransferase,GGACT,Humans
6461,DB01942,Formic acid,"['experimental', 'investigational']",BE0004470,Parvalbumin alpha,PVALB,Humans
6462,DB01942,Formic acid,"['experimental', 'investigational']",BE0004569,Acylphosphatase-2,ACYP2,Humans
6466,DB01942,Formic acid,"['experimental', 'investigational']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6472,DB01942,Formic acid,"['experimental', 'investigational']",BE0002652,Gephyrin,GPHN,Humans
6474,DB01942,Formic acid,"['experimental', 'investigational']",BE0002654,Cytohesin-2,CYTH2,Humans
6487,DB01944,(S)-blebbistatin,['experimental'],BE0003893,Myosin-14,MYH14,Humans
6488,DB01946,Bisindolylmaleimide VIII,['experimental'],BE0003890,Myotonin-protein kinase,DMPK,Humans
6489,DB01946,Bisindolylmaleimide VIII,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
6490,DB01947,RU78262,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6491,DB01948,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6492,DB01949,"2-Amino-N,3,3-Trimethylbutanamide",['experimental'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
6493,DB01950,AR-AO-14418,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
6494,DB01951,Gpi-1046,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
6496,DB01953,Inhibitor of P38 Kinase,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6497,DB01954,Rolipram,['investigational'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
6498,DB01954,Rolipram,['investigational'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
6499,DB01954,Rolipram,['investigational'],BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,Humans
6500,DB01955,"1,4-Butanediol",['experimental'],BE0001414,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,Humans
6501,DB01955,"1,4-Butanediol",['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
6502,DB01955,"1,4-Butanediol",['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
6505,DB01956,Taurine,"['approved', 'nutraceutical']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
6506,DB01956,Taurine,"['approved', 'nutraceutical']",BE0000745,Glycine receptor subunit alpha-2,GLRA2,Humans
6507,DB01956,Taurine,"['approved', 'nutraceutical']",BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
6508,DB01956,Taurine,"['approved', 'nutraceutical']",BE0004797,GABA(A) Receptor,GABRA1,Humans
6509,DB01956,Taurine,"['approved', 'nutraceutical']",BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
6510,DB01956,Taurine,"['approved', 'nutraceutical']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
6514,DB01958,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
6516,DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
6517,DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
6518,DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
6520,DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",['experimental'],BE0000957,Eukaryotic translation initiation factor 4E,EIF4E,Humans
6521,DB01961,Cytidine 3'-monophosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
6522,DB01962,Phosphonotyrosine,['experimental'],BE0001424,Tyrosine-protein kinase HCK,HCK,Humans
6523,DB01962,Phosphonotyrosine,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6524,DB01962,Phosphonotyrosine,['experimental'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
6525,DB01963,Phenylethane Boronic Acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
6526,DB01964,AL5424,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6529,DB01966,Di-Stearoyl-3-Sn-Phosphatidylethanolamine,['experimental'],BE0001175,Proactivator polypeptide,PSAP,Humans
6533,DB01969,Trifluoroacetonyl coenzyme A,['experimental'],BE0004459,"Citrate synthase, mitochondrial",CS,Humans
6534,DB01970,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",['experimental'],BE0001223,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,Humans
6536,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0002351,Guanylate kinase,GUK1,Humans
6539,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0004524,Disks large homolog 4,DLG4,Humans
6540,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0001376,GMP reductase 1,GMPR,Humans
6541,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
6542,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0001473,Histidine triad nucleotide-binding protein 1,HINT1,Humans
6543,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
6545,DB01972,Guanosine-5'-Monophosphate,['experimental'],BE0001273,Protein-glutamine gamma-glutamyltransferase E,TGM3,Humans
6551,DB01973,O-Benzylsulfonyl-Serine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
6557,DB01977,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
6559,DB01979,Methyl alpha-D-mannoside,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
6564,DB01983,2(S)-Amino-6-Boronohexanoic Acid,['experimental'],BE0000286,Arginase-1,ARG1,Humans
6574,DB01988,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6575,DB01989,Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate,['experimental'],BE0004479,Tolloid-like protein 2,TLL2,Humans
6576,DB01990,Cholesterol sulfate,['experimental'],BE0004545,Nuclear receptor ROR-alpha,RORA,Humans
6579,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
6581,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0004578,Histone acetyltransferase KAT5,KAT5,Humans
6583,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0001317,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,Humans
6586,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0004459,"Citrate synthase, mitochondrial",CS,Humans
6592,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0004476,Acyl-CoA-binding protein,DBI,Humans
6594,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0000496,Carnitine O-acetyltransferase,CRAT,Humans
6611,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0004583,Histone acetyltransferase KAT2A,KAT2A,Humans
6613,DB01992,Coenzyme A,"['investigational', 'nutraceutical']",BE0002683,Histone acetyltransferase KAT2B,KAT2B,Humans
6624,DB01996,3-Methylpyridine,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
6625,DB01996,3-Methylpyridine,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
6626,DB01997,3-Bromo-7-Nitroindazole,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6627,DB01997,3-Bromo-7-Nitroindazole,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6628,DB01997,3-Bromo-7-Nitroindazole,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6629,DB01998,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",['experimental'],BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
6630,DB02001,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
6632,DB02004,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
6634,DB02007,alpha-D-glucose 6-phosphate,['experimental'],BE0001108,Hexokinase-1,HK1,Humans
6637,DB02007,alpha-D-glucose 6-phosphate,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
6641,DB02007,alpha-D-glucose 6-phosphate,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
6642,DB02007,alpha-D-glucose 6-phosphate,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6643,DB02008,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,['experimental'],BE0000906,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,Humans
6645,DB02010,Staurosporine,['experimental'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
6646,DB02010,Staurosporine,['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
6647,DB02010,Staurosporine,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
6648,DB02010,Staurosporine,['experimental'],BE0001341,Tyrosine-protein kinase ITK/TSK,ITK,Humans
6649,DB02010,Staurosporine,['experimental'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
6650,DB02010,Staurosporine,['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
6651,DB02010,Staurosporine,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
6652,DB02010,Staurosporine,['experimental'],BE0001356,Tyrosine-protein kinase CSK,CSK,Humans
6653,DB02010,Staurosporine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6654,DB02010,Staurosporine,['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
6655,DB02010,Staurosporine,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
6656,DB02010,Staurosporine,['experimental'],BE0001385,Protein kinase C theta type,PRKCQ,Humans
6657,DB02010,Staurosporine,['experimental'],BE0001312,Tyrosine-protein kinase ZAP-70,ZAP70,Humans
6658,DB02010,Staurosporine,['experimental'],BE0004895,Protein kinase C,PRKCA,Humans
6659,DB02011,N-(Phosphonoacetyl)-L-Ornithine,['experimental'],BE0000306,"Ornithine carbamoyltransferase, mitochondrial",OTC,Humans
6660,DB02014,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
6663,DB02016,R048-8071,['experimental'],BE0001466,Lanosterol synthase,LSS,Humans
6665,DB02018,Amido Phenyl Pyruvic Acid,['experimental'],BE0001474,Tryptase beta-2,TPSB2,Humans
6667,DB02020,Alrestatin,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6668,DB02021,Fidarestat,['experimental'],BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
6669,DB02021,Fidarestat,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6677,DB02027,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6678,DB02027,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6679,DB02028,"(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]",['experimental'],BE0004544,Tubby protein homolog,TUB,Humans
6680,DB02029,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
6687,DB02032,Epicaptopril,['experimental'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
6691,DB02034,Tridolgosir,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
6692,DB02035,Hexadecanesulfonyl fluoride,['experimental'],BE0004538,Palmitoyl-protein thioesterase 1,PPT1,Humans
6698,DB02039,S-Acetyl-Cysteine,['experimental'],BE0004578,Histone acetyltransferase KAT5,KAT5,Humans
6706,DB02044,N-[3-(aminomethyl)benzyl]acetamidine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6707,DB02044,N-[3-(aminomethyl)benzyl]acetamidine,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6708,DB02044,N-[3-(aminomethyl)benzyl]acetamidine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6709,DB02045,Amylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6710,DB02046,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
6711,DB02047,(+)-2-(4-biphenyl)propionic acid,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
6712,DB02048,"1,2,4-Triazole-Carboxamidine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6713,DB02049,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
6715,DB02052,Indirubin-3'-monoxime,['experimental'],BE0003819,Cyclin-dependent kinase 5 activator 1,CDK5R1,Humans
6716,DB02052,Indirubin-3'-monoxime,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6717,DB02052,Indirubin-3'-monoxime,['experimental'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
6718,DB02052,Indirubin-3'-monoxime,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
6719,DB02052,Indirubin-3'-monoxime,['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
6720,DB02052,Indirubin-3'-monoxime,['experimental'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
6724,DB02054,Gabaculine,['experimental'],BE0000424,"Ornithine aminotransferase, mitochondrial",OAT,Humans
6726,DB02056,Prostaglandin D2,['investigational'],BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
6727,DB02056,Prostaglandin D2,['investigational'],BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
6728,DB02057,(S)-AMPA,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
6729,DB02058,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,['experimental'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
6730,DB02058,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,['experimental'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
6731,DB02059,Adenosine-5-Diphosphoribose,['experimental'],BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,Humans
6735,DB02059,Adenosine-5-Diphosphoribose,['experimental'],BE0004281,Elongation factor 2,EEF2,Humans
6736,DB02059,Adenosine-5-Diphosphoribose,['experimental'],BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
6741,DB02059,Adenosine-5-Diphosphoribose,['experimental'],BE0004547,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",SIRT3,Humans
6746,DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
6747,DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",['experimental'],BE0000266,Neprilysin,MME,Humans
6748,DB02063,CRA_16847,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6751,DB02067,Triglu-5-formyl-tetrahydrofolate,['experimental'],BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
6752,DB02068,Delta-Amino Valeric Acid,['experimental'],BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
6753,DB02068,Delta-Amino Valeric Acid,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
6754,DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6755,DB02071,WAY-151693,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
6756,DB02072,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
6757,DB02073,Biliverdine IX Alpha,['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
6758,DB02073,Biliverdine IX Alpha,['experimental'],BE0004467,Myoglobin,MB,Humans
6759,DB02073,Biliverdine IX Alpha,['experimental'],BE0000595,Flavin reductase (NADPH),BLVRB,Humans
6761,DB02076,6-phospho-D-gluconic acid,['experimental'],BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,Humans
6762,DB02076,6-phospho-D-gluconic acid,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
6764,DB02077,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6765,DB02077,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6766,DB02078,Triglyme,['experimental'],BE0004295,Profilin-2,PFN2,Humans
6770,DB02078,Triglyme,['experimental'],BE0000839,Tyrosine-protein kinase Fyn,FYN,Humans
6771,DB02078,Triglyme,['experimental'],BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,Humans
6776,DB02079,Aminooxyacetic acid,['experimental'],BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
6777,DB02080,"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
6779,DB02081,Bis-Benzamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6780,DB02082,Phosphoaminophosphonic acid guanylate ester,['experimental'],BE0004478,Ras-related protein Rab-8B,RAB8B,Humans
6782,DB02084,CRA_17312,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6785,DB02087,"3,5-Difluorobenzenesulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6788,DB02090,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
6789,DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
6790,DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6792,DB02093,5-phospho-D-arabinohydroxamic acid,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
6794,DB02095,Isatin,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
6795,DB02096,FR221647,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
6796,DB02097,Cytidine,['experimental'],BE0001480,Uridine-cytidine kinase 2,UCK2,Humans
6797,DB02098,Adenosine-2'-5'-Diphosphate,['experimental'],BE0000908,Eosinophil cationic protein,RNASE3,Humans
6798,DB02098,Adenosine-2'-5'-Diphosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
6799,DB02098,Adenosine-2'-5'-Diphosphate,['experimental'],BE0001306,Non-secretory ribonuclease,RNASE2,Humans
6800,DB02101,"(S,R)-fidarestat",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6802,DB02103,2-Chlorodideoxyadenosine,['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
6803,DB02104,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
6804,DB02105,"3,5-Dinitrocatechol",['experimental'],BE0002089,Catechol O-methyltransferase,COMT,Humans
6805,DB02106,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",['experimental'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
6806,DB02107,Leucine - Reduced Carbonyl,['experimental'],BE0004563,Serine protease inhibitor Kazal-type 6,SPINK6,Humans
6807,DB02108,2-Aminoethanimidic Acid,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
6809,DB02109,Hadacidin,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
6811,DB02110,Protoporphyrin Ix Containing Co,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
6812,DB02110,Protoporphyrin Ix Containing Co,['experimental'],BE0001009,Cytochrome c,CYCS,Humans
6814,DB02112,Zk-806450,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
6816,DB02114,Cumidine,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
6817,DB02115,Daidzin,['experimental'],BE0000133,"Aldehyde dehydrogenase, mitochondrial",ALDH2,Humans
6818,DB02116,Olomoucine,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
6819,DB02116,Olomoucine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6820,DB02116,Olomoucine,['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
6821,DB02116,Olomoucine,['experimental'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
6822,DB02118,CP-271485,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
6836,DB02126,4-Carboxycinnamic Acid,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
6837,DB02126,4-Carboxycinnamic Acid,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
6843,DB02131,N-1-methylheptylformamide,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
6844,DB02132,Zenarestat,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
6854,DB02140,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,['experimental'],BE0003970,Pro-cathepsin H,CTSH,Humans
6855,DB02141,"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6862,DB02142,Pyridoxamine-5'-Phosphate,['experimental'],BE0000273,Kynurenine--oxoglutarate transaminase 1,CCBL1,Humans
6864,DB02142,Pyridoxamine-5'-Phosphate,['experimental'],BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
6866,DB02143,1-hydroxy-2-isopropylguanidine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6867,DB02144,"1,2-diacyl-sn-glycero-3-phosphoinositol",['experimental'],BE0001505,Phosphatidylinositol transfer protein alpha isoform,PITPNA,Humans
6870,DB02148,3-Amino-4-Oxybenzyl-2-Butanone,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
6873,DB02152,K-252a,['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
6874,DB02152,K-252a,['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
6877,DB02153,3-sulfino-L-alanine,['experimental'],BE0004515,Poly(A) polymerase alpha,PAPOLA,Humans
6879,DB02153,3-sulfino-L-alanine,['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
6883,DB02153,3-sulfino-L-alanine,['experimental'],BE0001972,Peroxiredoxin-2,PRDX2,Humans
6890,DB02155,3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
6891,DB02158,"(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol",['experimental'],BE0001128,S-methyl-5'-thioadenosine phosphorylase,MTAP,Humans
6894,DB02159,(R)-Propylene glycol,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
6896,DB02161,Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
6897,DB02162,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,['experimental'],BE0001473,Histidine triad nucleotide-binding protein 1,HINT1,Humans
6899,DB02164,N-sulfo-flavin mononucleotide,['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
6900,DB02165,Zinc trihydroxide,['experimental'],BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
6901,DB02166,Propidium,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
6903,DB02169,"9,10-Deepithio-9,10-Didehydroacanthifolicin",['experimental'],BE0001447,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,Humans
6904,DB02170,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
6908,DB02175,Malonic acid,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
6911,DB02175,Malonic acid,['experimental'],BE0002708,U1 small nuclear ribonucleoprotein A,SNRPA,Humans
6914,DB02177,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,['experimental'],BE0000516,Integrin alpha-L,ITGAL,Humans
6917,DB02180,Myristoyl-Coa,['experimental'],BE0003780,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,Humans
6918,DB02181,2'-Deoxyguanosine-5'-Triphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
6921,DB02183,Adenosine-5'-ditungstate,['experimental'],BE0001473,Histidine triad nucleotide-binding protein 1,HINT1,Humans
6923,DB02185,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",['experimental'],BE0004111,Lactase-like protein,LCTL,Humans
6926,DB02187,Equilin,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
6927,DB02187,Equilin,['experimental'],BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
6929,DB02189,"2',3'-Dideoxyadenosine triphosphate",['experimental'],BE0004486,DNA nucleotidylexotransferase,DNTT,Humans
6934,DB02195,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
6935,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,['experimental'],BE0001429,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,Humans
6936,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
6938,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
6940,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,['experimental'],BE0004629,Exostosin-like 2,EXTL2,Humans
6942,DB02197,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
6943,DB02198,2-Bromoacetyl Group,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
6946,DB02201,Malonate Ion,['experimental'],BE0004444,Stromal cell-derived factor 2,SDF2,Humans
6947,DB02205,(+)-Rutamarin alcohol,['experimental'],BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
6949,DB02207,7-Nitroindazole,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6950,DB02207,7-Nitroindazole,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6951,DB02207,7-Nitroindazole,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
6953,DB02209,Pyridoxine phosphate,['experimental'],BE0000404,Ornithine decarboxylase,ODC1,Humans
6954,DB02210,"Hexane-1,6-Diol",['experimental'],BE0001076,GTPase HRas,HRAS,Humans
6955,DB02210,"Hexane-1,6-Diol",['experimental'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
6958,DB02210,"Hexane-1,6-Diol",['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
6960,DB02211,(R)-N-methyl-N-2-propynyl-1-indanamine,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
6964,DB02215,Furoyl-Leucine,['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
6965,DB02216,S-Methylcysteine,['experimental'],BE0000941,Cathepsin D,CTSD,Humans
6966,DB02216,S-Methylcysteine,['experimental'],BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
6967,DB02217,Dpb-T,['experimental'],BE0001515,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,Humans
6968,DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
6969,DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
6971,DB02220,AL7089A,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6972,DB02221,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
6973,DB02222,"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
6976,DB02226,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
6980,DB02230,Immucillin-G,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
6985,DB02234,S-Ethylisothiourea,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
6986,DB02234,S-Ethylisothiourea,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
6989,DB02235,L-methionine (R)-S-oxide,['experimental'],BE0003392,Amyloid beta A4 protein,APP,Humans
6992,DB02236,Glycinamide Ribonucleotide,['experimental'],BE0000882,Trifunctional purine biosynthetic protein adenosine-3,GART,Humans
6996,DB02239,Laevulinic Acid,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
6999,DB02243,4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
7001,DB02249,2-Ethoxyethanol,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
7008,DB02255,Ilomastat,['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
7009,DB02255,Ilomastat,['experimental'],BE0004104,Aggrecan core protein,ACAN,Humans
7014,DB02258,SR11254,['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
7015,DB02259,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7016,DB02260,4-Oxosebacic Acid,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
7018,DB02261,Platelet Activating Factor,['experimental'],BE0005561,Platelet-activating factor receptor,PTAFR,Humans
7019,DB02261,Platelet Activating Factor,['experimental'],BE0001432,Ganglioside GM2 activator,GM2A,Humans
7021,DB02262,Orotic acid,['investigational'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
7028,DB02264,O2-Sulfo-Glucuronic Acid,['experimental'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
7029,DB02264,O2-Sulfo-Glucuronic Acid,['experimental'],BE0001121,Hepatocyte growth factor,HGF,Humans
7030,DB02264,O2-Sulfo-Glucuronic Acid,['experimental'],BE0001541,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,Humans
7033,DB02266,Flufenamic acid,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
7034,DB02266,Flufenamic acid,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
7035,DB02266,Flufenamic acid,['approved'],BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
7036,DB02266,Flufenamic acid,['approved'],BE0000132,Androgen receptor,AR,Humans
7037,DB02266,Flufenamic acid,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
7038,DB02266,Flufenamic acid,['approved'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
7039,DB02267,Argininosuccinate,['experimental'],BE0000520,Argininosuccinate lyase,ASL,Humans
7042,DB02269,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7046,DB02271,S-(2-oxo)pentadecylcoa,['experimental'],BE0003780,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,Humans
7047,DB02272,Porphobilinogen,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
7050,DB02277,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
7052,DB02279,Benzoylformic Acid,['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
7055,DB02281,Formycin,['experimental'],BE0001128,S-methyl-5'-thioadenosine phosphorylase,MTAP,Humans
7058,DB02282,5'-S-methyl-5'-thioadenosine,['experimental'],BE0001128,S-methyl-5'-thioadenosine phosphorylase,MTAP,Humans
7060,DB02285,Protoporphyrin,['experimental'],BE0000085,Ferritin light chain,FTL,Humans
7061,DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,['experimental'],BE0000048,Prothrombin,F2,Humans
7062,DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7063,DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7064,DB02288,CRA-9334,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7067,DB02292,Irosustat,['investigational'],BE0001197,Steryl-sulfatase,STS,Humans
7068,DB02292,Irosustat,['investigational'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7070,DB02296,Isoamyl alcohol,['experimental'],BE0000270,Renin,REN,Humans
7071,DB02297,2-Amino-6-Chloropyrazine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7072,DB02299,Arginineamide,['experimental'],BE0004502,Potassium voltage-gated channel subfamily A member 4,KCNA4,Humans
7073,DB02300,Calcipotriol,['approved'],BE0000779,Vitamin D3 receptor,VDR,Humans
7078,DB02303,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",['experimental'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
7080,DB02306,Palmitoyl-Linoleoyl Phosphatidylcholine,['experimental'],BE0000935,Phosphatidylcholine transfer protein,PCTP,Humans
7082,DB02308,"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
7083,DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,['experimental'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
7084,DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,['experimental'],BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,Humans
7085,DB02310,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
7086,DB02311,Methyl Methylsulfinylmethyl Sulfide,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
7091,DB02315,Cyclic GMP,['experimental'],BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,Humans
7092,DB02315,Cyclic GMP,['experimental'],BE0004631,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,Humans
7093,DB02315,Cyclic GMP,['experimental'],BE0003425,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,Humans
7096,DB02318,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
7098,DB02320,N-beta-D-glucopyranosylacetamide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7101,DB02322,Heparin Disaccharide I-S,['experimental'],BE0000975,C-C motif chemokine 5,CCL5,Humans
7102,DB02323,EM-1745,['experimental'],BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
7104,DB02326,1-Hydroxyamine-2-Isobutylmalonic Acid,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
7108,DB02328,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,['experimental'],BE0000791,Cystathionine gamma-lyase,CTH,Humans
7110,DB02329,Carbenoxolone,['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
7119,DB02335,2-Aminothiazoline,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
7120,DB02336,RU83876,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
7121,DB02337,S-(D-Carboxybutyl)-L-Homocysteine,['experimental'],BE0000845,Betaine--homocysteine S-methyltransferase 1,BHMT,Humans
7122,DB02338,NADPH,['experimental'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
7126,DB02338,NADPH,['experimental'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
7127,DB02338,NADPH,['experimental'],BE0000073,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,Humans
7129,DB02340,N-Acetyl-Serine,['experimental'],BE0000004,Coagulation factor XIII A chain,F13A1,Humans
7130,DB02341,"Mdl 101,146",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
7131,DB02341,"Mdl 101,146",['experimental'],BE0000394,Neutrophil elastase,ELANE,Humans
7132,DB02342,2-Methoxyestradiol,['investigational'],BE0002089,Catechol O-methyltransferase,COMT,Humans
7133,DB02342,2-Methoxyestradiol,['investigational'],BE0003543,Cytochrome P450 1A1,CYP1A1,Humans
7134,DB02342,2-Methoxyestradiol,['investigational'],BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
7135,DB02342,2-Methoxyestradiol,['investigational'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
7136,DB02342,2-Methoxyestradiol,['investigational'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
7138,DB02343,"3,6,9,12,15-Pentaoxaheptadecane",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
7140,DB02345,Selenocysteine,['experimental'],BE0004543,Cathelicidin antimicrobial peptide,CAMP,Humans
7141,DB02345,Selenocysteine,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
7145,DB02347,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
7146,DB02348,Monofluorophosphate ion,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7147,DB02350,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
7148,DB02352,3-(Benzyloxy)Pyridin-2-Amine,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
7149,DB02352,3-(Benzyloxy)Pyridin-2-Amine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
7150,DB02353,Heparin Disaccharide Iii-S,['experimental'],BE0000975,C-C motif chemokine 5,CCL5,Humans
7151,DB02354,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7153,DB02358,LY374571,['experimental'],BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,Humans
7154,DB02359,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
7155,DB02360,Bis-Napthyl Beta-Ketophosphonic Acid,['experimental'],BE0001010,Cathepsin G,CTSG,Humans
7159,DB02363,2'-Monophosphoadenosine-5'-Diphosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
7164,DB02366,CRA_10762,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7165,DB02367,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
7168,DB02371,"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",['experimental'],BE0001529,Complement C1s subcomponent,C1S,Humans
7169,DB02373,Adenosine monotungstate,['experimental'],BE0001687,Bis(5'-adenosyl)-triphosphatase,FHIT,Humans
7171,DB02375,Myricetin,['experimental'],BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
7172,DB02375,Myricetin,['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
7173,DB02376,"D-gluconhydroximo-1,5-lactam",['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
7174,DB02377,Guanine,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
7177,DB02377,Guanine,['experimental'],BE0001055,GTP cyclohydrolase 1,GCH1,Humans
7179,DB02378,MMI-175,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
7183,DB02379,Beta-D-Glucose,['experimental'],BE0004111,Lactase-like protein,LCTL,Humans
7184,DB02379,Beta-D-Glucose,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7186,DB02379,Beta-D-Glucose,['experimental'],BE0001056,Glucokinase,GCK,Humans
7190,DB02379,Beta-D-Glucose,['experimental'],BE0004467,Myoglobin,MB,Humans
7191,DB02379,Beta-D-Glucose,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
7192,DB02379,Beta-D-Glucose,['experimental'],BE0001108,Hexokinase-1,HK1,Humans
7197,DB02379,Beta-D-Glucose,['experimental'],BE0001008,Galectin-7,LGALS7,Humans
7200,DB02379,Beta-D-Glucose,['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
7211,DB02379,Beta-D-Glucose,['experimental'],BE0001107,Pulmonary surfactant-associated protein D,SFTPD,Humans
7212,DB02379,Beta-D-Glucose,['experimental'],BE0000926,Interferon beta,IFNB1,Humans
7214,DB02379,Beta-D-Glucose,['experimental'],BE0004501,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,Humans
7215,DB02379,Beta-D-Glucose,['experimental'],BE0001567,Glucosamine-6-phosphate isomerase 1,GNPDA1,Humans
7217,DB02379,Beta-D-Glucose,['experimental'],BE0001935,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,Humans
7218,DB02379,Beta-D-Glucose,['experimental'],BE0004581,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,Humans
7221,DB02379,Beta-D-Glucose,['experimental'],BE0001671,Alpha-amylase 1,AMY1A,Humans
7224,DB02379,Beta-D-Glucose,['experimental'],BE0004512,Neurocan core protein,NCAN,Humans
7246,DB02379,Beta-D-Glucose,['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
7252,DB02379,Beta-D-Glucose,['experimental'],BE0004492,Keratin-associated protein 5-2,KRTAP5-2,Humans
7253,DB02379,Beta-D-Glucose,['experimental'],BE0004592,Sialoadhesin,SIGLEC1,Humans
7260,DB02379,Beta-D-Glucose,['experimental'],BE0003247,Galectin-2,LGALS2,Humans
7266,DB02379,Beta-D-Glucose,['experimental'],BE0004472,Keratin-associated protein 5-3,KRTAP5-3,Humans
7271,DB02381,nor-NOHA,['investigational'],BE0000286,Arginase-1,ARG1,Humans
7274,DB02383,Tolrestat,['withdrawn'],BE0004352,Alcohol dehydrogenase [NADP(+)],AKR1A1,Humans
7275,DB02383,Tolrestat,['withdrawn'],BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
7276,DB02383,Tolrestat,['withdrawn'],BE0000747,Aldose reductase,AKR1B1,Humans
7279,DB02386,Leucine Phosphonic Acid,['experimental'],BE0003882,Cytosol aminopeptidase,LAP3,Humans
7280,DB02388,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
7281,DB02391,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
7282,DB02393,"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",['experimental'],BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,Humans
7284,DB02395,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
7285,DB02396,Methylethylamine,['experimental'],BE0004467,Myoglobin,MB,Humans
7286,DB02398,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7288,DB02400,ES-936,['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
7290,DB02401,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",['experimental'],BE0000068,L-lactate dehydrogenase B chain,LDHB,Humans
7291,DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
7294,DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
7295,DB02405,12-Bromododecanoic Acid,['experimental'],BE0003957,Glycodelin,PAEP,Humans
7297,DB02407,6-O-Cyclohexylmethyl Guanine,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
7298,DB02407,6-O-Cyclohexylmethyl Guanine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7308,DB02418,"(R,R)-2,3-Butanediol",['experimental'],BE0004530,Ubiquitin-conjugating enzyme E2 D2,UBE2D2,Humans
7309,DB02419,Ethyl Oxo(Piperidin-1-Yl)Acetate,['experimental'],BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
7310,DB02420,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7312,DB02422,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,['experimental'],BE0001414,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,Humans
7313,DB02424,Geldanamycin,"['experimental', 'investigational']",BE0001165,Endoplasmin,HSP90B1,Humans
7314,DB02424,Geldanamycin,"['experimental', 'investigational']",BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
7315,DB02424,Geldanamycin,"['experimental', 'investigational']",BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
7317,DB02426,Carboxyatractyloside,['experimental'],BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
7318,DB02427,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
7321,DB02429,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7324,DB02431,Cytidine-5'-Triphosphate,['experimental'],BE0001480,Uridine-cytidine kinase 2,UCK2,Humans
7331,DB02432,RU90395,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
7336,DB02435,Aminomethylcyclohexane,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7337,DB02436,{4-[(2S)-2-({[(1S)-1-Carboxy-2-phenylethyl]carbamoyl}amino)-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7346,DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,['experimental'],BE0001567,Glucosamine-6-phosphate isomerase 1,GNPDA1,Humans
7349,DB02447,"3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7350,DB02448,N-Tridecanoic Acid,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
7351,DB02448,N-Tridecanoic Acid,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
7352,DB02448,N-Tridecanoic Acid,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
7353,DB02449,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
7359,DB02451,B-nonylglucoside,['experimental'],BE0001200,Rhodopsin,RHO,Humans
7360,DB02451,B-nonylglucoside,['experimental'],BE0000880,Aquaporin-1,AQP1,Humans
7361,DB02451,B-nonylglucoside,['experimental'],BE0003898,Colipase,CLPS,Humans
7362,DB02451,B-nonylglucoside,['experimental'],BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
7365,DB02451,B-nonylglucoside,['experimental'],BE0003901,Lens fiber major intrinsic protein,MIP,Humans
7367,DB02451,B-nonylglucoside,['experimental'],BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
7370,DB02452,Thymidine 5'-triphosphate,['experimental'],BE0001260,"Thymidine kinase, cytosolic",TK1,Humans
7376,DB02452,Thymidine 5'-triphosphate,['experimental'],BE0004639,"Thymidine kinase 2, mitochondrial",TK2,Humans
7382,DB02457,Undecyl-Phosphinic Acid Butyl Ester,['experimental'],BE0003620,Gastric triacylglycerol lipase,LIPF,Humans
7383,DB02458,"S-(2,4-dinitrophenyl)glutathione",['experimental'],BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
7384,DB02458,"S-(2,4-dinitrophenyl)glutathione",['experimental'],BE0001189,Glutathione S-transferase Mu 2,GSTM2,Humans
7385,DB02459,4-guanidinobenzoic acid,['experimental'],BE0001701,Complement factor B,CFB,Humans
7388,DB02462,Thiocoumarin,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
7389,DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7390,DB02464,Benzylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7391,DB02464,Benzylamine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
7392,DB02465,Methoxy arachidonyl fluorophosphonate,['experimental'],BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
7393,DB02466,BMS-181156,['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
7396,DB02467,L-methionine (S)-S-oxide,['experimental'],BE0004533,Ras-related protein Rab-5A,RAB5A,Humans
7400,DB02468,12-Phenylheme,['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
7403,DB02471,Nojirimycine Tetrazole,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7404,DB02471,Nojirimycine Tetrazole,['experimental'],BE0004111,Lactase-like protein,LCTL,Humans
7405,DB02471,Nojirimycine Tetrazole,['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
7406,DB02472,"7,8-dihydroinosine",['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
7407,DB02473,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7411,DB02479,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7413,DB02481,N-Benzylformamide,['experimental'],BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
7414,DB02482,Phosphonothreonine,['experimental'],BE0001385,Protein kinase C theta type,PRKCQ,Humans
7415,DB02482,Phosphonothreonine,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
7416,DB02482,Phosphonothreonine,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
7417,DB02482,Phosphonothreonine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
7418,DB02482,Phosphonothreonine,['experimental'],BE0004475,cAMP-dependent protein kinase catalytic subunit beta,PRKACB,Humans
7419,DB02482,Phosphonothreonine,['experimental'],BE0001913,Cyclin-dependent kinase 7,CDK7,Humans
7421,DB02482,Phosphonothreonine,['experimental'],BE0001200,Rhodopsin,RHO,Humans
7422,DB02482,Phosphonothreonine,['experimental'],BE0002789,Protein S100-A11,S100A11,Humans
7423,DB02482,Phosphonothreonine,['experimental'],BE0002790,Mitogen-activated protein kinase 12,MAPK12,Humans
7424,DB02483,Etheno-NAD,['experimental'],BE0001241,ADP-ribosyl cyclase 2,BST1,Humans
7425,DB02483,Etheno-NAD,['experimental'],BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
7427,DB02485,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,['experimental'],BE0004564,N-acylneuraminate cytidylyltransferase,CMAS,Humans
7429,DB02486,2-Hydroxyethyl Disulfide,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
7431,DB02490,(Diaminomethyl-Methyl-Amino)-Acetic Acid,['experimental'],BE0000714,Creatine kinase M-type,CKM,Humans
7432,DB02491,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,['experimental'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
7433,DB02492,Ghavamiol,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
7436,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003823,60S ribosomal protein L10-like,RPL10L,Humans
7437,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003824,60S ribosomal protein L13a,RPL13A,Humans
7438,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003825,60S ribosomal protein L23,RPL23,Humans
7439,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003826,60S ribosomal protein L15,RPL15,Humans
7440,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003827,60S ribosomal protein L19,RPL19,Humans
7441,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003828,60S ribosomal protein L23a,RPL23A,Humans
7442,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003829,Probable ribosome biogenesis protein RLP24,RSL24D1,Humans
7443,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003830,60S ribosomal protein L26-like 1,RPL26L1,Humans
7444,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003831,60S ribosomal protein L8,RPL8,Humans
7445,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003832,60S ribosomal protein L37,RPL37,Humans
7446,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003833,60S ribosomal protein L3,RPL3,Humans
7447,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003834,60S ribosomal protein L11,RPL11,Humans
7448,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003835,NHP2-like protein 1,SNU13,Humans
7449,DB02494,(S)-3-phenyllactic acid,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
7453,DB02497,L-Alpha-Glycerophosphorylserine,['experimental'],BE0004149,Annexin A5,ANXA5,Humans
7454,DB02498,Carba-nicotinamide-adenine-dinucleotide,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
7455,DB02499,Dinor-N(Omega)-Hydroxy-L-Arginine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
7459,DB02504,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
7461,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",['experimental'],BE0003810,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,PPP1CA,Humans
7462,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",['experimental'],BE0003750,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,Humans
7463,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",['experimental'],BE0002326,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,Humans
7464,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",['experimental'],BE0003749,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,Humans
7465,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",['experimental'],BE0003811,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PPP2R2A,Humans
7466,DB02508,Isopentyl Pyrophosphate,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
7470,DB02509,Farnesol,['experimental'],BE0001777,Bile acid receptor,NR1H4,Humans
7471,DB02509,Farnesol,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
7472,DB02510,5'-O-(L-Prolylsulfamoyl)adenosine,['experimental'],BE0000188,Bifunctional glutamate/proline--tRNA ligase,EPRS,Humans
7474,DB02512,"1,6-Fructose Diphosphate (Linear Form)",['experimental'],BE0004565,Fructose-bisphosphate aldolase B,ALDOB,Humans
7475,DB02512,"1,6-Fructose Diphosphate (Linear Form)",['experimental'],BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
7477,DB02515,sn-glycerol 3-phosphate,['experimental'],BE0004565,Fructose-bisphosphate aldolase B,ALDOB,Humans
7480,DB02515,sn-glycerol 3-phosphate,['experimental'],BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,Humans
7483,DB02518,N-Acetylalanine,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
7484,DB02519,Indirubin-5-sulphonate,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7490,DB02526,CRA_10655,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7491,DB02526,CRA_10655,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7492,DB02527,Cyclic adenosine monophosphate,['experimental'],BE0004631,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,Humans
7493,DB02527,Cyclic adenosine monophosphate,['experimental'],BE0003425,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,Humans
7494,DB02527,Cyclic adenosine monophosphate,['experimental'],BE0004497,cAMP-dependent protein kinase type II-beta regulatory subunit,PRKAR2B,Humans
7498,DB02528,Tetrazolyl Histidine,['experimental'],BE0004467,Myoglobin,MB,Humans
7500,DB02530,gamma-Aminobutyric acid,"['approved', 'investigational']",BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
7501,DB02530,gamma-Aminobutyric acid,"['approved', 'investigational']",BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,Humans
7502,DB02530,gamma-Aminobutyric acid,"['approved', 'investigational']",BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
7504,DB02532,"2,4,6-Triaminoquinazoline",['experimental'],BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,Humans
7507,DB02535,Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7509,DB02538,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7511,DB02541,4-Hydroxybutan-1-Aminium,['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
7512,DB02542,(4s)-5-Fluoro-L-Leucine,['experimental'],BE0004560,Polyubiquitin-B,UBB,Humans
7515,DB02545,Fexaramine,['experimental'],BE0001777,Bile acid receptor,NR1H4,Humans
7516,DB02546,Vorinostat,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
7517,DB02546,Vorinostat,"['approved', 'investigational']",BE0002366,Histone deacetylase 2,HDAC2,Humans
7518,DB02546,Vorinostat,"['approved', 'investigational']",BE0002367,Histone deacetylase 3,HDAC3,Humans
7519,DB02546,Vorinostat,"['approved', 'investigational']",BE0002368,Histone deacetylase 6,HDAC6,Humans
7520,DB02546,Vorinostat,"['approved', 'investigational']",BE0001608,Histone deacetylase 8,HDAC8,Humans
7522,DB02546,Vorinostat,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
7523,DB02547,Guanosine-5'-Diphosphate-Rhamnose,['experimental'],BE0003278,"GDP-mannose 4,6 dehydratase",GMDS,Humans
7524,DB02548,D-glucitol 6-phosphate,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
7526,DB02550,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
7527,DB02551,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7529,DB02552,Geranyl Diphosphate,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
7531,DB02552,Geranyl Diphosphate,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
7536,DB02553,Glutathionylspermidine disulfide,['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
7537,DB02555,SP4160,['experimental'],BE0001029,Interleukin-2,IL2,Humans
7538,DB02556,D-Phenylalanine,['experimental'],BE0000273,Kynurenine--oxoglutarate transaminase 1,CCBL1,Humans
7539,DB02556,D-Phenylalanine,['experimental'],BE0001026,Corticoliberin,CRH,Humans
7540,DB02557,Phosphoramidon,['experimental'],BE0008984,Kell blood group glycoprotein,KEL,Humans
7541,DB02557,Phosphoramidon,['experimental'],BE0000266,Neprilysin,MME,Humans
7542,DB02558,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,['experimental'],BE0000266,Neprilysin,MME,Humans
7543,DB02559,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
7547,DB02562,"Quinonoid 7,8-Tetrahydrobiopterin",['experimental'],BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
7548,DB02563,Hexanoyl-CoA,['experimental'],BE0004500,"Enoyl-CoA hydratase, mitochondrial",ECHS1,Humans
7549,DB02565,4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide,['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
7553,DB02568,Peldesine,['investigational'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
7554,DB02569,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
7555,DB02570,PD150606,['experimental'],BE0004144,Calpain small subunit 1,CAPNS1,Humans
7558,DB02573,"2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate",['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
7563,DB02580,Pentaglyme,['experimental'],BE0004295,Profilin-2,PFN2,Humans
7574,DB02581,"N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide",['experimental'],BE0001029,Interleukin-2,IL2,Humans
7575,DB02583,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
7576,DB02585,4-(Hydroxymethyl)Benzamidine,['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
7578,DB02587,Colforsin,"['experimental', 'investigational']",BE0003732,Adenylate cyclase type 2,ADCY2,Humans
7579,DB02587,Colforsin,"['experimental', 'investigational']",BE0003731,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,Humans
7580,DB02587,Colforsin,"['experimental', 'investigational']",BE0003733,Adenylate cyclase type 5,ADCY5,Humans
7581,DB02587,Colforsin,"['experimental', 'investigational']",BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
7582,DB02587,Colforsin,"['experimental', 'investigational']",BE0010179,Adenylate cyclase,ADCY1,Humans
7583,DB02587,Colforsin,"['experimental', 'investigational']",BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
7584,DB02587,Colforsin,"['experimental', 'investigational']",BE0004367,CREB-binding protein,CREBBP,Humans
7585,DB02587,Colforsin,"['experimental', 'investigational']",BE0009668,Extracellular signal-regulated kinase (ERK),MAPK1,Humans
7586,DB02587,Colforsin,"['experimental', 'investigational']",BE0001034,Mucin-2,MUC2,Humans
7587,DB02587,Colforsin,"['experimental', 'investigational']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
7589,DB02589,Se-Ethyl-Isoselenourea,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
7594,DB02594,2'-Deoxycytidine,"['experimental', 'investigational']",BE0004639,"Thymidine kinase 2, mitochondrial",TK2,Humans
7596,DB02594,2'-Deoxycytidine,"['experimental', 'investigational']",BE0002804,Deoxycytidine kinase,DCK,Humans
7602,DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",['experimental'],BE0001832,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,Humans
7609,DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",['experimental'],BE0000266,Neprilysin,MME,Humans
7610,DB02598,"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",['experimental'],BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,PAM,Humans
7613,DB02602,AL7182,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7614,DB02603,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7615,DB02604,2-Deoxy-Glucose-6-Phosphate,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7617,DB02607,Adenosine Phosphonoacetic Acid,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
7620,DB02610,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7621,DB02611,Balanol Analog 1,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
7622,DB02613,Capric dimethyl amine oxide,['experimental'],BE0004027,Pancreatic lipase-related protein 2,PNLIPRP2,Humans
7624,DB02613,Capric dimethyl amine oxide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
7628,DB02615,Compound 19,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
7629,DB02615,Compound 19,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7630,DB02616,FR117016,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
7632,DB02620,3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7633,DB02621,Latrunculin A,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
7634,DB02621,Latrunculin A,['experimental'],BE0004161,Gelsolin,GSN,Humans
7636,DB02622,2-(Oxalyl-Amino)-Benzoic Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7637,DB02623,Aminophosphonic acid-guanylate ester,['experimental'],BE0004618,Cell division control protein 42 homolog,CDC42,Humans
7638,DB02624,Homoserine Lactone,['experimental'],BE0000752,Sodium/hydrogen exchanger 1,SLC9A1,Humans
7642,DB02628,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",['experimental'],BE0001156,E3 ubiquitin-protein ligase XIAP,XIAP,Humans
7647,DB02633,Cibacron Blue,['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
7648,DB02633,Cibacron Blue,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
7649,DB02635,N-[O-Phosphono-Pyridoxyl]-Isoleucine,['experimental'],BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
7650,DB02636,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
7651,DB02637,Oxaloacetate Ion,['experimental'],BE0004459,"Citrate synthase, mitochondrial",CS,Humans
7653,DB02637,Oxaloacetate Ion,['experimental'],BE0000909,Sepiapterin reductase,SPR,Humans
7656,DB02638,Terlipressin,"['approved', 'investigational']",BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
7657,DB02638,Terlipressin,"['approved', 'investigational']",BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
7658,DB02638,Terlipressin,"['approved', 'investigational']",BE0000293,Vasopressin V2 receptor,AVPR2,Humans
7659,DB02640,Fumagillin,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
7664,DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",['experimental'],BE0003418,Insulin-like growth factor I,IGF1,Humans
7665,DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
7667,DB02644,N-omega-propyl-L-arginine,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
7668,DB02644,N-omega-propyl-L-arginine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
7670,DB02646,Nitrosoethane,['experimental'],BE0004467,Myoglobin,MB,Humans
7671,DB02647,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7672,DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,['experimental'],BE0000496,Carnitine O-acetyltransferase,CRAT,Humans
7673,DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,['experimental'],BE0000373,Peroxisomal carnitine O-octanoyltransferase,CROT,Humans
7675,DB02651,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7676,DB02652,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
7679,DB02656,LY-294002,['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
7680,DB02656,LY-294002,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
7684,DB02659,Cholic Acid,['approved'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
7685,DB02659,Cholic Acid,['approved'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
7686,DB02659,Cholic Acid,['approved'],BE0001967,Gastrotropin,FABP6,Humans
7687,DB02659,Cholic Acid,['approved'],BE0003986,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,Humans
7688,DB02659,Cholic Acid,['approved'],BE0000335,Cytochrome c oxidase subunit 1,MT-CO1,Humans
7689,DB02659,Cholic Acid,['approved'],BE0003385,Cytochrome c oxidase subunit 2,MT-CO2,Humans
7690,DB02659,Cholic Acid,['approved'],BE0003987,Cytochrome c oxidase subunit 3,MT-CO3,Humans
7691,DB02659,Cholic Acid,['approved'],BE0003988,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,Humans
7692,DB02659,Cholic Acid,['approved'],BE0003989,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,Humans
7693,DB02659,Cholic Acid,['approved'],BE0003990,Cytochrome c oxidase subunit 6C,COX6C,Humans
7694,DB02659,Cholic Acid,['approved'],BE0003991,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,Humans
7695,DB02659,Cholic Acid,['approved'],BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,Humans
7696,DB02659,Cholic Acid,['approved'],BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,Humans
7697,DB02659,Cholic Acid,['approved'],BE0003994,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,Humans
7698,DB02659,Cholic Acid,['approved'],BE0003995,Cytochrome c oxidase subunit 6B1,COX6B1,Humans
7699,DB02659,Cholic Acid,['approved'],BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,Humans
7700,DB02659,Cholic Acid,['approved'],BE0003997,Phospholipase A2,PLA2G1B,Humans
7701,DB02659,Cholic Acid,['approved'],BE0002705,Liver carboxylesterase 1,CES1,Humans
7704,DB02659,Cholic Acid,['approved'],BE0001777,Bile acid receptor,NR1H4,Humans
7705,DB02659,Cholic Acid,['approved'],BE0005788,G-protein coupled bile acid receptor 1,GPBAR1,Humans
7706,DB02659,Cholic Acid,['approved'],BE0001033,"Ferrochelatase, mitochondrial",FECH,Humans
7707,DB02660,Filaminast,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
7708,DB02661,"Adenosine-5'-diphosphate-2',3'-vanadate",['experimental'],BE0003094,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,Humans
7709,DB02662,Novo Nordisk a/S Compound,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7712,DB02665,"(1R,2S)-2-Phenylcyclopropanaminium",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7719,DB02670,4-Deoxy-Alpha-D-Glucose,['experimental'],BE0004581,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,Humans
7720,DB02671,1-Methylimidazole,['experimental'],BE0004467,Myoglobin,MB,Humans
7722,DB02673,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
7724,DB02676,"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
7726,DB02678,beta-D-Galactosamine,['experimental'],BE0001008,Galectin-7,LGALS7,Humans
7727,DB02679,Cyanamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
7728,DB02679,Cyanamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
7731,DB02681,"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",['experimental'],BE0004552,Cyclin-dependent kinases regulatory subunit 1,CKS1B,Humans
7733,DB02684,5'-O-(L-Cysteinylsulfamoyl)adenosine,['experimental'],BE0000188,Bifunctional glutamate/proline--tRNA ligase,EPRS,Humans
7734,DB02685,3-Methylphenylalanine,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
7737,DB02689,S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
7738,DB02690,NU1025,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
7739,DB02691,Glycocholic acid,"['experimental', 'investigational']",BE0001967,Gastrotropin,FABP6,Humans
7743,DB02696,"6-Aminohexyl-uridine-C1,5'-diphosphate",['experimental'],BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
7744,DB02697,Hydroxyaminovaline,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
7745,DB02697,Hydroxyaminovaline,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
7747,DB02701,Nicotinamide,"['approved', 'investigational']",BE0001241,ADP-ribosyl cyclase 2,BST1,Humans
7749,DB02701,Nicotinamide,"['approved', 'investigational']",BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,Humans
7750,DB02701,Nicotinamide,"['approved', 'investigational']",BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
7751,DB02701,Nicotinamide,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
7757,DB02705,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
7759,DB02709,Resveratrol,['investigational'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
7760,DB02709,Resveratrol,['investigational'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
7761,DB02709,Resveratrol,['investigational'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
7762,DB02709,Resveratrol,['investigational'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
7763,DB02709,Resveratrol,['investigational'],BE0000309,Arachidonate 15-lipoxygenase,ALOX15,Humans
7764,DB02709,Resveratrol,['investigational'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
7765,DB02709,Resveratrol,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
7766,DB02709,Resveratrol,['investigational'],BE0008985,Phosphatidylinositol 4-kinase type 2-beta,PI4K2B,Humans
7767,DB02709,Resveratrol,['investigational'],BE0008988,Integrin alpha-5,ITGA5,Humans
7768,DB02709,Resveratrol,['investigational'],BE0001155,Integrin beta-3,ITGB3,Humans
7769,DB02709,Resveratrol,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
7770,DB02709,Resveratrol,['investigational'],BE0000878,Alpha-synuclein,SNCA,Humans
7771,DB02709,Resveratrol,['investigational'],BE0002461,NAD-dependent protein deacetylase sirtuin-1,SIRT1,Humans
7772,DB02709,Resveratrol,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
7773,DB02709,Resveratrol,['investigational'],BE0000515,Melatonin receptor type 1A,MTNR1A,Humans
7774,DB02709,Resveratrol,['investigational'],BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
7775,DB02709,Resveratrol,['investigational'],BE0005467,C-type lectin domain family 14 member A,CLEC14A,Humans
7776,DB02709,Resveratrol,['investigational'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
7777,DB02709,Resveratrol,['investigational'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
7778,DB02709,Resveratrol,['investigational'],BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,Humans
7779,DB02709,Resveratrol,['investigational'],BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
7780,DB02709,Resveratrol,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
7781,DB02709,Resveratrol,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
7782,DB02709,Resveratrol,['investigational'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
7783,DB02709,Resveratrol,['investigational'],BE0009095,Far upstream element-binding protein 2,KHSRP,Humans
7784,DB02709,Resveratrol,['investigational'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
7785,DB02710,"2,3,-Dihydroxybenzoylserine",['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
7787,DB02712,Sorbinil,"['experimental', 'investigational']",BE0000747,Aldose reductase,AKR1B1,Humans
7789,DB02714,3'-Uridinemonophosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
7790,DB02715,Compound 18,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
7791,DB02716,7-methyl-guanosine-5'-triphosphate,['experimental'],BE0000957,Eukaryotic translation initiation factor 4E,EIF4E,Humans
7793,DB02719,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7794,DB02720,alpha-D-glucopyranosyl-2-carboxylic acid amide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7795,DB02721,4-Iodopyrazole,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
7796,DB02721,4-Iodopyrazole,['experimental'],BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
7797,DB02721,4-Iodopyrazole,['experimental'],BE0000227,Alcohol dehydrogenase 1A,ADH1A,Humans
7800,DB02723,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",['experimental'],BE0000048,Prothrombin,F2,Humans
7805,DB02726,2-Phosphoglycolic Acid,['experimental'],BE0004460,Beta-enolase,ENO3,Humans
7806,DB02726,2-Phosphoglycolic Acid,['experimental'],BE0000046,Pyruvate kinase PKLR,PKLR,Humans
7810,DB02726,2-Phosphoglycolic Acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
7811,DB02726,2-Phosphoglycolic Acid,['experimental'],BE0000088,Pyruvate kinase PKM,PKM,Humans
7814,DB02726,2-Phosphoglycolic Acid,['experimental'],BE0004550,Gamma-enolase,ENO2,Humans
7817,DB02727,2-butyl-1-hydroxyguanidine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
7818,DB02728,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
7820,DB02730,4-Methylthio-Alpha-D-Mannose,['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
7821,DB02731,Ethylmercurithiosalicylic acid,['experimental'],BE0002256,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",OXCT1,Humans
7823,DB02733,Purvalanol,['experimental'],BE0004323,SRSF protein kinase 2,SRPK2,Humans
7824,DB02733,Purvalanol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7826,DB02733,Purvalanol,['experimental'],BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
7827,DB02733,Purvalanol,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
7828,DB02733,Purvalanol,['experimental'],BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
7831,DB02735,2-Amino-3-Oxo-4-Sulfo-Butyric Acid,['experimental'],BE0001197,Steryl-sulfatase,STS,Humans
7834,DB02740,3-Indolebutyric Acid,['experimental'],BE0003777,Beta-2-microglobulin,B2M,Humans
7835,DB02740,3-Indolebutyric Acid,['experimental'],BE0003778,T-cell receptor alpha chain C region,TRAC,Humans
7836,DB02740,3-Indolebutyric Acid,['experimental'],BE0003779,T-cell receptor beta-1 chain C region,TRBC1,Humans
7837,DB02740,3-Indolebutyric Acid,['experimental'],BE0003482,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,Humans
7839,DB02741,CD564,['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
7840,DB02742,Kifunensine,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
7841,DB02742,Kifunensine,['experimental'],BE0001414,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,Humans
7844,DB02744,RPR131247,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7845,DB02745,Uridine,"['experimental', 'investigational']",BE0004434,U6 snRNA-associated Sm-like protein LSm6,LSM6,Humans
7847,DB02746,Phthalic Acid,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
7848,DB02746,Phthalic Acid,['experimental'],BE0000557,Progesterone receptor,PGR,Humans
7849,DB02746,Phthalic Acid,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
7850,DB02746,Phthalic Acid,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
7851,DB02746,Phthalic Acid,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
7852,DB02746,Phthalic Acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
7853,DB02746,Phthalic Acid,['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
7854,DB02746,Phthalic Acid,['experimental'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
7855,DB02746,Phthalic Acid,['experimental'],BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
7858,DB02750,S-(Methylmercury)-L-Cysteine,['experimental'],BE0004053,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,Humans
7859,DB02751,Glycocyamine,['experimental'],BE0000567,Guanidinoacetate N-methyltransferase,GAMT,Humans
7862,DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
7863,DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
7864,DB02755,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,['experimental'],BE0004494,Cation-dependent mannose-6-phosphate receptor,M6PR,Humans
7865,DB02757,Pyrazole,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
7866,DB02757,Pyrazole,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
7867,DB02757,Pyrazole,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
7868,DB02758,Indolepropionic acid,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
7871,DB02759,4-methyl-umbelliferyl-N-acetyl-chitobiose,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
7879,DB02761,S-Mercaptocysteine,['experimental'],BE0004455,Thiosulfate sulfurtransferase,TST,Humans
7881,DB02762,RU79072,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
7882,DB02763,5-Mercapto-2-Nitro-Benzoic Acid,['experimental'],BE0000981,Interleukin-12 subunit beta,IL12B,Humans
7887,DB02767,(R)-3-hydroxytetradecanoic acid,['experimental'],BE0004024,Lymphocyte antigen 96,LY96,Humans
7888,DB02767,(R)-3-hydroxytetradecanoic acid,['experimental'],BE0002442,Toll-like receptor 4,TLR4,Humans
7892,DB02772,Sucrose,"['approved', 'experimental', 'investigational']",BE0000395,Taste receptor type 1 member 2,TAS1R2,Humans
7894,DB02772,Sucrose,"['approved', 'experimental', 'investigational']",BE0003751,Lysozyme C,LYZ,Humans
7895,DB02772,Sucrose,"['approved', 'experimental', 'investigational']",BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
7901,DB02772,Sucrose,"['approved', 'experimental', 'investigational']",BE0002833,Copper transport protein ATOX1,ATOX1,Humans
7902,DB02772,Sucrose,"['approved', 'experimental', 'investigational']",BE0004442,tRNA-splicing ligase RtcB homolog,RTCB,Humans
7906,DB02773,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
7908,DB02774,"1,3-Propanediol",['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
7911,DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
7912,DB02779,Dodecyltrimethylammonium,['experimental'],BE0001071,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,Humans
7915,DB02783,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,['experimental'],BE0000383,"Aspartate aminotransferase, mitochondrial",GOT2,Humans
7916,DB02784,N-(Bromoacetyl)-beta-alanyl-N-(2-{4-[(carboxycarbonyl)amino]phenyl}ethyl)-L-serinamide,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7920,DB02789,Pregnenolone,"['approved', 'experimental']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
7921,DB02789,Pregnenolone,"['approved', 'experimental']",BE0001264,Sulfotransferase family cytosolic 2B member 1,SULT2B1,Humans
7925,DB02795,P-Anisic Acid,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
7926,DB02795,P-Anisic Acid,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
7927,DB02796,9-deazainosine,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
7931,DB02800,"5-hydroxymethyl-5,6-dihydrofolic acid",['experimental'],BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
7936,DB02803,"3-Phenyl-1,2-Propandiol",['experimental'],BE0000270,Renin,REN,Humans
7938,DB02805,Arabinouridine 3'-phosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
7942,DB02811,Diethyl phosphonate,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
7943,DB02812,RWJ-56423,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
7944,DB02813,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",['experimental'],BE0001153,Beta-hexosaminidase subunit beta,HEXB,Humans
7948,DB02818,Iodo-Willardiine,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
7950,DB02820,"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",['experimental'],BE0000317,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,Humans
7951,DB02821,Canaline,['experimental'],BE0000424,"Ornithine aminotransferase, mitochondrial",OAT,Humans
7952,DB02822,Para-Bromobenzyl Alcohol,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
7954,DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,['experimental'],BE0000331,"Serine hydroxymethyltransferase, cytosolic",SHMT1,Humans
7955,DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,['experimental'],BE0000404,Ornithine decarboxylase,ODC1,Humans
7958,DB02825,Methylphosphinate,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
7959,DB02827,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
7962,DB02830,FR236913,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
7963,DB02831,Dihydrogenphosphate,['experimental'],BE0000869,L-xylulose reductase,DCXR,Humans
7966,DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
7967,DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
7968,DB02834,IDD552,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
7970,DB02835,"Alpha-D-Glucose 1,6-Bisphosphate",['experimental'],BE0004461,Phosphoglucomutase-1,PGM1,Humans
7973,DB02837,4-(Hydrogen sulfate)-beta-D-galactopyranose,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
7974,DB02838,"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
7977,DB02840,"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
7983,DB02843,alpha-D-glucose-1-phosphate,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
7988,DB02845,Methylphosphinic Acid,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
7989,DB02845,Methylphosphinic Acid,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
7991,DB02846,L-thioproline,['experimental'],BE0004149,Annexin A5,ANXA5,Humans
7992,DB02848,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
7994,DB02850,DAS869,['experimental'],BE0000455,4-hydroxyphenylpyruvate dioxygenase,HPD,Humans
7996,DB02852,Domoic Acid,['experimental'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
7997,DB02854,Aetiocholanolone,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
7998,DB02854,Aetiocholanolone,['experimental'],BE0000886,Bile salt sulfotransferase,SULT2A1,Humans
8000,DB02854,Aetiocholanolone,['experimental'],BE0002840,Estradiol 17-beta-dehydrogenase 11,HSD17B11,Humans
8001,DB02855,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
8004,DB02857,Guanosine,"['experimental', 'investigational']",BE0000250,Purine nucleoside phosphorylase,PNP,Humans
8007,DB02859,Soraphen A,['experimental'],BE0000702,Acetyl-CoA carboxylase 2,ACACB,Humans
8008,DB02860,Calyculin A,['experimental'],BE0001447,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,Humans
8009,DB02861,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8011,DB02866,Dansylamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8013,DB02868,Deacetoxyvinzolidine,['experimental'],BE0000418,Calmodulin,CALM1,Humans
8014,DB02869,3-amino-5-phenylpentane,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
8015,DB02869,3-amino-5-phenylpentane,['experimental'],BE0001909,Cathepsin L2,CTSV,Humans
8017,DB02871,3-Butylthiolane 1-Oxide,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
8018,DB02872,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",['experimental'],BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
8019,DB02873,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
8020,DB02875,CRA_1802,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8022,DB02877,Arotinoid acid,['experimental'],BE0000206,Retinoic acid receptor beta,RARB,Humans
8023,DB02878,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
8026,DB02884,3-Cyclohexyl-L-alanine,['experimental'],BE0002842,Zinc finger Y-chromosomal protein,ZFY,Humans
8028,DB02887,Stavudine triphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
8029,DB02888,FKB-001,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
8030,DB02889,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
8031,DB02890,6-hydroxyuridine-5'-phosphate,['experimental'],BE0004473,Uridine 5'-monophosphate synthase,UMPS,Humans
8034,DB02893,D-Methionine,"['approved', 'experimental', 'investigational']",BE0001534,Methionine aminopeptidase 2,METAP2,Humans
8036,DB02894,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8037,DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
8041,DB02898,(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8050,DB02900,alpha-D-mannose 6-phosphate,['experimental'],BE0003623,Cation-independent mannose-6-phosphate receptor,IGF2R,Humans
8051,DB02900,alpha-D-mannose 6-phosphate,['experimental'],BE0004494,Cation-dependent mannose-6-phosphate receptor,M6PR,Humans
8052,DB02901,Stanolone,"['illicit', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
8053,DB02901,Stanolone,"['illicit', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
8054,DB02901,Stanolone,"['illicit', 'investigational']",BE0000132,Androgen receptor,AR,Humans
8055,DB02901,Stanolone,"['illicit', 'investigational']",BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
8056,DB02902,3'-phospho-5'-adenylyl sulfate,['experimental'],BE0000951,Estrogen sulfotransferase,SULT1E1,Humans
8062,DB02908,RU78783,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8065,DB02910,Octanoyl-Coenzyme A,['experimental'],BE0004500,"Enoyl-CoA hydratase, mitochondrial",ECHS1,Humans
8066,DB02910,Octanoyl-Coenzyme A,['experimental'],BE0001764,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,Humans
8067,DB02910,Octanoyl-Coenzyme A,['experimental'],BE0001745,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,Humans
8068,DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8070,DB02915,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
8071,DB02915,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8072,DB02917,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
8073,DB02918,Zardaverine,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
8074,DB02919,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
8079,DB02924,"(4R)-limonene 1?,2?-epoxide",['experimental'],BE0004320,Epididymal-specific lipocalin-9,LCN9,Humans
8080,DB02925,Piretanide,['approved'],BE0000502,Solute carrier family 12 member 1,SLC12A1,Humans
8083,DB02929,K201 free base,"['experimental', 'investigational']",BE0004149,Annexin A5,ANXA5,Humans
8084,DB02930,Adenosine 5'-[gamma-thio]triphosphate,['experimental'],BE0001241,ADP-ribosyl cyclase 2,BST1,Humans
8085,DB02930,Adenosine 5'-[gamma-thio]triphosphate,['experimental'],BE0004488,Synapsin-1,SYN1,Humans
8086,DB02930,Adenosine 5'-[gamma-thio]triphosphate,['experimental'],BE0004571,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",BCKDK,Humans
8087,DB02930,Adenosine 5'-[gamma-thio]triphosphate,['experimental'],BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,Humans
8088,DB02930,Adenosine 5'-[gamma-thio]triphosphate,['experimental'],BE0002851,Mismatch repair endonuclease PMS2,PMS2,Humans
8098,DB02931,CoA-s-acetyl tryptamine,['experimental'],BE0004584,Serotonin N-acetyltransferase,AANAT,Humans
8099,DB02932,(R)-Bicalutamide,['experimental'],BE0000132,Androgen receptor,AR,Humans
8100,DB02933,5'-Deoxy-5'-(Methylthio)-Tubercidin,['experimental'],BE0001128,S-methyl-5'-thioadenosine phosphorylase,MTAP,Humans
8103,DB02935,Diglyme,['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
8104,DB02936,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
8107,DB02938,Heptanoic acid,"['experimental', 'investigational']",BE0003997,Phospholipase A2,PLA2G1B,Humans
8111,DB02942,"Inositol 1,3-Bisphosphate",['experimental'],BE0001815,Early endosome antigen 1,EEA1,Humans
8112,DB02943,N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
8117,DB02950,Hymenialdisine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8118,DB02950,Hymenialdisine,['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
8119,DB02950,Hymenialdisine,['experimental'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
8122,DB02952,2-aminoisobutyric acid,['experimental'],BE0001026,Corticoliberin,CRH,Humans
8123,DB02952,2-aminoisobutyric acid,['experimental'],BE0003476,Pro-neuropeptide Y,NPY,Humans
8124,DB02953,2-Thiomethyl-3-Phenylpropanoic Acid,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
8127,DB02955,Ricinoleic acid,['experimental'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
8128,DB02955,Ricinoleic acid,['experimental'],BE0000095,Cannabinoid receptor 2,CNR2,Humans
8129,DB02955,Ricinoleic acid,['experimental'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
8134,DB02963,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8135,DB02964,"8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8137,DB02966,Fluoro-Willardiine,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
8138,DB02967,N-Ethylmaleimide,['experimental'],BE0001886,Galectin-10,CLC,Humans
8144,DB02973,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8145,DB02974,4-(4-Chlorophenyl)Imidazole,['experimental'],BE0003549,Cytochrome P450 2B6,CYP2B6,Humans
8149,DB02977,PNU177836,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
8150,DB02979,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8153,DB02983,Para-Mercury-Benzenesulfonic Acid,['experimental'],BE0001886,Galectin-10,CLC,Humans
8154,DB02983,Para-Mercury-Benzenesulfonic Acid,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
8155,DB02984,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
8157,DB02986,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8158,DB02987,Cysteine-S-acetamide,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
8159,DB02987,Cysteine-S-acetamide,['experimental'],BE0004585,2'-5'-oligoadenylate synthase 1,OAS1,Humans
8160,DB02988,Imino-Tryptophan,['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
8161,DB02989,CRA_10972,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8163,DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
8166,DB02994,Cacodylic acid,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8167,DB02994,Cacodylic acid,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
8168,DB02994,Cacodylic acid,['experimental'],BE0003945,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,Humans
8170,DB02996,2-(Thiomethylene)-4-Methylpentanoic Acid,['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
8171,DB02998,Metribolone,['experimental'],BE0000132,Androgen receptor,AR,Humans
8172,DB02998,Metribolone,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
8173,DB02998,Metribolone,['experimental'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
8174,DB02998,Metribolone,['experimental'],BE0000557,Progesterone receptor,PGR,Humans
8175,DB02998,Metribolone,['experimental'],BE0008983,Prostate-specific antigen,KLK3,Humans
8176,DB02999,Quisqualic acid,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
8177,DB02999,Quisqualic acid,['experimental'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
8179,DB03003,Glutathione sulfonic acid,['experimental'],BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
8180,DB03003,Glutathione sulfonic acid,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
8181,DB03003,Glutathione sulfonic acid,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
8183,DB03005,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
8184,DB03006,Arsanilic acid,"['experimental', 'vet_approved']",BE0003751,Lysozyme C,LYZ,Humans
8185,DB03008,5-fluoro-beta-L-gulosyl fluoride,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
8186,DB03010,Patupilone,"['experimental', 'investigational']",BE0001425,Tubulin alpha-3C/D chain,TUBA3C,Humans
8187,DB03010,Patupilone,"['experimental', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
8188,DB03010,Patupilone,"['experimental', 'investigational']",BE0000026,Tubulin beta-1 chain,TUBB1,Humans
8189,DB03010,Patupilone,"['experimental', 'investigational']",BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
8190,DB03010,Patupilone,"['experimental', 'investigational']",BE0001408,Tubulin beta-4A chain,TUBB4A,Humans
8191,DB03010,Patupilone,"['experimental', 'investigational']",BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
8192,DB03010,Patupilone,"['experimental', 'investigational']",BE0001415,Tubulin beta-3 chain,TUBB3,Humans
8193,DB03010,Patupilone,"['experimental', 'investigational']",BE0001388,Tubulin alpha-1C chain,TUBA1C,Humans
8194,DB03010,Patupilone,"['experimental', 'investigational']",BE0001359,Tubulin alpha-8 chain,TUBA8,Humans
8195,DB03010,Patupilone,"['experimental', 'investigational']",BE0001275,Tubulin alpha-1B chain,TUBA1B,Humans
8196,DB03010,Patupilone,"['experimental', 'investigational']",BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
8198,DB03012,Phenylalanine-N-Sulfonamide,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
8200,DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
8201,DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,['experimental'],BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
8202,DB03015,"6-hydroxy-1,6-dihydro purine nucleoside",['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
8203,DB03016,CRA_1801,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8207,DB03017,Lauric acid,"['approved', 'experimental']",BE0004019,Hepatocyte nuclear factor 4-alpha,HNF4A,Humans
8208,DB03017,Lauric acid,"['approved', 'experimental']",BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
8209,DB03017,Lauric acid,"['approved', 'experimental']",BE0004020,Very low-density lipoprotein receptor,VLDLR,Humans
8210,DB03017,Lauric acid,"['approved', 'experimental']",BE0001854,Glycolipid transfer protein,GLTP,Humans
8212,DB03017,Lauric acid,"['approved', 'experimental']",BE0000994,Lactotransferrin,LTF,Humans
8214,DB03017,Lauric acid,"['approved', 'experimental']",BE0003266,Complement component C8 gamma chain,C8G,Humans
8215,DB03017,Lauric acid,"['approved', 'experimental']",BE0004022,Group IID secretory phospholipase A2,PLA2G2D,Humans
8217,DB03017,Lauric acid,"['approved', 'experimental']",BE0004024,Lymphocyte antigen 96,LY96,Humans
8218,DB03017,Lauric acid,"['approved', 'experimental']",BE0002442,Toll-like receptor 4,TLR4,Humans
8219,DB03017,Lauric acid,"['approved', 'experimental']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
8221,DB03017,Lauric acid,"['approved', 'experimental']",BE0001432,Ganglioside GM2 activator,GM2A,Humans
8222,DB03017,Lauric acid,"['approved', 'experimental']",BE0000009,Alcohol dehydrogenase class-3,ADH5,Humans
8226,DB03019,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8227,DB03020,5-beta-D-ribofuranosylnicotinamide adenine dinucleotide,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
8228,DB03021,Ulapualide A,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
8230,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",['experimental'],BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
8231,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8232,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
8233,DB03024,2-Methyl-3-(2-Aminothiazolo)Propanal,['experimental'],BE0000270,Renin,REN,Humans
8236,DB03026,Phosphoglycolohydroxamic Acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
8240,DB03028,1h-Benoximidazole-2-Carboxylic Acid,['experimental'],BE0000941,Cathepsin D,CTSD,Humans
8243,DB03032,S-octylglutathione,['experimental'],BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
8244,DB03033,4-methoxybenzenesulfinate,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
8245,DB03033,4-methoxybenzenesulfinate,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
8247,DB03035,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
8250,DB03039,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8251,DB03040,Nitrilotriacetic acid,['experimental'],BE0000994,Lactotransferrin,LTF,Humans
8252,DB03041,UDP-alpha-D-glucuronic acid,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
8253,DB03041,UDP-alpha-D-glucuronic acid,['experimental'],BE0001872,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,Humans
8256,DB03042,5-Phosphoarabinonic Acid,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
8257,DB03044,Doramapimod,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
8259,DB03046,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
8260,DB03048,6-Carboxymethyluracil,['experimental'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
8264,DB03052,Dazoxiben,['experimental'],BE0001893,Thromboxane-A synthase,TBXAS1,Humans
8266,DB03056,4-Piperidino-Piperidine,['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
8268,DB03058,2-Aminobenzyl alcohol,['experimental'],BE0001840,Complement factor D,CFD,Humans
8269,DB03059,Acetoacetyl-CoA,['experimental'],BE0000377,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,Humans
8271,DB03059,Acetoacetyl-CoA,['experimental'],BE0000762,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,Humans
8272,DB03059,Acetoacetyl-CoA,['experimental'],BE0004500,"Enoyl-CoA hydratase, mitochondrial",ECHS1,Humans
8277,DB03060,Sri-9662,['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
8278,DB03061,(R)-N-(1-Methyl-Hexyl)-Formamide,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
8279,DB03062,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,['experimental'],BE0004329,Glycylpeptide N-tetradecanoyltransferase 1,NMT1,Humans
8282,DB03064,"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
8283,DB03065,7-Nitroindazole-2-Carboxamidine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8285,DB03067,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8288,DB03070,Selenazole-4-carboxyamide-adenine dinucleotide,['experimental'],BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
8289,DB03072,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
8290,DB03073,3-Methoxybenzamide,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
8296,DB03078,PASBN,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8298,DB03081,"[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8299,DB03082,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
8300,DB03083,IC261,['experimental'],BE0003334,Casein kinase I isoform gamma-2,CSNK1G2,Humans
8301,DB03084,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
8302,DB03085,Glycolic acid,"['approved', 'investigational']",BE0001089,Glucose-6-phosphate 1-dehydrogenase,G6PD,Humans
8303,DB03086,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
8304,DB03087,2-(Sec-Butyl)Thiazole,['experimental'],BE0004320,Epididymal-specific lipocalin-9,LCN9,Humans
8305,DB03088,Pidolic acid,"['approved', 'investigational']",BE0004457,Alpha-amylase 2B,AMY2B,Humans
8306,DB03088,Pidolic acid,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
8307,DB03088,Pidolic acid,"['approved', 'investigational']",BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
8308,DB03088,Pidolic acid,"['approved', 'investigational']",BE0004465,Ig lambda-1 chain C regions,IGLC1,Humans
8310,DB03088,Pidolic acid,"['approved', 'investigational']",BE0004464,Trefoil factor 2,TFF2,Humans
8312,DB03088,Pidolic acid,"['approved', 'investigational']",BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
8315,DB03088,Pidolic acid,"['approved', 'investigational']",BE0004492,Keratin-associated protein 5-2,KRTAP5-2,Humans
8316,DB03088,Pidolic acid,"['approved', 'investigational']",BE0004439,Orexin,HCRT,Humans
8317,DB03088,Pidolic acid,"['approved', 'investigational']",BE0002941,C-C motif chemokine 8,CCL8,Humans
8321,DB03092,5-Hydroxymethyl-Chonduritol,['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
8322,DB03092,5-Hydroxymethyl-Chonduritol,['experimental'],BE0001671,Alpha-amylase 1,AMY1A,Humans
8323,DB03092,5-Hydroxymethyl-Chonduritol,['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
8324,DB03093,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
8325,DB03095,Tetramethylammonium,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
8326,DB03096,2-Morpholinoethylamine,['experimental'],BE0000941,Cathepsin D,CTSD,Humans
8329,DB03100,6-Nitroindazole,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
8330,DB03100,6-Nitroindazole,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8332,DB03101,Ribose-1-Phosphate,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
8333,DB03102,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
8334,DB03103,Thymidine-5'- Diphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
8335,DB03104,2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8336,DB03106,scyllo-inositol,['investigational'],BE0000978,Glucosylceramidase,GBA,Humans
8338,DB03106,scyllo-inositol,['investigational'],BE0002199,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,CDIPT,Humans
8342,DB03109,2-acetylamino-2-deoxy-b-D-allopyranose,['experimental'],BE0001058,Chitotriosidase-1,CHIT1,Humans
8345,DB03110,2-Chlorophenol,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
8349,DB03114,PAS219,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8350,DB03115,"5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
8354,DB03120,p-Toluenesulfonic acid,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
8355,DB03120,p-Toluenesulfonic acid,['experimental'],BE0003970,Pro-cathepsin H,CTSH,Humans
8356,DB03121,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
8357,DB03124,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,['experimental'],BE0001162,Caspase-3,CASP3,Humans
8358,DB03125,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
8360,DB03126,Mant-Adp,['experimental'],BE0003893,Myosin-14,MYH14,Humans
8361,DB03127,Benzamidine,['experimental'],BE0001091,Kallikrein-1,KLK1,Humans
8362,DB03127,Benzamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
8363,DB03127,Benzamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8364,DB03127,Benzamidine,['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
8365,DB03127,Benzamidine,['experimental'],BE0001586,Kallikrein-6,KLK6,Humans
8366,DB03127,Benzamidine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
8367,DB03127,Benzamidine,['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
8368,DB03127,Benzamidine,['experimental'],BE0002833,Copper transport protein ATOX1,ATOX1,Humans
8369,DB03127,Benzamidine,['experimental'],BE0001764,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,Humans
8371,DB03127,Benzamidine,['experimental'],BE0001656,Suppressor of tumorigenicity 14 protein,ST14,Humans
8372,DB03128,Acetylcholine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
8373,DB03128,Acetylcholine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
8374,DB03128,Acetylcholine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
8375,DB03128,Acetylcholine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
8376,DB03128,Acetylcholine,"['approved', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
8377,DB03129,"Diamino-N-[3-(1,3,2-dioxaborolan-2-yloxy)propyl]methaniminium",['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
8378,DB03130,S-P-Nitrobenzyloxycarbonylglutathione,['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
8379,DB03132,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
8381,DB03133,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8383,DB03135,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
8384,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,['experimental'],BE0000048,Prothrombin,F2,Humans
8385,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8386,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
8387,DB03137,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
8397,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8399,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
8400,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
8401,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
8404,DB03147,Flavin adenine dinucleotide,['approved'],BE0000305,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NDUFA9,Humans
8406,DB03147,Flavin adenine dinucleotide,['approved'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
8407,DB03147,Flavin adenine dinucleotide,['approved'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
8411,DB03147,Flavin adenine dinucleotide,['approved'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
8413,DB03147,Flavin adenine dinucleotide,['approved'],BE0000160,NADH-cytochrome b5 reductase 3,CYB5R3,Humans
8420,DB03147,Flavin adenine dinucleotide,['approved'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
8421,DB03147,Flavin adenine dinucleotide,['approved'],BE0000397,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,Humans
8422,DB03147,Flavin adenine dinucleotide,['approved'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
8424,DB03147,Flavin adenine dinucleotide,['approved'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
8426,DB03147,Flavin adenine dinucleotide,['approved'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
8427,DB03147,Flavin adenine dinucleotide,['approved'],BE0000605,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,Humans
8428,DB03147,Flavin adenine dinucleotide,['approved'],BE0000965,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,Humans
8432,DB03147,Flavin adenine dinucleotide,['approved'],BE0002364,NADPH--cytochrome P450 reductase,POR,Humans
8433,DB03147,Flavin adenine dinucleotide,['approved'],BE0001921,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,Humans
8434,DB03147,Flavin adenine dinucleotide,['approved'],BE0001745,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,Humans
8435,DB03147,Flavin adenine dinucleotide,['approved'],BE0004141,D-amino-acid oxidase,DAO,Humans
8438,DB03147,Flavin adenine dinucleotide,['approved'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
8439,DB03147,Flavin adenine dinucleotide,['approved'],BE0000762,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,Humans
8440,DB03147,Flavin adenine dinucleotide,['approved'],BE0004566,L-amino-acid oxidase,IL4I1,Humans
8459,DB03147,Flavin adenine dinucleotide,['approved'],BE0000737,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,Humans
8461,DB03147,Flavin adenine dinucleotide,['approved'],BE0004507,NADH-cytochrome b5 reductase 1,CYB5R1,Humans
8463,DB03147,Flavin adenine dinucleotide,['approved'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
8464,DB03147,Flavin adenine dinucleotide,['approved'],BE0004480,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,Humans
8465,DB03147,Flavin adenine dinucleotide,['approved'],BE0004135,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,Humans
8467,DB03147,Flavin adenine dinucleotide,['approved'],BE0004580,FAD-linked sulfhydryl oxidase ALR,GFER,Humans
8494,DB03150,"2',3'-Dideoxythymidine-5'-Monophosphate",['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
8502,DB03152,B-2-Octylglucoside,['experimental'],BE0001200,Rhodopsin,RHO,Humans
8503,DB03152,B-2-Octylglucoside,['experimental'],BE0001273,Protein-glutamine gamma-glutamyltransferase E,TGM3,Humans
8506,DB03153,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",['experimental'],BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,Humans
8507,DB03154,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
8508,DB03155,2'-fluoro-2'-deoxyuridine 3'-monophosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
8513,DB03158,"D-Myo-Inositol-1,4-Bisphosphate",['experimental'],BE0004437,"Type II inositol 1,4,5-trisphosphate 5-phosphatase",INPP5B,Humans
8514,DB03159,CRA_8696,['experimental'],BE0000048,Prothrombin,F2,Humans
8515,DB03159,CRA_8696,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8516,DB03159,CRA_8696,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
8524,DB03169,(S)-Hmg-Coa,['experimental'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
8532,DB03173,CRA_10433,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8534,DB03175,Propyl alcohol,['approved'],BE0003751,Lysozyme C,LYZ,Humans
8535,DB03176,KB-141,['experimental'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
8536,DB03176,KB-141,['experimental'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
8539,DB03179,Sinapoyl coenzyme A,['experimental'],BE0004586,Catechol O-methyltransferase domain-containing protein 1,COMTD1,Humans
8541,DB03181,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",['experimental'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
8542,DB03182,alpha-Fluoro-carboxymethyldethia coenzyme A complex,['experimental'],BE0004459,"Citrate synthase, mitochondrial",CS,Humans
8543,DB03183,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
8544,DB03185,"1-Beta-Ribofuranosyl-1,3-Diazepinone",['experimental'],BE0002443,Cytidine deaminase,CDA,Humans
8545,DB03186,Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate],['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
8546,DB03187,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,['experimental'],BE0002302,"Glycine cleavage system H protein, mitochondrial",GCSH,Humans
8547,DB03189,Cu-Cyclam,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
8549,DB03191,3-Oxiran-2ylalanine,['experimental'],BE0000407,S-adenosylmethionine synthase isoform type-1,MAT1A,Humans
8550,DB03192,(R)-3-hydroxydecanoyl-CoA,['experimental'],BE0000408,Peroxisomal multifunctional enzyme type 2,HSD17B4,Humans
8551,DB03193,Stearic acid,"['approved', 'experimental']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
8552,DB03193,Stearic acid,"['approved', 'experimental']",BE0004022,Group IID secretory phospholipase A2,PLA2G2D,Humans
8553,DB03194,Methyl beta-L-fucopyranoside,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
8554,DB03195,3'-Fluoro-3'-deoxythymidine 5'-monophosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
8560,DB03201,D-Cysteine,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
8561,DB03202,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
8566,DB03203,Sphingosine,['experimental'],BE0004247,Poliovirus receptor,PVR,Humans
8567,DB03203,Sphingosine,['experimental'],BE0001854,Glycolipid transfer protein,GLTP,Humans
8575,DB03206,Duvoglustat,['investigational'],BE0001414,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,Humans
8578,DB03207,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
8582,DB03213,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8583,DB03214,Vinylglycine,['experimental'],BE0004566,L-amino-acid oxidase,IL4I1,Humans
8584,DB03214,Vinylglycine,['experimental'],BE0003515,1-aminocyclopropane-1-carboxylate synthase-like protein 1,ACCS,Humans
8586,DB03216,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",['experimental'],BE0001684,Adenosylhomocysteinase,AHCY,Humans
8587,DB03217,DPI59,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8588,DB03218,N-acetyl-N'-beta-D-glucopyranosyl urea,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8590,DB03220,FR-234938,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
8591,DB03221,AL7099A,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8596,DB03222,dATP,['experimental'],BE0000113,DNA polymerase beta,POLB,Humans
8598,DB03223,Diphthamide,['experimental'],BE0004281,Elongation factor 2,EEF2,Humans
8600,DB03225,D-Tryptophan,['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
8601,DB03226,Trifluoroethanol,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
8602,DB03226,Trifluoroethanol,['experimental'],BE0001076,GTPase HRas,HRAS,Humans
8604,DB03227,Nicotinamide Mononucleotide,['experimental'],BE0001241,ADP-ribosyl cyclase 2,BST1,Humans
8605,DB03227,Nicotinamide Mononucleotide,['experimental'],BE0001809,Nicotinamide mononucleotide adenylyltransferase 1,NMNAT1,Humans
8606,DB03227,Nicotinamide Mononucleotide,['experimental'],BE0001832,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,Humans
8614,DB03233,3'-deoxy-3'-aminothymidine monophosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
8619,DB03240,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
8622,DB03243,4-Fluorobenzylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8623,DB03245,S-4-Nitrobutyryl-CoA,['experimental'],BE0001921,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,Humans
8625,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000595,Flavin reductase (NADPH),BLVRB,Humans
8626,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
8627,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000181,Pyridoxine-5'-phosphate oxidase,PNPO,Humans
8629,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000370,Riboflavin kinase,RFK,Humans
8631,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
8633,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
8634,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
8657,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0004105,Serine/threonine-protein kinase Sgk1,SGK1,Humans
8666,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0004614,Ribosomal protein S6 kinase alpha-4,RPS6KA4,Humans
8668,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0004577,Hydroxyacid oxidase 2,HAO2,Humans
8675,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0002364,NADPH--cytochrome P450 reductase,POR,Humans
8676,DB03247,Flavin mononucleotide,"['approved', 'investigational']",BE0003043,Phosphopantothenoylcysteine decarboxylase,PPCDC,Humans
8680,DB03250,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8681,DB03251,RWJ-51084,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8684,DB03253,(2s)-Pyrrolidin-2-Ylmethylamine,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
8686,DB03255,Phenol,"['approved', 'experimental']",BE0000530,Serum albumin,ALB,Humans
8691,DB03256,(6R)-Folinic acid,['experimental'],BE0000822,Formimidoyltransferase-cyclodeaminase,FTCD,Humans
8700,DB03262,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8703,DB03267,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,['experimental'],BE0000906,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,Humans
8704,DB03268,RU82197,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8705,DB03270,"2,6-Difluorobenzenesulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8706,DB03273,3'-Oxo-Adenosine,['experimental'],BE0001684,Adenosylhomocysteinase,AHCY,Humans
8708,DB03276,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",['experimental'],BE0000917,Growth factor receptor-bound protein 2,GRB2,Humans
8709,DB03277,alpha-maltotriose,['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
8712,DB03279,Dodecyl-Alpha-D-Maltoside,['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
8715,DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
8718,DB03283,beta-L-fucose,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
8721,DB03286,C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8725,DB03292,3-Phosphono-D-alanine,['experimental'],BE0004590,Phosphoserine phosphatase,PSPH,Humans
8726,DB03294,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8728,DB03297,Benzylsulfonic acid,['experimental'],BE0001038,Chymase,CMA1,Humans
8731,DB03297,Benzylsulfonic acid,['experimental'],BE0004453,"Superoxide dismutase [Mn], mitochondrial",SOD2,Humans
8732,DB03297,Benzylsulfonic acid,['experimental'],BE0002128,Serine protease hepsin,HPN,Humans
8735,DB03298,Phenylphosphate,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8740,DB03305,N(G)-Iminoethylornithine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8741,DB03306,RU78300,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
8742,DB03307,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8744,DB03309,N-cyclohexyltaurine,['experimental'],BE0001264,Sulfotransferase family cytosolic 2B member 1,SULT2B1,Humans
8746,DB03309,N-cyclohexyltaurine,['experimental'],BE0004484,Homeobox protein engrailed-2,EN2,Humans
8751,DB03310,Glutathione disulfide,"['approved', 'experimental', 'investigational']",BE0002282,Microsomal glutathione S-transferase 1,MGST1,Humans
8752,DB03310,Glutathione disulfide,"['approved', 'experimental', 'investigational']",BE0010006,Glutathione S-transferases (Cytosolic),GSTA1,Humans
8753,DB03310,Glutathione disulfide,"['approved', 'experimental', 'investigational']",BE0001189,Glutathione S-transferase Mu 2,GSTM2,Humans
8754,DB03310,Glutathione disulfide,"['approved', 'experimental', 'investigational']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
8755,DB03311,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
8756,DB03312,Brivudine,"['approved', 'investigational']",BE0004639,"Thymidine kinase 2, mitochondrial",TK2,Humans
8765,DB03314,5-fluorotryptophan,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
8766,DB03314,5-fluorotryptophan,['experimental'],BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
8770,DB03316,"1,4-Dioxane",['experimental'],BE0000999,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,Humans
8771,DB03316,"1,4-Dioxane",['experimental'],BE0004452,Epsin-1,EPN1,Humans
8773,DB03316,"1,4-Dioxane",['experimental'],BE0004506,Transforming growth factor beta-3,TGFB3,Humans
8780,DB03317,Ferroheme C,['experimental'],BE0001009,Cytochrome c,CYCS,Humans
8790,DB03317,Ferroheme C,['experimental'],BE0002793,Cytochrome P450 2C9,CYP2C9,Humans
8797,DB03319,"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
8801,DB03323,Maltose,"['experimental', 'investigational']",BE0004457,Alpha-amylase 2B,AMY2B,Humans
8810,DB03326,"Deoxycytidylyl-3',5'-guanosine",['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
8812,DB03328,Dioxo(sulfanyl)molybdenum,['experimental'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
8813,DB03329,2-Pyridinethiol,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
8814,DB03330,S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione,['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
8815,DB03331,"N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine",['experimental'],BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
8816,DB03332,"5,6-Cyclic-Tetrahydropteridine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
8817,DB03333,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8819,DB03336,BIA,['experimental'],BE0002089,Catechol O-methyltransferase,COMT,Humans
8820,DB03337,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8821,DB03338,Heptyl glucoside,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
8822,DB03338,Heptyl glucoside,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
8824,DB03341,CoA-S-acetyl 5-bromotryptamine,['experimental'],BE0004584,Serotonin N-acetyltransferase,AANAT,Humans
8827,DB03344,"Inositol-(1,3,4,5,6)-Pentakisphosphate",['experimental'],BE0004433,Cytohesin-3,CYTH3,Humans
8829,DB03345,Mercaptoethanol,['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
8830,DB03345,Mercaptoethanol,['experimental'],BE0000181,Pyridoxine-5'-phosphate oxidase,PNPO,Humans
8832,DB03345,Mercaptoethanol,['experimental'],BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
8834,DB03345,Mercaptoethanol,['experimental'],BE0004493,Galectin-1,LGALS1,Humans
8836,DB03345,Mercaptoethanol,['experimental'],BE0004637,Polycomb protein SCMH1,SCMH1,Humans
8838,DB03346,"3,3',5,5'-tetrachlorobiphenyl-4,4'-diol",['experimental'],BE0000951,Estrogen sulfotransferase,SULT1E1,Humans
8840,DB03347,Triethyl phosphate,['experimental'],BE0003380,Cellular tumor antigen p53,TP53,Humans
8842,DB03348,Huperzine B,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
8843,DB03349,8-Bromo-Adenosine-5'-Monophosphate,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
8844,DB03349,8-Bromo-Adenosine-5'-Monophosphate,['experimental'],BE0001473,Histidine triad nucleotide-binding protein 1,HINT1,Humans
8847,DB03351,Sri-9439,['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
8852,DB03354,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8857,DB03359,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
8862,DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8865,DB03366,Imidazole,"['experimental', 'investigational']",BE0004467,Myoglobin,MB,Humans
8866,DB03366,Imidazole,"['experimental', 'investigational']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
8867,DB03366,Imidazole,"['experimental', 'investigational']",BE0004477,"Adenylate kinase 2, mitochondrial",AK2,Humans
8868,DB03366,Imidazole,"['experimental', 'investigational']",BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
8871,DB03366,Imidazole,"['experimental', 'investigational']",BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
8872,DB03366,Imidazole,"['experimental', 'investigational']",BE0002652,Gephyrin,GPHN,Humans
8875,DB03366,Imidazole,"['experimental', 'investigational']",BE0001009,Cytochrome c,CYCS,Humans
8881,DB03366,Imidazole,"['experimental', 'investigational']",BE0004532,Unconventional myosin-Ie,MYO1E,Humans
8882,DB03366,Imidazole,"['experimental', 'investigational']",BE0004447,Meiotic recombination protein DMC1/LIM15 homolog,DMC1,Humans
8889,DB03367,PF-00356231,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
8890,DB03368,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
8892,DB03370,FR239087,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
8894,DB03372,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",['experimental'],BE0001029,Interleukin-2,IL2,Humans
8895,DB03373,ZK-806711,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8896,DB03374,"3,5-Diiodotyrosine",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
8897,DB03374,"3,5-Diiodotyrosine",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
8899,DB03374,"3,5-Diiodotyrosine",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8901,DB03374,"3,5-Diiodotyrosine",['experimental'],BE0004373,Iodotyrosine dehalogenase 1,IYD,Humans
8902,DB03376,5'-O-(N-(Alanyl)sulfamoyl)adenosine,['experimental'],BE0000188,Bifunctional glutamate/proline--tRNA ligase,EPRS,Humans
8903,DB03379,2-Carboxyethylphosphonic Acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
8904,DB03380,L-tyrosinamide,['experimental'],BE0003476,Pro-neuropeptide Y,NPY,Humans
8905,DB03380,L-tyrosinamide,['experimental'],BE0004370,Valacyclovir hydrolase,BPHL,Humans
8906,DB03381,Hexadecanal,['experimental'],BE0001200,Rhodopsin,RHO,Humans
8907,DB03381,Hexadecanal,['experimental'],BE0004476,Acyl-CoA-binding protein,DBI,Humans
8909,DB03382,S-oxy-L-cysteine,['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
8913,DB03382,S-oxy-L-cysteine,['experimental'],BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
8915,DB03383,CP-320626,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8916,DB03384,Fica,['experimental'],BE0001826,Caspase-7,CASP7,Humans
8917,DB03385,4-Methylimidazole,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
8918,DB03385,4-Methylimidazole,['experimental'],BE0004467,Myoglobin,MB,Humans
8919,DB03385,4-Methylimidazole,['experimental'],BE0003626,"Carbonic anhydrase 5A, mitochondrial",CA5A,Humans
8935,DB03389,alpha-D-Xylopyranose,['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
8937,DB03390,"(2R,3R)-2,3-Dihydroxy-4-oxo-4-(propylamino)butanoic acid",['experimental'],BE0001102,Prostatic acid phosphatase,ACPP,Humans
8938,DB03392,"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
8939,DB03393,Sanglifehrin A,['experimental'],BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
8940,DB03394,Heptaethylene glycol,['experimental'],BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
8941,DB03395,Enalkiren,['experimental'],BE0000270,Renin,REN,Humans
8942,DB03396,"(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
8943,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,['experimental'],BE0001429,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,Humans
8945,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
8947,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,['experimental'],BE0004629,Exostosin-like 2,EXTL2,Humans
8948,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,['experimental'],BE0004519,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",MGAT1,Humans
8951,DB03399,Ethyl Isocyanide,['experimental'],BE0004467,Myoglobin,MB,Humans
8953,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0002654,Cytohesin-2,CYTH2,Humans
8954,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0004452,Epsin-1,EPN1,Humans
8955,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0004490,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,Humans
8956,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0004516,Radixin,RDX,Humans
8957,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0004593,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,Humans
8958,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0004522,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,Humans
8959,DB03401,"1D-myo-inositol 1,4,5-trisphosphate",['experimental'],BE0001627,Inositol-trisphosphate 3-kinase A,ITPKA,Humans
8960,DB03403,Cytidine-5'-Monophosphate,['experimental'],BE0001480,Uridine-cytidine kinase 2,UCK2,Humans
8964,DB03403,Cytidine-5'-Monophosphate,['experimental'],BE0000637,UMP-CMP kinase,CMPK1,Humans
8969,DB03405,N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
8970,DB03408,gamma-Glutamylcysteine,['experimental'],BE0000185,Glutathione synthetase,GSS,Humans
8974,DB03413,Deoxyuridine-5'-Diphosphate,['experimental'],BE0001205,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,Humans
8979,DB03414,5-Thio-a/B-D-Mannopyranosylamine,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
8980,DB03415,3-thiaoctanoyl-CoA,['experimental'],BE0001745,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,Humans
8982,DB03417,"(2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
8983,DB03419,Uracil,"['experimental', 'investigational']",BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
8984,DB03419,Uracil,"['experimental', 'investigational']",BE0004582,Uridine-cytidine kinase-like 1,UCKL1,Humans
8994,DB03424,Ubenimex,['investigational'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
8995,DB03425,"2s,4r-4-Methylglutamate",['experimental'],BE0000826,"Glutamate receptor ionotropic, kainate 2",GRIK2,Humans
8996,DB03428,SU9516,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
8997,DB03428,SU9516,['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
8998,DB03428,SU9516,['experimental'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
8999,DB03429,Tetrastearoyl cardiolipin,['experimental'],BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
9000,DB03430,(S)-4-hydroxymandelonitrile,['experimental'],BE0004111,Lactase-like protein,LCTL,Humans
9004,DB03434,3-(N-morpholino)propanesulfonic acid,['experimental'],BE0001926,Granulysin,GNLY,Humans
9006,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
9009,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0001242,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,Humans
9011,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0004629,Exostosin-like 2,EXTL2,Humans
9012,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0004501,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,Humans
9014,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0000637,UMP-CMP kinase,CMPK1,Humans
9017,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0001872,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,Humans
9019,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0004498,Glycogenin-1,GYG1,Humans
9020,DB03435,Uridine-5'-Diphosphate,['experimental'],BE0010169,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,Humans
9023,DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",['experimental'],BE0001671,Alpha-amylase 1,AMY1A,Humans
9024,DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
9026,DB03441,2-Benzyl-3-Iodopropanoic Acid,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
9027,DB03442,Acid yellow 54 free acid,['experimental'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
9028,DB03443,bis(5-amidino-benzimidazolyl)methanone zinc,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9029,DB03444,6-bromoindirubin-3'-oxime,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
9032,DB03447,Uridylyl-2'-5'-phospho-adenosine,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9033,DB03448,2'-Deoxyuridine 3'-Monophosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9034,DB03448,2'-Deoxyuridine 3'-Monophosphate,['experimental'],BE0001924,Ribonuclease 4,RNASE4,Humans
9035,DB03449,N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
9036,DB03449,N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
9039,DB03451,Lexacalcitol,['experimental'],BE0000779,Vitamin D3 receptor,VDR,Humans
9041,DB03453,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,['experimental'],BE0001029,Interleukin-2,IL2,Humans
9043,DB03455,(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,['experimental'],BE0001029,Interleukin-2,IL2,Humans
9044,DB03456,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
9046,DB03459,Sparfosic acid,['experimental'],BE0002227,CAD protein,CAD,Humans
9048,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
9050,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000622,Aldo-keto reductase family 1 member C2,AKR1C2,Humans
9051,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
9052,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000008,"NAD(P) transhydrogenase, mitochondrial",NNT,Humans
9053,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
9054,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000909,Sepiapterin reductase,SPR,Humans
9056,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000869,L-xylulose reductase,DCXR,Humans
9057,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,Humans
9058,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
9059,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
9060,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0001089,Glucose-6-phosphate 1-dehydrogenase,G6PD,Humans
9061,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
9063,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,Humans
9064,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
9065,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000595,Flavin reductase (NADPH),BLVRB,Humans
9068,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0001185,Quinone oxidoreductase,CRYZ,Humans
9069,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
9070,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
9071,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0002364,NADPH--cytochrome P450 reductase,POR,Humans
9077,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000604,NADP-dependent malic enzyme,ME1,Humans
9081,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0003011,Dehydrogenase/reductase SDR family member 11,DHRS11,Humans
9082,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000589,"Malate dehydrogenase, cytoplasmic",MDH1,Humans
9085,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0000578,Estradiol 17-beta-dehydrogenase 8,HSD17B8,Humans
9086,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0004352,Alcohol dehydrogenase [NADP(+)],AKR1A1,Humans
9088,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0003119,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,Humans
9095,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0004480,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,Humans
9100,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0003795,Prostaglandin reductase 1,PTGR1,Humans
9102,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
9105,DB03461,Nicotinamide adenine dinucleotide phosphate,['experimental'],BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,Humans
9110,DB03466,BMS184394,['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
9112,DB03467,Naringenin,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
9113,DB03467,Naringenin,['experimental'],BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
9114,DB03467,Naringenin,['experimental'],BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
9115,DB03467,Naringenin,['experimental'],BE0009091,KAT8 regulatory NSL complex subunit 3,KANSL3,Humans
9116,DB03467,Naringenin,['experimental'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
9117,DB03467,Naringenin,['experimental'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
9118,DB03467,Naringenin,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
9119,DB03468,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
9123,DB03471,6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
9128,DB03476,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
9129,DB03477,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
9130,DB03478,2'-O-Acetyl Adenosine-5-Diphosphoribose,['experimental'],BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,Humans
9131,DB03479,"8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9132,DB03480,Brequinar Analog,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
9135,DB03483,(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9136,DB03484,sn-glycero-3-phosphoethanolamine,['experimental'],BE0004149,Annexin A5,ANXA5,Humans
9137,DB03485,alpha-D-Fucopyranose,['experimental'],BE0000994,Lactotransferrin,LTF,Humans
9139,DB03486,Phosphomethylphosphonic acid guanosyl ester,['experimental'],BE0001746,Soluble calcium-activated nucleotidase 1,CANT1,Humans
9140,DB03487,(S)-Aspartimide,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
9144,DB03490,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9145,DB03491,2'-Deoxyguanosine-5'-Diphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
9148,DB03495,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
9149,DB03496,Alvocidib,"['experimental', 'investigational']",BE0002150,"Glycogen phosphorylase, brain form",PYGB,Humans
9151,DB03496,Alvocidib,"['experimental', 'investigational']",BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9152,DB03496,Alvocidib,"['experimental', 'investigational']",BE0001913,Cyclin-dependent kinase 7,CDK7,Humans
9153,DB03496,Alvocidib,"['experimental', 'investigational']",BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
9154,DB03496,Alvocidib,"['experimental', 'investigational']",BE0002207,Cyclin-dependent kinase 9,CDK9,Humans
9155,DB03496,Alvocidib,"['experimental', 'investigational']",BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
9156,DB03496,Alvocidib,"['experimental', 'investigational']",BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
9157,DB03496,Alvocidib,"['experimental', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
9158,DB03496,Alvocidib,"['experimental', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
9159,DB03496,Alvocidib,"['experimental', 'investigational']",BE0002224,Cyclin-dependent kinase 8,CDK8,Humans
9160,DB03496,Alvocidib,"['experimental', 'investigational']",BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9162,DB03499,D-Malic acid,['experimental'],BE0000148,"NAD-dependent malic enzyme, mitochondrial",ME2,Humans
9163,DB03499,D-Malic acid,['experimental'],BE0004459,"Citrate synthase, mitochondrial",CS,Humans
9169,DB03501,Galactose-uridine-5'-diphosphate,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
9170,DB03501,Galactose-uridine-5'-diphosphate,['experimental'],BE0001521,UDP-glucose 4-epimerase,GALE,Humans
9171,DB03501,Galactose-uridine-5'-diphosphate,['experimental'],BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
9172,DB03501,Galactose-uridine-5'-diphosphate,['experimental'],BE0010169,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,Humans
9175,DB03504,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
9177,DB03506,"5H-pyrrolo[3,2-d]pyrimidin-4-amine",['experimental'],BE0000115,Adenine phosphoribosyltransferase,APRT,Humans
9178,DB03507,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",['experimental'],BE0001139,Tumor necrosis factor receptor superfamily member 1A,TNFRSF1A,Humans
9179,DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
9180,DB03510,6-O-Phosphoryl Inosine Monophosphate,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
9182,DB03512,"Uridine-2',3'-vanadate",['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9185,DB03516,Eniluracil,['investigational'],BE0003539,Aldehyde oxidase,AOX1,Humans
9186,DB03516,Eniluracil,['investigational'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
9187,DB03516,Eniluracil,['investigational'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
9191,DB03523,Brequinar,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
9193,DB03525,RU79073,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9194,DB03526,AL5927,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9198,DB03531,Flavin-adenine dinucleotide-N5-isobutyl ketone,['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
9202,DB03535,Z-Pro-Prolinal,['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
9204,DB03536,Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
9206,DB03539,2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,['experimental'],BE0001058,Chitotriosidase-1,CHIT1,Humans
9208,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",['experimental'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
9209,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
9210,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",['experimental'],BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,Humans
9214,DB03542,L-Myo-Inositol-1-Phosphate,['experimental'],BE0001152,Inositol monophosphatase 1,IMPA1,Humans
9219,DB03546,"N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid",['experimental'],BE0000882,Trifunctional purine biosynthetic protein adenosine-3,GART,Humans
9222,DB03551,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
9224,DB03552,3-Tyrosine,['experimental'],BE0000614,Tyrosine 3-monooxygenase,TH,Humans
9228,DB03554,5-Iodouracil,['experimental'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
9229,DB03555,CRA_11092,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9230,DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",['experimental'],BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
9232,DB03557,4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[[2-[4-[difluoro(phosphono)methyl]phenyl]acetyl]amino]-4-oxobutanoic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9234,DB03559,Cyclohexylformamide,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
9235,DB03559,Cyclohexylformamide,['experimental'],BE0000360,Alcohol dehydrogenase 4,ADH4,Humans
9239,DB03565,1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
9240,DB03566,Spermidine,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
9241,DB03566,Spermidine,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
9242,DB03566,Spermidine,['experimental'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
9246,DB03568,Butyric Acid,"['experimental', 'investigational']",BE0002180,Cholinesterase,BCHE,Humans
9253,DB03572,FR230513,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
9254,DB03573,WRR-99,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
9257,DB03575,Phencyclidine,['illicit'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
9258,DB03575,Phencyclidine,['illicit'],BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
9260,DB03577,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,['experimental'],BE0001102,Prostatic acid phosphatase,ACPP,Humans
9262,DB03581,Glucose-6-Phosphate,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
9264,DB03583,"(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9269,DB03585,Oxyphenbutazone,"['approved', 'withdrawn']",BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
9271,DB03587,Pyruvaldehyde,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
9272,DB03588,Diphenylacetic acid,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
9273,DB03589,Mesoxalic acid,['experimental'],BE0000148,"NAD-dependent malic enzyme, mitochondrial",ME2,Humans
9276,DB03591,RU82209,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9279,DB03593,7-methyl-5'-guanylic acid,['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
9280,DB03594,"1,2,4-Triazole",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9281,DB03595,CRA_9785,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9282,DB03596,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9283,DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,['experimental'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
9284,DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,['experimental'],BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
9285,DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,['experimental'],BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,Humans
9286,DB03598,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9287,DB03600,Capric acid,['experimental'],BE0002397,Furin,FURIN,Humans
9289,DB03600,Capric acid,['experimental'],BE0001854,Glycolipid transfer protein,GLTP,Humans
9292,DB03600,Capric acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
9294,DB03602,S-benzylglutathione,['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
9295,DB03602,S-benzylglutathione,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
9297,DB03604,Tiratricol,['investigational'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
9299,DB03606,(S)-Rolipram,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
9300,DB03606,(S)-Rolipram,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
9303,DB03608,Diminazene,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9304,DB03608,Diminazene,['experimental'],BE0000351,Amiloride-sensitive amine oxidase [copper-containing],AOC1,Humans
9305,DB03608,Diminazene,['experimental'],BE0000907,"Peroxiredoxin-5, mitochondrial",PRDX5,Humans
9306,DB03609,3'-deoxyguanosine,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
9307,DB03611,L-2-amino-4-methoxy-cis-but-3-enoic acid,['experimental'],BE0000407,S-adenosylmethionine synthase isoform type-1,MAT1A,Humans
9308,DB03612,3-Hydroxybutyryl-Coenzyme A,['experimental'],BE0000377,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,Humans
9311,DB03614,Mecobalamin,"['approved', 'investigational']",BE0000734,Methionine synthase,MTR,Humans
9312,DB03615,Ribostamycin,"['approved', 'experimental']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
9316,DB03616,Kabiramide C,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
9319,DB03619,Deoxycholic acid,['approved'],BE0004053,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,Humans
9325,DB03619,Deoxycholic acid,['approved'],BE0001777,Bile acid receptor,NR1H4,Humans
9326,DB03619,Deoxycholic acid,['approved'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
9327,DB03619,Deoxycholic acid,['approved'],BE0005788,G-protein coupled bile acid receptor 1,GPBAR1,Humans
9328,DB03619,Deoxycholic acid,['approved'],BE0010006,Glutathione S-transferases (Cytosolic),GSTA1,Humans
9329,DB03621,"L-709,587",['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
9330,DB03622,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
9331,DB03623,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
9333,DB03626,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
9335,DB03628,ISO24,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9338,DB03632,Argifin,['experimental'],BE0001058,Chitotriosidase-1,CHIT1,Humans
9340,DB03633,Lpc-Ether,['experimental'],BE0001432,Ganglioside GM2 activator,GM2A,Humans
9341,DB03633,Lpc-Ether,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
9342,DB03635,Ethanesulfonic acid,['experimental'],BE0000946,Platelet basic protein,PPBP,Humans
9344,DB03636,Glycinamide,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
9345,DB03637,Guanidine-3-propanol,['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
9346,DB03639,1-Guanidinium-7-Aminoheptane,['experimental'],BE0001149,Deoxyhypusine synthase,DHPS,Humans
9349,DB03642,N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
9350,DB03643,CRA_1144,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9351,DB03643,CRA_1144,['experimental'],BE0002128,Serine protease hepsin,HPN,Humans
9353,DB03645,Phosphonoacetohydroxamic Acid,['experimental'],BE0004460,Beta-enolase,ENO3,Humans
9357,DB03650,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
9363,DB03657,1-deoxy-1-methoxycarbamido-beta-D-glucopyranose,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9366,DB03660,4-Iodo-L-phenylalanine,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
9371,DB03661,L-cysteic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9375,DB03661,L-cysteic acid,['experimental'],BE0001705,M-phase inducer phosphatase 2,CDC25B,Humans
9378,DB03661,L-cysteic acid,['experimental'],BE0002135,Cathepsin L1,CTSL,Humans
9382,DB03661,L-cysteic acid,['experimental'],BE0003142,Golgi-associated plant pathogenesis-related protein 1,GLIPR2,Humans
9386,DB03663,"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9387,DB03664,P1-(adenosine-5'-P5-(uridine-5')pentaphosphate,['experimental'],BE0000637,UMP-CMP kinase,CMPK1,Humans
9388,DB03666,Zidovudine monophosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
9390,DB03667,Acetic Acid Salicyloyl-Amino-Ester,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
9393,DB03670,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9394,DB03672,9-N-Phenylmethylamino-Tacrine,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
9395,DB03673,beta-2-Thienyl-L-alanine,['experimental'],BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
9398,DB03677,N-Cyclohexyl-N'-Decylurea,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
9400,DB03680,Tartronate,['experimental'],BE0000148,"NAD-dependent malic enzyme, mitochondrial",ME2,Humans
9401,DB03680,Tartronate,['experimental'],BE0000328,"NADP-dependent malic enzyme, mitochondrial",ME3,Humans
9402,DB03683,2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,['experimental'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
9403,DB03685,Uridine monophosphate,['experimental'],BE0004582,Uridine-cytidine kinase-like 1,UCKL1,Humans
9406,DB03685,Uridine monophosphate,['experimental'],BE0004501,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,Humans
9407,DB03685,Uridine monophosphate,['experimental'],BE0004434,U6 snRNA-associated Sm-like protein LSm6,LSM6,Humans
9409,DB03685,Uridine monophosphate,['experimental'],BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
9410,DB03685,Uridine monophosphate,['experimental'],BE0001938,Interferon-stimulated gene 20 kDa protein,ISG20,Humans
9416,DB03686,S-(4-nitrobenzyl)glutathione,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
9421,DB03690,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",['experimental'],BE0001505,Phosphatidylinositol transfer protein alpha isoform,PITPNA,Humans
9422,DB03691,WRR-112,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
9425,DB03693,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,['experimental'],BE0003334,Casein kinase I isoform gamma-2,CSNK1G2,Humans
9426,DB03695,Piritrexim,['investigational'],BE0000330,Dihydrofolate reductase,DHFR,Humans
9427,DB03696,Lanosterol,['experimental'],BE0001466,Lanosterol synthase,LSS,Humans
9428,DB03697,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9432,DB03701,Vanoxerine,['investigational'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
9433,DB03701,Vanoxerine,['investigational'],BE0009629,HERG human cardiac K+ channel,KCNH2,Humans
9434,DB03702,"N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
9435,DB03703,Cyclohexanol,['experimental'],BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
9436,DB03704,12-Hydroxydodecanoic Acid,['experimental'],BE0000009,Alcohol dehydrogenase class-3,ADH5,Humans
9438,DB03706,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane,['experimental'],BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
9439,DB03707,S-Ethyl-N-Phenyl-Isothiourea,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9440,DB03707,S-Ethyl-N-Phenyl-Isothiourea,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
9441,DB03708,Adenosine 5'-phosphosulfate,"['experimental', 'investigational']",BE0003094,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,Humans
9443,DB03709,Bicine,['experimental'],BE0000211,Plasminogen,PLG,Humans
9446,DB03710,[(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
9447,DB03711,6-Hydroxy-6-Methyl-Heptan-3-One,['experimental'],BE0004320,Epididymal-specific lipocalin-9,LCN9,Humans
9448,DB03712,RU85053,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9449,DB03714,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9452,DB03719,N-Ethyl-5'-Carboxamido Adenosine,['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
9457,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0001159,P-selectin,SELP,Humans
9458,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
9459,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0001074,E-selectin,SELE,Humans
9460,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0000912,Lithostathine-1-alpha,REG1A,Humans
9466,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0004592,Sialoadhesin,SIGLEC1,Humans
9467,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0002857,Zinc-alpha-2-glycoprotein,AZGP1,Humans
9470,DB03721,N-acetyl-alpha-neuraminic acid,['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
9471,DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
9474,DB03725,5'-Guanylylmethylenebisphosphonate,['experimental'],BE0000906,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,Humans
9475,DB03726,Purine Riboside-5'-Monophosphate,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9476,DB03727,Coproporphyrin I,['experimental'],BE0001629,Uroporphyrinogen decarboxylase,UROD,Humans
9478,DB03729,2-Amino-1H-benzimidazol-5-ol,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
9480,DB03731,S-2-(Boronoethyl)-L-Cysteine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
9481,DB03731,S-2-(Boronoethyl)-L-Cysteine,['experimental'],BE0000758,"Arginase-2, mitochondrial",ARG2,Humans
9482,DB03732,Etheno-Nadp,['experimental'],BE0001241,ADP-ribosyl cyclase 2,BST1,Humans
9486,DB03736,2-Cyclopropylmethylenepropanal,['experimental'],BE0000270,Renin,REN,Humans
9487,DB03737,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9488,DB03738,Pantothenoylaminoethenethiol,['experimental'],BE0003043,Phosphopantothenoylcysteine decarboxylase,PPCDC,Humans
9490,DB03740,N-acetyl-alpha-D-glucosamine,['experimental'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
9491,DB03740,N-acetyl-alpha-D-glucosamine,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
9492,DB03740,N-acetyl-alpha-D-glucosamine,['experimental'],BE0000978,Glucosylceramidase,GBA,Humans
9494,DB03740,N-acetyl-alpha-D-glucosamine,['experimental'],BE0001648,Sialic acid-binding Ig-like lectin 7,SIGLEC7,Humans
9498,DB03740,N-acetyl-alpha-D-glucosamine,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
9500,DB03742,Compound 4-D,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
9505,DB03747,N-Acetyl-glucosamine thiazoline,['experimental'],BE0001153,Beta-hexosaminidase subunit beta,HEXB,Humans
9508,DB03749,"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
9517,DB03752,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
9518,DB03753,Flurbiprofen Methyl Ester,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
9519,DB03754,Tromethamine,['approved'],BE0003392,Amyloid beta A4 protein,APP,Humans
9521,DB03756,Doconexent,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
9522,DB03756,Doconexent,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
9523,DB03756,Doconexent,"['approved', 'investigational']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
9524,DB03756,Doconexent,"['approved', 'investigational']",BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
9525,DB03756,Doconexent,"['approved', 'investigational']",BE0000707,Retinoic acid receptor RXR-gamma,RXRG,Humans
9526,DB03756,Doconexent,"['approved', 'investigational']",BE0005540,Sterol regulatory element-binding protein 1,SREBF1,Humans
9527,DB03756,Doconexent,"['approved', 'investigational']",BE0004689,Myc proto-oncogene protein,MYC,Humans
9528,DB03757,N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
9529,DB03758,Radicicol,['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
9530,DB03758,Radicicol,['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
9531,DB03758,Radicicol,['experimental'],BE0000065,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,Humans
9532,DB03758,Radicicol,['experimental'],BE0004330,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",PDK3,Humans
9534,DB03759,FG-9041,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
9535,DB03760,Dihydrolipoic Acid,['experimental'],BE0002302,"Glycine cleavage system H protein, mitochondrial",GCSH,Humans
9536,DB03760,Dihydrolipoic Acid,['experimental'],BE0000065,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,Humans
9537,DB03760,Dihydrolipoic Acid,['experimental'],BE0004330,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",PDK3,Humans
9544,DB03765,2'-cytidylic acid,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9546,DB03766,Propanoic acid,"['approved', 'vet_approved']",BE0002652,Gephyrin,GPHN,Humans
9548,DB03767,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
9550,DB03769,D-Eritadenine,['experimental'],BE0001684,Adenosylhomocysteinase,AHCY,Humans
9552,DB03772,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
9553,DB03773,alpha-D-quinovopyranose,['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
9561,DB03777,Bisindolylmaleimide I,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
9562,DB03777,Bisindolylmaleimide I,['experimental'],BE0003889,Protein kinase C iota type,PRKCI,Humans
9563,DB03777,Bisindolylmaleimide I,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
9566,DB03781,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",['experimental'],BE0000702,Acetyl-CoA carboxylase 2,ACACB,Humans
9567,DB03782,N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
9568,DB03783,Phenacetin,['withdrawn'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
9569,DB03784,Elaidamide,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
9572,DB03788,GC-24,['experimental'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
9574,DB03791,GW-3965,['experimental'],BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
9575,DB03792,5-Aminouracil,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9576,DB03793,Benzoic acid,"['approved', 'investigational']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
9578,DB03793,Benzoic acid,"['approved', 'investigational']",BE0004141,D-amino-acid oxidase,DAO,Humans
9586,DB03796,Palmitic Acid,['approved'],BE0003601,Alpha-lactalbumin,LALBA,Humans
9587,DB03796,Palmitic Acid,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
9588,DB03796,Palmitic Acid,['approved'],BE0001200,Rhodopsin,RHO,Humans
9589,DB03796,Palmitic Acid,['approved'],BE0004538,Palmitoyl-protein thioesterase 1,PPT1,Humans
9590,DB03796,Palmitic Acid,['approved'],BE0004171,Myelin P2 protein,PMP2,Humans
9591,DB03796,Palmitic Acid,['approved'],BE0003957,Glycodelin,PAEP,Humans
9592,DB03796,Palmitic Acid,['approved'],BE0003179,Hepatocyte nuclear factor 4-gamma,HNF4G,Humans
9594,DB03796,Palmitic Acid,['approved'],BE0002887,Cytochrome P450 2C8,CYP2C8,Humans
9595,DB03796,Palmitic Acid,['approved'],BE0003181,Trafficking protein particle complex subunit 3,TRAPPC3,Humans
9604,DB03800,Deoxyuridine monophosphate,['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
9616,DB03801,Lysine Nz-Carboxylic Acid,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9628,DB03802,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
9631,DB03807,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
9634,DB03809,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
9640,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
9644,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0001038,Chymase,CMA1,Humans
9645,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
9646,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
9652,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000259,"Beta-1,4-galactosyltransferase 1",B4GALT1,Humans
9662,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000540,Dihydropteridine reductase,QDPR,Humans
9663,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0000520,Argininosuccinate lyase,ASL,Humans
9665,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0004638,ADP-ribosylation factor-like protein 3,ARL3,Humans
9668,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0003191,Lethal(3)malignant brain tumor-like protein 1,L3MBTL1,Humans
9669,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
9671,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0004641,Peroxiredoxin-6,PRDX6,Humans
9674,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0004481,Pulmonary surfactant-associated protein A1,SFTPA1,Humans
9678,DB03814,2-(N-morpholino)ethanesulfonic acid,['experimental'],BE0004634,Interferon-inducible GTPase 5,IRGC,Humans
9684,DB03821,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,['experimental'],BE0003195,Arylsulfatase A,ARSA,Humans
9686,DB03822,Ethyl dihydrogen phosphate,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
9687,DB03824,"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
9691,DB03828,RU78299,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9693,DB03832,"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",['experimental'],BE0000373,Peroxisomal carnitine O-octanoyltransferase,CROT,Humans
9696,DB03835,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9698,DB03837,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
9700,DB03841,Niraxostat,['experimental'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
9704,DB03844,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9705,DB03845,P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
9707,DB03847,gamma-carboxy-L-glutamic acid,['experimental'],BE0000048,Prothrombin,F2,Humans
9708,DB03847,gamma-carboxy-L-glutamic acid,['experimental'],BE0000724,Osteocalcin,BGLAP,Humans
9709,DB03847,gamma-carboxy-L-glutamic acid,['experimental'],BE0000216,Coagulation factor X,F10,Humans
9710,DB03848,Benzenesulfinic acid,['experimental'],BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
9711,DB03849,Cilomilast,['investigational'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
9712,DB03849,Cilomilast,['investigational'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
9713,DB03850,Jaspisamide A,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
9716,DB03856,L-Eflornithine,"['experimental', 'investigational']",BE0000404,Ornithine decarboxylase,ODC1,Humans
9719,DB03860,ICI-164384,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
9720,DB03861,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",['experimental'],BE0001153,Beta-hexosaminidase subunit beta,HEXB,Humans
9721,DB03861,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",['experimental'],BE0003196,Calcium-activated potassium channel subunit beta-2,KCNMB2,Humans
9726,DB03864,Monothioglycerol,['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
9727,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,['experimental'],BE0000048,Prothrombin,F2,Humans
9728,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9729,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
9730,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,['experimental'],BE0002128,Serine protease hepsin,HPN,Humans
9731,DB03866,Prostaglandin G2,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
9732,DB03867,3-nitro-L-tyrosine,['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
9738,DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9739,DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
9740,DB03877,AL-4623,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9741,DB03878,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
9743,DB03879,alpha-L-methyl-fucose,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
9745,DB03880,Batimastat,['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
9746,DB03880,Batimastat,['experimental'],BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,Humans
9747,DB03880,Batimastat,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
9748,DB03880,Batimastat,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
9749,DB03880,Batimastat,['experimental'],BE0001637,Matrix metalloproteinase-16,MMP16,Humans
9751,DB03881,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
9752,DB03882,"5-Alpha-Androstane-3-Beta,17beta-Diol",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
9754,DB03884,Phenylpyruvic acid,['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
9759,DB03886,Biopterin,['experimental'],BE0000909,Sepiapterin reductase,SPR,Humans
9760,DB03886,Biopterin,['experimental'],BE0004520,6-pyruvoyl tetrahydrobiopterin synthase,PTS,Humans
9761,DB03886,Biopterin,['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
9764,DB03889,S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione,['experimental'],BE0001825,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,Humans
9765,DB03890,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
9766,DB03891,"Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate",['experimental'],BE0003417,Cathepsin K,CTSK,Humans
9767,DB03892,5-N-Allyl-arginine,['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
9768,DB03893,Thionicotinamide-Adenine-Dinucleotide,['experimental'],BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
9769,DB03894,N-Propargyl-1(S)-Aminoindan,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
9771,DB03896,Triphosphoric acid,['experimental'],BE0004515,Poly(A) polymerase alpha,PAPOLA,Humans
9775,DB03899,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
9776,DB03900,tert-butanol,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
9777,DB03900,tert-butanol,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
9778,DB03900,tert-butanol,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
9780,DB03900,tert-butanol,['experimental'],BE0000418,Calmodulin,CALM1,Humans
9782,DB03902,Oxalic Acid,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
9783,DB03903,Tmr,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
9785,DB03904,Urea,"['approved', 'investigational']",BE0000286,Arginase-1,ARG1,Humans
9786,DB03904,Urea,"['approved', 'investigational']",BE0000322,Carbonic anhydrase 2,CA2,Humans
9787,DB03904,Urea,"['approved', 'investigational']",BE0000985,Catenin beta-1,CTNNB1,Humans
9790,DB03906,2-Phenylheme,['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
9791,DB03907,"N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide",['experimental'],BE0002089,Catechol O-methyltransferase,COMT,Humans
9798,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",['experimental'],BE0000033,Insulin receptor,INSR,Humans
9799,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",['experimental'],BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,Humans
9800,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",['experimental'],BE0000042,Pyridoxal kinase,PDXK,Humans
9801,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",['experimental'],BE0004454,Phosphoglycerate kinase 1,PGK1,Humans
9806,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",['experimental'],BE0003115,Kinesin-like protein KIF1A,KIF1A,Humans
9807,DB03910,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9815,DB03918,"6S-5,6,7,8-Tetrahydrobiopterin",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9817,DB03921,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
9818,DB03923,Feruloyl Coenzyme A,['experimental'],BE0004586,Catechol O-methyltransferase domain-containing protein 1,COMTD1,Humans
9819,DB03924,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
9820,DB03925,Freselestat,"['experimental', 'investigational']",BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
9821,DB03925,Freselestat,"['experimental', 'investigational']",BE0000394,Neutrophil elastase,ELANE,Humans
9823,DB03928,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",['experimental'],BE0000791,Cystathionine gamma-lyase,CTH,Humans
9824,DB03929,D-Serine,"['approved', 'experimental']",BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
9825,DB03929,D-Serine,"['approved', 'experimental']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
9826,DB03929,D-Serine,"['approved', 'experimental']",BE0004463,Serpin B3,SERPINB3,Humans
9829,DB03932,LFA703,['experimental'],BE0000516,Integrin alpha-L,ITGAL,Humans
9831,DB03934,Zinc protoporphyrin,['experimental'],BE0001009,Cytochrome c,CYCS,Humans
9832,DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",['experimental'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
9833,DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",['experimental'],BE0004149,Annexin A5,ANXA5,Humans
9836,DB03937,D-erythrose 4-phosphate,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
9842,DB03940,Oxamic Acid,['experimental'],BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
9843,DB03940,Oxamic Acid,['experimental'],BE0000068,L-lactate dehydrogenase B chain,LDHB,Humans
9849,DB03944,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",['experimental'],BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
9850,DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",['experimental'],BE0000877,C-reactive protein,CRP,Humans
9851,DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",['experimental'],BE0004471,Epididymal sperm-binding protein 1,ELSPBP1,Humans
9854,DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",['experimental'],BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
9855,DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",['experimental'],BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
9857,DB03950,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9858,DB03951,N-acetyl-D-glucosamine-6-phosphate,['experimental'],BE0001567,Glucosamine-6-phosphate isomerase 1,GNPDA1,Humans
9861,DB03953,Thiocitrulline,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
9862,DB03955,1-deoxymannojirimycin,['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
9863,DB03956,"Inositol 2,4,5-trisphosphate",['experimental'],BE0004490,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,Humans
9864,DB03957,SP2456,['experimental'],BE0001029,Interleukin-2,IL2,Humans
9865,DB03958,7-methyl-guanosine-5'-triphosphate-5'-guanosine,['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
9867,DB03959,"N,O6-Disulfo-Glucosamine",['experimental'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
9868,DB03959,"N,O6-Disulfo-Glucosamine",['experimental'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
9869,DB03959,"N,O6-Disulfo-Glucosamine",['experimental'],BE0001541,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,Humans
9870,DB03959,"N,O6-Disulfo-Glucosamine",['experimental'],BE0001121,Hepatocyte growth factor,HGF,Humans
9872,DB03959,"N,O6-Disulfo-Glucosamine",['experimental'],BE0004149,Annexin A5,ANXA5,Humans
9874,DB03962,Nicotinamide 8-bromo-adenine dinucleotide phosphate,['experimental'],BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,Humans
9875,DB03963,S-(Dimethylarsenic)Cysteine,['experimental'],BE0001164,Toll-like receptor 2,TLR2,Humans
9878,DB03963,S-(Dimethylarsenic)Cysteine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9879,DB03963,S-(Dimethylarsenic)Cysteine,['experimental'],BE0001597,Coatomer subunit gamma-1,COPG1,Humans
9881,DB03963,S-(Dimethylarsenic)Cysteine,['experimental'],BE0001585,DNA repair protein XRCC4,XRCC4,Humans
9883,DB03964,4-Hydroxy-Aconitate Ion,['experimental'],BE0004504,"Aconitate hydratase, mitochondrial",ACO2,Humans
9885,DB03967,Dodecyl sulfate,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
9887,DB03968,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",['experimental'],BE0000270,Renin,REN,Humans
9892,DB03971,Acarbose Derived Hexasaccharide,['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
9894,DB03974,L-homoarginine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9895,DB03975,Mercuribenzoic Acid,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9897,DB03976,Phosphorylisopropane,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
9898,DB03976,Phosphorylisopropane,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
9899,DB03976,Phosphorylisopropane,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9901,DB03977,Trimethyllysine,['experimental'],BE0001009,Cytochrome c,CYCS,Humans
9902,DB03977,Trimethyllysine,['experimental'],BE0000418,Calmodulin,CALM1,Humans
9904,DB03978,Tyrosinal,['experimental'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
9908,DB03980,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
9909,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",['experimental'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
9910,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",['experimental'],BE0001541,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,Humans
9911,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",['experimental'],BE0004149,Annexin A5,ANXA5,Humans
9912,DB03982,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9913,DB03983,"{[2-Amino-4-oxo-6,7-di(sulfanyl-?S)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum",['experimental'],BE0002927,"Sulfite oxidase, mitochondrial",SUOX,Humans
9914,DB03984,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
9916,DB03987,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
9918,DB03988,"2,6-Diamino-Hexanoic Acid Amide",['experimental'],BE0003199,Pituitary adenylate cyclase-activating polypeptide,ADCYAP1,Humans
9924,DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",['experimental'],BE0003200,Sialidase-2,NEU2,Humans
9927,DB03994,Ethanolamine,['experimental'],BE0003201,Annexin A3,ANXA3,Humans
9931,DB03996,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
9935,DB04000,Bromo-Willardiine,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
9936,DB04001,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
9937,DB04002,4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
9938,DB04003,{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid,['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
9940,DB04005,Uridine 5'-triphosphate,"['experimental', 'investigational']",BE0001480,Uridine-cytidine kinase 2,UCK2,Humans
9943,DB04006,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
9945,DB04008,Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
9946,DB04009,Dimethyl Propionate Ester Heme,['experimental'],BE0001173,Cytochrome b5,CYB5A,Humans
9947,DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
9948,DB04012,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
9949,DB04013,1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9950,DB04014,Alsterpaullone,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
9951,DB04014,Alsterpaullone,['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
9952,DB04014,Alsterpaullone,['experimental'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
9955,DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,['experimental'],BE0001010,Cathepsin G,CTSG,Humans
9956,DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,['experimental'],BE0001038,Chymase,CMA1,Humans
9957,DB04017,Clorgiline,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
9958,DB04018,S-Isopropyl-Isothiourea,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
9959,DB04020,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
9960,DB04021,MF268,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
9965,DB04027,D-arginine,['experimental'],BE0000714,Creatine kinase M-type,CKM,Humans
9978,DB04036,Coenzyme A persulfide,['experimental'],BE0000397,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,Humans
9987,DB04043,Carboxymycobactin T,['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
9988,DB04044,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9992,DB04048,N-Carbamoyl-Alanine,['experimental'],BE0001972,Peroxiredoxin-2,PRDX2,Humans
9993,DB04050,N-Propyl Isocyanide,['experimental'],BE0004467,Myoglobin,MB,Humans
9997,DB04054,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
9998,DB04055,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
9999,DB04057,"N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid",['experimental'],BE0001240,Bifunctional purine biosynthesis protein PURH,ATIC,Humans
10000,DB04058,N-Carbamoylphenylalanine,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
10002,DB04059,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
10007,DB04065,N-Cyclopentyl-N-Cyclobutylformamide,['experimental'],BE0000227,Alcohol dehydrogenase 1A,ADH1A,Humans
10008,DB04066,p-Coumaric acid,['experimental'],BE0003795,Prostaglandin reductase 1,PTGR1,Humans
10014,DB04068,"2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate",['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
10015,DB04069,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",['experimental'],BE0001776,Death-associated protein kinase 1,DAPK1,Humans
10017,DB04071,Cpad,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
10018,DB04072,Alpha-Methylisocitric Acid,['experimental'],BE0004504,"Aconitate hydratase, mitochondrial",ACO2,Humans
10020,DB04074,alpha-Ketoisovalerate,['experimental'],BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,Humans
10026,DB04076,Hypoxanthine,['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
10027,DB04079,"Heptane-1,2,3-Triol",['experimental'],BE0001200,Rhodopsin,RHO,Humans
10030,DB04080,RU78191,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
10031,DB04081,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10034,DB04083,N(6)-(pyridoxal phosphate)-L-lysine,['experimental'],BE0000273,Kynurenine--oxoglutarate transaminase 1,CCBL1,Humans
10035,DB04083,N(6)-(pyridoxal phosphate)-L-lysine,['experimental'],BE0000404,Ornithine decarboxylase,ODC1,Humans
10037,DB04083,N(6)-(pyridoxal phosphate)-L-lysine,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
10038,DB04083,N(6)-(pyridoxal phosphate)-L-lysine,['experimental'],BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
10050,DB04088,2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
10051,DB04089,AL5300,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10052,DB04090,RH-1,"['experimental', 'investigational']",BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
10054,DB04094,4-hydroxybutan-2-one,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
10057,DB04098,Balanol,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
10060,DB04099,Deamido-Nad+,['experimental'],BE0001809,Nicotinamide mononucleotide adenylyltransferase 1,NMNAT1,Humans
10062,DB04099,Deamido-Nad+,['experimental'],BE0001832,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,Humans
10065,DB04101,"N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
10068,DB04105,N-Heptylformamide,['experimental'],BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
10069,DB04106,Fotemustine,['investigational'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
10070,DB04107,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10071,DB04108,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
10072,DB04109,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
10073,DB04112,(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
10074,DB04113,N-Formylpiperidine,['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
10075,DB04114,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
10076,DB04115,Berberine,"['approved', 'investigational']",BE0003408,Baculoviral IAP repeat-containing protein 5,BIRC5,Humans
10079,DB04117,"4-(N,N-Dimethylamino)cinnamoyl-CoA",['experimental'],BE0004500,"Enoyl-CoA hydratase, mitochondrial",ECHS1,Humans
10080,DB04119,Hexatantalum Dodecabromide,['experimental'],BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,Humans
10081,DB04119,Hexatantalum Dodecabromide,['experimental'],BE0004573,Ubiquitin-like modifier-activating enzyme 1,UBA1,Humans
10084,DB04121,Guanosine-3'-monophosphate-5'-diphosphate,['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
10088,DB04125,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10089,DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,['experimental'],BE0000939,Cathepsin B,CTSB,Humans
10090,DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,['experimental'],BE0003970,Pro-cathepsin H,CTSH,Humans
10093,DB04129,Willardiine,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
10096,DB04132,S-Hexylglutathione,['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
10097,DB04132,S-Hexylglutathione,['experimental'],BE0000812,Glutathione S-transferase Mu 4,GSTM4,Humans
10098,DB04132,S-Hexylglutathione,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
10100,DB04132,S-Hexylglutathione,['experimental'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
10101,DB04132,S-Hexylglutathione,['experimental'],BE0004541,Glutathione S-transferase theta-2,GSTT2,Humans
10105,DB04136,Lysophosphotidylserine,['experimental'],BE0000048,Prothrombin,F2,Humans
10107,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0004582,Uridine-cytidine kinase-like 1,UCKL1,Humans
10108,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0001076,GTPase HRas,HRAS,Humans
10110,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0004602,Rho-related GTP-binding protein RhoE,RND3,Humans
10112,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0004594,GTP-binding protein Rheb,RHEB,Humans
10114,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,Humans
10115,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0004533,Ras-related protein Rab-5A,RAB5A,Humans
10119,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
10122,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0000180,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,Humans
10123,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
10124,DB04137,Guanosine-5'-Triphosphate,['experimental'],BE0001843,Ras-related protein Rap-2a,RAP2A,Humans
10127,DB04140,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
10128,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
10129,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
10130,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
10131,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
10132,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
10133,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
10134,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
10135,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
10136,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
10137,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,Humans
10138,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,Humans
10139,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,Humans
10140,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0003887,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",ETFDH,Humans
10141,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,Humans
10142,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
10143,DB04142,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
10146,DB04144,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",['experimental'],BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
10153,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0004165,Ig heavy chain V-III region VH26,IGHV3-23,Humans
10159,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0004166,Destrin,DSTN,Humans
10160,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0001200,Rhodopsin,RHO,Humans
10162,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0004168,Nuclear factor erythroid 2-related factor 1,NFE2L1,Humans
10167,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0004171,Myelin P2 protein,PMP2,Humans
10174,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0004174,Cofilin-1,CFL1,Humans
10186,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
10195,DB04147,Dodecyldimethylamine N-oxide,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
10196,DB04149,(R)-Rolipram,['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
10197,DB04149,(R)-Rolipram,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
10198,DB04150,"N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine",['experimental'],BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,PAM,Humans
10199,DB04151,1-Methylhistidine,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
10200,DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
10201,DB04153,S-Hydroxymethyl Glutathione,['experimental'],BE0000009,Alcohol dehydrogenase class-3,ADH5,Humans
10205,DB04156,Aspartate beryllium trifluoride,['experimental'],BE0004551,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,Humans
10213,DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
10217,DB04166,Anthranilic acid,['experimental'],BE0004566,L-amino-acid oxidase,IL4I1,Humans
10218,DB04166,Anthranilic acid,['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
10223,DB04172,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
10226,DB04175,Mdl-29951,['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
10228,DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,['experimental'],BE0001112,Bactericidal permeability-increasing protein,BPI,Humans
10229,DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,['experimental'],BE0000599,ADP/ATP translocase 1,SLC25A4,Humans
10231,DB04180,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10234,DB04185,Norvaline,['experimental'],BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
10235,DB04185,Norvaline,['experimental'],BE0000306,"Ornithine carbamoyltransferase, mitochondrial",OTC,Humans
10236,DB04186,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
10237,DB04187,"(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",['experimental'],BE0000807,Glutathione S-transferase Mu 1,GSTM1,Humans
10238,DB04188,MDL72527,['experimental'],BE0000566,Spermine oxidase,SMOX,Humans
10241,DB04194,Triacetylchitotriose,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
10242,DB04195,Heptulose-2-Phosphate,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
10244,DB04197,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
10250,DB04200,Matairesinol,['experimental'],BE0004192,Dehydrogenase/reductase SDR family member 4-like 2,DHRS4L2,Humans
10253,DB04203,3-Mercuri-4-Aminobenzenesulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10254,DB04204,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
10258,DB04207,L-Saccharopine,['experimental'],BE0000073,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,Humans
10260,DB04209,Dequalinium,"['approved', 'investigational']",BE0001156,E3 ubiquitin-protein ligase XIAP,XIAP,Humans
10261,DB04209,Dequalinium,"['approved', 'investigational']",BE0005300,cGMP-gated cation channel alpha-1,CNGA1,Humans
10262,DB04209,Dequalinium,"['approved', 'investigational']",BE0000553,Calcium-activated potassium channel subunit alpha-1,KCNMA1,Humans
10265,DB04209,Dequalinium,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
10266,DB04209,Dequalinium,"['approved', 'investigational']",BE0004427,Small conductance calcium-activated potassium channel protein 3,KCNN3,Humans
10267,DB04209,Dequalinium,"['approved', 'investigational']",BE0004895,Protein kinase C,PRKCA,Humans
10268,DB04209,Dequalinium,"['approved', 'investigational']",BE0000878,Alpha-synuclein,SNCA,Humans
10272,DB04213,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
10273,DB04214,4-Nitrophenyl Phosphate,['experimental'],BE0003786,Low molecular weight phosphotyrosine protein phosphatase,ACP1,Humans
10274,DB04214,4-Nitrophenyl Phosphate,['experimental'],BE0003787,Dual specificity protein phosphatase 23,DUSP23,Humans
10275,DB04215,CRA_9076,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10276,DB04216,Quercetin,"['experimental', 'investigational']",BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
10277,DB04216,Quercetin,"['experimental', 'investigational']",BE0004151,UDP-glucuronosyltransferase 3A1,UGT3A1,Humans
10278,DB04216,Quercetin,"['experimental', 'investigational']",BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
10279,DB04216,Quercetin,"['experimental', 'investigational']",BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
10280,DB04216,Quercetin,"['experimental', 'investigational']",BE0003842,"ATP synthase subunit gamma, mitochondrial",ATP5C1,Humans
10281,DB04216,Quercetin,"['experimental', 'investigational']",BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
10283,DB04216,Quercetin,"['experimental', 'investigational']",BE0004327,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",HIBCH,Humans
10285,DB04216,Quercetin,"['experimental', 'investigational']",BE0004328,Serine/threonine-protein kinase 17B,STK17B,Humans
10286,DB04216,Quercetin,"['experimental', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
10287,DB04216,Quercetin,"['experimental', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
10288,DB04216,Quercetin,"['experimental', 'investigational']",BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
10289,DB04216,Quercetin,"['experimental', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
10290,DB04216,Quercetin,"['experimental', 'investigational']",BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
10291,DB04216,Quercetin,"['experimental', 'investigational']",BE0004966,"Actin, cytoplasmic 1",ACTB,Humans
10292,DB04216,Quercetin,"['experimental', 'investigational']",BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
10293,DB04216,Quercetin,"['experimental', 'investigational']",BE0005435,Casein kinase II subunit beta,CSNK2B,Humans
10294,DB04216,Quercetin,"['experimental', 'investigational']",BE0009017,Eukaryotic translation initiation factor 3 subunit F,EIF3F,Humans
10295,DB04216,Quercetin,"['experimental', 'investigational']",BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
10296,DB04216,Quercetin,"['experimental', 'investigational']",BE0009018,Heat shock-related 70 kDa protein 2,HSPA2,Humans
10297,DB04216,Quercetin,"['experimental', 'investigational']",BE0009019,RuvB-like 2,RUVBL2,Humans
10298,DB04216,Quercetin,"['experimental', 'investigational']",BE0009020,Splicing factor 3B subunit 3,SF3B3,Humans
10299,DB04216,Quercetin,"['experimental', 'investigational']",BE0004573,Ubiquitin-like modifier-activating enzyme 1,UBA1,Humans
10300,DB04216,Quercetin,"['experimental', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
10301,DB04216,Quercetin,"['experimental', 'investigational']",BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
10302,DB04216,Quercetin,"['experimental', 'investigational']",BE0005461,CCAAT/enhancer-binding protein beta,CEBPB,Humans
10303,DB04216,Quercetin,"['experimental', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
10304,DB04216,Quercetin,"['experimental', 'investigational']",BE0001424,Tyrosine-protein kinase HCK,HCK,Humans
10306,DB04217,L-2-amino-3-butynoic acid,['experimental'],BE0000791,Cystathionine gamma-lyase,CTH,Humans
10307,DB04218,1-Deaza-Adenosine,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
10311,DB04223,Nitroarginine,"['experimental', 'investigational']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
10312,DB04223,Nitroarginine,"['experimental', 'investigational']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
10313,DB04224,Oleic Acid,"['approved', 'investigational', 'vet_approved']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
10314,DB04224,Oleic Acid,"['approved', 'investigational', 'vet_approved']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
10315,DB04224,Oleic Acid,"['approved', 'investigational', 'vet_approved']",BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
10316,DB04224,Oleic Acid,"['approved', 'investigational', 'vet_approved']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
10317,DB04224,Oleic Acid,"['approved', 'investigational', 'vet_approved']",BE0004171,Myelin P2 protein,PMP2,Humans
10320,DB04230,Nitromethyldethia coenzyme A,['experimental'],BE0004459,"Citrate synthase, mitochondrial",CS,Humans
10322,DB04232,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
10323,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,['experimental'],BE0003898,Colipase,CLPS,Humans
10324,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,['experimental'],BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
10325,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,['experimental'],BE0001200,Rhodopsin,RHO,Humans
10348,DB04234,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
10349,DB04235,4-Amino Hexanoic Acid,['experimental'],BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,Humans
10350,DB04237,Tris(Hydroxyethyl)Aminomethane,['experimental'],BE0001671,Alpha-amylase 1,AMY1A,Humans
10353,DB04238,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10361,DB04244,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
10362,DB04246,CRA_23653,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10364,DB04249,Zinc Substituted Heme C,['experimental'],BE0001009,Cytochrome c,CYCS,Humans
10365,DB04250,Butyrylthiocholine,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
10367,DB04253,Tretazicar,['investigational'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
10369,DB04254,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
10371,DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,['experimental'],BE0000824,Metabotropic glutamate receptor 1,GRM1,Humans
10375,DB04258,Seocalcitol,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
10376,DB04260,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
10379,DB04263,Geneticin,['experimental'],BE0000404,Ornithine decarboxylase,ODC1,Humans
10387,DB04268,Methylumbelliferyl chitotriose,['experimental'],BE0003751,Lysozyme C,LYZ,Humans
10388,DB04269,Cyclotheonamide A,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10389,DB04270,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
10390,DB04271,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
10392,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000747,Aldose reductase,AKR1B1,Humans
10396,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004459,"Citrate synthase, mitochondrial",CS,Humans
10397,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
10398,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0003317,Ribonuclease pancreatic,RNASE1,Humans
10399,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000908,Eosinophil cationic protein,RNASE3,Humans
10402,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004566,L-amino-acid oxidase,IL4I1,Humans
10403,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004551,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,Humans
10405,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004625,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,Humans
10409,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000780,"Malate dehydrogenase, mitochondrial",MDH2,Humans
10412,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0003257,Carboxypeptidase B,CPB1,Humans
10419,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004434,U6 snRNA-associated Sm-like protein LSm6,LSM6,Humans
10420,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0003262,Pleckstrin homology domain-containing family A member 1,PLEKHA1,Humans
10425,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0003266,Complement component C8 gamma chain,C8G,Humans
10430,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0000115,Adenine phosphoribosyltransferase,APRT,Humans
10436,DB04272,Citric acid,"['approved', 'nutraceutical', 'vet_approved']",BE0004443,Inosine triphosphate pyrophosphatase,ITPA,Humans
10441,DB04273,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
10442,DB04275,N-acetylserotonin,['experimental'],BE0000909,Sepiapterin reductase,SPR,Humans
10444,DB04276,4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium,['experimental'],BE0003346,Calpain-1 catalytic subunit,CAPN1,Humans
10446,DB04278,2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide,['experimental'],BE0001029,Interleukin-2,IL2,Humans
10450,DB04281,"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
10454,DB04282,2-deoxy-2-fluoro-?-D-glucose,['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
10456,DB04285,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
10459,DB04287,KH064,['experimental'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
10460,DB04288,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
10464,DB04295,N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
10466,DB04297,Trichostatin A,['experimental'],BE0003525,Histone deacetylase 7,HDAC7,Humans
10467,DB04297,Trichostatin A,['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
10469,DB04297,Trichostatin A,['experimental'],BE0003460,Caspase-8,CASP8,Humans
10470,DB04297,Trichostatin A,['experimental'],BE0010100,Prostaglandin E2 Receptors,PTGER1,Humans
10471,DB04297,Trichostatin A,['experimental'],BE0000704,Tumor necrosis factor,TNF,Humans
10477,DB04299,Maleic acid,['experimental'],BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
10478,DB04301,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10484,DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
10486,DB04307,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
10493,DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,['experimental'],BE0002201,"Peptide deformylase, mitochondrial",PDF,Humans
10498,DB04311,4-Phenylbutylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10499,DB04312,"2,3-Difluorobenzyl Alcohol",['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
10501,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001076,GTPase HRas,HRAS,Humans
10502,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001190,Transforming protein RhoA,RHOA,Humans
10503,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001035,Protein-glutamine gamma-glutamyltransferase 2,TGM2,Humans
10504,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004558,Ras-related protein Rab-11A,RAB11A,Humans
10507,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001273,Protein-glutamine gamma-glutamyltransferase E,TGM3,Humans
10508,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004478,Ras-related protein Rab-8B,RAB8B,Humans
10509,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004242,ADP-ribosylation factor 6,ARF6,Humans
10510,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
10512,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004542,"Elongation factor Tu, mitochondrial",TUFM,Humans
10516,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004636,Eukaryotic translation initiation factor 2 subunit 3,EIF2S3,Humans
10517,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004491,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,Humans
10519,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003945,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,Humans
10521,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001710,Ras-related protein Rab-9A,RAB9A,Humans
10522,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
10523,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004594,GTP-binding protein Rheb,RHEB,Humans
10524,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004618,Cell division control protein 42 homolog,CDC42,Humans
10526,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
10527,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004281,Elongation factor 2,EEF2,Humans
10529,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001843,Ras-related protein Rap-2a,RAP2A,Humans
10530,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004053,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,Humans
10531,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004535,ADP-ribosylation factor-like protein 1,ARL1,Humans
10532,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004559,GTP-binding nuclear protein Ran,RAN,Humans
10533,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004485,Ras-related protein Rab-7a,RAB7A,Humans
10534,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004634,Interferon-inducible GTPase 5,IRGC,Humans
10535,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004448,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,GSPT1,Humans
10536,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004533,Ras-related protein Rab-5A,RAB5A,Humans
10537,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
10538,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003277,ADP-ribosylation factor 4,ARF4,Humans
10539,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003278,"GDP-mannose 4,6 dehydratase",GMDS,Humans
10540,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004562,Ras-related protein Ral-A,RALA,Humans
10542,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004627,ADP-ribosylation factor-like protein 5B,ARL5B,Humans
10544,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004638,ADP-ribosylation factor-like protein 3,ARL3,Humans
10545,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003281,Nucleoside diphosphate kinase B,NME2,Humans
10547,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0001109,Ras-related C3 botulinum toxin substrate 1,RAC1,Humans
10549,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0004633,GTP-binding protein SAR1b,SAR1B,Humans
10551,DB04315,Guanosine-5'-Diphosphate,['experimental'],BE0003284,ADP-ribosylation factor-like protein 5A,ARL5A,Humans
10552,DB04316,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
10554,DB04318,N?-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide,['experimental'],BE0003691,Stromelysin-3,MMP11,Humans
10556,DB04322,LY249543,['experimental'],BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,Humans
10557,DB04324,Ovalicin,['experimental'],BE0004117,Methionine aminopeptidase 1,METAP1,Humans
10558,DB04324,Ovalicin,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
10560,DB04325,Phenethylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10561,DB04325,Phenethylamine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
10562,DB04326,Dihydroxyacetone phosphate,['investigational'],BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
10563,DB04326,Dihydroxyacetone phosphate,['investigational'],BE0003844,Triosephosphate isomerase,TPI1,Humans
10564,DB04326,Dihydroxyacetone phosphate,['investigational'],BE0004565,Fructose-bisphosphate aldolase B,ALDOB,Humans
10566,DB04327,Phosphatidylethanolamine,['experimental'],BE0005530,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",PTEN,Humans
10567,DB04327,Phosphatidylethanolamine,['experimental'],BE0001161,Endothelial protein C receptor,PROCR,Humans
10572,DB04331,Monastrol,['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
10573,DB04334,6-hydroxydopa quinone,['experimental'],BE0001002,Membrane primary amine oxidase,AOC3,Humans
10576,DB04335,Inosine,"['experimental', 'investigational']",BE0000250,Purine nucleoside phosphorylase,PNP,Humans
10579,DB04336,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10580,DB04337,Isocyanomethane,['experimental'],BE0004467,Myoglobin,MB,Humans
10581,DB04338,SB220025,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
10582,DB04338,SB220025,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
10583,DB04339,Carbocisteine,"['approved', 'investigational']",BE0010046,PI-PLC X domain-containing protein 3,PLCXD3,Humans
10584,DB04339,Carbocisteine,"['approved', 'investigational']",BE0004604,"Lactosylceramide alpha-2,3-sialyltransferase",ST3GAL5,Humans
10591,DB04345,Lumichrome,['experimental'],BE0000595,Flavin reductase (NADPH),BLVRB,Humans
10596,DB04348,Taurocholic acid,"['approved', 'experimental']",BE0004523,Bile salt-activated lipase,CEL,Humans
10597,DB04348,Taurocholic acid,"['approved', 'experimental']",BE0001777,Bile acid receptor,NR1H4,Humans
10598,DB04348,Taurocholic acid,"['approved', 'experimental']",BE0001967,Gastrotropin,FABP6,Humans
10601,DB04350,Argadin,['experimental'],BE0001058,Chitotriosidase-1,CHIT1,Humans
10603,DB04351,Aconitate Ion,['experimental'],BE0004504,"Aconitate hydratase, mitochondrial",ACO2,Humans
10606,DB04352,beta-D-Ribose-5-phosphate,['experimental'],BE0001935,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,Humans
10608,DB04356,9-Deazaguanine,['experimental'],BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,Humans
10612,DB04363,Mesobiliverdin IV alpha,['experimental'],BE0000595,Flavin reductase (NADPH),BLVRB,Humans
10613,DB04365,Arecoline,['experimental'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
10614,DB04365,Arecoline,['experimental'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
10615,DB04366,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
10616,DB04367,Debromohymenialdisine,['experimental'],BE0000772,Activated CDC42 kinase 1,TNK2,Humans
10617,DB04367,Debromohymenialdisine,['experimental'],BE0001824,Dual specificity protein kinase CLK1,CLK1,Humans
10619,DB04368,Bb-3497,['experimental'],BE0002201,"Peptide deformylase, mitochondrial",PDF,Humans
10620,DB04369,"1,3,2-Dioxaborolan-2-Ol",['experimental'],BE0001583,Trypsin-3,PRSS3,Humans
10621,DB04371,AL6528,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10622,DB04372,L-Dilinoleoyllecithin,['experimental'],BE0000935,Phosphatidylcholine transfer protein,PCTP,Humans
10624,DB04374,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
10625,DB04376,13-Acetylphorbol,['experimental'],BE0002417,Protein kinase C delta type,PRKCD,Humans
10626,DB04377,Meglutol,['experimental'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
10628,DB04379,N-Methyl-N-(Methylbenzyl)Formamide,['experimental'],BE0000270,Renin,REN,Humans
10630,DB04381,Crotonaldehyde,['experimental'],BE0000133,"Aldehyde dehydrogenase, mitochondrial",ALDH2,Humans
10634,DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,['experimental'],BE0000270,Renin,REN,Humans
10637,DB04389,Ado-P-Ch2-P-Ps-Ado,['experimental'],BE0001687,Bis(5'-adenosyl)-triphosphatase,FHIT,Humans
10638,DB04391,Aeruginosin 98-B,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10639,DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
10643,DB04394,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
10644,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
10645,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001221,Thymidylate kinase,DTYMK,Humans
10647,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
10648,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
10651,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001108,Hexokinase-1,HK1,Humans
10653,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
10654,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
10655,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0000841,Ephrin type-A receptor 2,EPHA2,Humans
10657,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
10661,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004622,Kinesin-like protein KIF2C,KIF2C,Humans
10662,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001627,Inositol-trisphosphate 3-kinase A,ITPKA,Humans
10663,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
10664,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0000185,Glutathione synthetase,GSS,Humans
10666,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0003931,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,Humans
10668,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001776,Death-associated protein kinase 1,DAPK1,Humans
10670,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
10675,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004549,Ephrin type-B receptor 2,EPHB2,Humans
10677,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
10678,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004572,Transitional endoplasmic reticulum ATPase,VCP,Humans
10679,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004624,Transient receptor potential cation channel subfamily M member 7,TRPM7,Humans
10680,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0003115,Kinesin-like protein KIF1A,KIF1A,Humans
10681,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004554,T-complex protein 1 subunit gamma,CCT3,Humans
10683,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0004323,SRSF protein kinase 2,SRPK2,Humans
10684,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0002790,Mitogen-activated protein kinase 12,MAPK12,Humans
10689,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0003295,Galactokinase,GALK1,Humans
10691,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,['experimental'],BE0002412,DNA repair protein RAD51 homolog 1,RAD51,Humans
10695,DB04396,Thiodigalactoside,['experimental'],BE0004512,Neurocan core protein,NCAN,Humans
10696,DB04396,Thiodigalactoside,['experimental'],BE0004493,Galectin-1,LGALS1,Humans
10697,DB04397,Alpha-D-Glucose-1-Phosphate-6-Vanadate,['experimental'],BE0004461,Phosphoglucomutase-1,PGM1,Humans
10700,DB04400,"L-erythro-7,8-dihydrobiopterin",['experimental'],BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
10702,DB04400,"L-erythro-7,8-dihydrobiopterin",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
10703,DB04400,"L-erythro-7,8-dihydrobiopterin",['experimental'],BE0000614,Tyrosine 3-monooxygenase,TH,Humans
10704,DB04400,"L-erythro-7,8-dihydrobiopterin",['experimental'],BE0004555,Pterin-4-alpha-carbinolamine dehydratase,PCBD1,Humans
10707,DB04404,Allosamizoline,['experimental'],BE0001058,Chitotriosidase-1,CHIT1,Humans
10710,DB04405,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
10711,DB04407,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
10713,DB04409,Naphthalene Trisulfonate,['experimental'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
10714,DB04410,3-Phenylpropylamine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10715,DB04410,3-Phenylpropylamine,['experimental'],BE0004529,Trypsin-2,PRSS2,Humans
10718,DB04416,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
10719,DB04417,P-Nitrophenol,['experimental'],BE0000927,Sulfotransferase 1A1,SULT1A1,Humans
10720,DB04417,P-Nitrophenol,['experimental'],BE0004457,Alpha-amylase 2B,AMY2B,Humans
10721,DB04418,Adenylosuccinic acid,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
10722,DB04419,D-norleucine,['experimental'],BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
10723,DB04419,D-norleucine,['experimental'],BE0003309,Parathyroid hormone,PTH,Humans
10724,DB04419,D-norleucine,['experimental'],BE0004514,Hepatocyte nuclear factor 1-alpha,HNF1A,Humans
10728,DB04424,RPR128515,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10730,DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,['experimental'],BE0004482,Mannose-binding protein C,MBL2,Humans
10732,DB04429,4'-Hydroxyflavanone,['experimental'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
10735,DB04432,ZK-805623,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10737,DB04434,Naphthyridine Inhibitor,['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
10738,DB04436,3-Fluoro-L-tyrosine,['experimental'],BE0004453,"Superoxide dismutase [Mn], mitochondrial",SOD2,Humans
10741,DB04440,Nebularine,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
10743,DB04442,"Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10744,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0003893,Myosin-14,MYH14,Humans
10747,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0004491,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,Humans
10748,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,Humans
10749,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0003945,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,Humans
10750,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0000637,UMP-CMP kinase,CMPK1,Humans
10751,DB04444,Tetrafluoroaluminate Ion,['experimental'],BE0004489,Myosin-11,MYH11,Humans
10753,DB04445,Mercuric iodide,['experimental'],BE0000886,Bile salt sulfotransferase,SULT2A1,Humans
10754,DB04446,Benzo[B]Thiophene-2-Carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10756,DB04447,"1,4-Dithiothreitol",['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
10757,DB04447,"1,4-Dithiothreitol",['experimental'],BE0000819,Maleylacetoacetate isomerase,GSTZ1,Humans
10758,DB04447,"1,4-Dithiothreitol",['experimental'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
10764,DB04447,"1,4-Dithiothreitol",['experimental'],BE0004493,Galectin-1,LGALS1,Humans
10765,DB04447,"1,4-Dithiothreitol",['experimental'],BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,Humans
10767,DB04447,"1,4-Dithiothreitol",['experimental'],BE0000554,Retinal dehydrogenase 1,ALDH1A1,Humans
10770,DB04447,"1,4-Dithiothreitol",['experimental'],BE0004624,Transient receptor potential cation channel subfamily M member 7,TRPM7,Humans
10774,DB04447,"1,4-Dithiothreitol",['experimental'],BE0000170,Mitochondrial peptide methionine sulfoxide reductase,MSRA,Humans
10776,DB04447,"1,4-Dithiothreitol",['experimental'],BE0003316,Axin-1,AXIN1,Humans
10777,DB04447,"1,4-Dithiothreitol",['experimental'],BE0002332,Peptidyl-prolyl cis-trans isomerase B,PPIB,Humans
10779,DB04448,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",['experimental'],BE0000465,Alcohol dehydrogenase 1C,ADH1C,Humans
10780,DB04450,Heptyl 1-Thiohexopyranoside,['experimental'],BE0001200,Rhodopsin,RHO,Humans
10785,DB04451,4-Methylpiperazin-1-Yl Carbonyl Group,['experimental'],BE0001909,Cathepsin L2,CTSV,Humans
10787,DB04453,"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
10788,DB04454,Alpha-Aminobutyric Acid,['experimental'],BE0000347,"Glycine amidinotransferase, mitochondrial",GATM,Humans
10790,DB04454,Alpha-Aminobutyric Acid,['experimental'],BE0000953,Pro-epidermal growth factor,EGF,Humans
10798,DB04459,"3,4-Dichloroisocoumarin",['experimental'],BE0001840,Complement factor D,CFD,Humans
10800,DB04461,Coproporphyrinogen III,['experimental'],BE0001629,Uroporphyrinogen decarboxylase,UROD,Humans
10801,DB04462,Tetrabromo-2-Benzotriazole,['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
10802,DB04463,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",['experimental'],BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
10803,DB04464,N-Formylmethionine,['experimental'],BE0004072,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,Humans
10804,DB04464,N-Formylmethionine,['experimental'],BE0004073,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,Humans
10813,DB04464,N-Formylmethionine,['experimental'],BE0000280,Antithrombin-III,SERPINC1,Humans
10814,DB04464,N-Formylmethionine,['experimental'],BE0003777,Beta-2-microglobulin,B2M,Humans
10815,DB04464,N-Formylmethionine,['experimental'],BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
10816,DB04464,N-Formylmethionine,['experimental'],BE0004082,"HLA class I histocompatibility antigen, B-27 alpha chain",HLA-B,Humans
10820,DB04464,N-Formylmethionine,['experimental'],BE0004083,Protein S100-G,S100G,Humans
10822,DB04464,N-Formylmethionine,['experimental'],BE0003986,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,Humans
10823,DB04464,N-Formylmethionine,['experimental'],BE0000335,Cytochrome c oxidase subunit 1,MT-CO1,Humans
10824,DB04464,N-Formylmethionine,['experimental'],BE0003385,Cytochrome c oxidase subunit 2,MT-CO2,Humans
10825,DB04464,N-Formylmethionine,['experimental'],BE0003987,Cytochrome c oxidase subunit 3,MT-CO3,Humans
10826,DB04464,N-Formylmethionine,['experimental'],BE0003988,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,Humans
10827,DB04464,N-Formylmethionine,['experimental'],BE0003989,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,Humans
10828,DB04464,N-Formylmethionine,['experimental'],BE0003990,Cytochrome c oxidase subunit 6C,COX6C,Humans
10829,DB04464,N-Formylmethionine,['experimental'],BE0003991,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,Humans
10830,DB04464,N-Formylmethionine,['experimental'],BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,Humans
10831,DB04464,N-Formylmethionine,['experimental'],BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,Humans
10832,DB04464,N-Formylmethionine,['experimental'],BE0003994,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,Humans
10833,DB04464,N-Formylmethionine,['experimental'],BE0003995,Cytochrome c oxidase subunit 6B1,COX6B1,Humans
10834,DB04464,N-Formylmethionine,['experimental'],BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,Humans
10837,DB04464,N-Formylmethionine,['experimental'],BE0001177,Protein S100-B,S100B,Humans
10839,DB04464,N-Formylmethionine,['experimental'],BE0004087,Polyubiquitin-C,UBC,Humans
10844,DB04464,N-Formylmethionine,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
10845,DB04464,N-Formylmethionine,['experimental'],BE0002769,"Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial",CLPP,Humans
10846,DB04465,Lactose,"['approved', 'experimental', 'investigational']",BE0001353,Galectin-3,LGALS3,Humans
10848,DB04465,Lactose,"['approved', 'experimental', 'investigational']",BE0009999,Beta-galactosidase,GLB1,Humans
10850,DB04465,Lactose,"['approved', 'experimental', 'investigational']",BE0004501,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,Humans
10851,DB04465,Lactose,"['approved', 'experimental', 'investigational']",BE0001854,Glycolipid transfer protein,GLTP,Humans
10854,DB04466,SR12813,['experimental'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
10858,DB04468,Afimoxifene,['investigational'],BE0008981,Trefoil factor 1,TFF1,Humans
10859,DB04468,Afimoxifene,['investigational'],BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
10860,DB04468,Afimoxifene,['investigational'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
10861,DB04468,Afimoxifene,['investigational'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
10862,DB04468,Afimoxifene,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
10863,DB04468,Afimoxifene,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
10864,DB04468,Afimoxifene,['investigational'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
10865,DB04469,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
10866,DB04470,CRA_10656,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
10867,DB04471,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
10868,DB04472,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,['experimental'],BE0004333,Galectin-9,LGALS9,Humans
10872,DB04473,alpha-L-fucose,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
10874,DB04474,8-anilinonaphthalene-1-sulfonic acid,['experimental'],BE0003756,Protein S100-A7,S100A7,Humans
10876,DB04476,"Trencam-3,2-Hopo",['experimental'],BE0001084,Neutrophil gelatinase-associated lipocalin,LCN2,Humans
10877,DB04477,"2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine",['experimental'],BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
10878,DB04478,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",['experimental'],BE0000299,Sorbitol dehydrogenase,SORD,Humans
10879,DB04480,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
10888,DB04485,Thymidine,"['experimental', 'investigational']",BE0004639,"Thymidine kinase 2, mitochondrial",TK2,Humans
10891,DB04487,N-Methylleucine,['experimental'],BE0000934,C-X-C motif chemokine 10,CXCL10,Humans
10893,DB04489,Guanidinoethylmercaptosuccinic acid,['experimental'],BE0004568,Carboxypeptidase D,CPD,Humans
10895,DB04491,Diisopropylphosphono Group,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
10897,DB04491,Diisopropylphosphono Group,['experimental'],BE0001701,Complement factor B,CFB,Humans
10900,DB04493,Fructose-6-phosphate,['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
10901,DB04493,Fructose-6-phosphate,['experimental'],BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,Humans
10903,DB04493,Fructose-6-phosphate,['experimental'],BE0003931,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,Humans
10904,DB04493,Fructose-6-phosphate,['experimental'],BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
10906,DB04495,Paratoulene phosphate,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
10913,DB04505,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
10917,DB04510,3-phospho-D-glyceric acid,['experimental'],BE0004462,Phosphoglycerate mutase 2,PGAM2,Humans
10918,DB04510,3-phospho-D-glyceric acid,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
10919,DB04510,3-phospho-D-glyceric acid,['experimental'],BE0004454,Phosphoglycerate kinase 1,PGK1,Humans
10922,DB04512,2-Isobutyl-3-methoxypyrazine,['experimental'],BE0004320,Epididymal-specific lipocalin-9,LCN9,Humans
10923,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,['experimental'],BE0000418,Calmodulin,CALM1,Humans
10924,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,['experimental'],BE0001024,"Troponin C, slow skeletal and cardiac muscles",TNNC1,Humans
10925,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,['experimental'],BE0000656,"Troponin I, cardiac muscle",TNNI3,Humans
10926,DB04514,Uridylyl-2'-5'-phospho-guanosine,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
10928,DB04516,2-Deoxy-Glucitol-6-Phosphate,['experimental'],BE0004496,Inositol-3-phosphate synthase 1,ISYNA1,Humans
10930,DB04518,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
10931,DB04519,Caprylic acid,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
10936,DB04521,4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol,['experimental'],BE0000809,Glutathione S-transferase A3,GSTA3,Humans
10937,DB04522,Dexfosfoserine,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
10938,DB04522,Dexfosfoserine,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
10939,DB04522,Dexfosfoserine,['experimental'],BE0001385,Protein kinase C theta type,PRKCQ,Humans
10942,DB04522,Dexfosfoserine,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
10943,DB04522,Dexfosfoserine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
10947,DB04522,Dexfosfoserine,['experimental'],BE0001200,Rhodopsin,RHO,Humans
10948,DB04522,Dexfosfoserine,['experimental'],BE0004463,Serpin B3,SERPINB3,Humans
10950,DB04522,Dexfosfoserine,['experimental'],BE0004632,Serine/threonine-protein kinase TAO2,TAOK2,Humans
10951,DB04522,Dexfosfoserine,['experimental'],BE0003319,Potassium voltage-gated channel subfamily C member 4,KCNC4,Humans
10952,DB04522,Dexfosfoserine,['experimental'],BE0000912,Lithostathine-1-alpha,REG1A,Humans
10953,DB04522,Dexfosfoserine,['experimental'],BE0004445,Mothers against decapentaplegic homolog 2,SMAD2,Humans
10957,DB04522,Dexfosfoserine,['experimental'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
10958,DB04523,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
10960,DB04525,N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
10962,DB04527,beta-Hydroxyasparagine,['experimental'],BE0004630,Mannan-binding lectin serine protease 2,MASP2,Humans
10967,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
10968,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
10969,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
10970,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
10971,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0000286,Arginase-1,ARG1,Humans
10974,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0001845,Serpin B5,SERPINB5,Humans
10978,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0003323,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,Humans
10979,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0004579,Sorting nexin-3,SNX3,Humans
10981,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",['experimental'],BE0002654,Cytohesin-2,CYTH2,Humans
10982,DB04531,S-Benzylcysteine,['experimental'],BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
10986,DB04534,5-Nitroindazole,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
10987,DB04534,5-Nitroindazole,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
10988,DB04537,Tryptophanamide,['experimental'],BE0000228,"Tryptophan--tRNA ligase, cytoplasmic",WARS,Humans
10991,DB04539,Glyphosate,['experimental'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
10994,DB04540,Cholesterol,"['approved', 'investigational']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
10995,DB04540,Cholesterol,"['approved', 'investigational']",BE0000779,Vitamin D3 receptor,VDR,Humans
10996,DB04540,Cholesterol,"['approved', 'investigational']",BE0009096,C-type lectin domain family 4 member E,CLEC4E,Humans
10997,DB04540,Cholesterol,"['approved', 'investigational']",BE0004545,Nuclear receptor ROR-alpha,RORA,Humans
10999,DB04542,Zidovudine diphosphate,['experimental'],BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
11001,DB04544,1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11011,DB04549,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
11012,DB04551,"beta-D-fructofuranose 1,6-bisphosphate",['experimental'],BE0000046,Pyruvate kinase PKLR,PKLR,Humans
11014,DB04552,Niflumic acid,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
11015,DB04552,Niflumic acid,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
11016,DB04552,Niflumic acid,['experimental'],BE0002376,Chloride channel protein ClC-Ka,CLCNKA,Humans
11017,DB04552,Niflumic acid,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
11018,DB04552,Niflumic acid,['experimental'],BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
11019,DB04552,Niflumic acid,['experimental'],BE0003538,UDP-glucuronosyltransferase 1-9,UGT1A9,Humans
11029,DB04556,NAP-226-90,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
11030,DB04557,Arachidonic Acid,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
11031,DB04557,Arachidonic Acid,['experimental'],BE0001777,Bile acid receptor,NR1H4,Humans
11032,DB04557,Arachidonic Acid,['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
11033,DB04557,Arachidonic Acid,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
11035,DB04559,N-(Chlorophenyl)-N'-hydroxyguanidine,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
11036,DB04560,"4,7-Dioxosebacic Acid",['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
11040,DB04562,Tricarballylic acid,['experimental'],BE0004504,"Aconitate hydratase, mitochondrial",ACO2,Humans
11041,DB04563,CRA_9678,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11042,DB04564,Gluconolactone,"['approved', 'experimental']",BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
11044,DB04566,Inosinic Acid,['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11046,DB04566,Inosinic Acid,['experimental'],BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
11047,DB04566,Inosinic Acid,['experimental'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
11060,DB04573,Estriol,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
11061,DB04573,Estriol,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
11062,DB04573,Estriol,"['approved', 'investigational', 'vet_approved']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
11063,DB04574,Estrone sulfate,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
11064,DB04574,Estrone sulfate,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
11065,DB04575,Quinestrol,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
11068,DB04576,Fleroxacin,['experimental'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11069,DB04577,1-(1-phenylcyclopentyl)methylamine,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
11070,DB04578,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
11071,DB04579,"N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
11073,DB04581,1-benzylimidazole,['experimental'],BE0003330,Glutaminyl-peptide cyclotransferase,QPCT,Humans
11074,DB04583,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
11075,DB04585,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,['experimental'],BE0000286,Arginase-1,ARG1,Humans
11077,DB04588,"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
11078,DB04590,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,['experimental'],BE0000333,Coagulation factor VII,F7,Humans
11079,DB04591,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",['experimental'],BE0000048,Prothrombin,F2,Humans
11081,DB04593,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,['experimental'],BE0000333,Coagulation factor VII,F7,Humans
11082,DB04594,3-hydroxyglutaric acid,['experimental'],BE0003332,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",HMGCL,Humans
11086,DB04599,Aniracetam,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
11087,DB04599,Aniracetam,['experimental'],BE0000831,Glutamate receptor 3,GRIA3,Humans
11088,DB04599,Aniracetam,['experimental'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11089,DB04599,Aniracetam,['experimental'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11090,DB04600,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
11091,DB04601,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
11092,DB04602,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,['experimental'],BE0003832,60S ribosomal protein L37,RPL37,Humans
11093,DB04604,5-iodotubercidin,['experimental'],BE0003794,Serine/threonine-protein kinase haspin,GSG2,Humans
11094,DB04604,5-iodotubercidin,['experimental'],BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
11095,DB04604,5-iodotubercidin,['experimental'],BE0003334,Casein kinase I isoform gamma-2,CSNK1G2,Humans
11097,DB04606,2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),['experimental'],BE0000333,Coagulation factor VII,F7,Humans
11098,DB04607,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
11099,DB04608,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
11102,DB04612,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",['experimental'],BE0001156,E3 ubiquitin-protein ligase XIAP,XIAP,Humans
11103,DB04614,(R)-tacrine(10)-hupyridone,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
11104,DB04615,(S)-tacrine(10)-hupyridone,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
11105,DB04616,TACRINE(8)-4-AMINOQUINOLINE,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
11106,DB04617,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
11107,DB04618,"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",['experimental'],BE0002639,Pancreatic alpha-amylase,AMY2A,Humans
11109,DB04620,Cycloleucine,['experimental'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
11110,DB04622,N-acetylhistamine,['experimental'],BE0003330,Glutaminyl-peptide cyclotransferase,QPCT,Humans
11117,DB04629,Aplyronine A,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
11118,DB04630,Aldosterone,"['experimental', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
11119,DB04630,Aldosterone,"['experimental', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
11124,DB04632,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
11125,DB04633,"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",['experimental'],BE0000111,Diamine acetyltransferase 1,SAT1,Humans
11129,DB04636,Glutamine t-butyl ester,['experimental'],BE0003330,Glutaminyl-peptide cyclotransferase,QPCT,Humans
11131,DB04638,"2,5-di-tert-butylhydroquinone",['experimental'],BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,Humans
11132,DB04639,Biphenylalanine,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
11137,DB04642,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11138,DB04643,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11139,DB04644,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11140,DB04645,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
11151,DB04648,S-propylamine-L-cysteine,['experimental'],BE0000286,Arginase-1,ARG1,Humans
11155,DB04652,Corticosterone,['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
11156,DB04652,Corticosterone,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
11157,DB04652,Corticosterone,['experimental'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
11158,DB04653,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide,['experimental'],BE0003346,Calpain-1 catalytic subunit,CAPN1,Humans
11159,DB04654,4-PIPERIDIN-4-YLBUTANAL,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11160,DB04654,4-PIPERIDIN-4-YLBUTANAL,['experimental'],BE0001474,Tryptase beta-2,TPSB2,Humans
11161,DB04655,Metoprine,['experimental'],BE0002436,Histamine N-methyltransferase,HNMT,Humans
11163,DB04657,Carboxin,"['approved', 'experimental']",BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,Humans
11165,DB04659,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
11166,DB04660,Choline alfoscerate,"['experimental', 'investigational']",BE0001432,Ganglioside GM2 activator,GM2A,Humans
11167,DB04661,cis-tetracosenoyl sulfatide,['experimental'],BE0004495,Antigen-presenting glycoprotein CD1d,CD1D,Humans
11168,DB04662,OLOMOUCINE II,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
11169,DB04664,Cyclohexyl-pentyl-maltoside,['experimental'],BE0003549,Cytochrome P450 2B6,CYP2B6,Humans
11170,DB04665,Coumarin,['experimental'],BE0003336,Cytochrome P450 2A6,CYP2A6,Humans
11171,DB04669,TRIAZOLOPYRIMIDINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
11173,DB04672,"Cyclic 3',5'-thymidine monophosphate",['experimental'],BE0001515,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,Humans
11174,DB04673,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
11175,DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",['experimental'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
11176,DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",['experimental'],BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
11177,DB04676,Dansyllysine,['experimental'],BE0004610,Ig alpha-2 chain C region,IGHA2,Humans
11178,DB04677,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
11179,DB04678,H TYPE II TRISACCHARIDE,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
11180,DB04679,Human blood group H type 1 trisaccharide,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
11181,DB04680,GALACTOSE GREASE,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
11182,DB04681,BETA-METHYLLACTOSIDE,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
11183,DB04682,Octylphenoxy polyethoxyethanol,['experimental'],BE0003566,"Troponin C, skeletal muscle",TNNC2,Humans
11184,DB04683,"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",['experimental'],BE0003359,Steroidogenic factor 1,NR5A1,Humans
11185,DB04685,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",['experimental'],BE0001205,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,Humans
11188,DB04688,Methylecgonine,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
11189,DB04688,Methylecgonine,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
11190,DB04689,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
11191,DB04690,Camptothecin,['experimental'],BE0000971,DNA topoisomerase 1,TOP1,Humans
11193,DB04695,Farnesyl thiopyrophosphate,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
11194,DB04695,Farnesyl thiopyrophosphate,['experimental'],BE0004094,Mevalonate kinase,MVK,Humans
11198,DB04697,TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
11201,DB04700,GLUTATHIONE SULFINATE,['experimental'],BE0000808,Glutathione S-transferase kappa 1,GSTK1,Humans
11202,DB04701,S-Methyl glutathione,['experimental'],BE0001189,Glutathione S-transferase Mu 2,GSTM2,Humans
11204,DB04703,Hesperidin,"['approved', 'investigational']",BE0003404,Aurora kinase B,AURKB,Humans
11205,DB04707,Hydroxyfasudil,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
11206,DB04707,Hydroxyfasudil,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
11207,DB04707,Hydroxyfasudil,['experimental'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
11208,DB04709,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",['experimental'],BE0000132,Androgen receptor,AR,Humans
11210,DB04714,ISOPENTENYL PYROPHOSPHATE,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
11215,DB04714,ISOPENTENYL PYROPHOSPHATE,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
11216,DB04715,IMIDAZOPYRIDAZIN 1,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
11217,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",['experimental'],BE0003788,Death-associated protein kinase 3,DAPK3,Humans
11218,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",['experimental'],BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
11219,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",['experimental'],BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
11220,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",['experimental'],BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
11221,DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",['experimental'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
11222,DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
11223,DB04720,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
11224,DB04721,"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
11225,DB04722,"2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide",['experimental'],BE0000048,Prothrombin,F2,Humans
11226,DB04723,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
11227,DB04724,"(S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide",['experimental'],BE0000516,Integrin alpha-L,ITGAL,Humans
11228,DB04725,Licofelone,['investigational'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
11229,DB04725,Licofelone,['investigational'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
11230,DB04725,Licofelone,['investigational'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
11231,DB04727,"1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11237,DB04733,"1,6-DI-O-PHOSPHONO-D-MANNITOL",['experimental'],BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
11240,DB04736,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",['experimental'],BE0003077,Peptidoglycan recognition protein 3,PGLYRP3,Humans
11241,DB04738,Motuporin,['experimental'],BE0001447,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,Humans
11242,DB04739,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
11244,DB04741,Myxothiazol,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
11246,DB04743,Nimesulide,"['approved', 'investigational', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
11247,DB04743,Nimesulide,"['approved', 'investigational', 'withdrawn']",BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
11248,DB04743,Nimesulide,"['approved', 'investigational', 'withdrawn']",BE0000994,Lactotransferrin,LTF,Humans
11253,DB04751,Purvalanol A,['experimental'],BE0003958,Casein kinase I isoform gamma-3,CSNK1G3,Humans
11254,DB04751,Purvalanol A,['experimental'],BE0004274,Ribosomal protein S6 kinase alpha-1,RPS6KA1,Humans
11255,DB04751,Purvalanol A,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
11256,DB04752,Phosphatidyl ethanol,['experimental'],BE0003359,Steroidogenic factor 1,NR5A1,Humans
11257,DB04753,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
11258,DB04754,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
11259,DB04757,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",['experimental'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
11260,DB04758,2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),['experimental'],BE0000333,Coagulation factor VII,F7,Humans
11261,DB04759,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
11262,DB04760,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
11263,DB04761,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
11265,DB04763,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
11266,DB04764,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,['experimental'],BE0001474,Tryptase beta-2,TPSB2,Humans
11268,DB04767,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,['experimental'],BE0000333,Coagulation factor VII,F7,Humans
11269,DB04768,Pyrithiamine Pyrophosphate,['experimental'],BE0000157,Thiamin pyrophosphokinase 1,TPK1,Humans
11270,DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
11271,DB04770,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",['experimental'],BE0000042,Pyridoxal kinase,PDXK,Humans
11272,DB04771,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,['experimental'],BE0000048,Prothrombin,F2,Humans
11273,DB04772,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,['experimental'],BE0000048,Prothrombin,F2,Humans
11275,DB04774,Reidispongiolide A,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
11276,DB04775,Reidispongiolide C,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
11277,DB04776,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,['experimental'],BE0000042,Pyridoxal kinase,PDXK,Humans
11279,DB04779,ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
11280,DB04781,5-hydroxyvaleric acid,['experimental'],BE0000050,Delta-aminolevulinic acid dehydratase,ALAD,Humans
11282,DB04783,Sphinxolide B,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
11284,DB04786,Suramin,['investigational'],BE0002401,P2Y purinoceptor 2,P2RY2,Humans
11285,DB04786,Suramin,['investigational'],BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,Humans
11286,DB04786,Suramin,['investigational'],BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
11287,DB04786,Suramin,['investigational'],BE0000739,Ryanodine receptor 1,RYR1,Humans
11288,DB04786,Suramin,['investigational'],BE0000048,Prothrombin,F2,Humans
11289,DB04786,Suramin,['investigational'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
11291,DB04787,Tanaproget,['investigational'],BE0000557,Progesterone receptor,PGR,Humans
11294,DB04789,5-methyltetrahydrofolic acid,"['investigational', 'nutraceutical']",BE0000010,"Aminomethyltransferase, mitochondrial",AMT,Humans
11295,DB04790,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11296,DB04791,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11297,DB04792,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11298,DB04793,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
11300,DB04794,Bifonazole,"['approved', 'investigational']",BE0003549,Cytochrome P450 2B6,CYP2B6,Humans
11301,DB04795,Thenoyltrifluoroacetone,['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
11302,DB04795,Thenoyltrifluoroacetone,['experimental'],BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,Humans
11303,DB04796,Inecalcitol,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
11304,DB04797,Triazolopyridine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
11305,DB04798,THIO-ATPA,['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
11306,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
11307,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
11308,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
11309,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
11310,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
11311,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
11312,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
11313,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
11314,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
11315,DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
11316,DB04800,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
11317,DB04801,cis-Vaccenic acid,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
11318,DB04803,Verdoheme,['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
11319,DB04805,Virginiamycin S1,['experimental'],BE0003832,60S ribosomal protein L37,RPL37,Humans
11324,DB04817,Metamizole,"['approved', 'investigational', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
11325,DB04820,Nialamide,"['approved', 'withdrawn']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
11326,DB04820,Nialamide,"['approved', 'withdrawn']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
11327,DB04820,Nialamide,"['approved', 'withdrawn']",BE0002089,Catechol O-methyltransferase,COMT,Humans
11328,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11329,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
11330,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
11331,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
11332,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0001075,Myeloperoxidase,MPO,Humans
11333,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11334,DB04821,Nomifensine,"['approved', 'withdrawn']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
11335,DB04824,Phenolphthalein,"['approved', 'withdrawn']",BE0003538,UDP-glucuronosyltransferase 1-9,UGT1A9,Humans
11336,DB04824,Phenolphthalein,"['approved', 'withdrawn']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
11337,DB04824,Phenolphthalein,"['approved', 'withdrawn']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
11338,DB04824,Phenolphthalein,"['approved', 'withdrawn']",BE0000123,Estrogen receptor alpha,ESR1,Humans
11339,DB04824,Phenolphthalein,"['approved', 'withdrawn']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
11340,DB04825,Prenylamine,"['approved', 'withdrawn']",BE0000418,Calmodulin,CALM1,Humans
11341,DB04825,Prenylamine,"['approved', 'withdrawn']",BE0004946,"Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK2,Humans
11342,DB04828,Zomepirac,['withdrawn'],BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
11343,DB04829,Lysergic acid diethylamide,"['illicit', 'investigational', 'withdrawn']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11344,DB04829,Lysergic acid diethylamide,"['illicit', 'investigational', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
11345,DB04829,Lysergic acid diethylamide,"['illicit', 'investigational', 'withdrawn']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
11346,DB04832,Zimelidine,"['approved', 'withdrawn']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
11347,DB04832,Zimelidine,"['approved', 'withdrawn']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
11348,DB04832,Zimelidine,"['approved', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11349,DB04834,Rapacuronium,"['approved', 'withdrawn']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
11350,DB04835,Maraviroc,"['approved', 'investigational']",BE0000911,C-C chemokine receptor type 5,CCR5,Humans
11351,DB04836,Amineptine,"['illicit', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11352,DB04836,Amineptine,"['illicit', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11353,DB04837,Clofedanol,"['approved', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
11354,DB04838,Cyclandelate,['approved'],BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
11355,DB04838,Cyclandelate,['approved'],BE0002705,Liver carboxylesterase 1,CES1,Humans
11356,DB04839,Cyproterone acetate,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
11357,DB04839,Cyproterone acetate,"['approved', 'investigational']",BE0008983,Prostate-specific antigen,KLK3,Humans
11358,DB04840,Debrisoquine,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11359,DB04841,Flunarizine,['approved'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
11360,DB04841,Flunarizine,['approved'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
11361,DB04841,Flunarizine,['approved'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
11362,DB04841,Flunarizine,['approved'],BE0000418,Calmodulin,CALM1,Humans
11363,DB04841,Flunarizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
11364,DB04842,Fluspirilene,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
11365,DB04842,Fluspirilene,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11366,DB04842,Fluspirilene,"['approved', 'investigational']",BE0000679,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,Humans
11367,DB04843,Mepenzolate,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
11368,DB04843,Mepenzolate,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
11369,DB04844,Tetrabenazine,"['approved', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
11370,DB04844,Tetrabenazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
11371,DB04845,Ixabepilone,"['approved', 'investigational']",BE0001415,Tubulin beta-3 chain,TUBB3,Humans
11372,DB04846,Celiprolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
11373,DB04846,Celiprolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
11374,DB04846,Celiprolol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
11375,DB04846,Celiprolol,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
11376,DB04846,Celiprolol,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
11377,DB04846,Celiprolol,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
11378,DB04847,Roxadustat,"['approved', 'investigational']",BE0002217,Egl nine homolog 1,EGLN1,Humans
11379,DB04847,Roxadustat,"['approved', 'investigational']",BE0002211,Egl nine homolog 2,EGLN2,Humans
11380,DB04847,Roxadustat,"['approved', 'investigational']",BE0002219,Egl nine homolog 3,EGLN3,Humans
11381,DB04849,Cediranib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11383,DB04850,Posizolid,['investigational'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
11384,DB04851,Biricodar,['investigational'],BE0002369,ATP-binding cassette sub-family B member 5,ABCB5,Humans
11385,DB04851,Biricodar,['investigational'],BE0000785,Multidrug resistance-associated protein 1,ABCC1,Humans
11386,DB04851,Biricodar,['investigational'],BE0001067,ATP-binding cassette sub-family G member 2,ABCG2,Humans
11387,DB04852,Implitapide,['investigational'],BE0000232,Microsomal triglyceride transfer protein large subunit,MTTP,Humans
11388,DB04853,Binodenoson,['investigational'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
11389,DB04854,Febuxostat,['approved'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
11390,DB04855,Dronedarone,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
11391,DB04855,Dronedarone,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
11392,DB04855,Dronedarone,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
11393,DB04855,Dronedarone,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
11394,DB04855,Dronedarone,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
11395,DB04855,Dronedarone,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
11396,DB04855,Dronedarone,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
11397,DB04855,Dronedarone,['approved'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
11398,DB04855,Dronedarone,['approved'],BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
11399,DB04855,Dronedarone,['approved'],BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
11400,DB04855,Dronedarone,['approved'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
11401,DB04855,Dronedarone,['approved'],BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
11402,DB04855,Dronedarone,['approved'],BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
11403,DB04855,Dronedarone,['approved'],BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,Humans
11404,DB04855,Dronedarone,['approved'],BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,Humans
11405,DB04855,Dronedarone,['approved'],BE0000210,Potassium channel subfamily K member 2,KCNK2,Humans
11406,DB04855,Dronedarone,['approved'],BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
11407,DB04855,Dronedarone,['approved'],BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
11408,DB04855,Dronedarone,['approved'],BE0000672,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,Humans
11409,DB04855,Dronedarone,['approved'],BE0009631,Inward rectifier potassium channel,KCNJ12,Humans
11410,DB04855,Dronedarone,['approved'],BE0000986,Sodium/calcium exchanger 1,SLC8A1,Humans
11411,DB04855,Dronedarone,['approved'],BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
11412,DB04855,Dronedarone,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
11413,DB04855,Dronedarone,['approved'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
11414,DB04856,Dexloxiglumide,['investigational'],BE0000402,Cholecystokinin receptor type A,CCKAR,Humans
11415,DB04857,Brasofensine,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11417,DB04859,Zanapezil,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
11418,DB04860,Isatoribine,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
11419,DB04861,Nebivolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
11420,DB04861,Nebivolol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
11421,DB04861,Nebivolol,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
11423,DB04863,Lefradafiban,['investigational'],BE0000439,Integrin alpha-IIb,ITGA2B,Humans
11424,DB04863,Lefradafiban,['investigational'],BE0001155,Integrin beta-3,ITGB3,Humans
11425,DB04864,Huperzine A,"['approved', 'experimental']",BE0000426,Acetylcholinesterase,ACHE,Humans
11427,DB04865,Omacetaxine mepesuccinate,"['approved', 'investigational']",BE0003833,60S ribosomal protein L3,RPL3,Humans
11428,DB04866,Halofuginone,"['investigational', 'vet_approved']",BE0000025,Collagen alpha-1(I) chain,COL1A1,Humans
11429,DB04866,Halofuginone,"['investigational', 'vet_approved']",BE0000642,72 kDa type IV collagenase,MMP2,Humans
11430,DB04867,Lintitript,['investigational'],BE0000402,Cholecystokinin receptor type A,CCKAR,Humans
11431,DB04868,Nilotinib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
11432,DB04868,Nilotinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
11433,DB04869,Olcegepant,['investigational'],BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
11434,DB04869,Olcegepant,['investigational'],BE0001103,Calcitonin gene-related peptide 1,CALCA,Humans
11435,DB04871,Lorcaserin,"['approved', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
11436,DB04872,Osanetant,['investigational'],BE0002371,Neuromedin-K receptor,TACR3,Humans
11437,DB04873,Piboserod,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
11439,DB04875,Pralnacasan,['investigational'],BE0000444,Caspase-1,CASP1,Humans
11440,DB04876,Vildagliptin,"['approved', 'investigational']",BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
11441,DB04877,Voacamine,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
11442,DB04878,Voglibose,['investigational'],BE0000837,"Maltase-glucoamylase, intestinal",MGAM,Humans
11443,DB04879,Vatalanib,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
11444,DB04879,Vatalanib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11445,DB04879,Vatalanib,['investigational'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
11446,DB04880,Enoximone,"['approved', 'investigational']",BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
11447,DB04881,Elacridar,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
11448,DB04882,Edotecarin,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
11449,DB04883,Darusentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
11450,DB04884,Dapoxetine,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11451,DB04884,Dapoxetine,['investigational'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
11452,DB04884,Dapoxetine,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
11453,DB04885,Cilansetron,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
11456,DB04888,Bifeprunox,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11457,DB04888,Bifeprunox,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11458,DB04889,Bicifadine,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11459,DB04889,Bicifadine,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11460,DB04889,Bicifadine,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11461,DB04890,Bepotastine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
11462,DB04891,Becocalcidiol,['investigational'],BE0004382,Mediator of RNA polymerase II transcription subunit 1,MED1,Humans
11463,DB04891,Becocalcidiol,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
11464,DB04892,Phenserine,['investigational'],BE0002180,Cholinesterase,BCHE,Humans
11465,DB04892,Phenserine,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
11466,DB04892,Phenserine,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
11467,DB04893,AZD3409,['investigational'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
11468,DB04893,AZD3409,['investigational'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
11469,DB04894,Vapreotide,"['experimental', 'investigational']",BE0003528,Somatostatin receptor type 2,SSTR2,Humans
11470,DB04894,Vapreotide,"['experimental', 'investigational']",BE0002147,Somatostatin receptor type 5,SSTR5,Humans
11471,DB04894,Vapreotide,"['experimental', 'investigational']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
11472,DB04895,Pegaptanib,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
11473,DB04896,Milnacipran,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11474,DB04896,Milnacipran,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11475,DB04896,Milnacipran,"['approved', 'investigational']",BE0004956,NMDA receptor,GRIN1,Humans
11476,DB04898,Ximelagatran,"['approved', 'investigational', 'withdrawn']",BE0000048,Prothrombin,F2,Humans
11477,DB04899,Nesiritide,"['approved', 'investigational']",BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
11478,DB04899,Nesiritide,"['approved', 'investigational']",BE0000997,Atrial natriuretic peptide receptor 2,NPR2,Humans
11479,DB04899,Nesiritide,"['approved', 'investigational']",BE0002426,Atrial natriuretic peptide receptor 3,NPR3,Humans
11480,DB04901,Galiximab,['investigational'],BE0000847,T-lymphocyte activation antigen CD80,CD80,Humans
11481,DB04903,Pagoclone,['investigational'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
11482,DB04903,Pagoclone,['investigational'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
11483,DB04905,Tesmilifene,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
11484,DB04905,Tesmilifene,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
11485,DB04908,Flibanserin,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11486,DB04908,Flibanserin,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11487,DB04908,Flibanserin,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
11488,DB04910,Oxibendazole,"['investigational', 'vet_approved']",BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
11492,DB04912,Stannsoporfin,['investigational'],BE0000735,Heme oxygenase 1,HMOX1,Humans
11493,DB04912,Stannsoporfin,['investigational'],BE0000587,Heme oxygenase 2,HMOX2,Humans
11494,DB04915,Idronoxil,['investigational'],BE0002434,Ecto-NOX disulfide-thiol exchanger 2,ENOX2,Humans
11495,DB04917,Renzapride,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
11496,DB04917,Renzapride,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
11500,DB04919,Alfimeprase,['investigational'],BE0000538,Fibrinogen alpha chain,FGA,Humans
11501,DB04919,Alfimeprase,['investigational'],BE0002091,Fibrinogen beta chain,FGB,Humans
11502,DB04920,Clevidipine,"['approved', 'investigational']",BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
11503,DB04920,Clevidipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
11504,DB04920,Clevidipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
11505,DB04920,Clevidipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
11506,DB04924,Itopride,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11507,DB04924,Itopride,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
11508,DB04925,Desmoteplase,['investigational'],BE0000211,Plasminogen,PLG,Humans
11509,DB04926,Neramexane,['investigational'],BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
11510,DB04929,DG031,['investigational'],BE0002382,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,Humans
11511,DB04930,Permethrin,"['approved', 'investigational']",BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
11512,DB04930,Permethrin,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
11513,DB04930,Permethrin,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
11514,DB04931,Afamelanotide,"['approved', 'investigational']",BE0002447,Melanocyte-stimulating hormone receptor,MC1R,Humans
11515,DB04932,Defibrotide,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
11516,DB04932,Defibrotide,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
11517,DB04932,Defibrotide,"['approved', 'investigational']",BE0000241,Adenosine receptor A2b,ADORA2B,Humans
11518,DB04933,Eritoran,['investigational'],BE0002442,Toll-like receptor 4,TLR4,Humans
11520,DB04938,Ospemifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
11521,DB04941,Crofelemer,['approved'],BE0004746,Anoctamin-1,ANO1,Humans
11522,DB04941,Crofelemer,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
11523,DB04942,Tamibarotene,['investigational'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
11524,DB04942,Tamibarotene,['investigational'],BE0000206,Retinoic acid receptor beta,RARB,Humans
11525,DB04946,Iloperidone,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11526,DB04946,Iloperidone,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11527,DB04946,Iloperidone,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
11528,DB04946,Iloperidone,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
11529,DB04946,Iloperidone,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
11530,DB04946,Iloperidone,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11531,DB04946,Iloperidone,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
11532,DB04946,Iloperidone,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
11533,DB04946,Iloperidone,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
11534,DB04946,Iloperidone,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
11535,DB04946,Iloperidone,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
11536,DB04947,Altropane,['investigational'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
11537,DB04948,Lofexidine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
11538,DB04948,Lofexidine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
11539,DB04948,Lofexidine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11540,DB04948,Lofexidine,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
11541,DB04948,Lofexidine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
11542,DB04948,Lofexidine,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
11544,DB04953,Ezogabine,"['approved', 'investigational']",BE0000897,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,Humans
11545,DB04953,Ezogabine,"['approved', 'investigational']",BE0002398,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,Humans
11546,DB04953,Ezogabine,"['approved', 'investigational']",BE0002399,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,Humans
11547,DB04953,Ezogabine,"['approved', 'investigational']",BE0002400,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,Humans
11548,DB04954,Tecadenoson,['investigational'],BE0000013,Adenosine receptor A1,ADORA1,Humans
11549,DB04956,Afelimomab,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11550,DB04957,Azimilide,['investigational'],BE0000489,Potassium voltage-gated channel subfamily E member 1,KCNE1,Humans
11551,DB04957,Azimilide,['investigational'],BE0000672,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,Humans
11552,DB04957,Azimilide,['investigational'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
11553,DB04958,Epratuzumab,['investigational'],BE0000183,B-cell receptor CD22,CD22,Humans
11554,DB04959,Verpasep caltespen,['investigational'],BE0002459,"Keratin, type II cytoskeletal 7",KRT7,Humans
11555,DB04959,Verpasep caltespen,['investigational'],BE0002460,E3 ubiquitin-protein ligase UBR4,UBR4,Humans
11556,DB04960,Tipifarnib,['investigational'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
11558,DB04964,Oregovomab,['investigational'],BE0002439,Mucin-16,MUC16,Humans
11559,DB04967,Lucanthone,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11560,DB04967,Lucanthone,['investigational'],BE0002414,DNA-(apurinic or apyrimidinic site) lyase,APEX1,Humans
11562,DB04967,Lucanthone,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
11563,DB04970,Lesopitron,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11564,DB04971,Reglitazar,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
11565,DB04971,Reglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
11566,DB04972,Canfosfamide,['investigational'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
11567,DB04973,LErafAON,['investigational'],BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
11568,DB04974,Rimiducid,['investigational'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
11569,DB04975,Banoxantrone,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11570,DB04977,Plitidepsin,['investigational'],BE0010196,Elongation factor 1-alpha 2,EEF1A2,Humans
11571,DB04978,SP1049C,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11572,DB04982,Talampanel,['investigational'],BE0000640,Glutamate receptor 1,GRIA1,Humans
11573,DB04982,Talampanel,['investigational'],BE0000829,Glutamate receptor 2,GRIA2,Humans
11574,DB04982,Talampanel,['investigational'],BE0000831,Glutamate receptor 3,GRIA3,Humans
11575,DB04982,Talampanel,['investigational'],BE0000830,Glutamate receptor 4,GRIA4,Humans
11576,DB04983,Denufosol,['investigational'],BE0002401,P2Y purinoceptor 2,P2RY2,Humans
11577,DB04985,Tigapotide,['investigational'],BE0002402,40S ribosomal protein SA,RPSA,Humans
11578,DB04988,IGN311,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
11579,DB04988,IGN311,['investigational'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
11580,DB04991,XL784,['investigational'],BE0002404,Disintegrin and metalloproteinase domain-containing protein 10,ADAM10,Humans
11583,DB04997,ATL1102,['investigational'],BE0000590,Integrin alpha-4,ITGA4,Humans
11584,DB04998,AGRO100,['investigational'],BE0002394,NF-kappa-B essential modulator,IKBKG,Humans
11585,DB05001,PSN9301,['investigational'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
11586,DB05003,Imexon,['investigational'],BE0002450,Ribonucleoside-diphosphate reductase subunit M2,RRM2,Humans
11587,DB05003,Imexon,['investigational'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
11588,DB05004,Peptide YY (3-36),['investigational'],BE0002419,Neuropeptide Y receptor type 2,NPY2R,Humans
11589,DB05004,Peptide YY (3-36),['investigational'],BE0002451,Neuropeptide Y receptor type 1,NPY1R,Humans
11590,DB05004,Peptide YY (3-36),['investigational'],BE0002452,Neuropeptide Y receptor type 5,NPY5R,Humans
11591,DB05004,Peptide YY (3-36),['investigational'],BE0002418,Neuropeptide Y receptor type 4,NPY4R,Humans
11592,DB05009,Apadenoson,['investigational'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
11593,DB05010,SGS-742,['investigational'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
11594,DB05010,SGS-742,['investigational'],BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,Humans
11595,DB05012,XEN-2174,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
11596,DB05013,Ingenol mebutate,['approved'],BE0002417,Protein kinase C delta type,PRKCD,Humans
11597,DB05013,Ingenol mebutate,['approved'],BE0001132,Protein kinase C alpha type,PRKCA,Humans
11598,DB05014,XL999,['investigational'],BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
11599,DB05014,XL999,['investigational'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
11600,DB05014,XL999,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11601,DB05014,XL999,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
11602,DB05014,XL999,['investigational'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
11603,DB05014,XL999,['investigational'],BE0001104,RET proto-oncogene,RET,Humans
11604,DB05015,Belinostat,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
11605,DB05017,YSIL6,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11606,DB05017,YSIL6,['investigational'],BE0000918,Interleukin-6,IL6,Humans
11607,DB05018,Migalastat,"['approved', 'investigational']",BE0002422,Alpha-galactosidase A,GLA,Humans
11609,DB05022,Amonafide,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11610,DB05022,Amonafide,['investigational'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
11611,DB05023,ATL1101,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
11612,DB05024,CTA018,['investigational'],BE0002250,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",CYP24A1,Humans
11613,DB05024,CTA018,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
11614,DB05025,Arimoclomol,['investigational'],BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
11615,DB05032,REV131,['investigational'],BE0000146,Histamine H4 receptor,HRH4,Humans
11616,DB05033,INCB7839,['investigational'],BE0003412,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,Humans
11617,DB05034,Ularitide,['investigational'],BE0000556,Atrial natriuretic peptide receptor 1,NPR1,Humans
11618,DB05035,Eprotirome,['investigational'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
11619,DB05035,Eprotirome,['investigational'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
11620,DB05036,Grn163l,['investigational'],BE0002478,Telomerase-binding protein EST1A,SMG6,Humans
11621,DB05036,Grn163l,['investigational'],BE0002479,N-terminal kinase-like protein,SCYL1,Humans
11622,DB05036,Grn163l,['investigational'],BE0002480,Prostaglandin E synthase 3,PTGES3,Humans
11623,DB05036,Grn163l,['investigational'],BE0002449,Telomerase reverse transcriptase,TERT,Humans
11624,DB05038,Anatibant,['investigational'],BE0003513,B2 bradykinin receptor,BDKRB2,Humans
11625,DB05039,Indacaterol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
11626,DB05042,SGS518,['investigational'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
11628,DB05045,Obinepitide,['investigational'],BE0002418,Neuropeptide Y receptor type 4,NPY4R,Humans
11629,DB05045,Obinepitide,['investigational'],BE0002419,Neuropeptide Y receptor type 2,NPY2R,Humans
11630,DB05046,V1003,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
11631,DB05046,V1003,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
11632,DB05047,CX-717,"['illicit', 'investigational']",BE0003394,Brain-derived neurotrophic factor,BDNF,Humans
11633,DB05047,CX-717,"['illicit', 'investigational']",BE0000640,Glutamate receptor 1,GRIA1,Humans
11634,DB05047,CX-717,"['illicit', 'investigational']",BE0000829,Glutamate receptor 2,GRIA2,Humans
11635,DB05047,CX-717,"['illicit', 'investigational']",BE0000831,Glutamate receptor 3,GRIA3,Humans
11636,DB05047,CX-717,"['illicit', 'investigational']",BE0000830,Glutamate receptor 4,GRIA4,Humans
11637,DB05049,DDP733,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
11638,DB05050,ADL5859,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
11639,DB05052,MF101,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
11640,DB05053,MB-07803,['investigational'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
11642,DB05064,INCB13739,['investigational'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
11643,DB05069,ATG003,['investigational'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
11644,DB05069,ATG003,['investigational'],BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
11645,DB05070,ADX10059,['investigational'],BE0001192,Metabotropic glutamate receptor 5,GRM5,Humans
11646,DB05072,AV608,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
11647,DB05075,TG-100801,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
11648,DB05075,TG-100801,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11649,DB05075,TG-100801,['investigational'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
11650,DB05075,TG-100801,['investigational'],BE0001356,Tyrosine-protein kinase CSK,CSK,Humans
11651,DB05077,SLV319,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
11652,DB05078,AER001,['investigational'],BE0002420,Interleukin-4 receptor subunit alpha,IL4R,Humans
11653,DB05078,AER001,['investigational'],BE0002421,Interleukin-13 receptor subunit alpha-2,IL13RA2,Humans
11654,DB05079,HY10275,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
11655,DB05079,HY10275,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11656,DB05080,OBE101,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
11657,DB05080,OBE101,['investigational'],BE0000968,Histamine H3 receptor,HRH3,Humans
11658,DB05084,Abaloparatide,"['approved', 'investigational']",BE0003508,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Humans
11659,DB05085,TM30339,['investigational'],BE0002418,Neuropeptide Y receptor type 4,NPY4R,Humans
11660,DB05087,Ganaxolone,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
11661,DB05088,Tetrathiomolybdate,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
11662,DB05091,M0002,['investigational'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
11663,DB05092,CDP323,['investigational'],BE0000590,Integrin alpha-4,ITGA4,Humans
11664,DB05095,Cimicoxib,['investigational'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
11665,DB05096,LY2140023,['investigational'],BE0000974,Metabotropic glutamate receptor 2,GRM2,Humans
11666,DB05096,LY2140023,['investigational'],BE0002342,Metabotropic glutamate receptor 3,GRM3,Humans
11667,DB05097,Labetuzumab,['investigational'],BE0004224,Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,Humans
11668,DB05098,Leptin,['investigational'],BE0003376,Leptin receptor,LEPR,Humans
11669,DB05099,Ancrod,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
11670,DB05101,Matuzumab,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
11672,DB05103,AN-9,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
11673,DB05103,AN-9,['investigational'],BE0003460,Caspase-8,CASP8,Humans
11674,DB05104,Asimadoline,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
11676,DB05107,16-Bromoepiandrosterone,['investigational'],BE0001089,Glucose-6-phosphate 1-dehydrogenase,G6PD,Humans
11678,DB05110,VIR201,['investigational'],BE0000944,Interferon gamma,IFNG,Humans
11679,DB05111,Fontolizumab,['investigational'],BE0000944,Interferon gamma,IFNG,Humans
11680,DB05115,NN344,['investigational'],BE0000033,Insulin receptor,INSR,Humans
11681,DB05116,Thymectacin,['investigational'],BE0000324,Thymidylate synthase,TYMS,Humans
11682,DB05119,Rilapladib,['investigational'],BE0002409,Platelet-activating factor acetylhydrolase,PLA2G7,Humans
11683,DB05120,AT1391,['investigational'],BE0000033,Insulin receptor,INSR,Humans
11684,DB05121,1D09C3,['investigational'],BE0004790,HLA-DR,HLA-DRA,Humans
11685,DB05122,R1295,['investigational'],BE0000590,Integrin alpha-4,ITGA4,Humans
11686,DB05122,R1295,['investigational'],BE0003298,Integrin beta-4,ITGB4,Humans
11687,DB05122,R1295,['investigational'],BE0003414,Integrin beta-7,ITGB7,Humans
11688,DB05125,SC12267,['investigational'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
11689,DB05127,ANA971,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
11691,DB05129,Elsamitrucin,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
11692,DB05129,Elsamitrucin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
11693,DB05130,INCB3284,['investigational'],BE0003387,C-C chemokine receptor type 2,CCR2,Humans
11694,DB05131,TTP889,['investigational'],BE0000364,Coagulation factor IX,F9,Humans
11695,DB05133,VP025,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
11696,DB05134,Tanespimycin,['investigational'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
11697,DB05134,Tanespimycin,['investigational'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
11698,DB05137,Lobeline,['investigational'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
11699,DB05137,Lobeline,['investigational'],BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
11700,DB05137,Lobeline,['investigational'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
11701,DB05139,CR002,['investigational'],BE0003411,Platelet-derived growth factor D,PDGFD,Humans
11702,DB05141,LY2181308,['investigational'],BE0003408,Baculoviral IAP repeat-containing protein 5,BIRC5,Humans
11703,DB05142,ND7001,['investigational'],BE0003393,"Phosphodiesterase 2A, cGMP-stimulated",PDE2A,Humans
11704,DB05142,ND7001,['investigational'],BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,Humans
11705,DB05146,XL820,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11706,DB05146,XL820,['investigational'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
11707,DB05146,XL820,['investigational'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
11708,DB05146,XL820,['investigational'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
11709,DB05147,CYT997,['investigational'],BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
11710,DB05147,CYT997,['investigational'],BE0001275,Tubulin alpha-1B chain,TUBA1B,Humans
11711,DB05147,CYT997,['investigational'],BE0001388,Tubulin alpha-1C chain,TUBA1C,Humans
11712,DB05147,CYT997,['investigational'],BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
11713,DB05147,CYT997,['investigational'],BE0001425,Tubulin alpha-3C/D chain,TUBA3C,Humans
11714,DB05147,CYT997,['investigational'],BE0003397,Tubulin alpha-3E chain,TUBA3E,Humans
11715,DB05147,CYT997,['investigational'],BE0003398,Putative tubulin-like protein alpha-4B,TUBA4B,Humans
11716,DB05147,CYT997,['investigational'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
11717,DB05147,CYT997,['investigational'],BE0003400,Tubulin beta-2A chain,TUBB2A,Humans
11718,DB05147,CYT997,['investigational'],BE0003401,Tubulin beta-2B chain,TUBB2B,Humans
11719,DB05147,CYT997,['investigational'],BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
11720,DB05147,CYT997,['investigational'],BE0001415,Tubulin beta-3 chain,TUBB3,Humans
11721,DB05147,CYT997,['investigational'],BE0001408,Tubulin beta-4A chain,TUBB4A,Humans
11722,DB05147,CYT997,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
11723,DB05147,CYT997,['investigational'],BE0003402,Tubulin beta-6 chain,TUBB6,Humans
11724,DB05149,XL844,['investigational'],BE0003381,Serine/threonine-protein kinase Chk2,CHEK2,Humans
11725,DB05149,XL844,['investigational'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
11726,DB05150,CAD106,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
11727,DB05152,NGX267,['investigational'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
11733,DB05155,CR665,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
11734,DB05157,KC706,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
11735,DB05157,KC706,['investigational'],BE0003390,Mitogen-activated protein kinase 11,MAPK11,Humans
11736,DB05157,KC706,['investigational'],BE0002790,Mitogen-activated protein kinase 12,MAPK12,Humans
11737,DB05157,KC706,['investigational'],BE0003391,Mitogen-activated protein kinase 13,MAPK13,Humans
11738,DB05159,CCX915,['investigational'],BE0003387,C-C chemokine receptor type 2,CCR2,Humans
11739,DB05161,Elafin,['investigational'],BE0000394,Neutrophil elastase,ELANE,Humans
11740,DB05161,Elafin,['investigational'],BE0000954,Myeloblastin,PRTN3,Humans
11742,DB05165,LY2275796,['investigational'],BE0000957,Eukaryotic translation initiation factor 4E,EIF4E,Humans
11743,DB05166,APD668,['investigational'],BE0003378,Glucose-dependent insulinotropic receptor,GPR119,Humans
11744,DB05168,Vintafolide,['investigational'],BE0000271,Folate receptor beta,FOLR2,Humans
11745,DB05168,Vintafolide,['investigational'],BE0000652,Folate receptor gamma,FOLR3,Humans
11746,DB05168,Vintafolide,['investigational'],BE0003405,Folate receptor alpha,FOLR1,Humans
11747,DB05169,AT9283,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
11748,DB05169,AT9283,['investigational'],BE0003404,Aurora kinase B,AURKB,Humans
11749,DB05171,E-2012,['investigational'],BE0003409,Gamma-secretase subunit APH-1A,APH1A,Humans
11750,DB05171,E-2012,['investigational'],BE0003410,Gamma-secretase subunit PEN-2,PSENEN,Humans
11751,DB05177,DG051,['investigational'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
11752,DB05183,MLN0415,['investigational'],BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
11753,DB05184,XL228,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
11754,DB05184,XL228,['investigational'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
11755,DB05184,XL228,['investigational'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
11756,DB05184,XL228,['investigational'],BE0000435,Abelson tyrosine-protein kinase 2,ABL2,Humans
11757,DB05187,Elafibranor,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
11758,DB05187,Elafibranor,['investigational'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
11759,DB05187,Elafibranor,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
11760,DB05188,KD3010,['investigational'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
11761,DB05190,XL281,['investigational'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
11762,DB05190,XL281,['investigational'],BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
11763,DB05191,Atl146e,['investigational'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
11764,DB05192,MB07811,['investigational'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
11765,DB05194,KB002,['investigational'],BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
11766,DB05194,KB002,['investigational'],BE0002481,Granulocyte-macrophage colony-stimulating factor,CSF2,Humans
11767,DB05194,KB002,['investigational'],BE0002482,GM-CSF receptor alpha subunit,CSF2RA,Humans
11768,DB05198,CYC116,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
11769,DB05198,CYC116,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
11770,DB05199,LX1031,['investigational'],BE0000121,Tryptophan 5-hydroxylase 1,TPH1,Humans
11771,DB05200,AT2220,['investigational'],BE0000876,Lysosomal alpha-glucosidase,GAA,Humans
11772,DB05201,V24343,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
11773,DB05202,Egaptivon pegol,['investigational'],BE0001043,von Willebrand factor,VWF,Humans
11774,DB05202,Egaptivon pegol,['investigational'],BE0001025,Platelet glycoprotein Ib alpha chain,GP1BA,Humans
11775,DB05203,SPP1148,['investigational'],BE0000270,Renin,REN,Humans
11776,DB05203,SPP1148,['investigational'],BE0000982,Angiotensin-converting enzyme 2,ACE2,Humans
11777,DB05204,XL418,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
11778,DB05205,CX157,['investigational'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
11779,DB05207,SD118,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11780,DB05207,SD118,['investigational'],BE0000565,Interleukin-1 receptor type 1,IL1R1,Humans
11781,DB05209,Rozrolimupab,['investigational'],BE0002389,Rhesus blood group D antigen,RHD,Humans
11782,DB05210,SF1126,['investigational'],BE0000955,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,Humans
11783,DB05210,SF1126,['investigational'],BE0002383,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,Humans
11784,DB05210,SF1126,['investigational'],BE0002384,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,Humans
11785,DB05210,SF1126,['investigational'],BE0002385,DNA-dependent protein kinase catalytic subunit,PRKDC,Humans
11786,DB05210,SF1126,['investigational'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
11787,DB05212,HE3286,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
11788,DB05212,HE3286,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
11789,DB05214,KD7040,['investigational'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
11790,DB05217,GMX1777,['investigational'],BE0002413,Nicotinamide phosphoribosyltransferase,NAMPT,Humans
11791,DB05218,PN0621,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11792,DB05219,Crisaborole,"['approved', 'investigational']",BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
11793,DB05219,Crisaborole,"['approved', 'investigational']",BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
11794,DB05219,Crisaborole,"['approved', 'investigational']",BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
11795,DB05219,Crisaborole,"['approved', 'investigational']",BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
11796,DB05220,Alisertib,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
11798,DB05223,Pracinostat,['investigational'],BE0002365,Histone deacetylase 1,HDAC1,Humans
11799,DB05223,Pracinostat,['investigational'],BE0002366,Histone deacetylase 2,HDAC2,Humans
11800,DB05223,Pracinostat,['investigational'],BE0002367,Histone deacetylase 3,HDAC3,Humans
11801,DB05223,Pracinostat,['investigational'],BE0002368,Histone deacetylase 6,HDAC6,Humans
11803,DB05225,AM103,['investigational'],BE0002382,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,Humans
11805,DB05227,APD791,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11807,DB05229,Beraprost,['investigational'],BE0000475,Prostacyclin receptor,PTGIR,Humans
11808,DB05232,Tetrodotoxin,['investigational'],BE0000141,Sodium channel protein type 1 subunit alpha,SCN1A,Humans
11809,DB05232,Tetrodotoxin,['investigational'],BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
11810,DB05232,Tetrodotoxin,['investigational'],BE0002082,Sodium channel protein type 3 subunit alpha,SCN3A,Humans
11811,DB05232,Tetrodotoxin,['investigational'],BE0002084,Sodium channel protein type 8 subunit alpha,SCN8A,Humans
11812,DB05233,AP1081,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
11813,DB05234,LGD2941,['investigational'],BE0000132,Androgen receptor,AR,Humans
11814,DB05235,NRP409,['investigational'],BE0000104,Ketimine reductase mu-crystallin,CRYM,Humans
11815,DB05235,NRP409,['investigational'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
11816,DB05239,Cobimetinib,"['approved', 'investigational']",BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
11817,DB05241,XL765,['investigational'],BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
11818,DB05241,XL765,['investigational'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
11819,DB05241,XL765,['investigational'],BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
11820,DB05241,XL765,['investigational'],BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,Humans
11821,DB05241,XL765,['investigational'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
11822,DB05243,XL019,['investigational'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
11824,DB05246,Methsuximide,['approved'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
11825,DB05249,FavId,['investigational'],BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
11826,DB05252,Fenoxaprop-ethyl,['investigational'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
11827,DB05253,Telapristone acetate,['investigational'],BE0000557,Progesterone receptor,PGR,Humans
11828,DB05254,Fibrinolysin,['investigational'],BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
11829,DB05254,Fibrinolysin,['investigational'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
11830,DB05255,Ronacaleret,['investigational'],BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
11831,DB05258,Interferon alfa,['investigational'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
11832,DB05259,Glatiramer,"['approved', 'investigational']",BE0002416,"HLA class II histocompatibility antigen, DRB1-1 beta chain",HLA-DRB1,Humans
11833,DB05259,Glatiramer,"['approved', 'investigational']",BE0009777,"HLA class II histocompatibility antigen, DRB1-15 beta chain",HLA-DRB1,Humans
11834,DB05259,Glatiramer,"['approved', 'investigational']",BE0009774,"HLA class II histocompatibility antigen, DRB1-4 beta chain",HLA-DRB1,Humans
11835,DB05260,Gallium nitrate,"['approved', 'investigational']",BE0002450,Ribonucleoside-diphosphate reductase subunit M2,RRM2,Humans
11836,DB05260,Gallium nitrate,"['approved', 'investigational']",BE0003813,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,Humans
11837,DB05260,Gallium nitrate,"['approved', 'investigational']",BE0000724,Osteocalcin,BGLAP,Humans
11839,DB05260,Gallium nitrate,"['approved', 'investigational']",BE0001051,Interleukin-1 beta,IL1B,Humans
11841,DB05262,Oxypurinol,['investigational'],BE0002204,Xanthine dehydrogenase/oxidase,XDH,Humans
11842,DB05264,NPI 32101,['investigational'],BE0002115,Cytokine receptor common subunit beta,CSF2RB,Humans
11844,DB05265,Ecabet,['investigational'],BE0002423,NADPH oxidase organizer 1,NOXO1,Humans
11845,DB05266,Ibudilast,['investigational'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
11846,DB05266,Ibudilast,['investigational'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
11847,DB05266,Ibudilast,['investigational'],BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
11848,DB05266,Ibudilast,['investigational'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
11849,DB05266,Ibudilast,['investigational'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
11850,DB05268,iCo-007,['investigational'],BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
11851,DB05271,Rotigotine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
11852,DB05271,Rotigotine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
11853,DB05271,Rotigotine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
11854,DB05271,Rotigotine,['approved'],BE0000145,Dopamine D5 receptor,DRD5,Humans
11855,DB05271,Rotigotine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
11856,DB05271,Rotigotine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11857,DB05271,Rotigotine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
11859,DB05282,MCC,['investigational'],BE0000965,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,Humans
11860,DB05284,CA4P,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
11861,DB05289,Tarenflurbil,['investigational'],BE0002394,NF-kappa-B essential modulator,IKBKG,Humans
11862,DB05290,SPP 301,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
11863,DB05294,Vandetanib,['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
11864,DB05294,Vandetanib,['approved'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
11865,DB05294,Vandetanib,['approved'],BE0004731,Protein-tyrosine kinase 6,PTK6,Humans
11866,DB05294,Vandetanib,['approved'],BE0003379,Angiopoietin-1 receptor,TEK,Humans
11867,DB05294,Vandetanib,['approved'],BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
11868,DB05295,Eldecalcitol,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
11869,DB05297,Paclitaxel docosahexaenoic acid,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
11870,DB05298,Tetomilast,['investigational'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
11871,DB05299,Keyhole limpet hemocyanin,"['approved', 'investigational']",BE0001029,Interleukin-2,IL2,Humans
11872,DB05301,LAX-101,['investigational'],BE0002181,Phospholipase D1,PLD1,Humans
11873,DB05301,LAX-101,['investigational'],BE0000444,Caspase-1,CASP1,Humans
11874,DB05303,OMS-103HP,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11875,DB05303,OMS-103HP,['investigational'],BE0000565,Interleukin-1 receptor type 1,IL1R1,Humans
11876,DB05304,Girentuximab,['investigational'],BE0002437,Carbonic anhydrase 9,CA9,Humans
11877,DB05304,Girentuximab,['investigational'],BE0001029,Interleukin-2,IL2,Humans
11878,DB05305,Cintredekin besudotox,['investigational'],BE0002438,Interleukin-13,IL13,Humans
11879,DB05308,ANX-510,['investigational'],BE0000324,Thymidylate synthase,TYMS,Humans
11880,DB05309,TP-508,['investigational'],BE0000326,Fibroblast growth factor 4,FGF4,Humans
11881,DB05311,Ecallantide,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
11882,DB05316,Pimavanserin,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
11883,DB05316,Pimavanserin,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
11884,DB05316,Pimavanserin,"['approved', 'investigational']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
11885,DB05317,TAK-475,['investigational'],BE0002444,Squalene synthase,FDFT1,Humans
11886,DB05317,TAK-475,['investigational'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
11887,DB05319,Oportuzumab monatox,['investigational'],BE0002446,Epithelial cell adhesion molecule,EPCAM,Humans
11889,DB05327,Ranirestat,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
11891,DB05332,Romiplostim,['approved'],BE0003440,Thrombopoietin receptor,MPL,Humans
11892,DB05337,SOT-107,['investigational'],BE0002455,Glioma pathogenesis-related protein 1,GLIPR1,Humans
11893,DB05339,MN-305,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
11894,DB05343,Arundic acid,['investigational'],BE0001177,Protein S100-B,S100B,Humans
11895,DB05345,SO-101,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
11896,DB05351,Dexlansoprazole,"['approved', 'investigational']",BE0000619,Potassium-transporting ATPase subunit beta,ATP4B,Humans
11897,DB05351,Dexlansoprazole,"['approved', 'investigational']",BE0000349,Potassium-transporting ATPase alpha chain 1,ATP4A,Humans
11898,DB05351,Dexlansoprazole,"['approved', 'investigational']",BE0000766,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,Humans
11899,DB05361,SR-123781A,['investigational'],BE0000280,Antithrombin-III,SERPINC1,Humans
11900,DB05361,SR-123781A,['investigational'],BE0000928,Proteinase-activated receptor 1,F2R,Humans
11901,DB05362,SSR-126517E,['investigational'],BE0000216,Coagulation factor X,F10,Humans
11902,DB05364,ROX-888,['investigational'],BE0002471,C-C motif chemokine 3,CCL3,Humans
11903,DB05367,Actelion-1,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
11904,DB05369,HZT-501,['investigational'],BE0000112,Histamine H2 receptor,HRH2,Humans
11905,DB05374,Rindopepimut,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
11906,DB05381,Histamine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
11907,DB05381,Histamine,"['approved', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
11908,DB05381,Histamine,"['approved', 'investigational']",BE0000968,Histamine H3 receptor,HRH3,Humans
11909,DB05381,Histamine,"['approved', 'investigational']",BE0000146,Histamine H4 receptor,HRH4,Humans
11910,DB05381,Histamine,"['approved', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
11911,DB05382,Iodine,"['approved', 'investigational']",BE0009346,Sodium/iodide cotransporter,SLC5A5,Humans
11913,DB05383,Pimagedine,['investigational'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
11914,DB05383,Pimagedine,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
11915,DB05383,Pimagedine,['investigational'],BE0003371,Metalloproteinase inhibitor 3,TIMP3,Humans
11916,DB05383,Pimagedine,['investigational'],BE0000351,Amiloride-sensitive amine oxidase [copper-containing],AOC1,Humans
11917,DB05386,Regramostim,['investigational'],BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
11918,DB05386,Regramostim,['investigational'],BE0002482,GM-CSF receptor alpha subunit,CSF2RA,Humans
11919,DB05387,AE-941,['investigational'],BE0000642,72 kDa type IV collagenase,MMP2,Humans
11920,DB05387,AE-941,['investigational'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
11921,DB05387,AE-941,['investigational'],BE0001198,Macrophage metalloelastase,MMP12,Humans
11922,DB05389,Tetrachlorodecaoxide,"['approved', 'investigational']",BE0003374,Macrophage erythroblast attacher,MAEA,Humans
11923,DB05389,Tetrachlorodecaoxide,"['approved', 'investigational']",BE0003375,Scavenger receptor cysteine-rich type 1 protein M130,CD163,Humans
11924,DB05390,INS 316,['investigational'],BE0002401,P2Y purinoceptor 2,P2RY2,Humans
11925,DB05391,liposomal prostaglandin E1,['investigational'],BE0001025,Platelet glycoprotein Ib alpha chain,GP1BA,Humans
11926,DB05395,Amibegron,['investigational'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
11928,DB05398,C31G,['investigational'],BE0003377,CD9 antigen,CD9,Humans
11929,DB05399,Succinobucol,['investigational'],BE0001114,Vascular cell adhesion protein 1,VCAM1,Humans
11930,DB05403,CEP-1347,['investigational'],BE0002790,Mitogen-activated protein kinase 12,MAPK12,Humans
11931,DB05404,AZD 3355,['investigational'],BE0003380,Cellular tumor antigen p53,TP53,Humans
11932,DB05407,TBC-3711,['investigational'],BE0003384,Endothelin-1,EDN1,Humans
11933,DB05408,Emricasan,['investigational'],BE0000444,Caspase-1,CASP1,Humans
11934,DB05408,Emricasan,['investigational'],BE0001162,Caspase-3,CASP3,Humans
11935,DB05408,Emricasan,['investigational'],BE0001826,Caspase-7,CASP7,Humans
11936,DB05412,Talmapimod,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
11937,DB05412,Talmapimod,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11938,DB05412,Talmapimod,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
11939,DB05412,Talmapimod,['investigational'],BE0003385,Cytochrome c oxidase subunit 2,MT-CO2,Humans
11940,DB05413,Tifuvirtide,['investigational'],BE0002112,Plasma serine protease inhibitor,SERPINA5,Humans
11942,DB05415,OSI-461,['investigational'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
11943,DB05416,Cardarine,['investigational'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
11944,DB05416,Cardarine,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
11945,DB05417,GW 468816,['investigational'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
11946,DB05418,GW 597599,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
11947,DB05419,ADX-10061,['investigational'],BE0000666,Neuron-specific vesicular protein calcyon,CALY,Humans
11948,DB05420,Gallium maltolate,['investigational'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
11949,DB05421,CP-122721,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
11950,DB05422,OPC-14523,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
11951,DB05423,ORG-34517,['investigational'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
11952,DB05424,Canertinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
11953,DB05428,Motexafin gadolinium,['investigational'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
11954,DB05428,Motexafin gadolinium,['investigational'],BE0003388,"Thioredoxin reductase 2, mitochondrial",TXNRD2,Humans
11955,DB05428,Motexafin gadolinium,['investigational'],BE0002450,Ribonucleoside-diphosphate reductase subunit M2,RRM2,Humans
11956,DB05429,CAT-213,['investigational'],BE0003389,Eotaxin,CCL11,Humans
11957,DB05431,MLN-977,['investigational'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
11958,DB05432,DAS-431 IV,['investigational'],BE0000666,Neuron-specific vesicular protein calcyon,CALY,Humans
11959,DB05434,ABT-510,['investigational'],BE0001015,Fibroblast growth factor 2,FGF2,Humans
11960,DB05434,ABT-510,['investigational'],BE0001121,Hepatocyte growth factor,HGF,Humans
11961,DB05434,ABT-510,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
11962,DB05434,ABT-510,['investigational'],BE0000961,Interleukin-8,CXCL8,Humans
11963,DB05442,Etiprednol dicloacetate,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
11964,DB05443,ADL 10-0101,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
11965,DB05446,LJP 1082,['investigational'],BE0002854,Beta-2-glycoprotein 1,APOH,Humans
11966,DB05447,AVI-4557,['investigational'],BE0004019,Hepatocyte nuclear factor 4-alpha,HNF4A,Humans
11967,DB05448,PX-12,['investigational'],BE0001979,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Humans
11968,DB05449,FM-VP4,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
11969,DB05451,P54,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
11970,DB05451,P54,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
11971,DB05452,PH-284,['investigational'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
11972,DB05452,PH-284,['investigational'],BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
11973,DB05455,SR 121463,['investigational'],BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
11974,DB05457,OSI-7904L,['investigational'],BE0000324,Thymidylate synthase,TYMS,Humans
11975,DB05458,Pozanicline,['investigational'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
11976,DB05458,Pozanicline,['investigational'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
11977,DB05459,Briakinumab,['investigational'],BE0000981,Interleukin-12 subunit beta,IL12B,Humans
11978,DB05459,Briakinumab,['investigational'],BE0003415,Interleukin-23 subunit alpha,IL23A,Humans
11979,DB05460,Ezatiostat,['investigational'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
11980,DB05461,OPC-28326,['investigational'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
11981,DB05461,OPC-28326,['investigational'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
11982,DB05461,OPC-28326,['investigational'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
11983,DB05463,ISS-1018,['investigational'],BE0001171,Toll-like receptor 9,TLR9,Humans
11984,DB05464,NOX-700,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
11985,DB05464,NOX-700,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
11986,DB05465,Tandutinib,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
11987,DB05465,Tandutinib,['investigational'],BE0003411,Platelet-derived growth factor D,PDGFD,Humans
11988,DB05466,R673,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
11989,DB05467,Palovarotene,"['approved', 'investigational']",BE0000144,Retinoic acid receptor gamma,RARG,Humans
11990,DB05468,R411,['investigational'],BE0000590,Integrin alpha-4,ITGA4,Humans
11991,DB05469,R450,['investigational'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
11992,DB05469,R450,['investigational'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
11993,DB05469,R450,['investigational'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
11994,DB05470,VX-702,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
11995,DB05470,VX-702,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
11996,DB05470,VX-702,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
11997,DB05470,VX-702,['investigational'],BE0000918,Interleukin-6,IL6,Humans
11998,DB05471,SGN-30,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
11999,DB05471,SGN-30,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
12000,DB05472,Human interferon omega-1,['investigational'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
12001,DB05472,Human interferon omega-1,['investigational'],BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
12002,DB05475,Golotimod,['investigational'],BE0001164,Toll-like receptor 2,TLR2,Humans
12003,DB05475,Golotimod,['investigational'],BE0002442,Toll-like receptor 4,TLR4,Humans
12004,DB05475,Golotimod,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
12005,DB05475,Golotimod,['investigational'],BE0001171,Toll-like receptor 9,TLR9,Humans
12006,DB05476,WX-UK1,['investigational'],BE0000717,Urokinase plasminogen activator surface receptor,PLAUR,Humans
12007,DB05478,Pradefovir mesylate,['investigational'],BE0002638,Cytochrome P450 3A4,CYP3A4,Humans
12008,DB05479,CZEN 002,['investigational'],BE0002447,Melanocyte-stimulating hormone receptor,MC1R,Humans
12009,DB05481,Recombinant alpha 1-antitrypsin,['investigational'],BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
12010,DB05482,7-ethyl-10-hydroxycamptothecin,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
12011,DB05483,Picolinic acid,['investigational'],BE0002460,E3 ubiquitin-protein ligase UBR4,UBR4,Humans
12012,DB05483,Picolinic acid,['investigational'],BE0002842,Zinc finger Y-chromosomal protein,ZFY,Humans
12013,DB05484,MDX-018,['investigational'],BE0000961,Interleukin-8,CXCL8,Humans
12014,DB05487,Custirsen,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12015,DB05487,Custirsen,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
12016,DB05487,Custirsen,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
12018,DB05488,Technetium Tc-99m ciprofloxacin,['investigational'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
12020,DB05490,AMG-131,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12021,DB05492,Epicept NP-1,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12022,DB05492,Epicept NP-1,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12023,DB05492,Epicept NP-1,['investigational'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12024,DB05492,Epicept NP-1,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12025,DB05492,Epicept NP-1,['investigational'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12026,DB05492,Epicept NP-1,['investigational'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12027,DB05492,Epicept NP-1,['investigational'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12028,DB05492,Epicept NP-1,['investigational'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12029,DB05492,Epicept NP-1,['investigational'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12030,DB05492,Epicept NP-1,['investigational'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12031,DB05492,Epicept NP-1,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
12032,DB05492,Epicept NP-1,['investigational'],BE0002378,Nociceptin receptor,OPRL1,Humans
12033,DB05494,Elacytarabine,['investigational'],BE0002804,Deoxycytidine kinase,DCK,Humans
12034,DB05495,PG-530742,['investigational'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
12035,DB05501,AMD-070,['investigational'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
12036,DB05501,AMD-070,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
12037,DB05505,NM-702,['investigational'],BE0001893,Thromboxane-A synthase,TBXAS1,Humans
12038,DB05506,ISIS 113715,['investigational'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
12039,DB05507,VX-765,['investigational'],BE0000444,Caspase-1,CASP1,Humans
12040,DB05507,VX-765,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
12041,DB05509,LI-301,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12042,DB05509,LI-301,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12043,DB05511,Piclidenoson,['investigational'],BE0000354,Adenosine receptor A3,ADORA3,Humans
12044,DB05513,Atiprimod,['investigational'],BE0000918,Interleukin-6,IL6,Humans
12045,DB05513,Atiprimod,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12046,DB05514,Cobiprostone,['investigational'],BE0000765,Chloride channel protein 2,CLCN2,Humans
12047,DB05518,Managlinat dialanetil,['investigational'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
12049,DB05521,Telaprevir,"['approved', 'withdrawn']",BE0001004,Solute carrier organic anion transporter family member 1B1,SLCO1B1,Humans
12050,DB05521,Telaprevir,"['approved', 'withdrawn']",BE0001042,Solute carrier organic anion transporter family member 2B1,SLCO2B1,Humans
12051,DB05524,Pelitinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
12053,DB05530,CPG 10101,['investigational'],BE0001171,Toll-like receptor 9,TLR9,Humans
12054,DB05532,BMS-488043,['investigational'],BE0003399,Free fatty acid receptor 4,FFAR4,Humans
12055,DB05533,QR-333,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
12057,DB05540,Alanosine,['investigational'],BE0002228,Adenylosuccinate synthetase isozyme 2,ADSS,Humans
12058,DB05540,Alanosine,['investigational'],BE0002231,Adenylosuccinate synthetase isozyme 1,ADSSL1,Humans
12059,DB05541,Brivaracetam,"['approved', 'investigational']",BE0000993,Synaptic vesicle glycoprotein 2A,SV2A,Humans
12060,DB05541,Brivaracetam,"['approved', 'investigational']",BE0004901,Sodium channel protein,SCN1A,Humans
12061,DB05542,Naronapride,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
12062,DB05550,Iratumumab,['investigational'],BE0003479,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,Humans
12063,DB05552,TG100-115,['investigational'],BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
12064,DB05552,TG100-115,['investigational'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
12065,DB05553,Regrelor,['investigational'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
12066,DB05559,NF-kappaB Decoy,['investigational'],BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
12067,DB05562,Naluzotan,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12068,DB05578,Ramucirumab,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12069,DB05590,Bedoradrine,['investigational'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
12070,DB05595,Farletuzumab,['investigational'],BE0003405,Folate receptor alpha,FOLR1,Humans
12071,DB05607,PRX-08066,['investigational'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12072,DB05624,Teverelix,['investigational'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12073,DB05630,Sodium stibogluconate,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
12074,DB05642,DDP-225,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
12075,DB05642,DDP-225,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12080,DB05662,NP-50301,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12081,DB05667,Levoketoconazole,"['approved', 'investigational']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
12082,DB05667,Levoketoconazole,"['approved', 'investigational']",BE0000731,"Cytochrome P450 11B1, mitochondrial",CYP11B1,Humans
12083,DB05667,Levoketoconazole,"['approved', 'investigational']",BE0003542,"Cytochrome P450 11B2, mitochondrial",CYP11B2,Humans
12084,DB05667,Levoketoconazole,"['approved', 'investigational']",BE0003537,"Cholesterol side-chain cleavage enzyme, mitochondrial",CYP11A1,Humans
12085,DB05667,Levoketoconazole,"['approved', 'investigational']",BE0000875,Lanosterol 14-alpha demethylase,CYP51A1,Humans
12086,DB05668,Palifosfamide,['investigational'],BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
12087,DB05675,EP-2104R,['investigational'],BE0000538,Fibrinogen alpha chain,FGA,Humans
12089,DB05678,SLx-4090,['investigational'],BE0000232,Microsomal triglyceride transfer protein large subunit,MTTP,Humans
12090,DB05679,Ustekinumab,"['approved', 'investigational']",BE0008663,Interleukin-23,IL12B,Humans
12091,DB05679,Ustekinumab,"['approved', 'investigational']",BE0000981,Interleukin-12 subunit beta,IL12B,Humans
12092,DB05685,FX06,['investigational'],BE0003403,Cadherin-5,CDH5,Humans
12093,DB05687,BL-1020,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12094,DB05687,BL-1020,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12095,DB05688,CRx-119,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12096,DB05688,CRx-119,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12097,DB05695,NPS-2143,['investigational'],BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
12098,DB05697,Trabedersen,['investigational'],BE0003481,Transforming growth factor beta-2,TGFB2,Humans
12099,DB05706,13-deoxydoxorubicin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12101,DB05708,GTS-21,['investigational'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
12102,DB05710,Gantacurium,['investigational'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
12103,DB05712,AZD-9684,['investigational'],BE0003407,Carboxypeptidase B2,CPB2,Humans
12104,DB05713,LY-517717,['investigational'],BE0000216,Coagulation factor X,F10,Humans
12105,DB05714,Flovagatran,['investigational'],BE0000048,Prothrombin,F2,Humans
12106,DB05736,MIV-701,['investigational'],BE0003417,Cathepsin K,CTSK,Humans
12107,DB05737,Varespladib methyl,['investigational'],BE0001640,"Phospholipase A2, membrane associated",PLA2G2A,Humans
12108,DB05737,Varespladib methyl,['investigational'],BE0000070,Group 10 secretory phospholipase A2,PLA2G10,Humans
12109,DB05739,CYT006-AngQb,['investigational'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
12110,DB05739,CYT006-AngQb,['investigational'],BE0003426,Type-2 angiotensin II receptor,AGTR2,Humans
12111,DB05740,RPI-78M,['investigational'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
12112,DB05740,RPI-78M,['investigational'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
12113,DB05740,RPI-78M,['investigational'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
12114,DB05740,RPI-78M,['investigational'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
12115,DB05740,RPI-78M,['investigational'],BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
12116,DB05740,RPI-78M,['investigational'],BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
12117,DB05744,CRx-139,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12118,DB05744,CRx-139,['investigational'],BE0000918,Interleukin-6,IL6,Humans
12119,DB05744,CRx-139,['investigational'],BE0000877,C-reactive protein,CRP,Humans
12120,DB05744,CRx-139,['investigational'],BE0002484,Interleukin-10,IL10,Humans
12121,DB05749,MPI-674,['investigational'],BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
12122,DB05750,AVE-1625,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
12123,DB05752,ALKS 27,['investigational'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12124,DB05752,ALKS 27,['investigational'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
12125,DB05752,ALKS 27,['investigational'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
12126,DB05752,ALKS 27,['investigational'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
12127,DB05752,ALKS 27,['investigational'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
12128,DB05758,CYT007-TNFQb,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12129,DB05766,Norclozapine,['investigational'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12130,DB05766,Norclozapine,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12131,DB05766,Norclozapine,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
12132,DB05767,Andrographolide,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12133,DB05767,Andrographolide,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
12134,DB05767,Andrographolide,['investigational'],BE0000918,Interleukin-6,IL6,Humans
12135,DB05767,Andrographolide,['investigational'],BE0002387,Nuclear factor NF-kappa-B p100 subunit,NFKB2,Humans
12136,DB05767,Andrographolide,['investigational'],BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
12137,DB05771,LLL-3348,['investigational'],BE0002484,Interleukin-10,IL10,Humans
12138,DB05773,Trastuzumab emtansine,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
12139,DB05777,Thrombomodulin Alfa,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
12140,DB05777,Thrombomodulin Alfa,"['approved', 'investigational']",BE0000041,Coagulation factor V,F5,Humans
12141,DB05785,LGD-1550,['investigational'],BE0000663,Retinoic acid receptor alpha,RARA,Humans
12142,DB05785,LGD-1550,['investigational'],BE0000206,Retinoic acid receptor beta,RARB,Humans
12143,DB05785,LGD-1550,['investigational'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
12144,DB05785,LGD-1550,['investigational'],BE0001040,Transcription factor AP-1,JUN,Humans
12145,DB05786,Irofulven,['investigational'],BE0003422,Far upstream element-binding protein 1,FUBP1,Humans
12146,DB05787,LM-609,['investigational'],BE0001155,Integrin beta-3,ITGB3,Humans
12147,DB05790,SR 140333,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
12148,DB05792,Arylacenamide,['investigational'],BE0000290,"HCG20471, isoform CRA_c",SIGMAR1,Humans
12149,DB05793,PRO-542,['investigational'],BE0003399,Free fatty acid receptor 4,FFAR4,Humans
12150,DB05796,Daglutril,['investigational'],BE0000266,Neprilysin,MME,Humans
12151,DB05797,TNX-901,['investigational'],BE0000015,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,Humans
12152,DB05798,GEM-231,['investigational'],BE0003424,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,Humans
12153,DB05798,GEM-231,['investigational'],BE0003425,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,Humans
12154,DB05801,GTI 2040,['investigational'],BE0002450,Ribonucleoside-diphosphate reductase subunit M2,RRM2,Humans
12155,DB05806,Cositecan,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
12156,DB05812,Abiraterone,['approved'],BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
12157,DB05814,GPI-1485,['investigational'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
12158,DB05824,CNS-5161,['investigational'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
12159,DB05829,Parathyroid hormone,"['approved', 'investigational']",BE0004703,Parathyroid hormone 2 receptor,PTH2R,Humans
12160,DB05829,Parathyroid hormone,"['approved', 'investigational']",BE0003508,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Humans
12161,DB05831,ING-1,['investigational'],BE0002446,Epithelial cell adhesion molecule,EPCAM,Humans
12162,DB05838,OPC-51803,['investigational'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
12163,DB05846,Mito-4509,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
12164,DB05848,humanized SMART Anti-IL-12 Antibody,['investigational'],BE0000981,Interleukin-12 subunit beta,IL12B,Humans
12165,DB05849,NCX 950,['investigational'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
12166,DB05854,CLX-0921,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12167,DB05855,Rivanicline,['investigational'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
12168,DB05855,Rivanicline,['investigational'],BE0000961,Interleukin-8,CXCL8,Humans
12169,DB05864,PPI-2458,['investigational'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
12170,DB05867,99mTc-14 F7 Mab,['investigational'],BE0004604,"Lactosylceramide alpha-2,3-sialyltransferase",ST3GAL5,Humans
12172,DB05869,Ethyl pyruvate,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12173,DB05869,Ethyl pyruvate,['investigational'],BE0003428,High mobility group protein B1,HMGB1,Humans
12175,DB05879,AME-527,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12176,DB05882,CHF 4227,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12177,DB05882,CHF 4227,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
12178,DB05883,ABX-PTH,['investigational'],BE0003309,Parathyroid hormone,PTH,Humans
12179,DB05885,Seletracetam,['investigational'],BE0000993,Synaptic vesicle glycoprotein 2A,SV2A,Humans
12180,DB05885,Seletracetam,['investigational'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
12181,DB05885,Seletracetam,['investigational'],BE0004857,Glycine receptor (alpha-1/beta),GLRA1,Humans
12183,DB05889,Inotuzumab ozogamicin,"['approved', 'investigational']",BE0000183,B-cell receptor CD22,CD22,Humans
12184,DB05890,Veglin,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
12185,DB05892,RI 624,['investigational'],BE0001094,Beta-nerve growth factor,NGF,Humans
12186,DB05895,HGS-TR2J,['investigational'],BE0003433,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,Humans
12187,DB05897,rhIGFBP-3,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
12188,DB05905,TD-2749,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
12189,DB05906,CCR5 mAb,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
12190,DB05913,OSI-930,['investigational'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
12191,DB05913,OSI-930,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12192,DB05915,Stamulumab,['investigational'],BE0003435,Growth/differentiation factor 8,MSTN,Humans
12193,DB05916,CT-011,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
12194,DB05920,RTA 744,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12195,DB05928,Dovitinib,['investigational'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
12196,DB05930,SB-559448,['investigational'],BE0003440,Thrombopoietin receptor,MPL,Humans
12197,DB05931,Pegdinetanib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12198,DB05932,Denibulin,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
12199,DB05932,Denibulin,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12200,DB05932,Denibulin,['investigational'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
12201,DB05934,CTCE-0214,['investigational'],BE0001150,Stromal cell-derived factor 1,CXCL12,Humans
12202,DB05936,CVT-6883,['investigational'],BE0000241,Adenosine receptor A2b,ADORA2B,Humans
12203,DB05938,Edonerpic,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
12204,DB05939,MK-0354,['investigational'],BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
12205,DB05941,Leronlimab,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
12206,DB05943,Resatorvid,['investigational'],BE0002115,Cytokine receptor common subunit beta,CSF2RB,Humans
12207,DB05943,Resatorvid,['investigational'],BE0002102,Cytokine receptor common subunit gamma,IL2RG,Humans
12208,DB05944,Varlitinib,['investigational'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
12209,DB05944,Varlitinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
12210,DB05945,MDX-1303,['investigational'],BE0003223,Anthrax toxin receptor 2,ANTXR2,Humans
12211,DB05945,MDX-1303,['investigational'],BE0003447,Anthrax toxin receptor 1,ANTXR1,Humans
12212,DB05950,Contulakin-G,['investigational'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
12213,DB05956,EVT-101,['investigational'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
12214,DB05956,EVT-101,['investigational'],BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
12215,DB05959,ENMD-1198,['investigational'],BE0003461,Tumor necrosis factor receptor superfamily member 11A,TNFRSF11A,Humans
12216,DB05959,ENMD-1198,['investigational'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
12217,DB05959,ENMD-1198,['investigational'],BE0003462,Signal transducer and activator of transcription 3,STAT3,Humans
12218,DB05961,PPL-100,['investigational'],BE0002458,Plasma protease C1 inhibitor,SERPING1,Humans
12219,DB05961,PPL-100,['investigational'],BE0002112,Plasma serine protease inhibitor,SERPINA5,Humans
12220,DB05961,PPL-100,['investigational'],BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
12221,DB05964,Amitifadine,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12222,DB05964,Amitifadine,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12223,DB05964,Amitifadine,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12224,DB05966,TAS-108,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12225,DB05966,TAS-108,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
12226,DB05967,ANZ-100,['investigational'],BE0003468,KiSS-1 receptor,KISS1R,Humans
12227,DB05968,PR-104,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12228,DB05969,SNS-032,['investigational'],BE0001913,Cyclin-dependent kinase 7,CDK7,Humans
12229,DB05969,SNS-032,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
12230,DB05971,Archexin,['investigational'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
12231,DB05983,Bardoxolone methyl,['investigational'],BE0003469,NF-kappa-B inhibitor alpha,NFKBIA,Humans
12232,DB05984,RAF-265,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12233,DB05984,RAF-265,['investigational'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
12234,DB05990,Obeticholic acid,['approved'],BE0001777,Bile acid receptor,NR1H4,Humans
12235,DB05992,Plinabulin,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12236,DB05993,PRX-07034,['investigational'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
12237,DB05996,Glembatumumab vedotin,['investigational'],BE0003473,Transmembrane glycoprotein NMB,GPNMB,Humans
12238,DB06011,AMG-222,['investigational'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
12239,DB06013,Aldoxorubicin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12241,DB06016,Cariprazine,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
12242,DB06016,Cariprazine,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
12243,DB06016,Cariprazine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12244,DB06016,Cariprazine,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12245,DB06016,Cariprazine,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12246,DB06016,Cariprazine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
12247,DB06016,Cariprazine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12248,DB06016,Cariprazine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12249,DB06021,AV-412,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
12250,DB06021,AV-412,['investigational'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
12252,DB06040,Filanesib,['investigational'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
12253,DB06042,ZEN-012,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
12254,DB06042,ZEN-012,['investigational'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
12255,DB06042,ZEN-012,['investigational'],BE0001415,Tubulin beta-3 chain,TUBB3,Humans
12256,DB06042,ZEN-012,['investigational'],BE0001408,Tubulin beta-4A chain,TUBB4A,Humans
12257,DB06042,ZEN-012,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12258,DB06042,ZEN-012,['investigational'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
12259,DB06043,Olaratumab,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
12260,DB06050,TB-402,['investigational'],BE0000016,Coagulation factor VIII,F8,Humans
12262,DB06061,AZD-8330,['investigational'],BE0003430,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,Humans
12263,DB06064,KAI-1455,['investigational'],BE0003431,Protein kinase C epsilon type,PRKCE,Humans
12264,DB06069,XMT-1001,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
12265,DB06070,SNX-5422,['investigational'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
12266,DB06070,SNX-5422,['investigational'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
12267,DB06073,CTS-21166,['investigational'],BE0000988,Beta-secretase 1,BACE1,Humans
12268,DB06075,Linsitinib,['investigational'],BE0000033,Insulin receptor,INSR,Humans
12269,DB06075,Linsitinib,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
12270,DB06077,Lumateperone,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12271,DB06077,Lumateperone,"['approved', 'investigational']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
12272,DB06077,Lumateperone,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12273,DB06077,Lumateperone,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
12274,DB06077,Lumateperone,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
12275,DB06080,Linifanib,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
12276,DB06080,Linifanib,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12277,DB06080,Linifanib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12278,DB06080,Linifanib,['investigational'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
12279,DB06080,Linifanib,['investigational'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
12280,DB06080,Linifanib,['investigational'],BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
12281,DB06081,Caplacizumab,"['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
12282,DB06082,PX-478,['investigational'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
12283,DB06083,Tapinarof,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
12284,DB06089,ICA-105665,['investigational'],BE0000672,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,Humans
12285,DB06089,ICA-105665,['investigational'],BE0002398,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,Humans
12286,DB06089,ICA-105665,['investigational'],BE0002399,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,Humans
12287,DB06089,ICA-105665,['investigational'],BE0002400,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,Humans
12288,DB06089,ICA-105665,['investigational'],BE0000897,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,Humans
12289,DB06090,Bradanicline,['investigational'],BE0003438,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,Humans
12290,DB06094,Apatorsen,['investigational'],BE0003432,Heat shock protein beta-1,HSPB1,Humans
12291,DB06096,NXN-188,['investigational'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
12292,DB06096,NXN-188,['investigational'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
12293,DB06096,NXN-188,['investigational'],BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
12294,DB06097,GSK-923295,['investigational'],BE0003434,Centromere-associated protein E,CENPE,Humans
12295,DB06098,PRLX 93936,['investigational'],BE0002469,Voltage-dependent anion-selective channel protein 2,VDAC2,Humans
12296,DB06098,PRLX 93936,['investigational'],BE0002470,Voltage-dependent anion-selective channel protein 3,VDAC3,Humans
12297,DB06101,IMC-1C11,['investigational'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12298,DB06101,IMC-1C11,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12299,DB06101,IMC-1C11,['investigational'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
12300,DB06103,VX-148,['investigational'],BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
12301,DB06103,VX-148,['investigational'],BE0000722,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,Humans
12302,DB06109,YKP-1358,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12303,DB06109,YKP-1358,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12304,DB06116,Eldelumab,['investigational'],BE0000934,C-X-C motif chemokine 10,CXCL10,Humans
12305,DB06124,L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,['investigational'],BE0003470,Calpain-3,CAPN3,Humans
12306,DB06127,Bisegliptin,['investigational'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
12307,DB06133,Dimethylcurcumin,['investigational'],BE0000132,Androgen receptor,AR,Humans
12308,DB06134,SNS-314,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
12309,DB06134,SNS-314,['investigational'],BE0004601,Aurora kinase C,AURKC,Humans
12310,DB06137,Tirbanibulin,"['approved', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
12311,DB06137,Tirbanibulin,"['approved', 'investigational']",BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
12312,DB06138,IRL-1620,['investigational'],BE0000043,Endothelin B receptor,EDNRB,Humans
12313,DB06140,SUVN-502,['investigational'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
12314,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
12315,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12316,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12317,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
12318,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
12319,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12320,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12321,DB06144,Sertindole,"['approved', 'investigational', 'withdrawn']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12324,DB06148,Mianserin,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12325,DB06148,Mianserin,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12326,DB06148,Mianserin,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12327,DB06148,Mianserin,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
12328,DB06148,Mianserin,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12329,DB06148,Mianserin,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12330,DB06148,Mianserin,"['approved', 'investigational']",BE0000146,Histamine H4 receptor,HRH4,Humans
12331,DB06148,Mianserin,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12332,DB06148,Mianserin,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12333,DB06148,Mianserin,"['approved', 'investigational']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12334,DB06148,Mianserin,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
12335,DB06148,Mianserin,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12336,DB06148,Mianserin,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
12337,DB06148,Mianserin,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12338,DB06148,Mianserin,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12339,DB06148,Mianserin,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
12340,DB06148,Mianserin,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
12341,DB06148,Mianserin,"['approved', 'investigational']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
12342,DB06148,Mianserin,"['approved', 'investigational']",BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
12343,DB06148,Mianserin,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
12345,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000185,Glutathione synthetase,GSS,Humans
12346,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
12348,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000481,Aminoacylase-1,ACY1,Humans
12349,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
12350,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0004655,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,Humans
12351,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
12352,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
12353,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000760,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,Humans
12354,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000396,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,Humans
12355,DB06151,Acetylcysteine,"['approved', 'investigational']",BE0000641,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,Humans
12356,DB06152,Nylidrin,['approved'],BE0000385,Interferon alpha/beta receptor 2,IFNAR2,Humans
12357,DB06152,Nylidrin,['approved'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
12358,DB06153,Pizotifen,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12359,DB06153,Pizotifen,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
12360,DB06153,Pizotifen,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
12361,DB06153,Pizotifen,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12362,DB06153,Pizotifen,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12363,DB06153,Pizotifen,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12364,DB06153,Pizotifen,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12365,DB06153,Pizotifen,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
12366,DB06153,Pizotifen,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
12367,DB06153,Pizotifen,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12368,DB06153,Pizotifen,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12369,DB06153,Pizotifen,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12370,DB06153,Pizotifen,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12371,DB06153,Pizotifen,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12372,DB06153,Pizotifen,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12373,DB06154,Pentaerythritol tetranitrate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
12374,DB06154,Pentaerythritol tetranitrate,['approved'],BE0000629,Hemoglobin subunit beta,HBB,Humans
12376,DB06155,Rimonabant,"['approved', 'investigational']",BE0000061,Cannabinoid receptor 1,CNR1,Humans
12377,DB06155,Rimonabant,"['approved', 'investigational']",BE0005802,G-protein coupled receptor 55,GPR55,Humans
12378,DB06156,Tesofensine,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12379,DB06156,Tesofensine,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12380,DB06156,Tesofensine,['investigational'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12381,DB06157,Istaroxime,['investigational'],BE0003477,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,ATP2A2,Humans
12382,DB06157,Istaroxime,['investigational'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
12383,DB06159,Rubitecan,['investigational'],BE0000971,DNA topoisomerase 1,TOP1,Humans
12384,DB06162,Lumiliximab,['investigational'],BE0003465,Low affinity immunoglobulin epsilon Fc receptor,FCER2,Humans
12385,DB06168,Canakinumab,"['approved', 'investigational']",BE0001051,Interleukin-1 beta,IL1B,Humans
12386,DB06174,Noscapine,"['approved', 'investigational']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
12387,DB06176,Romidepsin,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
12388,DB06176,Romidepsin,"['approved', 'investigational']",BE0002366,Histone deacetylase 2,HDAC2,Humans
12389,DB06176,Romidepsin,"['approved', 'investigational']",BE0003523,Histone deacetylase 4,HDAC4,Humans
12390,DB06176,Romidepsin,"['approved', 'investigational']",BE0002368,Histone deacetylase 6,HDAC6,Humans
12391,DB06176,Romidepsin,"['approved', 'investigational']",BE0000785,Multidrug resistance-associated protein 1,ABCC1,Humans
12392,DB06176,Romidepsin,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
12393,DB06184,AEG35156,['investigational'],BE0001156,E3 ubiquitin-protein ligase XIAP,XIAP,Humans
12394,DB06185,Forodesine,['investigational'],BE0000250,Purine nucleoside phosphorylase,PNP,Humans
12395,DB06186,Ipilimumab,['approved'],BE0000887,Cytotoxic T-lymphocyte protein 4,CTLA4,Humans
12396,DB06190,Solabegron,['investigational'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
12397,DB06191,Zosuquidar,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
12398,DB06194,Elocalcitol,['investigational'],BE0000779,Vitamin D3 receptor,VDR,Humans
12399,DB06195,Seliciclib,['investigational'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
12400,DB06195,Seliciclib,['investigational'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
12401,DB06195,Seliciclib,['investigational'],BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
12402,DB06195,Seliciclib,['investigational'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
12403,DB06195,Seliciclib,['investigational'],BE0001913,Cyclin-dependent kinase 7,CDK7,Humans
12404,DB06195,Seliciclib,['investigational'],BE0002207,Cyclin-dependent kinase 9,CDK9,Humans
12405,DB06195,Seliciclib,['investigational'],BE0003512,Casein kinase I isoform epsilon,CSNK1E,Humans
12406,DB06196,Icatibant,"['approved', 'investigational']",BE0003513,B2 bradykinin receptor,BDKRB2,Humans
12407,DB06196,Icatibant,"['approved', 'investigational']",BE0001078,Aminopeptidase N,ANPEP,Humans
12409,DB06199,Atrasentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
12410,DB06201,Rufinamide,['approved'],BE0001143,Sodium channel protein type 9 subunit alpha,SCN9A,Humans
12411,DB06201,Rufinamide,['approved'],BE0001192,Metabotropic glutamate receptor 5,GRM5,Humans
12412,DB06202,Lasofoxifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
12413,DB06202,Lasofoxifene,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
12414,DB06202,Lasofoxifene,"['approved', 'investigational']",BE0000095,Cannabinoid receptor 2,CNR2,Humans
12415,DB06203,Alogliptin,['approved'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
12416,DB06204,Tapentadol,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12417,DB06204,Tapentadol,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12418,DB06204,Tapentadol,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12419,DB06204,Tapentadol,['approved'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
12420,DB06204,Tapentadol,['approved'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
12421,DB06204,Tapentadol,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12423,DB06205,Hyaluronidase (human recombinant),"['approved', 'investigational']",BE0000984,Transforming growth factor beta-1,TGFB1,Humans
12424,DB06207,Silodosin,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12425,DB06207,Silodosin,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12426,DB06207,Silodosin,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12427,DB06207,Silodosin,['approved'],BE0009629,HERG human cardiac K+ channel,KCNH2,Humans
12428,DB06209,Prasugrel,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
12429,DB06210,Eltrombopag,['approved'],BE0003440,Thrombopoietin receptor,MPL,Humans
12435,DB06212,Tolvaptan,['approved'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
12436,DB06212,Tolvaptan,['approved'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
12437,DB06213,Regadenoson,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
12438,DB06216,Asenapine,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12439,DB06216,Asenapine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12440,DB06216,Asenapine,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12441,DB06216,Asenapine,['approved'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
12442,DB06216,Asenapine,['approved'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12443,DB06216,Asenapine,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12444,DB06216,Asenapine,['approved'],BE0004688,5-hydroxytryptamine receptor 5A,HTR5A,Humans
12445,DB06216,Asenapine,['approved'],BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
12446,DB06216,Asenapine,['approved'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
12447,DB06216,Asenapine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
12448,DB06216,Asenapine,['approved'],BE0000389,Dopamine D4 receptor,DRD4,Humans
12449,DB06216,Asenapine,['approved'],BE0000020,Dopamine D1 receptor,DRD1,Humans
12450,DB06216,Asenapine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12451,DB06216,Asenapine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12452,DB06216,Asenapine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12453,DB06216,Asenapine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12454,DB06216,Asenapine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
12455,DB06216,Asenapine,['approved'],BE0000112,Histamine H2 receptor,HRH2,Humans
12456,DB06216,Asenapine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
12457,DB06216,Asenapine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
12458,DB06217,Vernakalant,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
12459,DB06217,Vernakalant,"['approved', 'investigational']",BE0004717,Potassium voltage-gated channel subfamily A member 5,KCNA5,Humans
12460,DB06217,Vernakalant,"['approved', 'investigational']",BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
12461,DB06217,Vernakalant,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
12462,DB06218,Lacosamide,['approved'],BE0001143,Sodium channel protein type 9 subunit alpha,SCN9A,Humans
12463,DB06218,Lacosamide,['approved'],BE0002082,Sodium channel protein type 3 subunit alpha,SCN3A,Humans
12464,DB06218,Lacosamide,['approved'],BE0000177,Sodium channel protein type 10 subunit alpha,SCN10A,Humans
12466,DB06226,Nelipepimut-S,['investigational'],BE0003482,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,Humans
12467,DB06226,Nelipepimut-S,['investigational'],BE0003483,"HLA class I histocompatibility antigen, A-3 alpha chain",HLA-A,Humans
12468,DB06228,Rivaroxaban,['approved'],BE0000216,Coagulation factor X,F10,Humans
12469,DB06229,Ocaperidone,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12470,DB06229,Ocaperidone,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
12471,DB06229,Ocaperidone,['investigational'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12472,DB06229,Ocaperidone,['investigational'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12473,DB06229,Ocaperidone,['investigational'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12474,DB06229,Ocaperidone,['investigational'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12475,DB06229,Ocaperidone,['investigational'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12476,DB06229,Ocaperidone,['investigational'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12477,DB06229,Ocaperidone,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12478,DB06229,Ocaperidone,['investigational'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
12479,DB06229,Ocaperidone,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12480,DB06230,Nalmefene,"['approved', 'investigational', 'withdrawn']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12481,DB06230,Nalmefene,"['approved', 'investigational', 'withdrawn']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
12482,DB06230,Nalmefene,"['approved', 'investigational', 'withdrawn']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
12483,DB06231,Caldaret,['investigational'],BE0000986,Sodium/calcium exchanger 1,SLC8A1,Humans
12484,DB06233,Ridaforolimus,['investigational'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
12487,DB06237,Avanafil,['approved'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
12488,DB06240,Tariquidar,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
12489,DB06241,Clenoliximab,['investigational'],BE0003488,T-cell surface glycoprotein CD4,CD4,Humans
12490,DB06243,Eflornithine,"['approved', 'withdrawn']",BE0000404,Ornithine decarboxylase,ODC1,Humans
12491,DB06245,Lanoteplase,['investigational'],BE0000717,Urokinase plasminogen activator surface receptor,PLAUR,Humans
12492,DB06245,Lanoteplase,['investigational'],BE0000538,Fibrinogen alpha chain,FGA,Humans
12493,DB06245,Lanoteplase,['investigational'],BE0001091,Kallikrein-1,KLK1,Humans
12494,DB06245,Lanoteplase,['investigational'],BE0002103,Laminin subunit alpha-5,LAMA5,Humans
12495,DB06245,Lanoteplase,['investigational'],BE0000216,Coagulation factor X,F10,Humans
12496,DB06245,Lanoteplase,['investigational'],BE0001180,Fibronectin,FN1,Humans
12497,DB06245,Lanoteplase,['investigational'],BE0000969,Plasminogen activator inhibitor 2,SERPINB2,Humans
12498,DB06245,Lanoteplase,['investigational'],BE0002104,Tetranectin,CLEC3B,Humans
12499,DB06245,Lanoteplase,['investigational'],BE0002105,"Keratin, type II cytoskeletal 8",KRT8,Humans
12500,DB06245,Lanoteplase,['investigational'],BE0001170,Annexin A2,ANXA2,Humans
12501,DB06245,Lanoteplase,['investigational'],BE0002106,Laminin subunit beta-1,LAMB1,Humans
12502,DB06245,Lanoteplase,['investigational'],BE0002107,Laminin subunit gamma-1,LAMC1,Humans
12503,DB06245,Lanoteplase,['investigational'],BE0002108,Laminin subunit alpha-1,LAMA1,Humans
12504,DB06245,Lanoteplase,['investigational'],BE0002109,Calreticulin,CALR,Humans
12505,DB06245,Lanoteplase,['investigational'],BE0001011,Calnexin,CANX,Humans
12506,DB06245,Lanoteplase,['investigational'],BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
12507,DB06245,Lanoteplase,['investigational'],BE0002111,Laminin subunit alpha-3,LAMA3,Humans
12508,DB06246,Exisulind,['investigational'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
12509,DB06246,Exisulind,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
12510,DB06246,Exisulind,['investigational'],BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
12511,DB06246,Exisulind,['investigational'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
12512,DB06246,Exisulind,['investigational'],BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,Humans
12513,DB06246,Exisulind,['investigational'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
12514,DB06246,Exisulind,['investigational'],BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,Humans
12515,DB06247,CX516,['investigational'],BE0000640,Glutamate receptor 1,GRIA1,Humans
12516,DB06248,Amelubant,['investigational'],BE0003489,Leukotriene B4 receptor 2,LTB4R2,Humans
12517,DB06248,Amelubant,['investigational'],BE0003490,Leukotriene B4 receptor 1,LTB4R,Humans
12518,DB06249,Arzoxifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
12519,DB06249,Arzoxifene,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
12520,DB06255,Incadronic acid,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
12521,DB06255,Incadronic acid,['experimental'],BE0001162,Caspase-3,CASP3,Humans
12522,DB06255,Incadronic acid,['experimental'],BE0009964,Caspase-4,CASP4,Humans
12523,DB06255,Incadronic acid,['experimental'],BE0001826,Caspase-7,CASP7,Humans
12524,DB06258,Bimoclomol,['investigational'],BE0003514,Heat shock factor protein 1,HSF1,Humans
12525,DB06262,Droxidopa,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12526,DB06262,Droxidopa,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12527,DB06262,Droxidopa,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12528,DB06262,Droxidopa,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12529,DB06262,Droxidopa,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12530,DB06262,Droxidopa,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12531,DB06262,Droxidopa,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
12532,DB06262,Droxidopa,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
12533,DB06262,Droxidopa,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
12534,DB06262,Droxidopa,"['approved', 'investigational']",BE0000753,Phenylalanine-4-hydroxylase,PAH,Humans
12535,DB06263,Amrubicin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12537,DB06266,Lonidamine,['investigational'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
12538,DB06266,Lonidamine,['investigational'],BE0001108,Hexokinase-1,HK1,Humans
12539,DB06267,Udenafil,"['approved', 'investigational']",BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
12540,DB06268,Sitaxentan,"['approved', 'investigational', 'withdrawn']",BE0000521,Endothelin-1 receptor,EDNRA,Humans
12541,DB06268,Sitaxentan,"['approved', 'investigational', 'withdrawn']",BE0000043,Endothelin B receptor,EDNRB,Humans
12542,DB06271,Sulodexide,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
12543,DB06271,Sulodexide,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
12544,DB06273,Tocilizumab,['approved'],BE0002859,Interleukin-6 receptor subunit alpha,IL6R,Humans
12545,DB06274,Alvimopan,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
12546,DB06274,Alvimopan,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12547,DB06274,Alvimopan,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
12548,DB06281,Torcetrapib,['investigational'],BE0003516,Cholesteryl ester transfer protein,CETP,Humans
12549,DB06282,Levocetirizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
12550,DB06283,Ziconotide,['approved'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
12551,DB06283,Ziconotide,['approved'],BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,Humans
12552,DB06285,Teriparatide,"['approved', 'investigational']",BE0003508,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Humans
12553,DB06287,Temsirolimus,['approved'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
12554,DB06288,Amisulpride,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
12555,DB06288,Amisulpride,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12556,DB06288,Amisulpride,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
12557,DB06288,Amisulpride,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
12558,DB06288,Amisulpride,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
12559,DB06288,Amisulpride,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
12560,DB06288,Amisulpride,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12562,DB06292,Dapagliflozin,['approved'],BE0004753,Sodium/glucose cotransporter 2,SLC5A2,Humans
12563,DB06307,Apoptone,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
12564,DB06311,Darapladib,['investigational'],BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
12565,DB06314,SGX-523,['investigational'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
12566,DB06317,Elotuzumab,['approved'],BE0003492,SLAM family member 7,SLAMF7,Humans
12567,DB06318,AVE9633,['investigational'],BE0000674,Myeloid cell surface antigen CD33,CD33,Humans
12568,DB06321,R-348,['investigational'],BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
12569,DB06322,Carotuximab,['investigational'],BE0003494,Endoglin,ENG,Humans
12570,DB06324,XmAb 2513,['investigational'],BE0003479,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,Humans
12571,DB06325,Pegpleranib,['investigational'],BE0003495,Platelet-derived growth factor subunit B,PDGFB,Humans
12573,DB06329,RG-7795,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
12575,DB06333,Trodusquemine,['investigational'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
12576,DB06333,Trodusquemine,['investigational'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12577,DB06333,Trodusquemine,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12578,DB06335,Saxagliptin,['approved'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
12579,DB06342,Coltuximab ravtansine,['investigational'],BE0003496,B-lymphocyte antigen CD19,CD19,Humans
12580,DB06343,Teprotumumab,"['approved', 'investigational']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
12581,DB06345,AR-9281,['investigational'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
12582,DB06346,Fiboflapon,['investigational'],BE0002382,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,Humans
12583,DB06347,Cenisertib,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
12584,DB06350,Elinogrel,['investigational'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
12585,DB06354,Tezampanel,['investigational'],BE0000346,"Glutamate receptor ionotropic, kainate 1",GRIK1,Humans
12586,DB06354,Tezampanel,['investigational'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
12587,DB06356,TRC093,['investigational'],BE0003498,Collagen alpha-4(IV) chain,COL4A4,Humans
12588,DB06358,Iclaprim,['investigational'],BE0000330,Dihydrofolate reductase,DHFR,Humans
12589,DB06360,Lucatumumab,['investigational'],BE0001196,Tumor necrosis factor receptor superfamily member 5,CD40,Humans
12590,DB06362,Becatecarin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12591,DB06362,Becatecarin,['investigational'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
12592,DB06366,Pertuzumab,['approved'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
12593,DB06367,Relacatib,['investigational'],BE0003417,Cathepsin K,CTSK,Humans
12594,DB06371,Siplizumab,['investigational'],BE0000719,T-cell surface antigen CD2,CD2,Humans
12595,DB06372,Rilonacept,"['approved', 'investigational']",BE0001051,Interleukin-1 beta,IL1B,Humans
12596,DB06372,Rilonacept,"['approved', 'investigational']",BE0004734,Interleukin-1 alpha,IL1A,Humans
12597,DB06372,Rilonacept,"['approved', 'investigational']",BE0004735,Interleukin-1 receptor antagonist protein,IL1RN,Humans
12598,DB06374,Elacestrant,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12599,DB06376,CHGN111,['investigational'],BE0001824,Dual specificity protein kinase CLK1,CLK1,Humans
12600,DB06393,Xaliproden,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12601,DB06401,Bazedoxifene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
12602,DB06401,Bazedoxifene,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
12603,DB06403,Ambrisentan,"['approved', 'investigational']",BE0000521,Endothelin-1 receptor,EDNRA,Humans
12604,DB06403,Ambrisentan,"['approved', 'investigational']",BE0000043,Endothelin B receptor,EDNRB,Humans
12605,DB06404,Human C1-esterase inhibitor,['approved'],BE0002093,Complement C1r subcomponent,C1R,Humans
12606,DB06404,Human C1-esterase inhibitor,['approved'],BE0001529,Complement C1s subcomponent,C1S,Humans
12607,DB06404,Human C1-esterase inhibitor,['approved'],BE0002440,Plasma kallikrein,KLKB1,Humans
12608,DB06404,Human C1-esterase inhibitor,['approved'],BE0004672,Coagulation factor XII,F12,Humans
12609,DB06404,Human C1-esterase inhibitor,['approved'],BE0001021,Coagulation factor XI,F11,Humans
12610,DB06404,Human C1-esterase inhibitor,['approved'],BE0001088,Tissue-type plasminogen activator,PLAT,Humans
12611,DB06404,Human C1-esterase inhibitor,['approved'],BE0000048,Prothrombin,F2,Humans
12612,DB06406,Idraparinux,['investigational'],BE0000216,Coagulation factor X,F10,Humans
12615,DB06408,Taribavirin,['investigational'],BE0000457,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,Humans
12617,DB06408,Taribavirin,['investigational'],BE0000261,Cytosolic purine 5'-nucleotidase,NT5C2,Humans
12618,DB06408,Taribavirin,['investigational'],BE0000761,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,Humans
12619,DB06409,Morphine glucuronide,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12620,DB06409,Morphine glucuronide,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
12621,DB06409,Morphine glucuronide,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12622,DB06410,Doxercalciferol,['approved'],BE0000779,Vitamin D3 receptor,VDR,Humans
12623,DB06412,Oxymetholone,"['approved', 'illicit']",BE0000132,Androgen receptor,AR,Humans
12624,DB06412,Oxymetholone,"['approved', 'illicit']",BE0000979,Natriuretic peptides B,NPPB,Humans
12625,DB06413,Armodafinil,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12630,DB06420,Annamycin,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12633,DB06421,Declopramide,['investigational'],BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
12634,DB06421,Declopramide,['investigational'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
12635,DB06422,Ticalopride,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
12636,DB06422,Ticalopride,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
12637,DB06423,Endostatin,['investigational'],BE0000642,72 kDa type IV collagenase,MMP2,Humans
12638,DB06423,Endostatin,['investigational'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
12639,DB06423,Endostatin,['investigational'],BE0000966,Collagenase 3,MMP13,Humans
12640,DB06423,Endostatin,['investigational'],BE0003090,Focal adhesion kinase 1,PTK2,Humans
12641,DB06423,Endostatin,['investigational'],BE0001074,E-selectin,SELE,Humans
12642,DB06429,Talnetant,['investigational'],BE0002371,Neuromedin-K receptor,TACR3,Humans
12643,DB06433,Tezacitabine,['investigational'],BE0000325,Ribonucleoside-diphosphate reductase large subunit,RRM1,Humans
12644,DB06436,Semaxanib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12645,DB06439,Tyloxapol,"['approved', 'investigational']",BE0000239,Lipoprotein lipase,LPL,Humans
12646,DB06441,Cangrelor,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
12647,DB06442,Avasimibe,['investigational'],BE0002705,Liver carboxylesterase 1,CES1,Humans
12648,DB06444,Dexanabinol,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12649,DB06446,Dotarizine,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12650,DB06446,Dotarizine,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12651,DB06446,Dotarizine,['investigational'],BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,Humans
12652,DB06446,Dotarizine,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12653,DB06447,E5531,['investigational'],BE0002442,Toll-like receptor 4,TLR4,Humans
12654,DB06448,Lonafarnib,"['approved', 'investigational']",BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
12655,DB06448,Lonafarnib,"['approved', 'investigational']",BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
12656,DB06451,Aprinocarsen,['investigational'],BE0001132,Protein kinase C alpha type,PRKCA,Humans
12657,DB06454,Sarizotan,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12658,DB06454,Sarizotan,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
12659,DB06454,Sarizotan,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12660,DB06457,Tecastemizole,['investigational'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
12661,DB06460,Enrasentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
12662,DB06460,Enrasentan,['investigational'],BE0000043,Endothelin B receptor,EDNRB,Humans
12663,DB06468,Cariporide,['investigational'],BE0000752,Sodium/hydrogen exchanger 1,SLC9A1,Humans
12664,DB06469,Lestaurtinib,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
12665,DB06470,Clomethiazole,['investigational'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
12666,DB06471,Naxifylline,['investigational'],BE0000013,Adenosine receptor A1,ADORA1,Humans
12667,DB06472,Fradafiban,['investigational'],BE0000439,Integrin alpha-IIb,ITGA2B,Humans
12668,DB06472,Fradafiban,['investigational'],BE0001155,Integrin beta-3,ITGB3,Humans
12669,DB06474,Sibrotuzumab,['investigational'],BE0003507,Seprase,FAP,Humans
12670,DB06475,Ruplizumab,['investigational'],BE0001006,CD40 ligand,CD40LG,Humans
12671,DB06477,Sumanirole,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
12672,DB06477,Sumanirole,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
12673,DB06477,Sumanirole,['investigational'],BE0000389,Dopamine D4 receptor,DRD4,Humans
12674,DB06479,Propentofylline,['investigational'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
12675,DB06480,Prucalopride,['approved'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
12676,DB06481,Manitimus,['investigational'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
12677,DB06486,Enzastaurin,['investigational'],BE0000872,Protein kinase C beta type,PRKCB,Humans
12678,DB06486,Enzastaurin,['investigational'],BE0003404,Aurora kinase B,AURKB,Humans
12679,DB06486,Enzastaurin,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
12680,DB06486,Enzastaurin,['investigational'],BE0000437,Cyclin-dependent kinase 15,CDK15,Humans
12681,DB06486,Enzastaurin,['investigational'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
12682,DB06486,Enzastaurin,['investigational'],BE0003381,Serine/threonine-protein kinase Chk2,CHEK2,Humans
12683,DB06486,Enzastaurin,['investigational'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
12684,DB06486,Enzastaurin,['investigational'],BE0000955,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,Humans
12685,DB06492,Mirococept,['investigational'],BE0003455,Complement C3,C3,Humans
12686,DB06494,Sufugolix,['investigational'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12687,DB06495,Onercept,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
12688,DB06497,Aplaviroc,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
12689,DB06503,MLN2222,['investigational'],BE0001701,Complement factor B,CFB,Humans
12690,DB06506,Repinotan,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12691,DB06510,Muraglitazar,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
12692,DB06510,Muraglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12693,DB06511,AMGN-0007,['investigational'],BE0003517,Tumor necrosis factor ligand superfamily member 11,TNFSF11,Humans
12694,DB06512,Deramciclane,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
12695,DB06512,Deramciclane,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12696,DB06515,Resiniferatoxin,['investigational'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
12697,DB06518,R-1487,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
12698,DB06521,Ertiprotafib,['investigational'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
12699,DB06521,Ertiprotafib,['investigational'],BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
12700,DB06521,Ertiprotafib,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
12701,DB06521,Ertiprotafib,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12702,DB06525,Ganstigmine,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
12703,DB06530,Resiquimod,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
12704,DB06530,Resiquimod,['investigational'],BE0003518,Toll-like receptor 8,TLR8,Humans
12705,DB06533,Ragaglitazar,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
12706,DB06533,Ragaglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12707,DB06534,Thrombopoietin,['investigational'],BE0003440,Thrombopoietin receptor,MPL,Humans
12708,DB06536,Tesaglitazar,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
12709,DB06536,Tesaglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
12710,DB06538,Robalzotan,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12711,DB06543,Astaxanthin,['investigational'],BE0003469,NF-kappa-B inhibitor alpha,NFKBIA,Humans
12712,DB06546,Atibuclimab,['investigational'],BE0003519,Monocyte differentiation antigen CD14,CD14,Humans
12713,DB06548,Minodronic acid,['investigational'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
12714,DB06548,Minodronic acid,['investigational'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
12715,DB06549,Labradimil,['investigational'],BE0003513,B2 bradykinin receptor,BDKRB2,Humans
12716,DB06550,Bivatuzumab,['investigational'],BE0001113,CD44 antigen,CD44,Humans
12717,DB06552,rNAPc2,['investigational'],BE0000333,Coagulation factor VII,F7,Humans
12718,DB06552,rNAPc2,['investigational'],BE0001178,Tissue factor,F3,Humans
12719,DB06552,rNAPc2,['investigational'],BE0000216,Coagulation factor X,F10,Humans
12720,DB06558,Tezosentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
12721,DB06558,Tezosentan,['investigational'],BE0000043,Endothelin B receptor,EDNRB,Humans
12722,DB06560,Pascolizumab,['investigational'],BE0003520,Interleukin-4,IL4,Humans
12723,DB06579,Adipiplon,['investigational'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
12725,DB06584,TG4010,['investigational'],BE0003501,Mucin-1,MUC1,Humans
12726,DB06584,TG4010,['investigational'],BE0001029,Interleukin-2,IL2,Humans
12727,DB06586,Cetilistat,['investigational'],BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
12728,DB06587,Mitemcinal,['investigational'],BE0003521,Motilin receptor,MLNR,Humans
12729,DB06589,Pazopanib,['approved'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12730,DB06589,Pazopanib,['approved'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12731,DB06589,Pazopanib,['approved'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
12732,DB06589,Pazopanib,['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
12733,DB06589,Pazopanib,['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
12734,DB06589,Pazopanib,['approved'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
12735,DB06589,Pazopanib,['approved'],BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
12736,DB06589,Pazopanib,['approved'],BE0001341,Tyrosine-protein kinase ITK/TSK,ITK,Humans
12737,DB06589,Pazopanib,['approved'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
12738,DB06589,Pazopanib,['approved'],BE0004714,SH2B adapter protein 3,SH2B3,Humans
12739,DB06594,Agomelatine,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
12740,DB06594,Agomelatine,"['approved', 'investigational']",BE0000515,Melatonin receptor type 1A,MTNR1A,Humans
12741,DB06594,Agomelatine,"['approved', 'investigational']",BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
12742,DB06595,Midostaurin,"['approved', 'investigational']",BE0001132,Protein kinase C alpha type,PRKCA,Humans
12743,DB06595,Midostaurin,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12744,DB06595,Midostaurin,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
12745,DB06595,Midostaurin,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
12746,DB06595,Midostaurin,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
12747,DB06595,Midostaurin,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
12748,DB06599,Lexatumumab,['investigational'],BE0003433,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,Humans
12749,DB06602,Reslizumab,"['approved', 'investigational']",BE0001208,Interleukin-5,IL5,Humans
12750,DB06603,Panobinostat,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
12751,DB06605,Apixaban,['approved'],BE0000216,Coagulation factor X,F10,Humans
12752,DB06606,Teplizumab,"['approved', 'investigational']",BE0000274,T-cell surface glycoprotein CD3 epsilon chain,CD3E,Humans
12753,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
12754,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
12755,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
12756,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0000274,T-cell surface glycoprotein CD3 epsilon chain,CD3E,Humans
12757,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
12758,DB06607,Catumaxomab,"['approved', 'investigational', 'withdrawn']",BE0002446,Epithelial cell adhesion molecule,EPCAM,Humans
12759,DB06612,Mepolizumab,"['approved', 'investigational']",BE0001208,Interleukin-5,IL5,Humans
12763,DB06616,Bosutinib,['approved'],BE0004743,Breakpoint cluster region protein,BCR,Humans
12764,DB06616,Bosutinib,['approved'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
12765,DB06616,Bosutinib,['approved'],BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
12766,DB06616,Bosutinib,['approved'],BE0001424,Tyrosine-protein kinase HCK,HCK,Humans
12767,DB06616,Bosutinib,['approved'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
12768,DB06616,Bosutinib,['approved'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
12769,DB06616,Bosutinib,['approved'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
12770,DB06616,Bosutinib,['approved'],BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,Humans
12771,DB06616,Bosutinib,['approved'],BE0004745,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,Humans
12772,DB06616,Bosutinib,['approved'],BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,Humans
12774,DB06623,Flupirtine,['investigational'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12775,DB06626,Axitinib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
12776,DB06626,Axitinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
12777,DB06626,Axitinib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
12778,DB06634,Casopitant,['investigational'],BE0002638,Cytochrome P450 3A4,CYP3A4,Humans
12779,DB06634,Casopitant,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
12780,DB06635,Otamixaban,['investigational'],BE0000216,Coagulation factor X,F10,Humans
12781,DB06637,Dalfampridine,['approved'],BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
12782,DB06637,Dalfampridine,['approved'],BE0004715,Potassium voltage-gated channel subfamily A member 2,KCNA2,Humans
12783,DB06637,Dalfampridine,['approved'],BE0004716,Potassium voltage-gated channel subfamily A member 3,KCNA3,Humans
12784,DB06637,Dalfampridine,['approved'],BE0004502,Potassium voltage-gated channel subfamily A member 4,KCNA4,Humans
12785,DB06637,Dalfampridine,['approved'],BE0004717,Potassium voltage-gated channel subfamily A member 5,KCNA5,Humans
12786,DB06637,Dalfampridine,['approved'],BE0004718,Potassium voltage-gated channel subfamily A member 6,KCNA6,Humans
12787,DB06637,Dalfampridine,['approved'],BE0004719,Potassium voltage-gated channel subfamily A member 7,KCNA7,Humans
12788,DB06637,Dalfampridine,['approved'],BE0004720,Potassium voltage-gated channel subfamily A member 10,KCNA10,Humans
12789,DB06637,Dalfampridine,['approved'],BE0004721,Potassium voltage-gated channel subfamily B member 1,KCNB1,Humans
12790,DB06637,Dalfampridine,['approved'],BE0004722,Potassium voltage-gated channel subfamily B member 2,KCNB2,Humans
12791,DB06637,Dalfampridine,['approved'],BE0004723,Potassium voltage-gated channel subfamily C member 1,KCNC1,Humans
12792,DB06637,Dalfampridine,['approved'],BE0004724,Potassium voltage-gated channel subfamily C member 2,KCNC2,Humans
12793,DB06637,Dalfampridine,['approved'],BE0004725,Potassium voltage-gated channel subfamily C member 3,KCNC3,Humans
12794,DB06637,Dalfampridine,['approved'],BE0004726,Potassium voltage-gated channel subfamily D member 1,KCND1,Humans
12795,DB06637,Dalfampridine,['approved'],BE0003603,Potassium voltage-gated channel subfamily D member 2,KCND2,Humans
12796,DB06637,Dalfampridine,['approved'],BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
12797,DB06641,Perifosine,['investigational'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
12798,DB06641,Perifosine,['investigational'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
12799,DB06641,Perifosine,['investigational'],BE0001132,Protein kinase C alpha type,PRKCA,Humans
12800,DB06642,Bevasiranib,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
12801,DB06643,Denosumab,['approved'],BE0003517,Tumor necrosis factor ligand superfamily member 11,TNFSF11,Humans
12802,DB06650,Ofatumumab,['approved'],BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
12803,DB06652,Vicriviroc,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
12804,DB06654,Safinamide,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
12805,DB06655,Liraglutide,['approved'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
12806,DB06660,Saredutant,['investigational'],BE0002222,Substance-K receptor,TACR2,Humans
12807,DB06663,Pasireotide,['approved'],BE0000452,Somatostatin receptor type 1,SSTR1,Humans
12808,DB06663,Pasireotide,['approved'],BE0003528,Somatostatin receptor type 2,SSTR2,Humans
12809,DB06663,Pasireotide,['approved'],BE0003529,Somatostatin receptor type 3,SSTR3,Humans
12810,DB06663,Pasireotide,['approved'],BE0002147,Somatostatin receptor type 5,SSTR5,Humans
12811,DB06670,Odanacatib,['investigational'],BE0003417,Cathepsin K,CTSK,Humans
12812,DB06674,Golimumab,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
12813,DB06677,Clazosentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
12814,DB06678,Esmirtazapine,['investigational'],BE0000442,Histamine H1 receptor,HRH1,Humans
12815,DB06678,Esmirtazapine,['investigational'],BE0004957,5-hydroxytryptamine receptor 2,HTR2A,Humans
12816,DB06678,Esmirtazapine,['investigational'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
12817,DB06680,Asoprisnil,['investigational'],BE0000557,Progesterone receptor,PGR,Humans
12818,DB06681,Belatacept,"['approved', 'investigational']",BE0000846,T-lymphocyte activation antigen CD86,CD86,Humans
12819,DB06681,Belatacept,"['approved', 'investigational']",BE0000847,T-lymphocyte activation antigen CD80,CD80,Humans
12820,DB06684,Vilazodone,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12821,DB06684,Vilazodone,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
12822,DB06688,Sipuleucel-T,"['approved', 'investigational']",BE0001102,Prostatic acid phosphatase,ACPP,Humans
12824,DB06689,Ethanolamine oleate,['approved'],BE0004672,Coagulation factor XII,F12,Humans
12825,DB06691,Mepyramine,"['approved', 'vet_approved']",BE0000442,Histamine H1 receptor,HRH1,Humans
12826,DB06692,Aprotinin,"['approved', 'investigational', 'withdrawn']",BE0001739,Trypsin-1,PRSS1,Humans
12827,DB06692,Aprotinin,"['approved', 'investigational', 'withdrawn']",BE0003531,Chymotrypsinogen B,CTRB1,Humans
12828,DB06692,Aprotinin,"['approved', 'investigational', 'withdrawn']",BE0000211,Plasminogen,PLG,Humans
12829,DB06692,Aprotinin,"['approved', 'investigational', 'withdrawn']",BE0001091,Kallikrein-1,KLK1,Humans
12830,DB06693,Mevastatin,['experimental'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
12831,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12832,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
12833,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12834,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
12835,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
12836,DB06694,Xylometazoline,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
12837,DB06695,Dabigatran etexilate,['approved'],BE0000048,Prothrombin,F2,Humans
12839,DB06698,Betahistine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
12840,DB06698,Betahistine,"['approved', 'investigational']",BE0000968,Histamine H3 receptor,HRH3,Humans
12841,DB06699,Degarelix,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12842,DB06700,Desvenlafaxine,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12843,DB06700,Desvenlafaxine,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12844,DB06700,Desvenlafaxine,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12845,DB06701,Dexmethylphenidate,"['approved', 'investigational']",BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
12846,DB06701,Dexmethylphenidate,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
12847,DB06701,Dexmethylphenidate,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
12848,DB06702,Fesoterodine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
12849,DB06702,Fesoterodine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
12850,DB06702,Fesoterodine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12851,DB06702,Fesoterodine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
12852,DB06702,Fesoterodine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
12853,DB06706,Isometheptene,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12854,DB06706,Isometheptene,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
12855,DB06707,Levonordefrin,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
12856,DB06709,Methacholine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
12857,DB06709,Methacholine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
12858,DB06709,Methacholine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12859,DB06709,Methacholine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
12860,DB06709,Methacholine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
12861,DB06710,Methyltestosterone,['approved'],BE0000132,Androgen receptor,AR,Humans
12862,DB06710,Methyltestosterone,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12863,DB06711,Naphazoline,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
12864,DB06711,Naphazoline,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
12865,DB06712,Nilvadipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
12866,DB06712,Nilvadipine,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
12867,DB06712,Nilvadipine,"['approved', 'investigational']",BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,Humans
12868,DB06712,Nilvadipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
12869,DB06712,Nilvadipine,"['approved', 'investigational']",BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
12870,DB06712,Nilvadipine,"['approved', 'investigational']",BE0003563,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,Humans
12871,DB06712,Nilvadipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
12872,DB06712,Nilvadipine,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
12873,DB06712,Nilvadipine,"['approved', 'investigational']",BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
12874,DB06712,Nilvadipine,"['approved', 'investigational']",BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
12875,DB06713,Norelgestromin,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
12876,DB06713,Norelgestromin,"['approved', 'investigational']",BE0000530,Serum albumin,ALB,Humans
12877,DB06713,Norelgestromin,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
12878,DB06714,Propylhexedrine,['approved'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
12879,DB06714,Propylhexedrine,['approved'],BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
12881,DB06716,Fospropofol,"['approved', 'illicit', 'investigational']",BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,Humans
12882,DB06716,Fospropofol,"['approved', 'illicit', 'investigational']",BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
12883,DB06718,Stanozolol,"['approved', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
12885,DB06719,Buserelin,"['approved', 'investigational']",BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
12886,DB06719,Buserelin,"['approved', 'investigational']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12887,DB06720,Velaglucerase alfa,"['approved', 'investigational']",BE0000978,Glucosylceramidase,GBA,Humans
12888,DB06725,Lornoxicam,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
12889,DB06725,Lornoxicam,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
12890,DB06726,Bufuralol,['experimental'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
12891,DB06728,Aniline,['experimental'],BE0001091,Kallikrein-1,KLK1,Humans
12892,DB06728,Aniline,['experimental'],BE0000530,Serum albumin,ALB,Humans
12894,DB06730,Gestodene,['investigational'],BE0000557,Progesterone receptor,PGR,Humans
12895,DB06732,beta-Naphthoflavone,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
12896,DB06732,beta-Naphthoflavone,['experimental'],BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
12897,DB06732,beta-Naphthoflavone,['experimental'],BE0008953,COUP transcription factor 1,NR2F1,Humans
12898,DB06732,beta-Naphthoflavone,['experimental'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
12899,DB06732,beta-Naphthoflavone,['experimental'],BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
12900,DB06733,Bafilomycin A1,['experimental'],BE0003569,V-type proton ATPase catalytic subunit A,ATP6V1A,Humans
12901,DB06734,Bafilomycin B1,['experimental'],BE0003569,V-type proton ATPase catalytic subunit A,ATP6V1A,Humans
12902,DB06736,Aceclofenac,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
12903,DB06736,Aceclofenac,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
12904,DB06738,Ketobemidone,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12905,DB06738,Ketobemidone,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12906,DB06738,Ketobemidone,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
12907,DB06738,Ketobemidone,['investigational'],BE0004956,NMDA receptor,GRIN1,Humans
12908,DB06739,Seratrodast,['experimental'],BE0000759,Thromboxane A2 receptor,TBXA2R,Humans
12909,DB06741,Gavestinel,['investigational'],BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
12910,DB06749,Ginsenoside Rb1,['nutraceutical'],BE0003659,Solute carrier organic anion transporter family member 1B3,SLCO1B3,Humans
12911,DB06750,Ginsenoside Rg1,['nutraceutical'],BE0003659,Solute carrier organic anion transporter family member 1B3,SLCO1B3,Humans
12912,DB06751,Drotaverine,"['approved', 'investigational']",BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
12913,DB06751,Drotaverine,"['approved', 'investigational']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
12914,DB06752,Chymopapain,"['approved', 'withdrawn']",BE0002114,Bone marrow proteoglycan,PRG2,Humans
12915,DB06754,Danaparoid,"['approved', 'withdrawn']",BE0000280,Antithrombin-III,SERPINC1,Humans
12917,DB06756,Betaine,"['approved', 'investigational', 'nutraceutical']",BE0000845,Betaine--homocysteine S-methyltransferase 1,BHMT,Humans
12918,DB06757,Manganese,"['approved', 'nutraceutical']",BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,Humans
12919,DB06757,Manganese,"['approved', 'nutraceutical']",BE0000771,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",IDH3G,Humans
12920,DB06757,Manganese,"['approved', 'nutraceutical']",BE0005824,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,TAB1,Humans
12921,DB06757,Manganese,"['approved', 'nutraceutical']",BE0000286,Arginase-1,ARG1,Humans
12922,DB06757,Manganese,"['approved', 'nutraceutical']",BE0000510,Serotransferrin,TF,Humans
12925,DB06764,Tetryzoline,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
12926,DB06764,Tetryzoline,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
12927,DB06766,Alcaftadine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
12932,DB06772,Cabazitaxel,['approved'],BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
12933,DB06772,Cabazitaxel,['approved'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
12934,DB06773,Human calcitonin,"['approved', 'investigational']",BE0008968,Alpha-actinin-1,ACTN1,Humans
12935,DB06774,Capsaicin,['approved'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
12936,DB06774,Capsaicin,['approved'],BE0009007,Prohibitin-2,PHB2,Humans
12937,DB06775,Carglumic acid,['approved'],BE0004671,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",CPS1,Humans
12939,DB06777,Chenodeoxycholic acid,['approved'],BE0001777,Bile acid receptor,NR1H4,Humans
12940,DB06777,Chenodeoxycholic acid,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
12941,DB06777,Chenodeoxycholic acid,['approved'],BE0005788,G-protein coupled bile acid receptor 1,GPBAR1,Humans
12942,DB06777,Chenodeoxycholic acid,['approved'],BE0000622,Aldo-keto reductase family 1 member C2,AKR1C2,Humans
12943,DB06779,Dalteparin,['approved'],BE0000280,Antithrombin-III,SERPINC1,Humans
12944,DB06779,Dalteparin,['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
12945,DB06779,Dalteparin,['approved'],BE0000967,Tissue factor pathway inhibitor,TFPI,Humans
12946,DB06779,Dalteparin,['approved'],BE0001159,P-selectin,SELP,Humans
12947,DB06780,Desoxycorticosterone acetate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
12948,DB06781,Difluprednate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
12952,DB06782,Dimercaprol,['approved'],BE0003392,Amyloid beta A4 protein,APP,Humans
12953,DB06785,Ganirelix,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12954,DB06786,Halcinonide,"['approved', 'investigational', 'withdrawn']",BE0004659,Smoothened homolog,SMO,Humans
12955,DB06787,Hexocyclium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
12956,DB06787,Hexocyclium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
12957,DB06787,Hexocyclium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
12958,DB06787,Hexocyclium,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
12959,DB06788,Histrelin,"['approved', 'withdrawn']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12960,DB06789,Hydroxyprogesterone caproate,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
12961,DB06791,Lanreotide,['approved'],BE0003528,Somatostatin receptor type 2,SSTR2,Humans
12962,DB06791,Lanreotide,['approved'],BE0002147,Somatostatin receptor type 5,SSTR5,Humans
12964,DB06795,Mafenide,"['approved', 'vet_approved', 'withdrawn']",BE0003628,Carbonic anhydrase 6,CA6,Humans
12965,DB06800,Methylnaltrexone,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
12966,DB06800,Methylnaltrexone,['approved'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
12967,DB06802,Nepafenac,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
12968,DB06802,Nepafenac,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
12970,DB06809,Plerixafor,['approved'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
12972,DB06813,Pralatrexate,"['approved', 'investigational']",BE0000330,Dihydrofolate reductase,DHFR,Humans
12973,DB06813,Pralatrexate,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
12974,DB06813,Pralatrexate,"['approved', 'investigational']",BE0000700,"Folylpolyglutamate synthase, mitochondrial",FPGS,Humans
12975,DB06814,Protokylol,"['approved', 'vet_approved']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
12978,DB06819,Phenylbutyric acid,"['approved', 'investigational']",BE0008667,Histone deacetylase,HDAC1,Humans
12980,DB06822,Tinzaparin,['approved'],BE0000280,Antithrombin-III,SERPINC1,Humans
12981,DB06822,Tinzaparin,['approved'],BE0000590,Integrin alpha-4,ITGA4,Humans
12982,DB06822,Tinzaparin,['approved'],BE0001150,Stromal cell-derived factor 1,CXCL12,Humans
12983,DB06825,Triptorelin,"['approved', 'vet_approved']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
12985,DB06828,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
12986,DB06829,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
12987,DB06830,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
12988,DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
12989,DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,['experimental'],BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
12990,DB06832,Prinaberel,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
12991,DB06832,Prinaberel,['investigational'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
12992,DB06833,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,['experimental'],BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
12993,DB06834,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",['experimental'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
12994,DB06835,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
12995,DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
12996,DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",['experimental'],BE0003729,Phosphatidylinositol 3-kinase catalytic subunit type 3,PIK3C3,Humans
12997,DB06837,"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",['experimental'],BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,Humans
12999,DB06838,methyl L-phenylalaninate,['experimental'],BE0000048,Prothrombin,F2,Humans
13000,DB06840,"diethyl [(1R)-1,5-diaminopentyl]boronate",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13001,DB06841,"[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium",['experimental'],BE0000048,Prothrombin,F2,Humans
13002,DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,['experimental'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
13003,DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
13004,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",['experimental'],BE0003731,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,Humans
13005,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",['experimental'],BE0003732,Adenylate cyclase type 2,ADCY2,Humans
13006,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",['experimental'],BE0003733,Adenylate cyclase type 5,ADCY5,Humans
13007,DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13008,DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13009,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13010,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13012,DB06848,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",['experimental'],BE0003736,Tryptase alpha/beta-1,TPSAB1,Humans
13013,DB06849,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",['experimental'],BE0003736,Tryptase alpha/beta-1,TPSAB1,Humans
13014,DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13015,DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13017,DB06851,N-(pyridin-3-ylmethyl)aniline,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13018,DB06852,CHIR-124,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13019,DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13020,DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13021,DB06855,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13022,DB06855,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13023,DB06856,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13024,DB06857,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13025,DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13026,DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13027,DB06859,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13029,DB06861,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,['experimental'],BE0000048,Prothrombin,F2,Humans
13030,DB06862,2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,['experimental'],BE0001162,Caspase-3,CASP3,Humans
13032,DB06865,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,['experimental'],BE0000048,Prothrombin,F2,Humans
13033,DB06866,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,['experimental'],BE0000048,Prothrombin,F2,Humans
13034,DB06867,"3,6,9,12,15,18-HEXAOXAICOSANE",['experimental'],BE0003739,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,Humans
13035,DB06868,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13036,DB06869,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13037,DB06870,Tetrahydrogestrinone,['experimental'],BE0000132,Androgen receptor,AR,Humans
13038,DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13039,DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13043,DB06875,ERB-196,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13044,DB06875,ERB-196,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13045,DB06876,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13046,DB06877,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
13047,DB06878,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13048,DB06879,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13049,DB06880,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13051,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
13052,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13053,DB06883,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
13054,DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,['experimental'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
13055,DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,['experimental'],BE0003742,Nuclear receptor-interacting protein 1,NRIP1,Humans
13057,DB06887,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13058,DB06888,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13061,DB06891,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13062,DB06892,"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
13065,DB06894,1-Dodecanol,['experimental'],BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
13066,DB06896,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
13067,DB06897,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",['experimental'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
13068,DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13069,DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13070,DB06899,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",['experimental'],BE0000270,Renin,REN,Humans
13071,DB06900,1-[4-(hydroxymethyl)phenyl]guanidine,['experimental'],BE0003746,Prostasin,PRSS8,Humans
13072,DB06901,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,['experimental'],BE0003747,Chymotrypsin-like elastase family member 2A,CELA2A,Humans
13073,DB06902,p-Cumylphenol,['experimental'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
13076,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",['experimental'],BE0003749,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,Humans
13077,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",['experimental'],BE0002326,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,Humans
13078,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",['experimental'],BE0003750,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,Humans
13080,DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13081,DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13082,DB06909,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
13084,DB06911,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13085,DB06912,"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",['experimental'],BE0003751,Lysozyme C,LYZ,Humans
13087,DB06914,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
13088,DB06916,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13089,DB06917,(4-fluorophenyl)(pyridin-4-yl)methanone,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13090,DB06918,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13091,DB06919,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13092,DB06920,Eribaxaban,['experimental'],BE0000216,Coagulation factor X,F10,Humans
13093,DB06921,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
13095,DB06923,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13096,DB06924,(2R)-2-benzyl-3-nitropropanoic acid,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
13097,DB06925,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
13098,DB06926,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13099,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13100,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13101,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13102,DB06928,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,['experimental'],BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
13103,DB06929,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13104,DB06930,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13105,DB06931,"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
13106,DB06932,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13107,DB06933,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
13109,DB06936,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13110,DB06937,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13111,DB06938,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13112,DB06939,"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13113,DB06940,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13114,DB06941,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,['experimental'],BE0001177,Protein S100-B,S100B,Humans
13115,DB06942,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13116,DB06943,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13117,DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13118,DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13119,DB06945,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,['experimental'],BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,Humans
13121,DB06947,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13122,DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13123,DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13126,DB06951,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
13128,DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
13129,DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
13130,DB06954,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13132,DB06956,"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13133,DB06957,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13134,DB06958,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13135,DB06959,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13136,DB06959,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
13138,DB06961,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13139,DB06962,JNJ-27390467,['experimental'],BE0001474,Tryptase beta-2,TPSB2,Humans
13140,DB06963,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",['experimental'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
13141,DB06964,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13144,DB06967,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",['experimental'],BE0000270,Renin,REN,Humans
13146,DB06969,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13148,DB06971,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
13149,DB06972,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",['experimental'],BE0000516,Integrin alpha-L,ITGAL,Humans
13150,DB06973,Bisphenol A,['experimental'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
13152,DB06976,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13153,DB06977,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13155,DB06979,"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
13156,DB06980,(2S)-2-(1H-indol-3-yl)hexanoic acid,['experimental'],BE0003767,S-phase kinase-associated protein 1,SKP1,Humans
13157,DB06981,(2S)-2-(1H-indol-3-yl)pentanoic acid,['experimental'],BE0003767,S-phase kinase-associated protein 1,SKP1,Humans
13158,DB06982,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,['experimental'],BE0003767,S-phase kinase-associated protein 1,SKP1,Humans
13159,DB06983,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13160,DB06984,"(1R,2R,3R,4S,5R)-4-(Benzylamino)-5-(methylthio)cyclopentane-1,2,3-triol",['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
13161,DB06986,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
13162,DB06987,(R)-Atenolol,['experimental'],BE0000994,Lactotransferrin,LTF,Humans
13163,DB06987,(R)-Atenolol,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
13165,DB06989,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,['experimental'],BE0003769,Receptor-type tyrosine-protein phosphatase beta,PTPRB,Humans
13166,DB06990,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",['experimental'],BE0003770,Uracil-DNA glycosylase,UNG,Humans
13167,DB06991,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13168,DB06992,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13169,DB06993,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13170,DB06994,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13171,DB06995,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
13172,DB06996,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13173,DB06997,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
13175,DB06999,PLX-4720,['experimental'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
13176,DB07000,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",['experimental'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
13177,DB07001,"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
13178,DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13179,DB07003,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13180,DB07004,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,['experimental'],BE0001177,Protein S100-B,S100B,Humans
13181,DB07005,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13182,DB07006,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
13183,DB07007,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13184,DB07008,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13185,DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13186,DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13187,DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
13188,DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
13189,DB07011,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13191,DB07013,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,['experimental'],BE0000966,Collagenase 3,MMP13,Humans
13192,DB07014,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13193,DB07015,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13194,DB07016,"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",['experimental'],BE0000048,Prothrombin,F2,Humans
13195,DB07017,"(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13197,DB07019,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13198,DB07020,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",['experimental'],BE0003772,Mitogen-activated protein kinase 9,MAPK9,Humans
13199,DB07021,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13200,DB07022,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13201,DB07023,"(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate",['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13202,DB07024,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13203,DB07025,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13204,DB07026,"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
13205,DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13206,DB07028,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13207,DB07029,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13208,DB07030,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13209,DB07031,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
13210,DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13211,DB07033,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13212,DB07034,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13214,DB07036,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13215,DB07037,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13216,DB07038,2-(cyclohexylamino)benzoic acid,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13217,DB07039,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,['experimental'],BE0000132,Androgen receptor,AR,Humans
13224,DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",['experimental'],BE0003774,BAG family molecular chaperone regulator 1,BAG1,Humans
13225,DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",['experimental'],BE0003775,Heat shock cognate 71 kDa protein,HSPA8,Humans
13226,DB07046,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
13227,DB07048,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13228,DB07049,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13229,DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13230,DB07051,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
13232,DB07053,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13233,DB07054,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13235,DB07056,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13237,DB07058,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13238,DB07059,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",['experimental'],BE0000270,Renin,REN,Humans
13239,DB07060,3-(INDOL-3-YL) LACTATE,['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
13241,DB07061,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",['experimental'],BE0003780,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,Humans
13243,DB07063,Lidorestat,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
13244,DB07064,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
13245,DB07065,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13246,DB07066,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
13247,DB07067,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13248,DB07068,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",['experimental'],BE0003769,Receptor-type tyrosine-protein phosphatase beta,PTPRB,Humans
13249,DB07069,m-Hydroxyhippuric acid,['experimental'],BE0000392,Kynureninase,KYNU,Humans
13250,DB07070,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
13251,DB07071,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine",['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13252,DB07072,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13253,DB07073,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
13254,DB07074,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13255,DB07075,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13256,DB07076,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13257,DB07077,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine",['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13258,DB07078,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13259,DB07079,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13260,DB07080,TO-901317,['experimental'],BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
13261,DB07080,TO-901317,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13262,DB07080,TO-901317,['experimental'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
13263,DB07080,TO-901317,['experimental'],BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
13264,DB07080,TO-901317,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13265,DB07080,TO-901317,['experimental'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
13266,DB07081,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13267,DB07082,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",['experimental'],BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
13268,DB07083,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13271,DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13272,DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13273,DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13274,DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13275,DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13276,DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13277,DB07089,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13279,DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13280,DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13281,DB07092,"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13282,DB07093,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13283,DB07094,"1-(2,2'-bithiophen-5-yl)methanamine",['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13284,DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13285,DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13286,DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
13289,DB07099,N-[4-(benzyloxy)phenyl]glycinamide,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13290,DB07100,"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13291,DB07101,Mirdametinib,['investigational'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
13292,DB07102,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13294,DB07104,4-amino-N-[4-(benzyloxy)phenyl]butanamide,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13295,DB07105,2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13296,DB07106,SKF-91488,['experimental'],BE0002436,Histamine N-methyltransferase,HNMT,Humans
13297,DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13298,DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
13299,DB07108,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",['experimental'],BE0003510,Bcl-2-like protein 1,BCL2L1,Humans
13301,DB07110,4-(4-FLUOROBENZYL)PIPERIDINE,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13302,DB07111,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13303,DB07112,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,['experimental'],BE0002217,Egl nine homolog 1,EGLN1,Humans
13304,DB07113,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",['experimental'],BE0000270,Renin,REN,Humans
13306,DB07115,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",['experimental'],BE0003633,Carbonic anhydrase 13,CA13,Humans
13307,DB07116,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,['experimental'],BE0003770,Uracil-DNA glycosylase,UNG,Humans
13308,DB07117,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",['experimental'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
13310,DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13311,DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13312,DB07120,"3-Carbamimidamido-1,1-diphenylurea",['experimental'],BE0000048,Prothrombin,F2,Humans
13313,DB07121,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13314,DB07122,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13316,DB07124,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13317,DB07125,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",['experimental'],BE0003788,Death-associated protein kinase 3,DAPK3,Humans
13318,DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13319,DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13320,DB07127,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",['experimental'],BE0003769,Receptor-type tyrosine-protein phosphatase beta,PTPRB,Humans
13321,DB07128,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",['experimental'],BE0000048,Prothrombin,F2,Humans
13322,DB07129,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13323,DB07130,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13324,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13325,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13326,DB07132,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13327,DB07133,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13328,DB07134,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13329,DB07135,"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13330,DB07136,BX-528,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
13331,DB07137,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13332,DB07137,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13333,DB07138,Neflamapimod,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13334,DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13335,DB07140,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
13337,DB07141,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
13338,DB07142,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
13340,DB07143,D-phenylalanyl-N-benzyl-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13341,DB07144,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
13342,DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13343,DB07146,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
13344,DB07147,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13345,DB07148,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
13346,DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13347,DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13348,DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13349,DB07151,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
13350,DB07152,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
13352,DB07154,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13354,DB07156,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",['experimental'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
13355,DB07157,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
13356,DB07158,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13357,DB07159,Tamatinib,"['experimental', 'investigational']",BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
13358,DB07160,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13359,DB07161,5-phenyl-1H-indazol-3-amine,['experimental'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
13360,DB07162,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,['experimental'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
13361,DB07163,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13362,DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13363,DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13364,DB07165,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13365,DB07167,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,['experimental'],BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
13366,DB07168,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,['experimental'],BE0003792,Calcium/calmodulin-dependent protein kinase type II subunit beta,CAMK2B,Humans
13369,DB07171,"5-(2-hydroxyethyl)nonane-1,9-diol",['experimental'],BE0003793,Endothelin-converting enzyme 1,ECE1,Humans
13370,DB07172,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13371,DB07173,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",['experimental'],BE0003540,Adenosine kinase,ADK,Humans
13372,DB07174,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",['experimental'],BE0000270,Renin,REN,Humans
13373,DB07175,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13374,DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",['experimental'],BE0003795,Prostaglandin reductase 1,PTGR1,Humans
13375,DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",['experimental'],BE0003560,Prostaglandin reductase 2,PTGR2,Humans
13377,DB07179,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13378,DB07180,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",['experimental'],BE0003796,Serine/threonine-protein kinase Nek2,NEK2,Humans
13379,DB07181,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13380,DB07182,(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
13381,DB07183,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13384,DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
13385,DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",['experimental'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
13386,DB07187,CP-744809,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13388,DB07189,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13389,DB07190,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
13391,DB07193,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13392,DB07194,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",['experimental'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
13393,DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13394,DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13395,DB07196,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13396,DB07197,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13397,DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13398,DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13403,DB07202,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,['experimental'],BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
13404,DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13405,DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13406,DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
13407,DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13408,DB07205,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,['experimental'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
13409,DB07206,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13410,DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,['experimental'],BE0000333,Coagulation factor VII,F7,Humans
13411,DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,['experimental'],BE0001178,Tissue factor,F3,Humans
13412,DB07208,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13413,DB07209,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13414,DB07210,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13415,DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13416,DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
13417,DB07212,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13418,DB07213,"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13419,DB07215,GW-590735,['investigational'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13420,DB07215,GW-590735,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
13421,DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
13422,DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
13423,DB07217,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
13424,DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",['experimental'],BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,Humans
13425,DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
13426,DB07219,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13427,DB07220,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13428,DB07221,"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
13430,DB07223,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13431,DB07224,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13432,DB07225,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13433,DB07226,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
13434,DB07227,L-778123,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
13435,DB07227,L-778123,['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
13436,DB07227,L-778123,['experimental'],BE0001142,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,Humans
13437,DB07228,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13438,DB07229,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13439,DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13440,DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13441,DB07231,"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",['experimental'],BE0000939,Cathepsin B,CTSB,Humans
13442,DB07232,Veliparib,['investigational'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
13443,DB07232,Veliparib,['investigational'],BE0003798,Poly [ADP-ribose] polymerase 2,PARP2,Humans
13444,DB07233,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
13445,DB07234,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
13446,DB07235,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13447,DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13448,DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13449,DB07237,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13452,DB07239,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13454,DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",['experimental'],BE0003788,Death-associated protein kinase 3,DAPK3,Humans
13455,DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
13456,DB07243,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13457,DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
13458,DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",['experimental'],BE0000270,Renin,REN,Humans
13459,DB07245,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13460,DB07246,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",['experimental'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
13461,DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",['experimental'],BE0000333,Coagulation factor VII,F7,Humans
13462,DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",['experimental'],BE0001178,Tissue factor,F3,Humans
13463,DB07248,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",['experimental'],BE0003090,Focal adhesion kinase 1,PTK2,Humans
13464,DB07249,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13465,DB07250,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13466,DB07251,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13467,DB07252,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13468,DB07253,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13469,DB07254,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13470,DB07255,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13471,DB07256,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",['experimental'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
13472,DB07257,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
13473,DB07258,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13474,DB07259,1-(4-thiophen-2-ylphenyl)methanamine,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13475,DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13476,DB07261,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
13478,DB07263,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13479,DB07264,(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
13480,DB07265,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
13481,DB07266,AKI-001,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
13482,DB07267,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
13483,DB07268,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
13484,DB07269,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,['experimental'],BE0003257,Carboxypeptidase B,CPB1,Humans
13485,DB07270,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
13486,DB07271,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13487,DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",['experimental'],BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,Humans
13488,DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
13490,DB07274,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13492,DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",['experimental'],BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,Humans
13493,DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
13494,DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13495,DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
13496,DB07278,GW-813893,['experimental'],BE0000048,Prothrombin,F2,Humans
13497,DB07278,GW-813893,['experimental'],BE0000216,Coagulation factor X,F10,Humans
13498,DB07279,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
13499,DB07280,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,['experimental'],BE0003540,Adenosine kinase,ADK,Humans
13500,DB07281,"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13501,DB07284,"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13502,DB07285,"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",['experimental'],BE0000058,Matrix metalloproteinase-9,MMP9,Humans
13503,DB07286,BMS-564929,['experimental'],BE0000132,Androgen receptor,AR,Humans
13505,DB07288,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,['experimental'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
13506,DB07289,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13509,DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
13511,DB07294,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",['experimental'],BE0000144,Retinoic acid receptor gamma,RARG,Humans
13512,DB07295,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13514,DB07297,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
13515,DB07298,"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13516,DB07299,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,['experimental'],BE0001021,Coagulation factor XI,F11,Humans
13517,DB07300,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13520,DB07302,9(S)-HODE,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13521,DB07303,"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13524,DB07306,ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13525,DB07307,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13527,DB07309,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
13528,DB07310,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13529,DB07311,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13530,DB07312,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
13531,DB07313,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
13532,DB07314,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13534,DB07316,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13535,DB07317,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13536,DB07318,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13537,DB07319,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13538,DB07320,"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13539,DB07321,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
13540,DB07322,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
13541,DB07323,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
13542,DB07324,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13543,DB07325,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13544,DB07326,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13547,DB07328,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13548,DB07329,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
13549,DB07330,A-620223,['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
13553,DB07333,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13554,DB07334,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13555,DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
13556,DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
13557,DB07336,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13561,DB07339,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",['experimental'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
13562,DB07340,Reversine,['experimental'],BE0003404,Aurora kinase B,AURKB,Humans
13563,DB07340,Reversine,['experimental'],BE0003809,Inner centromere protein,INCENP,Humans
13564,DB07341,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
13565,DB07342,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,['experimental'],BE0000735,Heme oxygenase 1,HMOX1,Humans
13567,DB07344,"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",['experimental'],BE0003812,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial",MCAT,Humans
13568,DB07345,4-(2-aminoethyl)-2-cyclohexylphenol,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13569,DB07346,4-(2-aminoethyl)-2-ethylphenol,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13570,DB07347,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,['experimental'],BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
13571,DB07347,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,['experimental'],BE0003813,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,Humans
13572,DB07348,Brefeldin A,['experimental'],BE0002654,Cytohesin-2,CYTH2,Humans
13573,DB07348,Brefeldin A,['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
13578,DB07350,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
13579,DB07351,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
13581,DB07353,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",['experimental'],BE0000048,Prothrombin,F2,Humans
13582,DB07354,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",['experimental'],BE0000971,DNA topoisomerase 1,TOP1,Humans
13584,DB07356,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13585,DB07357,"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
13586,DB07358,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",['experimental'],BE0001056,Glucokinase,GCK,Humans
13587,DB07359,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",['experimental'],BE0001056,Glucokinase,GCK,Humans
13588,DB07360,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
13589,DB07362,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
13590,DB07363,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13591,DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",['experimental'],BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
13592,DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",['experimental'],BE0003819,Cyclin-dependent kinase 5 activator 1,CDK5R1,Humans
13595,DB07366,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,['experimental'],BE0000048,Prothrombin,F2,Humans
13597,DB07368,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13598,DB07369,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
13600,DB07371,3-(10-methyl-9-anthryl)propanoic acid,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
13602,DB07374,Anisomycin,['experimental'],BE0003823,60S ribosomal protein L10-like,RPL10L,Humans
13603,DB07374,Anisomycin,['experimental'],BE0003824,60S ribosomal protein L13a,RPL13A,Humans
13604,DB07374,Anisomycin,['experimental'],BE0003825,60S ribosomal protein L23,RPL23,Humans
13605,DB07374,Anisomycin,['experimental'],BE0003826,60S ribosomal protein L15,RPL15,Humans
13606,DB07374,Anisomycin,['experimental'],BE0003827,60S ribosomal protein L19,RPL19,Humans
13607,DB07374,Anisomycin,['experimental'],BE0003828,60S ribosomal protein L23a,RPL23A,Humans
13608,DB07374,Anisomycin,['experimental'],BE0003829,Probable ribosome biogenesis protein RLP24,RSL24D1,Humans
13609,DB07374,Anisomycin,['experimental'],BE0003830,60S ribosomal protein L26-like 1,RPL26L1,Humans
13610,DB07374,Anisomycin,['experimental'],BE0003831,60S ribosomal protein L8,RPL8,Humans
13611,DB07374,Anisomycin,['experimental'],BE0003832,60S ribosomal protein L37,RPL37,Humans
13612,DB07374,Anisomycin,['experimental'],BE0003833,60S ribosomal protein L3,RPL3,Humans
13613,DB07374,Anisomycin,['experimental'],BE0003834,60S ribosomal protein L11,RPL11,Humans
13614,DB07374,Anisomycin,['experimental'],BE0003835,NHP2-like protein 1,SNU13,Humans
13615,DB07375,Etiocholanedione,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
13616,DB07375,Etiocholanedione,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
13617,DB07375,Etiocholanedione,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
13619,DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),['experimental'],BE0000048,Prothrombin,F2,Humans
13620,DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),['experimental'],BE0000333,Coagulation factor VII,F7,Humans
13621,DB07377,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
13622,DB07378,"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
13623,DB07379,(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,['experimental'],BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
13625,DB07380,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
13627,DB07382,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",['experimental'],BE0003839,Serine/threonine-protein kinase/endoribonuclease IRE1,ERN1,Humans
13628,DB07383,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
13629,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,['experimental'],BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
13630,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,['experimental'],BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
13631,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,['experimental'],BE0003842,"ATP synthase subunit gamma, mitochondrial",ATP5C1,Humans
13632,DB07385,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",['experimental'],BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
13633,DB07387,3-(BUTYLSULPHONYL)-PROPANOIC ACID,['experimental'],BE0003844,Triosephosphate isomerase,TPI1,Humans
13634,DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13635,DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
13636,DB07389,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13637,DB07390,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
13643,DB07393,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
13644,DB07394,AUROVERTIN B,['experimental'],BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
13645,DB07394,AUROVERTIN B,['experimental'],BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
13646,DB07394,AUROVERTIN B,['experimental'],BE0003842,"ATP synthase subunit gamma, mitochondrial",ATP5C1,Humans
13649,DB07397,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
13651,DB07400,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,['experimental'],BE0000048,Prothrombin,F2,Humans
13652,DB07401,Azoxystrobin,['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
13653,DB07401,Azoxystrobin,['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
13654,DB07401,Azoxystrobin,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
13655,DB07401,Azoxystrobin,['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
13656,DB07401,Azoxystrobin,['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
13657,DB07401,Azoxystrobin,['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
13658,DB07401,Azoxystrobin,['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
13659,DB07401,Azoxystrobin,['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
13660,DB07401,Azoxystrobin,['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
13661,DB07401,Azoxystrobin,['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
13662,DB07403,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",['experimental'],BE0003862,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",PDK1,Humans
13664,DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
13665,DB07406,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
13669,DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
13672,DB07412,1-biphenyl-2-ylmethanamine,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13675,DB07415,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13677,DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
13680,DB07419,S-23,['experimental'],BE0000132,Androgen receptor,AR,Humans
13682,DB07421,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",['experimental'],BE0000132,Androgen receptor,AR,Humans
13683,DB07422,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,['experimental'],BE0000132,Androgen receptor,AR,Humans
13684,DB07423,Andarine,['experimental'],BE0000132,Androgen receptor,AR,Humans
13687,DB07425,Sobetirome,['investigational'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
13689,DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
13690,DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
13691,DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
13692,DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
13694,DB07430,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
13695,DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
13696,DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13699,DB07433,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
13701,DB07435,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",['experimental'],BE0003870,DNA polymerase kappa,POLK,Humans
13705,DB07437,5-Benzylacyclouridine,['experimental'],BE0002456,Uridine phosphorylase 1,UPP1,Humans
13707,DB07440,4-TERT-BUTYLBENZENESULFONIC ACID,['experimental'],BE0000048,Prothrombin,F2,Humans
13708,DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
13709,DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
13710,DB07443,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
13711,DB07444,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",['experimental'],BE0001776,Death-associated protein kinase 1,DAPK1,Humans
13713,DB07446,N-(biphenyl-4-ylsulfonyl)-D-leucine,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
13714,DB07447,5beta-dihydrotestosterone,['experimental'],BE0003610,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,Humans
13715,DB07448,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,['experimental'],BE0003882,Cytosol aminopeptidase,LAP3,Humans
13716,DB07449,N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide,['experimental'],BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
13717,DB07450,(R)-minalrestat,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13720,DB07453,alpha-Naphthoflavone,['experimental'],BE0002433,Cytochrome P450 1A2,CYP1A2,Humans
13721,DB07454,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,['experimental'],BE0000132,Androgen receptor,AR,Humans
13722,DB07455,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
13723,DB07456,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13724,DB07457,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",['experimental'],BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
13725,DB07458,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13726,DB07459,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13727,DB07460,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,['experimental'],BE0003090,Focal adhesion kinase 1,PTK2,Humans
13728,DB07461,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",['experimental'],BE0000048,Prothrombin,F2,Humans
13729,DB07462,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",['experimental'],BE0002089,Catechol O-methyltransferase,COMT,Humans
13732,DB07465,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13734,DB07467,(S)-Indapamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13735,DB07468,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",['experimental'],BE0003893,Myosin-14,MYH14,Humans
13736,DB07469,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",['experimental'],BE0003893,Myosin-14,MYH14,Humans
13737,DB07470,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",['experimental'],BE0003893,Myosin-14,MYH14,Humans
13738,DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13739,DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13742,DB07474,3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,['experimental'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
13743,DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13744,DB07477,Felbinac,['experimental'],BE0002135,Cathepsin L1,CTSL,Humans
13746,DB07479,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",['experimental'],BE0000113,DNA polymerase beta,POLB,Humans
13747,DB07480,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13749,DB07482,(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13751,DB07484,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
13752,DB07485,Bisphenol Z,['experimental'],BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
13753,DB07486,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",['experimental'],BE0000516,Integrin alpha-L,ITGAL,Humans
13755,DB07488,"{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone",['experimental'],BE0003958,Casein kinase I isoform gamma-3,CSNK1G3,Humans
13756,DB07489,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",['experimental'],BE0003958,Casein kinase I isoform gamma-3,CSNK1G3,Humans
13761,DB07491,"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
13763,DB07493,5-Bromoindirubin,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13764,DB07494,"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",['experimental'],BE0003963,CHRNA7-FAM7A fusion protein,CHRFAM7A,Humans
13765,DB07495,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13768,DB07497,"5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal",['experimental'],BE0000698,"Pyruvate carboxylase, mitochondrial",PC,Humans
13770,DB07498,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
13772,DB07500,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
13773,DB07501,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13774,DB07502,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13775,DB07503,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
13776,DB07504,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13778,DB07506,L-BENZYLSUCCINIC ACID,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
13780,DB07506,L-BENZYLSUCCINIC ACID,['experimental'],BE0003968,Retinoid-inducible serine carboxypeptidase,SCPEP1,Humans
13782,DB07508,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,['experimental'],BE0000048,Prothrombin,F2,Humans
13783,DB07509,difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13786,DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
13787,DB07513,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
13788,DB07514,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13789,DB07515,"1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol",['experimental'],BE0000048,Prothrombin,F2,Humans
13792,DB07519,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13793,DB07520,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
13794,DB07521,"(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol",['experimental'],BE0000048,Prothrombin,F2,Humans
13795,DB07522,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",['experimental'],BE0000048,Prothrombin,F2,Humans
13796,DB07524,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
13797,DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",['experimental'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
13799,DB07527,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",['experimental'],BE0000048,Prothrombin,F2,Humans
13800,DB07528,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13801,DB07529,"(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13802,DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13803,DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",['experimental'],BE0000779,Vitamin D3 receptor,VDR,Humans
13804,DB07531,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13805,DB07533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13806,DB07533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13807,DB07534,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13808,DB07534,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13809,DB07535,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13811,DB07537,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
13812,DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13813,DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13814,DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13815,DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13816,DB07540,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13818,DB07542,5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid,['experimental'],BE0000941,Cathepsin D,CTSD,Humans
13820,DB07543,(S)-carazolol,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
13821,DB07544,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,['experimental'],BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,Humans
13822,DB07545,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
13823,DB07546,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,['experimental'],BE0003984,Casein kinase II subunit alpha',CSNK2A2,Humans
13825,DB07548,"2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-6-pyridinyl)methyl]acetamide",['experimental'],BE0000048,Prothrombin,F2,Humans
13826,DB07549,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",['experimental'],BE0000048,Prothrombin,F2,Humans
13827,DB07550,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",['experimental'],BE0000048,Prothrombin,F2,Humans
13837,DB07555,"Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
13838,DB07556,CGS-27023,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
13839,DB07556,CGS-27023,['experimental'],BE0000920,Interstitial collagenase,MMP1,Humans
13840,DB07557,"3,20-Pregnanedione",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
13841,DB07557,"3,20-Pregnanedione",['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
13842,DB07557,"3,20-Pregnanedione",['experimental'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
13843,DB07557,"3,20-Pregnanedione",['experimental'],BE0003610,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,Humans
13844,DB07558,acetylleucyl-leucyl-norleucinal,['experimental'],BE0003916,Proteasome subunit alpha type-7,PSMA7,Humans
13845,DB07559,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
13847,DB07561,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
13848,DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13849,DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
13850,DB07563,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",['experimental'],BE0003417,Cathepsin K,CTSK,Humans
13853,DB07567,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13859,DB07573,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
13860,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",['experimental'],BE0004003,Stathmin-4,STMN4,Humans
13861,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",['experimental'],BE0003401,Tubulin beta-2B chain,TUBB2B,Humans
13862,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",['experimental'],BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
13863,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",['experimental'],BE0001388,Tubulin alpha-1C chain,TUBA1C,Humans
13864,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",['experimental'],BE0001275,Tubulin alpha-1B chain,TUBA1B,Humans
13866,DB07577,"2,4-Diamino-5-phenyl-6-ethylpyrimidine",['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
13868,DB07579,"Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane",['experimental'],BE0001213,Serum amyloid P-component,APCS,Humans
13869,DB07580,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",['experimental'],BE0001213,Serum amyloid P-component,APCS,Humans
13873,DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
13874,DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
13875,DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",['experimental'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
13876,DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13877,DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",['experimental'],BE0000428,RAC-alpha serine/threonine-protein kinase,AKT1,Humans
13878,DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13879,DB07586,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
13880,DB07587,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
13882,DB07589,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
13885,DB07592,(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
13886,DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
13887,DB07594,CCT-018159,['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
13888,DB07594,CCT-018159,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13889,DB07595,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13890,DB07596,"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13891,DB07597,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
13892,DB07598,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
13894,DB07601,"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
13895,DB07602,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,['experimental'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
13896,DB07604,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",['experimental'],BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,Humans
13897,DB07605,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
13898,DB07606,"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13899,DB07607,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
13900,DB07608,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,['experimental'],BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,Humans
13901,DB07609,"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",['experimental'],BE0003336,Cytochrome P450 2A6,CYP2A6,Humans
13904,DB07612,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13905,DB07613,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
13906,DB07614,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
13907,DB07615,Tranilast,['investigational'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
13908,DB07616,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
13909,DB07617,N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,['experimental'],BE0003336,Cytochrome P450 2A6,CYP2A6,Humans
13910,DB07618,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13911,DB07619,"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13914,DB07621,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,['experimental'],BE0003336,Cytochrome P450 2A6,CYP2A6,Humans
13915,DB07622,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13916,DB07623,"4,4'-DIPYRIDYL DISULFIDE",['experimental'],BE0003336,Cytochrome P450 2A6,CYP2A6,Humans
13917,DB07624,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
13918,DB07625,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13919,DB07626,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
13920,DB07627,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,['experimental'],BE0003346,Calpain-1 catalytic subunit,CAPN1,Humans
13921,DB07628,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",['experimental'],BE0000088,Pyruvate kinase PKM,PKM,Humans
13922,DB07629,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
13923,DB07630,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
13925,DB07632,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
13926,DB07633,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,['experimental'],BE0000214,Histo-blood group ABO system transferase,ABO,Humans
13929,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
13930,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
13931,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
13932,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
13933,DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
13934,DB07637,Dibromotyrosine,['experimental'],BE0000654,Erythropoietin receptor,EPOR,Humans
13935,DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13936,DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
13937,DB07639,3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,['experimental'],BE0000048,Prothrombin,F2,Humans
13940,DB07641,Decyl(dimethyl)phosphine oxide,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
13941,DB07642,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
13942,DB07643,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
13943,DB07644,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",['experimental'],BE0001215,m7GpppX diphosphatase,DCPS,Humans
13944,DB07645,Sebacic acid,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
13945,DB07645,Sebacic acid,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
13948,DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
13949,DB07647,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13950,DB07648,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13953,DB07651,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
13954,DB07652,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",['experimental'],BE0003870,DNA polymerase kappa,POLK,Humans
13956,DB07653,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13957,DB07654,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13958,DB07655,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
13959,DB07657,PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
13960,DB07658,AC-(D)Phe-pro-borolys-OH,['experimental'],BE0000048,Prothrombin,F2,Humans
13961,DB07659,AC-(D)PHE-PRO-BOROHOMOLYS-OH,['experimental'],BE0000048,Prothrombin,F2,Humans
13962,DB07660,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,['experimental'],BE0000048,Prothrombin,F2,Humans
13964,DB07662,PD-168393,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
13965,DB07662,PD-168393,['experimental'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
13967,DB07664,K-00546,['experimental'],BE0003958,Casein kinase I isoform gamma-3,CSNK1G3,Humans
13968,DB07664,K-00546,['experimental'],BE0004041,STE20-like serine/threonine-protein kinase,SLK,Humans
13969,DB07664,K-00546,['experimental'],BE0004042,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,Humans
13970,DB07664,K-00546,['experimental'],BE0004043,Dual specificity protein kinase CLK3,CLK3,Humans
13971,DB07664,K-00546,['experimental'],BE0000435,Abelson tyrosine-protein kinase 2,ABL2,Humans
13972,DB07665,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",['experimental'],BE0000048,Prothrombin,F2,Humans
13973,DB07666,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
13975,DB07668,alpha-Methyl-2-hydroxy-4-diethylaminocinnamic acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
13979,DB07670,"N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide",['experimental'],BE0003611,Cytochrome P450 2C18,CYP2C18,Humans
13984,DB07672,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
13987,DB07675,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
13988,DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
13989,DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",['experimental'],BE0004042,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,Humans
13990,DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",['experimental'],BE0004049,Poly [ADP-ribose] polymerase 3,PARP3,Humans
13991,DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
13992,DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
13994,DB07680,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,['experimental'],BE0001038,Chymase,CMA1,Humans
13995,DB07681,DODECANESULFONATE ION,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
13996,DB07683,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
13997,DB07684,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,['experimental'],BE0001088,Tissue-type plasminogen activator,PLAT,Humans
13998,DB07685,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
13999,DB07686,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14000,DB07687,"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14001,DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14002,DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14003,DB07689,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",['experimental'],BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,Humans
14004,DB07691,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
14005,DB07692,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",['experimental'],BE0000088,Pyruvate kinase PKM,PKM,Humans
14006,DB07696,methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,['experimental'],BE0001162,Caspase-3,CASP3,Humans
14007,DB07697,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",['experimental'],BE0000088,Pyruvate kinase PKM,PKM,Humans
14008,DB07698,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",['experimental'],BE0003794,Serine/threonine-protein kinase haspin,GSG2,Humans
14009,DB07700,"3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran",['experimental'],BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
14010,DB07701,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
14011,DB07702,17alpha-Estriol,['experimental'],BE0004057,Nuclear receptor coactivator 5,NCOA5,Humans
14012,DB07702,17alpha-Estriol,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
14016,DB07705,(S)-econazole,['experimental'],BE0000875,Lanosterol 14-alpha demethylase,CYP51A1,Humans
14018,DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14019,DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14020,DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14021,DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14022,DB07710,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14023,DB07711,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
14024,DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14025,DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14026,DB07713,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
14027,DB07714,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",['experimental'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
14028,DB07715,Emodin,['investigational'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14031,DB07715,Emodin,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
14032,DB07716,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14033,DB07717,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",['experimental'],BE0000132,Androgen receptor,AR,Humans
14034,DB07718,4-Hydroxyphenylpyruvic acid,['experimental'],BE0000048,Prothrombin,F2,Humans
14035,DB07718,4-Hydroxyphenylpyruvic acid,['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
14037,DB07719,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14038,DB07720,Epibatidine,['experimental'],BE0003963,CHRNA7-FAM7A fusion protein,CHRFAM7A,Humans
14039,DB07720,Epibatidine,['experimental'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
14040,DB07720,Epibatidine,['experimental'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
14041,DB07720,Epibatidine,['experimental'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
14042,DB07720,Epibatidine,['experimental'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
14043,DB07720,Epibatidine,['experimental'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
14044,DB07720,Epibatidine,['experimental'],BE0003584,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,Humans
14047,DB07723,3-(5-methoxy-1H-indol-3-yl)propanoic acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14048,DB07724,Indeglitazar,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
14049,DB07724,Indeglitazar,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
14050,DB07724,Indeglitazar,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
14051,DB07724,Indeglitazar,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14054,DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
14055,DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",['experimental'],BE0004064,MAP kinase-activated protein kinase 3,MAPKAPK3,Humans
14057,DB07730,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14058,DB07731,CAN-508,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14061,DB07733,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",['experimental'],BE0000444,Caspase-1,CASP1,Humans
14062,DB07734,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14063,DB07735,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14064,DB07736,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14065,DB07737,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14066,DB07738,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14067,DB07739,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14068,DB07740,"(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid",['experimental'],BE0004067,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",HMGCS1,Humans
14069,DB07741,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",['experimental'],BE0000048,Prothrombin,F2,Humans
14070,DB07742,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14073,DB07744,Z-Val-Ala-Asp fluoromethyl ketone,['experimental'],BE0000444,Caspase-1,CASP1,Humans
14076,DB07746,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,['experimental'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
14077,DB07747,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14080,DB07749,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
14081,DB07750,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14082,DB07751,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14083,DB07754,DCFBC,['experimental'],BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
14084,DB07755,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14085,DB07756,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
14086,DB07757,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
14089,DB07760,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",['experimental'],BE0003770,Uracil-DNA glycosylase,UNG,Humans
14090,DB07761,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14092,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
14093,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
14094,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
14095,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
14096,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
14097,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
14098,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
14099,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
14100,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
14101,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
14102,DB07764,Fluorescin,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14103,DB07765,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",['experimental'],BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,Humans
14104,DB07766,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",['experimental'],BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,Humans
14105,DB07766,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",['experimental'],BE0004077,Cyclin-dependent kinase 16,CDK16,Humans
14110,DB07768,Epitestosterone,['experimental'],BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
14111,DB07768,Epitestosterone,['experimental'],BE0000622,Aldo-keto reductase family 1 member C2,AKR1C2,Humans
14112,DB07769,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,['experimental'],BE0000132,Androgen receptor,AR,Humans
14114,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",['experimental'],BE0004071,GTPase KRas,KRAS,Humans
14115,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
14116,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
14117,DB07772,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
14121,DB07776,Flavone,"['approved', 'experimental']",BE0003722,Steroid hormone receptor ERR1,ESRRA,Humans
14122,DB07776,Flavone,"['approved', 'experimental']",BE0005001,Steroid hormone receptor ERR2,ESRRB,Humans
14123,DB07776,Flavone,"['approved', 'experimental']",BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
14124,DB07778,(S)-famoxadone,['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
14125,DB07778,(S)-famoxadone,['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
14126,DB07778,(S)-famoxadone,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
14127,DB07778,(S)-famoxadone,['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
14128,DB07778,(S)-famoxadone,['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
14129,DB07778,(S)-famoxadone,['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
14130,DB07778,(S)-famoxadone,['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
14131,DB07778,(S)-famoxadone,['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
14132,DB07778,(S)-famoxadone,['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
14133,DB07778,(S)-famoxadone,['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
14134,DB07779,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14135,DB07780,Farnesyl diphosphate,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
14136,DB07780,Farnesyl diphosphate,['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
14137,DB07780,Farnesyl diphosphate,['experimental'],BE0004071,GTPase KRas,KRAS,Humans
14139,DB07780,Farnesyl diphosphate,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
14142,DB07780,Farnesyl diphosphate,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
14144,DB07780,Farnesyl diphosphate,['experimental'],BE0004072,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,Humans
14145,DB07780,Farnesyl diphosphate,['experimental'],BE0004073,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,Humans
14148,DB07783,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
14149,DB07784,"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14150,DB07785,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
14151,DB07786,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",['experimental'],BE0002214,Adenosine deaminase,ADA,Humans
14152,DB07787,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",['experimental'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
14153,DB07788,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
14154,DB07789,"1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea",['experimental'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
14155,DB07790,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14156,DB07791,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14157,DB07792,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14158,DB07793,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14159,DB07794,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
14161,DB07795,Fisetin,['experimental'],BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
14162,DB07796,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",['experimental'],BE0000048,Prothrombin,F2,Humans
14164,DB07798,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14165,DB07800,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14166,DB07801,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
14167,DB07802,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14169,DB07804,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
14172,DB07807,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14174,DB07809,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
14176,DB07811,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14177,DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",['experimental'],BE0001172,RAC-beta serine/threonine-protein kinase,AKT2,Humans
14178,DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
14180,DB07814,Gibberellic acid,['experimental'],BE0004098,Arylacetamide deacetylase-like 2,AADACL2,Humans
14181,DB07815,Gibberellin A4,['experimental'],BE0004098,Arylacetamide deacetylase-like 2,AADACL2,Humans
14182,DB07816,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14190,DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
14191,DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",['experimental'],BE0004103,Platelet-activating factor acetylhydrolase IB subunit gamma,PAFAH1B3,Humans
14192,DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",['experimental'],BE0002409,Platelet-activating factor acetylhydrolase,PLA2G7,Humans
14199,DB07827,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
14200,DB07829,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14201,DB07830,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14202,DB07831,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
14203,DB07832,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14204,DB07833,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14205,DB07834,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14206,DB07835,"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14207,DB07836,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,['experimental'],BE0003997,Phospholipase A2,PLA2G1B,Humans
14208,DB07837,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",['experimental'],BE0004105,Serine/threonine-protein kinase Sgk1,SGK1,Humans
14209,DB07838,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,['experimental'],BE0003780,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,Humans
14210,DB07839,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
14211,DB07840,"(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",['experimental'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
14212,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
14213,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0001142,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,Humans
14214,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
14215,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
14216,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0000776,Farnesyl pyrophosphate synthase,FDPS,Humans
14217,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0004072,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,Humans
14218,DB07841,Geranylgeranyl diphosphate,['experimental'],BE0004073,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,Humans
14219,DB07842,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14220,DB07843,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14221,DB07844,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14222,DB07845,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",['experimental'],BE0003790,Mitogen-activated protein kinase 8,MAPK8,Humans
14223,DB07846,"(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
14224,DB07847,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14225,DB07848,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14226,DB07849,S-NONYL-CYSTEINE,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
14228,DB07851,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14229,DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14230,DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14231,DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",['experimental'],BE0004041,STE20-like serine/threonine-protein kinase,SLK,Humans
14232,DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",['experimental'],BE0004108,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,Humans
14233,DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",['experimental'],BE0004109,Serine/threonine-protein kinase MST4,STK26,Humans
14234,DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14235,DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14236,DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14237,DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14238,DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14239,DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14240,DB07857,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14241,DB07857,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14242,DB07858,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14243,DB07858,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14244,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14245,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14246,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,['experimental'],BE0001172,RAC-beta serine/threonine-protein kinase,AKT2,Humans
14247,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
14248,DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14249,DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14251,DB07862,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
14252,DB07863,2-chloro-5-nitro-N-phenylbenzamide,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14253,DB07863,2-chloro-5-nitro-N-phenylbenzamide,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14254,DB07863,2-chloro-5-nitro-N-phenylbenzamide,['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
14257,DB07866,"(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
14261,DB07870,Haloxyfop-P,['experimental'],BE0000702,Acetyl-CoA carboxylase 2,ACACB,Humans
14263,DB07872,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14264,DB07873,Lauryl alcohol diphosphonic acid,['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
14265,DB07874,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14266,DB07875,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",['experimental'],BE0000216,Coagulation factor X,F10,Humans
14267,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14268,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14269,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,['experimental'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
14270,DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14271,DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
14272,DB07878,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
14273,DB07879,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",['experimental'],BE0003523,Histone deacetylase 4,HDAC4,Humans
14275,DB07881,N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14276,DB07882,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14277,DB07883,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14280,DB07887,"(R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine",['experimental'],BE0001021,Coagulation factor XI,F11,Humans
14281,DB07888,"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
14282,DB07889,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14286,DB07893,PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14289,DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
14290,DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
14292,DB07897,1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,['experimental'],BE0000048,Prothrombin,F2,Humans
14294,DB07899,(2S) N-acetyl-L-alanyl-?L-phenylalanyl-chloroethylketone,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
14295,DB07900,3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
14296,DB07901,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,['experimental'],BE0004117,Methionine aminopeptidase 1,METAP1,Humans
14297,DB07902,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",['experimental'],BE0004117,Methionine aminopeptidase 1,METAP1,Humans
14298,DB07903,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",['experimental'],BE0004117,Methionine aminopeptidase 1,METAP1,Humans
14299,DB07905,Hypothemycin,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
14300,DB07906,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14301,DB07907,(2S)-2-HYDROXYOCTANOIC ACID,['experimental'],BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
14303,DB07908,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,['experimental'],BE0004118,Profilin-1,PFN1,Humans
14305,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14306,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14312,DB07912,2-OXOHEPTYLPHOSPHONIC ACID,['experimental'],BE0004122,Enolase-phosphatase E1,ENOPH1,Humans
14313,DB07913,HOMOPHENYLALANINYLMETHANE,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
14317,DB07916,3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,['experimental'],BE0000444,Caspase-1,CASP1,Humans
14318,DB07917,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
14328,DB07919,Harmine,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
14329,DB07920,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
14330,DB07921,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
14331,DB07922,N-oxo-2-(phenylsulfonylamino)ethanamide,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
14336,DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,['experimental'],BE0000920,Interstitial collagenase,MMP1,Humans
14339,DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",['experimental'],BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
14340,DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",['experimental'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
14341,DB07930,(3R)-3-HYDROXYDODECANOIC ACID,['experimental'],BE0004135,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,Humans
14342,DB07931,Hexestrol,['withdrawn'],BE0000126,Aldo-keto reductase family 1 member C1,AKR1C1,Humans
14343,DB07931,Hexestrol,['withdrawn'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14344,DB07931,Hexestrol,['withdrawn'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
14345,DB07931,Hexestrol,['withdrawn'],BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
14346,DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14347,DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14348,DB07933,Erteberel,"['experimental', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
14349,DB07933,Erteberel,"['experimental', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
14350,DB07934,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,['experimental'],BE0000048,Prothrombin,F2,Humans
14352,DB07936,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14356,DB07940,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",['experimental'],BE0002180,Cholinesterase,BCHE,Humans
14357,DB07941,PH-797804,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14358,DB07942,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14359,DB07943,SD-0006,['investigational'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14360,DB07944,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,['experimental'],BE0000048,Prothrombin,F2,Humans
14361,DB07946,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",['experimental'],BE0000048,Prothrombin,F2,Humans
14362,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14363,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14364,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,['experimental'],BE0001172,RAC-beta serine/threonine-protein kinase,AKT2,Humans
14365,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
14366,DB07949,"({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14367,DB07950,Indoleacetic acid,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
14368,DB07950,Indoleacetic acid,['experimental'],BE0003767,S-phase kinase-associated protein 1,SKP1,Humans
14369,DB07950,Indoleacetic acid,['experimental'],BE0000273,Kynurenine--oxoglutarate transaminase 1,CCBL1,Humans
14376,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
14377,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0001223,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,Humans
14378,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0000706,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,Humans
14379,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
14380,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,Humans
14381,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0003717,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",PDE8A,Humans
14382,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,Humans
14383,DB07954,3-isobutyl-1-methyl-7H-xanthine,['experimental'],BE0003556,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,Humans
14384,DB07955,(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
14385,DB07956,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
14386,DB07957,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
14387,DB07958,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
14388,DB07959,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
14389,DB07960,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",['experimental'],BE0003200,Sialidase-2,NEU2,Humans
14391,DB07964,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",['experimental'],BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,Humans
14392,DB07965,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
14393,DB07966,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
14394,DB07967,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
14396,DB07969,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
14397,DB07970,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,['experimental'],BE0004140,Ephrin type-A receptor 7,EPHA7,Humans
14400,DB07973,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14401,DB07974,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14402,DB07975,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14403,DB07976,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14404,DB07977,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14405,DB07978,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14406,DB07979,"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",['experimental'],BE0004141,D-amino-acid oxidase,DAO,Humans
14407,DB07981,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
14408,DB07982,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14409,DB07983,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
14410,DB07984,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
14411,DB07985,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
14412,DB07986,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14413,DB07987,"[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14414,DB07988,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide",['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14417,DB07991,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14418,DB07993,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14419,DB07994,"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
14420,DB07995,H-89,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14421,DB07995,H-89,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14422,DB07995,H-89,['experimental'],BE0003794,Serine/threonine-protein kinase haspin,GSG2,Humans
14423,DB07995,H-89,['experimental'],BE0009434,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,Humans
14424,DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14425,DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14426,DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14427,DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14428,DB07999,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
14429,DB08000,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
14430,DB08001,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14431,DB08003,ISOTHIAZOLIDINONE ANALOG,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14432,DB08004,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",['experimental'],BE0003794,Serine/threonine-protein kinase haspin,GSG2,Humans
14433,DB08005,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14434,DB08006,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14435,DB08007,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
14436,DB08008,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14437,DB08009,SU-11652,['experimental'],BE0004147,Calcium/calmodulin-dependent protein kinase type 1G,CAMK1G,Humans
14438,DB08010,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14439,DB08011,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14446,DB08015,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14450,DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
14451,DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
14452,DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",['experimental'],BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
14453,DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",['experimental'],BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
14454,DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
14455,DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14456,DB08021,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14457,DB08022,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
14458,DB08023,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14459,DB08024,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14460,DB08025,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14461,DB08026,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
14463,DB08028,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
14464,DB08029,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14465,DB08030,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14467,DB08032,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14468,DB08033,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14470,DB08035,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",['experimental'],BE0000132,Androgen receptor,AR,Humans
14472,DB08037,MK-0731,['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14473,DB08038,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",['experimental'],BE0004150,Kallikrein-7,KLK7,Humans
14474,DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",['experimental'],BE0000418,Calmodulin,CALM1,Humans
14475,DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",['experimental'],BE0004108,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,Humans
14476,DB08040,Kelatorphan,['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
14478,DB08042,"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
14479,DB08043,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
14480,DB08044,ABT-341,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14481,DB08045,"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14482,DB08046,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14483,DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14484,DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14485,DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14486,DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14487,DB08049,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",['experimental'],BE0002089,Catechol O-methyltransferase,COMT,Humans
14489,DB08051,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14490,DB08052,PP-121,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
14491,DB08053,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
14492,DB08054,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
14493,DB08055,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
14494,DB08056,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
14495,DB08057,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",['experimental'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
14496,DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",['experimental'],BE0004049,Poly [ADP-ribose] polymerase 3,PARP3,Humans
14497,DB08059,Wortmannin,['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
14498,DB08059,Wortmannin,['experimental'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
14499,DB08059,Wortmannin,['experimental'],BE0000955,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,Humans
14500,DB08059,Wortmannin,['experimental'],BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
14501,DB08060,4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,['experimental'],BE0000316,Serine--pyruvate aminotransferase,AGXT,Humans
14502,DB08061,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,['experimental'],BE0000048,Prothrombin,F2,Humans
14503,DB08062,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",['experimental'],BE0000048,Prothrombin,F2,Humans
14504,DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
14505,DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",['experimental'],BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
14506,DB08064,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14507,DB08065,2-(1H-pyrazol-3-yl)-1H-benzimidazole,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
14508,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,['experimental'],BE0000991,Aurora kinase A,AURKA,Humans
14509,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14510,DB08067,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,['experimental'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
14511,DB08068,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14513,DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14514,DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14516,DB08072,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
14517,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,['experimental'],BE0001172,RAC-beta serine/threonine-protein kinase,AKT2,Humans
14518,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
14519,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14520,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14524,DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
14525,DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
14526,DB08078,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
14527,DB08079,AMG-208,['investigational'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
14528,DB08080,Latrunculin B,['experimental'],BE0002101,"Actin, alpha skeletal muscle",ACTA1,Humans
14529,DB08080,Latrunculin B,['experimental'],BE0004156,MKL/myocardin-like protein 1,MKL1,Humans
14530,DB08080,Latrunculin B,['experimental'],BE0004157,Protein spire homolog 2,SPIRE2,Humans
14534,DB08082,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
14535,DB08083,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14536,DB08084,IDD594,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
14537,DB08085,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,['experimental'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
14539,DB08087,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",['experimental'],BE0000132,Androgen receptor,AR,Humans
14540,DB08088,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",['experimental'],BE0000132,Androgen receptor,AR,Humans
14541,DB08089,LGD-2226,['experimental'],BE0000132,Androgen receptor,AR,Humans
14543,DB08091,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14544,DB08092,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14545,DB08093,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14546,DB08094,RO-4584820,['investigational'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14547,DB08095,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14548,DB08096,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14549,DB08097,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14550,DB08098,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
14551,DB08099,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",['experimental'],BE0000270,Renin,REN,Humans
14560,DB08113,3-pyridin-4-yl-1H-indazole,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14561,DB08113,3-pyridin-4-yl-1H-indazole,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14562,DB08114,"5-benzyl-1,3-thiazol-2-amine",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14563,DB08114,"5-benzyl-1,3-thiazol-2-amine",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14566,DB08118,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",['experimental'],BE0001056,Glucokinase,GCK,Humans
14567,DB08119,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
14569,DB08121,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14570,DB08122,"N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14571,DB08123,"N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14572,DB08124,"3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14573,DB08125,"4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14574,DB08126,"3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14575,DB08128,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14576,DB08129,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
14577,DB08130,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
14579,DB08132,5-hydroxynaphthalene-1-sulfonamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14580,DB08133,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14581,DB08134,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14582,DB08135,N-phenyl-1H-pyrazole-3-carboxamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14583,DB08136,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14584,DB08137,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14585,DB08138,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14586,DB08139,"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14587,DB08140,"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14588,DB08141,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14589,DB08142,AT-7519,['investigational'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14590,DB08142,AT-7519,['investigational'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
14591,DB08143,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
14595,DB08147,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14596,DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14597,DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14598,DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14599,DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14600,DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14601,DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14602,DB08151,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14603,DB08152,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,['experimental'],BE0000048,Prothrombin,F2,Humans
14604,DB08153,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14606,DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,['experimental'],BE0000267,Carbonic anhydrase 1,CA1,Humans
14607,DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14608,DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,['experimental'],BE0000267,Carbonic anhydrase 1,CA1,Humans
14609,DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14610,DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,['experimental'],BE0000267,Carbonic anhydrase 1,CA1,Humans
14611,DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14613,DB08159,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",['experimental'],BE0000971,DNA topoisomerase 1,TOP1,Humans
14616,DB08162,Fasudil,['investigational'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14617,DB08162,Fasudil,['investigational'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14618,DB08162,Fasudil,['investigational'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
14619,DB08162,Fasudil,['investigational'],BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
14620,DB08163,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,['experimental'],BE0000101,S-adenosylmethionine decarboxylase proenzyme,AMD1,Humans
14621,DB08164,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14622,DB08165,indane-5-sulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14623,DB08166,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
14624,DB08167,Methylthioninium,"['experimental', 'investigational']",BE0000426,Acetylcholinesterase,ACHE,Humans
14627,DB08168,Coumarin 120,['experimental'],BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,Humans
14628,DB08168,Coumarin 120,['experimental'],BE0001608,Histone deacetylase 8,HDAC8,Humans
14629,DB08169,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14630,DB08170,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",['experimental'],BE0003690,Matrilysin,MMP7,Humans
14632,DB08172,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14633,DB08173,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
14634,DB08174,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
14635,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14636,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",['experimental'],BE0000078,Retinoic acid receptor RXR-beta,RXRB,Humans
14637,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",['experimental'],BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
14638,DB08176,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
14640,DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14641,DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14642,DB08179,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",['experimental'],BE0000962,Lactoylglutathione lyase,GLO1,Humans
14643,DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
14644,DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,['experimental'],BE0001142,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,Humans
14646,DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14647,DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14648,DB08184,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
14676,DB08186,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,['experimental'],BE0002683,Histone acetyltransferase KAT2B,KAT2B,Humans
14677,DB08187,N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide,['experimental'],BE0000048,Prothrombin,F2,Humans
14679,DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,['experimental'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
14680,DB08191,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",['experimental'],BE0004105,Serine/threonine-protein kinase Sgk1,SGK1,Humans
14681,DB08192,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
14683,DB08194,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
14684,DB08195,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
14686,DB08197,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
14687,DB08198,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14689,DB08200,(1R)-menthyl hexyl phosphonate group,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
14690,DB08201,(1S)-menthyl hexyl phosphonate group,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
14691,DB08202,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14692,DB08203,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",['experimental'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
14694,DB08208,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",['experimental'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
14696,DB08210,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",['experimental'],BE0001056,Glucokinase,GCK,Humans
14699,DB08213,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",['experimental'],BE0001162,Caspase-3,CASP3,Humans
14700,DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
14709,DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",['experimental'],BE0000957,Eukaryotic translation initiation factor 4E,EIF4E,Humans
14711,DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",['experimental'],BE0004224,Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,Humans
14713,DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14714,DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14715,DB08219,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14716,DB08219,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14717,DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
14718,DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",['experimental'],BE0001777,Bile acid receptor,NR1H4,Humans
14719,DB08221,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,['experimental'],BE0003379,Angiopoietin-1 receptor,TEK,Humans
14720,DB08222,METHOXYUNDECYLPHOSPHINIC ACID,['experimental'],BE0003898,Colipase,CLPS,Humans
14721,DB08222,METHOXYUNDECYLPHOSPHINIC ACID,['experimental'],BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
14722,DB08224,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",['experimental'],BE0002705,Liver carboxylesterase 1,CES1,Humans
14729,DB08228,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",['experimental'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
14730,DB08229,[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid,['experimental'],BE0001162,Caspase-3,CASP3,Humans
14731,DB08230,Tricetin,['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
14736,DB08231,Myristic acid,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
14737,DB08231,Myristic acid,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
14744,DB08231,Myristic acid,['experimental'],BE0004233,"Enoyl-CoA delta isomerase 2, mitochondrial",ECI2,Humans
14745,DB08231,Myristic acid,['experimental'],BE0004234,Recoverin,RCVRN,Humans
14746,DB08231,Myristic acid,['experimental'],BE0000418,Calmodulin,CALM1,Humans
14749,DB08231,Myristic acid,['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
14752,DB08231,Myristic acid,['experimental'],BE0004019,Hepatocyte nuclear factor 4-alpha,HNF4A,Humans
14753,DB08231,Myristic acid,['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
14756,DB08231,Myristic acid,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
14757,DB08231,Myristic acid,['experimental'],BE0000358,Calcineurin subunit B type 1,PPP3R1,Humans
14758,DB08231,Myristic acid,['experimental'],BE0004238,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,PPP3CA,Humans
14761,DB08231,Myristic acid,['experimental'],BE0003181,Trafficking protein particle complex subunit 3,TRAPPC3,Humans
14762,DB08231,Myristic acid,['experimental'],BE0003491,Insulin,INS,Humans
14765,DB08231,Myristic acid,['experimental'],BE0001432,Ganglioside GM2 activator,GM2A,Humans
14766,DB08231,Myristic acid,['experimental'],BE0004242,ADP-ribosylation factor 6,ARF6,Humans
14767,DB08231,Myristic acid,['experimental'],BE0004024,Lymphocyte antigen 96,LY96,Humans
14771,DB08231,Myristic acid,['experimental'],BE0003814,ADP-ribosylation factor 1,ARF1,Humans
14772,DB08231,Myristic acid,['experimental'],BE0004244,Guanylyl cyclase-activating protein 1,GUCA1A,Humans
14774,DB08231,Myristic acid,['experimental'],BE0004247,Poliovirus receptor,PVR,Humans
14775,DB08231,Myristic acid,['experimental'],BE0002442,Toll-like receptor 4,TLR4,Humans
14776,DB08231,Myristic acid,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
14777,DB08232,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",['experimental'],BE0000333,Coagulation factor VII,F7,Humans
14778,DB08232,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",['experimental'],BE0001178,Tissue factor,F3,Humans
14779,DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14780,DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14782,DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
14785,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004249,Actin-related protein 2/3 complex subunit 1B,ARPC1B,Humans
14786,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004250,Actin-related protein 2,ACTR2,Humans
14787,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004251,Actin-related protein 3,ACTR3,Humans
14788,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004252,Actin-related protein 2/3 complex subunit 2,ARPC2,Humans
14789,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004253,Actin-related protein 2/3 complex subunit 3,ARPC3,Humans
14790,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004254,Actin-related protein 2/3 complex subunit 4,ARPC4,Humans
14791,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,['experimental'],BE0004255,Actin-related protein 2/3 complex subunit 5,ARPC5,Humans
14792,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004249,Actin-related protein 2/3 complex subunit 1B,ARPC1B,Humans
14793,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004250,Actin-related protein 2,ACTR2,Humans
14794,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004251,Actin-related protein 3,ACTR3,Humans
14795,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004252,Actin-related protein 2/3 complex subunit 2,ARPC2,Humans
14796,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004253,Actin-related protein 2/3 complex subunit 3,ARPC3,Humans
14797,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004254,Actin-related protein 2/3 complex subunit 4,ARPC4,Humans
14798,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",['experimental'],BE0004255,Actin-related protein 2/3 complex subunit 5,ARPC5,Humans
14799,DB08237,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),['experimental'],BE0003870,DNA polymerase kappa,POLK,Humans
14800,DB08238,5-aminonaphthalene-2-sulfonic acid,['experimental'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
14801,DB08239,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14802,DB08240,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,['experimental'],BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
14803,DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14804,DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14805,DB08242,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14806,DB08244,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14808,DB08246,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14809,DB08247,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14810,DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14811,DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14812,DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",['experimental'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
14816,DB08250,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",['experimental'],BE0001852,Kinesin-like protein KIF11,KIF11,Humans
14817,DB08251,4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,['experimental'],BE0001162,Caspase-3,CASP3,Humans
14820,DB08254,2-Naphthalenesulfonic acid,['experimental'],BE0000048,Prothrombin,F2,Humans
14821,DB08254,2-Naphthalenesulfonic acid,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
14823,DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
14824,DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
14825,DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
14826,DB08259,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,['experimental'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
14829,DB08262,"2,6-dicarboxynaphthalene",['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
14830,DB08262,"2,6-dicarboxynaphthalene",['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
14831,DB08263,N-(carboxycarbonyl)-D-phenylalanine,['experimental'],BE0002503,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,Humans
14842,DB08270,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",['experimental'],BE0003417,Cathepsin K,CTSK,Humans
14843,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,['experimental'],BE0003689,Stromelysin-2,MMP10,Humans
14844,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
14845,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
14846,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,['experimental'],BE0003696,Matrix metalloproteinase-20,MMP20,Humans
14848,DB08273,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,['experimental'],BE0004264,Ig heavy chain V-I region ND,IGHV1-2,Humans
14852,DB08276,trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-),['experimental'],BE0003893,Myosin-14,MYH14,Humans
14853,DB08277,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
14856,DB08280,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
14859,DB08283,"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",['experimental'],BE0000978,Glucosylceramidase,GBA,Humans
14861,DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14862,DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14865,DB08287,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",['experimental'],BE0003417,Cathepsin K,CTSK,Humans
14866,DB08289,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
14867,DB08291,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,['experimental'],BE0002683,Histone acetyltransferase KAT2B,KAT2B,Humans
14868,DB08292,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14869,DB08293,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14870,DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,['experimental'],BE0004264,Ig heavy chain V-I region ND,IGHV1-2,Humans
14871,DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14872,DB08295,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,['experimental'],BE0004264,Ig heavy chain V-I region ND,IGHV1-2,Humans
14874,DB08296,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14876,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",['experimental'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
14877,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",['experimental'],BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,Humans
14878,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",['experimental'],BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,Humans
14879,DB08300,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",['experimental'],BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
14880,DB08301,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14881,DB08302,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
14882,DB08303,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
14883,DB08304,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
14884,DB08305,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",['experimental'],BE0000829,Glutamate receptor 2,GRIA2,Humans
14888,DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14889,DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14891,DB08312,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14892,DB08313,Nocodazole,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
14899,DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
14900,DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
14901,DB08321,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",['experimental'],BE0003505,Alpha-mannosidase 2,MAN2A1,Humans
14902,DB08322,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
14903,DB08323,3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
14905,DB08325,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,['experimental'],BE0004270,Casein kinase I isoform gamma-1,CSNK1G1,Humans
14906,DB08325,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,['experimental'],BE0004271,Tyrosine-protein kinase Mer,MERTK,Humans
14907,DB08326,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",['experimental'],BE0004272,Long-chain-fatty-acid--CoA ligase ACSBG1,ACSBG1,Humans
14910,DB08329,Sulthiame,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
14911,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
14912,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
14913,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
14914,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
14915,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
14916,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
14917,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
14918,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
14919,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
14920,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
14922,DB08332,9-(2-carboxyethyl)-10-methylanthracene endoperoxide,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14923,DB08333,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
14924,DB08334,3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
14925,DB08335,"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
14928,DB08338,"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14929,DB08339,PD-166326,['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
14930,DB08340,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14931,DB08341,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",['experimental'],BE0000871,Protein-tyrosine kinase 2-beta,PTK2B,Humans
14932,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0004275,Trafficking protein particle complex subunit 6A,TRAPPC6A,Humans
14933,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0003181,Trafficking protein particle complex subunit 3,TRAPPC3,Humans
14934,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0004276,Trafficking protein particle complex subunit 6B,TRAPPC6B,Humans
14935,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0004277,Trafficking protein particle complex subunit 5,TRAPPC5,Humans
14936,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0004278,Trafficking protein particle complex subunit 4,TRAPPC4,Humans
14937,DB08342,S-palmitoyl-L-cysteine,['experimental'],BE0004279,Trafficking protein particle complex subunit 1,TRAPPC1,Humans
14939,DB08345,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14940,DB08346,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
14941,DB08347,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
14943,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",['experimental'],BE0004281,Elongation factor 2,EEF2,Humans
14945,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",['experimental'],BE0004049,Poly [ADP-ribose] polymerase 3,PARP3,Humans
14946,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",['experimental'],BE0004283,Poly [ADP-ribose] polymerase 15,PARP15,Humans
14947,DB08349,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14948,DB08350,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
14949,DB08351,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14950,DB08352,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
14951,DB08353,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14952,DB08354,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14953,DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
14954,DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
14955,DB08356,"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",['experimental'],BE0004284,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",PDK4,Humans
14956,DB08357,Diethylene glycol diethyl ether,['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
14959,DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",['experimental'],BE0001373,MAP kinase-activated protein kinase 2,MAPKAPK2,Humans
14960,DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",['experimental'],BE0004064,MAP kinase-activated protein kinase 3,MAPKAPK3,Humans
14962,DB08360,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14963,DB08361,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",['experimental'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
14964,DB08362,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
14965,DB08363,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,['experimental'],BE0003380,Cellular tumor antigen p53,TP53,Humans
14967,DB08365,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",['experimental'],BE0003335,Wee1-like protein kinase,WEE1,Humans
14970,DB08368,"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
14971,DB08369,1-(biphenyl-4-ylmethyl)-1H-imidazole,['experimental'],BE0003549,Cytochrome P450 2B6,CYP2B6,Humans
14972,DB08370,S-(4-BROMOBENZYL)CYSTEINE,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
14973,DB08371,p-Benzoyl-L-phenylalanine,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
14974,DB08371,p-Benzoyl-L-phenylalanine,['experimental'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
14977,DB08373,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",['experimental'],BE0004289,Uteroglobin,SCGB1A1,Humans
14978,DB08374,Phenylalanylmethylchloride,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
14983,DB08377,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
14984,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",['experimental'],BE0004292,Myosin light chain 6B,MYL6B,Humans
14985,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",['experimental'],BE0004293,Myosin regulatory light chain 12A,MYL12A,Humans
14986,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",['experimental'],BE0004294,Myosin-7,MYH7,Humans
14988,DB08382,Gosogliptin,['investigational'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
14989,DB08383,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14990,DB08384,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14991,DB08385,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,['experimental'],BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
14992,DB08386,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14993,DB08387,Mardepodect,['investigational'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14994,DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
14995,DB08389,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14997,DB08391,PQ-10,['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
14998,DB08392,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
14999,DB08393,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15000,DB08394,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15001,DB08395,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15002,DB08396,"4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid",['experimental'],BE0004312,Ig heavy chain V-III region CAM,IGHV3-30,Humans
15003,DB08397,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
15004,DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
15005,DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",['investigational'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
15006,DB08399,Piceatannol,['experimental'],BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
15007,DB08399,Piceatannol,['experimental'],BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
15008,DB08399,Piceatannol,['experimental'],BE0003842,"ATP synthase subunit gamma, mitochondrial",ATP5C1,Humans
15009,DB08400,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,['experimental'],BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
15011,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15012,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
15013,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
15014,DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,['experimental'],BE0000920,Interstitial collagenase,MMP1,Humans
15015,DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
15018,DB08406,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
15021,DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15022,DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
15023,DB08410,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15024,DB08411,N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15025,DB08412,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15026,DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
15027,DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,['experimental'],BE0004314,"Alkaline phosphatase, placental type",ALPP,Humans
15029,DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15030,DB08418,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15032,DB08420,1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
15034,DB08422,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,['experimental'],BE0000048,Prothrombin,F2,Humans
15035,DB08423,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15036,DB08424,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15037,DB08426,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
15041,DB08429,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15042,DB08430,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,['experimental'],BE0004111,Lactase-like protein,LCTL,Humans
15047,DB08435,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15048,DB08436,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15049,DB08437,Puromycin,['experimental'],BE0003823,60S ribosomal protein L10-like,RPL10L,Humans
15050,DB08437,Puromycin,['experimental'],BE0003824,60S ribosomal protein L13a,RPL13A,Humans
15051,DB08437,Puromycin,['experimental'],BE0003825,60S ribosomal protein L23,RPL23,Humans
15052,DB08437,Puromycin,['experimental'],BE0003826,60S ribosomal protein L15,RPL15,Humans
15053,DB08437,Puromycin,['experimental'],BE0003827,60S ribosomal protein L19,RPL19,Humans
15054,DB08437,Puromycin,['experimental'],BE0003828,60S ribosomal protein L23a,RPL23A,Humans
15055,DB08437,Puromycin,['experimental'],BE0003829,Probable ribosome biogenesis protein RLP24,RSL24D1,Humans
15056,DB08437,Puromycin,['experimental'],BE0003830,60S ribosomal protein L26-like 1,RPL26L1,Humans
15057,DB08437,Puromycin,['experimental'],BE0003831,60S ribosomal protein L8,RPL8,Humans
15058,DB08437,Puromycin,['experimental'],BE0003832,60S ribosomal protein L37,RPL37,Humans
15059,DB08437,Puromycin,['experimental'],BE0003833,60S ribosomal protein L3,RPL3,Humans
15060,DB08437,Puromycin,['experimental'],BE0003834,60S ribosomal protein L11,RPL11,Humans
15063,DB08439,Parecoxib,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
15064,DB08439,Parecoxib,['approved'],BE0000994,Lactotransferrin,LTF,Humans
15066,DB08441,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15067,DB08442,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15068,DB08443,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15070,DB08445,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15072,DB08447,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,['experimental'],BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
15073,DB08448,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
15074,DB08449,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
15075,DB08450,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,['experimental'],BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
15077,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
15078,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
15079,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
15080,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
15081,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
15082,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
15083,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
15084,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
15085,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
15086,DB08453,2-Nonyl-4-quinolinol 1-oxide,['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
15095,DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,['experimental'],BE0004324,Calcium/calmodulin-dependent protein kinase type 1D,CAMK1D,Humans
15101,DB08461,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",['experimental'],BE0000132,Androgen receptor,AR,Humans
15102,DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
15103,DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15104,DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
15105,DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
15106,DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
15107,DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
15108,DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",['experimental'],BE0001165,Endoplasmin,HSP90B1,Humans
15109,DB08466,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",['experimental'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
15114,DB08473,Dichlororibofuranosylbenzimidazole,['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
15117,DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,['experimental'],BE0001182,Neutrophil collagenase,MMP8,Humans
15118,DB08478,N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
15119,DB08479,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
15120,DB08480,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
15122,DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,['experimental'],BE0000920,Interstitial collagenase,MMP1,Humans
15123,DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,['experimental'],BE0002431,"Fructose-1,6-bisphosphatase 1",FBP1,Humans
15125,DB08486,Efaproxiral,['investigational'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
15126,DB08486,Efaproxiral,['investigational'],BE0000629,Hemoglobin subunit beta,HBB,Humans
15127,DB08487,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
15128,DB08488,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",['experimental'],BE0000216,Coagulation factor X,F10,Humans
15129,DB08489,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",['experimental'],BE0003690,Matrilysin,MMP7,Humans
15130,DB08490,CTS-1027,"['experimental', 'investigational']",BE0000966,Collagenase 3,MMP13,Humans
15131,DB08491,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,['experimental'],BE0000920,Interstitial collagenase,MMP1,Humans
15132,DB08492,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,['experimental'],BE0000309,Arachidonate 15-lipoxygenase,ALOX15,Humans
15133,DB08493,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",['experimental'],BE0003690,Matrilysin,MMP7,Humans
15135,DB08495,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
15136,DB08497,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",['experimental'],BE0001162,Caspase-3,CASP3,Humans
15137,DB08498,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",['experimental'],BE0001162,Caspase-3,CASP3,Humans
15138,DB08499,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",['experimental'],BE0001162,Caspase-3,CASP3,Humans
15139,DB08500,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
15143,DB08503,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",['experimental'],BE0000916,"Glycogen phosphorylase, muscle form",PYGM,Humans
15144,DB08504,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15147,DB08507,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
15150,DB08510,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
15153,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
15154,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,['experimental'],BE0000033,Insulin receptor,INSR,Humans
15155,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,['experimental'],BE0000977,Insulin receptor substrate 1,IRS1,Humans
15157,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003910,Proteasome subunit alpha type-1,PSMA1,Humans
15158,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003911,Proteasome subunit alpha type-2,PSMA2,Humans
15159,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003912,Proteasome subunit alpha type-3,PSMA3,Humans
15160,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003913,Proteasome subunit alpha type-4,PSMA4,Humans
15161,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003914,Proteasome subunit alpha type-5,PSMA5,Humans
15162,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003915,Proteasome subunit alpha type-6,PSMA6,Humans
15163,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003916,Proteasome subunit alpha type-7,PSMA7,Humans
15164,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0002347,Proteasome subunit beta type-1,PSMB1,Humans
15165,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0002349,Proteasome subunit beta type-2,PSMB2,Humans
15166,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003917,Proteasome subunit beta type-3,PSMB3,Humans
15167,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003918,Proteasome subunit beta type-4,PSMB4,Humans
15168,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0002348,Proteasome subunit beta type-5,PSMB5,Humans
15169,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003919,Proteasome subunit beta type-6,PSMB6,Humans
15170,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",['experimental'],BE0003920,Proteasome subunit beta type-7,PSMB7,Humans
15171,DB08516,(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],['experimental'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
15173,DB08519,"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",['experimental'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15174,DB08520,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
15175,DB08521,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15176,DB08521,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,['experimental'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
15177,DB08522,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15182,DB08526,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,['experimental'],BE0003970,Pro-cathepsin H,CTSH,Humans
15183,DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
15184,DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15186,DB08529,"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",['experimental'],BE0003570,Geranylgeranyl pyrophosphate synthase,GGPS1,Humans
15187,DB08530,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15188,DB08531,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15189,DB08532,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15190,DB08533,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15191,DB08534,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15192,DB08535,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15193,DB08536,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15194,DB08537,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15195,DB08538,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15196,DB08539,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15203,DB08546,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",['experimental'],BE0000048,Prothrombin,F2,Humans
15204,DB08547,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
15206,DB08549,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
15207,DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
15212,DB08553,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",['experimental'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
15215,DB08555,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",['experimental'],BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
15217,DB08557,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15220,DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15221,DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",['experimental'],BE0004338,Lactase-phlorizin hydrolase,LCT,Humans
15223,DB08560,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15224,DB08561,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",['experimental'],BE0000966,Collagenase 3,MMP13,Humans
15225,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
15226,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,['experimental'],BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
15227,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,['experimental'],BE0004341,Ig kappa chain V-II region TEW,IGKV2D-28,Humans
15228,DB08564,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,['experimental'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
15229,DB08565,L-1-naphthyl-2-acetamido-ethane boronic acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
15230,DB08566,D-1-naphthyl-2-acetamido-ethane boronic acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
15231,DB08568,A-674563,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
15232,DB08568,A-674563,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
15233,DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
15234,DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
15238,DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
15239,DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15241,DB08574,"(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one",['experimental'],BE0004342,Afadin,MLLT4,Humans
15242,DB08575,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",['experimental'],BE0000266,Neprilysin,MME,Humans
15244,DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,['experimental'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
15250,DB08583,"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",['experimental'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
15254,DB08588,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15256,DB08590,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,['experimental'],BE0004344,Interleukin-1 receptor-associated kinase 4,IRAK4,Humans
15257,DB08591,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
15258,DB08593,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
15259,DB08594,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,['experimental'],BE0003417,Cathepsin K,CTSK,Humans
15260,DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
15261,DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
15262,DB08596,5'-deoxy-5'-piperidin-1-ylthymidine,['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
15263,DB08597,Dorsomorphin,['experimental'],BE0000264,Activin receptor type-1,ACVR1,Humans
15264,DB08597,Dorsomorphin,['experimental'],BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,Humans
15267,DB08599,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,['experimental'],BE0001198,Macrophage metalloelastase,MMP12,Humans
15269,DB08601,Tributyltin,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
15270,DB08601,Tributyltin,['experimental'],BE0000412,Retinoic acid receptor RXR-alpha,RXRA,Humans
15271,DB08602,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",['experimental'],BE0000706,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,Humans
15278,DB08604,Triclosan,"['approved', 'investigational']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
15279,DB08604,Triclosan,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
15280,DB08604,Triclosan,"['approved', 'investigational']",BE0003848,Nuclear receptor subfamily 1 group I member 3,NR1I3,Humans
15281,DB08604,Triclosan,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15282,DB08604,Triclosan,"['approved', 'investigational']",BE0000507,Thyroid peroxidase,TPO,Humans
15283,DB08605,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",['experimental'],BE0003119,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,Humans
15286,DB08607,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",['experimental'],BE0002887,Cytochrome P450 2C8,CYP2C8,Humans
15287,DB08608,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",['experimental'],BE0004348,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,Humans
15288,DB08609,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",['experimental'],BE0004348,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,Humans
15289,DB08610,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,['experimental'],BE0004348,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,Humans
15290,DB08611,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",['experimental'],BE0001646,Cathepsin S,CTSS,Humans
15291,DB08612,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",['experimental'],BE0004349,Putative inactive carboxylesterase 4,CES1P1,Humans
15292,DB08613,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",['experimental'],BE0003523,Histone deacetylase 4,HDAC4,Humans
15293,DB08614,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
15294,DB08615,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",['experimental'],BE0000426,Acetylcholinesterase,ACHE,Humans
15295,DB08617,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",['experimental'],BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",YARS,Humans
15296,DB08618,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,['experimental'],BE0003805,Ig gamma-2 chain C region,IGHG2,Humans
15298,DB08620,Thiacloprid,['experimental'],BE0003963,CHRNA7-FAM7A fusion protein,CHRFAM7A,Humans
15302,DB08624,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",['experimental'],BE0000048,Prothrombin,F2,Humans
15303,DB08624,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",['experimental'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
15304,DB08626,Thiorphan,['experimental'],BE0000266,Neprilysin,MME,Humans
15307,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",['experimental'],BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
15308,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",['experimental'],BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
15309,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",['experimental'],BE0003842,"ATP synthase subunit gamma, mitochondrial",ATP5C1,Humans
15310,DB08631,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
15311,DB08632,Trimesic acid,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
15312,DB08632,Trimesic acid,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
15313,DB08633,TNP-470,['investigational'],BE0001534,Methionine aminopeptidase 2,METAP2,Humans
15315,DB08635,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,['experimental'],BE0004312,Ig heavy chain V-III region CAM,IGHV3-30,Humans
15320,DB08640,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
15321,DB08641,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",['experimental'],BE0003758,Chymotrypsin-like elastase family member 1,CELA1,Humans
15322,DB08642,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",['experimental'],BE0000330,Dihydrofolate reductase,DHFR,Humans
15323,DB08643,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,['experimental'],BE0001116,Stromelysin-1,MMP3,Humans
15325,DB08645,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15333,DB08647,Trazeolide,['experimental'],BE0003836,Ig kappa chain C region,IGKC,Humans
15340,DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,['experimental'],BE0002425,DNA topoisomerase 2-beta,TOP2B,Humans
15345,DB08654,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",['experimental'],BE0000865,Phenylethanolamine N-methyltransferase,PNMT,Humans
15346,DB08655,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",['experimental'],BE0004367,CREB-binding protein,CREBBP,Humans
15349,DB08658,Ethyl hydrogen diethylamidophosphate,['experimental'],BE0002180,Cholinesterase,BCHE,Humans
15350,DB08659,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15351,DB08660,Quinalizarin,['experimental'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
15352,DB08661,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",['experimental'],BE0003317,Ribonuclease pancreatic,RNASE1,Humans
15363,DB08672,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15364,DB08673,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15365,DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
15366,DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
15367,DB08675,"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid",['experimental'],BE0000117,Prostacyclin synthase,PTGIS,Humans
15368,DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",['experimental'],BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,Humans
15369,DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",['experimental'],BE0002372,Protein farnesyltransferase subunit beta,FNTB,Humans
15370,DB08677,N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15371,DB08678,(4-ETHYLPHENYL)SULFAMIC ACID,['experimental'],BE0003769,Receptor-type tyrosine-protein phosphatase beta,PTPRB,Humans
15375,DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15379,DB08687,FG-2216,['investigational'],BE0002217,Egl nine homolog 1,EGLN1,Humans
15380,DB08687,FG-2216,['investigational'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
15381,DB08688,2-Undecanone,['experimental'],BE0004376,Acyl-coenzyme A thioesterase 13,ACOT13,Humans
15386,DB08689,Ubiquinone Q1,['experimental'],BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,Humans
15387,DB08689,Ubiquinone Q1,['experimental'],BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,Humans
15388,DB08689,Ubiquinone Q1,['experimental'],BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,Humans
15389,DB08689,Ubiquinone Q1,['experimental'],BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,Humans
15399,DB08690,Ubiquinone Q2,['experimental'],BE0003854,"Cytochrome c1, heme protein, mitochondrial",CYC1,Humans
15400,DB08690,Ubiquinone Q2,['experimental'],BE0000938,Cytochrome b,MT-CYB,Humans
15401,DB08690,Ubiquinone Q2,['experimental'],BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,Humans
15402,DB08690,Ubiquinone Q2,['experimental'],BE0003855,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,Humans
15403,DB08690,Ubiquinone Q2,['experimental'],BE0003856,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,Humans
15404,DB08690,Ubiquinone Q2,['experimental'],BE0003857,Cytochrome b-c1 complex subunit 8,UQCRQ,Humans
15405,DB08690,Ubiquinone Q2,['experimental'],BE0003858,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,Humans
15406,DB08690,Ubiquinone Q2,['experimental'],BE0003859,Cytochrome b-c1 complex subunit 10,UQCR11,Humans
15407,DB08690,Ubiquinone Q2,['experimental'],BE0003860,Cytochrome b-c1 complex subunit 7,UQCRB,Humans
15408,DB08690,Ubiquinone Q2,['experimental'],BE0003861,Cytochrome b-c1 complex subunit 9,UQCR10,Humans
15420,DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",['experimental'],BE0001824,Dual specificity protein kinase CLK1,CLK1,Humans
15421,DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",['experimental'],BE0004043,Dual specificity protein kinase CLK3,CLK3,Humans
15422,DB08692,D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
15423,DB08693,L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,['experimental'],BE0003531,Chymotrypsinogen B,CTRB1,Humans
15424,DB08694,Variolin B,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15425,DB08694,Variolin B,['experimental'],BE0003734,Cyclin-A2,CCNA2,Humans
15426,DB08695,3-(4-nitrophenyl)-1H-pyrazole,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
15427,DB08697,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",['experimental'],BE0000895,Urokinase-type plasminogen activator,PLAU,Humans
15429,DB08699,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",['experimental'],BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,Humans
15433,DB08703,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",['experimental'],BE0004386,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,Humans
15435,DB08705,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
15437,DB08707,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
15438,DB08708,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
15439,DB08709,"2,3-diphenyl-1H-indole-7-carboxylic acid",['experimental'],BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
15462,DB08729,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",['experimental'],BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
15463,DB08730,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,['experimental'],BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
15467,DB08733,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",['experimental'],BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,Humans
15468,DB08734,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",['experimental'],BE0000324,Thymidylate synthase,TYMS,Humans
15469,DB08737,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
15470,DB08738,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
15471,DB08739,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",['experimental'],BE0002148,Prolyl endopeptidase,PREP,Humans
15472,DB08740,"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",['experimental'],BE0000941,Cathepsin D,CTSD,Humans
15474,DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",['experimental'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
15475,DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",['experimental'],BE0000779,Vitamin D3 receptor,VDR,Humans
15476,DB08743,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",['experimental'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15477,DB08744,Casimiroin,['experimental'],BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,Humans
15478,DB08745,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
15479,DB08746,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,['experimental'],BE0000216,Coagulation factor X,F10,Humans
15483,DB08749,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,['experimental'],BE0000988,Beta-secretase 1,BACE1,Humans
15484,DB08750,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",['experimental'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
15485,DB08751,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",['experimental'],BE0001076,GTPase HRas,HRAS,Humans
15486,DB08752,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
15489,DB08755,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,['experimental'],BE0001646,Cathepsin S,CTSS,Humans
15490,DB08756,Y-27632,['experimental'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
15491,DB08756,Y-27632,['experimental'],BE0003762,cAMP-dependent protein kinase inhibitor alpha,PKIA,Humans
15492,DB08756,Y-27632,['experimental'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
15493,DB08756,Y-27632,['experimental'],BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
15497,DB08760,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15499,DB08762,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,['experimental'],BE0003753,Carboxypeptidase A1,CPA1,Humans
15500,DB08763,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
15501,DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15502,DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",['experimental'],BE0001855,Macrophage migration inhibitory factor,MIF,Humans
15503,DB08766,Zofenoprilat,['experimental'],BE0003882,Cytosol aminopeptidase,LAP3,Humans
15506,DB08768,N(6)-dimethylallyladenine,['experimental'],BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
15507,DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",['experimental'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
15508,DB08771,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one",['experimental'],BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
15509,DB08772,Zopolrestat,['experimental'],BE0004353,Aldo-keto reductase family 1 member B10,AKR1B10,Humans
15510,DB08772,Zopolrestat,['experimental'],BE0000747,Aldose reductase,AKR1B1,Humans
15511,DB08773,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
15512,DB08773,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,['experimental'],BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
15513,DB08774,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15514,DB08775,Benzoyl-tyrosine-alanine-fluoro-methyl ketone,['experimental'],BE0001504,Cathepsin F,CTSF,Humans
15515,DB08776,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15516,DB08777,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15517,DB08778,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15518,DB08779,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15519,DB08780,6-MORPHOLIN-4-YL-9H-PURINE,['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15520,DB08781,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",['experimental'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
15521,DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,['experimental'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15522,DB08783,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,['experimental'],BE0000623,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,Humans
15523,DB08784,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,['experimental'],BE0004420,NmrA-like family domain-containing protein 1,NMRAL1,Humans
15525,DB08786,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15526,DB08787,"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15527,DB08788,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15528,DB08789,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
15529,DB08790,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,['experimental'],BE0001167,Hematopoietic prostaglandin D synthase,HPGDS,Humans
15530,DB08791,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",['experimental'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
15537,DB08799,Antazoline,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
15538,DB08800,Chloropyramine,['experimental'],BE0000442,Histamine H1 receptor,HRH1,Humans
15539,DB08801,Dimetindene,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
15540,DB08801,Dimetindene,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
15541,DB08802,Isothipendyl,['experimental'],BE0000442,Histamine H1 receptor,HRH1,Humans
15542,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0000132,Androgen receptor,AR,Humans
15543,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0001126,Proto-oncogene c-Fos,FOS,Humans
15544,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0004881,5-hydroxytryptamine 2 receptor,HTR2A,Humans
15545,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
15546,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
15547,DB08804,Nandrolone decanoate,"['approved', 'illicit']",BE0009376,Dopamine receptor,DRD1,Humans
15548,DB08805,Metiamide,['experimental'],BE0000112,Histamine H2 receptor,HRH2,Humans
15549,DB08806,Roxatidine acetate,['experimental'],BE0000112,Histamine H2 receptor,HRH2,Humans
15550,DB08807,Bopindolol,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15551,DB08807,Bopindolol,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
15552,DB08807,Bopindolol,['experimental'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15553,DB08807,Bopindolol,['experimental'],BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
15554,DB08807,Bopindolol,['experimental'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
15555,DB08808,Bupranolol,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15556,DB08808,Bupranolol,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
15557,DB08808,Bupranolol,['experimental'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
15558,DB08809,Dichloroacetic acid,"['approved', 'investigational']",BE0003862,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",PDK1,Humans
15559,DB08809,Dichloroacetic acid,"['approved', 'investigational']",BE0000819,Maleylacetoacetate isomerase,GSTZ1,Humans
15560,DB08810,Cinitapride,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15561,DB08810,Cinitapride,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15562,DB08810,Cinitapride,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
15563,DB08811,Tofisopam,['experimental'],BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,Humans
15564,DB08811,Tofisopam,['experimental'],BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
15565,DB08811,Tofisopam,['experimental'],BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,Humans
15566,DB08811,Tofisopam,['experimental'],BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,Humans
15567,DB08813,Nadroparin,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
15568,DB08813,Nadroparin,"['approved', 'investigational']",BE0001159,P-selectin,SELP,Humans
15569,DB08813,Nadroparin,"['approved', 'investigational']",BE0001126,Proto-oncogene c-Fos,FOS,Humans
15570,DB08813,Nadroparin,"['approved', 'investigational']",BE0004689,Myc proto-oncogene protein,MYC,Humans
15571,DB08814,Triflusal,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
15572,DB08814,Triflusal,"['approved', 'investigational']",BE0001086,Nuclear factor NF-kappa-B p105 subunit,NFKB1,Humans
15573,DB08814,Triflusal,"['approved', 'investigational']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
15574,DB08814,Triflusal,"['approved', 'investigational']",BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,Humans
15575,DB08815,Lurasidone,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
15576,DB08815,Lurasidone,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15577,DB08815,Lurasidone,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
15578,DB08815,Lurasidone,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15579,DB08815,Lurasidone,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
15580,DB08815,Lurasidone,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
15581,DB08816,Ticagrelor,['approved'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
15582,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0001113,CD44 antigen,CD44,Humans
15583,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0001085,Intercellular adhesion molecule 1,ICAM1,Humans
15584,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004702,Hyaluronan mediated motility receptor,HMMR,Humans
15585,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004512,Neurocan core protein,NCAN,Humans
15586,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004606,Versican core protein,VCAN,Humans
15587,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004930,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,Humans
15588,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004933,Hyaluronan and proteoglycan link protein 1,HAPLN1,Humans
15589,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004935,Hyaluronan and proteoglycan link protein 3,HAPLN3,Humans
15590,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004940,Hyaluronan-binding protein 2,HABP2,Humans
15591,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004944,Layilin,LAYN,Humans
15592,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004948,Stabilin-2,STAB2,Humans
15593,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004952,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,Humans
15594,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004942,Interphotoreceptor matrix proteoglycan 2,IMPG2,Humans
15595,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0004943,Intracellular hyaluronan-binding protein 4,HABP4,Humans
15596,DB08818,Hyaluronic acid,"['approved', 'vet_approved']",BE0010044,Lymphatic vessel endothelial hyaluronic acid receptor 1,LYVE1,Humans
15597,DB08819,Tafluprost,['approved'],BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
15598,DB08820,Ivacaftor,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
15599,DB08822,Azilsartan medoxomil,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
15601,DB08827,Lomitapide,"['approved', 'investigational']",BE0000232,Microsomal triglyceride transfer protein large subunit,MTTP,Humans
15602,DB08828,Vismodegib,"['approved', 'investigational']",BE0004659,Smoothened homolog,SMO,Humans
15603,DB08834,Tauroursodeoxycholic acid,"['approved', 'investigational']",BE0008988,Integrin alpha-5,ITGA5,Humans
15604,DB08835,Spaglumic acid,['experimental'],BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
15605,DB08836,Temocapril,"['experimental', 'investigational']",BE0000221,Angiotensin-converting enzyme,ACE,Humans
15607,DB08837,Tetraethylammonium,"['experimental', 'investigational']",BE0002343,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,Humans
15609,DB08837,Tetraethylammonium,"['experimental', 'investigational']",BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
15610,DB08838,Agmatine,['experimental'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
15611,DB08838,Agmatine,['experimental'],BE0003580,Nischarin,NISCH,Humans
15612,DB08838,Agmatine,['experimental'],BE0004661,Acetylcholine receptor subunit alpha,CHRNA1,Humans
15613,DB08838,Agmatine,['experimental'],BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
15614,DB08838,Agmatine,['experimental'],BE0000644,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,Humans
15615,DB08838,Agmatine,['experimental'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
15616,DB08838,Agmatine,['experimental'],BE0004768,Acid-sensing ion channel 3,ASIC3,Humans
15617,DB08839,Serotonin,"['investigational', 'nutraceutical']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
15618,DB08839,Serotonin,"['investigational', 'nutraceutical']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15619,DB08839,Serotonin,"['investigational', 'nutraceutical']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
15620,DB08839,Serotonin,"['investigational', 'nutraceutical']",BE0009583,5-hydroxytryptamine receptor 3B,HTR3B,Humans
15621,DB08839,Serotonin,"['investigational', 'nutraceutical']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
15624,DB08846,Ellagic acid,['investigational'],BE0000267,Carbonic anhydrase 1,CA1,Humans
15625,DB08846,Ellagic acid,['investigational'],BE0000322,Carbonic anhydrase 2,CA2,Humans
15626,DB08846,Ellagic acid,['investigational'],BE0003625,Carbonic anhydrase 3,CA3,Humans
15627,DB08846,Ellagic acid,['investigational'],BE0000535,Carbonic anhydrase 4,CA4,Humans
15628,DB08846,Ellagic acid,['investigational'],BE0003626,"Carbonic anhydrase 5A, mitochondrial",CA5A,Humans
15629,DB08846,Ellagic acid,['investigational'],BE0003627,"Carbonic anhydrase 5B, mitochondrial",CA5B,Humans
15630,DB08846,Ellagic acid,['investigational'],BE0003628,Carbonic anhydrase 6,CA6,Humans
15631,DB08846,Ellagic acid,['investigational'],BE0003629,Carbonic anhydrase 7,CA7,Humans
15632,DB08846,Ellagic acid,['investigational'],BE0002437,Carbonic anhydrase 9,CA9,Humans
15633,DB08846,Ellagic acid,['investigational'],BE0001653,Carbonic anhydrase 12,CA12,Humans
15634,DB08846,Ellagic acid,['investigational'],BE0003634,Carbonic anhydrase 14,CA14,Humans
15635,DB08846,Ellagic acid,['investigational'],BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
15636,DB08846,Ellagic acid,['investigational'],BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
15637,DB08846,Ellagic acid,['investigational'],BE0001132,Protein kinase C alpha type,PRKCA,Humans
15638,DB08846,Ellagic acid,['investigational'],BE0000872,Protein kinase C beta type,PRKCB,Humans
15639,DB08846,Ellagic acid,['investigational'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
15640,DB08846,Ellagic acid,['investigational'],BE0000577,Squalene monooxygenase,SQLE,Humans
15641,DB08848,Guvacine,['experimental'],BE0004776,Sodium- and chloride-dependent GABA transporter 2,SLC6A13,Humans
15642,DB08848,Guvacine,['experimental'],BE0000249,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,Humans
15643,DB08848,Guvacine,['experimental'],BE0004733,Sodium- and chloride-dependent GABA transporter 3,SLC6A11,Humans
15644,DB08848,Guvacine,['experimental'],BE0004777,Sodium- and chloride-dependent betaine transporter,SLC6A12,Humans
15645,DB08855,Leukotriene C4,"['experimental', 'investigational']",BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
15646,DB08855,Leukotriene C4,"['experimental', 'investigational']",BE0000099,Cysteinyl leukotriene receptor 2,CYSLTR2,Humans
15647,DB08855,Leukotriene C4,"['experimental', 'investigational']",BE0000785,Multidrug resistance-associated protein 1,ABCC1,Humans
15648,DB08860,Pitavastatin,['approved'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
15649,DB08860,Pitavastatin,['approved'],BE0000516,Integrin alpha-L,ITGAL,Humans
15650,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0000402,Cholecystokinin receptor type A,CCKAR,Humans
15651,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
15652,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
15653,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0000953,Pro-epidermal growth factor,EGF,Humans
15654,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0000872,Protein kinase C beta type,PRKCB,Humans
15655,DB08862,Cholecystokinin,"['approved', 'investigational']",BE0001158,Gastrin/cholecystokinin type B receptor,CCKBR,Humans
15657,DB08864,Rilpivirine,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
15658,DB08865,Crizotinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
15659,DB08865,Crizotinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
15660,DB08865,Crizotinib,"['approved', 'investigational']",BE0009534,Proto-oncogene tyrosine-protein kinase ROS,ROS1,Humans
15661,DB08865,Crizotinib,"['approved', 'investigational']",BE0009490,Macrophage-stimulating protein receptor,MST1R,Humans
15662,DB08867,Ulipristal,['approved'],BE0000557,Progesterone receptor,PGR,Humans
15663,DB08867,Ulipristal,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
15664,DB08867,Ulipristal,['approved'],BE0000132,Androgen receptor,AR,Humans
15665,DB08868,Fingolimod,"['approved', 'investigational']",BE0002432,Sphingosine 1-phosphate receptor 5,S1PR5,Humans
15666,DB08868,Fingolimod,"['approved', 'investigational']",BE0008652,Sphingosine 1-phosphate receptor 1,S1PR1,Humans
15667,DB08868,Fingolimod,"['approved', 'investigational']",BE0009881,Sphingosine 1-phosphate receptor 3,S1PR3,Humans
15668,DB08868,Fingolimod,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
15669,DB08868,Fingolimod,"['approved', 'investigational']",BE0009882,Sphingosine 1-phosphate receptor 4,S1PR4,Humans
15670,DB08869,Tesamorelin,"['approved', 'investigational']",BE0000625,Growth hormone-releasing hormone receptor,GHRHR,Humans
15671,DB08870,Brentuximab vedotin,"['approved', 'investigational']",BE0003479,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,Humans
15672,DB08871,Eribulin,"['approved', 'investigational']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
15673,DB08871,Eribulin,"['approved', 'investigational']",BE0000026,Tubulin beta-1 chain,TUBB1,Humans
15674,DB08872,Gabapentin enacarbil,"['approved', 'investigational']",BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,Humans
15675,DB08872,Gabapentin enacarbil,"['approved', 'investigational']",BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,Humans
15678,DB08875,Cabozantinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
15679,DB08875,Cabozantinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15680,DB08875,Cabozantinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
15682,DB08877,Ruxolitinib,['approved'],BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
15683,DB08877,Ruxolitinib,['approved'],BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
15684,DB08877,Ruxolitinib,['approved'],BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
15685,DB08877,Ruxolitinib,['approved'],BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
15686,DB08879,Belimumab,['approved'],BE0000999,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,Humans
15687,DB08880,Teriflunomide,['approved'],BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,Humans
15688,DB08881,Vemurafenib,['approved'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
15689,DB08882,Linagliptin,['approved'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
15690,DB08883,Perampanel,['approved'],BE0000640,Glutamate receptor 1,GRIA1,Humans
15691,DB08885,Aflibercept,['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
15692,DB08885,Aflibercept,['approved'],BE0003148,Placenta growth factor,PGF,Humans
15693,DB08885,Aflibercept,['approved'],BE0004736,Vascular endothelial growth factor B,VEGFB,Humans
15694,DB08888,Ocriplasmin,['approved'],BE0001180,Fibronectin,FN1,Humans
15695,DB08888,Ocriplasmin,['approved'],BE0000910,Alpha-2-macroglobulin,A2M,Humans
15696,DB08888,Ocriplasmin,['approved'],BE0001125,Alpha-2-antiplasmin,SERPINF2,Humans
15697,DB08889,Carfilzomib,"['approved', 'investigational']",BE0002348,Proteasome subunit beta type-5,PSMB5,Humans
15698,DB08889,Carfilzomib,"['approved', 'investigational']",BE0004739,Proteasome subunit beta type-8,PSMB8,Humans
15699,DB08889,Carfilzomib,"['approved', 'investigational']",BE0002347,Proteasome subunit beta type-1,PSMB1,Humans
15700,DB08889,Carfilzomib,"['approved', 'investigational']",BE0004737,Proteasome subunit beta type-9,PSMB9,Humans
15701,DB08889,Carfilzomib,"['approved', 'investigational']",BE0002349,Proteasome subunit beta type-2,PSMB2,Humans
15702,DB08889,Carfilzomib,"['approved', 'investigational']",BE0004738,Proteasome subunit beta type-10,PSMB10,Humans
15703,DB08890,Linaclotide,['approved'],BE0003502,Heat-stable enterotoxin receptor,GUCY2C,Humans
15704,DB08891,Arbaclofen,['investigational'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
15705,DB08891,Arbaclofen,['investigational'],BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,Humans
15706,DB08892,Arbaclofen Placarbil,['investigational'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
15707,DB08892,Arbaclofen Placarbil,['investigational'],BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,Humans
15708,DB08893,Mirabegron,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
15709,DB08893,Mirabegron,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15710,DB08894,Peginesatide,"['approved', 'investigational']",BE0000654,Erythropoietin receptor,EPOR,Humans
15711,DB08895,Tofacitinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
15712,DB08895,Tofacitinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
15713,DB08895,Tofacitinib,"['approved', 'investigational']",BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
15714,DB08895,Tofacitinib,"['approved', 'investigational']",BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
15715,DB08896,Regorafenib,['approved'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
15716,DB08896,Regorafenib,['approved'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15717,DB08896,Regorafenib,['approved'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
15718,DB08896,Regorafenib,['approved'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
15719,DB08896,Regorafenib,['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
15720,DB08896,Regorafenib,['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
15721,DB08896,Regorafenib,['approved'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
15722,DB08896,Regorafenib,['approved'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
15723,DB08896,Regorafenib,['approved'],BE0003379,Angiopoietin-1 receptor,TEK,Humans
15724,DB08896,Regorafenib,['approved'],BE0004741,Discoidin domain-containing receptor 2,DDR2,Humans
15725,DB08896,Regorafenib,['approved'],BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
15726,DB08896,Regorafenib,['approved'],BE0000841,Ephrin type-A receptor 2,EPHA2,Humans
15727,DB08896,Regorafenib,['approved'],BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
15728,DB08896,Regorafenib,['approved'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
15729,DB08896,Regorafenib,['approved'],BE0003390,Mitogen-activated protein kinase 11,MAPK11,Humans
15730,DB08896,Regorafenib,['approved'],BE0004742,Tyrosine-protein kinase FRK,FRK,Humans
15731,DB08896,Regorafenib,['approved'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
15732,DB08896,Regorafenib,['approved'],BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
15733,DB08897,Aclidinium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
15734,DB08897,Aclidinium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
15735,DB08897,Aclidinium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
15736,DB08897,Aclidinium,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
15737,DB08897,Aclidinium,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
15738,DB08899,Enzalutamide,['approved'],BE0000132,Androgen receptor,AR,Humans
15739,DB08900,Teduglutide,['approved'],BE0002134,Glucagon-like peptide 2 receptor,GLP2R,Humans
15740,DB08901,Ponatinib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
15741,DB08901,Ponatinib,"['approved', 'investigational']",BE0004743,Breakpoint cluster region protein,BCR,Humans
15742,DB08901,Ponatinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
15743,DB08901,Ponatinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
15744,DB08901,Ponatinib,"['approved', 'investigational']",BE0003379,Angiopoietin-1 receptor,TEK,Humans
15745,DB08901,Ponatinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
15746,DB08901,Ponatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
15747,DB08901,Ponatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
15748,DB08901,Ponatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
15749,DB08901,Ponatinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
15750,DB08901,Ponatinib,"['approved', 'investigational']",BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
15751,DB08901,Ponatinib,"['approved', 'investigational']",BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
15752,DB08901,Ponatinib,"['approved', 'investigational']",BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
15753,DB08901,Ponatinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15754,DB08901,Ponatinib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
15757,DB08904,Certolizumab pegol,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
15758,DB08906,Fluticasone furoate,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
15759,DB08906,Fluticasone furoate,['approved'],BE0000557,Progesterone receptor,PGR,Humans
15760,DB08906,Fluticasone furoate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
15761,DB08907,Canagliflozin,['approved'],BE0004753,Sodium/glucose cotransporter 2,SLC5A2,Humans
15762,DB08908,Dimethyl fumarate,"['approved', 'investigational']",BE0004756,Kelch-like ECH-associated protein 1,KEAP1,Humans
15763,DB08908,Dimethyl fumarate,"['approved', 'investigational']",BE0005551,Transcription factor p65,RELA,Humans
15764,DB08910,Pomalidomide,['approved'],BE0004755,Protein cereblon,CRBN,Humans
15765,DB08910,Pomalidomide,['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
15766,DB08910,Pomalidomide,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
15767,DB08911,Trametinib,['approved'],BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
15768,DB08911,Trametinib,['approved'],BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,Humans
15769,DB08912,Dabrafenib,"['approved', 'investigational']",BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
15770,DB08912,Dabrafenib,"['approved', 'investigational']",BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
15771,DB08912,Dabrafenib,"['approved', 'investigational']",BE0004757,Serine/threonine-protein kinase SIK1,SIK1,Humans
15772,DB08912,Dabrafenib,"['approved', 'investigational']",BE0004758,Serine/threonine-protein kinase Nek11,NEK11,Humans
15773,DB08912,Dabrafenib,"['approved', 'investigational']",BE0004759,LIM domain kinase 1,LIMK1,Humans
15774,DB08915,Aleglitazar,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
15775,DB08915,Aleglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15776,DB08915,Aleglitazar,['investigational'],BE0003728,Nuclear receptor coactivator 1,NCOA1,Humans
15777,DB08916,Afatinib,['approved'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
15778,DB08916,Afatinib,['approved'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
15779,DB08916,Afatinib,['approved'],BE0004772,Receptor tyrosine-protein kinase erbB-4,ERBB4,Humans
15780,DB08918,Levomilnacipran,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
15781,DB08918,Levomilnacipran,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
15782,DB08922,Perospirone,['experimental'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15783,DB08922,Perospirone,['experimental'],BE0000756,Dopamine D2 receptor,DRD2,Humans
15784,DB08922,Perospirone,['experimental'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15785,DB08922,Perospirone,['experimental'],BE0000442,Histamine H1 receptor,HRH1,Humans
15786,DB08922,Perospirone,['experimental'],BE0000389,Dopamine D4 receptor,DRD4,Humans
15787,DB08922,Perospirone,['experimental'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
15788,DB08927,Amperozide,['experimental'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15790,DB08931,Riociguat,['approved'],BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
15791,DB08932,Macitentan,['approved'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
15792,DB08932,Macitentan,['approved'],BE0000043,Endothelin B receptor,EDNRB,Humans
15795,DB08935,Obinutuzumab,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
15796,DB08936,Chlorcyclizine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
15797,DB08949,Inositol nicotinate,"['approved', 'withdrawn']",BE0000836,Hydroxycarboxylic acid receptor 3,HCAR3,Humans
15798,DB08949,Inositol nicotinate,"['approved', 'withdrawn']",BE0000635,Hydroxycarboxylic acid receptor 2,HCAR2,Humans
15799,DB08950,Indoramin,"['approved', 'withdrawn']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
15800,DB08951,Indoprofen,['withdrawn'],BE0000088,Pyruvate kinase PKM,PKM,Humans
15801,DB08954,Ifenprodil,"['investigational', 'withdrawn']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
15802,DB08954,Ifenprodil,"['investigational', 'withdrawn']",BE0000365,"Glutamate receptor ionotropic, NMDA 1",GRIN1,Humans
15803,DB08954,Ifenprodil,"['investigational', 'withdrawn']",BE0001028,G protein-activated inward rectifier potassium channel 1,KCNJ3,Humans
15804,DB08954,Ifenprodil,"['investigational', 'withdrawn']",BE0001030,G protein-activated inward rectifier potassium channel 2,KCNJ6,Humans
15805,DB08954,Ifenprodil,"['investigational', 'withdrawn']",BE0002218,G protein-activated inward rectifier potassium channel 4,KCNJ5,Humans
15806,DB08960,Hexamethonium,['experimental'],BE0000738,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,Humans
15807,DB08964,Gemeprost,"['approved', 'withdrawn']",BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
15808,DB08964,Gemeprost,"['approved', 'withdrawn']",BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
15809,DB08995,Diosmin,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
15810,DB08996,Dimetacrine,"['experimental', 'withdrawn']",BE0000426,Acetylcholinesterase,ACHE,Humans
15811,DB09006,Clinofibrate,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
15812,DB09006,Clinofibrate,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15813,DB09006,Clinofibrate,['experimental'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
15814,DB09013,Befunolol,['experimental'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15815,DB09013,Befunolol,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
15816,DB09014,Captodiame,['experimental'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
15817,DB09014,Captodiame,['experimental'],BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
15818,DB09014,Captodiame,['experimental'],BE0000581,Dopamine D3 receptor,DRD3,Humans
15819,DB09016,Butriptyline,"['approved', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
15820,DB09016,Butriptyline,"['approved', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
15821,DB09016,Butriptyline,"['approved', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15822,DB09017,Brotizolam,"['investigational', 'withdrawn']",BE0004797,GABA(A) Receptor,GABRA1,Humans
15823,DB09017,Brotizolam,"['investigational', 'withdrawn']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
15824,DB09018,Bromopride,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
15825,DB09019,Bromhexine,['approved'],BE0009920,Transmembrane protease serine 2,TMPRSS2,Humans
15826,DB09019,Bromhexine,['approved'],BE0000982,Angiotensin-converting enzyme 2,ACE2,Humans
15827,DB09020,Bisacodyl,['approved'],BE0009664,Aquaporin-3,AQP3,Humans
15828,DB09020,Bisacodyl,['approved'],BE0010055,Sodium/Potassium Transporting ATPase subunits,ATP1A1,Humans
15829,DB09026,Aliskiren,"['approved', 'investigational']",BE0000270,Renin,REN,Humans
15831,DB09028,Cytisine,['experimental'],BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
15832,DB09028,Cytisine,['experimental'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
15833,DB09028,Cytisine,['experimental'],BE0003585,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,Humans
15834,DB09028,Cytisine,['experimental'],BE0003587,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,Humans
15835,DB09028,Cytisine,['experimental'],BE0000850,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,Humans
15836,DB09029,Secukinumab,['approved'],BE0005863,Interleukin-17A,IL17A,Humans
15837,DB09030,Vorapaxar,['approved'],BE0000928,Proteinase-activated receptor 1,F2R,Humans
15838,DB09031,Miltefosine,"['approved', 'investigational']",BE0001032,P-glycoprotein 1,ABCB1,Humans
15839,DB09033,Vedolizumab,['approved'],BE0000590,Integrin alpha-4,ITGA4,Humans
15840,DB09033,Vedolizumab,['approved'],BE0003414,Integrin beta-7,ITGB7,Humans
15841,DB09034,Suvorexant,"['approved', 'investigational']",BE0005864,Orexin receptor type 1,HCRTR1,Humans
15842,DB09034,Suvorexant,"['approved', 'investigational']",BE0005865,Orexin receptor type 2,HCRTR2,Humans
15843,DB09035,Nivolumab,['approved'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
15844,DB09035,Nivolumab,['approved'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
15845,DB09036,Siltuximab,"['approved', 'investigational']",BE0000918,Interleukin-6,IL6,Humans
15846,DB09037,Pembrolizumab,['approved'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
15847,DB09037,Pembrolizumab,['approved'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
15848,DB09038,Empagliflozin,['approved'],BE0004753,Sodium/glucose cotransporter 2,SLC5A2,Humans
15849,DB09039,Eliglustat,"['approved', 'investigational']",BE0000477,Ceramide glucosyltransferase,UGCG,Humans
15853,DB09043,Albiglutide,['approved'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
15854,DB09045,Dulaglutide,"['approved', 'investigational']",BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
15855,DB09046,Metreleptin,['approved'],BE0003376,Leptin receptor,LEPR,Humans
15858,DB09047,Finafloxacin,"['approved', 'investigational']",BE0000742,DNA topoisomerase 2-alpha,TOP2A,Humans
15859,DB09048,Netupitant,"['approved', 'investigational']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
15860,DB09049,Naloxegol,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
15866,DB09052,Blinatumomab,"['approved', 'investigational']",BE0003496,B-lymphocyte antigen CD19,CD19,Humans
15867,DB09052,Blinatumomab,"['approved', 'investigational']",BE0003456,T-cell surface glycoprotein CD3 delta chain,CD3D,Humans
15868,DB09053,Ibrutinib,['approved'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
15869,DB09054,Idelalisib,['approved'],BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
15871,DB09059,Atosiban,"['approved', 'investigational']",BE0000844,Oxytocin receptor,OXTR,Humans
15872,DB09059,Atosiban,"['approved', 'investigational']",BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
15873,DB09059,Atosiban,"['approved', 'investigational']",BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
15874,DB09059,Atosiban,"['approved', 'investigational']",BE0000293,Vasopressin V2 receptor,AVPR2,Humans
15885,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000061,Cannabinoid receptor 1,CNR1,Humans
15886,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000095,Cannabinoid receptor 2,CNR2,Humans
15887,DB09061,Cannabidiol,"['approved', 'investigational']",BE0009153,G-protein coupled receptor 12,GPR12,Humans
15888,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
15889,DB09061,Cannabidiol,"['approved', 'investigational']",BE0004857,Glycine receptor (alpha-1/beta),GLRA1,Humans
15890,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
15891,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002304,N-arachidonyl glycine receptor,GPR18,Humans
15892,DB09061,Cannabidiol,"['approved', 'investigational']",BE0005802,G-protein coupled receptor 55,GPR55,Humans
15893,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15894,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
15895,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
15896,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
15897,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
15898,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
15899,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
15900,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
15901,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
15902,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
15903,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
15904,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
15905,DB09061,Cannabidiol,"['approved', 'investigational']",BE0009158,Transient receptor potential cation channel subfamily V member 2,TRPV2,Humans
15906,DB09061,Cannabidiol,"['approved', 'investigational']",BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
15907,DB09061,Cannabidiol,"['approved', 'investigational']",BE0009159,Transient receptor potential cation channel subfamily V member 4,TRPV4,Humans
15908,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002468,Voltage-dependent anion-selective channel protein 1,VDAC1,Humans
15909,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
15910,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
15911,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
15912,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
15913,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,Humans
15914,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
15915,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
15916,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
15917,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000816,Glutathione peroxidase 1,GPX1,Humans
15918,DB09061,Cannabidiol,"['approved', 'investigational']",BE0000693,"Indoleamine 2,3-dioxygenase 1",IDO1,Humans
15919,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
15920,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001184,NAD(P)H dehydrogenase [quinone] 1,NQO1,Humans
15921,DB09061,Cannabidiol,"['approved', 'investigational']",BE0001207,Catalase,CAT,Humans
15922,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002362,Cytochrome P450 3A5,CYP3A5,Humans
15923,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002363,Cytochrome P450 2D6,CYP2D6,Humans
15924,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
15925,DB09061,Cannabidiol,"['approved', 'investigational']",BE0002433,Cytochrome P450 1A2,CYP1A2,Humans
15926,DB09061,Cannabidiol,"['approved', 'investigational']",BE0003612,Cytochrome P450 3A7,CYP3A7,Humans
15927,DB09061,Cannabidiol,"['approved', 'investigational']",BE0009154,Arylalkylamine N-acetyltransferase,AANAT,Humans
15928,DB09061,Cannabidiol,"['approved', 'investigational']",BE0009156,N-acylethanolamine-hydrolyzing acid amidase,NAAA,Humans
15929,DB09063,Ceritinib,['approved'],BE0000359,ALK tyrosine kinase receptor,ALK,Humans
15930,DB09064,Ciprofibrate,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
15931,DB09065,Cobicistat,['approved'],BE0002638,Cytochrome P450 3A4,CYP3A4,Humans
15932,DB09066,Corifollitropin alfa,"['approved', 'investigational']",BE0000387,Follicle-stimulating hormone receptor,FSHR,Humans
15934,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
15935,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
15936,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
15937,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
15938,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
15939,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
15940,DB09068,Vortioxetine,"['approved', 'investigational']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
15941,DB09069,Trimetazidine,"['approved', 'investigational']",BE0010052,"3-ketoacyl-CoA thiolase, mitochondrial",ACAA2,Humans
15942,DB09070,Tibolone,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
15943,DB09071,Tasimelteon,"['approved', 'investigational']",BE0000515,Melatonin receptor type 1A,MTNR1A,Humans
15944,DB09071,Tasimelteon,"['approved', 'investigational']",BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
15946,DB09072,Sodium oxybate,['approved'],BE0004841,Gamma-hydroxybutyrate (GHB) receptor,SLC52A2,Humans
15947,DB09073,Palbociclib,"['approved', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
15948,DB09073,Palbociclib,"['approved', 'investigational']",BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
15949,DB09074,Olaparib,['approved'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
15950,DB09074,Olaparib,['approved'],BE0003798,Poly [ADP-ribose] polymerase 2,PARP2,Humans
15951,DB09074,Olaparib,['approved'],BE0004049,Poly [ADP-ribose] polymerase 3,PARP3,Humans
15952,DB09074,Olaparib,['approved'],BE0000592,Aldo-keto reductase family 1 member C3,AKR1C3,Humans
15953,DB09075,Edoxaban,['approved'],BE0000216,Coagulation factor X,F10,Humans
15954,DB09076,Umeclidinium,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
15955,DB09076,Umeclidinium,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
15956,DB09076,Umeclidinium,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
15957,DB09076,Umeclidinium,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
15958,DB09076,Umeclidinium,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
15960,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
15961,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15962,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
15963,DB09078,Lenvatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
15964,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
15965,DB09078,Lenvatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
15966,DB09078,Lenvatinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
15967,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
15968,DB09078,Lenvatinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
15969,DB09078,Lenvatinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
15970,DB09079,Nintedanib,['approved'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
15971,DB09079,Nintedanib,['approved'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
15972,DB09079,Nintedanib,['approved'],BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
15973,DB09079,Nintedanib,['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
15974,DB09079,Nintedanib,['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
15975,DB09079,Nintedanib,['approved'],BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
15976,DB09079,Nintedanib,['approved'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
15977,DB09079,Nintedanib,['approved'],BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
15978,DB09079,Nintedanib,['approved'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
15979,DB09079,Nintedanib,['approved'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
15980,DB09079,Nintedanib,['approved'],BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
15981,DB09079,Nintedanib,['approved'],BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
15982,DB09080,Olodaterol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
15983,DB09082,Vilanterol,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
15984,DB09083,Ivabradine,['approved'],BE0004631,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,Humans
15985,DB09085,Tetracaine,"['approved', 'vet_approved']",BE0000739,Ryanodine receptor 1,RYR1,Humans
15986,DB09085,Tetracaine,"['approved', 'vet_approved']",BE0005295,Ryanodine receptor 2,RYR2,Humans
15987,DB09085,Tetracaine,"['approved', 'vet_approved']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
15988,DB09086,Eugenol,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
15989,DB09086,Eugenol,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
15990,DB09086,Eugenol,['approved'],BE0000132,Androgen receptor,AR,Humans
15991,DB09086,Eugenol,['approved'],BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
15992,DB09088,Amylocaine,"['approved', 'withdrawn']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
15993,DB09089,Trimebutine,['approved'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
15994,DB09089,Trimebutine,['approved'],BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
15995,DB09089,Trimebutine,['approved'],BE0004906,Calcium-activated potassium channel,KCNMA1,Humans
15996,DB09089,Trimebutine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
15997,DB09089,Trimebutine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
15998,DB09089,Trimebutine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
15999,DB09089,Trimebutine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
16000,DB09089,Trimebutine,['approved'],BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
16001,DB09090,Pinaverium,['approved'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
16002,DB09091,Tixocortol,"['approved', 'withdrawn']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
16003,DB09091,Tixocortol,"['approved', 'withdrawn']",BE0002366,Histone deacetylase 2,HDAC2,Humans
16004,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0000008,"NAD(P) transhydrogenase, mitochondrial",NNT,Humans
16005,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
16006,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,Humans
16007,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0000162,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,Humans
16008,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0000780,"Malate dehydrogenase, mitochondrial",MDH2,Humans
16009,DB09092,Xanthinol,"['approved', 'withdrawn']",BE0003833,60S ribosomal protein L3,RPL3,Humans
16016,DB09093,Chlortetracycline,"['approved', 'investigational', 'vet_approved']",BE0003814,ADP-ribosylation factor 1,ARF1,Humans
16018,DB09093,Chlortetracycline,"['approved', 'investigational', 'vet_approved']",BE0009441,Ephrin type-B receptor 1,EPHB1,Humans
16019,DB09093,Chlortetracycline,"['approved', 'investigational', 'vet_approved']",BE0000683,Pancreatic triacylglycerol lipase,PNLIP,Humans
16020,DB09093,Chlortetracycline,"['approved', 'investigational', 'vet_approved']",BE0001092,Protein-arginine deiminase type-4,PADI4,Humans
16021,DB09095,Difluocortolone,"['approved', 'investigational', 'withdrawn']",BE0003201,Annexin A3,ANXA3,Humans
16022,DB09095,Difluocortolone,"['approved', 'investigational', 'withdrawn']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
16023,DB09096,Benzoyl peroxide,['approved'],BE0001207,Catalase,CAT,Humans
16025,DB09096,Benzoyl peroxide,['approved'],BE0000448,Arginine decarboxylase,AZIN2,Humans
16026,DB09096,Benzoyl peroxide,['approved'],BE0004895,Protein kinase C,PRKCA,Humans
16027,DB09096,Benzoyl peroxide,['approved'],BE0010057,Superoxide Dismutases,SOD3,Humans
16028,DB09097,Quinagolide,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
16029,DB09097,Quinagolide,"['approved', 'investigational']",BE0004889,D(1) dopamine receptor,DRD1,Humans
16030,DB09098,Somatrem,"['approved', 'investigational', 'withdrawn']",BE0000075,Growth hormone receptor,GHR,Humans
16031,DB09098,Somatrem,"['approved', 'investigational', 'withdrawn']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16032,DB09099,Somatostatin,"['approved', 'investigational']",BE0000452,Somatostatin receptor type 1,SSTR1,Humans
16033,DB09099,Somatostatin,"['approved', 'investigational']",BE0003528,Somatostatin receptor type 2,SSTR2,Humans
16034,DB09099,Somatostatin,"['approved', 'investigational']",BE0003529,Somatostatin receptor type 3,SSTR3,Humans
16035,DB09099,Somatostatin,"['approved', 'investigational']",BE0009273,Somatostatin receptor type 4,SSTR4,Humans
16036,DB09099,Somatostatin,"['approved', 'investigational']",BE0002147,Somatostatin receptor type 5,SSTR5,Humans
16037,DB09100,"Thyroid, porcine",['approved'],BE0000687,Thyroid hormone receptor alpha,THRA,Humans
16038,DB09100,"Thyroid, porcine",['approved'],BE0000315,Thyroid hormone receptor beta,THRB,Humans
16041,DB09103,Ancestim,"['approved', 'investigational', 'withdrawn']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
16043,DB09107,Methoxy polyethylene glycol-epoetin beta,['approved'],BE0000654,Erythropoietin receptor,EPOR,Humans
16044,DB09108,Simoctocog alfa,['approved'],BE0001043,von Willebrand factor,VWF,Humans
16045,DB09109,Turoctocog alfa,"['approved', 'investigational']",BE0000364,Coagulation factor IX,F9,Humans
16046,DB09109,Turoctocog alfa,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
16047,DB09109,Turoctocog alfa,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
16048,DB09112,Nitrous acid,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
16049,DB09112,Nitrous acid,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
16050,DB09112,Nitrous acid,"['approved', 'investigational']",BE0004467,Myoglobin,MB,Humans
16051,DB09116,Calcium carbimide,"['approved', 'withdrawn']",BE0000193,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,Humans
16052,DB09118,Stiripentol,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
16053,DB09118,Stiripentol,['approved'],BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
16054,DB09118,Stiripentol,['approved'],BE0000068,L-lactate dehydrogenase B chain,LDHB,Humans
16055,DB09119,Eslicarbazepine acetate,['approved'],BE0005793,P2X purinoceptor 4,P2RX4,Humans
16056,DB09120,Zucapsaicin,"['approved', 'investigational']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
16057,DB09121,Aurothioglucose,"['approved', 'withdrawn']",BE0000269,Adenylate cyclase type 1,ADCY1,Humans
16058,DB09121,Aurothioglucose,"['approved', 'withdrawn']",BE0003732,Adenylate cyclase type 2,ADCY2,Humans
16059,DB09121,Aurothioglucose,"['approved', 'withdrawn']",BE0003733,Adenylate cyclase type 5,ADCY5,Humans
16060,DB09122,Peginterferon beta-1a,['approved'],BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
16061,DB09123,Dienogest,['approved'],BE0000557,Progesterone receptor,PGR,Humans
16062,DB09123,Dienogest,['approved'],BE0000132,Androgen receptor,AR,Humans
16063,DB09124,Medrogestone,"['approved', 'withdrawn']",BE0000557,Progesterone receptor,PGR,Humans
16064,DB09126,Chorionic Gonadotropin (Human),"['approved', 'vet_approved']",BE0000134,Lutropin-choriogonadotropic hormone receptor,LHCGR,Humans
16065,DB09128,Brexpiprazole,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
16066,DB09128,Brexpiprazole,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
16067,DB09128,Brexpiprazole,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16068,DB09128,Brexpiprazole,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
16069,DB09128,Brexpiprazole,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
16070,DB09129,Chromic chloride,['approved'],BE0000033,Insulin receptor,INSR,Humans
16071,DB09130,Copper,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
16072,DB09130,Copper,"['approved', 'investigational']",BE0001684,Adenosylhomocysteinase,AHCY,Humans
16073,DB09130,Copper,"['approved', 'investigational']",BE0005156,Histone H2B type 1-C/E/F/G/I,HIST1H2BC,Humans
16074,DB09130,Copper,"['approved', 'investigational']",BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
16075,DB09130,Copper,"['approved', 'investigational']",BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
16076,DB09130,Copper,"['approved', 'investigational']",BE0005131,Histone H1.4,HIST1H1E,Humans
16077,DB09130,Copper,"['approved', 'investigational']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
16078,DB09130,Copper,"['approved', 'investigational']",BE0008955,Protein S100-A8,S100A8,Humans
16079,DB09130,Copper,"['approved', 'investigational']",BE0002402,40S ribosomal protein SA,RPSA,Humans
16080,DB09130,Copper,"['approved', 'investigational']",BE0005013,"Actin, cytoplasmic 2",ACTG1,Humans
16081,DB09130,Copper,"['approved', 'investigational']",BE0005807,Alpha-enolase,ENO1,Humans
16082,DB09130,Copper,"['approved', 'investigational']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
16083,DB09130,Copper,"['approved', 'investigational']",BE0002105,"Keratin, type II cytoskeletal 8",KRT8,Humans
16084,DB09130,Copper,"['approved', 'investigational']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
16085,DB09130,Copper,"['approved', 'investigational']",BE0008980,Protein disulfide-isomerase A3,PDIA3,Humans
16086,DB09130,Copper,"['approved', 'investigational']",BE0008956,"60 kDa heat shock protein, mitochondrial",HSPD1,Humans
16087,DB09130,Copper,"['approved', 'investigational']",BE0008957,Heat shock 70 kDa protein 13,HSPA13,Humans
16088,DB09130,Copper,"['approved', 'investigational']",BE0001098,78 kDa glucose-regulated protein,HSPA5,Humans
16089,DB09130,Copper,"['approved', 'investigational']",BE0001165,Endoplasmin,HSP90B1,Humans
16090,DB09130,Copper,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
16092,DB09130,Copper,"['approved', 'investigational']",BE0008959,40S ribosomal protein S2,RPS2,Humans
16093,DB09130,Copper,"['approved', 'investigational']",BE0009139,Serine/arginine-rich splicing factor 1,SRSF1,Humans
16094,DB09130,Copper,"['approved', 'investigational']",BE0008960,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,Humans
16095,DB09130,Copper,"['approved', 'investigational']",BE0008961,Heterogeneous nuclear ribonucleoprotein H,HNRNPH1,Humans
16096,DB09130,Copper,"['approved', 'investigational']",BE0008962,Heterogeneous nuclear ribonucleoprotein H3,HNRNPH3,Humans
16098,DB09130,Copper,"['approved', 'investigational']",BE0008964,Heterogeneous nuclear ribonucleoprotein L,HNRNPL,Humans
16099,DB09130,Copper,"['approved', 'investigational']",BE0008965,"Splicing factor, proline- and glutamine-rich",SFPQ,Humans
16100,DB09130,Copper,"['approved', 'investigational']",BE0008966,Splicing factor 3A subunit 2,SF3A2,Humans
16102,DB09130,Copper,"['approved', 'investigational']",BE0008968,Alpha-actinin-1,ACTN1,Humans
16103,DB09130,Copper,"['approved', 'investigational']",BE0000481,Aminoacylase-1,ACY1,Humans
16104,DB09130,Copper,"['approved', 'investigational']",BE0008969,Annexin A4,ANXA4,Humans
16105,DB09130,Copper,"['approved', 'investigational']",BE0004149,Annexin A5,ANXA5,Humans
16106,DB09130,Copper,"['approved', 'investigational']",BE0002109,Calreticulin,CALR,Humans
16107,DB09130,Copper,"['approved', 'investigational']",BE0000088,Pyruvate kinase PKM,PKM,Humans
16108,DB09130,Copper,"['approved', 'investigational']",BE0004352,Alcohol dehydrogenase [NADP(+)],AKR1A1,Humans
16109,DB09130,Copper,"['approved', 'investigational']",BE0000160,NADH-cytochrome b5 reductase 3,CYB5R3,Humans
16110,DB09130,Copper,"['approved', 'investigational']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
16111,DB09130,Copper,"['approved', 'investigational']",BE0000039,Transketolase,TKT,Humans
16112,DB09130,Copper,"['approved', 'investigational']",BE0001972,Peroxiredoxin-2,PRDX2,Humans
16113,DB09130,Copper,"['approved', 'investigational']",BE0004641,Peroxiredoxin-6,PRDX6,Humans
16114,DB09130,Copper,"['approved', 'investigational']",BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
16115,DB09130,Copper,"['approved', 'investigational']",BE0003775,Heat shock cognate 71 kDa protein,HSPA8,Humans
16116,DB09130,Copper,"['approved', 'investigational']",BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
16117,DB09130,Copper,"['approved', 'investigational']",BE0002480,Prostaglandin E synthase 3,PTGES3,Humans
16118,DB09130,Copper,"['approved', 'investigational']",BE0008970,Stress-induced-phosphoprotein 1,STIP1,Humans
16120,DB09130,Copper,"['approved', 'investigational']",BE0008972,Eukaryotic translation initiation factor 6,EIF6,Humans
16121,DB09130,Copper,"['approved', 'investigational']",BE0008973,Eukaryotic initiation factor 4A-I,EIF4A1,Humans
16122,DB09130,Copper,"['approved', 'investigational']",BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
16123,DB09130,Copper,"['approved', 'investigational']",BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
16124,DB09130,Copper,"['approved', 'investigational']",BE0004454,Phosphoglycerate kinase 1,PGK1,Humans
16125,DB09130,Copper,"['approved', 'investigational']",BE0001425,Tubulin alpha-3C/D chain,TUBA3C,Humans
16126,DB09130,Copper,"['approved', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
16127,DB09130,Copper,"['approved', 'investigational']",BE0004174,Cofilin-1,CFL1,Humans
16128,DB09130,Copper,"['approved', 'investigational']",BE0008974,14-3-3 protein beta/alpha,YWHAB,Humans
16129,DB09130,Copper,"['approved', 'investigational']",BE0000529,"Aspartate aminotransferase, cytoplasmic",GOT1,Humans
16130,DB09130,Copper,"['approved', 'investigational']",BE0000185,Glutathione synthetase,GSS,Humans
16131,DB09130,Copper,"['approved', 'investigational']",BE0008975,Hepatoma-derived growth factor,HDGF,Humans
16132,DB09130,Copper,"['approved', 'investigational']",BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,Humans
16133,DB09130,Copper,"['approved', 'investigational']",BE0005284,Chloride intracellular channel protein 1,CLIC1,Humans
16134,DB09130,Copper,"['approved', 'investigational']",BE0008976,Proteasome activator complex subunit 1,PSME1,Humans
16135,DB09130,Copper,"['approved', 'investigational']",BE0001179,Phosphatidylethanolamine-binding protein 1,PEBP1,Humans
16136,DB09130,Copper,"['approved', 'investigational']",BE0008977,Phosphoglycerate mutase 1,PGAM1,Humans
16137,DB09130,Copper,"['approved', 'investigational']",BE0008978,Ran-specific GTPase-activating protein,RANBP1,Humans
16138,DB09130,Copper,"['approved', 'investigational']",BE0000645,UDP-glucose 6-dehydrogenase,UGDH,Humans
16139,DB09130,Copper,"['approved', 'investigational']",BE0003777,Beta-2-microglobulin,B2M,Humans
16140,DB09130,Copper,"['approved', 'investigational']",BE0005818,"Protein SCO1 homolog, mitochondrial",SCO1,Humans
16141,DB09130,Copper,"['approved', 'investigational']",BE0008989,Alternative prion protein,PRNP,Humans
16142,DB09130,Copper,"['approved', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
16143,DB09130,Copper,"['approved', 'investigational']",BE0008995,Huntingtin,HTT,Humans
16144,DB09130,Copper,"['approved', 'investigational']",BE0003175,Endonuclease 8-like 1,NEIL1,Humans
16145,DB09130,Copper,"['approved', 'investigational']",BE0005817,Endonuclease 8-like 2,NEIL2,Humans
16146,DB09130,Copper,"['approved', 'investigational']",BE0005816,Hephaestin-like protein 1,HEPHL1,Humans
16147,DB09130,Copper,"['approved', 'investigational']",BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
16148,DB09130,Copper,"['approved', 'investigational']",BE0003602,Protein S100-A2,S100A2,Humans
16149,DB09130,Copper,"['approved', 'investigational']",BE0004350,Protein S100-A4,S100A4,Humans
16150,DB09130,Copper,"['approved', 'investigational']",BE0000878,Alpha-synuclein,SNCA,Humans
16151,DB09130,Copper,"['approved', 'investigational']",BE0003394,Brain-derived neurotrophic factor,BDNF,Humans
16152,DB09130,Copper,"['approved', 'investigational']",BE0000992,Protein DJ-1,PARK7,Humans
16153,DB09130,Copper,"['approved', 'investigational']",BE0000921,Islet amyloid polypeptide,IAPP,Humans
16154,DB09130,Copper,"['approved', 'investigational']",BE0009046,Tachykinin-3,TAC3,Humans
16155,DB09130,Copper,"['approved', 'investigational']",BE0009047,Alpha-1B-glycoprotein,A1BG,Humans
16156,DB09130,Copper,"['approved', 'investigational']",BE0008979,Afamin,AFM,Humans
16157,DB09130,Copper,"['approved', 'investigational']",BE0001060,Angiotensinogen,AGT,Humans
16158,DB09130,Copper,"['approved', 'investigational']",BE0009048,Alpha-2-HS-glycoprotein,AHSG,Humans
16159,DB09130,Copper,"['approved', 'investigational']",BE0001213,Serum amyloid P-component,APCS,Humans
16160,DB09130,Copper,"['approved', 'investigational']",BE0003449,Apolipoprotein A-I,APOA1,Humans
16161,DB09130,Copper,"['approved', 'investigational']",BE0000922,Apolipoprotein A-II,APOA2,Humans
16162,DB09130,Copper,"['approved', 'investigational']",BE0009049,Apolipoprotein A-IV,APOA4,Humans
16163,DB09130,Copper,"['approved', 'investigational']",BE0005852,Apolipoprotein B receptor,APOBR,Humans
16164,DB09130,Copper,"['approved', 'investigational']",BE0008879,Apolipoprotein C-II,APOC2,Humans
16165,DB09130,Copper,"['approved', 'investigational']",BE0008880,Apolipoprotein C-III,APOC3,Humans
16166,DB09130,Copper,"['approved', 'investigational']",BE0005056,Apolipoprotein D,APOD,Humans
16167,DB09130,Copper,"['approved', 'investigational']",BE0001119,Apolipoprotein E,APOE,Humans
16168,DB09130,Copper,"['approved', 'investigational']",BE0002854,Beta-2-glycoprotein 1,APOH,Humans
16169,DB09130,Copper,"['approved', 'investigational']",BE0002857,Zinc-alpha-2-glycoprotein,AZGP1,Humans
16170,DB09130,Copper,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
16171,DB09130,Copper,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
16172,DB09130,Copper,"['approved', 'investigational']",BE0003455,Complement C3,C3,Humans
16173,DB09130,Copper,"['approved', 'investigational']",BE0004686,Complement C4-B,C4B,Humans
16174,DB09130,Copper,"['approved', 'investigational']",BE0009050,C4b-binding protein alpha chain,C4BPA,Humans
16175,DB09130,Copper,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
16176,DB09130,Copper,"['approved', 'investigational']",BE0009051,Complement component C8 beta chain,C8B,Humans
16177,DB09130,Copper,"['approved', 'investigational']",BE0009052,Complement component C9,C9,Humans
16178,DB09130,Copper,"['approved', 'investigational']",BE0009053,Complement factor H,CFH,Humans
16179,DB09130,Copper,"['approved', 'investigational']",BE0009054,Complement factor I,CFI,Humans
16180,DB09130,Copper,"['approved', 'investigational']",BE0002104,Tetranectin,CLEC3B,Humans
16181,DB09130,Copper,"['approved', 'investigational']",BE0009055,Clusterin,CLU,Humans
16182,DB09130,Copper,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
16183,DB09130,Copper,"['approved', 'investigational']",BE0004930,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,Humans
16184,DB09130,Copper,"['approved', 'investigational']",BE0004161,Gelsolin,GSN,Humans
16185,DB09130,Copper,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
16186,DB09130,Copper,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
16187,DB09130,Copper,"['approved', 'investigational']",BE0009056,Chromobox protein homolog 5,CBX5,Humans
16188,DB09130,Copper,"['approved', 'investigational']",BE0009057,Haptoglobin-related protein,HPR,Humans
16189,DB09130,Copper,"['approved', 'investigational']",BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,Humans
16190,DB09130,Copper,"['approved', 'investigational']",BE0002815,Ig gamma-1 chain C region,IGHG1,Humans
16191,DB09130,Copper,"['approved', 'investigational']",BE0005089,Ig gamma-4 chain C region,IGHG4,Humans
16193,DB09130,Copper,"['approved', 'investigational']",BE0009059,Immunoglobulin lambda-like polypeptide 1,IGLL1,Humans
16194,DB09130,Copper,"['approved', 'investigational']",BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,Humans
16195,DB09130,Copper,"['approved', 'investigational']",BE0001017,Kininogen-1,KNG1,Humans
16196,DB09130,Copper,"['approved', 'investigational']",BE0009061,"Keratin, type II cytoskeletal 1",KRT1,Humans
16197,DB09130,Copper,"['approved', 'investigational']",BE0009062,"Keratin, type I cytoskeletal 10",KRT10,Humans
16198,DB09130,Copper,"['approved', 'investigational']",BE0009063,"Keratin, type II cytoskeletal 2 epidermal",KRT2,Humans
16199,DB09130,Copper,"['approved', 'investigational']",BE0009064,"Keratin, type I cytoskeletal 9",KRT9,Humans
16200,DB09130,Copper,"['approved', 'investigational']",BE0009065,Leucine-rich alpha-2-glycoprotein,LRG1,Humans
16201,DB09130,Copper,"['approved', 'investigational']",BE0009066,Lumican,LUM,Humans
16202,DB09130,Copper,"['approved', 'investigational']",BE0004613,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,Humans
16203,DB09130,Copper,"['approved', 'investigational']",BE0000211,Plasminogen,PLG,Humans
16204,DB09130,Copper,"['approved', 'investigational']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
16205,DB09130,Copper,"['approved', 'investigational']",BE0000946,Platelet basic protein,PPBP,Humans
16206,DB09130,Copper,"['approved', 'investigational']",BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
16207,DB09130,Copper,"['approved', 'investigational']",BE0009067,Kallistatin,SERPINA4,Humans
16208,DB09130,Copper,"['approved', 'investigational']",BE0000209,Corticosteroid-binding globulin,SERPINA6,Humans
16209,DB09130,Copper,"['approved', 'investigational']",BE0000537,Thyroxine-binding globulin,SERPINA7,Humans
16210,DB09130,Copper,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
16211,DB09130,Copper,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
16212,DB09130,Copper,"['approved', 'investigational']",BE0009068,Pigment epithelium-derived factor,SERPINF1,Humans
16213,DB09130,Copper,"['approved', 'investigational']",BE0001125,Alpha-2-antiplasmin,SERPINF2,Humans
16214,DB09130,Copper,"['approved', 'investigational']",BE0002458,Plasma protease C1 inhibitor,SERPING1,Humans
16215,DB09130,Copper,"['approved', 'investigational']",BE0000337,Transthyretin,TTR,Humans
16216,DB09130,Copper,"['approved', 'investigational']",BE0001068,Vitronectin,VTN,Humans
16217,DB09130,Copper,"['approved', 'investigational']",BE0009092,Amyloid-like protein 1,APLP1,Humans
16218,DB09131,Cupric Chloride,"['approved', 'investigational']",BE0000380,Vitamin K-dependent protein C,PROC,Humans
16219,DB09131,Cupric Chloride,"['approved', 'investigational']",BE0008992,Cystatin-B,CSTB,Humans
16220,DB09140,Oxygen,"['approved', 'vet_approved']",BE0000335,Cytochrome c oxidase subunit 1,MT-CO1,Humans
16221,DB09140,Oxygen,"['approved', 'vet_approved']",BE0005803,NADPH oxidase 1,NOX1,Humans
16222,DB09141,Protamine sulfate,['approved'],BE0000216,Coagulation factor X,F10,Humans
16223,DB09141,Protamine sulfate,['approved'],BE0000280,Antithrombin-III,SERPINC1,Humans
16224,DB09143,Sonidegib,"['approved', 'investigational']",BE0004659,Smoothened homolog,SMO,Humans
16225,DB09147,Ferric pyrophosphate,['experimental'],BE0000085,Ferritin light chain,FTL,Humans
16226,DB09147,Ferric pyrophosphate,['experimental'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
16227,DB09147,Ferric pyrophosphate,['experimental'],BE0000629,Hemoglobin subunit beta,HBB,Humans
16228,DB09148,Florbetaben (18F),['approved'],BE0003392,Amyloid beta A4 protein,APP,Humans
16229,DB09149,Florbetapir (18F),"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
16230,DB09151,Flutemetamol (18F),"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
16233,DB09166,Etizolam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
16234,DB09166,Etizolam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
16235,DB09166,Etizolam,['experimental'],BE0005561,Platelet-activating factor receptor,PTAFR,Humans
16236,DB09167,Dosulepin,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
16237,DB09167,Dosulepin,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16238,DB09167,Dosulepin,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16239,DB09167,Dosulepin,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16240,DB09167,Dosulepin,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16241,DB09167,Dosulepin,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16242,DB09167,Dosulepin,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
16243,DB09167,Dosulepin,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
16244,DB09167,Dosulepin,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16245,DB09167,Dosulepin,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16246,DB09167,Dosulepin,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
16247,DB09167,Dosulepin,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
16248,DB09173,Butyrfentanyl,['illicit'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
16249,DB09173,Butyrfentanyl,['illicit'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
16250,DB09173,Butyrfentanyl,['illicit'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
16252,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
16253,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
16254,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
16255,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
16256,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
16257,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000442,Histamine H1 receptor,HRH1,Humans
16258,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000112,Histamine H2 receptor,HRH2,Humans
16259,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16260,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16261,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16262,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
16263,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
16264,DB09185,Viloxazine,"['approved', 'investigational', 'withdrawn']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
16265,DB09186,Nisoxetine,['experimental'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
16266,DB09194,Etoperidone,['withdrawn'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16267,DB09194,Etoperidone,['withdrawn'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
16268,DB09194,Etoperidone,['withdrawn'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16269,DB09194,Etoperidone,['withdrawn'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16270,DB09194,Etoperidone,['withdrawn'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16271,DB09194,Etoperidone,['withdrawn'],BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
16272,DB09195,Lorpiprazole,['approved'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16273,DB09195,Lorpiprazole,['approved'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
16274,DB09195,Lorpiprazole,['approved'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16275,DB09195,Lorpiprazole,['approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16276,DB09195,Lorpiprazole,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16277,DB09195,Lorpiprazole,['approved'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
16278,DB09198,Lobeglitazone,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
16279,DB09201,Ciglitazone,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
16280,DB09202,Cirazoline,['experimental'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
16281,DB09202,Cirazoline,['experimental'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
16282,DB09202,Cirazoline,['experimental'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
16283,DB09202,Cirazoline,['experimental'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16284,DB09203,Synephrine,['experimental'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16285,DB09204,Arotinolol,['investigational'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
16286,DB09204,Arotinolol,['investigational'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
16287,DB09204,Arotinolol,['investigational'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16288,DB09205,Moxisylyte,"['approved', 'investigational']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
16289,DB09207,AS-8112,['experimental'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16290,DB09207,AS-8112,['experimental'],BE0000581,Dopamine D3 receptor,DRD3,Humans
16293,DB09209,Pholcodine,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
16294,DB09209,Pholcodine,"['approved', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
16295,DB09209,Pholcodine,"['approved', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
16296,DB09211,Limaprost,['investigational'],BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
16297,DB09211,Limaprost,['investigational'],BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
16298,DB09211,Limaprost,['investigational'],BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
16299,DB09211,Limaprost,['investigational'],BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
16300,DB09212,Loxoprofen,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16301,DB09212,Loxoprofen,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16302,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16303,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16304,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
16305,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0001151,Thrombomodulin,THBD,Humans
16306,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0001088,Tissue-type plasminogen activator,PLAT,Humans
16307,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0003591,"Fatty acid-binding protein, intestinal",FABP2,Humans
16308,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
16309,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
16310,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0001018,Solute carrier family 15 member 1,SLC15A1,Humans
16311,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
16312,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0001025,Platelet glycoprotein Ib alpha chain,GP1BA,Humans
16313,DB09213,Dexibuprofen,"['approved', 'investigational']",BE0003756,Protein S100-A7,S100A7,Humans
16314,DB09214,Dexketoprofen,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16315,DB09214,Dexketoprofen,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16316,DB09215,Droxicam,['withdrawn'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16317,DB09215,Droxicam,['withdrawn'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16318,DB09216,Tolfenamic acid,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16319,DB09216,Tolfenamic acid,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16320,DB09217,Firocoxib,"['experimental', 'vet_approved']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16321,DB09220,Nicorandil,"['approved', 'investigational']",BE0000469,ATP-binding cassette sub-family C member 9,ABCC9,Humans
16322,DB09221,Polaprezinc,['experimental'],BE0000704,Tumor necrosis factor,TNF,Humans
16323,DB09221,Polaprezinc,['experimental'],BE0000918,Interleukin-6,IL6,Humans
16324,DB09221,Polaprezinc,['experimental'],BE0000125,Interleukin-3,IL3,Humans
16325,DB09221,Polaprezinc,['experimental'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
16326,DB09221,Polaprezinc,['experimental'],BE0001094,Beta-nerve growth factor,NGF,Humans
16327,DB09221,Polaprezinc,['experimental'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
16328,DB09221,Polaprezinc,['experimental'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
16329,DB09221,Polaprezinc,['experimental'],BE0001898,Heat shock protein HSP 90-beta,HSP90AB1,Humans
16330,DB09223,Blonanserin,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16331,DB09223,Blonanserin,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
16332,DB09223,Blonanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16333,DB09224,Melperone,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16334,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0004889,D(1) dopamine receptor,DRD1,Humans
16335,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000756,Dopamine D2 receptor,DRD2,Humans
16336,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16337,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
16338,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
16339,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
16340,DB09225,Zotepine,"['approved', 'investigational', 'withdrawn']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
16341,DB09227,Barnidipine,['experimental'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
16342,DB09227,Barnidipine,['experimental'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
16343,DB09227,Barnidipine,['experimental'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
16344,DB09228,Conestat alfa,"['approved', 'investigational']",BE0002093,Complement C1r subcomponent,C1R,Humans
16345,DB09228,Conestat alfa,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
16346,DB09228,Conestat alfa,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
16347,DB09228,Conestat alfa,"['approved', 'investigational']",BE0004672,Coagulation factor XII,F12,Humans
16348,DB09228,Conestat alfa,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
16349,DB09228,Conestat alfa,"['approved', 'investigational']",BE0001021,Coagulation factor XI,F11,Humans
16350,DB09228,Conestat alfa,"['approved', 'investigational']",BE0001088,Tissue-type plasminogen activator,PLAT,Humans
16351,DB09229,Aranidipine,['experimental'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
16352,DB09229,Aranidipine,['experimental'],BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
16353,DB09229,Aranidipine,['experimental'],BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,Humans
16354,DB09229,Aranidipine,['experimental'],BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,Humans
16355,DB09229,Aranidipine,['experimental'],BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
16356,DB09229,Aranidipine,['experimental'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
16357,DB09230,Azelnidipine,['investigational'],BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,Humans
16358,DB09231,Benidipine,['experimental'],BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
16359,DB09231,Benidipine,['experimental'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
16360,DB09231,Benidipine,['experimental'],BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
16361,DB09232,Cilnidipine,['investigational'],BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,Humans
16362,DB09232,Cilnidipine,['investigational'],BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
16363,DB09235,Efonidipine,['experimental'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
16364,DB09235,Efonidipine,['experimental'],BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
16365,DB09235,Efonidipine,['experimental'],BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
16366,DB09235,Efonidipine,['experimental'],BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
16367,DB09235,Efonidipine,['experimental'],BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
16368,DB09235,Efonidipine,['experimental'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
16369,DB09235,Efonidipine,['experimental'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
16370,DB09236,Lacidipine,"['approved', 'investigational']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
16371,DB09237,Levamlodipine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
16372,DB09237,Levamlodipine,"['approved', 'investigational']",BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,Humans
16373,DB09237,Levamlodipine,"['approved', 'investigational']",BE0000263,"Nitric oxide synthase, endothelial",NOS3,Humans
16374,DB09237,Levamlodipine,"['approved', 'investigational']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
16375,DB09238,Manidipine,"['approved', 'investigational']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
16376,DB09238,Manidipine,"['approved', 'investigational']",BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
16377,DB09238,Manidipine,"['approved', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
16378,DB09238,Manidipine,"['approved', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
16379,DB09238,Manidipine,"['approved', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
16380,DB09239,Niguldipine,['experimental'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
16381,DB09241,Methylene blue,"['approved', 'investigational']",BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
16382,DB09241,Methylene blue,"['approved', 'investigational']",BE0000067,"Nitric oxide synthase, brain",NOS1,Humans
16383,DB09242,Moxonidine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
16384,DB09242,Moxonidine,"['approved', 'investigational']",BE0003580,Nischarin,NISCH,Humans
16385,DB09244,Pirlindole,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
16386,DB09244,Pirlindole,['experimental'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
16387,DB09244,Pirlindole,['experimental'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
16388,DB09245,Toloxatone,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
16389,DB09256,Tegafur,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
16390,DB09257,Gimeracil,['approved'],BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
16391,DB09258,Bemiparin,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
16392,DB09258,Bemiparin,"['approved', 'investigational']",BE0000280,Antithrombin-III,SERPINC1,Humans
16393,DB09258,Bemiparin,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
16394,DB09262,Imidafenacin,['investigational'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16395,DB09262,Imidafenacin,['investigational'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16396,DB09262,Imidafenacin,['investigational'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16398,DB09265,Lixisenatide,['approved'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
16399,DB09266,Technetium Tc-99m tilmanocept,"['approved', 'investigational']",BE0009334,Macrophage mannose receptor 1,MRC1,Humans
16400,DB09270,Ubidecarenone,"['approved', 'investigational', 'nutraceutical']",BE0000027,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NDUFV3,Humans
16401,DB09270,Ubidecarenone,"['approved', 'investigational', 'nutraceutical']",BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,Humans
16402,DB09272,Eluxadoline,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
16403,DB09272,Eluxadoline,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
16404,DB09272,Eluxadoline,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
16405,DB09273,Doxofylline,['experimental'],BE0003393,"Phosphodiesterase 2A, cGMP-stimulated",PDE2A,Humans
16406,DB09273,Doxofylline,['experimental'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
16407,DB09273,Doxofylline,['experimental'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
16410,DB09279,Fimasartan,['investigational'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
16411,DB09280,Lumacaftor,['approved'],BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
16412,DB09282,Molsidomine,"['approved', 'investigational']",BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
16413,DB09283,Trapidil,['experimental'],BE0004922,Cyclic nucleotide phosphodiesterase,PDE1A,Humans
16414,DB09283,Trapidil,['experimental'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
16415,DB09285,Morniflumate,['experimental'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
16416,DB09285,Morniflumate,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16417,DB09285,Morniflumate,['experimental'],BE0003490,Leukotriene B4 receptor 1,LTB4R,Humans
16418,DB09285,Morniflumate,['experimental'],BE0000759,Thromboxane A2 receptor,TBXA2R,Humans
16419,DB09286,Pipamperone,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16420,DB09286,Pipamperone,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
16421,DB09286,Pipamperone,['investigational'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
16422,DB09286,Pipamperone,['investigational'],BE0000389,Dopamine D4 receptor,DRD4,Humans
16423,DB09286,Pipamperone,['investigational'],BE0000020,Dopamine D1 receptor,DRD1,Humans
16424,DB09286,Pipamperone,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
16425,DB09286,Pipamperone,['investigational'],BE0000393,5-hydroxytryptamine receptor 2B,HTR2B,Humans
16426,DB09286,Pipamperone,['investigational'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
16427,DB09288,Propacetamol,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16428,DB09288,Propacetamol,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16429,DB09288,Propacetamol,['experimental'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
16430,DB09288,Propacetamol,['experimental'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
16431,DB09289,Tianeptine,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
16432,DB09289,Tianeptine,['investigational'],BE0000640,Glutamate receptor 1,GRIA1,Humans
16433,DB09289,Tianeptine,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
16434,DB09289,Tianeptine,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
16435,DB09290,Ramosetron,['investigational'],BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
16436,DB09291,Rolapitant,"['approved', 'investigational']",BE0000384,Neurokinin 1 receptor,TACR1,Humans
16437,DB09292,Sacubitril,['approved'],BE0000266,Neprilysin,MME,Humans
16438,DB09295,Talniflumate,['experimental'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16439,DB09295,Talniflumate,['experimental'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16440,DB09295,Talniflumate,['experimental'],BE0002376,Chloride channel protein ClC-Ka,CLCNKA,Humans
16446,DB09300,Butylscopolamine,"['approved', 'investigational', 'vet_approved']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16447,DB09300,Butylscopolamine,"['approved', 'investigational', 'vet_approved']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16448,DB09301,Chondroitin sulfate,"['approved', 'investigational', 'nutraceutical']",BE0003394,Brain-derived neurotrophic factor,BDNF,Humans
16449,DB09301,Chondroitin sulfate,"['approved', 'investigational', 'nutraceutical']",BE0002486,Glial cell line-derived neurotrophic factor,GDNF,Humans
16450,DB09301,Chondroitin sulfate,"['approved', 'investigational', 'nutraceutical']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
16451,DB09301,Chondroitin sulfate,"['approved', 'investigational', 'nutraceutical']",BE0001047,C-C motif chemokine 2,CCL2,Humans
16452,DB09302,Alirocumab,['approved'],BE0008643,Proprotein convertase subtilisin/kexin type 9,PCSK9,Humans
16453,DB09303,Evolocumab,['approved'],BE0008643,Proprotein convertase subtilisin/kexin type 9,PCSK9,Humans
16454,DB09304,Setiptiline,['experimental'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16455,DB09304,Setiptiline,['experimental'],BE0004862,Serotonin Receptors,HTR1A,Humans
16456,DB09310,Catridecacog,['approved'],BE0009075,Coagulation factor XIII B chain,F13B,Humans
16457,DB09317,"Synthetic Conjugated Estrogens, A",['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16458,DB09318,"Synthetic Conjugated Estrogens, B",['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16462,DB09327,Tegafur-uracil,"['approved', 'investigational']",BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,Humans
16463,DB09327,Tegafur-uracil,"['approved', 'investigational']",BE0000324,Thymidylate synthase,TYMS,Humans
16466,DB09329,"Antihemophilic factor (recombinant), PEGylated","['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
16467,DB09330,Osimertinib,['approved'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
16468,DB09331,Daratumumab,['approved'],BE0005459,ADP-ribosyl cyclase 1,CD38,Humans
16469,DB09332,Kappadione,['approved'],BE0000048,Prothrombin,F2,Humans
16470,DB09332,Kappadione,['approved'],BE0000333,Coagulation factor VII,F7,Humans
16471,DB09332,Kappadione,['approved'],BE0000364,Coagulation factor IX,F9,Humans
16472,DB09332,Kappadione,['approved'],BE0000216,Coagulation factor X,F10,Humans
16473,DB09332,Kappadione,['approved'],BE0000380,Vitamin K-dependent protein C,PROC,Humans
16474,DB09332,Kappadione,['approved'],BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
16475,DB09332,Kappadione,['approved'],BE0000943,Vitamin K-dependent protein S,PROS1,Humans
16476,DB09333,Iopodic acid,"['approved', 'investigational', 'withdrawn']",BE0009333,Thyroxine 5-deiodinase,DIO3,Humans
16477,DB09334,Seractide acetate,['approved'],BE0000848,Adrenocorticotropic hormone receptor,MC2R,Humans
16478,DB09336,Technetium Tc-99m nofetumomab merpentan,"['approved', 'withdrawn']",BE0002446,Epithelial cell adhesion molecule,EPCAM,Humans
16479,DB09336,Technetium Tc-99m nofetumomab merpentan,"['approved', 'withdrawn']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
16480,DB09338,Mersalyl,['experimental'],BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",ALPL,Humans
16481,DB09338,Mersalyl,['experimental'],BE0000880,Aquaporin-1,AQP1,Humans
16482,DB09338,Mersalyl,['experimental'],BE0000669,Monocarboxylate transporter 1,SLC16A1,Humans
16483,DB09342,Propoxycaine,['approved'],BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
16484,DB09343,Tipiracil,"['approved', 'investigational']",BE0002193,Thymidine phosphorylase,TYMP,Humans
16485,DB09345,Pramocaine,['approved'],BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
16487,DB09351,Levobetaxolol,"['approved', 'investigational']",BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
16488,DB09363,Rauwolfia serpentina root,['investigational'],BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
16489,DB09369,Polyestradiol phosphate,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16490,DB09371,Norethynodrel,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16491,DB09371,Norethynodrel,['approved'],BE0000132,Androgen receptor,AR,Humans
16492,DB09371,Norethynodrel,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
16493,DB09389,Norgestrel,['approved'],BE0000557,Progesterone receptor,PGR,Humans
16494,DB09389,Norgestrel,['approved'],BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,Humans
16495,DB09389,Norgestrel,['approved'],BE0000132,Androgen receptor,AR,Humans
16497,DB09409,Magnesium acetate tetrahydrate,['approved'],BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
16498,DB09418,Potassium perchlorate,"['approved', 'investigational']",BE0009346,Sodium/iodide cotransporter,SLC5A5,Humans
16499,DB09421,Protirelin,"['approved', 'investigational']",BE0008659,Thyrotropin Releasing Hormone Receptor,TRHR,Humans
16500,DB09422,Soybean oil,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
16501,DB09456,Insulin beef,['approved'],BE0000033,Insulin receptor,INSR,Humans
16502,DB09456,Insulin beef,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16503,DB09460,Sodium carbonate,['approved'],BE0000267,Carbonic anhydrase 1,CA1,Humans
16504,DB09460,Sodium carbonate,['approved'],BE0000322,Carbonic anhydrase 2,CA2,Humans
16505,DB09460,Sodium carbonate,['approved'],BE0000535,Carbonic anhydrase 4,CA4,Humans
16506,DB09460,Sodium carbonate,['approved'],BE0002437,Carbonic anhydrase 9,CA9,Humans
16507,DB09462,Glycerin,"['approved', 'investigational']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
16508,DB09462,Glycerin,"['approved', 'investigational']",BE0003768,Group IIE secretory phospholipase A2,PLA2G2E,Humans
16509,DB09462,Glycerin,"['approved', 'investigational']",BE0004496,Inositol-3-phosphate synthase 1,ISYNA1,Humans
16510,DB09462,Glycerin,"['approved', 'investigational']",BE0000400,Alcohol dehydrogenase 1B,ADH1B,Humans
16511,DB09462,Glycerin,"['approved', 'investigational']",BE0004522,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,Humans
16512,DB09462,Glycerin,"['approved', 'investigational']",BE0003957,Glycodelin,PAEP,Humans
16513,DB09462,Glycerin,"['approved', 'investigational']",BE0004619,Alpha-N-acetylgalactosaminidase,NAGA,Humans
16514,DB09462,Glycerin,"['approved', 'investigational']",BE0003814,ADP-ribosylation factor 1,ARF1,Humans
16515,DB09462,Glycerin,"['approved', 'investigational']",BE0003094,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,Humans
16519,DB09462,Glycerin,"['approved', 'investigational']",BE0002517,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,Humans
16520,DB09462,Glycerin,"['approved', 'investigational']",BE0000819,Maleylacetoacetate isomerase,GSTZ1,Humans
16521,DB09472,Sodium sulfate,"['approved', 'vet_approved']",BE0000322,Carbonic anhydrase 2,CA2,Humans
16522,DB09472,Sodium sulfate,"['approved', 'vet_approved']",BE0000267,Carbonic anhydrase 1,CA1,Humans
16523,DB09477,Enalaprilat,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
16524,DB09477,Enalaprilat,['approved'],BE0005831,B1 bradykinin receptor,BDKRB1,Humans
16525,DB09481,Magnesium carbonate,"['approved', 'investigational']",BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
16526,DB09488,Acrivastine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16529,DB09517,Sodium ferric gluconate complex,['approved'],BE0000085,Ferritin light chain,FTL,Humans
16530,DB09517,Sodium ferric gluconate complex,['approved'],BE0000629,Hemoglobin subunit beta,HBB,Humans
16531,DB09517,Sodium ferric gluconate complex,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
16532,DB09526,Hydroquinone,"['approved', 'investigational']",BE0000252,Tyrosinase,TYR,Humans
16533,DB09526,Hydroquinone,"['approved', 'investigational']",BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
16534,DB09532,Secretin human,['approved'],BE0000318,Secretin receptor,SCTR,Humans
16535,DB09535,Octocrylene,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
16536,DB09535,Octocrylene,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
16537,DB09536,Titanium dioxide,['approved'],BE0009001,Macrophage receptor MARCO,MARCO,Humans
16538,DB09539,Omega-3-acid ethyl esters,"['approved', 'investigational']",BE0005540,Sterol regulatory element-binding protein 1,SREBF1,Humans
16539,DB09552,Thonzonium,['approved'],BE0004525,V-type proton ATPase subunit C 1,ATP6V1C1,Humans
16540,DB09555,Dexchlorpheniramine maleate,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16541,DB09559,Necitumumab,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
16542,DB09564,Insulin degludec,['approved'],BE0000033,Insulin receptor,INSR,Humans
16543,DB09564,Insulin degludec,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16544,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0008719,Diacylglycerol O-acyltransferase 2,DGAT2,Humans
16545,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0000317,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,Humans
16546,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0004500,"Enoyl-CoA hydratase, mitochondrial",ECHS1,Humans
16547,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0000377,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,Humans
16548,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0002247,Elongation of very long chain fatty acids protein 4,ELOVL4,Humans
16549,DB09568,Omega-3-carboxylic acids,"['approved', 'investigational']",BE0000239,Lipoprotein lipase,LPL,Humans
16550,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
16551,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000918,Interleukin-6,IL6,Humans
16552,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000565,Interleukin-1 receptor type 1,IL1R1,Humans
16553,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0001861,TGF-beta receptor type-2,TGFBR2,Humans
16554,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
16555,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000944,Interferon gamma,IFNG,Humans
16556,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
16557,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
16558,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
16559,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000984,Transforming growth factor beta-1,TGFB1,Humans
16560,DB10770,Foreskin fibroblast (neonatal),['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
16561,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000689,Fibroblast growth factor 1,FGF1,Humans
16562,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
16563,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
16564,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0001051,Interleukin-1 beta,IL1B,Humans
16565,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000918,Interleukin-6,IL6,Humans
16566,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000944,Interferon gamma,IFNG,Humans
16567,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
16568,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0001861,TGF-beta receptor type-2,TGFBR2,Humans
16569,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000984,Transforming growth factor beta-1,TGFB1,Humans
16570,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000704,Tumor necrosis factor,TNF,Humans
16571,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
16572,DB10772,Foreskin keratinocyte (neonatal),['approved'],BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
16574,DB11059,Carboxymethylcellulose,"['approved', 'investigational']",BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,Humans
16575,DB11064,Homosalate,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
16576,DB11064,Homosalate,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
16577,DB11064,Homosalate,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
16580,DB11071,Phenyl salicylate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16581,DB11071,Phenyl salicylate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16582,DB11075,Hypromellose,['approved'],BE0002446,Epithelial cell adhesion molecule,EPCAM,Humans
16583,DB11077,Polyethylene glycol 400,['approved'],BE0000457,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,Humans
16584,DB11077,Polyethylene glycol 400,['approved'],BE0002476,Oxidoreductase HTATIP2,HTATIP2,Humans
16585,DB11079,Trolamine salicylate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16586,DB11079,Trolamine salicylate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16587,DB11081,Aluminum chloride,"['approved', 'investigational']",BE0000180,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,Humans
16588,DB11085,Resorcinol,['approved'],BE0000507,Thyroid peroxidase,TPO,Humans
16589,DB11087,Pyrethrum extract,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
16590,DB11090,Potassium nitrate,['approved'],BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
16591,DB11093,Calcium citrate,"['approved', 'investigational']",BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
16592,DB11093,Calcium citrate,"['approved', 'investigational']",BE0002109,Calreticulin,CALR,Humans
16593,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008691,Calcium and integrin-binding protein 1,CIB1,Humans
16594,DB11093,Calcium citrate,"['approved', 'investigational']",BE0005812,Programmed cell death protein 6,PDCD6,Humans
16595,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008692,Sorcin,SRI,Humans
16596,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008693,Calcineurin B homologous protein 1,CHP1,Humans
16597,DB11093,Calcium citrate,"['approved', 'investigational']",BE0002145,SPARC,SPARC,Humans
16598,DB11093,Calcium citrate,"['approved', 'investigational']",BE0001011,Calnexin,CANX,Humans
16599,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008694,Fibrillin-2,FBN2,Humans
16600,DB11093,Calcium citrate,"['approved', 'investigational']",BE0001177,Protein S100-B,S100B,Humans
16601,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008695,Calsequestrin-2,CASQ2,Humans
16602,DB11093,Calcium citrate,"['approved', 'investigational']",BE0005259,Regucalcin,RGN,Humans
16603,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008696,Peflin,PEF1,Humans
16604,DB11093,Calcium citrate,"['approved', 'investigational']",BE0002950,Protein S100-A6,S100A6,Humans
16605,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008697,Translationally-controlled tumor protein,TPT1,Humans
16606,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008698,Calcium and integrin-binding family member 2,CIB2,Humans
16607,DB11093,Calcium citrate,"['approved', 'investigational']",BE0000885,Protein S100-A13,S100A13,Humans
16608,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008699,Calsequestrin-1,CASQ1,Humans
16609,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008700,Nucleobindin-1,NUCB1,Humans
16610,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008701,Nucleobindin-2,NUCB2,Humans
16611,DB11093,Calcium citrate,"['approved', 'investigational']",BE0000418,Calmodulin,CALM1,Humans
16612,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008702,Fibrillin-3,FBN3,Humans
16613,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008703,Grancalcin,GCA,Humans
16614,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008704,Calcium-dependent secretion activator 1,CADPS,Humans
16615,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008705,Calmodulin-2,CALM2,Humans
16616,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008706,Calmodulin-3,CALM3,Humans
16617,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008707,Protein S100-A16,S100A16,Humans
16618,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008708,Calretinin,CALB2,Humans
16619,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008709,Calcyphosin,CAPS,Humans
16620,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008710,Calcium-dependent secretion activator 2,CADPS2,Humans
16621,DB11093,Calcium citrate,"['approved', 'investigational']",BE0008711,Calreticulin-3,CALR3,Humans
16622,DB11093,Calcium citrate,"['approved', 'investigational']",BE0005274,Neurexin-1,NRXN1,Humans
16623,DB11093,Calcium citrate,"['approved', 'investigational']",BE0004557,Neuronal calcium sensor 1,NCS1,Humans
16624,DB11094,Vitamin D,"['approved', 'nutraceutical', 'vet_approved']",BE0000779,Vitamin D3 receptor,VDR,Humans
16625,DB11094,Vitamin D,"['approved', 'nutraceutical', 'vet_approved']",BE0001141,Vitamin D-binding protein,GC,Humans
16627,DB11113,Castor oil,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0002375,Prostaglandin E2 receptor EP3 subtype,PTGER3,Humans
16628,DB11113,Castor oil,"['approved', 'investigational', 'nutraceutical', 'vet_approved']",BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
16629,DB11120,Turpentine,"['approved', 'experimental']",BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
16630,DB11124,Racepinephrine,['approved'],BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
16631,DB11124,Racepinephrine,['approved'],BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
16632,DB11124,Racepinephrine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
16633,DB11124,Racepinephrine,['approved'],BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
16634,DB11124,Racepinephrine,['approved'],BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
16635,DB11124,Racepinephrine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
16636,DB11124,Racepinephrine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
16637,DB11124,Racepinephrine,['approved'],BE0000715,Alpha-1D adrenergic receptor,ADRA1D,Humans
16638,DB11124,Racepinephrine,['approved'],BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
16639,DB11130,Opium,"['approved', 'illicit']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
16640,DB11130,Opium,"['approved', 'illicit']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
16641,DB11130,Opium,"['approved', 'illicit']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
16642,DB11131,Capsicum oleoresin,['approved'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
16643,DB11132,Silicon dioxide,['approved'],BE0009001,Macrophage receptor MARCO,MARCO,Humans
16644,DB11133,Omega-3 fatty acids,"['approved', 'nutraceutical']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
16645,DB11133,Omega-3 fatty acids,"['approved', 'nutraceutical']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
16646,DB11133,Omega-3 fatty acids,"['approved', 'nutraceutical']",BE0005540,Sterol regulatory element-binding protein 1,SREBF1,Humans
16647,DB11136,Chromium,['approved'],BE0001173,Cytochrome b5,CYB5A,Humans
16648,DB11148,Butamben,"['approved', 'withdrawn']",BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
16649,DB11148,Butamben,"['approved', 'withdrawn']",BE0004905,ATP-sensitive potassium channel,KCNJ1,Humans
16650,DB11148,Butamben,"['approved', 'withdrawn']",BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
16651,DB11148,Butamben,"['approved', 'withdrawn']",BE0009159,Transient receptor potential cation channel subfamily V member 4,TRPV4,Humans
16653,DB11156,Pyrantel,"['approved', 'vet_approved']",BE0005562,G-protein coupled receptor 35,GPR35,Humans
16654,DB11156,Pyrantel,"['approved', 'vet_approved']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16655,DB11157,Anthralin,['approved'],BE0009063,"Keratin, type II cytoskeletal 2 epidermal",KRT2,Humans
16656,DB11157,Anthralin,['approved'],BE0004660,"Keratin, type I cytoskeletal 12",KRT12,Humans
16657,DB11157,Anthralin,['approved'],BE0003789,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,Humans
16659,DB11166,Antithrombin Alfa,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
16660,DB11166,Antithrombin Alfa,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
16661,DB11181,Homatropine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16662,DB11181,Homatropine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16663,DB11181,Homatropine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16664,DB11181,Homatropine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
16665,DB11181,Homatropine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
16667,DB11186,Pentoxyverine,"['approved', 'investigational', 'withdrawn']",BE0000156,Sigma non-opioid intracellular receptor 1,SIGMAR1,Humans
16668,DB11186,Pentoxyverine,"['approved', 'investigational', 'withdrawn']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
16669,DB11186,Pentoxyverine,"['approved', 'investigational', 'withdrawn']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
16670,DB11186,Pentoxyverine,"['approved', 'investigational', 'withdrawn']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
16671,DB11186,Pentoxyverine,"['approved', 'investigational', 'withdrawn']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
16672,DB11193,Papain,['approved'],BE0002442,Toll-like receptor 4,TLR4,Humans
16679,DB11201,Menthyl salicylate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16680,DB11201,Menthyl salicylate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16681,DB11217,Arbutin,['approved'],BE0000252,Tyrosinase,TYR,Humans
16682,DB11219,Enzacamene,['approved'],BE0000557,Progesterone receptor,PGR,Humans
16683,DB11219,Enzacamene,['approved'],BE0000132,Androgen receptor,AR,Humans
16684,DB11219,Enzacamene,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
16685,DB11219,Enzacamene,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16686,DB11221,Dioxybenzone,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
16687,DB11235,Thonzylamine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16688,DB11235,Thonzylamine,['approved'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
16689,DB11235,Thonzylamine,['approved'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
16690,DB11235,Thonzylamine,['approved'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
16691,DB11235,Thonzylamine,['approved'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
16692,DB11235,Thonzylamine,['approved'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
16694,DB11254,Hexylresorcinol,['approved'],BE0000971,DNA topoisomerase 1,TOP1,Humans
16695,DB11254,Hexylresorcinol,['approved'],BE0001035,Protein-glutamine gamma-glutamyltransferase 2,TGM2,Humans
16696,DB11254,Hexylresorcinol,['approved'],BE0000252,Tyrosinase,TYR,Humans
16697,DB11263,Polydatin,['approved'],BE0000088,Pyruvate kinase PKM,PKM,Humans
16698,DB11273,Dihydroergocornine,['approved'],BE0004862,Serotonin Receptors,HTR1A,Humans
16699,DB11273,Dihydroergocornine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
16700,DB11273,Dihydroergocornine,['approved'],BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
16701,DB11274,Dihydro-alpha-ergocryptine,['approved'],BE0000756,Dopamine D2 receptor,DRD2,Humans
16702,DB11274,Dihydro-alpha-ergocryptine,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
16703,DB11274,Dihydro-alpha-ergocryptine,['approved'],BE0000581,Dopamine D3 receptor,DRD3,Humans
16704,DB11275,Epicriptine,['approved'],BE0009376,Dopamine receptor,DRD1,Humans
16705,DB11278,DL-Methylephedrine,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
16706,DB11278,DL-Methylephedrine,['approved'],BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
16707,DB11278,DL-Methylephedrine,['approved'],BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
16708,DB11278,DL-Methylephedrine,['approved'],BE0004872,Beta adrenergic receptor,ADRB1,Humans
16709,DB11294,Coccidioides immitis spherule,['approved'],BE0003482,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,Humans
16710,DB11294,Coccidioides immitis spherule,['approved'],BE0004790,HLA-DR,HLA-DRA,Humans
16711,DB11294,Coccidioides immitis spherule,['approved'],BE0003483,"HLA class I histocompatibility antigen, A-3 alpha chain",HLA-A,Humans
16712,DB11294,Coccidioides immitis spherule,['approved'],BE0004082,"HLA class I histocompatibility antigen, B-27 alpha chain",HLA-B,Humans
16713,DB11300,Thrombin,"['approved', 'investigational']",BE0001021,Coagulation factor XI,F11,Humans
16714,DB11300,Thrombin,"['approved', 'investigational']",BE0000004,Coagulation factor XIII A chain,F13A1,Humans
16715,DB11300,Thrombin,"['approved', 'investigational']",BE0009075,Coagulation factor XIII B chain,F13B,Humans
16716,DB11300,Thrombin,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
16717,DB11300,Thrombin,"['approved', 'investigational']",BE0002091,Fibrinogen beta chain,FGB,Humans
16718,DB11300,Thrombin,"['approved', 'investigational']",BE0002092,Fibrinogen gamma chain,FGG,Humans
16719,DB11300,Thrombin,"['approved', 'investigational']",BE0000041,Coagulation factor V,F5,Humans
16720,DB11300,Thrombin,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
16721,DB11300,Thrombin,"['approved', 'investigational']",BE0000928,Proteinase-activated receptor 1,F2R,Humans
16722,DB11300,Thrombin,"['approved', 'investigational']",BE0008986,Proteinase-activated receptor 4,F2RL3,Humans
16723,DB11311,Prothrombin,['approved'],BE0000538,Fibrinogen alpha chain,FGA,Humans
16724,DB11311,Prothrombin,['approved'],BE0002091,Fibrinogen beta chain,FGB,Humans
16725,DB11311,Prothrombin,['approved'],BE0000004,Coagulation factor XIII A chain,F13A1,Humans
16726,DB11311,Prothrombin,['approved'],BE0003407,Carboxypeptidase B2,CPB2,Humans
16727,DB11312,Protein C,['approved'],BE0000041,Coagulation factor V,F5,Humans
16728,DB11312,Protein C,['approved'],BE0000016,Coagulation factor VIII,F8,Humans
16729,DB11323,Glycol salicylate,['approved'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
16730,DB11323,Glycol salicylate,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16731,DB11324,Nonivamide,['investigational'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
16732,DB11327,Dipyrithione,['approved'],BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
16733,DB11327,Dipyrithione,['approved'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
16734,DB11328,Tetradecyl hydrogen sulfate (ester),['approved'],BE0001161,Endothelial protein C receptor,PROCR,Humans
16736,DB11338,Clove oil,"['approved', 'nutraceutical']",BE0001114,Vascular cell adhesion protein 1,VCAM1,Humans
16737,DB11338,Clove oil,"['approved', 'nutraceutical']",BE0000934,C-X-C motif chemokine 10,CXCL10,Humans
16738,DB11338,Clove oil,"['approved', 'nutraceutical']",BE0000025,Collagen alpha-1(I) chain,COL1A1,Humans
16739,DB11338,Clove oil,"['approved', 'nutraceutical']",BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,Humans
16740,DB11345,(S)-camphor,['experimental'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
16741,DB11345,(S)-camphor,['experimental'],BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
16742,DB11345,(S)-camphor,['experimental'],BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
16743,DB11345,(S)-camphor,['experimental'],BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
16744,DB11348,Calcium Phosphate,['approved'],BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
16745,DB11348,Calcium Phosphate,['approved'],BE0002109,Calreticulin,CALR,Humans
16746,DB11348,Calcium Phosphate,['approved'],BE0008691,Calcium and integrin-binding protein 1,CIB1,Humans
16747,DB11348,Calcium Phosphate,['approved'],BE0005812,Programmed cell death protein 6,PDCD6,Humans
16748,DB11348,Calcium Phosphate,['approved'],BE0008692,Sorcin,SRI,Humans
16749,DB11348,Calcium Phosphate,['approved'],BE0008693,Calcineurin B homologous protein 1,CHP1,Humans
16750,DB11348,Calcium Phosphate,['approved'],BE0002145,SPARC,SPARC,Humans
16751,DB11348,Calcium Phosphate,['approved'],BE0001011,Calnexin,CANX,Humans
16752,DB11348,Calcium Phosphate,['approved'],BE0008694,Fibrillin-2,FBN2,Humans
16753,DB11348,Calcium Phosphate,['approved'],BE0001177,Protein S100-B,S100B,Humans
16754,DB11348,Calcium Phosphate,['approved'],BE0008695,Calsequestrin-2,CASQ2,Humans
16755,DB11348,Calcium Phosphate,['approved'],BE0005259,Regucalcin,RGN,Humans
16756,DB11348,Calcium Phosphate,['approved'],BE0008696,Peflin,PEF1,Humans
16757,DB11348,Calcium Phosphate,['approved'],BE0002950,Protein S100-A6,S100A6,Humans
16758,DB11348,Calcium Phosphate,['approved'],BE0008697,Translationally-controlled tumor protein,TPT1,Humans
16759,DB11348,Calcium Phosphate,['approved'],BE0008698,Calcium and integrin-binding family member 2,CIB2,Humans
16760,DB11348,Calcium Phosphate,['approved'],BE0000885,Protein S100-A13,S100A13,Humans
16761,DB11348,Calcium Phosphate,['approved'],BE0008699,Calsequestrin-1,CASQ1,Humans
16762,DB11348,Calcium Phosphate,['approved'],BE0008700,Nucleobindin-1,NUCB1,Humans
16763,DB11348,Calcium Phosphate,['approved'],BE0008701,Nucleobindin-2,NUCB2,Humans
16764,DB11348,Calcium Phosphate,['approved'],BE0000418,Calmodulin,CALM1,Humans
16765,DB11348,Calcium Phosphate,['approved'],BE0008702,Fibrillin-3,FBN3,Humans
16766,DB11348,Calcium Phosphate,['approved'],BE0008703,Grancalcin,GCA,Humans
16767,DB11348,Calcium Phosphate,['approved'],BE0008704,Calcium-dependent secretion activator 1,CADPS,Humans
16768,DB11348,Calcium Phosphate,['approved'],BE0008705,Calmodulin-2,CALM2,Humans
16769,DB11348,Calcium Phosphate,['approved'],BE0008706,Calmodulin-3,CALM3,Humans
16770,DB11348,Calcium Phosphate,['approved'],BE0008707,Protein S100-A16,S100A16,Humans
16771,DB11348,Calcium Phosphate,['approved'],BE0008708,Calretinin,CALB2,Humans
16772,DB11348,Calcium Phosphate,['approved'],BE0008709,Calcyphosin,CAPS,Humans
16773,DB11348,Calcium Phosphate,['approved'],BE0008710,Calcium-dependent secretion activator 2,CADPS2,Humans
16774,DB11348,Calcium Phosphate,['approved'],BE0008711,Calreticulin-3,CALR3,Humans
16775,DB11348,Calcium Phosphate,['approved'],BE0005274,Neurexin-1,NRXN1,Humans
16776,DB11348,Calcium Phosphate,['approved'],BE0004557,Neuronal calcium sensor 1,NCS1,Humans
16777,DB11359,Guaiacol,['approved'],BE0000530,Serum albumin,ALB,Humans
16778,DB11362,Selexipag,['approved'],BE0000475,Prostacyclin receptor,PTGIR,Humans
16779,DB11363,Alectinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
16780,DB11365,Sennosides,['experimental'],BE0009664,Aquaporin-3,AQP3,Humans
16783,DB11386,Chlorobutanol,"['approved', 'investigational', 'vet_approved']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
16784,DB11397,Dichlorvos,['vet_approved'],BE0000510,Serotransferrin,TF,Humans
16785,DB11397,Dichlorvos,['vet_approved'],BE0002180,Cholinesterase,BCHE,Humans
16786,DB11421,Imidacloprid,['vet_approved'],BE0003963,CHRNA7-FAM7A fusion protein,CHRFAM7A,Humans
16787,DB11425,Luprostiol,"['experimental', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
16788,DB11429,Mibolerone,['vet_approved'],BE0000132,Androgen receptor,AR,Humans
16792,DB11447,Phenothiazine,"['experimental', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
16794,DB11477,Xylazine,['vet_approved'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
16795,DB11478,Zeranol,"['experimental', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
16796,DB11478,Zeranol,"['experimental', 'vet_approved']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
16797,DB11496,2-mercaptobenzothiazole,"['approved', 'experimental', 'vet_approved']",BE0000507,Thyroid peroxidase,TPO,Humans
16798,DB11541,Ractopamine,['vet_approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16799,DB11560,Lesinurad,"['approved', 'investigational']",BE0004782,Solute carrier family 22 member 12,SLC22A12,Humans
16800,DB11560,Lesinurad,"['approved', 'investigational']",BE0000879,Solute carrier family 22 member 11,SLC22A11,Humans
16801,DB11564,Insulin argine,['experimental'],BE0000033,Insulin receptor,INSR,Humans
16802,DB11564,Insulin argine,['experimental'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16803,DB11567,Insulin peglispro,['investigational'],BE0000033,Insulin receptor,INSR,Humans
16804,DB11567,Insulin peglispro,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16805,DB11568,Insulin tregopil,['investigational'],BE0000033,Insulin receptor,INSR,Humans
16806,DB11568,Insulin tregopil,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
16807,DB11569,Ixekizumab,"['approved', 'investigational']",BE0005863,Interleukin-17A,IL17A,Humans
16808,DB11571,Human thrombin,['approved'],BE0000041,Coagulation factor V,F5,Humans
16809,DB11571,Human thrombin,['approved'],BE0000016,Coagulation factor VIII,F8,Humans
16810,DB11571,Human thrombin,['approved'],BE0001021,Coagulation factor XI,F11,Humans
16811,DB11571,Human thrombin,['approved'],BE0000004,Coagulation factor XIII A chain,F13A1,Humans
16812,DB11571,Human thrombin,['approved'],BE0009075,Coagulation factor XIII B chain,F13B,Humans
16813,DB11571,Human thrombin,['approved'],BE0000538,Fibrinogen alpha chain,FGA,Humans
16814,DB11571,Human thrombin,['approved'],BE0002091,Fibrinogen beta chain,FGB,Humans
16815,DB11571,Human thrombin,['approved'],BE0002092,Fibrinogen gamma chain,FGG,Humans
16816,DB11572,Thrombin alfa,['approved'],BE0000041,Coagulation factor V,F5,Humans
16817,DB11572,Thrombin alfa,['approved'],BE0000016,Coagulation factor VIII,F8,Humans
16818,DB11572,Thrombin alfa,['approved'],BE0000538,Fibrinogen alpha chain,FGA,Humans
16819,DB11572,Thrombin alfa,['approved'],BE0002091,Fibrinogen beta chain,FGB,Humans
16820,DB11572,Thrombin alfa,['approved'],BE0002092,Fibrinogen gamma chain,FGG,Humans
16823,DB11577,Indigotindisulfonic acid,"['approved', 'investigational']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
16824,DB11580,Ravulizumab,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
16825,DB11581,Venetoclax,"['approved', 'investigational']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
16826,DB11582,Thiocolchicoside,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
16827,DB11582,Thiocolchicoside,['experimental'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
16828,DB11582,Thiocolchicoside,['experimental'],BE0003517,Tumor necrosis factor ligand superfamily member 11,TNFSF11,Humans
16829,DB11584,Pipradrol,['approved'],BE0004889,D(1) dopamine receptor,DRD1,Humans
16831,DB11587,Etafedrine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
16832,DB11588,Carbon monoxide,"['approved', 'investigational']",BE0004467,Myoglobin,MB,Humans
16833,DB11590,Thimerosal,['approved'],BE0000734,Methionine synthase,MTR,Humans
16834,DB11590,Thimerosal,['approved'],BE0000030,Cystine/glutamate transporter,SLC7A11,Humans
16835,DB11590,Thimerosal,['approved'],BE0000229,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,Humans
16836,DB11591,Bilastine,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
16837,DB11595,Atezolizumab,"['approved', 'investigational']",BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
16838,DB11595,Atezolizumab,"['approved', 'investigational']",BE0003436,Programmed cell death protein 1,PDCD1,Humans
16840,DB11597,Human Rho(D) immune globulin,"['approved', 'investigational']",BE0002389,Rhesus blood group D antigen,RHD,Humans
16841,DB11598,Antithrombin III human,['approved'],BE0000280,Antithrombin-III,SERPINC1,Humans
16842,DB11601,Tuberculin purified protein derivative,['approved'],BE0001164,Toll-like receptor 2,TLR2,Humans
16845,DB11605,Myrrh,['approved'],BE0001777,Bile acid receptor,NR1H4,Humans
16846,DB11605,Myrrh,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
16847,DB11605,Myrrh,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
16848,DB11606,Susoctocog alfa,"['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
16849,DB11607,Efmoroctocog alfa,"['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
16850,DB11611,Lifitegrast,['approved'],BE0000516,Integrin alpha-L,ITGAL,Humans
16852,DB11614,Rupatadine,['approved'],BE0005561,Platelet-activating factor receptor,PTAFR,Humans
16853,DB11614,Rupatadine,['approved'],BE0000442,Histamine H1 receptor,HRH1,Humans
16854,DB11619,Gestrinone,['approved'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
16855,DB11619,Gestrinone,['approved'],BE0000557,Progesterone receptor,PGR,Humans
16856,DB11619,Gestrinone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
16857,DB11619,Gestrinone,['approved'],BE0000132,Androgen receptor,AR,Humans
16858,DB11619,Gestrinone,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
16859,DB11619,Gestrinone,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
16860,DB11623,Candoxatrilat,['experimental'],BE0000266,Neprilysin,MME,Humans
16861,DB11626,Tasonermin,['approved'],BE0001139,Tumor necrosis factor receptor superfamily member 1A,TNFRSF1A,Humans
16862,DB11626,Tasonermin,['approved'],BE0000949,Tumor necrosis factor receptor superfamily member 1B,TNFRSF1B,Humans
16863,DB11632,Opicapone,"['approved', 'investigational']",BE0002089,Catechol O-methyltransferase,COMT,Humans
16865,DB11633,Isavuconazole,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
16866,DB11633,Isavuconazole,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
16867,DB11633,Isavuconazole,"['approved', 'investigational']",BE0001030,G protein-activated inward rectifier potassium channel 2,KCNJ6,Humans
16868,DB11633,Isavuconazole,"['approved', 'investigational']",BE0005190,G protein-activated inward rectifier potassium channel 3,KCNJ9,Humans
16869,DB11633,Isavuconazole,"['approved', 'investigational']",BE0000708,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,Humans
16870,DB11633,Isavuconazole,"['approved', 'investigational']",BE0004717,Potassium voltage-gated channel subfamily A member 5,KCNA5,Humans
16871,DB11633,Isavuconazole,"['approved', 'investigational']",BE0003604,Potassium voltage-gated channel subfamily D member 3,KCND3,Humans
16872,DB11633,Isavuconazole,"['approved', 'investigational']",BE0000672,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,Humans
16873,DB11633,Isavuconazole,"['approved', 'investigational']",BE0000197,Sodium channel protein type 5 subunit alpha,SCN5A,Humans
16874,DB11635,Tocofersolan,['approved'],BE0001032,P-glycoprotein 1,ABCB1,Humans
16875,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005013,"Actin, cytoplasmic 2",ACTG1,Humans
16876,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000135,Alpha-aminoadipic semialdehyde dehydrogenase,ALDH7A1,Humans
16877,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001170,Annexin A2,ANXA2,Humans
16878,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003840,"ATP synthase subunit alpha, mitochondrial",ATP5A1,Humans
16879,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009022,"ATP synthase subunit g, mitochondrial",ATP5L,Humans
16880,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009097,"ATP synthase subunit O, mitochondrial",ATP5O,Humans
16881,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000904,Calpastatin,CAST,Humans
16882,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004554,T-complex protein 1 subunit gamma,CCT3,Humans
16883,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004174,Cofilin-1,CFL1,Humans
16884,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005284,Chloride intracellular channel protein 1,CLIC1,Humans
16885,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009098,Cysteine and glycine-rich protein 1,CSRP1,Humans
16886,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005806,Dihydropyrimidinase-related protein 2,DPYSL2,Humans
16887,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009074,Desmoplakin,DSP,Humans
16888,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
16889,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005807,Alpha-enolase,ENO1,Humans
16890,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009099,Filamin-A,FLNA,Humans
16891,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005795,Alpha-ketoglutarate-dependent dioxygenase FTO,FTO,Humans
16892,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001089,Glucose-6-phosphate 1-dehydrogenase,G6PD,Humans
16893,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
16894,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001199,Glucose-6-phosphate isomerase,GPI,Humans
16895,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0008960,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,Humans
16896,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009100,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,Humans
16897,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009026,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,Humans
16898,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009101,Heterochromatin protein 1-binding protein 3,HP1BP3,Humans
16899,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003432,Heat shock protein beta-1,HSPB1,Humans
16900,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009102,Ras GTPase-activating-like protein IQGAP1,IQGAP1,Humans
16901,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009095,Far upstream element-binding protein 2,KHSRP,Humans
16902,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000425,L-lactate dehydrogenase A chain,LDHA,Humans
16903,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000068,L-lactate dehydrogenase B chain,LDHB,Humans
16904,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004493,Galectin-1,LGALS1,Humans
16905,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003475,Microtubule-associated protein 4,MAP4,Humans
16906,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000589,"Malate dehydrogenase, cytoplasmic",MDH1,Humans
16907,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003419,Puromycin-sensitive aminopeptidase,NPEPPS,Humans
16908,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004118,Profilin-1,PFN1,Humans
16909,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004454,Phosphoglycerate kinase 1,PGK1,Humans
16910,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000088,Pyruvate kinase PKM,PKM,Humans
16911,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001014,Peptidyl-prolyl cis-trans isomerase A,PPIA,Humans
16912,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
16913,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009104,60S ribosomal protein L10,RPL10,Humans
16914,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009105,60S ribosomal protein L14,RPL14,Humans
16915,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009106,60S ribosomal protein L18,RPL18,Humans
16916,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003828,60S ribosomal protein L23a,RPL23A,Humans
16917,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009107,60S ribosomal protein L35,RPL35,Humans
16918,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009108,60S ribosomal protein L4,RPL4,Humans
16919,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009109,40S ribosomal protein S13,RPS13,Humans
16920,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009110,40S ribosomal protein S17,RPS17,Humans
16921,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009111,40S ribosomal protein S18,RPS18,Humans
16922,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009112,40S ribosomal protein S19,RPS19,Humans
16923,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009113,40S ribosomal protein S28,RPS28,Humans
16924,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009114,40S ribosomal protein S5,RPS5,Humans
16925,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009115,40S ribosomal protein S6,RPS6,Humans
16926,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009116,40S ribosomal protein S8,RPS8,Humans
16927,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009117,40S ribosomal protein S9,RPS9,Humans
16928,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009118,Splicing factor 1,SF1,Humans
16929,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0008965,"Splicing factor, proline- and glutamine-rich",SFPQ,Humans
16930,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009119,Small nuclear ribonucleoprotein Sm D2,SNRPD2,Humans
16931,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004503,Signal recognition particle 14 kDa protein,SRP14,Humans
16932,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009120,Serine/arginine-rich splicing factor 4,SRSF4,Humans
16933,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009160,Transgelin,TAGLN,Humans
16934,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009122,Transgelin-2,TAGLN2,Humans
16935,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003844,Triosephosphate isomerase,TPI1,Humans
16936,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009037,Tropomyosin alpha-1 chain,TPM1,Humans
16937,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
16938,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004469,Vimentin,VIM,Humans
16939,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009123,Zyxin,ZYX,Humans
16940,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003775,Heat shock cognate 71 kDa protein,HSPA8,Humans
16941,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0003402,Tubulin beta-6 chain,TUBB6,Humans
16942,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001408,Tubulin beta-4A chain,TUBB4A,Humans
16943,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
16944,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
16945,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,Humans
16946,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0001009,Cytochrome c,CYCS,Humans
16947,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0008977,Phosphoglycerate mutase 1,PGAM1,Humans
16948,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009161,Myosin-9,MYH9,Humans
16949,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
16950,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009162,Probable ATP-dependent RNA helicase DDX5,DDX5,Humans
16951,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000292,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,Humans
16952,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0004598,Spliceosome RNA helicase DDX39B,DDX39B,Humans
16953,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0009103,Nucleophosmin,NPM1,Humans
17065,DB11638,Artenimol,"['approved', 'experimental', 'investigational']",BE0000530,Serum albumin,ALB,Humans
17066,DB11639,Dibotermin alfa,"['approved', 'investigational']",BE0009324,Bone morphogenetic protein receptor type-2,BMPR2,Humans
17067,DB11639,Dibotermin alfa,"['approved', 'investigational']",BE0009272,Bone morphogenetic protein receptor type-1A,BMPR1A,Humans
17068,DB11640,Amifampridine,"['approved', 'investigational']",BE0000781,Potassium voltage-gated channel subfamily A member 1,KCNA1,Humans
17069,DB11641,Vinflunine,"['approved', 'investigational']",BE0000143,Tubulin beta chain,TUBB,Humans
17070,DB11642,Pitolisant,"['approved', 'investigational']",BE0000968,Histamine H3 receptor,HRH3,Humans
17071,DB11642,Pitolisant,"['approved', 'investigational']",BE0000090,Potassium voltage-gated channel subfamily H member 2,KCNH2,Humans
17072,DB11644,Tafamidis,"['approved', 'investigational']",BE0000337,Transthyretin,TTR,Humans
17073,DB11652,Tucatinib,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
17074,DB11652,Tucatinib,"['approved', 'investigational']",BE0009917,Receptor tyrosine-protein kinase erbB-3,ERBB3,Humans
17075,DB11653,Bremelanotide,"['approved', 'investigational']",BE0002447,Melanocyte-stimulating hormone receptor,MC1R,Humans
17076,DB11653,Bremelanotide,"['approved', 'investigational']",BE0009682,Melanocortin receptor 4,MC4R,Humans
17077,DB11653,Bremelanotide,"['approved', 'investigational']",BE0009683,Melanocortin receptor 3,MC3R,Humans
17078,DB11653,Bremelanotide,"['approved', 'investigational']",BE0009684,Melanocortin receptor 5,MC5R,Humans
17079,DB11653,Bremelanotide,"['approved', 'investigational']",BE0000848,Adrenocorticotropic hormone receptor,MC2R,Humans
17080,DB11660,Latanoprostene bunod,"['approved', 'investigational']",BE0000610,Prostaglandin F2-alpha receptor,PTGFR,Humans
17081,DB11672,Curcumin,"['approved', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
17082,DB11672,Curcumin,"['approved', 'investigational']",BE0000779,Vitamin D3 receptor,VDR,Humans
17083,DB11672,Curcumin,"['approved', 'investigational']",BE0003639,Multidrug resistance-associated protein 5,ABCC5,Humans
17084,DB11672,Curcumin,"['approved', 'investigational']",BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
17085,DB11672,Curcumin,"['approved', 'investigational']",BE0000814,Glutathione S-transferase P,GSTP1,Humans
17086,DB11674,Equol,['investigational'],BE0000792,Estrogen receptor beta,ESR2,Humans
17087,DB11674,Equol,['investigational'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
17089,DB11682,Daprodustat,['investigational'],BE0002217,Egl nine homolog 1,EGLN1,Humans
17090,DB11682,Daprodustat,['investigational'],BE0002211,Egl nine homolog 2,EGLN2,Humans
17091,DB11682,Daprodustat,['investigational'],BE0002219,Egl nine homolog 3,EGLN3,Humans
17092,DB11689,Selumetinib,"['approved', 'investigational']",BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,Humans
17093,DB11689,Selumetinib,"['approved', 'investigational']",BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,Humans
17094,DB11691,Naldemedine,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
17095,DB11691,Naldemedine,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
17096,DB11691,Naldemedine,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
17097,DB11692,Pavinetant,['investigational'],BE0002371,Neuromedin-K receptor,TACR3,Humans
17098,DB11693,Voclosporin,"['approved', 'investigational']",BE0000379,Calcium signal-modulating cyclophilin ligand,CAMLG,Humans
17099,DB11693,Voclosporin,"['approved', 'investigational']",BE0000358,Calcineurin subunit B type 1,PPP3R1,Humans
17100,DB11693,Voclosporin,"['approved', 'investigational']",BE0002143,Calcineurin subunit B type 2,PPP3R2,Humans
17101,DB11697,Pacritinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
17102,DB11697,Pacritinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17103,DB11699,Tropisetron,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
17104,DB11700,Setmelanotide,"['approved', 'investigational']",BE0009682,Melanocortin receptor 4,MC4R,Humans
17105,DB11703,Acalabrutinib,"['approved', 'investigational']",BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
17106,DB11712,Tezacaftor,"['approved', 'investigational']",BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
17107,DB11714,Durvalumab,"['approved', 'investigational']",BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
17108,DB11714,Durvalumab,"['approved', 'investigational']",BE0003436,Programmed cell death protein 1,PDCD1,Humans
17109,DB11718,Encorafenib,"['approved', 'investigational']",BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
17110,DB11718,Encorafenib,"['approved', 'investigational']",BE0001027,G1/S-specific cyclin-D1,CCND1,Humans
17111,DB11723,Dutogliptin,['investigational'],BE0000854,Dipeptidyl peptidase 4,DPP4,Humans
17112,DB11726,Encenicline,['investigational'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
17113,DB11730,Ribociclib,"['approved', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
17114,DB11730,Ribociclib,"['approved', 'investigational']",BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
17115,DB11731,Depatuxizumab mafodotin,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
17116,DB11731,Depatuxizumab mafodotin,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
17117,DB11731,Depatuxizumab mafodotin,['investigational'],BE0003496,B-lymphocyte antigen CD19,CD19,Humans
17118,DB11732,Lasmiditan,"['approved', 'investigational']",BE0000460,5-hydroxytryptamine receptor 1F,HTR1F,Humans
17119,DB11737,Icotinib,"['experimental', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
17120,DB11738,Rilmenidine,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
17121,DB11739,Vonoprazan,"['approved', 'investigational']",BE0009378,Hydrogen potassium ATPase,ATP4A,Humans
17122,DB11740,MK-1775,['investigational'],BE0003335,Wee1-like protein kinase,WEE1,Humans
17123,DB11745,Otenabant,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
17125,DB11752,Bryostatin 1,['investigational'],BE0001132,Protein kinase C alpha type,PRKCA,Humans
17126,DB11752,Bryostatin 1,['investigational'],BE0003431,Protein kinase C epsilon type,PRKCE,Humans
17127,DB11752,Bryostatin 1,['investigational'],BE0003460,Caspase-8,CASP8,Humans
17128,DB11752,Bryostatin 1,['investigational'],BE0009525,Serine/threonine-protein kinase D1,PRKD1,Humans
17129,DB11752,Bryostatin 1,['investigational'],BE0000846,T-lymphocyte activation antigen CD86,CD86,Humans
17130,DB11752,Bryostatin 1,['investigational'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
17131,DB11752,Bryostatin 1,['investigational'],BE0001027,G1/S-specific cyclin-D1,CCND1,Humans
17132,DB11752,Bryostatin 1,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
17137,DB11755,Tetrahydrocannabivarin,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
17138,DB11755,Tetrahydrocannabivarin,['investigational'],BE0005802,G-protein coupled receptor 55,GPR55,Humans
17139,DB11755,Tetrahydrocannabivarin,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
17140,DB11755,Tetrahydrocannabivarin,['investigational'],BE0009158,Transient receptor potential cation channel subfamily V member 2,TRPV2,Humans
17141,DB11755,Tetrahydrocannabivarin,['investigational'],BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
17142,DB11755,Tetrahydrocannabivarin,['investigational'],BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
17143,DB11755,Tetrahydrocannabivarin,['investigational'],BE0000095,Cannabinoid receptor 2,CNR2,Humans
17144,DB11757,Istradefylline,"['approved', 'investigational']",BE0000924,Adenosine receptor A2a,ADORA2A,Humans
17145,DB11757,Istradefylline,"['approved', 'investigational']",BE0000013,Adenosine receptor A1,ADORA1,Humans
17146,DB11758,Cenicriviroc,['investigational'],BE0003387,C-C chemokine receptor type 2,CCR2,Humans
17147,DB11760,Talazoparib,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
17148,DB11760,Talazoparib,"['approved', 'investigational']",BE0003798,Poly [ADP-ribose] polymerase 2,PARP2,Humans
17149,DB11761,Tenapanor,"['approved', 'investigational']",BE0009757,Sodium/hydrogen exchanger 3,SLC9A3,Humans
17150,DB11764,Spebrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
17151,DB11767,Sarilumab,"['approved', 'investigational']",BE0002859,Interleukin-6 receptor subunit alpha,IL6R,Humans
17152,DB11767,Sarilumab,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
17153,DB11767,Sarilumab,"['approved', 'investigational']",BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,Humans
17154,DB11767,Sarilumab,"['approved', 'investigational']",BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,Humans
17155,DB11767,Sarilumab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
17156,DB11767,Sarilumab,"['approved', 'investigational']",BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,Humans
17157,DB11771,Tremelimumab,"['approved', 'investigational']",BE0000887,Cytotoxic T-lymphocyte protein 4,CTLA4,Humans
17158,DB11772,Pilaralisib,['investigational'],BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
17160,DB11781,Tosedostat,['investigational'],BE0003419,Puromycin-sensitive aminopeptidase,NPEPPS,Humans
17161,DB11781,Tosedostat,['investigational'],BE0001680,Leukotriene A-4 hydrolase,LTA4H,Humans
17162,DB11791,Capmatinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
17163,DB11793,Niraparib,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
17164,DB11793,Niraparib,"['approved', 'investigational']",BE0003798,Poly [ADP-ribose] polymerase 2,PARP2,Humans
17168,DB11800,Tivozanib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
17169,DB11800,Tivozanib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
17170,DB11800,Tivozanib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
17171,DB11800,Tivozanib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
17172,DB11800,Tivozanib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
17173,DB11800,Tivozanib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17174,DB11800,Tivozanib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
17175,DB11800,Tivozanib,"['approved', 'investigational']",BE0004731,Protein-tyrosine kinase 6,PTK6,Humans
17176,DB11800,Tivozanib,"['approved', 'investigational']",BE0003379,Angiopoietin-1 receptor,TEK,Humans
17177,DB11800,Tivozanib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
17178,DB11800,Tivozanib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
17179,DB11811,Arhalofenate,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
17180,DB11817,Baricitinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
17181,DB11817,Baricitinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
17182,DB11817,Baricitinib,"['approved', 'investigational']",BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
17183,DB11817,Baricitinib,"['approved', 'investigational']",BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
17186,DB11823,Esketamine,"['approved', 'investigational']",BE0004956,NMDA receptor,GRIN1,Humans
17187,DB11823,Esketamine,"['approved', 'investigational']",BE0000417,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,Humans
17188,DB11823,Esketamine,"['approved', 'investigational']",BE0004281,Elongation factor 2,EEF2,Humans
17189,DB11823,Esketamine,"['approved', 'investigational']",BE0003394,Brain-derived neurotrophic factor,BDNF,Humans
17190,DB11823,Esketamine,"['approved', 'investigational']",BE0003605,BDNF/NT-3 growth factors receptor,NTRK2,Humans
17191,DB11827,Ertugliflozin,"['approved', 'investigational']",BE0004753,Sodium/glucose cotransporter 2,SLC5A2,Humans
17192,DB11828,Neratinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
17193,DB11830,Mocetinostat,['investigational'],BE0002365,Histone deacetylase 1,HDAC1,Humans
17194,DB11830,Mocetinostat,['investigational'],BE0002367,Histone deacetylase 3,HDAC3,Humans
17195,DB11830,Mocetinostat,['investigational'],BE0002366,Histone deacetylase 2,HDAC2,Humans
17196,DB11831,Dinitrochlorobenzene,['investigational'],BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
17197,DB11831,Dinitrochlorobenzene,['investigational'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
17198,DB11834,Guselkumab,"['approved', 'investigational']",BE0003415,Interleukin-23 subunit alpha,IL23A,Humans
17199,DB11837,Osilodrostat,"['approved', 'investigational']",BE0000731,"Cytochrome P450 11B1, mitochondrial",CYP11B1,Humans
17200,DB11837,Osilodrostat,"['approved', 'investigational']",BE0003542,"Cytochrome P450 11B2, mitochondrial",CYP11B2,Humans
17201,DB11840,Dalotuzumab,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
17202,DB11841,Entinostat,['investigational'],BE0008667,Histone deacetylase,HDAC1,Humans
17203,DB11842,Angiotensin II,"['approved', 'investigational']",BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
17204,DB11850,Ublituximab,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
17205,DB11853,Relugolix,"['approved', 'investigational']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
17207,DB11855,Revefenacin,"['approved', 'investigational']",BE0004890,Muscarinic acetylcholine receptor,CHRM1,Humans
17208,DB11856,Ligelizumab,['investigational'],BE0010138,Immunoglobulin heavy constant epsilon,IGHE,Humans
17209,DB11858,Leukotriene D4,['investigational'],BE0000705,Cysteinyl leukotriene receptor 1,CYSLTR1,Humans
17210,DB11858,Leukotriene D4,['investigational'],BE0000099,Cysteinyl leukotriene receptor 2,CYSLTR2,Humans
17211,DB11859,Brexanolone,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
17212,DB11866,Romosozumab,"['approved', 'investigational']",BE0009665,Sclerostin,SOST,Humans
17213,DB11886,Infigratinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
17214,DB11886,Infigratinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
17215,DB11886,Infigratinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
17216,DB11886,Infigratinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
17217,DB11901,Apalutamide,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
17218,DB11901,Apalutamide,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
17219,DB11914,Lebrikizumab,['investigational'],BE0002438,Interleukin-13,IL13,Humans
17220,DB11914,Lebrikizumab,['investigational'],BE0003464,IL13 protein,IL13,Humans
17222,DB11921,Deflazacort,"['approved', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
17223,DB11928,Vosoritide,"['approved', 'investigational']",BE0000997,Atrial natriuretic peptide receptor 2,NPR2,Humans
17224,DB11936,Bempedoic acid,"['approved', 'investigational']",BE0009867,ATP-citrate synthase,ACLY,Humans
17225,DB11937,Kynurenic Acid,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
17226,DB11937,Kynurenic Acid,['investigational'],BE0005562,G-protein coupled receptor 35,GPR35,Humans
17227,DB11938,Difelikefalin,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
17228,DB11942,Selinexor,"['approved', 'investigational']",BE0009694,Exportin-1,XPO1,Humans
17231,DB11945,Avelumab,"['approved', 'investigational']",BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
17232,DB11945,Avelumab,"['approved', 'investigational']",BE0003436,Programmed cell death protein 1,PDCD1,Humans
17233,DB11948,Lapachone,['investigational'],BE0000255,Retinol-binding protein 3,RBP3,Humans
17234,DB11949,Vestipitant,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
17235,DB11951,Lemborexant,"['approved', 'investigational']",BE0005864,Orexin receptor type 1,HCRTR1,Humans
17236,DB11951,Lemborexant,"['approved', 'investigational']",BE0005865,Orexin receptor type 2,HCRTR2,Humans
17237,DB11952,Duvelisib,"['approved', 'investigational']",BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
17238,DB11952,Duvelisib,"['approved', 'investigational']",BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
17239,DB11962,GSK-1059615,['investigational'],BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
17240,DB11962,GSK-1059615,['investigational'],BE0003729,Phosphatidylinositol 3-kinase catalytic subunit type 3,PIK3C3,Humans
17241,DB11963,Dacomitinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
17242,DB11967,Binimetinib,"['approved', 'investigational']",BE0003430,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,Humans
17243,DB11967,Binimetinib,"['approved', 'investigational']",BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,Humans
17244,DB11967,Binimetinib,"['approved', 'investigational']",BE0000918,Interleukin-6,IL6,Humans
17245,DB11967,Binimetinib,"['approved', 'investigational']",BE0000704,Tumor necrosis factor,TNF,Humans
17246,DB11967,Binimetinib,"['approved', 'investigational']",BE0001051,Interleukin-1 beta,IL1B,Humans
17247,DB11973,Tesevatinib,['investigational'],BE0000953,Pro-epidermal growth factor,EGF,Humans
17248,DB11973,Tesevatinib,['investigational'],BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
17249,DB11973,Tesevatinib,['investigational'],BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
17250,DB11976,Anifrolumab,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
17251,DB11978,Glasdegib,"['approved', 'investigational']",BE0004659,Smoothened homolog,SMO,Humans
17252,DB11979,Elagolix,"['approved', 'investigational']",BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
17253,DB11986,Entrectinib,"['approved', 'investigational']",BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
17254,DB11986,Entrectinib,"['approved', 'investigational']",BE0009501,NT-3 growth factor receptor,NTRK3,Humans
17255,DB11986,Entrectinib,"['approved', 'investigational']",BE0009534,Proto-oncogene tyrosine-protein kinase ROS,ROS1,Humans
17256,DB11986,Entrectinib,"['approved', 'investigational']",BE0003605,BDNF/NT-3 growth factors receptor,NTRK2,Humans
17257,DB11986,Entrectinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
17258,DB11986,Entrectinib,"['approved', 'investigational']",BE0000772,Activated CDC42 kinase 1,TNK2,Humans
17259,DB11988,Ocrelizumab,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
17260,DB11994,Diacerein,"['approved', 'investigational']",BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
17261,DB11994,Diacerein,"['approved', 'investigational']",BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
17263,DB11994,Diacerein,"['approved', 'investigational']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
17264,DB11994,Diacerein,"['approved', 'investigational']",BE0002433,Cytochrome P450 1A2,CYP1A2,Humans
17265,DB11994,Diacerein,"['approved', 'investigational']",BE0004866,Cytochrome P450 3A Subfamily,CYP3A4,Humans
17266,DB11994,Diacerein,"['approved', 'investigational']",BE0003533,Cytochrome P450 2E1,CYP2E1,Humans
17267,DB11994,Diacerein,"['approved', 'investigational']",BE0002793,Cytochrome P450 2C9,CYP2C9,Humans
17268,DB11994,Diacerein,"['approved', 'investigational']",BE0002363,Cytochrome P450 2D6,CYP2D6,Humans
17269,DB11995,Avatrombopag,"['approved', 'investigational']",BE0003440,Thrombopoietin receptor,MPL,Humans
17270,DB11995,Avatrombopag,"['approved', 'investigational']",BE0001067,ATP-binding cassette sub-family G member 2,ABCG2,Humans
17271,DB11995,Avatrombopag,"['approved', 'investigational']",BE0003645,Solute carrier family 22 member 8,SLC22A8,Humans
17272,DB12001,Abemaciclib,"['approved', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
17273,DB12001,Abemaciclib,"['approved', 'investigational']",BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
17274,DB12007,Isoflavone,['experimental'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
17275,DB12007,Isoflavone,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
17276,DB12008,Prexasertib,['investigational'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
17277,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
17278,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000354,Adenosine receptor A3,ADORA3,Humans
17280,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
17281,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001204,Equilibrative nucleoside transporter 1,SLC29A1,Humans
17282,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003541,UDP-glucuronosyltransferase 1-1,UGT1A1,Humans
17283,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,Humans
17284,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
17285,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001646,Cathepsin S,CTSS,Humans
17286,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002135,Cathepsin L1,CTSL,Humans
17287,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
17290,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009380,Ribosomal protein S6 kinase alpha-6,RPS6KA6,Humans
17291,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
17293,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
17294,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
17295,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009382,Serine/threonine-protein kinase NIM1,NIM1K,Humans
17296,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004109,Serine/threonine-protein kinase MST4,STK26,Humans
17297,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,Humans
17298,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009383,Serine/threonine-protein kinase 24,STK24,Humans
17299,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009384,Serine/threonine-protein kinase 3,STK3,Humans
17300,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009385,Tyrosine-protein kinase Tec,TEC,Humans
17301,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009386,Serine/threonine-protein kinase 33,STK33,Humans
17302,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009387,Serine/threonine-protein kinase 35,STK35,Humans
17303,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009388,Serine/threonine-protein kinase 36,STK36,Humans
17304,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009389,Serine/threonine-protein kinase 38,STK38,Humans
17305,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009390,Serine/threonine-protein kinase 38-like,STK38L,Humans
17306,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009391,STE20/SPS1-related proline-alanine-rich protein kinase,STK39,Humans
17307,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009392,Serine/threonine-protein kinase TAO1,TAOK1,Humans
17308,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004632,Serine/threonine-protein kinase TAO2,TAOK2,Humans
17309,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009393,Serine/threonine-protein kinase TAO3,TAOK3,Humans
17310,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009394,Serine/threonine-protein kinase TBK1,TBK1,Humans
17311,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003379,Angiopoietin-1 receptor,TEK,Humans
17312,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009395,Dual specificity testis-specific protein kinase 1,TESK1,Humans
17313,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003782,TGF-beta receptor type-1,TGFBR1,Humans
17314,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001861,TGF-beta receptor type-2,TGFBR2,Humans
17315,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009396,Tyrosine-protein kinase receptor Tie-1,TIE1,Humans
17316,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009397,Serine/threonine-protein kinase tousled-like 1,TLK1,Humans
17317,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009398,Serine/threonine-protein kinase tousled-like 2,TLK2,Humans
17318,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009399,TRAF2 and NCK-interacting protein kinase,TNIK,Humans
17319,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009400,Non-receptor tyrosine-protein kinase TNK1,TNK1,Humans
17320,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000772,Activated CDC42 kinase 1,TNK2,Humans
17321,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009401,Serine/threonine-protein kinase TNNI3K,TNNI3K,Humans
17322,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009402,Testis-specific serine/threonine-protein kinase 1,TSSK1B,Humans
17323,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003791,Dual specificity protein kinase TTK,TTK,Humans
17324,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009403,Tyrosine-protein kinase TXK,TXK,Humans
17325,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009404,Tyrosine-protein kinase receptor TYRO3,TYRO3,Humans
17326,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009405,Serine/threonine-protein kinase ULK1,ULK1,Humans
17327,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009406,Serine/threonine-protein kinase ULK2,ULK2,Humans
17328,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009407,Serine/threonine-protein kinase ULK3,ULK3,Humans
17329,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003335,Wee1-like protein kinase,WEE1,Humans
17330,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000840,Tyrosine-protein kinase Yes,YES1,Humans
17331,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009408,Mitogen-activated protein kinase kinase kinase 19,MAP3K19,Humans
17332,DB12010,Fostamatinib,"['approved', 'investigational']",BE0005595,Mitogen-activated protein kinase kinase kinase MLT,ZAK,Humans
17333,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001312,Tyrosine-protein kinase ZAP-70,ZAP70,Humans
17334,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009409,AP2-associated protein kinase 1,AAK1,Humans
17335,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000435,Abelson tyrosine-protein kinase 2,ABL2,Humans
17336,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000264,Activin receptor type-1,ACVR1,Humans
17337,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000665,Activin receptor type-1B,ACVR1B,Humans
17339,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
17340,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009411,Ankyrin repeat and protein kinase domain-containing protein 1,ANKK1,Humans
17341,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000991,Aurora kinase A,AURKA,Humans
17342,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003404,Aurora kinase B,AURKB,Humans
17343,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004601,Aurora kinase C,AURKC,Humans
17344,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009412,Tyrosine-protein kinase receptor UFO,AXL,Humans
17345,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009413,Tyrosine-protein kinase Blk,BLK,Humans
17346,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009414,BMP-2-inducible protein kinase,BMP2K,Humans
17347,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009415,Bone morphogenetic protein receptor type-1B,BMPR1B,Humans
17348,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009324,Bone morphogenetic protein receptor type-2,BMPR2,Humans
17349,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009416,Cytoplasmic tyrosine-protein kinase BMX,BMX,Humans
17350,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
17351,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
17352,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009417,Calcium/calmodulin-dependent protein kinase type 1,CAMK1,Humans
17353,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004324,Calcium/calmodulin-dependent protein kinase type 1D,CAMK1D,Humans
17354,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004147,Calcium/calmodulin-dependent protein kinase type 1G,CAMK1G,Humans
17355,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,Humans
17356,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003792,Calcium/calmodulin-dependent protein kinase type II subunit beta,CAMK2B,Humans
17357,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004108,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,Humans
17358,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,Humans
17359,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009418,Calcium/calmodulin-dependent protein kinase kinase 1,CAMKK1,Humans
17360,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009419,Calcium/calmodulin-dependent protein kinase kinase 2,CAMKK2,Humans
17361,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002641,Peripheral plasma membrane protein CASK,CASK,Humans
17362,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009420,Kappa-casein,CSN3,Humans
17363,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
17364,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009421,Serine/threonine-protein kinase MRCK gamma,CDC42BPG,Humans
17365,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
17366,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009422,Cyclin-dependent kinase-like 1,CDKL1,Humans
17367,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009423,Cyclin-dependent kinase-like 2,CDKL2,Humans
17368,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
17369,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003381,Serine/threonine-protein kinase Chk2,CHEK2,Humans
17370,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009424,Citron Rho-interacting kinase,CIT,Humans
17371,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001824,Dual specificity protein kinase CLK1,CLK1,Humans
17372,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009425,Dual specificity protein kinase CLK2,CLK2,Humans
17373,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004043,Dual specificity protein kinase CLK3,CLK3,Humans
17374,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009426,Dual specificity protein kinase CLK4,CLK4,Humans
17375,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
17376,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001356,Tyrosine-protein kinase CSK,CSK,Humans
17377,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009427,Casein kinase I isoform alpha,CSNK1A1,Humans
17378,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001209,Casein kinase II subunit alpha,CSNK2A1,Humans
17379,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003984,Casein kinase II subunit alpha',CSNK2A2,Humans
17380,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001776,Death-associated protein kinase 1,DAPK1,Humans
17381,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009428,Death-associated protein kinase 2,DAPK2,Humans
17382,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003788,Death-associated protein kinase 3,DAPK3,Humans
17383,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009429,Serine/threonine-protein kinase DCLK1,DCLK1,Humans
17384,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009430,Serine/threonine-protein kinase DCLK2,DCLK2,Humans
17385,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009431,Serine/threonine-protein kinase DCLK3,DCLK3,Humans
17386,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001124,Epithelial discoidin domain-containing receptor 1,DDR1,Humans
17387,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004741,Discoidin domain-containing receptor 2,DDR2,Humans
17388,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,Humans
17389,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009432,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,DYRK1B,Humans
17390,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
17391,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009433,Eukaryotic translation initiation factor 2-alpha kinase 1,EIF2AK1,Humans
17392,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009434,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,Humans
17393,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009435,eIF-2-alpha kinase GCN2,EIF2AK4,Humans
17394,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009436,Ephrin type-A receptor 1,EPHA1,Humans
17395,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000841,Ephrin type-A receptor 2,EPHA2,Humans
17396,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009437,Ephrin type-A receptor 3,EPHA3,Humans
17397,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009438,Ephrin type-A receptor 4,EPHA4,Humans
17398,DB12010,Fostamatinib,"['approved', 'investigational']",BE0005587,Ephrin type-A receptor 5,EPHA5,Humans
17399,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009439,Ephrin type-A receptor 6,EPHA6,Humans
17400,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004140,Ephrin type-A receptor 7,EPHA7,Humans
17401,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009440,Ephrin type-A receptor 8,EPHA8,Humans
17402,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009441,Ephrin type-B receptor 1,EPHB1,Humans
17403,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004549,Ephrin type-B receptor 2,EPHB2,Humans
17404,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002453,Ephrin type-B receptor 4,EPHB4,Humans
17405,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009442,Ephrin type-B receptor 6,EPHB6,Humans
17406,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
17407,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004772,Receptor tyrosine-protein kinase erbB-4,ERBB4,Humans
17408,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003839,Serine/threonine-protein kinase/endoribonuclease IRE1,ERN1,Humans
17409,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009443,Tyrosine-protein kinase Fer,FER,Humans
17410,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009444,Tyrosine-protein kinase Fes/Fps,FES,Humans
17411,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
17412,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
17413,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
17414,DB12010,Fostamatinib,"['approved', 'investigational']",BE0005539,Tyrosine-protein kinase Fgr,FGR,Humans
17415,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
17416,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17417,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
17418,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
17419,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004742,Tyrosine-protein kinase FRK,FRK,Humans
17420,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000839,Tyrosine-protein kinase Fyn,FYN,Humans
17421,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009445,Cyclin-G-associated kinase,GAK,Humans
17422,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009446,Glycogen synthase kinase-3 alpha,GSK3A,Humans
17423,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
17424,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001424,Tyrosine-protein kinase HCK,HCK,Humans
17425,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009447,Homeodomain-interacting protein kinase 2,HIPK2,Humans
17426,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009448,Homeodomain-interacting protein kinase 3,HIPK3,Humans
17427,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009449,Serine/threonine-protein kinase ICK,ICK,Humans
17428,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,Humans
17429,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009450,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,IKBKE,Humans
17430,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000033,Insulin receptor,INSR,Humans
17431,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009451,Insulin receptor-related protein,INSRR,Humans
17432,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009452,Interleukin-1 receptor-associated kinase 1,IRAK1,Humans
17433,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009453,Interleukin-1 receptor-associated kinase 3,IRAK3,Humans
17434,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004344,Interleukin-1 receptor-associated kinase 4,IRAK4,Humans
17435,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001341,Tyrosine-protein kinase ITK/TSK,ITK,Humans
17436,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
17437,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
17438,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
17439,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009454,Serine/threonine-protein kinase SIK3,SIK3,Humans
17440,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
17441,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009455,Serine/threonine-protein kinase LATS1,LATS1,Humans
17442,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
17443,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004759,LIM domain kinase 1,LIMK1,Humans
17444,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009456,LIM domain kinase 2,LIMK2,Humans
17445,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009457,Leucine-rich repeat serine/threonine-protein kinase 2,LRRK2,Humans
17446,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009458,Leukocyte tyrosine kinase receptor,LTK,Humans
17447,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004315,Tyrosine-protein kinase Lyn,LYN,Humans
17448,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,Humans
17449,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009459,Dual specificity mitogen-activated protein kinase kinase 3,MAP2K3,Humans
17450,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009460,Dual specificity mitogen-activated protein kinase kinase 5,MAP2K5,Humans
17451,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009461,Dual specificity mitogen-activated protein kinase kinase 6,MAP2K6,Humans
17452,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003430,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,Humans
17453,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009462,Mitogen-activated protein kinase kinase kinase 10,MAP3K10,Humans
17454,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009463,Mitogen-activated protein kinase kinase kinase 11,MAP3K11,Humans
17455,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009464,Mitogen-activated protein kinase kinase kinase 12,MAP3K12,Humans
17456,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009465,Mitogen-activated protein kinase kinase kinase 13,MAP3K13,Humans
17457,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009466,Mitogen-activated protein kinase kinase kinase 15,MAP3K15,Humans
17458,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004745,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,Humans
17459,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009467,Mitogen-activated protein kinase kinase kinase 3,MAP3K3,Humans
17460,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009468,Mitogen-activated protein kinase kinase kinase 4,MAP3K4,Humans
17461,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009469,Mitogen-activated protein kinase kinase kinase 6,MAP3K6,Humans
17462,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004386,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,Humans
17463,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009470,Mitogen-activated protein kinase kinase kinase kinase 1,MAP4K1,Humans
17464,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009471,Mitogen-activated protein kinase kinase kinase kinase 2,MAP4K2,Humans
17465,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009472,Mitogen-activated protein kinase kinase kinase kinase 3,MAP4K3,Humans
17466,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009473,Mitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,Humans
17467,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009474,Mitogen-activated protein kinase kinase kinase kinase 5,MAP4K5,Humans
17468,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001097,Mitogen-activated protein kinase 10,MAPK10,Humans
17469,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003391,Mitogen-activated protein kinase 13,MAPK13,Humans
17470,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001019,Mitogen-activated protein kinase 14,MAPK14,Humans
17471,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009475,Mitogen-activated protein kinase 15,MAPK15,Humans
17472,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009476,Mitogen-activated protein kinase 4,MAPK4,Humans
17473,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009477,Mitogen-activated protein kinase 7,MAPK7,Humans
17474,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003772,Mitogen-activated protein kinase 9,MAPK9,Humans
17475,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009478,MAP kinase-activated protein kinase 5,MAPKAPK5,Humans
17476,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009479,Serine/threonine-protein kinase MARK1,MARK1,Humans
17477,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009480,Serine/threonine-protein kinase MARK2,MARK2,Humans
17478,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009481,MAP/microtubule affinity-regulating kinase 3,MARK3,Humans
17479,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009482,MAP/microtubule affinity-regulating kinase 4,MARK4,Humans
17480,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009483,CLIP-associating protein 1,CLASP1,Humans
17481,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009484,Microtubule-associated serine/threonine-protein kinase 1,MAST1,Humans
17482,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009485,Megakaryocyte-associated tyrosine-protein kinase,MATK,Humans
17483,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009486,Maternal embryonic leucine zipper kinase,MELK,Humans
17484,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004271,Tyrosine-protein kinase Mer,MERTK,Humans
17485,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009487,Misshapen-like kinase 1,MINK1,Humans
17486,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009488,MAP kinase-interacting serine/threonine-protein kinase 1,MKNK1,Humans
17487,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009489,MAP kinase-interacting serine/threonine-protein kinase 2,MKNK2,Humans
17488,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009490,Macrophage-stimulating protein receptor,MST1R,Humans
17489,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009491,"Muscle, skeletal receptor tyrosine-protein kinase",MUSK,Humans
17490,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009492,"Myosin light chain kinase, smooth muscle",MYLK,Humans
17491,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004946,"Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK2,Humans
17492,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009493,Myosin light chain kinase 3,MYLK3,Humans
17493,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009494,Myosin light chain kinase family member 4,MYLK4,Humans
17494,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009495,Myosin-IIIa,MYO3A,Humans
17495,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009496,Serine/threonine-protein kinase Nek1,NEK1,Humans
17496,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004758,Serine/threonine-protein kinase Nek11,NEK11,Humans
17497,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003796,Serine/threonine-protein kinase Nek2,NEK2,Humans
17498,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009497,Serine/threonine-protein kinase Nek3,NEK3,Humans
17499,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009498,Serine/threonine-protein kinase Nek4,NEK4,Humans
17500,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009499,Serine/threonine-protein kinase Nek5,NEK5,Humans
17501,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009500,Serine/threonine-protein kinase Nek9,NEK9,Humans
17502,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
17503,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003605,BDNF/NT-3 growth factors receptor,NTRK2,Humans
17504,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009501,NT-3 growth factor receptor,NTRK3,Humans
17505,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009502,NUAK family SNF1-like kinase 1,NUAK1,Humans
17506,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009503,NUAK family SNF1-like kinase 2,NUAK2,Humans
17507,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009504,Serine/threonine-protein kinase OSR1,OXSR1,Humans
17508,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009505,Serine/threonine-protein kinase PAK 1,PAK1,Humans
17509,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009506,Serine/threonine-protein kinase PAK 2,PAK2,Humans
17510,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009507,Serine/threonine-protein kinase PAK 3,PAK3,Humans
17511,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009508,Serine/threonine-protein kinase PAK 4,PAK4,Humans
17512,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009509,Serine/threonine-protein kinase PAK 6,PAK6,Humans
17514,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004077,Cyclin-dependent kinase 16,CDK16,Humans
17515,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009511,Cyclin-dependent kinase 17,CDK17,Humans
17516,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
17517,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
17518,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001193,3-phosphoinositide-dependent protein kinase 1,PDPK1,Humans
17519,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000437,Cyclin-dependent kinase 15,CDK15,Humans
17520,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009512,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",PHKG1,Humans
17521,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009513,Phosphatidylinositol 4-kinase beta,PI4KB,Humans
17522,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009514,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,PIK3C2B,Humans
17523,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009515,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,PIK3C2G,Humans
17524,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
17525,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,Humans
17526,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001277,Serine/threonine-protein kinase pim-1,PIM1,Humans
17527,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009516,Serine/threonine-protein kinase pim-3,PIM3,Humans
17528,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009517,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,PIP4K2B,Humans
17529,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009518,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,PIP4K2C,Humans
17530,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009519,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,PKMYT1,Humans
17531,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009520,Serine/threonine-protein kinase N1,PKN1,Humans
17532,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009521,Serine/threonine-protein kinase N2,PKN2,Humans
17533,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
17534,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009522,Serine/threonine-protein kinase PLK2,PLK2,Humans
17535,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009523,Serine/threonine-protein kinase PLK3,PLK3,Humans
17536,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009524,Serine/threonine-protein kinase PLK4,PLK4,Humans
17537,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,Humans
17538,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004907,5'-AMP-activated protein kinase,PRKAA1,Humans
17539,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004475,cAMP-dependent protein kinase catalytic subunit beta,PRKACB,Humans
17540,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002417,Protein kinase C delta type,PRKCD,Humans
17541,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003431,Protein kinase C epsilon type,PRKCE,Humans
17542,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009588,Protein kinase C gamma type (PRKCG),PRKCG,Humans
17543,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003889,Protein kinase C iota type,PRKCI,Humans
17544,DB12010,Fostamatinib,"['approved', 'investigational']",BE0001385,Protein kinase C theta type,PRKCQ,Humans
17545,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009525,Serine/threonine-protein kinase D1,PRKD1,Humans
17546,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009526,cGMP-dependent protein kinase 2,PRKG2,Humans
17547,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009527,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,Humans
17548,DB12010,Fostamatinib,"['approved', 'investigational']",BE0003090,Focal adhesion kinase 1,PTK2,Humans
17549,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000871,Protein-tyrosine kinase 2-beta,PTK2B,Humans
17550,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004731,Protein-tyrosine kinase 6,PTK6,Humans
17551,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000036,RAF proto-oncogene serine/threonine-protein kinase,RAF1,Humans
17552,DB12010,Fostamatinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
17553,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009528,Serine/threonine-protein kinase RIO1,RIOK1,Humans
17554,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009529,Serine/threonine-protein kinase RIO2,RIOK2,Humans
17555,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009530,Serine/threonine-protein kinase RIO3,RIOK3,Humans
17556,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009531,Receptor-interacting serine/threonine-protein kinase 1,RIPK1,Humans
17557,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009532,Receptor-interacting serine/threonine-protein kinase 2,RIPK2,Humans
17558,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009533,Receptor-interacting serine/threonine-protein kinase 4,RIPK4,Humans
17559,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
17560,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009534,Proto-oncogene tyrosine-protein kinase ROS,ROS1,Humans
17561,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004274,Ribosomal protein S6 kinase alpha-1,RPS6KA1,Humans
17562,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004876,Ribosomal protein S6 kinase alpha-3,RPS6KA3,Humans
17563,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009535,Serine/threonine-protein kinase SBK1,SBK1,Humans
17564,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009536,Uncharacterized serine/threonine-protein kinase SBK3,SBK3,Humans
17565,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009537,Serine/threonine-protein kinase Sgk3,SGK3,Humans
17566,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004757,Serine/threonine-protein kinase SIK1,SIK1,Humans
17567,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009538,Serine/threonine-protein kinase SIK2,SIK2,Humans
17568,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004041,STE20-like serine/threonine-protein kinase,SLK,Humans
17569,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009539,SNF-related serine/threonine-protein kinase,SNRK,Humans
17570,DB12010,Fostamatinib,"['approved', 'investigational']",BE0000838,Proto-oncogene tyrosine-protein kinase Src,SRC,Humans
17571,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009540,Tyrosine-protein kinase Srms,SRMS,Humans
17572,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009541,Serine/threonine-protein kinase 10,STK10,Humans
17573,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009542,Serine/threonine-protein kinase 16,STK16,Humans
17574,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009543,Serine/threonine-protein kinase 17A,STK17A,Humans
17575,DB12010,Fostamatinib,"['approved', 'investigational']",BE0004328,Serine/threonine-protein kinase 17B,STK17B,Humans
17576,DB12010,Fostamatinib,"['approved', 'investigational']",BE0009544,Serine/threonine-protein kinase 32A,STK32A,Humans
17577,DB12015,Alpelisib,"['approved', 'investigational']",BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
17578,DB12016,Ponesimod,"['approved', 'investigational']",BE0008652,Sphingosine 1-phosphate receptor 1,S1PR1,Humans
17579,DB12018,Ulocuplumab,['investigational'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
17581,DB12023,Benralizumab,"['approved', 'investigational']",BE0003471,Interleukin-5 receptor subunit alpha,IL5RA,Humans
17582,DB12023,Benralizumab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
17584,DB12034,Gantenerumab,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
17585,DB12061,Pardoprunox,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17586,DB12061,Pardoprunox,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
17587,DB12061,Pardoprunox,['investigational'],BE0000389,Dopamine D4 receptor,DRD4,Humans
17588,DB12061,Pardoprunox,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
17589,DB12062,Volasertib,['investigational'],BE0003745,Serine/threonine-protein kinase PLK1,PLK1,Humans
17593,DB12077,Urelumab,['investigational'],BE0003463,Tumor necrosis factor receptor superfamily member 9,TNFRSF9,Humans
17594,DB12093,Tetrahydropalmatine,['investigational'],BE0000020,Dopamine D1 receptor,DRD1,Humans
17595,DB12093,Tetrahydropalmatine,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17596,DB12095,Telotristat ethyl,"['approved', 'investigational']",BE0000080,Tryptophan 5-hydroxylase 2,TPH2,Humans
17597,DB12095,Telotristat ethyl,"['approved', 'investigational']",BE0000121,Tryptophan 5-hydroxylase 1,TPH1,Humans
17598,DB12098,L-Baclofen,['investigational'],BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,Humans
17608,DB12110,m-Chlorophenylpiperazine,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
17609,DB12114,Poziotinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
17610,DB12116,Epigallocatechin gallate,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
17611,DB12116,Epigallocatechin gallate,['investigational'],BE0000892,DNA (cytosine-5)-methyltransferase 1,DNMT1,Humans
17612,DB12116,Epigallocatechin gallate,['investigational'],BE0004001,"Dihydrofolate reductase, mitochondrial",DHFRL1,Humans
17613,DB12118,Sotatercept,['investigational'],BE0003472,Activin receptor type-2A,ACVR2A,Humans
17614,DB12119,Gevokizumab,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
17615,DB12121,Entospletinib,['investigational'],BE0001316,Tyrosine-protein kinase SYK,SYK,Humans
17616,DB12128,Ulimorelin,['investigational'],BE0003383,Growth hormone secretagogue receptor type 1,GHSR,Humans
17617,DB12129,Tideglusib,"['investigational', 'withdrawn']",BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
17618,DB12130,Lorlatinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
17619,DB12140,Dilmapimod,['investigational'],BE0000704,Tumor necrosis factor,TNF,Humans
17620,DB12140,Dilmapimod,['investigational'],BE0001051,Interleukin-1 beta,IL1B,Humans
17621,DB12140,Dilmapimod,['investigational'],BE0000918,Interleukin-6,IL6,Humans
17622,DB12141,Gilteritinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17623,DB12141,Gilteritinib,"['approved', 'investigational']",BE0009412,Tyrosine-protein kinase receptor UFO,AXL,Humans
17624,DB12141,Gilteritinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
17625,DB12141,Gilteritinib,"['approved', 'investigational']",BE0004862,Serotonin Receptors,HTR1A,Humans
17626,DB12147,Erdafitinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
17627,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
17628,DB12147,Erdafitinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
17629,DB12147,Erdafitinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
17630,DB12147,Erdafitinib,"['approved', 'investigational']",BE0001104,RET proto-oncogene,RET,Humans
17631,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
17632,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
17633,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
17634,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
17635,DB12147,Erdafitinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
17639,DB12157,Fasinumab,['investigational'],BE0001094,Beta-nerve growth factor,NGF,Humans
17640,DB12159,Dupilumab,"['approved', 'investigational']",BE0002420,Interleukin-4 receptor subunit alpha,IL4R,Humans
17641,DB12159,Dupilumab,"['approved', 'investigational']",BE0002438,Interleukin-13,IL13,Humans
17642,DB12159,Dupilumab,"['approved', 'investigational']",BE0003520,Interleukin-4,IL4,Humans
17643,DB12161,Deutetrabenazine,"['approved', 'investigational']",BE0000118,Synaptic vesicular amine transporter,SLC18A2,Humans
17644,DB12163,Sarpogrelate,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
17645,DB12163,Sarpogrelate,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
17646,DB12169,Tralokinumab,"['approved', 'investigational']",BE0002438,Interleukin-13,IL13,Humans
17647,DB12177,Eplivanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
17648,DB12177,Eplivanserin,['investigational'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
17649,DB12189,Etrolizumab,['investigational'],BE0003414,Integrin beta-7,ITGB7,Humans
17650,DB12191,Obatoclax,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
17651,DB12200,Tivantinib,['investigational'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
17652,DB12202,Zalutumumab,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
17653,DB12228,Telcagepant,['investigational'],BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
17654,DB12228,Telcagepant,['investigational'],BE0001103,Calcitonin gene-related peptide 1,CALCA,Humans
17655,DB12228,Telcagepant,['investigational'],BE0002370,Calcitonin gene-related peptide 2,CALCB,Humans
17656,DB12235,Estetrol,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
17657,DB12235,Estetrol,"['approved', 'investigational']",BE0000792,Estrogen receptor beta,ESR2,Humans
17658,DB12239,Balicatib,['investigational'],BE0003417,Cathepsin K,CTSK,Humans
17659,DB12240,Polatuzumab vedotin,"['approved', 'investigational']",BE0009680,B-cell antigen receptor complex-associated protein beta chain,CD79B,Humans
17661,DB12248,Tulobuterol,['investigational'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
17662,DB12250,Cixutumumab,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
17663,DB12255,Vadadustat,['investigational'],BE0002217,Egl nine homolog 1,EGLN1,Humans
17664,DB12255,Vadadustat,['investigational'],BE0002211,Egl nine homolog 2,EGLN2,Humans
17665,DB12255,Vadadustat,['investigational'],BE0002219,Egl nine homolog 3,EGLN3,Humans
17666,DB12255,Vadadustat,['investigational'],BE0002374,Hypoxia-inducible factor 1-alpha,HIF1A,Humans
17667,DB12255,Vadadustat,['investigational'],BE0009679,Endothelial PAS domain-containing protein 1,EPAS1,Humans
17668,DB12267,Brigatinib,"['approved', 'investigational']",BE0000359,ALK tyrosine kinase receptor,ALK,Humans
17669,DB12267,Brigatinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
17670,DB12267,Brigatinib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
17671,DB12267,Brigatinib,"['approved', 'investigational']",BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
17672,DB12267,Brigatinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17673,DB12267,Brigatinib,"['approved', 'investigational']",BE0000033,Insulin receptor,INSR,Humans
17674,DB12267,Brigatinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
17675,DB12267,Brigatinib,"['approved', 'investigational']",BE0004772,Receptor tyrosine-protein kinase erbB-4,ERBB4,Humans
17676,DB12267,Brigatinib,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
17677,DB12271,ORE-1001,['investigational'],BE0003503,Carboxypeptidase N catalytic chain,CPN1,Humans
17678,DB12271,ORE-1001,['investigational'],BE0003504,Carboxypeptidase N subunit 2,CPN2,Humans
17679,DB12274,Aducanumab,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
17680,DB12278,Propiverine,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
17681,DB12278,Propiverine,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
17682,DB12278,Propiverine,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
17683,DB12278,Propiverine,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
17684,DB12278,Propiverine,"['approved', 'investigational']",BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,Humans
17685,DB12278,Propiverine,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
17686,DB12278,Propiverine,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
17687,DB12284,LY-2608204,['investigational'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
17688,DB12285,Verubecestat,['investigational'],BE0000988,Beta-secretase 1,BACE1,Humans
17690,DB12305,Dasotraline,['investigational'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
17691,DB12305,Dasotraline,['investigational'],BE0000749,Sodium-dependent serotonin transporter,SLC6A4,Humans
17692,DB12305,Dasotraline,['investigational'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
17693,DB12307,Foretinib,['investigational'],BE0001121,Hepatocyte growth factor,HGF,Humans
17694,DB12307,Foretinib,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
17695,DB12317,Vanucizumab,['investigational'],BE0010028,Angiopoietin-2,ANGPT2,Humans
17696,DB12317,Vanucizumab,['investigational'],BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
17697,DB12319,Benzbromarone,"['investigational', 'withdrawn']",BE0002793,Cytochrome P450 2C9,CYP2C9,Humans
17698,DB12319,Benzbromarone,"['investigational', 'withdrawn']",BE0003536,Cytochrome P450 2C19,CYP2C19,Humans
17699,DB12323,Radotinib,['investigational'],BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
17700,DB12328,Cantharidin,"['approved', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
17702,DB12332,Rucaparib,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
17703,DB12332,Rucaparib,"['approved', 'investigational']",BE0003798,Poly [ADP-ribose] polymerase 2,PARP2,Humans
17704,DB12332,Rucaparib,"['approved', 'investigational']",BE0004049,Poly [ADP-ribose] polymerase 3,PARP3,Humans
17705,DB12334,Milataxel,['investigational'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
17706,DB12334,Milataxel,['investigational'],BE0000143,Tubulin beta chain,TUBB,Humans
17707,DB12339,Radezolid,['investigational'],BE0003466,Ribosome-binding protein 1,RRBP1,Humans
17708,DB12339,Radezolid,['investigational'],BE0003467,60S ribosome subunit biogenesis protein NIP7 homolog,NIP7,Humans
17709,DB12340,Navitoclax,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
17710,DB12340,Navitoclax,['investigational'],BE0003420,Bcl-2-like protein 2,BCL2L2,Humans
17711,DB12340,Navitoclax,['investigational'],BE0003421,Bcl2 antagonist of cell death,BAD,Humans
17712,DB12364,Betrixaban,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
17713,DB12371,Siponimod,"['approved', 'investigational']",BE0002432,Sphingosine 1-phosphate receptor 5,S1PR5,Humans
17714,DB12371,Siponimod,"['approved', 'investigational']",BE0008652,Sphingosine 1-phosphate receptor 1,S1PR1,Humans
17720,DB12379,Indirubin,['investigational'],BE0003543,Cytochrome P450 1A1,CYP1A1,Humans
17721,DB12379,Indirubin,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
17722,DB12404,Remimazolam,"['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
17723,DB12404,Remimazolam,"['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
17725,DB12418,Saccharin,['investigational'],BE0003625,Carbonic anhydrase 3,CA3,Humans
17726,DB12436,Vofopitant,['investigational'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
17727,DB12442,Alvespimycin,['investigational'],BE0001120,Heat shock protein HSP 90-alpha,HSP90AA1,Humans
17728,DB12445,Nitroaspirin,['investigational'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
17729,DB12450,Propyl Gallate,['investigational'],BE0000123,Estrogen receptor alpha,ESR1,Humans
17736,DB12457,Rimegepant,"['approved', 'investigational']",BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
17737,DB12458,Muscimol,['investigational'],BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,Humans
17738,DB12458,Muscimol,['investigational'],BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,Humans
17739,DB12458,Muscimol,['investigational'],BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,Humans
17740,DB12465,Ketanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
17745,DB12478,Piribedil,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17746,DB12478,Piribedil,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
17747,DB12483,Copanlisib,"['approved', 'investigational']",BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,Humans
17748,DB12483,Copanlisib,"['approved', 'investigational']",BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
17749,DB12489,Mirvetuximab soravtansine,"['approved', 'investigational']",BE0003405,Folate receptor alpha,FOLR1,Humans
17750,DB12498,Mogamulizumab,"['approved', 'investigational']",BE0009787,C-C chemokine receptor type 4,CCR4,Humans
17751,DB12499,Clascoterone,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
17752,DB12500,Fedratinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
17753,DB12500,Fedratinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17754,DB12500,Fedratinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
17755,DB12518,Raclopride,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17756,DB12520,Plozalizumab,['investigational'],BE0003387,C-C chemokine receptor type 2,CCR2,Humans
17757,DB12530,Inebilizumab,"['approved', 'investigational']",BE0003496,B-lymphocyte antigen CD19,CD19,Humans
17758,DB12532,Oxetacaine,"['approved', 'investigational']",BE0009548,Gastrin,GAST,Humans
17759,DB12537,"1,2-Benzodiazepine","['approved', 'investigational']",BE0004797,GABA(A) Receptor,GABRA1,Humans
17760,DB12537,"1,2-Benzodiazepine","['approved', 'investigational']",BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
17761,DB12540,Lecozotan,['investigational'],BE0004958,5-hydroxytryptamine receptor 1,HTR1A,Humans
17762,DB12540,Lecozotan,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
17763,DB12543,Samidorphan,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
17764,DB12543,Samidorphan,"['approved', 'investigational']",BE0000632,Kappa-type opioid receptor,OPRK1,Humans
17765,DB12543,Samidorphan,"['approved', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
17766,DB12548,Sparsentan,['investigational'],BE0001060,Angiotensinogen,AGT,Humans
17767,DB12548,Sparsentan,['investigational'],BE0000521,Endothelin-1 receptor,EDNRA,Humans
17768,DB12555,Nelotanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
17769,DB12556,MK-5108,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
17770,DB12565,Abexinostat,['investigational'],BE0002365,Histone deacetylase 1,HDAC1,Humans
17771,DB12565,Abexinostat,['investigational'],BE0008667,Histone deacetylase,HDAC1,Humans
17772,DB12569,Tonapofylline,['investigational'],BE0000013,Adenosine receptor A1,ADORA1,Humans
17773,DB12579,JNJ-37822681,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17774,DB12582,Piperine,['investigational'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
17775,DB12589,Dacetuzumab,['investigational'],BE0001196,Tumor necrosis factor receptor superfamily member 5,CD40,Humans
17776,DB12597,Asciminib,"['approved', 'investigational']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
17777,DB12598,Nafamostat,['investigational'],BE0000048,Prothrombin,F2,Humans
17778,DB12598,Nafamostat,['investigational'],BE0000216,Coagulation factor X,F10,Humans
17779,DB12598,Nafamostat,['investigational'],BE0004672,Coagulation factor XII,F12,Humans
17780,DB12598,Nafamostat,['investigational'],BE0001739,Trypsin-1,PRSS1,Humans
17781,DB12598,Nafamostat,['investigational'],BE0001091,Kallikrein-1,KLK1,Humans
17782,DB12598,Nafamostat,['investigational'],BE0001085,Intercellular adhesion molecule 1,ICAM1,Humans
17783,DB12610,Ebselen,['investigational'],BE0000950,Bifunctional epoxide hydrolase 2,EPHX2,Humans
17784,DB12611,PF-477736,['investigational'],BE0003382,Serine/threonine-protein kinase Chk1,CHEK1,Humans
17785,DB12612,Ozanimod,"['approved', 'investigational']",BE0008652,Sphingosine 1-phosphate receptor 1,S1PR1,Humans
17786,DB12612,Ozanimod,"['approved', 'investigational']",BE0002432,Sphingosine 1-phosphate receptor 5,S1PR5,Humans
17789,DB12622,Lupeol,['investigational'],BE0000394,Neutrophil elastase,ELANE,Humans
17790,DB12637,Onapristone,['investigational'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
17792,DB12645,Givinostat,['investigational'],BE0008667,Histone deacetylase,HDAC1,Humans
17793,DB12651,Bardoxolone,['investigational'],BE0003460,Caspase-8,CASP8,Humans
17794,DB12662,Naveglitazar,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
17795,DB12668,Metenkefalin,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
17796,DB12668,Metenkefalin,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
17797,DB12670,Rolofylline,['investigational'],BE0000013,Adenosine receptor A1,ADORA1,Humans
17799,DB12688,Moxetumomab pasudotox,"['approved', 'investigational']",BE0000183,B-cell receptor CD22,CD22,Humans
17800,DB12688,Moxetumomab pasudotox,"['approved', 'investigational']",BE0004281,Elongation factor 2,EEF2,Humans
17801,DB12693,Ritanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
17802,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0005076,"Actin, aortic smooth muscle",ACTA2,Humans
17803,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004966,"Actin, cytoplasmic 1",ACTB,Humans
17804,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0003841,"ATP synthase subunit beta, mitochondrial",ATP5B,Humans
17805,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009021,"ATP synthase subunit e, mitochondrial",ATP5I,Humans
17806,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009022,"ATP synthase subunit g, mitochondrial",ATP5L,Humans
17807,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004474,Cytochrome b5 type B,CYB5B,Humans
17808,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009023,"Diablo homolog, mitochondrial",DIABLO,Humans
17809,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009024,F-box only protein 41,FBXO41,Humans
17810,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009025,Heterogeneous nuclear ribonucleoprotein F,HNRNPF,Humans
17811,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009026,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,Humans
17812,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009027,Heat shock 70 kDa protein 4,HSPA4,Humans
17813,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0003432,Heat shock protein beta-1,HSPB1,Humans
17814,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009028,"10 kDa heat shock protein, mitochondrial",HSPE1,Humans
17815,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009029,Heat shock protein 105 kDa,HSPH1,Humans
17816,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0000503,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,Humans
17817,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009030,Nuclear migration protein nudC,NUDC,Humans
17818,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009031,Pappalysin-1,PAPPA,Humans
17819,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0003912,Proteasome subunit alpha type-3,PSMA3,Humans
17820,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009032,26S protease regulatory subunit 6A,PSMC3,Humans
17821,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0008978,Ran-specific GTPase-activating protein,RANBP1,Humans
17822,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009033,Protein S100-A10,S100A10,Humans
17823,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009034,Splicing factor 3A subunit 3,SF3A3,Humans
17824,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009035,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,SMARCE1,Humans
17825,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0000355,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",SUCLG2,Humans
17826,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009036,Tumor protein D54,TPD52L2,Humans
17827,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009037,Tropomyosin alpha-1 chain,TPM1,Humans
17828,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009038,Tropomyosin alpha-3 chain,TPM3,Humans
17829,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009039,Tropomyosin alpha-4 chain,TPM4,Humans
17830,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
17831,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001425,Tubulin alpha-3C/D chain,TUBA3C,Humans
17832,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001391,Tubulin alpha-4A chain,TUBA4A,Humans
17833,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0000026,Tubulin beta-1 chain,TUBB1,Humans
17834,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0003400,Tubulin beta-2A chain,TUBB2A,Humans
17835,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001415,Tubulin beta-3 chain,TUBB3,Humans
17836,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001367,Tubulin beta-4B chain,TUBB4B,Humans
17837,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004965,Thioredoxin,TXN,Humans
17838,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0005767,Ubiquitin carboxyl-terminal hydrolase isozyme L1,UCHL1,Humans
17839,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009040,Ubiquitin carboxyl-terminal hydrolase 14,USP14,Humans
17840,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004572,Transitional endoplasmic reticulum ATPase,VCP,Humans
17841,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004469,Vimentin,VIM,Humans
17842,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0008974,14-3-3 protein beta/alpha,YWHAB,Humans
17843,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0004570,14-3-3 protein epsilon,YWHAE,Humans
17844,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009041,14-3-3 protein eta,YWHAH,Humans
17845,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0009042,14-3-3 protein theta,YWHAQ,Humans
17846,DB12695,Phenethyl Isothiocyanate,['investigational'],BE0001174,14-3-3 protein zeta/delta,YWHAZ,Humans
17847,DB12698,Ibalizumab,"['approved', 'investigational']",BE0000911,C-C chemokine receptor type 5,CCR5,Humans
17848,DB12698,Ibalizumab,"['approved', 'investigational']",BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
17849,DB12698,Ibalizumab,"['approved', 'investigational']",BE0003488,T-cell surface glycoprotein CD4,CD4,Humans
17850,DB12702,Velusetrag,['investigational'],BE0000084,5-hydroxytryptamine receptor 4,HTR4,Humans
17851,DB12709,Tributyrin,['investigational'],BE0001162,Caspase-3,CASP3,Humans
17852,DB12713,Sotagliflozin,"['approved', 'investigational']",BE0004753,Sodium/glucose cotransporter 2,SLC5A2,Humans
17853,DB12713,Sotagliflozin,"['approved', 'investigational']",BE0004754,Sodium/glucose cotransporter 1,SLC5A1,Humans
17854,DB12715,MSX-122,['investigational'],BE0000919,C-X-C chemokine receptor type 4,CXCR4,Humans
17855,DB12731,Daporinad,['investigational'],BE0002413,Nicotinamide phosphoribosyltransferase,NAMPT,Humans
17856,DB12733,Dipraglurant,['investigational'],BE0001192,Metabotropic glutamate receptor 5,GRM5,Humans
17857,DB12741,DTP-348,['investigational'],BE0002437,Carbonic anhydrase 9,CA9,Humans
17858,DB12742,Amuvatinib,['investigational'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
17859,DB12742,Amuvatinib,['investigational'],BE0000915,Hepatocyte growth factor receptor,MET,Humans
17860,DB12742,Amuvatinib,['investigational'],BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
17861,DB12742,Amuvatinib,['investigational'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
17862,DB12742,Amuvatinib,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17863,DB12742,Amuvatinib,['investigational'],BE0002412,DNA repair protein RAD51 homolog 1,RAD51,Humans
17864,DB12747,Tertomotide,['investigational'],BE0002449,Telomerase reverse transcriptase,TERT,Humans
17866,DB12756,TAK-901,['investigational'],BE0003404,Aurora kinase B,AURKB,Humans
17867,DB12756,TAK-901,['investigational'],BE0010137,Apoptosis regulator BAX,BAX,Humans
17868,DB12764,Opaganib,['investigational'],BE0010025,Sphingosine kinase 2,SPHK2,Humans
17870,DB12773,Sifalimumab,['investigational'],BE0003450,Interferon alpha-2,IFNA2,Humans
17871,DB12783,Benserazide,"['approved', 'investigational']",BE0002151,Aromatic-L-amino-acid decarboxylase,DDC,Humans
17872,DB12789,Dinoprost,"['approved', 'investigational']",BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
17873,DB12808,Trifarotene,"['approved', 'investigational']",BE0000144,Retinoic acid receptor gamma,RARG,Humans
17874,DB12808,Trifarotene,"['approved', 'investigational']",BE0000206,Retinoic acid receptor beta,RARB,Humans
17875,DB12808,Trifarotene,"['approved', 'investigational']",BE0000663,Retinoic acid receptor alpha,RARA,Humans
17876,DB12816,Terpinen-4-ol,['investigational'],BE0000426,Acetylcholinesterase,ACHE,Humans
17877,DB12816,Terpinen-4-ol,['investigational'],BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
17878,DB12816,Terpinen-4-ol,['investigational'],BE0001156,E3 ubiquitin-protein ligase XIAP,XIAP,Humans
17879,DB12816,Terpinen-4-ol,['investigational'],BE0009545,Intestinal-type alkaline phosphatase,ALPI,Humans
17880,DB12816,Terpinen-4-ol,['investigational'],BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
17882,DB12831,Gabexate,['investigational'],BE0002440,Plasma kallikrein,KLKB1,Humans
17883,DB12831,Gabexate,['investigational'],BE0000048,Prothrombin,F2,Humans
17884,DB12831,Gabexate,['investigational'],BE0000211,Plasminogen,PLG,Humans
17885,DB12836,Grapiprant,"['investigational', 'vet_approved']",BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
17886,DB12843,Oleandrin,"['experimental', 'investigational']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
17887,DB12843,Oleandrin,"['experimental', 'investigational']",BE0000642,72 kDa type IV collagenase,MMP2,Humans
17888,DB12843,Oleandrin,"['experimental', 'investigational']",BE0000246,Apoptosis regulator Bcl-2,BCL2,Humans
17889,DB12843,Oleandrin,"['experimental', 'investigational']",BE0001094,Beta-nerve growth factor,NGF,Humans
17890,DB12843,Oleandrin,"['experimental', 'investigational']",BE0001162,Caspase-3,CASP3,Humans
17891,DB12843,Oleandrin,"['experimental', 'investigational']",BE0003460,Caspase-8,CASP8,Humans
17892,DB12843,Oleandrin,"['experimental', 'investigational']",BE0004549,Ephrin type-B receptor 2,EPHB2,Humans
17893,DB12843,Oleandrin,"['experimental', 'investigational']",BE0000961,Interleukin-8,CXCL8,Humans
17895,DB12843,Oleandrin,"['experimental', 'investigational']",BE0000953,Pro-epidermal growth factor,EGF,Humans
17896,DB12843,Oleandrin,"['experimental', 'investigational']",BE0002386,Serine/threonine-protein kinase mTOR,MTOR,Humans
17897,DB12845,Amatuximab,['investigational'],BE0003459,Mesothelin,MSLN,Humans
17898,DB12847,Pyroxamide,['investigational'],BE0008667,Histone deacetylase,HDAC1,Humans
17899,DB12852,MK-0752,['investigational'],BE0003409,Gamma-secretase subunit APH-1A,APH1A,Humans
17901,DB12865,Etelcalcetide,"['approved', 'investigational']",BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
17902,DB12872,Vonicog alfa,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
17903,DB12872,Vonicog alfa,"['approved', 'investigational']",BE0000025,Collagen alpha-1(I) chain,COL1A1,Humans
17904,DB12874,Quizartinib,['investigational'],BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17905,DB12887,Tazemetostat,"['approved', 'investigational']",BE0009562,Histone-lysine N-methyltransferase EZH2,EZH2,Humans
17906,DB12887,Tazemetostat,"['approved', 'investigational']",BE0009849,Histone-lysine N-methyltransferase EZH1,EZH1,Humans
17907,DB12890,Dihydrexidine,['investigational'],BE0000020,Dopamine D1 receptor,DRD1,Humans
17908,DB12893,Sacituzumab govitecan,"['approved', 'investigational']",BE0009918,Tumor-associated calcium signal transducer 2,TACSTD2,Humans
17909,DB12893,Sacituzumab govitecan,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
17910,DB12893,Sacituzumab govitecan,"['approved', 'investigational']",BE0003422,Far upstream element-binding protein 1,FUBP1,Humans
17911,DB12917,Bimekizumab,"['approved', 'investigational']",BE0005863,Interleukin-17A,IL17A,Humans
17912,DB12917,Bimekizumab,"['approved', 'investigational']",BE0010184,Interleukin-17F,IL17F,Humans
17915,DB12941,Darolutamide,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
17916,DB12941,Darolutamide,"['approved', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
17917,DB12960,INCB-9471,['investigational'],BE0000911,C-C chemokine receptor type 5,CCR5,Humans
17918,DB12961,Leukotriene B4,['investigational'],BE0003490,Leukotriene B4 receptor 1,LTB4R,Humans
17919,DB12961,Leukotriene B4,['investigational'],BE0003489,Leukotriene B4 receptor 2,LTB4R2,Humans
17920,DB12961,Leukotriene B4,['investigational'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
17921,DB12965,Silver,"['approved', 'investigational']",BE0008688,Metallothionein,MTF1,Humans
17922,DB12965,Silver,"['approved', 'investigational']",BE0001140,Ceruloplasmin,CP,Humans
17923,DB12965,Silver,"['approved', 'investigational']",BE0000530,Serum albumin,ALB,Humans
17924,DB12965,Silver,"['approved', 'investigational']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
17925,DB12978,Pexidartinib,"['approved', 'investigational']",BE0000853,Macrophage colony-stimulating factor 1 receptor,CSF1R,Humans
17926,DB12978,Pexidartinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
17927,DB12978,Pexidartinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
17928,DB12978,Pexidartinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
17929,DB12980,CHS-828,['investigational'],BE0002413,Nicotinamide phosphoribosyltransferase,NAMPT,Humans
17930,DB13003,Cortivazol,['investigational'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
17932,DB13009,Carbendazim,['investigational'],BE0003721,Aryl hydrocarbon receptor,AHR,Humans
17933,DB13014,Hypericin,['investigational'],BE0002281,Glutathione S-transferase A1,GSTA1,Humans
17934,DB13014,Hypericin,['investigational'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
17935,DB13025,Tiapride,['investigational'],BE0000756,Dopamine D2 receptor,DRD2,Humans
17936,DB13025,Tiapride,['investigational'],BE0000581,Dopamine D3 receptor,DRD3,Humans
17937,DB13025,Tiapride,['investigational'],BE0004862,Serotonin Receptors,HTR1A,Humans
17938,DB13025,Tiapride,['investigational'],BE0004863,Alpha-1 adrenergic receptors,ADRA1A,Humans
17939,DB13025,Tiapride,['investigational'],BE0004864,Alpha-2 adrenergic receptors,ADRA2A,Humans
17940,DB13036,Ramatroban,['investigational'],BE0003561,Prostaglandin D2 receptor 2,PTGDR2,Humans
17941,DB13044,Gossypol,['investigational'],BE0003510,Bcl-2-like protein 1,BCL2L1,Humans
17942,DB13048,PAC-1,['investigational'],BE0001162,Caspase-3,CASP3,Humans
17944,DB13061,MLN8054,['investigational'],BE0000991,Aurora kinase A,AURKA,Humans
17945,DB13074,Macimorelin,"['approved', 'investigational']",BE0003383,Growth hormone secretagogue receptor type 1,GHSR,Humans
17946,DB13083,Talarozole,['investigational'],BE0003480,Cytochrome P450 26A1,CYP26A1,Humans
17949,DB13123,OTX-008,['investigational'],BE0004493,Galectin-1,LGALS1,Humans
17950,DB13125,Lusutrombopag,"['approved', 'investigational']",BE0003440,Thrombopoietin receptor,MPL,Humans
17951,DB13127,Olokizumab,['investigational'],BE0000918,Interleukin-6,IL6,Humans
17952,DB13133,Von Willebrand factor human,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
17953,DB13133,Von Willebrand factor human,"['approved', 'investigational']",BE0000025,Collagen alpha-1(I) chain,COL1A1,Humans
17954,DB13133,Von Willebrand factor human,"['approved', 'investigational']",BE0010188,Asialoglycoprotein receptor 1,ASGR1,Humans
17955,DB13133,Von Willebrand factor human,"['approved', 'investigational']",BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
17956,DB13139,Levosalbutamol,"['approved', 'investigational']",BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
17958,DB13144,Lenograstim,"['approved', 'investigational']",BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
17961,DB13146,Fluciclovine (18F),['approved'],BE0000236,Neutral amino acid transporter B(0),SLC1A5,Humans
17962,DB13146,Fluciclovine (18F),['approved'],BE0004769,Y+L amino acid transporter 1,SLC7A7,Humans
17963,DB13146,Fluciclovine (18F),['approved'],BE0000136,Cationic amino acid transporter 3,SLC7A3,Humans
17964,DB13146,Fluciclovine (18F),['approved'],BE0004852,Glutamate (NMDA) receptor,GRIN1,Humans
17965,DB13146,Fluciclovine (18F),['approved'],BE0000640,Glutamate receptor 1,GRIA1,Humans
17966,DB13146,Fluciclovine (18F),['approved'],BE0000829,Glutamate receptor 2,GRIA2,Humans
17967,DB13146,Fluciclovine (18F),['approved'],BE0000831,Glutamate receptor 3,GRIA3,Humans
17968,DB13146,Fluciclovine (18F),['approved'],BE0000830,Glutamate receptor 4,GRIA4,Humans
17970,DB13149,Protein S human,['approved'],BE0000041,Coagulation factor V,F5,Humans
17971,DB13149,Protein S human,['approved'],BE0000216,Coagulation factor X,F10,Humans
17972,DB13149,Protein S human,['approved'],BE0000380,Vitamin K-dependent protein C,PROC,Humans
17973,DB13150,Coagulation factor VII human,"['approved', 'investigational']",BE0001178,Tissue factor,F3,Humans
17974,DB13150,Coagulation factor VII human,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
17975,DB13150,Coagulation factor VII human,"['approved', 'investigational']",BE0000364,Coagulation factor IX,F9,Humans
17976,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
17977,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
17978,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
17979,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0002091,Fibrinogen beta chain,FGB,Humans
17980,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000004,Coagulation factor XIII A chain,F13A1,Humans
17981,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000041,Coagulation factor V,F5,Humans
17982,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
17983,DB13151,Anti-inhibitor coagulant complex,"['approved', 'investigational']",BE0000333,Coagulation factor VII,F7,Humans
17984,DB13152,Coagulation Factor IX Human,['approved'],BE0000216,Coagulation factor X,F10,Humans
17985,DB13152,Coagulation Factor IX Human,['approved'],BE0001021,Coagulation factor XI,F11,Humans
17986,DB13152,Coagulation Factor IX Human,['approved'],BE0000333,Coagulation factor VII,F7,Humans
17987,DB13152,Coagulation Factor IX Human,['approved'],BE0000016,Coagulation factor VIII,F8,Humans
17988,DB13152,Coagulation Factor IX Human,['approved'],BE0000048,Prothrombin,F2,Humans
17989,DB13152,Coagulation Factor IX Human,['approved'],BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
17990,DB13152,Coagulation Factor IX Human,['approved'],BE0000403,Vitamin K-dependent gamma-carboxylase,GGCX,Humans
17991,DB13154,Parachlorophenol,['approved'],BE0002083,Sodium channel protein type 4 subunit alpha,SCN4A,Humans
17992,DB13155,Esculin,['approved'],BE0000132,Androgen receptor,AR,Humans
17993,DB13158,Clobetasone,['approved'],BE0000794,Glucocorticoid receptor,NR3C1,Humans
17994,DB13161,Nusinersen,"['approved', 'investigational']",BE0009143,Survival motor neuron protein,SMN2,Humans
17995,DB13164,Olmutinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
17996,DB13165,Ripasudil,['experimental'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
17997,DB13165,Ripasudil,['experimental'],BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
17998,DB13166,Zofenopril,['approved'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
17999,DB13167,Alclofenac,"['approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18000,DB13170,Plecanatide,"['approved', 'investigational']",BE0003578,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,Humans
18001,DB13173,Cerliponase alfa,"['approved', 'investigational']",BE0003623,Cation-independent mannose-6-phosphate receptor,IGF2R,Humans
18002,DB13174,Rhein,['experimental'],BE0003781,Oxysterols receptor LXR-alpha,NR1H3,Humans
18003,DB13174,Rhein,['experimental'],BE0001598,Oxysterols receptor LXR-beta,NR1H2,Humans
18005,DB13174,Rhein,['experimental'],BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
18008,DB13179,Troleandomycin,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18009,DB13191,Phosphocreatine,['nutraceutical'],BE0000567,Guanidinoacetate N-methyltransferase,GAMT,Humans
18010,DB13191,Phosphocreatine,['nutraceutical'],BE0000375,Sodium- and chloride-dependent creatine transporter 1,SLC6A8,Humans
18011,DB13191,Phosphocreatine,['nutraceutical'],BE0000714,Creatine kinase M-type,CKM,Humans
18012,DB13191,Phosphocreatine,['nutraceutical'],BE0000171,"Creatine kinase U-type, mitochondrial",CKMT1A,Humans
18013,DB13191,Phosphocreatine,['nutraceutical'],BE0000410,"Creatine kinase S-type, mitochondrial",CKMT2,Humans
18014,DB13191,Phosphocreatine,['nutraceutical'],BE0000082,Creatine kinase B-type,CKB,Humans
18015,DB13192,Antihemophilic factor human,['approved'],BE0000364,Coagulation factor IX,F9,Humans
18016,DB13192,Antihemophilic factor human,['approved'],BE0000216,Coagulation factor X,F10,Humans
18017,DB13200,Lipegfilgrastim,"['approved', 'investigational']",BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
18018,DB13242,Bucladesine,['experimental'],BE0000240,Plasminogen activator inhibitor 1,SERPINE1,Humans
18019,DB13257,Ferrous sulfate anhydrous,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18020,DB13257,Ferrous sulfate anhydrous,['approved'],BE0004850,Transferrin receptor,TFRC,Humans
18021,DB13269,Dichlorobenzyl alcohol,['approved'],BE0004901,Sodium channel protein,SCN1A,Humans
18022,DB13310,Ormeloxifene,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18023,DB13310,Ormeloxifene,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
18024,DB13335,Pinazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18025,DB13335,Pinazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18026,DB13345,Dihydroergocristine,"['approved', 'experimental']",BE0004862,Serotonin Receptors,HTR1A,Humans
18027,DB13345,Dihydroergocristine,"['approved', 'experimental']",BE0004872,Beta adrenergic receptor,ADRB1,Humans
18028,DB13345,Dihydroergocristine,"['approved', 'experimental']",BE0004888,Alpha adrenergic receptor,ADRA1A,Humans
18029,DB13345,Dihydroergocristine,"['approved', 'experimental']",BE0009376,Dopamine receptor,DRD1,Humans
18030,DB13346,Bufexamac,"['approved', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
18031,DB13346,Bufexamac,"['approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18032,DB13346,Bufexamac,"['approved', 'withdrawn']",BE0002368,Histone deacetylase 6,HDAC6,Humans
18033,DB13346,Bufexamac,"['approved', 'withdrawn']",BE0009579,Histone deacetylase 10,HDAC10,Humans
18035,DB13437,Medazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18036,DB13437,Medazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18038,DB13501,Bendazac,"['approved', 'withdrawn']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
18039,DB13501,Bendazac,"['approved', 'withdrawn']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18041,DB13503,Tyrothricin,['approved'],BE0000426,Acetylcholinesterase,ACHE,Humans
18043,DB13520,Metergoline,['approved'],BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
18044,DB13581,Rociverine,['experimental'],BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
18045,DB13581,Rociverine,['experimental'],BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
18046,DB13581,Rociverine,['experimental'],BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
18047,DB13581,Rociverine,['experimental'],BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
18048,DB13581,Rociverine,['experimental'],BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
18049,DB13615,Mifamurtide,"['approved', 'experimental']",BE0002442,Toll-like receptor 4,TLR4,Humans
18050,DB13615,Mifamurtide,"['approved', 'experimental']",BE0009323,Nucleotide-binding oligomerization domain-containing protein 2,NOD2,Humans
18051,DB13624,Methoxyphenamine,['approved'],BE0000694,Beta-2 adrenergic receptor,ADRB2,Humans
18052,DB13643,Loprazolam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18053,DB13643,Loprazolam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18054,DB13720,Diphemanil,"['approved', 'vet_approved', 'withdrawn']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
18055,DB13729,Camostat,['experimental'],BE0001739,Trypsin-1,PRSS1,Humans
18056,DB13729,Camostat,['experimental'],BE0009920,Transmembrane protease serine 2,TMPRSS2,Humans
18057,DB13729,Camostat,['experimental'],BE0001656,Suppressor of tumorigenicity 14 protein,ST14,Humans
18058,DB13729,Camostat,['experimental'],BE0009923,Cholecystokinin,CCK,Humans
18060,DB13746,Bioallethrin,"['approved', 'experimental']",BE0009738,Voltage-gated sodium channel alpha subunit,SCN1A,Humans
18061,DB13746,Bioallethrin,"['approved', 'experimental']",BE0004902,Voltage-dependent calcium channel,CACNG1,Humans
18062,DB13746,Bioallethrin,"['approved', 'experimental']",BE0008716,Voltage-dependent T-type calcium channel,CACNA1G,Humans
18063,DB13746,Bioallethrin,"['approved', 'experimental']",BE0008717,Voltage-dependent P/Q-type calcium channel,CACNA1A,Humans
18064,DB13746,Bioallethrin,"['approved', 'experimental']",BE0008715,Voltage-dependent L-type calcium channel,CACNA1C,Humans
18065,DB13751,Glycyrrhizic acid,"['approved', 'experimental']",BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,Humans
18066,DB13751,Glycyrrhizic acid,"['approved', 'experimental']",BE0000704,Tumor necrosis factor,TNF,Humans
18067,DB13751,Glycyrrhizic acid,"['approved', 'experimental']",BE0001162,Caspase-3,CASP3,Humans
18068,DB13751,Glycyrrhizic acid,"['approved', 'experimental']",BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
18069,DB13751,Glycyrrhizic acid,"['approved', 'experimental']",BE0000239,Lipoprotein lipase,LPL,Humans
18070,DB13760,Niperotidine,"['experimental', 'investigational']",BE0000112,Histamine H2 receptor,HRH2,Humans
18072,DB13781,Xamoterol,['approved'],BE0000172,Beta-1 adrenergic receptor,ADRB1,Humans
18073,DB13783,Acemetacin,"['approved', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
18074,DB13783,Acemetacin,"['approved', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18075,DB13800,Calcium levulinate,"['approved', 'experimental']",BE0000418,Calmodulin,CALM1,Humans
18076,DB13800,Calcium levulinate,"['approved', 'experimental']",BE0008699,Calsequestrin-1,CASQ1,Humans
18077,DB13800,Calcium levulinate,"['approved', 'experimental']",BE0008708,Calretinin,CALB2,Humans
18078,DB13837,Doxefazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18079,DB13837,Doxefazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18080,DB13857,Demegestone,['experimental'],BE0000557,Progesterone receptor,PGR,Humans
18081,DB13867,Fluticasone,"['approved', 'experimental']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18082,DB13867,Fluticasone,"['approved', 'experimental']",BE0000557,Progesterone receptor,PGR,Humans
18083,DB13867,Fluticasone,"['approved', 'experimental']",BE0000657,Cytosolic phospholipase A2,PLA2G4A,Humans
18084,DB13867,Fluticasone,"['approved', 'experimental']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
18086,DB13869,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
18087,DB13869,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18088,DB13872,Lormetazepam,['approved'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18089,DB13872,Lormetazepam,['approved'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18090,DB13873,Fenofibric acid,['approved'],BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
18091,DB13873,Fenofibric acid,['approved'],BE0009742,Matrix metalloproteinase-25,MMP25,Humans
18092,DB13873,Fenofibric acid,['approved'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18093,DB13873,Fenofibric acid,['approved'],BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
18094,DB13873,Fenofibric acid,['approved'],BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18095,DB13874,Enasidenib,"['approved', 'investigational']",BE0004527,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,Humans
18096,DB13875,Harmaline,['experimental'],BE0002436,Histamine N-methyltransferase,HNMT,Humans
18097,DB13876,Brofaromine,['experimental'],BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
18098,DB13877,Iniparib,['investigational'],BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
18101,DB13881,Tisagenlecleucel,"['approved', 'investigational']",BE0003496,B-lymphocyte antigen CD19,CD19,Humans
18102,DB13884,Albutrepenonacog alfa,['approved'],BE0000216,Coagulation factor X,F10,Humans
18103,DB13893,Crotalus adamanteus antivenin,"['approved', 'experimental']",BE0000070,Group 10 secretory phospholipase A2,PLA2G10,Humans
18104,DB13894,Agkistrodon piscivorus antivenin,"['approved', 'experimental']",BE0000070,Group 10 secretory phospholipase A2,PLA2G10,Humans
18116,DB13908,Amylmetacresol,['approved'],BE0002081,Sodium channel protein type 2 subunit alpha,SCN2A,Humans
18117,DB13914,Volixibat,"['experimental', 'investigational']",BE0003643,Ileal sodium/bile acid cotransporter,SLC10A2,Humans
18118,DB13915,Axicabtagene ciloleucel,['approved'],BE0003496,B-lymphocyte antigen CD19,CD19,Humans
18119,DB13919,Candesartan,['experimental'],BE0000062,Type-1 angiotensin II receptor,AGTR1,Humans
18120,DB13923,Emicizumab,"['approved', 'investigational']",BE0000364,Coagulation factor IX,F9,Humans
18121,DB13923,Emicizumab,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
18122,DB13925,Dotatate gallium Ga-68,"['approved', 'investigational']",BE0003528,Somatostatin receptor type 2,SSTR2,Humans
18123,DB13926,Cenegermin,"['approved', 'investigational']",BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
18124,DB13928,Semaglutide,"['approved', 'investigational']",BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
18125,DB13929,Relcovaptan,['investigational'],BE0000844,Oxytocin receptor,OXTR,Humans
18126,DB13929,Relcovaptan,['investigational'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
18127,DB13930,Ulixertinib,['investigational'],BE0001062,Mitogen-activated protein kinase 3,MAPK3,Humans
18128,DB13930,Ulixertinib,['investigational'],BE0000923,Mitogen-activated protein kinase 1,MAPK1,Humans
18129,DB13931,Netarsudil,['approved'],BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
18130,DB13931,Netarsudil,['approved'],BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
18131,DB13931,Netarsudil,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
18132,DB13932,Voretigene neparvovec,['approved'],BE0009149,Retinoid isomerohydrolase,RPE65,Humans
18133,DB13933,Nonacog beta pegol,"['approved', 'investigational']",BE0000333,Coagulation factor VII,F7,Humans
18134,DB13933,Nonacog beta pegol,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
18135,DB13933,Nonacog beta pegol,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
18136,DB13934,Ligandrol,['investigational'],BE0000132,Androgen receptor,AR,Humans
18137,DB13940,"2,5-Dimethoxy-4-ethylthioamphetamine",['experimental'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18138,DB13940,"2,5-Dimethoxy-4-ethylthioamphetamine",['experimental'],BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
18139,DB13943,Testosterone cypionate,['approved'],BE0000132,Androgen receptor,AR,Humans
18140,DB13943,Testosterone cypionate,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18141,DB13943,Testosterone cypionate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
18142,DB13944,Testosterone enanthate,['approved'],BE0000132,Androgen receptor,AR,Humans
18143,DB13944,Testosterone enanthate,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18144,DB13944,Testosterone enanthate,['approved'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
18145,DB13946,Testosterone undecanoate,"['approved', 'investigational']",BE0000132,Androgen receptor,AR,Humans
18146,DB13948,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",['experimental'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18147,DB13949,Ferric cation,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18149,DB13951,Stanolone acetate,['experimental'],BE0000132,Androgen receptor,AR,Humans
18150,DB13951,Stanolone acetate,['experimental'],BE0000194,Estradiol 17-beta-dehydrogenase 1,HSD17B1,Humans
18151,DB13951,Stanolone acetate,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18152,DB13951,Stanolone acetate,['experimental'],BE0000668,Mineralocorticoid receptor,NR3C2,Humans
18153,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18154,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
18155,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18156,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
18157,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
18158,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
18159,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
18160,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
18161,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
18162,DB13952,Estradiol acetate,"['approved', 'investigational', 'vet_approved']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
18163,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18164,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
18165,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18166,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
18167,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
18168,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
18169,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
18170,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
18171,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
18172,DB13953,Estradiol benzoate,"['approved', 'investigational', 'vet_approved']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
18173,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18174,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
18175,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18176,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
18177,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
18178,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
18179,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
18180,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
18181,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
18182,DB13954,Estradiol cypionate,"['approved', 'investigational', 'vet_approved']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
18183,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18184,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
18185,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18186,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
18187,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
18188,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
18189,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
18190,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
18191,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
18192,DB13955,Estradiol dienanthate,"['approved', 'investigational', 'vet_approved']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
18193,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18194,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0000792,Estrogen receptor beta,ESR2,Humans
18195,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18196,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0000849,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,Humans
18197,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0003740,Nuclear receptor coactivator 2,NCOA2,Humans
18198,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0003446,G-protein coupled estrogen receptor 1,GPER1,Humans
18199,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0009014,ATP synthase subunit a,MT-ATP6,Humans
18200,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0009015,Beclin-1,BECN1,Humans
18201,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0000006,Estradiol 17-beta-dehydrogenase 2,HSD17B2,Humans
18202,DB13956,Estradiol valerate,"['approved', 'investigational', 'vet_approved']",BE0002088,Estrogen-related receptor gamma,ESRRG,Humans
18204,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0008719,Diacylglycerol O-acyltransferase 2,DGAT2,Humans
18205,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18206,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0003399,Free fatty acid receptor 4,FFAR4,Humans
18207,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0009739,Voltage gated L-type calcium channel,CACNA1C,Humans
18208,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0004901,Sodium channel protein,SCN1A,Humans
18210,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0004903,Nuclear factor NF-kappa-B,NFKB2,Humans
18211,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0005540,Sterol regulatory element-binding protein 1,SREBF1,Humans
18212,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0000071,Peroxisome proliferator-activated receptor alpha,PPARA,Humans
18213,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18214,DB13961,Fish oil,"['approved', 'nutraceutical']",BE0001007,Peroxisome proliferator-activated receptor delta,PPARD,Humans
18215,DB13967,Patent Blue,['approved'],BE0000530,Serum albumin,ALB,Humans
18216,DB13978,Selisistat,['experimental'],BE0002461,NAD-dependent protein deacetylase sirtuin-1,SIRT1,Humans
18218,DB13983,"5,7,2??trihydroxy-6,8-dimethoxyflavone",['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18219,DB13985,Lutetium Lu 177 dotatate,"['approved', 'investigational']",BE0003528,Somatostatin receptor type 2,SSTR2,Humans
18220,DB13985,Lutetium Lu 177 dotatate,"['approved', 'investigational']",BE0000452,Somatostatin receptor type 1,SSTR1,Humans
18221,DB13985,Lutetium Lu 177 dotatate,"['approved', 'investigational']",BE0003529,Somatostatin receptor type 3,SSTR3,Humans
18222,DB13985,Lutetium Lu 177 dotatate,"['approved', 'investigational']",BE0009273,Somatostatin receptor type 4,SSTR4,Humans
18223,DB13985,Lutetium Lu 177 dotatate,"['approved', 'investigational']",BE0002147,Somatostatin receptor type 5,SSTR5,Humans
18224,DB13988,SB-269970,['investigational'],BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
18225,DB13994,AZD-7325,['investigational'],BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,Humans
18226,DB13994,AZD-7325,['investigational'],BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,Humans
18227,DB13995,Ferric pyrophosphate citrate,"['approved', 'investigational']",BE0000085,Ferritin light chain,FTL,Humans
18228,DB13995,Ferric pyrophosphate citrate,"['approved', 'investigational']",BE0000399,Ferritin heavy chain,FTH1,Humans
18229,DB13995,Ferric pyrophosphate citrate,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18230,DB13995,Ferric pyrophosphate citrate,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
18231,DB13996,Magnesium acetate,['approved'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18233,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0000216,Coagulation factor X,F10,Humans
18234,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0000364,Coagulation factor IX,F9,Humans
18235,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0001043,von Willebrand factor,VWF,Humans
18236,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,Humans
18237,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002118,Asialoglycoprotein receptor 2,ASGR2,Humans
18238,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0001098,78 kDa glucose-regulated protein,HSPA5,Humans
18239,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002109,Calreticulin,CALR,Humans
18240,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0001011,Calnexin,CANX,Humans
18241,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002119,Protein ERGIC-53,LMAN1,Humans
18242,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
18243,DB13998,Lonoctocog alfa,"['approved', 'investigational']",BE0002120,Multiple coagulation factor deficiency protein 2,MCFD2,Humans
18244,DB13999,Moroctocog alfa,['approved'],BE0000216,Coagulation factor X,F10,Humans
18245,DB13999,Moroctocog alfa,['approved'],BE0000364,Coagulation factor IX,F9,Humans
18246,DB13999,Moroctocog alfa,['approved'],BE0001043,von Willebrand factor,VWF,Humans
18247,DB13999,Moroctocog alfa,['approved'],BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,Humans
18248,DB13999,Moroctocog alfa,['approved'],BE0002118,Asialoglycoprotein receptor 2,ASGR2,Humans
18249,DB13999,Moroctocog alfa,['approved'],BE0001098,78 kDa glucose-regulated protein,HSPA5,Humans
18250,DB13999,Moroctocog alfa,['approved'],BE0002109,Calreticulin,CALR,Humans
18251,DB13999,Moroctocog alfa,['approved'],BE0001011,Calnexin,CANX,Humans
18252,DB13999,Moroctocog alfa,['approved'],BE0002119,Protein ERGIC-53,LMAN1,Humans
18253,DB13999,Moroctocog alfa,['approved'],BE0002110,Prolow-density lipoprotein receptor-related protein 1,LRP1,Humans
18254,DB13999,Moroctocog alfa,['approved'],BE0002120,Multiple coagulation factor deficiency protein 2,MCFD2,Humans
18255,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0000339,SEC14-like protein 3,SEC14L3,Humans
18256,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0000256,SEC14-like protein 2,SEC14L2,Humans
18257,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18258,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0000872,Protein kinase C beta type,PRKCB,Humans
18259,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
18260,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0001132,Protein kinase C alpha type,PRKCA,Humans
18261,DB14001,alpha-Tocopherol succinate,"['approved', 'nutraceutical', 'vet_approved']",BE0009935,Diacylglycerol kinase,DGKA,Humans
18263,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0000339,SEC14-like protein 3,SEC14L3,Humans
18264,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0000256,SEC14-like protein 2,SEC14L2,Humans
18265,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18266,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0000872,Protein kinase C beta type,PRKCB,Humans
18267,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0000248,Arachidonate 5-lipoxygenase,ALOX5,Humans
18268,DB14002,D-alpha-Tocopherol acetate,"['approved', 'nutraceutical', 'vet_approved']",BE0001132,Protein kinase C alpha type,PRKCA,Humans
18270,DB14004,Tildrakizumab,"['approved', 'investigational']",BE0008663,Interleukin-23,IL12B,Humans
18271,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0000494,Choline-phosphate cytidylyltransferase B,PCYT1B,Humans
18272,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0000426,Acetylcholinesterase,ACHE,Humans
18273,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0000615,Choline-phosphate cytidylyltransferase A,PCYT1A,Humans
18274,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0002179,Phospholipase D2,PLD2,Humans
18275,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0002180,Cholinesterase,BCHE,Humans
18276,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0002181,Phospholipase D1,PLD1,Humans
18277,DB14006,Choline salicylate,"['approved', 'nutraceutical']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
18279,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000061,Cannabinoid receptor 1,CNR1,Humans
18280,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000095,Cannabinoid receptor 2,CNR2,Humans
18281,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009153,G-protein coupled receptor 12,GPR12,Humans
18282,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
18283,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0004857,Glycine receptor (alpha-1/beta),GLRA1,Humans
18284,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
18285,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0002304,N-arachidonyl glycine receptor,GPR18,Humans
18286,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0005802,G-protein coupled receptor 55,GPR55,Humans
18287,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
18288,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18289,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
18290,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000420,Delta-type opioid receptor,OPRD1,Humans
18291,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
18292,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18293,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
18294,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
18295,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
18296,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
18297,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
18298,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
18299,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009158,Transient receptor potential cation channel subfamily V member 2,TRPV2,Humans
18300,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
18301,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009159,Transient receptor potential cation channel subfamily V member 4,TRPV4,Humans
18302,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0002468,Voltage-dependent anion-selective channel protein 1,VDAC1,Humans
18303,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009157,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,NAPEPLD,Humans
18304,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009156,N-acylethanolamine-hydrolyzing acid amidase,NAAA,Humans
18305,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0009154,Arylalkylamine N-acetyltransferase,AANAT,Humans
18306,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0003997,Phospholipase A2,PLA2G1B,Humans
18307,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
18308,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
18309,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0001207,Catalase,CAT,Humans
18310,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0001185,Quinone oxidoreductase,CRYZ,Humans
18311,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000973,Sphingomyelin phosphodiesterase,SMPD1,Humans
18312,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000816,Glutathione peroxidase 1,GPX1,Humans
18313,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
18314,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
18315,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000693,"Indoleamine 2,3-dioxygenase 1",IDO1,Humans
18316,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
18317,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18318,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
18319,DB14009,Medical Cannabis,"['experimental', 'investigational']",BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,Humans
18320,DB14010,"5-methoxy-N,N-dimethyltryptamine","['experimental', 'illicit']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
18321,DB14010,"5-methoxy-N,N-dimethyltryptamine","['experimental', 'illicit']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18322,DB14011,Nabiximols,['investigational'],BE0000061,Cannabinoid receptor 1,CNR1,Humans
18323,DB14011,Nabiximols,['investigational'],BE0000095,Cannabinoid receptor 2,CNR2,Humans
18324,DB14011,Nabiximols,['investigational'],BE0009153,G-protein coupled receptor 12,GPR12,Humans
18325,DB14011,Nabiximols,['investigational'],BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
18326,DB14011,Nabiximols,['investigational'],BE0004857,Glycine receptor (alpha-1/beta),GLRA1,Humans
18327,DB14011,Nabiximols,['investigational'],BE0000414,Glycine receptor subunit alpha-3,GLRA3,Humans
18328,DB14011,Nabiximols,['investigational'],BE0002304,N-arachidonyl glycine receptor,GPR18,Humans
18329,DB14011,Nabiximols,['investigational'],BE0005802,G-protein coupled receptor 55,GPR55,Humans
18330,DB14011,Nabiximols,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
18331,DB14011,Nabiximols,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18332,DB14011,Nabiximols,['investigational'],BE0002341,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,Humans
18333,DB14011,Nabiximols,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
18334,DB14011,Nabiximols,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
18335,DB14011,Nabiximols,['investigational'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18336,DB14011,Nabiximols,['investigational'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
18337,DB14011,Nabiximols,['investigational'],BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,Humans
18338,DB14011,Nabiximols,['investigational'],BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,Humans
18339,DB14011,Nabiximols,['investigational'],BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,Humans
18340,DB14011,Nabiximols,['investigational'],BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
18341,DB14011,Nabiximols,['investigational'],BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
18342,DB14011,Nabiximols,['investigational'],BE0009158,Transient receptor potential cation channel subfamily V member 2,TRPV2,Humans
18343,DB14011,Nabiximols,['investigational'],BE0003416,Transient receptor potential cation channel subfamily V member 3,TRPV3,Humans
18344,DB14011,Nabiximols,['investigational'],BE0009159,Transient receptor potential cation channel subfamily V member 4,TRPV4,Humans
18345,DB14011,Nabiximols,['investigational'],BE0002468,Voltage-dependent anion-selective channel protein 1,VDAC1,Humans
18346,DB14011,Nabiximols,['investigational'],BE0000017,Prostaglandin G/H synthase 1,PTGS1,Humans
18347,DB14011,Nabiximols,['investigational'],BE0000262,Prostaglandin G/H synthase 2,PTGS2,Humans
18348,DB14011,Nabiximols,['investigational'],BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,Humans
18349,DB14011,Nabiximols,['investigational'],BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,Humans
18350,DB14011,Nabiximols,['investigational'],BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,Humans
18351,DB14011,Nabiximols,['investigational'],BE0000648,"Glutathione reductase, mitochondrial",GSR,Humans
18352,DB14011,Nabiximols,['investigational'],BE0000816,Glutathione peroxidase 1,GPX1,Humans
18353,DB14011,Nabiximols,['investigational'],BE0000693,"Indoleamine 2,3-dioxygenase 1",IDO1,Humans
18354,DB14011,Nabiximols,['investigational'],BE0009154,Arylalkylamine N-acetyltransferase,AANAT,Humans
18355,DB14011,Nabiximols,['investigational'],BE0001111,Cytochrome P450 1B1,CYP1B1,Humans
18356,DB14011,Nabiximols,['investigational'],BE0002362,Cytochrome P450 3A5,CYP3A5,Humans
18357,DB14011,Nabiximols,['investigational'],BE0002363,Cytochrome P450 2D6,CYP2D6,Humans
18358,DB14011,Nabiximols,['investigational'],BE0002433,Cytochrome P450 1A2,CYP1A2,Humans
18359,DB14011,Nabiximols,['investigational'],BE0003543,Cytochrome P450 1A1,CYP1A1,Humans
18360,DB14011,Nabiximols,['investigational'],BE0003612,Cytochrome P450 3A7,CYP3A7,Humans
18361,DB14011,Nabiximols,['investigational'],BE0001185,Quinone oxidoreductase,CRYZ,Humans
18362,DB14011,Nabiximols,['investigational'],BE0001207,Catalase,CAT,Humans
18363,DB14011,Nabiximols,['investigational'],BE0002194,Fatty-acid amide hydrolase 1,FAAH,Humans
18364,DB14011,Nabiximols,['investigational'],BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
18365,DB14011,Nabiximols,['investigational'],BE0009156,N-acylethanolamine-hydrolyzing acid amidase,NAAA,Humans
18366,DB14012,Burosumab,"['approved', 'investigational']",BE0009345,Fibroblast growth factor 23,FGF23,Humans
18367,DB14013,SR-9009,['experimental'],BE0009347,Nuclear receptor subfamily 1 group D member 1,NR1D1,Humans
18368,DB14013,SR-9009,['experimental'],BE0009348,Nuclear receptor subfamily 1 group D member 2,NR1D2,Humans
18369,DB14014,SR-9011,['experimental'],BE0009348,Nuclear receptor subfamily 1 group D member 2,NR1D2,Humans
18370,DB14014,SR-9011,['experimental'],BE0009347,Nuclear receptor subfamily 1 group D member 1,NR1D1,Humans
18371,DB14017,H3B-8800,['investigational'],BE0009359,Splicing factor 3B subunit 1,SF3B1,Humans
18372,DB14019,Fosnetupitant,['approved'],BE0000384,Neurokinin 1 receptor,TACR1,Humans
18373,DB14027,Taspoglutide,['investigational'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
18374,DB14028,Nordazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18375,DB14028,Nordazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18377,DB14034,Darglitazone,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18378,DB14039,Erenumab,"['approved', 'investigational']",BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
18379,DB14040,Eptinezumab,"['approved', 'investigational']",BE0001103,Calcitonin gene-related peptide 1,CALCA,Humans
18380,DB14040,Eptinezumab,"['approved', 'investigational']",BE0002370,Calcitonin gene-related peptide 2,CALCB,Humans
18381,DB14041,Fremanezumab,"['approved', 'investigational']",BE0001103,Calcitonin gene-related peptide 1,CALCA,Humans
18382,DB14041,Fremanezumab,"['approved', 'investigational']",BE0002370,Calcitonin gene-related peptide 2,CALCB,Humans
18383,DB14042,Galcanezumab,"['approved', 'investigational']",BE0001103,Calcitonin gene-related peptide 1,CALCA,Humans
18384,DB14042,Galcanezumab,"['approved', 'investigational']",BE0002370,Calcitonin gene-related peptide 2,CALCB,Humans
18386,DB14050,Cannabidivarin,['investigational'],BE0001023,Transient receptor potential cation channel subfamily V member 1,TRPV1,Humans
18387,DB14050,Cannabidivarin,['investigational'],BE0009158,Transient receptor potential cation channel subfamily V member 2,TRPV2,Humans
18388,DB14050,Cannabidivarin,['investigational'],BE0001122,Transient receptor potential cation channel subfamily A member 1,TRPA1,Humans
18389,DB14050,Cannabidivarin,['investigational'],BE0009155,Sn1-specific diacylglycerol lipase alpha,DAGLA,Humans
18394,DB14059,SC-236,"['experimental', 'investigational']",BE0009554,Nuclear factor NF-kappa-B complex,NFKB2,Humans
18396,DB14061,Hycanthone,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18397,DB14062,Concanamycin A,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18398,DB14063,Dexverapamil,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18399,DB14064,Emopamil,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18400,DB14065,Lomerizine,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18401,DB14066,Tetrandrine,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18402,DB14067,Dofequidar,"['experimental', 'investigational']",BE0002369,ATP-binding cassette sub-family B member 5,ABCB5,Humans
18403,DB14067,Dofequidar,"['experimental', 'investigational']",BE0001032,P-glycoprotein 1,ABCB1,Humans
18404,DB14068,Dexniguldipine,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18405,DB14069,ONT-093,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18406,DB14070,HM-30181,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18407,DB14071,Desmethylsertraline,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18408,DB14072,Reversin 121,['experimental'],BE0001032,P-glycoprotein 1,ABCB1,Humans
18410,DB14083,Bisphenol A diglycidyl ether,"['approved', 'experimental']",BE0008714,Cation channel sperm-associated protein 1,CATSPER1,Humans
18413,DB14109,alpha-Arbutin,"['approved', 'experimental']",BE0000876,Lysosomal alpha-glucosidase,GAA,Humans
18414,DB14123,Menthol,['approved'],BE0001186,Transient receptor potential cation channel subfamily M member 8,TRPM8,Humans
18418,DB14132,8-chlorotheophylline,['experimental'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
18419,DB14146,Loxicodegol,['investigational'],BE0000770,Mu-type opioid receptor,OPRM1,Humans
18420,DB14146,Loxicodegol,['investigational'],BE0000420,Delta-type opioid receptor,OPRD1,Humans
18421,DB14146,Loxicodegol,['investigational'],BE0000632,Kappa-type opioid receptor,OPRK1,Humans
18422,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000756,Dopamine D2 receptor,DRD2,Humans
18423,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
18424,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
18425,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000797,5-hydroxytryptamine receptor 1B,HTR1B,Humans
18426,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000659,5-hydroxytryptamine receptor 1D,HTR1D,Humans
18427,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000476,5-hydroxytryptamine receptor 1E,HTR1E,Humans
18428,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000020,Dopamine D1 receptor,DRD1,Humans
18429,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000145,Dopamine D5 receptor,DRD5,Humans
18430,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000581,Dopamine D3 receptor,DRD3,Humans
18431,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000389,Dopamine D4 receptor,DRD4,Humans
18432,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000533,5-hydroxytryptamine receptor 2C,HTR2C,Humans
18433,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000311,5-hydroxytryptamine receptor 3A,HTR3A,Humans
18434,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000945,5-hydroxytryptamine receptor 6,HTR6,Humans
18435,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000650,5-hydroxytryptamine receptor 7,HTR7,Humans
18436,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000442,Histamine H1 receptor,HRH1,Humans
18437,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000501,Alpha-1A adrenergic receptor,ADRA1A,Humans
18438,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000575,Alpha-1B adrenergic receptor,ADRA1B,Humans
18439,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000289,Alpha-2A adrenergic receptor,ADRA2A,Humans
18440,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000572,Alpha-2B adrenergic receptor,ADRA2B,Humans
18441,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000342,Alpha-2C adrenergic receptor,ADRA2C,Humans
18442,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000092,Muscarinic acetylcholine receptor M1,CHRM1,Humans
18443,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000560,Muscarinic acetylcholine receptor M2,CHRM2,Humans
18444,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000045,Muscarinic acetylcholine receptor M3,CHRM3,Humans
18445,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000405,Muscarinic acetylcholine receptor M4,CHRM4,Humans
18446,DB14185,Aripiprazole lauroxil,"['approved', 'investigational']",BE0000247,Muscarinic acetylcholine receptor M5,CHRM5,Humans
18447,DB14481,Calcium phosphate dihydrate,['approved'],BE0000509,Extracellular calcium-sensing receptor,CASR,Humans
18448,DB14481,Calcium phosphate dihydrate,['approved'],BE0002109,Calreticulin,CALR,Humans
18449,DB14481,Calcium phosphate dihydrate,['approved'],BE0008691,Calcium and integrin-binding protein 1,CIB1,Humans
18450,DB14481,Calcium phosphate dihydrate,['approved'],BE0005812,Programmed cell death protein 6,PDCD6,Humans
18451,DB14481,Calcium phosphate dihydrate,['approved'],BE0008692,Sorcin,SRI,Humans
18452,DB14481,Calcium phosphate dihydrate,['approved'],BE0008693,Calcineurin B homologous protein 1,CHP1,Humans
18453,DB14481,Calcium phosphate dihydrate,['approved'],BE0002145,SPARC,SPARC,Humans
18454,DB14481,Calcium phosphate dihydrate,['approved'],BE0001011,Calnexin,CANX,Humans
18455,DB14481,Calcium phosphate dihydrate,['approved'],BE0008694,Fibrillin-2,FBN2,Humans
18456,DB14481,Calcium phosphate dihydrate,['approved'],BE0001177,Protein S100-B,S100B,Humans
18457,DB14481,Calcium phosphate dihydrate,['approved'],BE0008695,Calsequestrin-2,CASQ2,Humans
18458,DB14481,Calcium phosphate dihydrate,['approved'],BE0005259,Regucalcin,RGN,Humans
18459,DB14481,Calcium phosphate dihydrate,['approved'],BE0008696,Peflin,PEF1,Humans
18460,DB14481,Calcium phosphate dihydrate,['approved'],BE0002950,Protein S100-A6,S100A6,Humans
18461,DB14481,Calcium phosphate dihydrate,['approved'],BE0008697,Translationally-controlled tumor protein,TPT1,Humans
18462,DB14481,Calcium phosphate dihydrate,['approved'],BE0008698,Calcium and integrin-binding family member 2,CIB2,Humans
18463,DB14481,Calcium phosphate dihydrate,['approved'],BE0000885,Protein S100-A13,S100A13,Humans
18464,DB14481,Calcium phosphate dihydrate,['approved'],BE0008699,Calsequestrin-1,CASQ1,Humans
18465,DB14481,Calcium phosphate dihydrate,['approved'],BE0008700,Nucleobindin-1,NUCB1,Humans
18466,DB14481,Calcium phosphate dihydrate,['approved'],BE0008701,Nucleobindin-2,NUCB2,Humans
18467,DB14481,Calcium phosphate dihydrate,['approved'],BE0000418,Calmodulin,CALM1,Humans
18468,DB14481,Calcium phosphate dihydrate,['approved'],BE0008702,Fibrillin-3,FBN3,Humans
18469,DB14481,Calcium phosphate dihydrate,['approved'],BE0008703,Grancalcin,GCA,Humans
18470,DB14481,Calcium phosphate dihydrate,['approved'],BE0008704,Calcium-dependent secretion activator 1,CADPS,Humans
18471,DB14481,Calcium phosphate dihydrate,['approved'],BE0008705,Calmodulin-2,CALM2,Humans
18472,DB14481,Calcium phosphate dihydrate,['approved'],BE0008706,Calmodulin-3,CALM3,Humans
18473,DB14481,Calcium phosphate dihydrate,['approved'],BE0008707,Protein S100-A16,S100A16,Humans
18474,DB14481,Calcium phosphate dihydrate,['approved'],BE0008708,Calretinin,CALB2,Humans
18475,DB14481,Calcium phosphate dihydrate,['approved'],BE0008709,Calcyphosin,CAPS,Humans
18476,DB14481,Calcium phosphate dihydrate,['approved'],BE0008710,Calcium-dependent secretion activator 2,CADPS2,Humans
18477,DB14481,Calcium phosphate dihydrate,['approved'],BE0008711,Calreticulin-3,CALR3,Humans
18478,DB14481,Calcium phosphate dihydrate,['approved'],BE0005274,Neurexin-1,NRXN1,Humans
18479,DB14481,Calcium phosphate dihydrate,['approved'],BE0004557,Neuronal calcium sensor 1,NCS1,Humans
18480,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005831,B1 bradykinin receptor,BDKRB1,Humans
18481,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
18482,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
18483,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
18484,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005807,Alpha-enolase,ENO1,Humans
18485,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
18486,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
18487,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
18488,DB14487,Zinc acetate,"['approved', 'investigational']",BE0008980,Protein disulfide-isomerase A3,PDIA3,Humans
18489,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
18490,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004590,Phosphoserine phosphatase,PSPH,Humans
18491,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003844,Triosephosphate isomerase,TPI1,Humans
18492,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004542,"Elongation factor Tu, mitochondrial",TUFM,Humans
18493,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18494,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000125,Interleukin-3,IL3,Humans
18495,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004779,Metallothionein-2,MT2A,Humans
18496,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005815,Copper chaperone for superoxide dismutase,CCS,Humans
18497,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
18498,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003523,Histone deacetylase 4,HDAC4,Humans
18499,DB14487,Zinc acetate,"['approved', 'investigational']",BE0008954,DNA-3-methyladenine glycosylase,MPG,Humans
18500,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005833,Semenogelin-1,SEMG1,Humans
18501,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
18502,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001608,Histone deacetylase 8,HDAC8,Humans
18503,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005834,Apoptosis regulatory protein Siva,SIVA1,Humans
18504,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
18505,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
18506,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003491,Insulin,INS,Humans
18507,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005835,Utrophin,UTRN,Humans
18508,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000187,Aspartoacylase,ASPA,Humans
18509,DB14487,Zinc acetate,"['approved', 'investigational']",BE0008955,Protein S100-A8,S100A8,Humans
18510,DB14487,Zinc acetate,"['approved', 'investigational']",BE0008993,Protein S100-A9,S100A9,Humans
18511,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
18512,DB14487,Zinc acetate,"['approved', 'investigational']",BE0008994,Tumor protein p73,TP73,Humans
18513,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003602,Protein S100-A2,S100A2,Humans
18514,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003380,Cellular tumor antigen p53,TP53,Humans
18515,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005770,Metallothionein-3,MT3,Humans
18516,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005812,Programmed cell death protein 6,PDCD6,Humans
18517,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005538,DAN domain family member 5,DAND5,Humans
18518,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004778,Metallothionein-1A,MT1A,Humans
18519,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009047,Alpha-1B-glycoprotein,A1BG,Humans
18520,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
18521,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001060,Angiotensinogen,AGT,Humans
18522,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009048,Alpha-2-HS-glycoprotein,AHSG,Humans
18523,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001213,Serum amyloid P-component,APCS,Humans
18524,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003449,Apolipoprotein A-I,APOA1,Humans
18525,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000922,Apolipoprotein A-II,APOA2,Humans
18526,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009049,Apolipoprotein A-IV,APOA4,Humans
18527,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005852,Apolipoprotein B receptor,APOBR,Humans
18528,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001119,Apolipoprotein E,APOE,Humans
18529,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009069,Apolipoprotein L1,APOL1,Humans
18530,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
18531,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
18532,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002093,Complement C1r subcomponent,C1R,Humans
18533,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
18534,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003455,Complement C3,C3,Humans
18535,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004686,Complement C4-B,C4B,Humans
18536,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009050,C4b-binding protein alpha chain,C4BPA,Humans
18537,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009070,C4b-binding protein beta chain,C4BPB,Humans
18538,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
18539,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009071,Lys-63-specific deubiquitinase BRCC36,BRCC3,Humans
18540,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009072,Complement component C8 alpha chain,C8A,Humans
18541,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009051,Complement component C8 beta chain,C8B,Humans
18542,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003266,Complement component C8 gamma chain,C8G,Humans
18543,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001701,Complement factor B,CFB,Humans
18544,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009053,Complement factor H,CFH,Humans
18545,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009054,Complement factor I,CFI,Humans
18546,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009055,Clusterin,CLU,Humans
18547,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001140,Ceruloplasmin,CP,Humans
18548,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003503,Carboxypeptidase N catalytic chain,CPN1,Humans
18549,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003504,Carboxypeptidase N subunit 2,CPN2,Humans
18550,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009073,Dermcidin,DCD,Humans
18551,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009074,Desmoplakin,DSP,Humans
18552,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004672,Coagulation factor XII,F12,Humans
18553,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009075,Coagulation factor XIII B chain,F13B,Humans
18554,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000048,Prothrombin,F2,Humans
18555,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009076,Ficolin-3,FCN3,Humans
18556,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
18557,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001180,Fibronectin,FN1,Humans
18558,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004161,Gelsolin,GSN,Humans
18559,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18560,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
18561,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009057,Haptoglobin-related protein,HPR,Humans
18562,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009077,Hornerin,HRNR,Humans
18563,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,Humans
18564,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005097,Ig alpha-1 chain C region,IGHA1,Humans
18565,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005098,Ig mu chain C region,IGHM,Humans
18566,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009078,Immunoglobulin kappa variable 1-17,IGKV1-17,Humans
18568,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009079,Immunoglobulin lambda variable 3-21,IGLV3-21,Humans
18569,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009080,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,Humans
18570,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,Humans
18571,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009081,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,Humans
18572,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009082,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,Humans
18574,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009084,Junction plakoglobin,JUP,Humans
18575,DB14487,Zinc acetate,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
18576,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001017,Kininogen-1,KNG1,Humans
18577,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009061,"Keratin, type II cytoskeletal 1",KRT1,Humans
18578,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009062,"Keratin, type I cytoskeletal 10",KRT10,Humans
18579,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009085,"Keratin, type I cytoskeletal 14",KRT14,Humans
18580,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009086,"Keratin, type I cytoskeletal 16",KRT16,Humans
18581,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009063,"Keratin, type II cytoskeletal 2 epidermal",KRT2,Humans
18582,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009087,"Keratin, type II cytoskeletal 5",KRT5,Humans
18583,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009088,"Keratin, type II cytoskeletal 6A",KRT6A,Humans
18584,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009064,"Keratin, type I cytoskeletal 9",KRT9,Humans
18585,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
18586,DB14487,Zinc acetate,"['approved', 'investigational']",BE0004613,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,Humans
18587,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
18588,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009089,Pregnancy zone protein,PZP,Humans
18589,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003756,Protein S100-A7,S100A7,Humans
18590,DB14487,Zinc acetate,"['approved', 'investigational']",BE0005533,Selenoprotein P,SEPP1,Humans
18591,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
18592,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009090,Alpha-1-antichymotrypsin,SERPINA3,Humans
18593,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009067,Kallistatin,SERPINA4,Humans
18594,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000209,Corticosteroid-binding globulin,SERPINA6,Humans
18595,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
18596,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
18597,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
18598,DB14487,Zinc acetate,"['approved', 'investigational']",BE0000337,Transthyretin,TTR,Humans
18599,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001068,Vitronectin,VTN,Humans
18600,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009092,Amyloid-like protein 1,APLP1,Humans
18601,DB14487,Zinc acetate,"['approved', 'investigational']",BE0009093,Amyloid-like protein 2,APLP2,Humans
18602,DB14487,Zinc acetate,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
18603,DB14487,Zinc acetate,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
18604,DB14488,Ferrous gluconate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18605,DB14488,Ferrous gluconate,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
18606,DB14488,Ferrous gluconate,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
18607,DB14488,Ferrous gluconate,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
18608,DB14488,Ferrous gluconate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18609,DB14488,Ferrous gluconate,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
18610,DB14488,Ferrous gluconate,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
18611,DB14488,Ferrous gluconate,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
18612,DB14488,Ferrous gluconate,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
18613,DB14488,Ferrous gluconate,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
18614,DB14488,Ferrous gluconate,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
18615,DB14488,Ferrous gluconate,['approved'],BE0001140,Ceruloplasmin,CP,Humans
18616,DB14488,Ferrous gluconate,['approved'],BE0000510,Serotransferrin,TF,Humans
18617,DB14489,Ferrous succinate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18618,DB14489,Ferrous succinate,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
18619,DB14489,Ferrous succinate,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
18620,DB14489,Ferrous succinate,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
18621,DB14489,Ferrous succinate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18622,DB14489,Ferrous succinate,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
18623,DB14489,Ferrous succinate,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
18624,DB14489,Ferrous succinate,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
18625,DB14489,Ferrous succinate,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
18626,DB14489,Ferrous succinate,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
18627,DB14489,Ferrous succinate,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
18628,DB14489,Ferrous succinate,['approved'],BE0001140,Ceruloplasmin,CP,Humans
18629,DB14489,Ferrous succinate,['approved'],BE0000510,Serotransferrin,TF,Humans
18630,DB14490,Ferrous ascorbate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18631,DB14490,Ferrous ascorbate,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
18632,DB14490,Ferrous ascorbate,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
18633,DB14490,Ferrous ascorbate,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
18634,DB14490,Ferrous ascorbate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18635,DB14490,Ferrous ascorbate,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
18636,DB14490,Ferrous ascorbate,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
18637,DB14490,Ferrous ascorbate,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
18638,DB14490,Ferrous ascorbate,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
18639,DB14490,Ferrous ascorbate,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
18640,DB14490,Ferrous ascorbate,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
18641,DB14490,Ferrous ascorbate,['approved'],BE0001140,Ceruloplasmin,CP,Humans
18642,DB14490,Ferrous ascorbate,['approved'],BE0000510,Serotransferrin,TF,Humans
18643,DB14491,Ferrous fumarate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18644,DB14491,Ferrous fumarate,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
18645,DB14491,Ferrous fumarate,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
18646,DB14491,Ferrous fumarate,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
18647,DB14491,Ferrous fumarate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18648,DB14491,Ferrous fumarate,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
18649,DB14491,Ferrous fumarate,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
18650,DB14491,Ferrous fumarate,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
18651,DB14491,Ferrous fumarate,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
18652,DB14491,Ferrous fumarate,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
18653,DB14491,Ferrous fumarate,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
18654,DB14491,Ferrous fumarate,['approved'],BE0001140,Ceruloplasmin,CP,Humans
18655,DB14491,Ferrous fumarate,['approved'],BE0000510,Serotransferrin,TF,Humans
18656,DB14498,Potassium acetate,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18657,DB14499,Potassium sulfate,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18658,DB14500,Potassium,"['approved', 'experimental']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18659,DB14501,Ferrous glycine sulfate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18660,DB14501,Ferrous glycine sulfate,['approved'],BE0002217,Egl nine homolog 1,EGLN1,Humans
18661,DB14501,Ferrous glycine sulfate,['approved'],BE0001608,Histone deacetylase 8,HDAC8,Humans
18662,DB14501,Ferrous glycine sulfate,['approved'],BE0008990,Alpha-hemoglobin-stabilizing protein,AHSP,Humans
18663,DB14501,Ferrous glycine sulfate,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18664,DB14501,Ferrous glycine sulfate,['approved'],BE0008991,"Frataxin, mitochondrial",FXN,Humans
18665,DB14501,Ferrous glycine sulfate,['approved'],BE0000399,Ferritin heavy chain,FTH1,Humans
18666,DB14501,Ferrous glycine sulfate,['approved'],BE0009013,Flap endonuclease 1,FEN1,Humans
18667,DB14501,Ferrous glycine sulfate,['approved'],BE0003175,Endonuclease 8-like 1,NEIL1,Humans
18668,DB14501,Ferrous glycine sulfate,['approved'],BE0005817,Endonuclease 8-like 2,NEIL2,Humans
18669,DB14501,Ferrous glycine sulfate,['approved'],BE0000113,DNA polymerase beta,POLB,Humans
18670,DB14501,Ferrous glycine sulfate,['approved'],BE0001140,Ceruloplasmin,CP,Humans
18671,DB14501,Ferrous glycine sulfate,['approved'],BE0000510,Serotransferrin,TF,Humans
18672,DB14507,Lithium citrate,['approved'],BE0000983,Inositol monophosphatase 2,IMPA2,Humans
18673,DB14507,Lithium citrate,['approved'],BE0001152,Inositol monophosphatase 1,IMPA1,Humans
18674,DB14507,Lithium citrate,['approved'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
18675,DB14507,Lithium citrate,['approved'],BE0000831,Glutamate receptor 3,GRIA3,Humans
18676,DB14508,Lithium succinate,['experimental'],BE0000983,Inositol monophosphatase 2,IMPA2,Humans
18677,DB14508,Lithium succinate,['experimental'],BE0001152,Inositol monophosphatase 1,IMPA1,Humans
18678,DB14508,Lithium succinate,['experimental'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
18679,DB14508,Lithium succinate,['experimental'],BE0000831,Glutamate receptor 3,GRIA3,Humans
18680,DB14509,Lithium carbonate,['approved'],BE0000983,Inositol monophosphatase 2,IMPA2,Humans
18681,DB14509,Lithium carbonate,['approved'],BE0001152,Inositol monophosphatase 1,IMPA1,Humans
18682,DB14509,Lithium carbonate,['approved'],BE0001065,Glycogen synthase kinase-3 beta,GSK3B,Humans
18683,DB14509,Lithium carbonate,['approved'],BE0000831,Glutamate receptor 3,GRIA3,Humans
18684,DB14512,Mometasone furoate,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18685,DB14512,Mometasone furoate,"['approved', 'investigational', 'vet_approved']",BE0000557,Progesterone receptor,PGR,Humans
18686,DB14514,Magnesium levulinate,['nutraceutical'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18687,DB14515,Magnesium lactate,['nutraceutical'],BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18688,DB14517,Aluminium phosphate,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
18689,DB14517,Aluminium phosphate,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18690,DB14517,Aluminium phosphate,"['approved', 'investigational']",BE0001091,Kallikrein-1,KLK1,Humans
18691,DB14517,Aluminium phosphate,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
18692,DB14518,Aluminum acetate,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
18693,DB14518,Aluminum acetate,"['approved', 'investigational']",BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,Humans
18694,DB14518,Aluminum acetate,"['approved', 'investigational']",BE0001091,Kallikrein-1,KLK1,Humans
18695,DB14518,Aluminum acetate,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
18696,DB14520,Tetraferric tricitrate decahydrate,['approved'],BE0008725,Transferrin receptor protein 1,TFRC,Humans
18698,DB14526,Chromic citrate,['experimental'],BE0001173,Cytochrome b5,CYB5A,Humans
18699,DB14527,Chromic nitrate,['approved'],BE0001173,Cytochrome b5,CYB5A,Humans
18700,DB14528,Chromium gluconate,['approved'],BE0001173,Cytochrome b5,CYB5A,Humans
18701,DB14529,Chromium nicotinate,"['approved', 'experimental']",BE0001173,Cytochrome b5,CYB5A,Humans
18702,DB14530,Chromous sulfate,['approved'],BE0001173,Cytochrome b5,CYB5A,Humans
18703,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005831,B1 bradykinin receptor,BDKRB1,Humans
18704,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
18705,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
18706,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
18707,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005807,Alpha-enolase,ENO1,Humans
18708,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
18709,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
18710,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
18711,DB14533,Zinc chloride,"['approved', 'investigational']",BE0008980,Protein disulfide-isomerase A3,PDIA3,Humans
18712,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
18713,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004590,Phosphoserine phosphatase,PSPH,Humans
18714,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003844,Triosephosphate isomerase,TPI1,Humans
18715,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004542,"Elongation factor Tu, mitochondrial",TUFM,Humans
18716,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18717,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000125,Interleukin-3,IL3,Humans
18718,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004779,Metallothionein-2,MT2A,Humans
18719,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005815,Copper chaperone for superoxide dismutase,CCS,Humans
18720,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002365,Histone deacetylase 1,HDAC1,Humans
18721,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003523,Histone deacetylase 4,HDAC4,Humans
18722,DB14533,Zinc chloride,"['approved', 'investigational']",BE0008954,DNA-3-methyladenine glycosylase,MPG,Humans
18723,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005833,Semenogelin-1,SEMG1,Humans
18724,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
18725,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001608,Histone deacetylase 8,HDAC8,Humans
18726,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005834,Apoptosis regulatory protein Siva,SIVA1,Humans
18727,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
18728,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
18729,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003491,Insulin,INS,Humans
18730,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005835,Utrophin,UTRN,Humans
18731,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000187,Aspartoacylase,ASPA,Humans
18732,DB14533,Zinc chloride,"['approved', 'investigational']",BE0008955,Protein S100-A8,S100A8,Humans
18733,DB14533,Zinc chloride,"['approved', 'investigational']",BE0008993,Protein S100-A9,S100A9,Humans
18734,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
18735,DB14533,Zinc chloride,"['approved', 'investigational']",BE0008994,Tumor protein p73,TP73,Humans
18736,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003602,Protein S100-A2,S100A2,Humans
18737,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003380,Cellular tumor antigen p53,TP53,Humans
18738,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005770,Metallothionein-3,MT3,Humans
18739,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004778,Metallothionein-1A,MT1A,Humans
18740,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
18741,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009048,Alpha-2-HS-glycoprotein,AHSG,Humans
18742,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003449,Apolipoprotein A-I,APOA1,Humans
18743,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005852,Apolipoprotein B receptor,APOBR,Humans
18744,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001119,Apolipoprotein E,APOE,Humans
18745,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009069,Apolipoprotein L1,APOL1,Humans
18746,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
18747,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
18748,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002093,Complement C1r subcomponent,C1R,Humans
18749,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
18750,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003455,Complement C3,C3,Humans
18751,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004686,Complement C4-B,C4B,Humans
18752,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009050,C4b-binding protein alpha chain,C4BPA,Humans
18753,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009070,C4b-binding protein beta chain,C4BPB,Humans
18754,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000855,Complement C5,C5,Humans
18755,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009071,Lys-63-specific deubiquitinase BRCC36,BRCC3,Humans
18756,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009053,Complement factor H,CFH,Humans
18757,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009055,Clusterin,CLU,Humans
18758,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001140,Ceruloplasmin,CP,Humans
18759,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003503,Carboxypeptidase N catalytic chain,CPN1,Humans
18760,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003504,Carboxypeptidase N subunit 2,CPN2,Humans
18761,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009073,Dermcidin,DCD,Humans
18762,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000538,Fibrinogen alpha chain,FGA,Humans
18763,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001180,Fibronectin,FN1,Humans
18764,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18765,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000629,Hemoglobin subunit beta,HBB,Humans
18766,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009911,Haptoglobin,HP,Humans
18767,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,Humans
18768,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009080,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,Humans
18769,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,Humans
18770,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009081,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,Humans
18771,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009082,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,Humans
18773,DB14533,Zinc chloride,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
18774,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001017,Kininogen-1,KNG1,Humans
18775,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009064,"Keratin, type I cytoskeletal 9",KRT9,Humans
18776,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
18777,DB14533,Zinc chloride,"['approved', 'investigational']",BE0004613,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,Humans
18778,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
18779,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009089,Pregnancy zone protein,PZP,Humans
18780,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003756,Protein S100-A7,S100A7,Humans
18781,DB14533,Zinc chloride,"['approved', 'investigational']",BE0005533,Selenoprotein P,SEPP1,Humans
18782,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
18783,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009090,Alpha-1-antichymotrypsin,SERPINA3,Humans
18784,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000209,Corticosteroid-binding globulin,SERPINA6,Humans
18785,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
18786,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
18787,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000510,Serotransferrin,TF,Humans
18788,DB14533,Zinc chloride,"['approved', 'investigational']",BE0000337,Transthyretin,TTR,Humans
18789,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001068,Vitronectin,VTN,Humans
18790,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009092,Amyloid-like protein 1,APLP1,Humans
18791,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009093,Amyloid-like protein 2,APLP2,Humans
18792,DB14533,Zinc chloride,"['approved', 'investigational']",BE0003392,Amyloid beta A4 protein,APP,Humans
18793,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
18794,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009908,Apolipoprotein B-100,APOB,Humans
18795,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009909,Hemopexin,HPX,Humans
18796,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009910,Histidine-rich glycoprotein,HRG,Humans
18797,DB14533,Zinc chloride,"['approved', 'investigational']",BE0001021,Coagulation factor XI,F11,Humans
18798,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009915,C->U-editing enzyme APOBEC-1,APOBEC1,Humans
18799,DB14533,Zinc chloride,"['approved', 'investigational']",BE0009916,Semenogelin-2,SEMG2,Humans
18800,DB14538,Hydrocortisone aceponate,"['experimental', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18801,DB14538,Hydrocortisone aceponate,"['experimental', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18802,DB14538,Hydrocortisone aceponate,"['experimental', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18803,DB14538,Hydrocortisone aceponate,"['experimental', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18804,DB14539,Hydrocortisone acetate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18805,DB14539,Hydrocortisone acetate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18806,DB14539,Hydrocortisone acetate,"['approved', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18807,DB14539,Hydrocortisone acetate,"['approved', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18808,DB14540,Hydrocortisone butyrate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18809,DB14540,Hydrocortisone butyrate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18810,DB14540,Hydrocortisone butyrate,"['approved', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18811,DB14540,Hydrocortisone butyrate,"['approved', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18812,DB14541,Hydrocortisone cypionate,"['approved', 'investigational', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18813,DB14541,Hydrocortisone cypionate,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18814,DB14541,Hydrocortisone cypionate,"['approved', 'investigational', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18815,DB14541,Hydrocortisone cypionate,"['approved', 'investigational', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18816,DB14542,Hydrocortisone phosphate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18817,DB14542,Hydrocortisone phosphate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18818,DB14542,Hydrocortisone phosphate,"['approved', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18819,DB14542,Hydrocortisone phosphate,"['approved', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18820,DB14543,Hydrocortisone probutate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18821,DB14543,Hydrocortisone probutate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18822,DB14543,Hydrocortisone probutate,"['approved', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18823,DB14543,Hydrocortisone probutate,"['approved', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18824,DB14544,Hydrocortisone valerate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18825,DB14544,Hydrocortisone valerate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18826,DB14544,Hydrocortisone valerate,"['approved', 'vet_approved']",BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,Humans
18827,DB14544,Hydrocortisone valerate,"['approved', 'vet_approved']",BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,Humans
18828,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005831,B1 bradykinin receptor,BDKRB1,Humans
18829,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001145,Methylated-DNA--protein-cysteine methyltransferase,MGMT,Humans
18830,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001683,Fructose-bisphosphate aldolase A,ALDOA,Humans
18831,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004528,Elongation factor 1-alpha 1,EEF1A1,Humans
18832,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005807,Alpha-enolase,ENO1,Humans
18833,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,Humans
18834,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003106,Nucleoside diphosphate kinase A,NME1,Humans
18835,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002467,Protein disulfide-isomerase,P4HB,Humans
18836,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0008980,Protein disulfide-isomerase A3,PDIA3,Humans
18837,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005844,Peroxiredoxin-1,PRDX1,Humans
18838,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004590,Phosphoserine phosphatase,PSPH,Humans
18839,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003844,Triosephosphate isomerase,TPI1,Humans
18840,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004542,"Elongation factor Tu, mitochondrial",TUFM,Humans
18841,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000123,Estrogen receptor alpha,ESR1,Humans
18842,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000125,Interleukin-3,IL3,Humans
18843,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004779,Metallothionein-2,MT2A,Humans
18844,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005815,Copper chaperone for superoxide dismutase,CCS,Humans
18845,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002365,Histone deacetylase 1,HDAC1,Humans
18846,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003523,Histone deacetylase 4,HDAC4,Humans
18847,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0008954,DNA-3-methyladenine glycosylase,MPG,Humans
18848,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005833,Semenogelin-1,SEMG1,Humans
18849,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002390,Superoxide dismutase [Cu-Zn],SOD1,Humans
18850,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001608,Histone deacetylase 8,HDAC8,Humans
18851,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005834,Apoptosis regulatory protein Siva,SIVA1,Humans
18852,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000433,Glycine receptor subunit alpha-1,GLRA1,Humans
18853,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001003,E3 ubiquitin-protein ligase Mdm2,MDM2,Humans
18854,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003491,Insulin,INS,Humans
18855,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005835,Utrophin,UTRN,Humans
18856,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000187,Aspartoacylase,ASPA,Humans
18857,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0008955,Protein S100-A8,S100A8,Humans
18858,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0008993,Protein S100-A9,S100A9,Humans
18859,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000058,Matrix metalloproteinase-9,MMP9,Humans
18860,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0008994,Tumor protein p73,TP73,Humans
18861,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003602,Protein S100-A2,S100A2,Humans
18862,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003380,Cellular tumor antigen p53,TP53,Humans
18863,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005770,Metallothionein-3,MT3,Humans
18864,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004778,Metallothionein-1A,MT1A,Humans
18865,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000910,Alpha-2-macroglobulin,A2M,Humans
18866,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009048,Alpha-2-HS-glycoprotein,AHSG,Humans
18867,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003449,Apolipoprotein A-I,APOA1,Humans
18868,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005852,Apolipoprotein B receptor,APOBR,Humans
18869,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001119,Apolipoprotein E,APOE,Humans
18870,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009069,Apolipoprotein L1,APOL1,Humans
18871,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002095,Complement C1q subcomponent subunit B,C1QB,Humans
18872,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002096,Complement C1q subcomponent subunit C,C1QC,Humans
18873,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002093,Complement C1r subcomponent,C1R,Humans
18874,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001529,Complement C1s subcomponent,C1S,Humans
18875,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003455,Complement C3,C3,Humans
18876,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004686,Complement C4-B,C4B,Humans
18877,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009050,C4b-binding protein alpha chain,C4BPA,Humans
18878,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009070,C4b-binding protein beta chain,C4BPB,Humans
18879,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000855,Complement C5,C5,Humans
18880,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009071,Lys-63-specific deubiquitinase BRCC36,BRCC3,Humans
18881,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009053,Complement factor H,CFH,Humans
18882,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009055,Clusterin,CLU,Humans
18883,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001140,Ceruloplasmin,CP,Humans
18884,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003503,Carboxypeptidase N catalytic chain,CPN1,Humans
18885,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003504,Carboxypeptidase N subunit 2,CPN2,Humans
18886,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009073,Dermcidin,DCD,Humans
18887,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000538,Fibrinogen alpha chain,FGA,Humans
18888,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001180,Fibronectin,FN1,Humans
18889,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
18890,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000629,Hemoglobin subunit beta,HBB,Humans
18891,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009911,Haptoglobin,HP,Humans
18892,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,Humans
18893,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009080,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,Humans
18894,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,Humans
18895,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009081,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,Humans
18896,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009082,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,Humans
18898,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0002440,Plasma kallikrein,KLKB1,Humans
18899,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001017,Kininogen-1,KNG1,Humans
18900,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009064,"Keratin, type I cytoskeletal 9",KRT9,Humans
18901,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003663,Alpha-1-acid glycoprotein 2,ORM2,Humans
18902,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0004613,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,Humans
18903,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000930,Serum paraoxonase/arylesterase 1,PON1,Humans
18904,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009089,Pregnancy zone protein,PZP,Humans
18905,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003756,Protein S100-A7,S100A7,Humans
18906,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0005533,Selenoprotein P,SEPP1,Humans
18907,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000952,Alpha-1-antitrypsin,SERPINA1,Humans
18908,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009090,Alpha-1-antichymotrypsin,SERPINA3,Humans
18909,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000209,Corticosteroid-binding globulin,SERPINA6,Humans
18910,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000775,Heparin cofactor 2,SERPIND1,Humans
18911,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000685,Sex hormone-binding globulin,SHBG,Humans
18912,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000510,Serotransferrin,TF,Humans
18913,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0000337,Transthyretin,TTR,Humans
18914,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001068,Vitronectin,VTN,Humans
18915,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009092,Amyloid-like protein 1,APLP1,Humans
18916,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009093,Amyloid-like protein 2,APLP2,Humans
18917,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0003392,Amyloid beta A4 protein,APP,Humans
18918,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001717,Poly [ADP-ribose] polymerase 1,PARP1,Humans
18919,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009908,Apolipoprotein B-100,APOB,Humans
18920,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009909,Hemopexin,HPX,Humans
18921,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009910,Histidine-rich glycoprotein,HRG,Humans
18922,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0001021,Coagulation factor XI,F11,Humans
18923,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009915,C->U-editing enzyme APOBEC-1,APOBEC1,Humans
18924,DB14548,"Zinc sulfate, unspecified form","['approved', 'experimental']",BE0009916,Semenogelin-2,SEMG2,Humans
18925,DB14562,Andexanet alfa,"['approved', 'investigational']",BE0000967,Tissue factor pathway inhibitor,TFPI,Humans
18926,DB14568,Ivosidenib,"['approved', 'investigational']",BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,Humans
18928,DB14575,Eslicarbazepine,['approved'],BE0005793,P2X purinoceptor 4,P2RX4,Humans
18929,DB14580,Lecanemab,['investigational'],BE0003392,Amyloid beta A4 protein,APP,Humans
18930,DB14581,CPI-1205,['investigational'],BE0009562,Histone-lysine N-methyltransferase EZH2,EZH2,Humans
18932,DB14583,Segesterone acetate,"['approved', 'experimental', 'investigational']",BE0000557,Progesterone receptor,PGR,Humans
18933,DB14583,Segesterone acetate,"['approved', 'experimental', 'investigational']",BE0000132,Androgen receptor,AR,Humans
18934,DB14583,Segesterone acetate,"['approved', 'experimental', 'investigational']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18935,DB14597,Lanadelumab,"['approved', 'investigational']",BE0002440,Plasma kallikrein,KLKB1,Humans
18942,DB14631,Prednisolone phosphate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18943,DB14631,Prednisolone phosphate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18944,DB14635,Curcumin sulfate,['experimental'],BE0000215,Peroxisome proliferator-activated receptor gamma,PPARG,Humans
18945,DB14635,Curcumin sulfate,['experimental'],BE0000779,Vitamin D3 receptor,VDR,Humans
18946,DB14635,Curcumin sulfate,['experimental'],BE0003639,Multidrug resistance-associated protein 5,ABCC5,Humans
18947,DB14635,Curcumin sulfate,['experimental'],BE0003074,Carbonyl reductase [NADPH] 1,CBR1,Humans
18948,DB14635,Curcumin sulfate,['experimental'],BE0000814,Glutathione S-transferase P,GSTP1,Humans
18949,DB14639,Boldenone undecylenate,"['illicit', 'vet_approved']",BE0000132,Androgen receptor,AR,Humans
18950,DB14641,Estriol tripropionate,['experimental'],BE0000123,Estrogen receptor alpha,ESR1,Humans
18951,DB14641,Estriol tripropionate,['experimental'],BE0000792,Estrogen receptor beta,ESR2,Humans
18952,DB14641,Estriol tripropionate,['experimental'],BE0000685,Sex hormone-binding globulin,SHBG,Humans
18953,DB14642,Lypressin,['approved'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
18954,DB14642,Lypressin,['approved'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
18955,DB14642,Lypressin,['approved'],BE0000773,Vasopressin V1b receptor,AVPR1B,Humans
18956,DB14649,Dexamethasone acetate,"['approved', 'investigational', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18957,DB14649,Dexamethasone acetate,"['approved', 'investigational', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18958,DB14649,Dexamethasone acetate,"['approved', 'investigational', 'vet_approved']",BE0000005,"Nitric oxide synthase, inducible",NOS2,Humans
18959,DB14649,Dexamethasone acetate,"['approved', 'investigational', 'vet_approved']",BE0000074,Nuclear receptor subfamily 0 group B member 1,NR0B1,Humans
18960,DB14649,Dexamethasone acetate,"['approved', 'investigational', 'vet_approved']",BE0000956,Nuclear receptor subfamily 1 group I member 2,NR1I2,Humans
18961,DB14669,Betamethasone phosphate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
18962,DB14669,Betamethasone phosphate,"['approved', 'vet_approved']",BE0000422,Annexin A1,ANXA1,Humans
18963,DB14672,Oxazepam acetate,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18964,DB14672,Oxazepam acetate,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18965,DB14700,Damoctocog alfa pegol,"['approved', 'investigational']",BE0000016,Coagulation factor VIII,F8,Humans
18966,DB14707,Cemiplimab,"['approved', 'investigational']",BE0003436,Programmed cell death protein 1,PDCD1,Humans
18969,DB14715,Cinazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18970,DB14715,Cinazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18971,DB14719,Bentazepam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
18972,DB14719,Bentazepam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
18973,DB14723,Larotrectinib,"['approved', 'investigational']",BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
18974,DB14723,Larotrectinib,"['approved', 'investigational']",BE0003605,BDNF/NT-3 growth factors receptor,NTRK2,Humans
18975,DB14723,Larotrectinib,"['approved', 'investigational']",BE0009501,NT-3 growth factor receptor,NTRK3,Humans
18976,DB14724,Emapalumab,"['approved', 'investigational']",BE0000944,Interferon gamma,IFNG,Humans
18978,DB14731,Tagraxofusp,"['approved', 'investigational']",BE0001036,Interleukin-3 receptor subunit alpha,IL3RA,Humans
18979,DB14738,Turoctocog alfa pegol,['approved'],BE0000364,Coagulation factor IX,F9,Humans
18980,DB14738,Turoctocog alfa pegol,['approved'],BE0000216,Coagulation factor X,F10,Humans
18981,DB14738,Turoctocog alfa pegol,['approved'],BE0000048,Prothrombin,F2,Humans
18982,DB14738,Turoctocog alfa pegol,['approved'],BE0001043,von Willebrand factor,VWF,Humans
18984,DB14740,Hyaluronidase,['approved'],BE0000984,Transforming growth factor beta-1,TGFB1,Humans
18986,DB14751,Mecasermin rinfabate,['approved'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
18987,DB14751,Mecasermin rinfabate,['approved'],BE0000033,Insulin receptor,INSR,Humans
18988,DB14751,Mecasermin rinfabate,['approved'],BE0003623,Cation-independent mannose-6-phosphate receptor,IGF2R,Humans
18990,DB14754,Solriamfetol,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
18991,DB14754,Solriamfetol,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
18996,DB14762,Risankizumab,"['approved', 'investigational']",BE0008663,Interleukin-23,IL12B,Humans
18997,DB14776,Camrelizumab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
18998,DB14776,Camrelizumab,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
18999,DB14783,Diroximel fumarate,"['approved', 'investigational']",BE0000411,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,Humans
19000,DB14785,Fenebrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19001,DB14805,Piflufolastat F 18,"['approved', 'investigational']",BE0000568,Glutamate carboxypeptidase 2,FOLH1,Humans
19002,DB14811,Isatuximab,"['approved', 'investigational']",BE0005459,ADP-ribosyl cyclase 1,CD38,Humans
19003,DB14840,Ripretinib,['approved'],BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
19004,DB14840,Ripretinib,['approved'],BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
19005,DB14840,Ripretinib,['approved'],BE0003379,Angiopoietin-1 receptor,TEK,Humans
19006,DB14840,Ripretinib,['approved'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
19007,DB14840,Ripretinib,['approved'],BE0000634,Serine/threonine-protein kinase B-raf,BRAF,Humans
19008,DB14840,Ripretinib,['approved'],BE0000852,Platelet-derived growth factor receptor alpha,PDGFRA,Humans
19009,DB14845,Filgotinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
19010,DB14851,Relatlimab,"['approved', 'investigational']",BE0010189,Lymphocyte activation gene 3 protein,LAG3,Humans
19011,DB14864,Brolucizumab,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
19017,DB14881,Oliceridine,"['approved', 'investigational']",BE0000770,Mu-type opioid receptor,OPRM1,Humans
19018,DB14892,Spartalizumab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19019,DB14895,Vibegron,"['approved', 'investigational']",BE0001012,Beta-3 adrenergic receptor,ADRB3,Humans
19020,DB14901,Inclisiran,"['approved', 'investigational']",BE0008643,Proprotein convertase subtilisin/kexin type 9,PCSK9,Humans
19021,DB14904,Pimasertib,['investigational'],BE0010124,Mitogen-activated protein kinase kinase (MAPKK),MAP2K1,Humans
19022,DB14914,Flortaucipir F-18,"['approved', 'investigational']",BE0003474,Microtubule-associated protein tau,MAPT,Humans
19023,DB14914,Flortaucipir F-18,"['approved', 'investigational']",BE0002198,Amine oxidase [flavin-containing] A,MAOA,Humans
19024,DB14914,Flortaucipir F-18,"['approved', 'investigational']",BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
19025,DB14917,Ceralasertib,['investigational'],BE0010060,Serine/threonine-protein kinase ATR,ATR,Humans
19026,DB14921,Mavacamten,"['approved', 'investigational']",BE0004294,Myosin-7,MYH7,Humans
19027,DB14922,Tislelizumab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19028,DB14962,Trastuzumab deruxtecan,"['approved', 'investigational']",BE0000710,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,Humans
19029,DB14962,Trastuzumab deruxtecan,"['approved', 'investigational']",BE0000971,DNA topoisomerase 1,TOP1,Humans
19030,DB14967,Margetuximab,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
19031,DB14973,Abrocitinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
19032,DB14973,Abrocitinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
19033,DB14973,Abrocitinib,"['approved', 'investigational']",BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
19034,DB14973,Abrocitinib,"['approved', 'investigational']",BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
19035,DB14975,Voxelotor,"['approved', 'investigational']",BE0000130,Hemoglobin subunit alpha,HBA1,Humans
19037,DB14989,Umbralisib,"['approved', 'investigational', 'withdrawn']",BE0003512,Casein kinase I isoform epsilon,CSNK1E,Humans
19038,DB14989,Umbralisib,"['approved', 'investigational', 'withdrawn']",BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,Humans
19039,DB14989,Umbralisib,"['approved', 'investigational', 'withdrawn']",BE0000014,Tyrosine-protein kinase ABL1,ABL1,Humans
19040,DB14996,Sutimlimab,"['approved', 'investigational']",BE0001529,Complement C1s subcomponent,C1S,Humans
19041,DB14999,Human interferon beta,"['approved', 'investigational']",BE0000661,Interferon alpha/beta receptor 1,IFNAR1,Humans
19042,DB15001,Eflapegrastim,"['approved', 'investigational']",BE0000793,Granulocyte colony-stimulating factor receptor,CSF3R,Humans
19044,DB15011,Avacopan,"['approved', 'investigational']",BE0010095,C5a anaphylatoxin chemotactic receptor 1,C5AR1,Humans
19045,DB15031,Daridorexant,['approved'],BE0005864,Orexin receptor type 1,HCRTR1,Humans
19046,DB15031,Daridorexant,['approved'],BE0005865,Orexin receptor type 2,HCRTR2,Humans
19047,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19048,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
19049,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0000511,Receptor tyrosine-protein kinase erbB-2,ERBB2,Humans
19050,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0004772,Receptor tyrosine-protein kinase erbB-4,ERBB4,Humans
19051,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0001341,Tyrosine-protein kinase ITK/TSK,ITK,Humans
19052,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0009416,Cytoplasmic tyrosine-protein kinase BMX,BMX,Humans
19053,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
19054,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0009385,Tyrosine-protein kinase Tec,TEC,Humans
19055,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0009413,Tyrosine-protein kinase Blk,BLK,Humans
19056,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0003493,Tyrosine-protein kinase JAK3,JAK3,Humans
19057,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0004731,Protein-tyrosine kinase 6,PTK6,Humans
19058,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0005539,Tyrosine-protein kinase Fgr,FGR,Humans
19059,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0004742,Tyrosine-protein kinase FRK,FRK,Humans
19060,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
19061,DB15035,Zanubrutinib,"['approved', 'investigational']",BE0009403,Tyrosine-protein kinase TXK,TXK,Humans
19062,DB15043,Toripalimab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19063,DB15044,Tafasitamab,"['approved', 'investigational']",BE0003496,B-lymphocyte antigen CD19,CD19,Humans
19065,DB15067,Volanesorsen,"['approved', 'investigational']",BE0008880,Apolipoprotein C-III,APOC3,Humans
19066,DB15071,Omidenepag isopropyl,"['approved', 'investigational']",BE0000368,Prostaglandin E2 receptor EP2 subtype,PTGER2,Humans
19067,DB15071,Omidenepag isopropyl,"['approved', 'investigational']",BE0000064,Prostaglandin E2 receptor EP1 subtype,PTGER1,Humans
19068,DB15090,Tezepelumab,"['approved', 'investigational']",BE0010181,Thymic stromal lymphopoietin,TSLP,Humans
19069,DB15091,Upadacitinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
19070,DB15093,Somapacitan,"['approved', 'investigational']",BE0000075,Growth hormone receptor,GHR,Humans
19071,DB15100,Cusatuzumab,['investigational'],BE0010130,CD70 antigen,CD70,Humans
19072,DB15102,Pemigatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
19073,DB15102,Pemigatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
19074,DB15102,Pemigatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
19075,DB15102,Pemigatinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
19076,DB15119,Ropeginterferon alfa-2b,"['approved', 'investigational']",BE0010136,Interferon alpha/beta receptor (IFNAR),IFNAR1,Humans
19077,DB15133,Tepotinib,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
19078,DB15133,Tepotinib,"['approved', 'investigational']",BE0003580,Nischarin,NISCH,Humans
19079,DB15133,Tepotinib,"['approved', 'investigational']",BE0000327,Melatonin receptor type 1B,MTNR1B,Humans
19080,DB15149,Futibatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
19081,DB15149,Futibatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
19082,DB15149,Futibatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
19083,DB15149,Futibatinib,"['approved', 'investigational']",BE0001203,Fibroblast growth factor receptor 4,FGFR4,Humans
19084,DB15163,Selatogrel,['investigational'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
19085,DB15170,Evobrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19086,DB15171,Tirzepatide,"['approved', 'investigational']",BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
19087,DB15171,Tirzepatide,"['approved', 'investigational']",BE0010190,Gastric inhibitory polypeptide,GIP,Humans
19088,DB15226,Dasiglucagon,"['approved', 'investigational']",BE0000527,Glucagon receptor,GCGR,Humans
19089,DB15227,Tirabrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19091,DB15233,Avapritinib,"['approved', 'investigational']",BE0000453,Mast/stem cell growth factor receptor Kit,KIT,Humans
19092,DB15248,Bulevirtide,"['approved', 'investigational']",BE0003644,Sodium/bile acid cotransporter,SLC10A1,Humans
19093,DB15250,Vercirnon,['investigational'],BE0002463,C-C chemokine receptor type 9,CCR9,Humans
19095,DB15270,Efgartigimod alfa,"['approved', 'investigational']",BE0010182,IgG receptor FcRn large subunit p51,FCGRT,Humans
19096,DB15271,Crizanlizumab,"['approved', 'investigational']",BE0001159,P-selectin,SELP,Humans
19097,DB15283,Tebentafusp,"['approved', 'investigational']",BE0010187,Melanocyte protein PMEL,PMEL,Humans
19098,DB15303,Faricimab,"['approved', 'investigational']",BE0000163,Vascular endothelial growth factor A,VEGFA,Humans
19099,DB15303,Faricimab,"['approved', 'investigational']",BE0010028,Angiopoietin-2,ANGPT2,Humans
19100,DB15327,Abivertinib,['investigational'],BE0000767,Epidermal growth factor receptor,EGFR,Humans
19101,DB15327,Abivertinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19102,DB15328,Ubrogepant,"['approved', 'investigational']",BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
19103,DB15347,Branebrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19104,DB15354,Evinacumab,"['approved', 'investigational']",BE0010034,Angiopoietin-related protein 3,ANGPTL3,Humans
19105,DB15399,BMS-754807,['investigational'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
19106,DB15399,BMS-754807,['investigational'],BE0000033,Insulin receptor,INSR,Humans
19107,DB15406,GLPG-0974,['investigational'],BE0010131,Free fatty acid receptor 2,FFAR2,Humans
19108,DB15413,Pafolacianine,"['approved', 'investigational']",BE0003405,Folate receptor alpha,FOLR1,Humans
19109,DB15434,Mosunetuzumab,"['approved', 'investigational']",BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
19110,DB15434,Mosunetuzumab,"['approved', 'investigational']",BE0000274,T-cell surface glycoprotein CD3 epsilon chain,CD3E,Humans
19111,DB15442,Trilaciclib,"['approved', 'investigational']",BE0002216,Cyclin-dependent kinase 4,CDK4,Humans
19112,DB15442,Trilaciclib,"['approved', 'investigational']",BE0002212,Cyclin-dependent kinase 6,CDK6,Humans
19113,DB15442,Trilaciclib,"['approved', 'investigational']",BE0002207,Cyclin-dependent kinase 9,CDK9,Humans
19114,DB15442,Trilaciclib,"['approved', 'investigational']",BE0001072,Cyclin-dependent kinase 2,CDK2,Humans
19115,DB15442,Trilaciclib,"['approved', 'investigational']",BE0000890,Cyclin-dependent kinase 5,CDK5,Humans
19116,DB15442,Trilaciclib,"['approved', 'investigational']",BE0001913,Cyclin-dependent kinase 7,CDK7,Humans
19117,DB15444,Elexacaftor,"['approved', 'investigational']",BE0001195,Cystic fibrosis transmembrane conductance regulator,CFTR,Humans
19119,DB15463,Belzutifan,"['approved', 'investigational']",BE0009679,Endothelial PAS domain-containing protein 1,EPAS1,Humans
19121,DB15488,Echinacoside,['experimental'],BE0003383,Growth hormone secretagogue receptor type 1,GHSR,Humans
19122,DB15488,Echinacoside,['experimental'],BE0000132,Androgen receptor,AR,Humans
19123,DB15489,Mexazolam,['experimental'],BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,Humans
19124,DB15489,Mexazolam,['experimental'],BE0004797,GABA(A) Receptor,GABRA1,Humans
19125,DB15493,Cambinol,['experimental'],BE0002461,NAD-dependent protein deacetylase sirtuin-1,SIRT1,Humans
19126,DB15493,Cambinol,['experimental'],BE0009759,NAD-dependent protein deacetylase sirtuin-2,SIRT2,Humans
19127,DB15493,Cambinol,['experimental'],BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,Humans
19128,DB15494,Edotreotide gallium Ga-68,['approved'],BE0003528,Somatostatin receptor type 2,SSTR2,Humans
19129,DB15494,Edotreotide gallium Ga-68,['approved'],BE0002147,Somatostatin receptor type 5,SSTR5,Humans
19130,DB15494,Edotreotide gallium Ga-68,['approved'],BE0003529,Somatostatin receptor type 3,SSTR3,Humans
19131,DB15494,Edotreotide gallium Ga-68,['approved'],BE0000452,Somatostatin receptor type 1,SSTR1,Humans
19132,DB15495,Rocaglamide,['experimental'],BE0009786,Prohibitin,PHB,Humans
19133,DB15495,Rocaglamide,['experimental'],BE0009007,Prohibitin-2,PHB2,Humans
19134,DB15496,Didesmethylrocaglamide,['experimental'],BE0009786,Prohibitin,PHB,Humans
19135,DB15496,Didesmethylrocaglamide,['experimental'],BE0009007,Prohibitin-2,PHB2,Humans
19136,DB15498,BOS172722,['experimental'],BE0003791,Dual specificity protein kinase TTK,TTK,Humans
19137,DB15534,Colchiceine,"['approved', 'experimental']",BE0000143,Tubulin beta chain,TUBB,Humans
19138,DB15534,Colchiceine,"['approved', 'experimental']",BE0001340,Tubulin alpha-1A chain,TUBA1A,Humans
19139,DB15565,Cilazaprilat,['experimental'],BE0000221,Angiotensin-converting enzyme,ACE,Humans
19140,DB15566,Prednisolone acetate,"['approved', 'vet_approved']",BE0000794,Glucocorticoid receptor,NR3C1,Humans
19141,DB15568,Adagrasib,"['approved', 'investigational']",BE0004071,GTPase KRas,KRAS,Humans
19142,DB15569,Sotorasib,"['approved', 'investigational']",BE0004071,GTPase KRas,KRAS,Humans
19143,DB15570,FLX475,['investigational'],BE0009787,C-C chemokine receptor type 4,CCR4,Humans
19144,DB15588,Ursolic acid,['experimental'],BE0001076,GTPase HRas,HRAS,Humans
19145,DB15588,Ursolic acid,['experimental'],BE0000394,Neutrophil elastase,ELANE,Humans
19146,DB15593,Golodirsen,['approved'],BE0009794,Dystrophin,DMD,Humans
19148,DB15598,Ferric maltol,['approved'],BE0001155,Integrin beta-3,ITGB3,Humans
19149,DB15598,Ferric maltol,['approved'],BE0008685,Natural resistance-associated macrophage protein 2,SLC11A2,Humans
19150,DB15599,MIV-711,['investigational'],BE0003417,Cathepsin K,CTSK,Humans
19151,DB15617,Ferric derisomaltose,['approved'],BE0000130,Hemoglobin subunit alpha,HBA1,Humans
19152,DB15617,Ferric derisomaltose,['approved'],BE0004850,Transferrin receptor,TFRC,Humans
19154,DB15624,Halicin,['experimental'],BE0009865,c-Jun N-terminal kinases,MAPK10,Humans
19155,DB15626,Spesolimab,"['approved', 'investigational']",BE0010198,Interleukin-1 receptor-like 2,IL1RL2,Humans
19156,DB15627,Dostarlimab,"['approved', 'investigational']",BE0003436,Programmed cell death protein 1,PDCD1,Humans
19157,DB15628,Inolimomab,['investigational'],BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
19158,DB15635,Omburtamab,['investigational'],BE0010140,CD276 antigen,CD276,Humans
19159,DB15636,Zilucoplan,['investigational'],BE0000855,Complement C5,C5,Humans
19160,DB15643,N-(2-Aminoethyl)-1-aziridineethanamine,['experimental'],BE0000982,Angiotensin-converting enzyme 2,ACE2,Humans
19161,DB15647,Ketodarolutamide,['experimental'],BE0000132,Androgen receptor,AR,Humans
19162,DB15650,Efpeglenatide,['investigational'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
19163,DB15665,SEP-363856,['investigational'],BE0001044,Trace amine-associated receptor 1,TAAR1,Humans
19164,DB15665,SEP-363856,['investigational'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
19166,DB15685,Selpercatinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
19167,DB15685,Selpercatinib,"['approved', 'investigational']",BE0000029,Vascular endothelial growth factor receptor 1,FLT1,Humans
19168,DB15685,Selpercatinib,"['approved', 'investigational']",BE0000023,Vascular endothelial growth factor receptor 3,FLT4,Humans
19169,DB15685,Selpercatinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
19170,DB15685,Selpercatinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
19171,DB15685,Selpercatinib,"['approved', 'investigational']",BE0002133,Fibroblast growth factor receptor 3,FGFR3,Humans
19174,DB15688,Zavegepant,['investigational'],BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
19175,DB15690,Fluoroestradiol F-18,['approved'],BE0000123,Estrogen receptor alpha,ESR1,Humans
19176,DB15690,Fluoroestradiol F-18,['approved'],BE0000792,Estrogen receptor beta,ESR2,Humans
19178,DB15694,Cedazuridine,"['approved', 'investigational']",BE0002443,Cytidine deaminase,CDA,Humans
19179,DB15699,Brexucabtagene autoleucel,['approved'],BE0003496,B-lymphocyte antigen CD19,CD19,Humans
19181,DB15719,Belantamab mafodotin,['approved'],BE0010010,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,Humans
19182,DB15762,Satralizumab,['approved'],BE0002859,Interleukin-6 receptor subunit alpha,IL6R,Humans
19183,DB15765,Sintilimab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19184,DB15766,Retifanlimab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19185,DB15767,AMP-224,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19186,DB15768,MEDI0680,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19187,DB15769,Envafolimab,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
19188,DB15770,Cosibelimab,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
19189,DB15771,AUNP-12,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
19190,DB15772,CA-170,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
19191,DB15773,anti-OX40 antibody BMS 986178,['investigational'],BE0003441,Programmed cell death 1 ligand 1,CD274,Humans
19192,DB15791,MK-0668,['experimental'],BE0010014,VLA-4 (very late antigen-4),ITGA4,Humans
19203,DB15822,Pralsetinib,"['approved', 'investigational']",BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,Humans
19204,DB15822,Pralsetinib,"['approved', 'investigational']",BE0001124,Epithelial discoidin domain-containing receptor 1,DDR1,Humans
19205,DB15822,Pralsetinib,"['approved', 'investigational']",BE0009501,NT-3 growth factor receptor,NTRK3,Humans
19206,DB15822,Pralsetinib,"['approved', 'investigational']",BE0000147,Receptor-type tyrosine-protein kinase FLT3,FLT3,Humans
19207,DB15822,Pralsetinib,"['approved', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
19208,DB15822,Pralsetinib,"['approved', 'investigational']",BE0002408,Tyrosine-protein kinase JAK2,JAK2,Humans
19209,DB15822,Pralsetinib,"['approved', 'investigational']",BE0001039,High affinity nerve growth factor receptor,NTRK1,Humans
19210,DB15822,Pralsetinib,"['approved', 'investigational']",BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
19211,DB15822,Pralsetinib,"['approved', 'investigational']",BE0000205,Platelet-derived growth factor receptor beta,PDGFRB,Humans
19212,DB15822,Pralsetinib,"['approved', 'investigational']",BE0002131,Fibroblast growth factor receptor 1,FGFR1,Humans
19213,DB15822,Pralsetinib,"['approved', 'investigational']",BE0000748,Fibroblast growth factor receptor 2,FGFR2,Humans
19214,DB15873,Copper oxodotreotide Cu-64,['approved'],BE0003528,Somatostatin receptor type 2,SSTR2,Humans
19220,DB15935,Lumasiran,"['approved', 'investigational']",BE0003766,Hydroxyacid oxidase 1,HAO1,Humans
19224,DB15982,Berotralstat,['approved'],BE0002440,Plasma kallikrein,KLKB1,Humans
19225,DB16007,Rurioctocog alfa pegol,"['approved', 'experimental']",BE0001043,von Willebrand factor,VWF,Humans
19226,DB16007,Rurioctocog alfa pegol,"['approved', 'experimental']",BE0000016,Coagulation factor VIII,F8,Humans
19227,DB16019,Gallium Ga-68 gozetotide,['approved'],BE0008983,Prostate-specific antigen,KLK3,Humans
19228,DB16098,Atogepant,"['approved', 'investigational']",BE0009009,Calcitonin gene-related peptide type 1 receptor,CALCRL,Humans
19229,DB16099,Avalglucosidase alfa,"['approved', 'investigational']",BE0003623,Cation-independent mannose-6-phosphate receptor,IGF2R,Humans
19230,DB16165,Finerenone,"['approved', 'investigational']",BE0000668,Mineralocorticoid receptor,NR3C2,Humans
19231,DB16220,Lonapegsomatropin,"['approved', 'investigational']",BE0000075,Growth hormone receptor,GHR,Humans
19232,DB16220,Lonapegsomatropin,"['approved', 'investigational']",BE0000345,Prolactin receptor,PRLR,Humans
19233,DB16222,Loncastuximab tesirine,"['approved', 'investigational']",BE0003496,B-lymphocyte antigen CD19,CD19,Humans
19234,DB16226,Maralixibat,"['approved', 'investigational']",BE0003643,Ileal sodium/bile acid cotransporter,SLC10A2,Humans
19235,DB16236,Mitapivat,"['approved', 'investigational']",BE0000046,Pyruvate kinase PKLR,PKLR,Humans
19236,DB16236,Mitapivat,"['approved', 'investigational']",BE0002090,Cytochrome P450 19A1,CYP19A1,Humans
19237,DB16255,Nidufexor,['investigational'],BE0001777,Bile acid receptor,NR1H4,Humans
19241,DB16261,Odevixibat,"['approved', 'investigational']",BE0003643,Ileal sodium/bile acid cotransporter,SLC10A2,Humans
19242,DB16265,Olinvacimab,['investigational'],BE0000369,Vascular endothelial growth factor receptor 2,KDR,Humans
19243,DB16266,Olodanrigan,['investigational'],BE0003426,Type-2 angiotensin II receptor,AGTR2,Humans
19244,DB16267,Olutasidenib,"['approved', 'investigational']",BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,Humans
19245,DB16275,Otlertuzumab,['investigational'],BE0010072,Leukocyte antigen CD37,CD37,Humans
19246,DB16279,Pecavaptan,['investigational'],BE0000165,Vasopressin V1a receptor,AVPR1A,Humans
19247,DB16279,Pecavaptan,['investigational'],BE0000293,Vasopressin V2 receptor,AVPR2,Humans
19248,DB16309,Revusiran,['investigational'],BE0000337,Transthyretin,TTR,Humans
19249,DB16315,Rivenprost,['investigational'],BE0003522,Prostaglandin E2 receptor EP4 subtype,PTGER4,Humans
19250,DB16315,Rivenprost,['investigational'],BE0010100,Prostaglandin E2 Receptors,PTGER1,Humans
19251,DB16318,Romilkimab,['investigational'],BE0002438,Interleukin-13,IL13,Humans
19252,DB16318,Romilkimab,['investigational'],BE0003520,Interleukin-4,IL4,Humans
19253,DB16321,S-777469,['investigational'],BE0000095,Cannabinoid receptor 2,CNR2,Humans
19254,DB16324,Selgantolimod,['investigational'],BE0003518,Toll-like receptor 8,TLR8,Humans
19255,DB16341,Tilsotolimod,['investigational'],BE0001171,Toll-like receptor 9,TLR9,Humans
19256,DB16343,Tropifexor,['investigational'],BE0001777,Bile acid receptor,NR1H4,Humans
19257,DB16346,Veliflapon,['investigational'],BE0002382,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,Humans
19258,DB16349,Vicagrel,['investigational'],BE0000110,P2Y purinoceptor 12,P2RY12,Humans
19259,DB16351,Volinanserin,['investigational'],BE0000451,5-hydroxytryptamine receptor 2A,HTR2A,Humans
19260,DB16353,Razuprotafib,['investigational'],BE0003769,Receptor-type tyrosine-protein phosphatase beta,PTPRB,Humans
19262,DB16370,Mezagitamab,['investigational'],BE0005459,ADP-ribosyl cyclase 1,CD38,Humans
19263,DB16379,Garetosmab,['investigational'],BE0010139,Inhibin beta A chain,INHBA,Humans
19265,DB16390,Mobocertinib,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
19269,DB16407,Azvudine,['investigational'],BE0001067,ATP-binding cassette sub-family G member 2,ABCG2,Humans
19270,DB16407,Azvudine,['investigational'],BE0001069,Canalicular multispecific organic anion transporter 1,ABCC2,Humans
19271,DB16407,Azvudine,['investigational'],BE0001032,P-glycoprotein 1,ABCB1,Humans
19272,DB16411,Camidanlumab tesirine,['investigational'],BE0000658,Interleukin-2 receptor subunit alpha,IL2RA,Humans
19273,DB16416,Vilobelimab,['investigational'],BE0000855,Complement C5,C5,Humans
19274,DB16417,Geptanolimab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19275,DB16418,Narsoplimab,['investigational'],BE0004630,Mannan-binding lectin serine protease 2,MASP2,Humans
19276,DB16446,Vafidemstat,['investigational'],BE0002196,Amine oxidase [flavin-containing] B,MAOB,Humans
19277,DB16446,Vafidemstat,['investigational'],BE0010091,Lysine-specific histone demethylase 1A,KDM1A,Humans
19278,DB16453,ATYR1923,['investigational'],BE0010030,Neuropilin-2,NRP2,Humans
19279,DB16474,Pam2csk4,['investigational'],BE0010079,Toll-like receptor 6,TLR6,Humans
19280,DB16474,Pam2csk4,['investigational'],BE0001164,Toll-like receptor 2,TLR2,Humans
19282,DB16515,PLN-74809,['investigational'],BE0003576,Integrin alpha-V,ITGAV,Humans
19283,DB16515,PLN-74809,['investigational'],BE0003575,Integrin beta-1,ITGB1,Humans
19284,DB16515,PLN-74809,['investigational'],BE0010033,Integrin beta-6,ITGB6,Humans
19286,DB16580,Afimetoran,['investigational'],BE0000155,Toll-like receptor 7,TLR7,Humans
19287,DB16580,Afimetoran,['investigational'],BE0003518,Toll-like receptor 8,TLR8,Humans
19288,DB16582,Lisocabtagene maraleucel,['approved'],BE0003496,B-lymphocyte antigen CD19,CD19,Humans
19290,DB16628,Fosdenopterin,['approved'],BE0010045,Molybdopterin synthase catalytic subunit,MOCS2,Humans
19291,DB16629,Serdexmethylphenidate,['approved'],BE0000647,Sodium-dependent dopamine transporter,SLC6A3,Humans
19292,DB16629,Serdexmethylphenidate,['approved'],BE0000486,Sodium-dependent noradrenaline transporter,SLC6A2,Humans
19293,DB16629,Serdexmethylphenidate,['approved'],BE0000291,5-hydroxytryptamine receptor 1A,HTR1A,Humans
19294,DB16630,OPB-111077,['investigational'],BE0003462,Signal transducer and activator of transcription 3,STAT3,Humans
19295,DB16637,KW-2450 free base,['experimental'],BE0000033,Insulin receptor,INSR,Humans
19296,DB16637,KW-2450 free base,['experimental'],BE0000858,Insulin-like growth factor 1 receptor,IGF1R,Humans
19297,DB16640,Almonertinib,['investigational'],BE0010047,Receptor protein-tyrosine kinase,EGFR,Humans
19298,DB16650,Deucravacitinib,"['approved', 'investigational']",BE0004146,Non-receptor tyrosine-protein kinase TYK2,TYK2,Humans
19299,DB16652,Avotaciclib,['investigational'],BE0001082,Cyclin-dependent kinase 1,CDK1,Humans
19300,DB16655,Teclistamab,"['approved', 'investigational']",BE0010202,T-cell surface glycoprotein CD3,CD3D,Humans
19301,DB16655,Teclistamab,"['approved', 'investigational']",BE0010010,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,Humans
19302,DB16656,Zotiraciclib,['investigational'],BE0002207,Cyclin-dependent kinase 9,CDK9,Humans
19303,DB16656,Zotiraciclib,['investigational'],BE0000839,Tyrosine-protein kinase Fyn,FYN,Humans
19304,DB16656,Zotiraciclib,['investigational'],BE0000842,Tyrosine-protein kinase Lck,LCK,Humans
19305,DB16657,Vecabrutinib,['investigational'],BE0001284,Tyrosine-protein kinase BTK,BTK,Humans
19306,DB16665,Idecabtagene vicleucel,['approved'],BE0010010,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,Humans
19307,DB16668,Budigalimab,['investigational'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19308,DB16684,Odronextamab,['investigational'],BE0000066,B-lymphocyte antigen CD20,MS4A1,Humans
19309,DB16684,Odronextamab,['investigational'],BE0010202,T-cell surface glycoprotein CD3,CD3D,Humans
19310,DB16690,Tegoprazan,['investigational'],BE0010055,Sodium/Potassium Transporting ATPase subunits,ATP1A1,Humans
19312,DB16694,Pegcetacoplan,['approved'],BE0003455,Complement C3,C3,Humans
19313,DB16695,Amivantamab,"['approved', 'investigational']",BE0000767,Epidermal growth factor receptor,EGFR,Humans
19314,DB16695,Amivantamab,"['approved', 'investigational']",BE0000915,Hepatocyte growth factor receptor,MET,Humans
19315,DB16695,Amivantamab,"['approved', 'investigational']",BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,Humans
19316,DB16697,Glutazumab,['investigational'],BE0000857,Glucagon-like peptide 1 receptor,GLP1R,Humans
19317,DB16698,Neihulizumab,['investigational'],BE0010069,P-selectin glycoprotein ligand 1,SELPLG,Humans
19319,DB16703,Belumosudil,"['approved', 'investigational']",BE0004191,Rho-associated protein kinase 2,ROCK2,Humans
19320,DB16703,Belumosudil,"['approved', 'investigational']",BE0001016,Rho-associated protein kinase 1,ROCK1,Humans
19321,DB16707,Gavorestat,['investigational'],BE0000747,Aldose reductase,AKR1B1,Humans
19322,DB16732,Tisotumab vedotin,['approved'],BE0001178,Tissue factor,F3,Humans
19323,DB16733,Rimtuzalcap,['investigational'],BE0004425,Small conductance calcium-activated potassium channel protein 1,KCNN1,Humans
19324,DB16733,Rimtuzalcap,['investigational'],BE0004426,Small conductance calcium-activated potassium channel protein 2,KCNN2,Humans
19325,DB16733,Rimtuzalcap,['investigational'],BE0004427,Small conductance calcium-activated potassium channel protein 3,KCNN3,Humans
19326,DB16737,MM3122,['experimental'],BE0009920,Transmembrane protease serine 2,TMPRSS2,Humans
19327,DB16738,Ciltacabtagene autoleucel,"['approved', 'investigational']",BE0010010,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,Humans
19328,DB16739,MK-886,['experimental'],BE0002382,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,Humans
19329,DB16740,Prolgolimab,['experimental'],BE0003436,Programmed cell death protein 1,PDCD1,Humans
19330,DB16754,TPMPA,['experimental'],BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,Humans
19331,DB16754,TPMPA,['experimental'],BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,Humans
19332,DB16754,TPMPA,['experimental'],BE0003619,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,Humans
19334,DB16756,Ivarmacitinib,"['experimental', 'investigational']",BE0004145,Tyrosine-protein kinase JAK1,JAK1,Humans
19335,DB16778,Lutetium Lu-177 vipivotide tetraxetan,['approved'],BE0008983,Prostate-specific antigen,KLK3,Humans
19336,DB16820,Letibotulinumtoxina,['approved'],BE0000390,Synaptosomal-associated protein 25,SNAP25,Humans
19337,DB16862,Indigo,"['experimental', 'investigational']",BE0003721,Aryl hydrocarbon receptor,AHR,Humans
19339,DB17080,KW-6356,['experimental'],BE0000924,Adenosine receptor A2a,ADORA2A,Humans
19340,DB17083,Linzagolix,['approved'],BE0000203,Gonadotropin-releasing hormone receptor,GNRHR,Humans
19341,DB17087,JNJ-17216498,['investigational'],BE0000968,Histamine H3 receptor,HRH3,Humans
